Citrus Sinensis ID: 039392
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 285 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.992 | 0.280 | 0.447 | 1e-66 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 1.0 | 0.278 | 0.432 | 2e-62 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.929 | 0.257 | 0.444 | 1e-57 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.982 | 0.285 | 0.379 | 3e-50 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.968 | 0.235 | 0.358 | 1e-44 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.929 | 0.285 | 0.379 | 6e-44 | |
| O49564 | 642 | Cysteine-rich receptor-li | no | no | 0.926 | 0.411 | 0.370 | 2e-43 | |
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.919 | 0.443 | 0.378 | 2e-43 | |
| C0LGR6 | 913 | Probable LRR receptor-lik | no | no | 0.929 | 0.290 | 0.365 | 2e-43 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.943 | 0.395 | 0.342 | 6e-43 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 253 bits (646), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 136/304 (44%), Positives = 189/304 (62%), Gaps = 21/304 (6%)
Query: 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII 59
GFS +N++G G FG+V+KA L + VAVKV N+Q KSF ECE +K I HRN++
Sbjct: 701 GFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLV 760
Query: 60 KVISSCSN-----EEFKALVLEYMPHGSLEKYLHS--------SNYILDIYQRLNIMIDV 106
K++++CS+ EF+AL+ E+MP+GSL+ +LH + L + +RLNI IDV
Sbjct: 761 KLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDV 820
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ----- 161
AS L+YLH + HCDLKPSNVLLDD++ AH+SDFG+A+LL + D + Q
Sbjct: 821 ASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAG 880
Query: 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
TIGY APEYG G+ S NGDVYSFGI+L+E FT K+PT+E+F G TL + LP
Sbjct: 881 VRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALP 940
Query: 222 ISTKEIVDPNLLS-REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
+IVD ++L + F E C++ VF V + C ESP R+ +V +L+ IR+
Sbjct: 941 ERILDIVDESILHIGLRVGFPVVE-CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRE 999
Query: 281 SLLR 284
+
Sbjct: 1000 RFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 132/305 (43%), Positives = 182/305 (59%), Gaps = 20/305 (6%)
Query: 1 GFSENNLIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII 59
GFS +NLIG G FG+VFK LG VA+KV NL KSF ECE + I HRN++
Sbjct: 718 GFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLV 777
Query: 60 KVISSCSNEEF-----KALVLEYMPHGSLEKYLH--------SSNYILDIYQRLNIMIDV 106
K+++ CS+ +F +ALV E+MP+G+L+ +LH + + L ++ RLNI IDV
Sbjct: 778 KLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDV 837
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ----- 161
AS L YLH + HCD+KPSN+LLD ++ AH+SDFG+A+LL + D T Q
Sbjct: 838 ASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAG 897
Query: 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
TIGY APEYG G S GDVYSFGI+L+E FT K+PT+++F +TL + L
Sbjct: 898 VRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQ 957
Query: 222 ISTK-EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
+I D +L +C++ VF V + C+ ESP RI+ E ++KLV IR+
Sbjct: 958 KRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRE 1017
Query: 281 SLLRN 285
S R+
Sbjct: 1018 SFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (568), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 133/299 (44%), Positives = 173/299 (57%), Gaps = 34/299 (11%)
Query: 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
FS NLIG G FG+VFK LG + VAVKV NL KSF ECE K I HRN++K
Sbjct: 712 FSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVK 771
Query: 61 VISSCSN-----EEFKALVLEYMPHGSLEKYL----------HSSNYILDIYQRLNIMID 105
+I+ CS+ +F+ALV E+MP GSL+ +L HS + L ++LNI ID
Sbjct: 772 LITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRS--LTPAEKLNIAID 829
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ---- 161
VAS LEYLH V HCD+KPSN+LLDD++ AH+SDFG+A+LL + D + Q
Sbjct: 830 VASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSA 889
Query: 162 -TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL 220
TIGY APEYG G+ S GDVYSFGI+L+E F+ KKPTDE F G+ L +
Sbjct: 890 GVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSY----- 944
Query: 221 PISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
TK I+ S A ++ + V V ++C+ E P R+ E V +L+ IR
Sbjct: 945 ---TKSILSGCTSSGGS---NAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (505), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 115/303 (37%), Positives = 177/303 (58%), Gaps = 23/303 (7%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFK-SFDVECEMMKSIHHRNII 59
GF+ ++LIG G FG V+K L + +VAVKV + + F SF EC+++K HRN+I
Sbjct: 660 GFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLI 719
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI---LDIYQRLNIMIDVASTLEYLHFG 116
++I++CS F ALVL MP+GSLE++L+ Y LD+ Q +NI DVA + YLH
Sbjct: 720 RIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHY 779
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--------TREDISTIQTQTL--ATI 166
+V+HCDLKPSN+LLDD M A ++DFGI++L+ T + +S T L ++
Sbjct: 780 SPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSV 839
Query: 167 GYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226
GY+APEYG R S +GDVYSFG++L+E + ++PTD + N +L ++ P S +
Sbjct: 840 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEG 899
Query: 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAME-------CTVESPEQRINAKEIVTKLVKIR 279
I++ LSR E+C V +E CT +P R + ++ ++ +++
Sbjct: 900 IIE-QALSRWKPQG-KPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLK 957
Query: 280 DSL 282
+ L
Sbjct: 958 EYL 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 104/290 (35%), Positives = 175/290 (60%), Gaps = 14/290 (4%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNII 59
F+ N+IG +V+K +L DG +AVKV NL+ K F E + + + HRN++
Sbjct: 870 FNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLV 929
Query: 60 KVIS-SCSNEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASTLEYLHFGY 117
K++ + + + KALVL +M +G+LE +H S+ I + +++++ + +AS ++YLH GY
Sbjct: 930 KILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGY 989
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDISTIQTQTL--ATIGYMAPEYG 174
++HCDLKP+N+LLD + VAH+SDFG A++L RED ST + + TIGY+APE+
Sbjct: 990 GFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFA 1049
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPT--DEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232
+V+ DV+SFGI+++E T+++PT ++ + +MTL+ V + K +V +
Sbjct: 1050 YMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMV--RV 1107
Query: 233 LSRE---DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
L E I + +E+ + + + CT PE R + EI+T L+K+R
Sbjct: 1108 LDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 106/279 (37%), Positives = 157/279 (56%), Gaps = 14/279 (5%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
+GRG FGSV+ R+ DG EVAVK+ + + F E ++ IHHRN++ +I C
Sbjct: 612 VGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEE 671
Query: 68 EEFKALVLEYMPHGSLEKYLH-SSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
+ + LV EYM +GSL +LH SS+Y LD RL I D A LEYLH G + +IH D
Sbjct: 672 ADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRD 731
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
+K SN+LLD NM A +SDFG+++ T ED++ + + T+GY+ PEY +++ DV
Sbjct: 732 VKSSNILLDINMRAKVSDFGLSR-QTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDV 790
Query: 186 YSFGIMLIETFTRKKP-TDEIFNGEMTLKHWVNDWLPIS-TKEIVDPNLLSREDIHFVAK 243
YSFG++L E + KKP + E F E+ + HW + I+DP + S I V +
Sbjct: 791 YSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIASNVKIESVWR 850
Query: 244 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
V VA +C + R +E++ V I+D++
Sbjct: 851 ------VAEVANQCVEQRGHNRPRMQEVI---VAIQDAI 880
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 176 bits (446), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 104/281 (37%), Positives = 157/281 (55%), Gaps = 17/281 (6%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
FS N IG GGFG V+K L DG+E+AVK ++ G+ F E +M + H+N++K+
Sbjct: 333 FSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHSGQGNAEFKTEVLLMTKLQHKNLVKL 392
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSS--NYILDIYQRLNIMIDVASTLEYLHFGYSA 119
E + LV E++P+ SL+++L LD +R NI++ V+ L YLH G
Sbjct: 393 FGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYNIIVGVSRGLLYLHEGSEF 452
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+IH DLK SNVLLD+ M+ +SDFG+A+ ++ + + + T GYMAPEY GR
Sbjct: 453 PIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRRVVGTYGYMAPEYAMHGRF 512
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEIFNGEMT---LKHWVNDWLPISTKEIVDPNLLSRE 236
S DVYSFG++++E T K+ + + GE T W N W+ ++ E++DP LL
Sbjct: 513 SVKTDVYSFGVLVLEIITGKRNSG-LGLGEGTDLPTFAWQN-WIEGTSMELIDPVLLQTH 570
Query: 237 DIHFVAKE--QCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
D KE QC+ +A+ C E+P +R +V+ L
Sbjct: 571 D----KKESMQCL----EIALSCVQENPTKRPTMDSVVSML 603
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (445), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 106/280 (37%), Positives = 161/280 (57%), Gaps = 18/280 (6%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVK-VFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
+E ++IG GGFG+V+K + DG A+K + L G + F+ E E++ SI HR ++
Sbjct: 306 LNEEHIIGCGGFGTVYKLAMDDGKVFALKRILKLNEG-FDRFFERELEILGSIKHRYLVN 364
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ C++ K L+ +Y+P GSL++ LH LD R+NI+I A L YLH S +
Sbjct: 365 LRGYCNSPTSKLLLYDYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPR 424
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
+IH D+K SN+LLD N+ A +SDFG+AKLL E+ S I T T GY+APEY + GR +
Sbjct: 425 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-SHITTIVAGTFGYLAPEYMQSGRAT 483
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIF-----NGEMTLKHWVNDWLPISTKEIVDPNLLSR 235
DVYSFG++++E + K+PTD F N LK +++ P ++IVDPN
Sbjct: 484 EKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRP---RDIVDPNC--- 537
Query: 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
E + + + + ++A +C SPE+R +V L
Sbjct: 538 EGMQM----ESLDALLSIATQCVSPSPEERPTMHRVVQLL 573
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR6|Y4291_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g29180 OS=Arabidopsis thaliana GN=At4g29180 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 176 bits (445), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 105/287 (36%), Positives = 159/287 (55%), Gaps = 22/287 (7%)
Query: 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFN-------------LQYGRVFKSFDVECEMMK 51
N +IG+GGFG V+ L DG E+AVK+ N +V K F VE E++
Sbjct: 570 NKVIGKGGFGIVYLGSLEDGTEIAVKMINDSSFGKSKGSSSSSSSSQVSKEFQVEAELLL 629
Query: 52 SIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTL 110
++HHRN+ + C + AL+ EYM +G+L+ YL S N L +RL+I ID A L
Sbjct: 630 TVHHRNLASFVGYCDDGRSMALIYEYMANGNLQDYLSSENAEDLSWEKRLHIAIDSAQGL 689
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMA 170
EYLH G ++H D+K +N+LL+DN+ A ++DFG++K+ +D+S + T + T GY+
Sbjct: 690 EYLHHGCRPPIVHRDVKTANILLNDNLEAKIADFGLSKVFPEDDLSHVVTAVMGTPGYVD 749
Query: 171 PEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE-MTLKHWVNDWLPISTKE-IV 228
PEY +++ DVYSFGI+L+E T K+ + +GE M + H+V +L + + +V
Sbjct: 750 PEYYNTFKLNEKSDVYSFGIVLLELITGKRSIMKTDDGEKMNVVHYVEPFLKMGDIDGVV 809
Query: 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
DP L + FV VAM C + R N +IV+ L
Sbjct: 810 DPRLHGD-----FSSNSAWKFV-EVAMSCVRDRGTNRPNTNQIVSDL 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 97/283 (34%), Positives = 158/283 (55%), Gaps = 14/283 (4%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
GFSE NL+G GGFG V+K L DG EVAVK + + + F E E++ +HHR+++
Sbjct: 338 GFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVT 397
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQ-RLNIMIDVASTLEYLHFGYSA 119
++ C +E+ + LV +Y+P+ +L +LH+ + ++ R+ + A + YLH
Sbjct: 398 LVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAARGIAYLHEDCHP 457
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST-IQTQTLATIGYMAPEYGKEGR 178
++IH D+K SN+LLD++ A ++DFG+AK+ D++T + T+ + T GYMAPEY G+
Sbjct: 458 RIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGK 517
Query: 179 VSANGDVYSFGIMLIETFTRKKPTDEIFN-GEMTLKHWVNDWLPISTK-----EIVDPNL 232
+S DVYS+G++L+E T +KP D G+ +L W L + + E+VDP L
Sbjct: 518 LSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRL 577
Query: 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
+F+ E + A C S +R ++V L
Sbjct: 578 ----GKNFIPGEMFR--MVEAAAACVRHSAAKRPKMSQVVRAL 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 285 | ||||||
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.992 | 0.277 | 0.619 | 2e-98 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.975 | 0.255 | 0.612 | 4e-98 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.982 | 0.192 | 0.602 | 3e-95 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.968 | 0.229 | 0.609 | 3e-95 | |
| 359485176 | 1160 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.241 | 0.618 | 3e-95 | |
| 302143440 | 929 | unnamed protein product [Vitis vinifera] | 0.982 | 0.301 | 0.599 | 4e-95 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.971 | 0.261 | 0.591 | 5e-94 | |
| 359483683 | 1228 | PREDICTED: LRR receptor-like serine/thre | 0.985 | 0.228 | 0.593 | 7e-94 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.992 | 0.271 | 0.573 | 1e-93 | |
| 359485449 | 1583 | PREDICTED: LRR receptor-like serine/thre | 0.978 | 0.176 | 0.613 | 3e-93 |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 365 bits (936), Expect = 2e-98, Method: Compositional matrix adjust.
Identities = 176/284 (61%), Positives = 221/284 (77%), Gaps = 1/284 (0%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
F E+NL+G G FGSV++ RL DG+ VAVK+FNLQ R F+SFD ECE+M++I HRN++K+
Sbjct: 731 FHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKI 790
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
I SCSN +FKALVLEYMP GSLEK+L+S NY LDI QR+NIMIDVAS LEYLH GY + V
Sbjct: 791 ICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPV 850
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+HCDLKPSNVLLD++MVAH+ DFGIAKLL E+ S QT+TLATIGYMAPEYG +G VS
Sbjct: 851 VHCDLKPSNVLLDEDMVAHVCDFGIAKLLG-ENESFAQTRTLATIGYMAPEYGLDGLVST 909
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
DVYSFGIML+E TRK+PTDE+F GEM+LK V + LP S +IVD N+L+R D + V
Sbjct: 910 KIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSV 969
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLRN 285
KE CV+ + +A++C ESP +R+ EI+ +L I+ LR+
Sbjct: 970 KKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRD 1013
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 363 bits (933), Expect = 4e-98, Method: Compositional matrix adjust.
Identities = 172/281 (61%), Positives = 218/281 (77%), Gaps = 3/281 (1%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
GFS NL+GRG GSV++ L DG A+KVFNLQ FKSFD ECE+M I HRN+IK
Sbjct: 803 GFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIK 862
Query: 61 VISSCSNE--EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
++SSCSN +FKALVLEY+P+GSLE++L+S NY LDI QRLNIMIDVA +EYLH G S
Sbjct: 863 IVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCS 922
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR 178
V+HCDLKPSN+LLD++ H+ DFGIAKLL RE+ S +TQTLATIGYMAP+Y G
Sbjct: 923 TPVVHCDLKPSNILLDEDFGGHVGDFGIAKLL-REEESIRETQTLATIGYMAPKYVSNGI 981
Query: 179 VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238
V+ +GDVYS+GI+L+ETFTR++PTDEIF+ EM++K+WV DWL S E+VD NLL ED
Sbjct: 982 VTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDE 1041
Query: 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
F+AK+QC+S + +AM+C +SPE+RI K++VT L KI+
Sbjct: 1042 QFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 354 bits (908), Expect = 3e-95, Method: Composition-based stats.
Identities = 170/282 (60%), Positives = 215/282 (76%), Gaps = 2/282 (0%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
F E+NLIG+G V+K L +G+ VAVKVFNL++ F+SFD ECE+M+SI HRN++K+
Sbjct: 1174 FGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKI 1233
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
I+ CSN +FKALVLEYMP GSL+K+L+S NY LD+ QRLNIMIDVAS LEYLH + V
Sbjct: 1234 ITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLV 1293
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+HCDLKP+N+LLDD+MVAH+ DFGIA+LLT E S QT+TL TIGYMAPEYG +G VS
Sbjct: 1294 VHCDLKPNNILLDDDMVAHVGDFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVST 1352
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
GDV+S+GIML+E F RKKP DE+FNG++TLK WV L S E+VD NLL RED F
Sbjct: 1353 KGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWVES-LADSMIEVVDANLLRREDEDFA 1411
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283
K C+S + +A+ CT +SPE+RI+ K++V L KI+ LL
Sbjct: 1412 TKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 354 bits (908), Expect = 3e-95, Method: Compositional matrix adjust.
Identities = 173/284 (60%), Positives = 215/284 (75%), Gaps = 8/284 (2%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
F E+NLIG+G G V+K L DG+ VAVKVFNL+ FKSF+VECE+M++I HRN+ K+
Sbjct: 918 FGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKI 977
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
ISSCSN +FKALVLEYMP+GSLEK+L+S NY LD QRL IMIDVAS LEYLH YS V
Sbjct: 978 ISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPV 1037
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+HCDLKPSNVLLDD+MVAH+SDFGIAKLL + +T+TL T+GYMAPEYG EG VS
Sbjct: 1038 VHCDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMK-RTKTLGTVGYMAPEYGSEGIVST 1096
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK---EIVDPNLLSREDI 238
GD+YS+GI+L+ETF RKKPTDE+F E+TLK WV ST E++D NLL+ ED
Sbjct: 1097 KGDIYSYGILLMETFVRKKPTDEMFVEELTLKSWVES----STNNIMEVIDANLLTEEDE 1152
Query: 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
F K C S + +A++CTVE PE+RIN K++V +L K+ + +
Sbjct: 1153 SFALKRACFSSIMTLALDCTVEPPEKRINTKDVVVRLKKLLNQI 1196
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485176|ref|XP_002280075.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 353 bits (907), Expect = 3e-95, Method: Compositional matrix adjust.
Identities = 175/283 (61%), Positives = 214/283 (75%), Gaps = 3/283 (1%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
F E+N+IG G G V + L DG VAVKVFNL++ FKSFD ECE+M++I HRN++K+
Sbjct: 878 FGEDNMIGTGSLGMVHRGVLSDGSIVAVKVFNLEFQGAFKSFDAECEIMRNIQHRNLVKI 937
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ- 120
ISSCS FKALVLEYMP+GSLEK+L+S NY L++ QRLNIMIDVAS LEYLH +S
Sbjct: 938 ISSCSILNFKALVLEYMPNGSLEKWLYSHNYCLNLVQRLNIMIDVASALEYLHHDFSVNP 997
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
V+HCDLKP+NVLLD+ MVA L DFGI+KLLT + S QT+TL TIGYMAPEYG EG VS
Sbjct: 998 VVHCDLKPNNVLLDEEMVARLGDFGISKLLTETE-SMEQTRTLGTIGYMAPEYGSEGIVS 1056
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240
GDVYS+GIM++ETF RKKPTDE+F GE+TL+ WV + L E+VD NL+ RED HF
Sbjct: 1057 TRGDVYSYGIMMMETFARKKPTDEMFGGEVTLRSWV-ESLAGRVMEVVDGNLVRREDQHF 1115
Query: 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283
KE C+ + +A+ECT ESP RI+ KE+V +L KIR LL
Sbjct: 1116 GIKESCLRSIMALALECTTESPRDRIDMKEVVVRLKKIRIKLL 1158
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143440|emb|CBI22001.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 353 bits (907), Expect = 4e-95, Method: Compositional matrix adjust.
Identities = 169/282 (59%), Positives = 216/282 (76%), Gaps = 2/282 (0%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
F E+NLIG+G V+K L +G+ VAVKVFNL++ F+SFD ECE+M+SI HRN++K+
Sbjct: 649 FGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKI 708
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
I+ CSN +FKALVLEYMP GSL+K+L+S NY LD+ QRLNIMIDVAS LEYLH + V
Sbjct: 709 ITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLV 768
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+HCDLKP+N+LLDD+MVAH+ DFGIA+LLT + S QT+TL TIGYMAPEYG +G VS
Sbjct: 769 VHCDLKPNNILLDDDMVAHVGDFGIARLLTETE-SMQQTKTLGTIGYMAPEYGSDGIVST 827
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
GDV+S+GIML+E F RKKP DE+FNG++TLK WV + L S E+VD NLL RED F
Sbjct: 828 KGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFA 886
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283
K C+S + +A+ CT +SPE+RI+ K++V L KI+ LL
Sbjct: 887 TKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 350 bits (897), Expect = 5e-94, Method: Compositional matrix adjust.
Identities = 165/279 (59%), Positives = 217/279 (77%), Gaps = 2/279 (0%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
GF+E NL+G G GSV+K L DG+ +AVKVF+LQ FD ECE+++ + HRN++K
Sbjct: 770 GFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVK 829
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ISSC N +FKAL+LE++PHGSLEK+L+S NY LDI QRLNIMIDVAS LEYLH G +
Sbjct: 830 IISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRP 889
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
V+HCDLKPSNVL++++MVAH+SDFGI++LL D T QT TLATIGYMAPEYG EG VS
Sbjct: 890 VVHCDLKPSNVLINEDMVAHVSDFGISRLLGEGDAVT-QTLTLATIGYMAPEYGLEGIVS 948
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240
GDVYS+GI L+ETFTRKKPTD++F GEM+LK+WV LP + E++D NLL E+ HF
Sbjct: 949 VKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEE-HF 1007
Query: 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
VAK+ C++ + N+A+EC+ + P +RI ++++ L KI+
Sbjct: 1008 VAKKDCITSILNLALECSADLPGERICMRDVLPALEKIK 1046
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 349 bits (896), Expect = 7e-94, Method: Compositional matrix adjust.
Identities = 168/283 (59%), Positives = 217/283 (76%), Gaps = 2/283 (0%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
GF E+NLIG+G G V+K L +G+ VA+KVFNL++ +SFD ECE+M+ I HRN+I+
Sbjct: 947 GFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIR 1006
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+I+ CSN +FKALVLEYMP GSL+K+L+S NY LD++QRLNIMIDVAS LEYLH S+
Sbjct: 1007 IITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEYLHHDCSSL 1066
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
V+HCDLKPSNVLLD+NMVAH++DFGIA+LLT + S QT+TL TIGYMAPEYG +G VS
Sbjct: 1067 VVHCDLKPSNVLLDNNMVAHVADFGIARLLTETE-SMQQTKTLGTIGYMAPEYGSDGIVS 1125
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240
GDVYS+GI+L+E F RKKP DE+F G++TLK WV + L S E+VD NLL R+D
Sbjct: 1126 TKGDVYSYGILLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVIEVVDANLLRRDDEDL 1184
Query: 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283
K +S + +A+ CT +SPE+RIN K++V +L KI+ LL
Sbjct: 1185 ATKLSYLSSLMALALACTADSPEERINMKDVVVELKKIKIKLL 1227
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 348 bits (894), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 164/286 (57%), Positives = 219/286 (76%), Gaps = 3/286 (1%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
F+E NL+GRG FGSV+K DG VAVKVFNLQ FKSFDVECE+++ I HRN++K+
Sbjct: 757 FNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKI 816
Query: 62 ISSCS--NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
I+SCS N +FKALVLE+MP+ SLEK+L S + L++ +RLNIM+DVAS +EYLH GY+
Sbjct: 817 ITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAM 876
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
++HCDLKPSN+LLD+NMVAH++DFGIAKLL E S IQT TLAT+GYMAPEYG EG V
Sbjct: 877 PIVHCDLKPSNILLDENMVAHVTDFGIAKLLGDEH-SFIQTITLATVGYMAPEYGSEGVV 935
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
S GD+YSFGI+L+ETFTRKKPTD++FN E+++K WV + +P +I DP+LL E+ H
Sbjct: 936 STGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQH 995
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLRN 285
F AK+ C+ V VA++C+ + PE+R N ++++ L + L++
Sbjct: 996 FSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTLNHTKVKFLKD 1041
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485449|ref|XP_002276919.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 347 bits (890), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 173/282 (61%), Positives = 213/282 (75%), Gaps = 3/282 (1%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
FSE NLIG+G G+V+K L DG+ A+KVFNL++ FK F+ ECE+M++I HRN+IK+
Sbjct: 1304 FSEGNLIGKGSMGTVYKGVLFDGLTAAIKVFNLEFLGSFKGFEAECEVMRNIRHRNLIKI 1363
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
ISSCSN FKALVLE+MP+ SLE++L+S NY LD+ QRLNIMIDVAS LEYLH YS V
Sbjct: 1364 ISSCSNLGFKALVLEFMPNRSLERWLYSHNYCLDLIQRLNIMIDVASALEYLHHDYSNPV 1423
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+HCDLKP+NVLLD++ VAH+ DFGIAKLL + S QT+TL IGYMAPEYG EG VS
Sbjct: 1424 VHCDLKPNNVLLDEDRVAHVGDFGIAKLLPGSE-SRQQTKTLGPIGYMAPEYGSEGIVST 1482
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
+ DVYS GIML+E F RKKPTDE+F G+ TLK WV + L + E VD NLL +ED HF
Sbjct: 1483 S-DVYSNGIMLLEVFARKKPTDEMFVGDPTLKSWV-ESLASTVMEFVDTNLLDKEDEHFA 1540
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283
KE CV + +A+ECT ESPE RIN +++V +L KIR LL
Sbjct: 1541 IKENCVLCIMALALECTAESPEDRINMRDVVARLKKIRIKLL 1582
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 285 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.992 | 0.280 | 0.447 | 1.2e-62 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.992 | 0.280 | 0.430 | 7.4e-60 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.992 | 0.279 | 0.427 | 4.4e-59 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 1.0 | 0.278 | 0.432 | 7.1e-57 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.940 | 0.533 | 0.442 | 9.2e-52 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.929 | 0.257 | 0.441 | 2.4e-51 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.814 | 0.226 | 0.417 | 6.7e-48 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.982 | 0.285 | 0.369 | 8.3e-46 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.975 | 0.236 | 0.354 | 1e-42 | |
| TAIR|locus:2058759 | 589 | FEI2 "FEI 2" [Arabidopsis thal | 0.926 | 0.448 | 0.380 | 1.9e-42 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 1.2e-62, Sum P(2) = 1.2e-62
Identities = 136/304 (44%), Positives = 189/304 (62%)
Query: 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII 59
GFS +N++G G FG+V+KA L + VAVKV N+Q KSF ECE +K I HRN++
Sbjct: 701 GFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLV 760
Query: 60 KVISSCSN-----EEFKALVLEYMPHGSLEKYLHSSNY--------ILDIYQRLNIMIDV 106
K++++CS+ EF+AL+ E+MP+GSL+ +LH L + +RLNI IDV
Sbjct: 761 KLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDV 820
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-- 164
AS L+YLH + HCDLKPSNVLLDD++ AH+SDFG+A+LL + D + Q +
Sbjct: 821 ASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAG 880
Query: 165 ---TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
TIGY APEYG G+ S NGDVYSFGI+L+E FT K+PT+E+F G TL + LP
Sbjct: 881 VRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALP 940
Query: 222 ISTKEIVDPNLLSRE-DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
+IVD ++L + F E C++ VF V + C ESP R+ +V +L+ IR+
Sbjct: 941 ERILDIVDESILHIGLRVGFPVVE-CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRE 999
Query: 281 SLLR 284
+
Sbjct: 1000 RFFK 1003
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 620 (223.3 bits), Expect = 7.4e-60, P = 7.4e-60
Identities = 131/304 (43%), Positives = 188/304 (61%)
Query: 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII 59
GFS +N++G G FG+VFKA L + VAVKV N+Q KSF ECE +K I HRN++
Sbjct: 700 GFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLV 759
Query: 60 KVISSCSN-----EEFKALVLEYMPHGSLEKYLHSSNY--------ILDIYQRLNIMIDV 106
K++++C++ EF+AL+ E+MP+GSL+K+LH L + +RLNI IDV
Sbjct: 760 KLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDV 819
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-- 164
AS L+YLH + HCDLKPSN+LLDD++ AH+SDFG+A+LL + D + Q +
Sbjct: 820 ASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAG 879
Query: 165 ---TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
TIGY APEYG G+ S +GDVYSFG++++E FT K+PT+E+F G TL + LP
Sbjct: 880 VRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALP 939
Query: 222 ISTKEIVDPNLL-SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
+I D ++L S + F E C+ + +V + C ESP R+ E +L+ IR+
Sbjct: 940 ERVLDIADKSILHSGLRVGFPVLE-CLKGILDVGLRCCEESPLNRLATSEAAKELISIRE 998
Query: 281 SLLR 284
+
Sbjct: 999 RFFK 1002
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 4.4e-59, P = 4.4e-59
Identities = 130/304 (42%), Positives = 186/304 (61%)
Query: 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII 59
GFS +N++G G FG+VFKA L + VAVKV N+Q KSF ECE +K HRN++
Sbjct: 702 GFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLV 761
Query: 60 KVISSCSN-----EEFKALVLEYMPHGSLEKYLHSSNY--------ILDIYQRLNIMIDV 106
K++++C++ EF+AL+ EY+P+GS++ +LH L + +RLNI+IDV
Sbjct: 762 KLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDV 821
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-- 164
AS L+YLH + HCDLKPSNVLL+D++ AH+SDFG+A+LL + D + Q +
Sbjct: 822 ASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAG 881
Query: 165 ---TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
TIGY APEYG G+ S +GDVYSFG++L+E FT K+PTDE+F G +TL + LP
Sbjct: 882 VRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALP 941
Query: 222 ISTKEIVDPNLLSRE-DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
EI D +L + F E C++ V V + C E P R+ E+ +L+ IR+
Sbjct: 942 EKVFEIADKAILHIGLRVGFRTAE-CLTLVLEVGLRCCEEYPTNRLATSEVAKELISIRE 1000
Query: 281 SLLR 284
+
Sbjct: 1001 RFFK 1004
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 593 (213.8 bits), Expect = 7.1e-57, P = 7.1e-57
Identities = 132/305 (43%), Positives = 182/305 (59%)
Query: 1 GFSENNLIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII 59
GFS +NLIG G FG+VFK LG VA+KV NL KSF ECE + I HRN++
Sbjct: 718 GFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLV 777
Query: 60 KVISSCSNEEF-----KALVLEYMPHGSLEKYLH--------SSNYILDIYQRLNIMIDV 106
K+++ CS+ +F +ALV E+MP+G+L+ +LH + + L ++ RLNI IDV
Sbjct: 778 KLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDV 837
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ----- 161
AS L YLH + HCD+KPSN+LLD ++ AH+SDFG+A+LL + D T Q
Sbjct: 838 ASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAG 897
Query: 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
TIGY APEYG G S GDVYSFGI+L+E FT K+PT+++F +TL + L
Sbjct: 898 VRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQ 957
Query: 222 I-STKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
+I D +L +C++ VF V + C+ ESP RI+ E ++KLV IR+
Sbjct: 958 KRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRE 1017
Query: 281 SLLRN 285
S R+
Sbjct: 1018 SFFRD 1022
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 9.2e-52, P = 9.2e-52
Identities = 132/298 (44%), Positives = 169/298 (56%)
Query: 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII 59
GFS +NLIG G F VFK LG + VAVKV NL KSF ECE K I HRN+
Sbjct: 208 GFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAECESFKGIRHRNLA 267
Query: 60 KVISSCSN-----EEFKALVLEYMPHGSLEKYLH------SSNYI--LDIYQRLNIMIDV 106
K+I+ CS+ +F+ALV E+MP GSL+ +L ++N+ L +++NI IDV
Sbjct: 268 KLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSLTFAEKVNIAIDV 327
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ----- 161
AS LEYLH V HCD+KPSNVLLDD++ AH+SDFG+A+LL D T Q
Sbjct: 328 ASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAG 387
Query: 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
TIGY APEYG + S GDVYSFG++L+E FT KKPTD F G L + L
Sbjct: 388 VRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYNLHGYTKSVLS 447
Query: 222 ISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
ST SR V ++ + V V ++C+ E P R+ E V +LV I+
Sbjct: 448 CST---------SRGGRTMV--DEWLRLVLEVGIKCSEEYPRDRMGMAEAVRELVSIK 494
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 2.4e-51, P = 2.4e-51
Identities = 132/299 (44%), Positives = 174/299 (58%)
Query: 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
FS NLIG G FG+VFK LG + VAVKV NL KSF ECE K I HRN++K
Sbjct: 712 FSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVK 771
Query: 61 VISSCSN-----EEFKALVLEYMPHGSLEKYL----------HSSNYILDIYQRLNIMID 105
+I+ CS+ +F+ALV E+MP GSL+ +L HS + L ++LNI ID
Sbjct: 772 LITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRS--LTPAEKLNIAID 829
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ---- 161
VAS LEYLH V HCD+KPSN+LLDD++ AH+SDFG+A+LL + D + Q
Sbjct: 830 VASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSA 889
Query: 162 -TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL 220
TIGY APEYG G+ S GDVYSFGI+L+E F+ KKPTDE F G+ L +
Sbjct: 890 GVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSY----- 944
Query: 221 PISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
TK I+ S + + ++ + V V ++C+ E P R+ E V +L+ IR
Sbjct: 945 ---TKSILS-GCTSSGGSNAI--DEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 6.7e-48, P = 6.7e-48
Identities = 104/249 (41%), Positives = 159/249 (63%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
GF+ NL+G G FGSV+K +L VAVKV L+ + KSF ECE ++++ HRN++K
Sbjct: 707 GFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVK 766
Query: 61 VISSCSN-----EEFKALVLEYMPHGSLEKYLH------SSNYILDIYQRLNIMIDVAST 109
+++ CS+ +FKA+V ++MP+GSLE ++H + L++++R+ I++DVA
Sbjct: 767 IVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACA 826
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT-----LA 164
L+YLH V+HCD+K SNVLLD +MVAH+ DFG+A++L + S IQ T +
Sbjct: 827 LDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILV-DGTSLIQQSTSSMGFIG 885
Query: 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST 224
TIGY APEYG S +GD+YS+GI+++E T K+PTD F ++ L+ +V L
Sbjct: 886 TIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRV 945
Query: 225 KEIVDPNLL 233
++VD L+
Sbjct: 946 TDVVDTKLI 954
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 8.3e-46, P = 8.3e-46
Identities = 112/303 (36%), Positives = 179/303 (59%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFK-SFDVECEMMKSIHHRNII 59
GF+ ++LIG G FG V+K L + +VAVKV + + F SF EC+++K HRN+I
Sbjct: 660 GFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLI 719
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI---LDIYQRLNIMIDVASTLEYLHFG 116
++I++CS F ALVL MP+GSLE++L+ Y LD+ Q +NI DVA + YLH
Sbjct: 720 RIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHY 779
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDISTIQTQTLAT--------I 166
+V+HCDLKPSN+LLDD M A ++DFGI++L+ E +ST + + + +
Sbjct: 780 SPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSV 839
Query: 167 GYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226
GY+APEYG R S +GDVYSFG++L+E + ++PTD + N +L ++ P S +
Sbjct: 840 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEG 899
Query: 227 IVDPNLLSR-------EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
I++ LSR E + +E + + + + CT +P R + ++ ++ +++
Sbjct: 900 IIE-QALSRWKPQGKPEKCEKLWREVILEMI-ELGLVCTQYNPSTRPDMLDVAHEMGRLK 957
Query: 280 DSL 282
+ L
Sbjct: 958 EYL 960
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 463 (168.0 bits), Expect = 1.0e-42, P = 1.0e-42
Identities = 102/288 (35%), Positives = 174/288 (60%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNII 59
F+ N+IG +V+K +L DG +AVKV NL+ K F E + + + HRN++
Sbjct: 870 FNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLV 929
Query: 60 KVIS-SCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGY 117
K++ + + + KALVL +M +G+LE +H S I + +++++ + +AS ++YLH GY
Sbjct: 930 KILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGY 989
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDISTIQTQTL--ATIGYMAPEYG 174
++HCDLKP+N+LLD + VAH+SDFG A++L RED ST + + TIGY+APE+
Sbjct: 990 GFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFA 1049
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPT--DEIFNGEMTLKHWVNDWLPISTKEIVDP-N 231
+V+ DV+SFGI+++E T+++PT ++ + +MTL+ V + K +V +
Sbjct: 1050 YMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLD 1109
Query: 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
+ + I + +E+ + + + CT PE R + EI+T L+K+R
Sbjct: 1110 MELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
| TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 1.9e-42, P = 1.9e-42
Identities = 105/276 (38%), Positives = 161/276 (58%)
Query: 3 SENNLIGRGGFGSVFKARLGDGMEVAVK-VFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+E ++IG GGFG+V+K + DG A+K + L G + F+ E E++ SI HR ++ +
Sbjct: 305 NEEHIIGCGGFGTVYKLSMDDGNVFALKRIVKLNEG-FDRFFERELEILGSIKHRYLVNL 363
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
C++ K L+ +Y+P GSL++ LH LD R+NI+I A L YLH S ++
Sbjct: 364 RGYCNSPTSKLLLYDYLPGGSLDEALHKRGEQLDWDSRVNIIIGAAKGLAYLHHDCSPRI 423
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
IH D+K SN+LLD N+ A +SDFG+AKLL E+ S I T T GY+APEY + GR +
Sbjct: 424 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-SHITTIVAGTFGYLAPEYMQSGRATE 482
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGE-MTLKHWVNDWLPIS-TKEIVDPNLLSREDIH 239
DVYSFG++++E + K PTD F + + W+N + + KEIVD LS E +
Sbjct: 483 KTDVYSFGVLVLEVLSGKLPTDASFIEKGFNIVGWLNFLISENRAKEIVD---LSCEGV- 538
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
+ + + + ++A +C SP++R +V L
Sbjct: 539 ---ERESLDALLSIATKCVSSSPDERPTMHRVVQLL 571
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XVI000210 | hypothetical protein (1019 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 285 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-40 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-33 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-25 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| COG2334 | 331 | COG2334, COG2334, Putative homoserine kinase type | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-04 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 8e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-51
Identities = 74/269 (27%), Positives = 114/269 (42%), Gaps = 28/269 (10%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHHRNIIKVIS 63
+G G FG V+ AR G VA+KV + + + E +++K + H NI+++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+E+ LV+EY G L L L + + + S LEYLH S ++H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYGKEGRVSAN 182
DLKP N+LLD++ L+DFG+A+ L + T T YMAPE
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLD----PGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 183 GDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVA 242
D++S G++L E T K P F G+ L +S E +
Sbjct: 177 VDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI- 231
Query: 243 KEQCVSFVFNVAMECTVESPEQRINAKEI 271
+ V + PE+R+ A+E
Sbjct: 232 -RKL--LVKD---------PEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 9e-50
Identities = 70/191 (36%), Positives = 106/191 (55%), Gaps = 9/191 (4%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G GGFG+V+ AR G +VA+K+ + + + E E++K ++H NI+K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
+E LV+EY GSL+ L + L + L I++ + LEYLH S +IH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 126 LKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK-EGRVSANG 183
LKP N+LLD DN L+DFG++KLLT ++ + T YMAPE +G S
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 184 DVYSFGIMLIE 194
D++S G++L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-47
Identities = 77/281 (27%), Positives = 124/281 (44%), Gaps = 42/281 (14%)
Query: 8 IGRGGFGSVFKARL-----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG V+K L G +VAVK + F E +MK + H NI+++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ C+ E +V EYMP G L +L L + L + + +A +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+H DL N L+ +N+V +SDFG+++ + +D + I +MAPE K+G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
DV+SFG++L E FT GE P + + E + +
Sbjct: 184 KSDVWSFGVLLWEIFTL---------GEQPY-----------------PGMSNEEVLELL 217
Query: 242 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
E C ++ + ++C PE R E+V L
Sbjct: 218 EDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-47
Identities = 81/269 (30%), Positives = 126/269 (46%), Gaps = 24/269 (8%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISS 64
+G G FG+V+KA+ G G VAVK+ + + ++ E +++ + H NI+++I +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
+++ LV+EY G L YL L + I + + LEYLH S +IH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR-VSANG 183
DLKP N+LLD+N V ++DFG+AK L + S+ T + T YMAPE G
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 184 DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243
DV+S G++L E T K P + L+ P + + S E + K
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 244 EQCVSFVFNVAMECTVESPEQRINAKEIV 272
C + P +R A+EI+
Sbjct: 240 -------------CLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 1e-46
Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 31/278 (11%)
Query: 5 NNLIGRGGFGSVFKARLGD-----GMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNI 58
+G G FG V+K +L +EVAVK + F E +M+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+K++ C+ EE +V+EYM G L YL + L + L+ + +A +EYL S
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR 178
IH DL N L+ +N+V +SDFG+++ L +D + I +MAPE KEG+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAPESLKEGK 179
Query: 179 VSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
++ DV+SFG++L E FT ++P M+ + + + + L +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--------LKNGYRLPQP- 225
Query: 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
C ++++ ++C E PE R E+V L
Sbjct: 226 ------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 8e-44
Identities = 83/285 (29%), Positives = 130/285 (45%), Gaps = 44/285 (15%)
Query: 5 NNLIGRGGFGSVFKARLGDG-----MEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNI 58
+G G FG V+K L +EVAVK + + F E +M+ + H NI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGY 117
+K++ C+ EE +V+EYMP G L YL + L + L+ + +A +EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG 177
S IH DL N L+ +N+V +SDFG+++ L +D I +MAPE KEG
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESLKEG 179
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
+ ++ DV+SFG++L E FT GE + +S E+
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL---------GEE-------PYPGMSNAEV---------- 213
Query: 238 IHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
+ ++ K C ++ + ++C E PE R E+V L
Sbjct: 214 LEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-43
Identities = 83/284 (29%), Positives = 131/284 (46%), Gaps = 37/284 (13%)
Query: 6 NLIGRGGFGSVFKARL----GDGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNIIK 60
+G G FG V+K +L G EVAVK + F E +MK + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSS--------NYILDIYQRLNIMIDVASTLEY 112
++ C+ EE LVLEYM G L YL S L + L+ I +A +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 113 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE 172
L S + +H DL N L+ +++V +SDFG+++ + +D +T I +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 173 YGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231
K+G ++ DV+SFG++L E FT P + N E+ L++ +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY------------LRKGY 224
Query: 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
L + E C ++ + + C PE R E+V +L
Sbjct: 225 RLPK-------PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 4e-40
Identities = 79/278 (28%), Positives = 114/278 (41%), Gaps = 43/278 (15%)
Query: 6 NLIGRGGFGSVFKARLGD-GMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVI 62
L+GRG FGSV+ A D G +AVK L ++ + E ++ S+ H NI++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 63 SSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQRLNI------MIDVASTLEYLH 114
S +EE L LEY+ GSL L + +L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH 118
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG 174
S ++H D+K +N+L+D + V L+DFG AK L + T +MAPE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD--PNL 232
+ D++S G +IE T K P E+ N L I + P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-------IGSSGEPPEIPEH 228
Query: 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
LS E F+ K C P++R A E
Sbjct: 229 LSEEAKDFLRK-------------CLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-34
Identities = 86/296 (29%), Positives = 128/296 (43%), Gaps = 54/296 (18%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNI 58
+G G FG VF D VAVK R K F+ E E++ + H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHENI 70
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-------------YILDIYQRLNIMID 105
+K C+ + +V EYM HG L K+L S L + Q L I +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 106 VASTLEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
+AS + YL HF +H DL N L+ ++V + DFG+++ + D + T
Sbjct: 131 IASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLP 221
+ I +M PE + + DV+SFG++L E FT K+P + N E+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV----------- 233
Query: 222 ISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277
+ I LL R C S V+++ + C P+QRIN K+I +L K
Sbjct: 234 --IECITQGRLLQR-------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-34
Identities = 82/296 (27%), Positives = 126/296 (42%), Gaps = 33/296 (11%)
Query: 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVI 62
+G G FG V+ AR D VA+KV + + + F E +++ S+ H NI+K+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY--QRLNIMIDVASTLEYLHFGYSAQ 120
+E LV+EY+ GSLE L + + L I+ + S LEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 121 VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLA----TIGYMAPEY-- 173
+IH D+KP N+LLD D V L DFG+AKLL ++ + T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 174 -GKEGRVSANGDVYSFGIMLIETFTRKKP---TDEIFNGEMTLKHWVNDWLPISTKEIVD 229
S++ D++S GI L E T P TLK + P +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLRN 285
N E ++ + + P+ R+++ ++ + L +
Sbjct: 242 SN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-34
Identities = 67/196 (34%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG+GGFG V+KAR G EVA+KV L+ + E +++K H NI+K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
++ +V+E+ GSL+ L S+N L Q + ++ LEYLH S +IH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYGKEGRVSANGDV 185
K +N+LL + L DFG++ L+ T T+ T +MAPE D+
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLS----DTKARNTMVGTPYWMAPEVINGKPYDYKADI 180
Query: 186 YSFGIMLIETFTRKKP 201
+S GI IE K P
Sbjct: 181 WSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 37/293 (12%)
Query: 6 NLIGRGGFGSVFKARL-----GDGMEVAVKVFN-LQYGRVFKSFDVECEMMKSIHHRNII 59
+G G FG V R G +VAVK N + F+ E E+++++ H NI+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 60 KVISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
K C ++ L++EY+P GSL YL +++ + L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DISTIQTQTLATIGYMAPEYGKE 176
S + IH DL N+L++ + +SDFG+AK+L + D ++ + I + APE +
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 177 GRVSANGDVYSFGIMLIETFTRKKPTDE----------IFNGEMTLKHWVNDWLPISTKE 226
+ S+ DV+SFG+ L E FT P+ I G+M + +
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE--------- 237
Query: 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
L +E C V+++ C P+ R + +++ + ++R
Sbjct: 238 ------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 5e-33
Identities = 83/274 (30%), Positives = 127/274 (46%), Gaps = 31/274 (11%)
Query: 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFK-SFDVECEMMKSIHHRNIIKVISSC 65
IG+G FG V+K L EVAVK K F E E++K H NI+K+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
++ +V+E +P GSL +L L + + L + +D A+ +EYL S IH D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT----IGYMAPEYGKEGRVSA 181
L N L+ +N V +SDFG ++RE+ I T + I + APE GR ++
Sbjct: 119 LAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
DV+S+GI+L ETF+ G+ N T+E ++
Sbjct: 175 ESDVWSYGILLWETFSL---------GDTPYPGMSNQ----QTRERIESGY------RMP 215
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
A + C ++ + ++C PE R + EI +L
Sbjct: 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-31
Identities = 71/276 (25%), Positives = 126/276 (45%), Gaps = 27/276 (9%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
F+ +G G FG V++ + + VA+K+ + F E + +K + H+++I +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ CS E ++ E M GSL +L S +L + +++ VA + YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
IH DL N+L+ +++V ++DFG+A+L+ +ED+ + + + APE G S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIP-YKWTAPEAASHGTFS 182
Query: 181 ANGDVYSFGIMLIETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
DV+SFGI+L E FT + P + N E+ + +P K
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAK-------------- 228
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
C ++ + +EC PE R + K + +L
Sbjct: 229 ------CPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-30
Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 14/195 (7%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V+ +VAVK L+ G + ++F E ++MK + H ++++ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMID----VASTLEYLHFGYSAQVI 122
EE +V EYM GSL +L S RL ++D +A + YL S I
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSAN 182
H DL N+L+ +N+V ++DFG+A+L+ +D T + I + APE GR +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 183 GDVYSFGIMLIETFT 197
DV+SFGI+L E T
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 1e-28
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNL------QYGRVFKSFDVECEMMKSIHHRNI 58
IG+G FG V+ R DG +K +L + E +++K ++H NI
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY---QRLNIMIDVASTLEYLHF 115
IK S + +V+EY G L + + + Q L+ + + L+YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYG 174
S +++H D+KP N+ L N + L DFGI+K+L+ + +T+ T Y++PE
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---TVDLAKTVVGTPYYLSPELC 175
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
+ + D++S G +L E T K P F GE
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 8 IGRGGFGSVFKAR------LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG VF A D M VAVK K F E E++ ++ H +I+K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHS---------------SNYILDIYQRLNIMIDV 106
C + + +V EYM HG L K+L + + L + Q L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI 166
AS + YL S +H DL N L+ N++ + DFG+++ + D + T+ I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 167 GYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226
+M PE + + DV+SFG++L E FT K W +S E
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK----------------QPWFQLSNTE 233
Query: 227 IVD----PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
+++ +L R + C V+++ + C P+QR+N KEI
Sbjct: 234 VIECITQGRVLERPRV-------CPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 68/261 (26%), Positives = 109/261 (41%), Gaps = 40/261 (15%)
Query: 7 LIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECE---MMKSIHHRNIIKV 61
+IG G F +V A+ E A+K+ + + + K V+ E + + H IIK+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ +EE VLEY P+G L +Y+ LD ++ LEYLH S +
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLH---SKGI 123
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG-------------- 167
IH DLKP N+LLD +M ++DFG AK+L I
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 168 ----YMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223
Y++PE E + D+++ G ++ + T K P F G N++L
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRG-------SNEYLTF- 231
Query: 224 TKEIVDPNLLSREDIHFVAKE 244
++I+ + AK+
Sbjct: 232 -QKILKLEYSFPPNFPPDAKD 251
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-27
Identities = 80/281 (28%), Positives = 125/281 (44%), Gaps = 46/281 (16%)
Query: 7 LIGRGGFGSVFKARLGD--GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS 64
IG+G FG V LGD G +VAVK ++F E +M ++ H N+++++
Sbjct: 13 TIGKGEFGDVM---LGDYRGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+V EYM GSL YL S ++ + Q+L +DV +EYL +H
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
DL NVL+ +++VA +SDFG+AK + S Q + + APE +E + S
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 184 DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV-- 241
DV+SFGI+L E ++ + + I K++V H
Sbjct: 181 DVWSFGILLWEIYSFGR----------------VPYPRIPLKDVVP---------HVEKG 215
Query: 242 ----AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
A E C V+ V +C P +R K++ +L I
Sbjct: 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 79/271 (29%), Positives = 116/271 (42%), Gaps = 33/271 (12%)
Query: 8 IGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG G G V+KA G EVA+K L+ + + E +MK H NI+ S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +V+EYM GSL + + ++ Q + +V LEYLH S VIH D+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI-G---YMAPEYGKEGRVSAN 182
K N+LL + L+DFG A LT+E ++ G +MAPE K
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKE------KSKRNSVVGTPYWMAPEVIKRKDYGPK 196
Query: 183 GDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVA 242
D++S GIM IE + P L +P + +P S E F+
Sbjct: 197 VDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP----PLKNPEKWSPEFKDFLN 251
Query: 243 KEQCVSFVFNVAMECTVESPEQRINAKEIVT 273
K C V+ PE+R +A+E++
Sbjct: 252 K-------------CLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 6 NLIGRGGFGSVFKA-RLGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVI 62
+LIGRG FG V+K L G VA+K +L+ KS E +++K++ H NI+K I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASTLEYL 113
S + ++LEY +GSL + + + Y+ YQ V L YL
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV---YQ-------VLQGLAYL 115
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173
H VIH D+K +N+L + V L+DFG+A L + T +MAPE
Sbjct: 116 H---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEV 170
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKP 201
+ S D++S G +IE T P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 8/192 (4%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V++ + VAVK L+ G + K F E ++MK + H +I++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
EE +V E M +GSL +YL L + Q +++ VAS + YL + IH D
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
L NVL+ +N + ++DFG+A+++ +EDI + I + APE R S DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 186 YSFGIMLIETFT 197
+SFGI+L E T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 67/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFK-SFDVECEMMKSIHHRNIIKVISSC 65
L+G+G FG VFK L D VAVK + K F E ++K H NI+K+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
+ + +V+E +P G +L L Q + +D A+ + YL S IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT--IGYMAPEYGKEGRVSANG 183
L N L+ +N V +SDFG+++ +ED + L I + APE GR S+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 184 DVYSFGIMLIETFT 197
DV+S+GI+L ETF+
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-27
Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 35/218 (16%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV----ECEMMKSIHHRNIIK-- 60
IG G +G V+KAR G VA+K ++ + + F + E ++++ + H NI++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 61 --VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
V S + +V EYM H L L S Q M + L+YLH S
Sbjct: 65 EIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---S 118
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE------ 172
++H D+K SN+L++++ V L+DFG+A+ T+ S T + T+ Y PE
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGAT 177
Query: 173 -YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
YG E V D++S G +L E F KP IF G
Sbjct: 178 RYGPE--V----DMWSVGCILAELFL-GKP---IFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 74/290 (25%), Positives = 136/290 (46%), Gaps = 44/290 (15%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIK 60
+G G FG V+K L +V + L+ +V + F E E+M + H NI+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSN-------------YILDIYQRLNIMID 105
++ C+ E+ ++ EY+ HG L ++L +S + LD L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165
+A+ +EYL S +H DL N L+ + + +SDFG+++ + D +Q+++L
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225
+ +M PE G+ + D++SFG++L E F+ + + + S +
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS----------------YGLQPYYGFSNQ 233
Query: 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
E+++ + R E C + V+ + +EC E P +R K+I T+L
Sbjct: 234 EVIE---MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-26
Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 44/289 (15%)
Query: 8 IGRGGFGSVFKARLG------DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG VF A D M VAVK + F E E++ + H++I++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSN---YILD-----------IYQRLNIMIDVA 107
C+ +V EYM HG L ++L S IL + Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG 167
S + YL S +H DL N L+ +V + DFG+++ + D + +T+ I
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 168 YMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKE 226
+M PE + + D++SFG++L E FT K+P W +S E
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-----------------WYQLSNTE 232
Query: 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
++ RE C V+ + C P+QR+ K+I ++L
Sbjct: 233 AIECITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 9e-26
Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 8 IGRGGFGSVFKARLGD-----GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
+G+G FG V R D M+V K ++ V + E ++ I+H I+K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ EE LVLEY P G L +L + R ++ LEYLH S +I
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGII 115
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYGKEGRVSA 181
+ DLKP N+LLD + L+DFG+AK L+ E +T T T Y+APE
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 182 NGDVYSFGIMLIETFTRKKP-----TDEIFN 207
D +S G++L E T K P EI+
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 85/295 (28%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 7 LIGRGGFGSVFKAR---LGD--GMEVAVKVFNLQYGRV--FKSFDVECEMMKSIHHRNII 59
+G+G FGSV R L D G VAVK LQ+ + F+ E E++KS+ H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 60 K---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
K V S + LV+EY+P+GSL YL LD + L + +EYL
Sbjct: 69 KYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-- 125
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DISTIQTQTLATIGYMAPEYGK 175
S + +H DL N+L++ + DFG+ K+L ++ + ++ + I + APE
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 176 EGRVSANGDVYSFGIMLIETFT----RKKPTDEIF-------NGEMTLKHWVNDWLPIST 224
E + S DV+SFG++L E FT P E G+M + H +
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE------- 237
Query: 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
L + + A C + ++ + EC P QR + E+ ++ IR
Sbjct: 238 --------LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-25
Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 34/276 (12%)
Query: 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNIIKVISSC 65
IGRG FG VF RL D VAVK K+ F E ++K H NI+++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
+ ++ +V+E + G +L + L + + + ++ + A+ +EYL S IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT----LATIGYMAPEYGKEGRVSA 181
L N L+ + V +SDFG ++RE+ + T + + APE GR S+
Sbjct: 120 LAARNCLVTEKNVLKISDFG----MSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 182 NGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240
DV+SFGI+L E F+ P + N + T+E ++ + +
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAIE------QGVRL 215
Query: 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276
E C V+ + C P QR + + +L
Sbjct: 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 4e-24
Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 53/280 (18%)
Query: 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHHRNIIKVISSC 65
+G+G G V+K R G A+K ++ F K E + ++S ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 66 SNEEFK----ALVLEYMPHGSLEKYLHSSNYILDIYQRLN---------IMIDVASTLEY 112
+K ++VLEYM GSL D+ +++ I + L+Y
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGLDY 114
Query: 113 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT-LATIGYMAP 171
LH +IH D+KPSN+L++ ++DFGI+K+L + Q T + T+ YM+P
Sbjct: 115 LH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN---TLDQCNTFVGTVTYMSP 169
Query: 172 EYGKEGRVSANGDVYSFGIMLIETFTRKKP-TDEIFNGEMTLKHWVNDWLPISTKEIVDP 230
E + S D++S G+ L+E K P L + D P S +
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS----LPA 225
Query: 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
S E F++ C + P++R +A E
Sbjct: 226 EEFSPEFRDFISA-------------CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-24
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 6 NLIGRGGFGSVFKAR----LGDGME---VAVKVFNLQYGRV---FKSFDVECEMMKSIHH 55
N +G G FG V++ LG G VAVK L+ G K F E +M + +H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNH 58
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY------ILDIYQRLNIMIDVA-- 107
NI+K++ C E + +++E M G L YL + +L + + L+I +DVA
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 108 -STLEYLHFGYSAQVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTREDISTIQTQ 161
LE +HF IH DL N L+ D + V + DFG+A+ + + D + +
Sbjct: 119 CVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172
Query: 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
L + +MAPE +G+ + DV+SFG+++ E T
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-23
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 8 IGRGGFGSVFKAR---LGDG--MEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKV 61
+G G FG+V+K G+ + VA+KV + K E +M S+ H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ C + + L+ + MP G L Y+ + + LN + +A + YL ++
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+H DL NVL+ ++DFG+AKLL ++ I +MA E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 182 NGDVYSFGIMLIETFT-RKKPTDEI 205
DV+S+G+ + E T KP + I
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-23
Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 17/194 (8%)
Query: 8 IGRGGFGSVFKARLGD--GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
IG+G FG V LGD G +VAVK ++ ++F E +M + H N+++++
Sbjct: 14 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 66 SNEEFKA-LVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
E+ +V EYM GSL YL S +L L +DV +EYL + +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
DL NVL+ ++ VA +SDFG LT+E ST T L + + APE +E + S
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLP-VKWTAPEALREKKFSTKS 180
Query: 184 DVYSFGIMLIETFT 197
DV+SFGI+L E ++
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 3e-23
Identities = 57/191 (29%), Positives = 105/191 (54%), Gaps = 13/191 (6%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
IG G FG+V + G +VAVK N++ ++F E +M +HH+N+++++ +
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 68 EEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+V+E M G+L +L + ++ + Q L +DVA +EYL S +++H DL
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
N+L+ ++ VA +SDFG+A++ + + + + APE K + S+ DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 187 SFGIMLIETFT 197
S+G++L E F+
Sbjct: 182 SYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-23
Identities = 74/292 (25%), Positives = 136/292 (46%), Gaps = 48/292 (16%)
Query: 8 IGRGGFGSVFKARLG-DGME----VAVKVF-NLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G FG ++K L GM+ VA+K ++ + + F E +M +HH NI+ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYL-----HSS-----------NYILDIYQRLNIMID 105
+ + E+ ++ EY+ G L ++L HS LD L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 106 VASTLEYL--HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163
+A+ +EYL HF +H DL N+L+ + + +SD G+++ + D +Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223
I +M PE G+ S++ D++SFG++L E F+ + + S
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS----------------FGLQPYYGFS 231
Query: 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
+E+++ + R+ E C ++++ EC E P +R K+I T+L
Sbjct: 232 NQEVIE---MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-23
Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 6 NLIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS 64
+ +G G +G V++ + VAVK V + F E +MK I H N+++++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
C+ E ++ E+M +G+L YL N ++ L + ++S +EYL IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
DL N L+ +N + ++DFG+++L+T D T I + APE + S
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 184 DVYSFGIMLIETFT 197
DV++FG++L E T
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 5e-23
Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 8 IGRGGFGSVFKARL-----GDGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNIIKV 61
+G G FG V G G VAVK + G+ S + E ++K+++H NI+K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 62 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
CS + K L++EY+P GSL YL L++ Q L + + YLH S
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDISTIQTQTLATIGYMAPEYGKEGR 178
IH DL NVLLD++ + + DFG+AK + + ++ + + + A E KE +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 179 VSANGDVYSFGIMLIETFTRKKP 201
S DV+SFG+ L E T
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 8e-23
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 6/204 (2%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
IG G FG V+ + +VA+K + + F E ++M + H ++++ C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 68 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLK 127
LV E+M HG L YL + L + +DV + YL S+ VIH DL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127
Query: 128 PSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 187
N L+ +N V +SDFG+ + + +D T T T + + +PE + S+ DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 188 FGIMLIETFTR-KKPTDEIFNGEM 210
FG+++ E F+ K P + N E+
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 1e-22
Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG VF A D + VAVK K F E E++ ++ H +I+K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYIL----------DIYQRLNIMIDVAST 109
C + +V EYM HG L K+L H + +L Q L+I +A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
+ YL S +H DL N L+ +N++ + DFG+++ + D + T+ I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 170 APEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229
PE + + DV+S G++L E FT K W +S E+++
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK----------------QPWYQLSNNEVIE 233
Query: 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
R C V+++ + C P R+N KEI + L
Sbjct: 234 CITQGRV---LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-22
Identities = 77/268 (28%), Positives = 122/268 (45%), Gaps = 53/268 (19%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKS-FDV-----ECEMMKSIHHRNI 58
IG G +G V A G +VA+K + VF D E ++++ + H NI
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKIS----NVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 59 IK---VISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL 113
I ++ S E+F + V E M L K + S + D + + + + L+YL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDISTIQTQTLATIGYMAPE 172
H SA VIH DLKPSN+L++ N + DFG+A+ + ED T+ + T Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 173 -------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225
Y K D++S G + E TR KP +F G + +++
Sbjct: 177 LLLSSSRYTK------AIDIWSVGCIFAELLTR-KP---LFPG----RDYIDQL-----N 217
Query: 226 EIVDPNLL---SREDIHFVAKEQCVSFV 250
IV+ +L S ED+ F+ E+ +++
Sbjct: 218 LIVE--VLGTPSEEDLKFITSEKARNYL 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-22
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 8/204 (3%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V + ++VA+K+ ++ G + + F E ++M + H N++++ C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKM--IREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +V EYM +G L YL L L++ DV +EYL S IH DL
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDL 126
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
N L+ ++ V +SDFG+A+ + +D T T + + PE R S+ DV+
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 187 SFGIMLIETFTRKK-PTDEIFNGE 209
SFG+++ E F+ K P + N E
Sbjct: 186 SFGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 74/282 (26%), Positives = 127/282 (45%), Gaps = 37/282 (13%)
Query: 4 ENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
E N+I RG G+ +K + + +GM+ VK N + S + M + H NI+K+I
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLI 749
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
C +E+ L+ EY+ +L + L + L +R I I +A L +LH S V+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSAN 182
+L P +++D HL + LL + I + Y+APE + ++
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEK 858
Query: 183 GDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW---------VNDWLPISTKEIVDPNLL 233
D+Y FG++LIE T K P D F ++ W ++ W +DP++
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW--------IDPSIR 910
Query: 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
++ + + V V N+A+ CT P R A +++ L
Sbjct: 911 GDVSVN---QNEIVE-VMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-22
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 8/196 (4%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNL-QYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G G G V K G +AVK L + K E +++ + I+ +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
N ++ +EYM GSL+K L + I + V L YLH + ++IH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRD 126
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
+KPSN+L++ L DFG++ L ++++ + T YMAPE + S D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKTFVGTSSYMAPERIQGNDYSVKSDI 182
Query: 186 YSFGIMLIETFTRKKP 201
+S G+ LIE T + P
Sbjct: 183 WSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 3e-22
Identities = 79/304 (25%), Positives = 123/304 (40%), Gaps = 76/304 (25%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNIIKVISS 64
+G G +G V+KAR G VA+K L + + E ++K + H NI+K++
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
E LV EY L+KYL L +IM + L Y H S +++H
Sbjct: 67 IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ--TQTLATIGYMAPE-------YGK 175
DLKP N+L++ + V L+DFG+A+ ++ T + T+ Y APE Y
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFG----IPLRTYTHEVVTLWYRAPEILLGSKHYST 178
Query: 176 EGRVSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTLKHW 215
V D++S G + E T K PT+E + G L +
Sbjct: 179 A--V----DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 216 VND---WLPISTKEIV---DPN---LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI 266
+ P ++++ DP LLS+ +N P +RI
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSK------------MLQYN---------PAKRI 271
Query: 267 NAKE 270
+AKE
Sbjct: 272 SAKE 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-22
Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 45/295 (15%)
Query: 7 LIGRGGFGSVFKARLGD------GMEVAVKVFNLQ-YGRVFKSFDVECEMMKSI-HHRNI 58
+G G FG V KA VAVK+ + E EMMK I H+NI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHS-------SNYILDIYQRLNIMI------- 104
I ++ C+ E +V+EY HG+L +L + ++ +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 105 -DVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163
VA +E+L S + IH DL NVL+ ++ V ++DFG+A+ + D T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223
+ +MAPE + + DV+SFG++L E FT G + + I
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------LGG--------SPYPGIP 239
Query: 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+E+ L +E + C ++++ +C E P QR K++V L ++
Sbjct: 240 VEELFK---LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-22
Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 1 GFSENNLIGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDV--ECEMMKSIHHRN 57
F +G+G +GSV+K RL D A+K +L + D E ++ S++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 58 IIKVISSCSNEEF-----KALVLEYMPHGSLEKYLHSSNYILDIYQR---LNIMIDVAST 109
II E F +V+EY P G L K + + I I +
Sbjct: 61 II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
L+ LH +++H DLK +N+LL N + + D GI+K+L + + +TQ T YM
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK---NMAKTQI-GTPHYM 168
Query: 170 APEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
APE K S D++S G +L E T P F
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-22
Identities = 62/206 (30%), Positives = 109/206 (52%), Gaps = 10/206 (4%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHHRNIIKVISSCS 66
+G+G FG V+ VA+K L+ G + ++F E ++MK + H ++++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 67 NEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
EE +V EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 72 -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
L+ +N+L+ +N+V ++DFG+A+L+ + + Q I + APE GR + DV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 186 YSFGIMLIETFTRKK-PTDEIFNGEM 210
+SFGI+L E T+ + P + N E+
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 4e-22
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 8 IGRGGFGSVFKAR---LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKV 61
I +G +G VF A+ GD A+KV + E +++ ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
S ++ LV+EY+P G L L + LD + ++ LEYLH S +
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGI 114
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKL------LTREDISTIQTQTLATIGYMAPE--- 172
IH DLKP N+L+D N L+DFG++K+ + D + + T Y+APE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 173 ---YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
+ K D +S G +L E P F+GE
Sbjct: 175 GQGHSKT------VDWWSLGCILYEFLVGIPP----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 6e-22
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 33/203 (16%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG G +G V+KAR + G VA+KV L+ G F+ E M+K H NI+ S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN----------IMIDVASTLEYLHFG 116
+ +V+EY GSL+ DIYQ + + L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT--LATIGYMAPEYG 174
IH D+K +N+LL ++ L+DFG++ LT TI + + T +MAPE
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA----TIAKRKSFIGTPYWMAPEVA 173
Query: 175 ---KEGRVSANGDVYSFGIMLIE 194
++G D+++ GI IE
Sbjct: 174 AVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 6e-22
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEV-AVKVFN----LQYGRVFKSFDVECEMMKSIHH 55
F +IG+G FG V + D ++ A+K N ++ G V + E +++ ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNH 59
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
++ + S +EE LV++ + G L +Y S Q + ++ LEYLH
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLH- 117
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK 175
S +IH D+KP N+LLD+ H++DF IA +T + ++ T T T GYMAPE
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLC 172
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKP 201
S D +S G+ E K+P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-21
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNL-QYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
IG G V+ A L + +VA+K +L + E + M +H N++K +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+ LV+ Y+ GSL + SS LD ++ +V LEYLH S IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125
Query: 124 CDLKPSNVLLDDNMVAHLSDFGI-AKLLTREDISTIQTQTLA-TIGYMAPEYGKEGR-VS 180
D+K N+LL ++ ++DFG+ A L D + +T T +MAPE ++
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 181 ANGDVYSFGIMLIETFTRKKP 201
D++SFGI IE T P
Sbjct: 186 FKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-21
Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 28/271 (10%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFK-SFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V + +VA+K+ ++ G + + F E ++M + H ++++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +V EYM +G L YL Q L + DV + YL S Q IH DL
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDL 126
Query: 127 KPSNVLLDDNMVAHLSDFGIAK-LLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
N L+DD +SDFG+++ +L E S++ ++ + + PE + S+ DV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLLYSKFSSKSDV 184
Query: 186 YSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQ 245
++FG+++ E ++ K E FN T++ + P+L S +
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFNNSETVEK------VSQGLRLYRPHLASEK--------- 229
Query: 246 CVSFVFNVAMECTVESPEQRINAKEIVTKLV 276
V+ + C E E+R +++++ +
Sbjct: 230 ----VYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 6 NLIGRGGFGSVFKARL---GDGMEVAVKVFNLQYGRV--FKSFDVECEMM-KSIHHRNII 59
++IG G FG V +A + G M A+K+ ++ + F E E++ K HH NII
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMI 104
++ +C N + + +EY P+G+L +L H + L Q L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 105 DVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164
DVA+ ++YL Q IH DL NVL+ +N+ + ++DFG+++ E++ +T
Sbjct: 127 DVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIE 194
+ +MA E + DV+SFG++L E
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-21
Identities = 80/280 (28%), Positives = 117/280 (41%), Gaps = 46/280 (16%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
F +G G +GSV+KA G VA+KV ++ + E ++K I+K
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
S +V+EY GS+ + +N L + I+ LEYLH S +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA----TIG---YMAPEY 173
IH D+K N+LL++ A L+DFG +S T T+A IG +MAPE
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFG---------VSGQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK---EIVDP 230
+E + D++S GI IE K P +I H + I K + DP
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDI--------HPMRAIFMIPNKPPPTLSDP 222
Query: 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
S E FV K C V+ PE+R +A +
Sbjct: 223 EKWSPEFNDFVKK-------------CLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 6 NLIGRGGFGSVFKARL-GDG--MEVAVKVFNLQYGRV--FKSFDVECEMMKSI-HHRNII 59
++IG G FG V KAR+ DG M+ A+K +Y + F E E++ + HH NII
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMI 104
++ +C + + L +EY PHG+L +L +S+ L Q L+
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 105 DVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164
DVA ++YL Q IH DL N+L+ +N VA ++DFG+++ +++ +T
Sbjct: 132 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 185
Query: 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIE 194
+ +MA E + N DV+S+G++L E
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-21
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 7 LIGRGGFGSVFKARLG----DGMEVAVKVFNLQYG---------RVFKSFDVECEMMKSI 53
LIG G FGSV+ LG G +AVK L + + E ++K +
Sbjct: 7 LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 54 HHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL 113
H NI++ + S + + + LEY+P GS+ L++ + R N + + L YL
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYL 122
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST---IQTQTL-ATIGYM 169
H + +IH D+K +N+L+D+ +SDFGI+K L +ST +L ++ +M
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 170 APEYGKEGRVSANGDVYSFGIMLIETFTRKKP 201
APE K+ + D++S G +++E T K P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-21
Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 27/230 (11%)
Query: 2 FSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQYGRVFKSFDVE-----CEMMKS 52
F+ ++G+G FGSV +A+L G +VAVK+ +F S D+E MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKE 57
Query: 53 IHHRNIIKVISSCSNEEFKA------LVLEYMPHGSLEKYLHSSN-----YILDIYQRLN 101
H N+IK+I K ++L +M HG L +L S + L + +
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 102 IMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161
MID+AS +EYL S IH DL N +L++NM ++DFG++K + D
Sbjct: 118 FMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEM 210
+ + ++A E + + + DV++FG+ + E TR + P + N E+
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-21
Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 41/290 (14%)
Query: 7 LIGRGGFGSVFKARL----GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIK 60
++G G FGSV + +L G ++VAVK L + F E MK H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 61 VISSC----SNEEFKA--LVLEYMPHGSLEKYLHSSN-----YILDIYQRLNIMIDVAST 109
+I C S ++ ++L +M HG L +L S L + L M+D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
+EYL + IH DL N +L ++M ++DFG++K + D + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 170 APEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228
A E + ++ DV++FG+ + E TR + P + N E+ D+L
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY------DYL-------- 228
Query: 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
R E C+ ++++ C P+ R ++ L I
Sbjct: 229 ------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-21
Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 30/283 (10%)
Query: 3 SENNLIGRGGFGSVFKA--RLGDGMEVAVKVFNLQYGRVFKS---FDVECEMMKSIHHRN 57
++ +IG G FG VF+ ++ EVAV + L+ G K F E +M H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
II++ + + ++ EYM +G+L+KYL + YQ + ++ +A+ ++YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ-TLATIGYMAPEYGKE 176
+H DL N+L++ N+ +SDFG++++L + T T I + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 177 GRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235
+ ++ DV+SFGI++ E + ++P ++ N E+ K I
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-------------MKAI-------N 224
Query: 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+ A C S V+ + ++C + +R +IV L K+
Sbjct: 225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 6e-21
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 6 NLIGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNIIKVI 62
N IG G FG V+ A L G +AVK +Q K E ++++ + H N++K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD--IYQRLNIMIDVASTLEYLHFGYSAQ 120
+ E + +EY G+LE+ L ILD + + + + L YLH S
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEG--LAYLH---SHG 119
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED--ISTIQTQTLATIGYMAPEYGKEGR 178
++H D+KP+N+ LD N V L DFG A L + T YMAPE G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 179 VSANG---DVYSFGIMLIETFTRKKP 201
+G D++S G +++E T K+P
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-20
Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 10/206 (4%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHHRNIIKVISSCS 66
+G+G FG V+ +VA+K L+ G + ++F E ++MK + H ++ + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTL-EYLHFGYSAQVIHCD 125
EE +V E+M GSL +L + Y +L ++D+A+ + + + + IH D
Sbjct: 72 -EEPIYIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
L+ +N+L+ DN+V ++DFG+A+L+ + + Q I + APE GR + DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 186 YSFGIMLIETFTRKK-PTDEIFNGEM 210
+SFGI+L E T+ + P + N E+
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-20
Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V+ +VAVK L+ G + +SF E ++MK + H ++++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
E +V EYM GSL +L L + +++ VA+ + Y+ IH D
Sbjct: 72 EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
L+ +N+L+ D +V ++DFG+A+L+ + + Q I + APE GR + DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 186 YSFGIMLIETFTRKK 200
+SFGI+L E T+ +
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-20
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 8 IGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVF---KSFDV-ECEMMKSIHHRNIIKVI 62
IG+G FG+V K R DG + K + YG + K V E +++ + H NI++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 63 SSCSNEEFKAL--VLEYMPHGSL----EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
+ + L V+EY G L +K YI + I+ + L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI-EEEFIWRILTQLLLALYECHNR 124
Query: 117 YSA--QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT-LATIGYMAPEY 173
V+H DLKP+N+ LD N L DFG+AK+L + +T + T YM+PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYVGTPYYMSPEQ 181
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKP 201
D++S G ++ E P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-20
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 6 NLIGRGGFGSVFKARL----GDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHHR 56
+IG+G FG V+ L G + AVK N R+ +V E +MK H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN----RITDLEEVEQFLKEGIIMKDFSHP 56
Query: 57 NIIKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
N++ ++ C E LV L YM HG L ++ S + + + + VA +EYL
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA- 115
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT--IGYMAPEY 173
S + +H DL N +LD++ ++DFG+A+ + ++ ++ T A + +MA E
Sbjct: 116 --SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKP 201
+ + + DV+SFG++L E TR P
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 6e-20
Identities = 68/213 (31%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 8 IGRGGFGSVFKA--RLGDGMEVAVKVFNLQYGRVF---KSFDVECEMMKSIHHRNIIKVI 62
+G G FGSV K + G EV V V L+ + K F E +M + H I+++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
C E LV+E P G L KYL + D+ + VA + YL S
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLE---SKH 115
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDISTIQTQTLATIGYMAPEYGKEGRV 179
+H DL NVLL + A +SDFG+++ L D T + + APE G+
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 180 SANGDVYSFGIMLIETFTR-KKPTDEIFNGEMT 211
S+ DV+S+G+ L E F+ KP E+ E+
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-20
Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 18/215 (8%)
Query: 2 FSENN---LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN 57
+ EN ++G+G +G V+ AR L + +A+K + R + E + + HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI----DVASTLEYL 113
I++ + S S F + +E +P GSL L S L + +I + L+YL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKYL 124
Query: 114 HFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE 172
H Q++H D+K NVL++ + V +SDFG +K L + T +T T T+ YMAPE
Sbjct: 125 H---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT-ETFT-GTLQYMAPE 179
Query: 173 YGKEGR--VSANGDVYSFGIMLIETFTRKKPTDEI 205
+G A D++S G ++E T K P E+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 8e-20
Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 33/280 (11%)
Query: 7 LIGRGGFGSV----FKARLGDGMEVAVKVFNLQYGRVFK---SFDVECEMMKSIHHRNII 59
+G G FG V + G + VAVK L+ ++ F E +M S+ H N+I
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYS 118
++ +V E P GSL L I + + +A+ + YL S
Sbjct: 60 RLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---S 115
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTREDISTIQTQTLATIGYMAPEYGKEG 177
+ IH DL N+LL + + DFG+ + L ED ++ + APE +
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
S DV+ FG+ L E FT GE W +S +I+ + +E
Sbjct: 176 TFSHASDVWMFGVTLWEMFTY---------GEEP-------WAGLSGSQIL--KKIDKEG 217
Query: 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277
E C ++NV ++C +P R + L +
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 9e-20
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 15/231 (6%)
Query: 2 FSENNLIGRGGFGSVFKA-RLGDGMEVAVKVFNLQ-YGRVFKSFDV-ECEMMKSIHHRNI 58
F N IG+G FG VFK R D A+K +L R + + E ++ + I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHF 115
I+ S ++ +V+EY +G L K L D R I I + L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLH- 118
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT-LATIGYMAPEYG 174
S +++H D+K N+ LD + D G+AKLL+ +T T + T Y++PE
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD---NTNFANTIVGTPYYLSPELC 173
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225
++ + DV++ G++L E T K P D G + LK + P+S
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 6 NLIGRGGFGSVFKARL---GDGMEVAVKVFNLQYGRV--FKSFDVECEMM-KSIHHRNII 59
++IG G FG V KAR+ G M+ A+K +Y + F E E++ K HH NII
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMI 104
++ +C + + L +EY PHG+L +L +S+ L Q L+
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 105 DVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164
DVA ++YL Q IH DL N+L+ +N VA ++DFG+++ +++ +T
Sbjct: 120 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 173
Query: 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIE 194
+ +MA E + N DV+S+G++L E
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 8 IGRGGFGSVFK---ARLGDG---MEVAVK-VFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
+G+G FG V++ + G VA+K V R F E +MK + ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYL--------HSSNYILDIYQR-LNIMIDVASTLE 111
++ S + +V+E M G L+ YL ++ Q+ + + ++A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
YL + + +H DL N ++ +++ + DFG+ + + D + L + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 172 EYGKEGRVSANGDVYSFGIMLIETFT 197
E K+G + DV+SFG++L E T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-19
Identities = 68/254 (26%), Positives = 111/254 (43%), Gaps = 45/254 (17%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKVFNL-----QYGRVFKSFDVECEMMKSIHHRNIIK 60
L+G+G FG V+ D G E+AVK + + + + E +++K++ H I++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASTLEYLHFG 116
++E ++ +EYMP GS++ L + + + Y R + +EYLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH-- 121
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPE- 172
S ++H D+K +N+L D L DFG +K L + I + T + G +M+PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVTGTPYWMSPEV 178
Query: 173 -----YGKEGRVSANGDVYSFGIMLIETFTRKKPTDE------IFNGEMTLKHWVNDWLP 221
YG++ DV+S G ++E T K P E IF N LP
Sbjct: 179 ISGEGYGRK------ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK---IATQPTNPQLP 229
Query: 222 ISTKEIVDPNLLSR 235
N L R
Sbjct: 230 SHVSPDAR-NFLRR 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-19
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 8 IGRGGFGSVFKAR-LG-----DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
IG+G FG VF+AR G VAVK+ + + F E +M H NI+K
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYI--------------------LDIYQR 99
++ C+ + L+ EYM +G L ++L H S L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 100 LNIMIDVASTLEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156
L I VA+ + YL F +H DL N L+ +NMV ++DFG+++ + D
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
I +M PE R + DV+++G++L E F+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-19
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNIIKVIS 63
++G G +G V K R G VA+K F V K+ E ++++ + H NI+ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+ + LV EY+ LE L +S L + + + + Y H S +IH
Sbjct: 68 AFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-------YGKE 176
D+KP N+L+ ++ V L DFG A+ L R ++ T +AT Y APE YGK
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARAL-RARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 177 GRVSANGDVYSFGIMLIETFT 197
DV++ G ++ E
Sbjct: 183 ------VDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-19
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG------RVFKSFDVECEMMKSIHHRNII 59
+G G F S ++AR + G +AVK V ++ E +M ++H +II
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASTLEYLHF 115
+++ + + L +E+M GS+ L ++ Y + L YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE-----QLLRGLSYLH- 120
Query: 116 GYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDIST--IQTQTLATIGYMAPE 172
Q+IH D+K +N+L+D ++DFG A L + Q Q L TI +MAPE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 173 YGKEGRVSANGDVYSFGIMLIETFTRKKP--TDEIFN 207
+ + + DV+S G ++IE T K P ++ N
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-19
Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 31/282 (10%)
Query: 5 NNLIGRGGFGSVFKA----RLGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSIHHRNII 59
IG G FG V++ + + VAVK N V + F E +M+ H +I+
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
K+I + E +V+E P G L YL + Y LD+ + +++ L YL S
Sbjct: 71 KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+ +H D+ NVL+ L DFG+++ L E L I +MAPE R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP-IKWMAPESINFRRF 185
Query: 180 SANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238
++ DV+ FG+ + E KP + N ++ + + LP+
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP--------------- 230
Query: 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
C ++++ +C P +R E+ +L I
Sbjct: 231 -----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 8e-19
Identities = 69/284 (24%), Positives = 124/284 (43%), Gaps = 37/284 (13%)
Query: 8 IGRGGFGSVFKARL---GD--GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG V R GD G +VAVK + G E E++++++H NI+K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 62 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
C+ + L++E++P GSL++YL + +++ Q+L + + ++YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDISTIQTQTLATIGYMAPEYGKEGR 178
Q +H DL NVL++ + DFG+ K + T ++ T++ + + + APE + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 179 VSANGDVYSFGIMLIETFT----RKKPTDEIF------NGEMTLKHWVNDWLPISTKEIV 228
DV+SFG+ L E T P +G+MT+ V
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR----------- 237
Query: 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272
+ E C V+ + +C P +R + ++
Sbjct: 238 ----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 9e-19
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 23/198 (11%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVI-- 62
IG G G VFKA+ G VA+K L+ G + E + +++ H ++K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 63 ----SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
S LV+EYMP L + L L Q + M + + Y+H +
Sbjct: 68 FPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---A 117
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--YGKE 176
++H DLKP+N+L+ + V ++DFG+A+L + E+ + + +AT Y APE YG
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 177 GRVSANGDVYSFGIMLIE 194
+ D+++ G + E
Sbjct: 177 -KYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNL-QYGRVFKSFDV-ECEMMKSIHHRNIIKVISS 64
IG G +G V+KAR G VA+K L + E +++K ++H NIIK++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
++ LV E+M L K + L + + + L + H S ++H
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--YGKEGRVSAN 182
DLKP N+L++ V L+DFG+A+ T + T Y APE G +G S
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKG-YSTP 179
Query: 183 GDVYSFGIMLIETFTRK 199
D++S G + E +R+
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-18
Identities = 65/261 (24%), Positives = 117/261 (44%), Gaps = 30/261 (11%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V+ +VA+K +L+ G + F E +MK + H ++++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
E ++ EYM +GSL +L + I L I + +++ +A + ++ IH D
Sbjct: 72 QEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
L+ +N+L+ + + ++DFG+A+L+ + T + I + APE G + DV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 186 YSFGIMLIETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKE 244
+SFGI+L E T + P + N E V NL +
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPE------------------VIQNL--ERGYRMPRPD 226
Query: 245 QCVSFVFNVAMECTVESPEQR 265
C ++ + C E PE+R
Sbjct: 227 NCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-18
Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVIS 63
++GRG FG V R D V +K ++ + EC+++K + H NII+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ ++ +V+EY P G+L +Y+ N +LD L+ + + L ++H + ++
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123
Query: 123 HCDLKPSNVLLDDN-MVAHLSDFGIAKLL-TREDISTIQTQTLATIGYMAPEYGKEGRVS 180
H DLK N+LLD + MV + DFGI+K+L ++ T+ + T Y++PE + +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV----VGTPCYISPELCEGKPYN 179
Query: 181 ANGDVYSFGIMLIETFTRKKPTD 203
D+++ G +L E + K+ +
Sbjct: 180 QKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 79/279 (28%), Positives = 122/279 (43%), Gaps = 47/279 (16%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNL----QYGR-VFKSFDVECEMMKSIHHRNIIK 60
L+G G FGSV++ L DG AVK +L Q G+ K + E ++ + H NI++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASTLEYLHFG 116
+ + E+ + LE +P GSL K L ++ +Y R + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPEY 173
+H D+K +N+L+D N V L+DFG+AK + + + G +MAPE
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE------FSFAKSFKGSPYWMAPEV 172
Query: 174 -GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232
++G D++S G ++E T K P ++ K + LP I P+
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP----PI--PDH 226
Query: 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
LS E F+ K C P R A E+
Sbjct: 227 LSDEAKDFILK-------------CLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 67/290 (23%), Positives = 128/290 (44%), Gaps = 37/290 (12%)
Query: 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFN-LQYGRVFKSFDVECEMMKSI 53
E +GRG FG VF A+ G V VK + + F E +M + +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 54 HHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI--------LDIYQRLNIMID 105
H+N+++++ C E ++LEY G L+++L ++ L Q++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165
+A +++L +A+ +H DL N L+ +S ++K + + ++ L
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALIP 181
Query: 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225
+ ++APE +E S DV+SFG+++ E FT+ GE+ +S +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ---------GELPFY-------GLSDE 225
Query: 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
E++ N L + E C S ++ + C +P+ R + E+V+ L
Sbjct: 226 EVL--NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVA---VKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG+G F V+KA L DG VA V++F + + + E +++K + H N+IK ++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 64 SCSNEEFKALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
S +VLE G L K+ ++ + + S LE++H S +
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKR 126
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAPEYGKEGRV 179
++H D+KP+NV + V L D G+ + + + T +L T YM+PE E
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK---TTAAHSLVGTPYYMSPERIHENGY 183
Query: 180 SANGDVYSFGIMLIETFTRKKP 201
+ D++S G +L E + P
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-18
Identities = 67/290 (23%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 8 IGRGGFGSVFKARL-----GDGME-VAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIK 60
+G FG V+K L G+ + VA+K + G + + F E M + H NI+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYL-----HSS----------NYILDIYQRLNIMID 105
++ + E+ +++ Y H L ++L HS L+ ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165
+A+ +E+L S V+H DL NVL+ D + +SD G+ + + D + +L
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225
I +M+PE G+ S + D++S+G++L E F+ + + + S +
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS----------------YGLQPYCGYSNQ 233
Query: 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
++++ + R + C ++V+ + +EC E P +R K+I ++L
Sbjct: 234 DVIE---MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-18
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVK---VFNLQYGRVFKSFDV--ECEMMKSIHHRNII 59
+G G + V+KAR G VA+K + + + +F E ++++ + H NII
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYIL---DIYQRLNIMIDVASTLEYLHFG 116
++ ++ LV E+M LEK + + +L DI M+ LEYLH
Sbjct: 66 GLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKS---YMLMTLRGLEYLH-- 119
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE---- 172
S ++H DLKP+N+L+ + V L+DFG+A+ + + T + T Y APE
Sbjct: 120 -SNWILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 173 ---YGKEGRVSANGDVYSFGIMLIETFTRK 199
YG V D++S G + E R
Sbjct: 177 ARHYG----VGV--DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-18
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 7 LIGRGGFGSVFKARL---GDGME--VAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIK 60
L+G G FG+V K GD ++ VA+K + GR F+ M S+ H I++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
++ C + LV + P GSL ++ LD + LN + +A + YL +
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
++H +L N+LL + + ++DFG+A LL +D ++ I +MA E GR +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 181 ANGDVYSFGIMLIETFT 197
DV+S+G+ + E +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 55/222 (24%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR----VFKSFDVECEMMKSIHHRNIIK 60
N IG G G+V+K G A+KV YG V + E E+++ ++H N++K
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 61 VISSC-----SNEEFKALVLEYMPHGSLE-KYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
C N E + L LE+M GSLE ++ ++ D+ ++ + S + YLH
Sbjct: 137 ----CHDMFDHNGEIQVL-LEFMDGGSLEGTHIADEQFLADVARQ------ILSGIAYLH 185
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT-----QTLATIGYM 169
++H D+KPSN+L++ ++DFG++++L QT ++ TI YM
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA-------QTMDPCNSSVGTIAYM 235
Query: 170 APEYGKEGRVSAN----------GDVYSFGIMLIETFTRKKP 201
+PE R++ + GD++S G+ ++E + + P
Sbjct: 236 SPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-18
Identities = 70/275 (25%), Positives = 115/275 (41%), Gaps = 39/275 (14%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V+KA+ + G+ A K+ ++ + F VE +++ H NI+ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
E +++E+ G+L+ + L Q + + L +LH S +VIH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT-IG---YMAPEY-----GKEG 177
K N+LL + L+DFG++ Q T IG +MAPE K+
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTL------QKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD-PNLLSRE 236
D++S GI LIE + P E+ + LK + S +D P+ S
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK------ILKSEPPTLDQPSKWSSS 237
Query: 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
F+ C V+ P+ R A E+
Sbjct: 238 FNDFLKS-------------CLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-18
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 8 IGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG+G G+V+ A + G EVA+K NLQ + E +M+ H NI+ + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +V+EY+ GSL + + +D Q + + LE+LH S QVIH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
K N+LL + L+DFG +T E + ++ + T +MAPE D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 187 SFGIMLIETFTRKKP 201
S GIM IE + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-18
Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG------RVFKSFDVECEMMKSIHH 55
+++ ++G+G +G+V+ G +AVK L + ++ E +++KS+ H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDI----YQRLNIMIDVASTLE 111
NI++ + +C ++ ++ +E++P GS+ L+ + + Y + I+ VA
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA---- 116
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---- 167
YLH + V+H D+K +NV+L N + L DFG A+ L + + L ++
Sbjct: 117 YLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 168 YMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKP 201
+MAPE E D++S G + E T K P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-18
Identities = 55/195 (28%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V+ + +VAVK L+ G + ++F E +MK++ H ++++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 67 NEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
EE ++ EYM GSL +L S + + + ++ +A + Y+ IH D
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
L+ +NVL+ ++++ ++DFG+A+++ ++ T + I + APE G + DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 186 YSFGIMLIETFTRKK 200
+SFGI+L E T K
Sbjct: 188 WSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-18
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 6 NLIGRGGFGSVFKA----RLGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNI 58
+G G FG V++ R GD +E+ V V L + F +E +M +H+NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN------YILDIYQRLNIMIDVASTLEY 112
+++I + ++LE M G L+ +L + L + L DVA +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 113 LHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
L IH D+ N LL VA ++DFG+A+ + R + + I +M
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 170 APEYGKEGRVSANGDVYSFGIMLIETFT 197
PE +G ++ DV+SFG++L E F+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-18
Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 35/223 (15%)
Query: 7 LIGRGGFGSVF---KARLGDGMEVA-VKVFNLQYGR-------VFKSFDVECEMMKSIHH 55
LIG+G +G V+ G+ M V V++ GR + K+ E E +K + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVAST 109
NI++ + + EE+ ++ LEY+P GS+ L Y R V
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGS-------CLRTYGRFEEQLVRFFTEQVLEG 120
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI-STIQTQTL-ATIG 167
L YLH S ++H DLK N+L+D + + +SDFGI+K +DI Q ++ ++
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVF 175
Query: 168 YMAPE--YGKEGRVSANGDVYSFGIMLIETFTRKKP--TDEIF 206
+MAPE + SA D++S G +++E F ++P +E
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-18
Identities = 56/250 (22%), Positives = 105/250 (42%), Gaps = 34/250 (13%)
Query: 41 KSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH--------SSNY 92
+ F E +++ + NI +++ C+ + +++EYM +G L ++L +
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 93 ILDIYQR--LNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150
+ L + +AS + YL S +H DL N L+ N ++DFG+++ L
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT--RKKPTDEIFNG 208
D +Q + I +MA E G+ + DV++FG+ L E T R++P + + +
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239
Query: 209 EMTLKHWVNDWLPISTKEIVDPNLLSRED---IHFVAKEQCVSFVFNVAMECTVESPEQR 265
V I + R+D I+ C ++ + +EC E R
Sbjct: 240 -----QQV----------IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284
Query: 266 INAKEIVTKL 275
+EI L
Sbjct: 285 PTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 5 NNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNII 59
+IG G FG V + RL ++VA+K + F E +M H NII
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL-HFGYS 118
++ + ++ EYM +GSL+K+L ++ + Q + ++ +AS ++YL Y
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA----TIGYMAPEYG 174
+H DL N+L++ N+V +SDFG L+R + T T I + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFG----LSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 175 KEGRVSANGDVYSFGIMLIETFT 197
+ ++ DV+SFGI++ E +
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-17
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 7 LIGRGGFGSVFKARLG--DGMEVAVKVFNLQYGRVFKS---FDVECEMMKSIHHRNIIKV 61
+IG G FG V RL E+ V + L+ G K F E +M H NII +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH-FGYSAQ 120
+ + +V EYM +GSL+ +L + + Q + ++ +AS ++YL GY
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG--YMAPEYGKEGR 178
+H DL N+L++ N+V +SDFG++++L +D T I + APE +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 179 VSANGDVYSFGIMLIETFT 197
++ DV+S+GI++ E +
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 61/201 (30%), Positives = 88/201 (43%), Gaps = 14/201 (6%)
Query: 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNI 58
E + +G G GSV K RL GM A+K + K E E+ KS I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 59 IKVISSCSNEEFK--ALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASTLEYL 113
+K + +E + +EY GSL+ K + + I V L YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173
H S ++IH D+KPSN+LL L DFG++ E ++++ T YMAPE
Sbjct: 122 H---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG----ELVNSLAGTFTGTSFYMAPER 174
Query: 174 GKEGRVSANGDVYSFGIMLIE 194
+ S DV+S G+ L+E
Sbjct: 175 IQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI------H 54
F+ IG+G FG V+KA VA+KV +L+ ++E ++ + I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIE-DIQQEIQFLSQCR 57
Query: 55 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
I K S +++EY GS L LD I+ +V LEYLH
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLH 115
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEY 173
IH D+K +N+LL + L+DFG++ LT + + T T +MAPE
Sbjct: 116 ---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS---TMSKRNTFVGTPFWMAPEV 169
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKP 201
K+ D++S GI IE + P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-17
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 33/201 (16%)
Query: 8 IGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDV-----ECEMMKSIHHRNIIKV 61
+G G FG V R + A+K+ + ++ K V E +++SI H ++ +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
S ++ LV+EY+P G L +L S V LEYLH S +
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEYLH---SLDI 122
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTREDISTIQTQTL-ATIGYMAPE------Y 173
++ DLKP N+LLD + ++DFG AK + R T TL T Y+APE Y
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------TYTLCGTPEYLAPEIILSKGY 175
Query: 174 GKEGRVSANGDVYSFGIMLIE 194
GK + D ++ GI++ E
Sbjct: 176 GK----AV--DWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-17
Identities = 74/229 (32%), Positives = 110/229 (48%), Gaps = 39/229 (17%)
Query: 6 NLIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDV----ECEMMKSIHHRNIIK 60
IG G +G V+KAR D G VA+K L + + F + E ++++ ++HRNI+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVN 70
Query: 61 ----VISSCSNEEFKA------LVLEYMPH---GSLEKYL--HSSNYILDIYQRLNIMID 105
V +FK LV EYM H G LE L S ++I ++L
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165
LE L++ + +H D+K SN+LL++ L+DFG+A+L E+ S T + T
Sbjct: 126 ----LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE-SRPYTNKVIT 180
Query: 166 IGYMAPE--YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL 212
+ Y PE G+E R DV+S G +L E FT+K IF L
Sbjct: 181 LWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKKP----IFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-17
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G +G V+KAR L G AVK+ L+ G F E M+K H NI+ S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ E + +EY GSL+ H + + L I TL+ L + +S +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPL----SELQIAYVCRETLQGLAYLHSKGKMHRDI 132
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT--LATIGYMAPEYG---KEGRVSA 181
K +N+LL DN L+DFG+A +T +TI + + T +MAPE K G +
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKIT----ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 182 NGDVYSFGIMLIETFTRKKP 201
D+++ GI IE + P
Sbjct: 189 LCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-17
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG G +G V+KAR + G A+KV L+ G F E MMK H NI+ S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ + +E+ GSL+ H + + I TL+ L++ +S +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPL----SESQIAYVSRETLQGLYYLHSKGKMHRDI 132
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT--LATIGYMAPEYG---KEGRVSA 181
K +N+LL DN L+DFG++ +T +TI + + T +MAPE ++G +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQIT----ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 182 NGDVYSFGIMLIETFTRKKP 201
D+++ GI IE + P
Sbjct: 189 LCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-17
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 8 IGRGGFGSVFKARLGDG---MEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVI 62
+G G FGSV + +L ++VAVK + + F E MK H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 63 SSC----SNEEFKA--LVLEYMPHGSLEKYLHSSNY-----ILDIYQRLNIMIDVASTLE 111
C +E + + ++L +M HG L +L S L + M D+AS +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
YL S IH DL N +L++NM ++DFG++K + D + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 172 EYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEM 210
E + + DV+SFG+ + E TR + P + N E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-16
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 7 LIGRGGFGSVFKARLG----DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKV 61
+IG G FG V + RL + VA+K Y + + F E +M H NII +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ ++ E+M +G+L+ +L ++ + Q + ++ +A+ ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-----TIGYMAPEYGKE 176
+H DL N+L++ N+V +SDFG+++ L ED ++ T T + I + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 177 GRVSANGDVYSFGIMLIETFT 197
+ ++ DV+S+GI++ E +
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 44/189 (23%)
Query: 8 IGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSIHHRN 57
IG G +G V A G +VA+K ++ +FDV E ++++ H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 58 I--IKVISSCSNEEFKA--LVLEYMPHGSLEKYLHSS--------NYILDIYQRLNIMID 105
I I+ I +FK +V++ M L +HS Y L YQ L
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFL--YQLLR---- 118
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR--EDISTIQTQTL 163
L+Y+H SA VIH DLKPSN+L++++ + DFG+A+ L+ + T+ +
Sbjct: 119 ---GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 164 ATIGYMAPE 172
AT Y APE
Sbjct: 173 ATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 34/230 (14%)
Query: 8 IGRGGFGSVF--------KARLGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSI-HHRN 57
+G G FG V K + + + VAVK+ + + E EMMK I H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYILDIYQ----------RLNI 102
II ++ +C+ + +++EY G+L +YL + Y DI + ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 103 MIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
VA +EYL S + IH DL NVL+ +N V ++DFG+A+ + D T
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK------PTDEIF 206
+ +MAPE + + DV+SFG+++ E FT P +E+F
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVK---VFNLQYGRVFKSFDVECEMMKSIHHRN 57
F IGRG F V++A L DG+ VA+K +F+L + E +++K ++H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
+IK +S + +VLE G L K+ ++ + + S LE++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG 174
S +V+H D+KP+NV + V L D G+ + + + +T + T YM+PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERI 178
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKP 201
E + D++S G +L E + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHH---RN 57
LIGRG +G+V++ + + G VA+K+ NL DV E ++ + N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
I K S +++EY GS+ + L + I + Y + I+ +V L+Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY-MAPEYGKE 176
VIH D+K +N+L+ + L DFG+A LL ++ + T Y MAPE E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITE 175
Query: 177 GRV-SANGDVYSFGIMLIETFTRKKP 201
G+ D++S GI + E T P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 78/303 (25%), Positives = 127/303 (41%), Gaps = 61/303 (20%)
Query: 8 IGRGGFGSVFKARLGDGME---------VAVKVF-NLQYGRVFKSFDVECEMMKSI-HHR 56
+G G FG V +A G++ VAVK+ + + E E+MK I H+
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYILDIYQR----------LN 101
NII ++ C+ E +++EY G+L ++L + +Y DI + ++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 102 IMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161
VA +EYL S + IH DL NVL+ ++ V ++DFG+A+ + D +
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK------PTDEIFNGEMTLKHW 215
+ +MAPE + + DV+SFGI++ E FT P +E+F
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK-------- 247
Query: 216 VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
L RE C ++ + EC P QR K++V L
Sbjct: 248 -----------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290
Query: 276 VKI 278
K+
Sbjct: 291 DKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 8 IGRGGFGSVF--------KARLGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSI-HHRN 57
+G G FG V K + + VAVK+ + + E EMMK I H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYILDIYQRLNIMI-------- 104
II ++ +C+ + +++EY G+L +YL + +Y D + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 105 --DVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
VA +EYL S + IH DL NVL+ ++ V ++DFG+A+ + D T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK------PTDEIFNGEMTLKHWV 216
+ +MAPE + + DV+SFG++L E FT P +E+F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK--------- 247
Query: 217 NDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276
L +E C ++ + EC P QR K++V L
Sbjct: 248 ----------------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291
Query: 277 KI 278
++
Sbjct: 292 RV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 24/268 (8%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
+G G FG V + ++VA+K N + + F E ++M + H ++++ C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 68 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLK 127
++ +V E+M +G L YL L L++ DV +EYL IH DL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127
Query: 128 PSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 187
N L+ V +SDFG+ + + +D T + + + PE + S+ DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 188 FGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCV 247
FG+++ E FT G+M + N E+V+ ++SR + K +
Sbjct: 187 FGVLMWEVFTE---------GKMPFEKKSN-------YEVVE--MISRGFRLYRPKLASM 228
Query: 248 SFVFNVAMECTVESPEQRINAKEIVTKL 275
+ V+ V C E PE R E++ +
Sbjct: 229 T-VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-16
Identities = 65/251 (25%), Positives = 104/251 (41%), Gaps = 37/251 (14%)
Query: 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVIS 63
+G GGFG V ++ A+K ++ + E E+++ +H I+K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+ ++++ +++EY G L L D Y + V EYLH + +I+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIY 116
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAPE--YGKEGRVS 180
DLKP N+LLD N L DFG AK L +T T T Y+APE K S
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVD-------PNL 232
D +S GI+L E T + P F + D P+ +I+ PN
Sbjct: 173 V--DYWSLGILLYELLTGRPP----FGED--------DEDPMEIYNDILKGNGKLEFPNY 218
Query: 233 LSREDIHFVAK 243
+ + + +
Sbjct: 219 IDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 2 FSENNL-----IGRGGFGSVFKA------RLGDGMEVAVKVFNLQYGRVFK-SFDVECEM 49
F NNL +G G FG V +A + M+VAVK+ + + E ++
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 50 MKSI-HHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVA 107
M + +H NI+ ++ +C+ ++ EY +G L +L L + L+ VA
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG 167
+ +L S IH DL NVLL + + DFG+A+ + + ++ +
Sbjct: 152 KGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 168 YMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
+MAPE + DV+S+GI+L E F+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-16
Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 32/282 (11%)
Query: 7 LIGRGGFGSVFKA-RLGDG----MEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
++G G FG+V+K + +G + VA+K+ N G + F E +M S+ H ++++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
++ C + + LV + MPHG L Y+H + LN + +A + YL +
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
++H DL NVL+ ++DFG+A+LL ++ I +MA E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 181 ANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
DV+S+G+ + E T KP D I T+EI P+LL + +
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDG-----------------IPTREI--PDLLEKGE-R 229
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI-RD 280
C V+ V ++C + + R KE+ + ++ RD
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 36/231 (15%)
Query: 8 IGRGGFGSVFKARLGDGME---------VAVKVFNLQYG-RVFKSFDVECEMMKSI-HHR 56
+G G FG V A G++ VAVK+ + E EMMK I H+
Sbjct: 26 LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLN 101
NII ++ +C+ + +++EY G+L +YL L ++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 102 IMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161
VA +EYL S + IH DL NVL+ ++ V ++DFG+A+ + D T
Sbjct: 145 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK------PTDEIF 206
+ +MAPE + + DV+SFG++L E FT P +E+F
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-16
Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS-- 64
IG+G G+VF A + G EVA+K NLQ + E +MK + + NI+ + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
+E F +V+EY+ GSL + + +D Q + + LE+LH + QVIH
Sbjct: 87 VGDELF--VVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHR 139
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGD 184
D+K NVLL + L+DFG +T E + ++ + T +MAPE D
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 185 VYSFGIMLIETFTRKKP 201
++S GIM IE + P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-16
Identities = 69/298 (23%), Positives = 121/298 (40%), Gaps = 46/298 (15%)
Query: 8 IGRGGFGSVFKAR------LGDGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIK 60
+G G FG V KA VAVK+ + E ++K ++H ++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI----LDIYQRLNIMIDVASTLEYLHFG 116
+ +CS + L++EY +GSL +L S + L N L G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 117 --------------YSAQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160
Y A+ ++H DL NVL+ + +SDFG+++ + ED ++
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL 220
+ + +MA E + + DV+SFG++L E T N +
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG----------------NPYP 231
Query: 221 PISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
I+ + + NLL + E C ++N+ + C + P++R +I +L K+
Sbjct: 232 GIAPERLF--NLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-16
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V+KA+ + G A KV + + + VE E++ + +H I+K++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +++E+ P G+++ + + L I + LE L + +S ++IH DL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT--LATIGYMAPEY-----GKEGRV 179
K NVLL + L+DFG++ +++ T+Q + + T +MAPE K+
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEI 205
D++S GI LIE + P E+
Sbjct: 193 DYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-16
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKVF--NLQYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
L+G G +G V K + + G VA+K F + V K E M+K + H N++ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 64 SCSNEEFKALVLEYMPH---GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
++ LV E++ H LEKY + LD + + + +E+ H S
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCH---SHN 120
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-------Y 173
+IH D+KP N+L+ + V L DFG A+ L + T +AT Y APE Y
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWYRAPELLVGDTKY 178
Query: 174 GKEGRVSANGDVYSFGIMLIETFT 197
G+ D+++ G ++ E T
Sbjct: 179 GRA------VDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-16
Identities = 51/183 (27%), Positives = 93/183 (50%), Gaps = 15/183 (8%)
Query: 27 VAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEK 85
VAVK+ + ++ F E ++M + + NII+++ C +++ ++ EYM +G L +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 86 YL----------HSSNYILDIYQRLNIM-IDVASTLEYLHFGYSAQVIHCDLKPSNVLLD 134
+L H++N L M + +AS ++YL S +H DL N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163
Query: 135 DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIE 194
++ ++DFG+++ L D IQ + + I +MA E G+ + DV++FG+ L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 195 TFT 197
FT
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVK---VFNLQYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
IGRG F V++A L D VA+K +F + + + E +++K ++H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 64 SCSNEEFKALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
S + +VLE G L KY ++ + + S +E++H S +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
V+H D+KP+NV + V L D G+ + + + +T + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN 184
Query: 181 ANGDVYSFGIMLIETFTRKKP 201
D++S G +L E + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 8 IGRGGFGS-VFKARLGDGMEVAVKVFNLQYGRVFKSFDV--ECEMMKSIHHRNIIKVISS 64
+G+G FG R D V K NL + D E ++ + H NII +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 65 CSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
++ + +EY G+L +K + + + L + + S + Y+H A ++H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILH 124
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
D+K N+ L + L DFGI+K+L E S +T + T YM+PE + + +
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAET-VVGTPYYMSPELCQGVKYNFKS 182
Query: 184 DVYSFGIMLIETFTRKK 200
D+++ G +L E T K+
Sbjct: 183 DIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
+G+GGFG V ++ G A K + L+ + + E ++++ + R I+ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 64 SCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ ++ LV+ M G L+ ++ + + + + LE+LH +++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIA-KLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+ DLKP NVLLDD+ +SD G+A +L + I T GYMAPE +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI----KGRAGTPGYMAPEVLQGEVYDF 173
Query: 182 NGDVYSFGIMLIETFTRKKP 201
+ D ++ G L E + P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-15
Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 7/191 (3%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
+G G FG V+ A +VAVK V ++F E +MK++ H ++K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 68 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTL-EYLHFGYSAQVIHCDL 126
E ++ E+M GSL +L S Q L +ID ++ + E + F IH DL
Sbjct: 73 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
+ +N+L+ ++V ++DFG+A+++ + + + I + APE G + DV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDVW 187
Query: 187 SFGIMLIETFT 197
SFGI+L+E T
Sbjct: 188 SFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-15
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG+G G+V+ A + G EVA++ NLQ + E +M+ + NI+ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +V+EY+ GSL + + +D Q + + LE+LH S QVIH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
K N+LL + L+DFG +T E + ++ + T +MAPE D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 187 SFGIMLIETFTRKKP 201
S GIM IE + P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 63/190 (33%), Positives = 96/190 (50%), Gaps = 47/190 (24%)
Query: 8 IGRGGFGSVFKARLGD---GMEVAVK-VF----NLQYG-RVFKSFDVECEMM---KSIHH 55
+G+G +G V+KA D VA+K +F N R F+ E+M + H
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR------EIMFLQELGDH 66
Query: 56 RNIIKVISSCSNEEFKA-------LVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMID 105
NI+K+++ KA LV EYM E LH+ +N + D+++R IM
Sbjct: 67 PNIVKLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQ 115
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST---IQTQT 162
+ L+Y+H S VIH DLKPSN+LL+ + L+DFG+A+ L+ + + + T
Sbjct: 116 LLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 163 LATIGYMAPE 172
+AT Y APE
Sbjct: 173 VATRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-15
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGR-VFKSFDVECEMMKSIHHRNII 59
F++ IG+G FG VFK +V A+K+ +L+ + E ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
K S + +++EY+ GS L LD Q I+ ++ L+YLH S
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+ IH D+K +NVLL ++ L+DFG+A LT D + + T +MAPE K+
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEI 205
+ D++S GI IE + P E+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-15
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 8 IGRGGFGSVFKARLGDGMEVA-VKVFNLQYGRVFK---SFDVECEMMKSIHHRNIIKVIS 63
IG G FG V GM A V V L+ F E + + ++H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYIL------DIYQRLNIMIDVASTLEYLHFGY 117
C LVLE+ P G L+ YL S+ ++ D+ QR+ +VAS L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE- 176
A IH DL N L ++ + D+G+A ED + + ++APE +
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 177 ------GRVSANGDVYSFGIMLIETFT 197
+ +++S G+ + E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-15
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 8 IGRGGFGSVFKARLGDGME-VAVKVFNLQYGRVFKSFDV-----ECEMMKSIHHRNIIKV 61
+G+GG+G VF A+ D E VA+K +FK +V E +++ + ++K+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSL--LFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI--MIDVASTLEYLHFGYSA 119
+ + ++E+ L +EY+P G L++ + + + R + M + L L GY
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL--GY-- 122
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--YGKEG 177
IH DLKP N L+D + L+DFG++K I T + + YMAPE GK
Sbjct: 123 --IHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 178 RVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHW 215
+ D +S G ML E P +E + LK+W
Sbjct: 176 DFTV--DYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-15
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V+KA+ + G+ A KV + + + + VE +++ S H NI+K++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
E +++E+ G+++ + L Q I + TLE L++ + ++IH DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQ---IRVVCKQTLEALNYLHENKIIHRDL 129
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT--LATIGYMAPEY-----GKEGRV 179
K N+L + L+DFG++ TR TIQ + + T +MAPE K+
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTR----TIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEI 205
DV+S GI LIE + P E+
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 51/221 (23%)
Query: 6 NLIGRGGFGSVFKA-RLGDGMEVAVK--------VFNLQYGRVFKSFDVECEMMKSIHHR 56
+ IG G +G V A G++VA+K F + R E ++++ H
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-------EIKILRRFKHE 63
Query: 57 NIIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD-----IYQRLNIMIDV 106
NII +I S E F +V E M L K + + + D +YQ L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR----- 117
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ-TQTLAT 165
L+Y+H SA V+H DLKPSN+LL+ N + DFG+A++ E T T+ +AT
Sbjct: 118 --GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 166 IGYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRK 199
Y APE Y K D++S G +L E + +
Sbjct: 173 RWYRAPEIMLNSKGYTKA------IDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 8 IGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG+G G+V+ A + G EVA+K NLQ + E +M+ + NI+ + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +V+EY+ GSL + + +D Q + + L++LH S QVIH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
K N+LL + L+DFG +T E + ++ + T +MAPE D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 187 SFGIMLIETFTRKKP 201
S GIM IE + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV----ECEMMKSIHHRNIIKVI 62
IG+G FG VFKAR VA+K + + F + E ++++ + H N++ +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 63 SSCSNE-----EFKA---LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
C + +K LV E+ H L L + N + + +M + + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTREDISTIQTQTLATIGYMAPE 172
+++H D+K +N+L+ + + L+DFG+A+ L++ T + T+ Y PE
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 173 -------YGKEGRVSANGDVYSFGIMLIETFTR 198
YG D++ G ++ E +TR
Sbjct: 194 LLLGERDYGPP------IDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 65/298 (21%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE-----------MMKSIHH 55
IG G +G V+KAR G VA+K L D E E ++K ++H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRL---------DTETEGVPSTAIREISLLKELNH 58
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
NI+K++ E LV E++ H L+K++ +S + I L I + L+ L F
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPL-IKSYLFQLLQGLAF 115
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK 175
+S +V+H DLKP N+L++ L+DFG+A+ + T T + T+ Y APE
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTY-THEVVTLWYRAPEILL 173
Query: 176 EGRV-SANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTLKH 214
+ S D++S G + E TR+ P + ++ G +L
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233
Query: 215 WVND---WLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK 269
+ W ++V P L + +++ P +RI+AK
Sbjct: 234 YKPSFPKWARQDFSKVVPP--LDEDGRDLLSQMLHY-------------DPNKRISAK 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 8 IGRGGFGSVFKARLGDGME-VAVKVFNL---QYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG G FG+V+ AR E VA+K + Q ++ E ++ + H N I+
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 64 SCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIY----QRLNIMIDVASTLEYLHFGYS 118
C E A LV+EY L S++ IL+++ Q + I L+ L + +S
Sbjct: 82 GCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY---GK 175
+ IH D+K N+LL + L+DFG A L +S + + T +MAPE
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANS-FVGTPYWMAPEVILAMD 187
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKPTDEIFN 207
EG+ DV+S GI IE RK P +FN
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP---LFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 31/250 (12%)
Query: 8 IGRGGFGSVFKA-RLGDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G G G+V+KA L +AVKV L + K E E++ II +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
E ++ E+M GSL+ Y ++L I + V L YL +S +++H D
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRD 120
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
+KPSN+L++ L DFG++ L +++I + T YMAPE + + DV
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 186 YSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE-IVDPN-------LLSRED 237
+S GI +E + P +I + +L +P+ + IVD + S +
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPPVLPVGQFSEKF 229
Query: 238 IHFVAKEQCV 247
+HF+ QC+
Sbjct: 230 VHFIT--QCM 237
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 78/304 (25%), Positives = 125/304 (41%), Gaps = 68/304 (22%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNIIKVISS 64
IG G +G V+K R G VA+K L+ V + E ++K + H NI+ +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH-------FGY 117
E L+ E++ L+KYL S +D YL+ F +
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL---TREDISTIQTQTLATIGYMAPE-- 172
S +V+H DLKP N+L+D+ V L+DFG+A+ R + T + T+ Y APE
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-----VYTHEVVTLWYRAPEVL 173
Query: 173 YGKEGRVSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTL 212
G R S D++S G + E T+K PT++++ G +L
Sbjct: 174 LGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 213 KHWVN---DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK 269
+ N W S + V N L + + + K + P +RI+AK
Sbjct: 233 PDYKNTFPKWKKGSLRSAV-KN-LDEDGLDLLEK-------------MLIYDPAKRISAK 277
Query: 270 EIVT 273
+ +
Sbjct: 278 KALN 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 66/291 (22%), Positives = 124/291 (42%), Gaps = 56/291 (19%)
Query: 8 IGRGGFGSVFKARL---------GDGMEVAVKVFNL-QYGRVFKSFDVECEMMKSIHHRN 57
+G+G F +++K L G G EV+V + L R +F +M + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
++K+ C +E +V EY+ G L+ +LH + ++ +L++ +AS L YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118
Query: 118 SAQVIHCDLKPSNVLL---DDNM----VAHLSDFGIAK-LLTREDISTIQTQTLATIGYM 169
+++H ++ N+L+ N LSD GI +L+RE + + I ++
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-------ERVERIPWI 171
Query: 170 APEYGKEGRVS--ANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPI-STK 225
APE + G+ S D +SFG L+E + ++P + + E + LP+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCA 231
Query: 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276
E+ N+ +C P +R + + I+ L
Sbjct: 232 EL-----------------------ANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 47/240 (19%)
Query: 8 IGRGGFGSV-----------------FKARLGDGMEVAVKVFNLQYGRVFKS-FDVECEM 49
+G G FG V F R G + VAVK+ + ++ F E ++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 50 MKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-------------- 95
+ + NII+++ C +E+ ++ EYM +G L ++L SS+++ D
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDDKEENGNDAVPPAHC 131
Query: 96 ----IYQRL-NIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150
Y L ++ + +AS ++YL S +H DL N L+ +N+ ++DFG+++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT--RKKP----TDE 204
D IQ + + I +MA E G+ + DV++FG+ L E +++P TDE
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 22/195 (11%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG G G V A G +VAVK +L+ + + E +M+ H NI+++ SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +V+E++ G+L + + ++ Q + + V L +LH + VIH D+
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY-MAPE------YGKEGRV 179
K ++LL + LSDFG +++E + ++L Y MAPE YG E
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPYGTE--- 195
Query: 180 SANGDVYSFGIMLIE 194
D++S GIM+IE
Sbjct: 196 ---VDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 68/224 (30%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 2 FSENNL-----IGRGGFGSVFKARLGD-GMEVAVK-----VFNLQYGRVFKSFDVECEMM 50
F+ +L IGRG FG+V K G +AVK V + R+ DV +M
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV---VM 57
Query: 51 KSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA-ST 109
+S I+K + E + +E M SL+K+ +L I+ +A +T
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVAT 116
Query: 110 LEYL-HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY 168
++ L + ++IH D+KPSN+LLD N L DFGI+ L S +T+ Y
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPY 173
Query: 169 MAPEYGKEGRVSANG--------DVYSFGIMLIETFTRKKPTDE 204
MAPE R+ + DV+S GI L E T K P +
Sbjct: 174 MAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 8 IGRGGFGSV----FKARLGDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVI 62
+G G FG V +K R ++VA+KV + + V E E+M + + I+++I
Sbjct: 3 LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
C E LV+E G L K+L + + + +M V+ ++YL +
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED-ISTIQTQTLATIGYMAPEYGKEGRVSA 181
H DL NVLL + A +SDFG++K L +D ++ + + APE + S+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 182 NGDVYSFGIMLIETFT 197
DV+S+GI + E F+
Sbjct: 178 RSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-14
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGR-VFKSFDVECEMMKSIHHRNII 59
F++ IG+G FG VFK +V A+K+ +L+ + E ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
K S +++EY+ GS L + + D +Q ++ ++ L+YLH S
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 120
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+ IH D+K +NVLL + L+DFG+A LT D + + T +MAPE ++
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEI 205
+ D++S GI IE + P ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-14
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 8 IGRGGFGSVFKARLGDGM---EVAVKVFNLQYGRVFK-SFDVECEMMKSIHHRNIIKVIS 63
IG G FG V + G +V VK + + F E + +S+ H N+++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
C+ LV+E+ P G L+ YL S D + ++A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE--G 177
IH DL N LL ++ + D+G++ +ED Q + ++APE E G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 178 RV-----SANGDVYSFGIMLIETF 196
+ + +V+S G+ + E F
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 38/233 (16%)
Query: 5 NNLIGRGGFGSVFKAR-LGDGMEVAVK-VFNLQY-----------GRVFKSFDV--ECEM 49
+G G +G V KA G VA+K V ++ G F E ++
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 50 MKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAST 109
M I H NI+ ++ +F LV++ M L+K + L Q I++ + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV-DRKIRLTESQVKCILLQILNG 131
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK-------LLTREDISTIQ--- 159
L LH Y +H DL P+N+ ++ + ++DFG+A+ T T+Q
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 160 --TQTLATIGYMAPE--YGKEGRVSANGDVYSFGIMLIETFTRKK---PTDEI 205
T + T+ Y APE G E A D++S G + E T K +EI
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAV-DMWSVGCIFAELLTGKPLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 51/186 (27%), Positives = 82/186 (44%), Gaps = 16/186 (8%)
Query: 24 GMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-FKALVLEYMP 79
G EVA+K+ F E + ++H NI+ ++ S V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL---DDN 136
+L + L + L + +M+ V L H + ++H DLKP N+++
Sbjct: 63 GRTLREVLAADG-ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118
Query: 137 MVAHLSDFGIAKLLT-REDIS----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 191
A + DFGI LL D T T+ L T Y APE + V+ N D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 192 LIETFT 197
+E T
Sbjct: 179 FLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-14
Identities = 56/176 (31%), Positives = 78/176 (44%), Gaps = 25/176 (14%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVF-NLQYGRVFKSFDV-ECEMMKSIHHRNIIKVISS 64
IG G +G VFK R + G VA+K F + V K + E M+K + H N++ +I
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI-- 66
Query: 65 CSNEEFKA-----LVLEYMPH---GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
E F+ LV EY H LEK I + TL+ ++F
Sbjct: 67 ---EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVP-------EHLIKKIIWQTLQAVNFC 116
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE 172
+ IH D+KP N+L+ L DFG A++LT T +AT Y APE
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDV---ECE--MMKSIHHRNIIK 60
L+GRG FG V+ D G E+AVK S +V ECE ++K++ H I++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 61 VISSCSNEEFKALVL--EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+ E K L + EYMP GS++ L + + + R + + YLH S
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY-MAPE----- 172
++H D+K +N+L D L DFG +K + +S +++ Y M+PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 173 -YGKEGRVSANGDVYSFGIMLIETFTRKKPTDE 204
YG++ DV+S ++E T K P E
Sbjct: 185 GYGRK------ADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 48/144 (33%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 8 IGRGGFGSVFKARLGDGME-VAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNIIKVISS 64
IG G +G+VFKA+ + E VA+K L V S E ++K + H+NI+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
+++ LV EY L+KY S N +D + M + L + H S V+H
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAK 148
DLKP N+L++ N L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 23 DGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81
+ VAVK+ + ++ F E ++M + NII++++ C + ++ EYM +G
Sbjct: 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 82 SLEKYL---------HSSNYILDIYQRLNIM-IDVASTLEYLHFGYSAQVIHCDLKPSNV 131
L ++L ++ + Y L M +AS ++YL S +H DL N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161
Query: 132 LLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 191
L+ N ++DFG+++ L D IQ + + I +M+ E G+ + DV++FG+
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 192 LIETFT--RKKP----TDE 204
L E T +++P +DE
Sbjct: 222 LWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 68/284 (23%), Positives = 121/284 (42%), Gaps = 38/284 (13%)
Query: 8 IGRGGFGSVFKARLGDGME------VAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
+G+G FG V++ D ++ VAVK N R F E +MK ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHS-----SNYILDIYQRLNIMI----DVASTLE 111
++ S + +V+E M HG L+ YL S N L MI ++A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
YL+ + + +H DL N ++ + + DFG+ + + D + L + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 172 EYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231
E K+G + + D++SFG++L E + + + + E LK ++D
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 238
Query: 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
L + + C V ++ C +P+ R EIV L
Sbjct: 239 YLDQ-------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSI---HH 55
+ E IG G +G+V+KAR L G VA+K + + S E ++K + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 56 RNIIKVISSC----SNEEFK-ALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVAST 109
NI++++ C ++ E K LV E++ L YL L ++M +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
+++LH S +++H DLKP N+L+ + ++DFG+A++ + E + T + T+ Y
Sbjct: 120 VDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MAL-TSVVVTLWYR 173
Query: 170 APEYGKEGRVSANGDVYSFGIMLIETFTRK 199
APE + + D++S G + E F R+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKV--FNLQYGRVFKSFD-VECE--MMKSIHHRNIIK 60
L+G+G FG V+ D G E+AVK F+ + K + +ECE ++K++ H I++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 61 VISSCSN--EEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLNIMIDVASTLEYLHFGY 117
+ E ++ +E+MP GS++ L S + + + ++ I LE + + +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY-MAPEYGKE 176
S ++H D+K +N+L D L DFG +K L +S +++ Y M+PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 177 GRVSANGDVYSFGIMLIETFTRKKPTDE 204
D++S G ++E T K P E
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 63/284 (22%), Positives = 127/284 (44%), Gaps = 38/284 (13%)
Query: 8 IGRGGFGSVF----KARLGDGME--VAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
+G+G FG V+ K + D E VA+K N R F E +MK + ++++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLNIMIDVASTLE 111
++ S + +++E M G L+ YL S +N + + + + + ++A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
YL+ + + +H DL N ++ ++ + DFG+ + + D + L + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 172 EYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231
E K+G + DV+SFG++L E T + + + E L+ +++
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------------VMEGG 238
Query: 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
LL + D C +F + C +P+ R + EI++ +
Sbjct: 239 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 2 FSENNLIGRGGFGSVFKARL---GDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHH 55
F + ++G G FG+V+K G+ +++ V + L+ + K E +M S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK 175
+++H DL NVL+ ++DFG+AKLL ++ I +MA E
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 176 EGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMT 211
+ DV+S+G+ + E T KP D I E++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 8 IGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSC 65
+G G GSV K + G +A KV ++ V K E ++M I+ +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
NE + +E+M GSL++ I ++I + I + V L YL+ +++H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGD 184
D+KPSN+L++ L DFG++ E I++I + T YM+PE + G+ + D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 185 VYSFGIMLIETFTRKKPTDE 204
V+S GI +IE K P
Sbjct: 185 VWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 68/236 (28%), Positives = 104/236 (44%), Gaps = 49/236 (20%)
Query: 7 LIGRGGFGSVFKARLGDGME----VAVKVFNLQYGRVFKS------FDVECEMMKSIHHR 56
++G+GG+G VF+ R G + A+KV L+ + ++ E +++++ H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI-MIDVAS------- 108
I+ +I + L+LEY+ G L +L +R I M D A
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEIS 110
Query: 109 -TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST-IQTQTL-AT 165
LE+LH +I+ DLKP N+LLD L+DFG+ K E I T T T
Sbjct: 111 LALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGT 163
Query: 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFT---------RKKPTDEIFNGEMTL 212
I YMAPE D +S G ++ + T RKK D+I G++ L
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-13
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKVFNL-----QYGRVFKSFDVECEMMKSIHHRNIIK 60
L+G+G FG V+ D G E+A K + + + + E +++K++ H I++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 61 VISSCSNEEFKALV--LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+ K L +EYMP GS++ L + + + R + + YLH S
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY-MAPEYGKEG 177
++H D+K +N+L D L DFG +K L +S +++ Y M+PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDE 204
DV+S G ++E T K P E
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-13
Identities = 77/296 (26%), Positives = 117/296 (39%), Gaps = 66/296 (22%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNI------ 58
+IG G +G V+KAR G VA+K+ ++ + E +++ +H NI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71
Query: 59 -IKVISSCSNEEFKALVLEYMPHGS---LEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
IK ++++ LV+E GS L K L L I+ + L YLH
Sbjct: 72 FIKKNPPGNDDQL-WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ-TQT-LATIGYMAPE 172
+VIH D+K N+LL N L DFG++ L ST+ T + T +MAPE
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD----STLGRRNTFIGTPYWMAPE 183
Query: 173 -----YGKEGRVSANGDVYSFGIMLIET------FTRKKPTDEIF----NGEMTLKHWVN 217
+ A DV+S GI IE P +F N TLK
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS--- 240
Query: 218 DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273
P S++ F++ EC +++ EQR +E++
Sbjct: 241 ------------PENWSKKFNDFIS-------------ECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-13
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRV--FKSFDVECEMMKSIHHRNIIKVISS 64
IG G FG ++ A+ D +K +L V ++ E ++ + H NI+ +S
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYIL-DIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+V+EY G L K ++ +L Q L+ + ++ L+++H +++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILH 124
Query: 124 CDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSAN 182
D+K N+ L N MVA L DFGIA+ L D + + T Y++PE + +
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQNRPYNNK 182
Query: 183 GDVYSFGIMLIETFTRKKP 201
D++S G +L E T K P
Sbjct: 183 TDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-13
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIH---HRNIIKV 61
IG G +G+V+KAR G VA+K +Q + S E ++K + H NI+++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 62 ISSC----SNEEFK-ALVLEYMPHGSLEKYLHSS-------NYILDIYQRLNIMIDVAST 109
+ C ++ E K LV E++ L YL I D+ ++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
L++LH + ++H DLKP N+L+ L+DFG+A++ + + T + T+ Y
Sbjct: 121 LDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYR 174
Query: 170 APEYGKEGRVSANGDVYSFGIMLIETFTRK 199
APE + + D++S G + E F RK
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-13
Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 7 LIGRGGFGSVFKA--RLGDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKV 61
++G G FG + + +L E+ V + L+ G + + F E + H NI+++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL-HFGYSAQ 120
+ +V EYM +G+L+ +L L Q + ++ +AS ++YL GY
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL---ATIGYMAPEYGKEG 177
+H L VL++ ++V +S F L + I T T+ + + + APE +
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYT-TMSGKSPVLWAAPEAIQYH 183
Query: 178 RVSANGDVYSFGIMLIE 194
S+ DV+SFGI++ E
Sbjct: 184 HFSSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-13
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 7 LIGRGGFGSVFKARLGDGME-VAVKVFNLQYGRVFKSFDV-----ECEMMKSIHHRNIIK 60
+G G FG V R A+KV + V + E ++K + H II+
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIP--EVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASTLEYLHFG 116
+ + ++ F +++EY+P G L YL + SN Y ++ LEYLH
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS-----EIVCALEYLH-- 118
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAPE-YG 174
S ++++ DLKP N+LLD L+DFG AK L +T TL T Y+APE
Sbjct: 119 -SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPEVIQ 171
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKP 201
+G A D ++ GI++ E P
Sbjct: 172 SKGHNKAV-DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 75/271 (27%), Positives = 120/271 (44%), Gaps = 66/271 (24%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFD---------VECEMMKSIHHRN 57
IGRG +G V A+ + +VA+K ++ +FD E ++++ + H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK-------KIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 58 IIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD------IYQRLNIMIDV 106
+I ++ E F +V E M L + + SS + D +YQ L
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR----- 119
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI 166
L+Y+H SA V+H DLKPSN+LL+ N + DFG+A+ T + T+ + T
Sbjct: 120 --GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTR 172
Query: 167 GYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDW 219
Y APE Y DV+S G + E RK +F G K +V+
Sbjct: 173 WYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGRKP----LFPG----KDYVHQ- 217
Query: 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFV 250
L + T+ + P S ED+ F+ E+ ++
Sbjct: 218 LKLITELLGSP---SEEDLGFIRNEKARRYI 245
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 56/174 (32%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEM------MKSIHHRNIIK 60
IG+G FG V A+ DG AVKV LQ + K + + M +K++ H ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ S + VL+Y+ G L +L + R ++AS L YLH S
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL--ATIGYMAPE 172
+I+ DLKP N+LLD L+DFG+ K E I +T + T Y+APE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 6 NLIGRGGFGSVFKARLGDGM-----EVAVKVFN-----LQYGRVFKSFDVECEMMKSIHH 55
+L+ G FG +F L D EV VK +Q + + E ++ + H
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ----ESCLLYGLSH 67
Query: 56 RNIIKVISSCSNEEFKALVLE-YMPHGSLEKYLHSSNYI-------LDIYQRLNIMIDVA 107
+NI+ ++ C + VL YM G+L+ +L L Q +++ I +A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG 167
+ YLH VIH D+ N ++D+ + ++D +++ L D + +
Sbjct: 128 CGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 168 YMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMT 211
+MA E S+ DV+SFG++L E T + P EI EM
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGME-VAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNI 58
F + N IG G +G V++AR E VA+K + R + S E ++ ++ H NI
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 59 IK----VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
++ V+ + F LV+EY L L + Q +M+ + L+YLH
Sbjct: 69 VELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-- 172
+ +IH DLK SN+LL D ++DFG+A+ T + T + T+ Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAPELL 180
Query: 173 YGKEGRVSANGDVYSFGIMLIETFTRK 199
G +A D+++ G +L E K
Sbjct: 181 LGCTTYTTAI-DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 8 IGRGGFGSVFKARL-GDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
+G+GGFG V ++ G A K N L+ + ++ VE ++ +H R I+ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ + LV+ M G L ++++ N + + S LE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT---LATIGYMAPEYGKEG 177
+I+ DLKP NVLLD++ +SD G+A L Q++T T G+MAPE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-----QSKTKGYAGTPGFMAPELLQGE 172
Query: 178 RVSANGDVYSFGIMLIETFTRKKP 201
+ D ++ G+ L E + P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 51/219 (23%)
Query: 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDV------ECEMMKSIHHRNI 58
+ +G G +G V A G +VA+K + R F+S E ++K + H N+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 59 IKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH----SSNYI-LDIYQRLNIMIDVA 107
I ++ + S E+F+ LV M L + S ++I +YQ L
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILR------ 129
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG 167
L+Y+H SA +IH DLKPSN+ ++++ + DFG+A+ E T +AT
Sbjct: 130 -GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 180
Query: 168 YMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRK 199
Y APE Y + D++S G ++ E T K
Sbjct: 181 YRAPEIMLNWMHYNQ------TVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-12
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 9/206 (4%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGR-VFKSFDVECEMMKSIHHRNII 59
F++ IG+G FG V+K EV A+K+ +L+ + E ++ I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ S +++EY+ GS L L+ I+ ++ L+YLH S
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---SE 120
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+ IH D+K +NVLL + L+DFG+A LT D + + T +MAPE K+
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEI 205
D++S GI IE + P ++
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 8 IGRGGFGSVFKAR--LGDGMEVAVKVFNLQYGRVFKSFDVECEM-----MKSIHHRNIIK 60
IG G +G VFKAR G VA+K +Q G E+ +++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 61 VISSCS----NEEFK-ALVLEYMPHGSLEKYLHS-------SNYILDIYQRLNIMIDVAS 108
+ C+ + E K LV E++ L YL + I D+ M +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM------MFQLLR 121
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY 168
L++LH S +V+H DLKP N+L+ + L+DFG+A++ + + T + T+ Y
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWY 175
Query: 169 MAPEYGKEGRVSANGDVYSFGIMLIETFTRK 199
APE + + D++S G + E F RK
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 22/235 (9%)
Query: 7 LIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMK------SIHHRNII 59
++G+G FG VF A L G A+K L+ V DVEC M++ + H +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ + +E V+EY+ G L ++ S + D+ + ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SK 115
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAPEYGKEGR 178
+++ DLK N+LLD + ++DFG+ K + +T T T Y+APE +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 179 VSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKEIV 228
+ + D +SFG++L E + P +E+F WL K+I+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 32/282 (11%)
Query: 7 LIGRGGFGSVFKA-RLGDG----MEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
++G G FG+V+K + DG + VA+KV + K E +M + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
++ C + LV + MP+G L Y+ + + LN + +A + YL +
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
++H DL NVL+ ++DFG+A+LL ++ I +MA E R +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 181 ANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
DV+S+G+ + E T KP D I +EI P+LL + +
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDG-----------------IPAREI--PDLLEKGE-R 229
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI-RD 280
C V+ + ++C + E R +E+V + ++ RD
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 44/290 (15%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEV-AVKVFNL---QYGRVFKSFDVECEMMKSIHHRN 57
F++ IG G FG+V+ AR EV A+K + Q ++ E + ++ I H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS----TLEYL 113
I+ E LV+EY L S++ +L+++++ +++A+ L+ L
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGL 138
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173
+ +S +IH D+K N+LL + L+DFG A + + + + T +MAPE
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWMAPEV 192
Query: 174 ---GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230
EG+ DV+S GI IE RK P + N L H I+ E P
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYH-------IAQNE--SP 242
Query: 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
L S E + N C + P+ R ++E++ + +R+
Sbjct: 243 TLQSNE---------WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-12
Identities = 41/106 (38%), Positives = 52/106 (49%), Gaps = 9/106 (8%)
Query: 102 IMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161
I + + LEYLH S VIH D+KPSNVL++ N L DFGI+ L S +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTI 162
Query: 162 TLATIGYMAPEY----GKEGRVSANGDVYSFGIMLIETFTRKKPTD 203
YMAPE + DV+S GI +IE T + P D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHH 55
F + ++G+GGFG V ++ G A K L+ R+ K E ++++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASTLEYLH 114
R ++ + + ++ LVL M G L+ ++ H + + + ++ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG 174
++++ DLKP N+LLDD+ +SD G+A + TI+ + + T+GYMAPE
Sbjct: 120 ---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGR-VGTVGYMAPEVV 173
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKP 201
K R + + D ++ G +L E + P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-12
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 8 IGRGGFGSVFKA---RLGDGMEVAVKVF-NLQYGRVFK-SFDVECEMMKSIHHRNIIKVI 62
+G G FG+V K VAVK+ N K E +M+ + + I+++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
C E + LV+E G L K+L + ++ + ++ V+ ++YL +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATIGYMAPEYGKEGRVSA 181
H DL NVLL A +SDFG++K L E+ +T + + APE + S+
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 182 NGDVYSFGIMLIETFTR-KKPTDEIFNGEMT 211
DV+SFG+++ E F+ +KP + E+T
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 23/243 (9%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMMK------SIHHRNII 59
++G+G FG V A L E A+K L+ V + DVEC M++ + H +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ + +E V+EY+ G L ++ SS D + ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTREDISTIQTQTLATIGYMAPEYGKEGR 178
+I+ DLK NVLLD + ++DFG+ K + E + T Y+APE K +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAPEILKGQK 172
Query: 179 VSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233
+ + D +SFG++L E + P DE+F+ + + W+ K+ + L
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLS-KLF 231
Query: 234 SRE 236
R+
Sbjct: 232 ERD 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNLQ-YGRVFK---SFDVECEMMKSIHHRNIIK- 60
++G G G+V A R+ DG AVKV +++ K +V C + + +I+K
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLL--NCDFFSIVKC 96
Query: 61 ----VISSCSNEE---FKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTL 110
N E ALVL+Y G L + + S +N ++ + I V +
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMA 170
++H S +IH D+K +N+LL N + L DFG +K+ + T Y+A
Sbjct: 157 HHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 171 PEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
PE + S D++S G++L E T K+P F+GE
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE 248
|
Length = 496 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 8 IGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG G G V AR G +VAVK+ +L+ + + E +M+ H+N++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
E +++E++ G+L + S L+ Q + V L YLH S VIH D+
Sbjct: 89 VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
K ++LL + LSDFG +++ D+ + + T +MAPE D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISK-DVPK-RKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 187 SFGIMLIETFTRKKP 201
S GIM+IE + P
Sbjct: 202 SLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 65/245 (26%), Positives = 116/245 (47%), Gaps = 27/245 (11%)
Query: 7 LIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMK----SIHHRN--II 59
++G+G FG V A L G G AVK L+ V DVEC M++ ++ N +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ + +E V+E++ G L ++ D+Y+ ++ L++LH S
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SK 115
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI--STIQTQTLATIGYMAPEYGKEG 177
+I+ DLK NV+LD + ++DFG+ K E++ + T Y+APE +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 178 RVSANGDVYSFGIMLIETFTRKKP-----TDEIFNG-EMTLKHWVNDWLPISTKEIVDPN 231
+ + + D +SFG++L E + P DE+F + H+ W+ +K+I++
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR-WITKESKDILE-K 229
Query: 232 LLSRE 236
L R+
Sbjct: 230 LFERD 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 71/274 (25%), Positives = 115/274 (41%), Gaps = 46/274 (16%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMM-KSI-----HHRNII 59
++G+G FG V A L E+ AVKV L+ + + DVEC M K + H +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
++ S ++ V+EY+ G L ++ S D + ++ L++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+I+ DLK NVLLD ++DFG+ K ++T + T Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQPY 173
Query: 180 SANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234
D ++ G++L E + P DE+F I E+ P LS
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS-------------ILEDEVRYPRWLS 220
Query: 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINA 268
+E AK SF+ ++PE+R+
Sbjct: 221 KE-----AKSILKSFL--------TKNPEKRLGC 241
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 39/225 (17%)
Query: 8 IGRGGFGSVFKAR---LGDGMEVAV----------KVFNLQYGRVFKSFDVECEMMKSIH 54
I +G FGSV+ A+ GD + V +V N++ R MM
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI--------MMIQGE 55
Query: 55 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
+ K+ S ++++ LV+EY+ G + + + + + + + +V +E LH
Sbjct: 56 SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH 114
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-- 172
+IH D+KP N+L+D L+DFG+++ + + T Y+APE
Sbjct: 115 ---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETI 165
Query: 173 YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN 217
G D +S G ++ E P F+ E + N
Sbjct: 166 LGVGD--DKMSDWWSLGCVIFEFLFGYPP----FHAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 26/232 (11%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNL---QYGRVFKSFDVECEMMKSIHHRN 57
FS+ IG G FG+V+ AR + + VA+K + Q ++ E ++ + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS----TLEYL 113
I+ E LV+EY L S++ +L+++++ +++A+ L+ L
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173
+ +S +IH D+K N+LL + + L DFG A ++ + + T +MAPE
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182
Query: 174 ---GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI 222
EG+ DV+S GI IE RK P + N L H + P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPA 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 61/195 (31%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDVECEM------MKSIHHRNII 59
+IG+G FG V A R DG AVKV LQ + K + M +K++ H ++
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ S E VL+Y+ G L +L L+ R +VAS + YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+I+ DLKP N+LLD L+DFG+ K + +T + T Y+APE ++
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT--STFCGTPEYLAPEVLRKEPY 173
Query: 180 SANGDVYSFGIMLIE 194
D + G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 8 IGRGGFG---SVFKARLGDGMEVAVK----VF-NL-QYGRVFKSFDVECEMMKSIHHRNI 58
IG G FG SV R DG VA+K VF NL RVF+ E +M+ H N+
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNV 61
Query: 59 IKVIS-------SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLE 111
+ + E + V+ + L K + S + + ++ + + L+
Sbjct: 62 LSALDILQPPHIDPFEEIY---VVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLK 117
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
YLH SA ++H D+KP N+L++ N V + DFG+A+ + D S TQ + T Y AP
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAP 173
Query: 172 E--YGKEGRVSANGDVYSFGIMLIETFTRK 199
E G SA D++S G + E R+
Sbjct: 174 EILMGSRHYTSAV-DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV----ECEMMKSIHHRNIIK 60
N I G +G V++AR G VA+K L+ + + F + E ++ + H NI+
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQHPNIVT 68
Query: 61 V--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
V + SN + +V+EY+ H L+ + + + +M+ + S + +LH
Sbjct: 69 VKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---D 124
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ--TQTLATIGYMAPE--YG 174
++H DLK SN+LL++ + + DFG+A RE S ++ TQ + T+ Y APE G
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLA----REYGSPLKPYTQLVVTLWYRAPELLLG 180
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
S D++S G + E KKP +F G+
Sbjct: 181 -AKEYSTAIDMWSVGCIFAE-LLTKKP---LFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 8/195 (4%)
Query: 8 IGRGGFGSV-FKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG G G V G +VAVK +L+ + + E +M+ HH N++ + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +V+E++ G+L + + ++ Q + + V L YLH + VIH D+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
K ++LL + LSDFG +++E + + T +MAPE D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 187 SFGIMLIETFTRKKP 201
S GIM+IE + P
Sbjct: 203 SLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 7 LIGRGGFGSVFKARLGDGME--VAVK---VFNLQYGRVFKSFD-------VECEMMK-SI 53
+G G FG V+K R + + +A+K V N +G+ + D E ++K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 54 HHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVA 107
H NI++ + + +V++ + L ++ +S + + QR NI + +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFTEERIWNIFVQMV 123
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG 167
L YLH +++H DL P+N++L ++ ++DFG+AK E + T + TI
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE---SKLTSVVGTIL 178
Query: 168 YMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKP 201
Y PE K DV++FG +L + T + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 33/195 (16%)
Query: 1 GFSENNLIGRGGFGSVFKARL---GDGMEVAVKVF---NLQYGRVFKSFDVECEMMKSIH 54
+ IGRG +G V+KA+ DG E A+K F QY + +S E +++ +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 55 HRNIIKVISSCSNEEFKA--LVLEYMPHGSLE--KYLHSSNYILDIYQRL--NIMIDVAS 108
H N++ ++ K+ L+ +Y H + K+ H + I + +++ + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLWQILN 119
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIA-------KLLTREDIST 157
+ YLH S V+H DLKP+N+L+ + V + D G+A K L D
Sbjct: 120 GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD--- 173
Query: 158 IQTQTLATIGYMAPE 172
+ TI Y APE
Sbjct: 174 ---PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 8 IGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISS 64
+G G + +V+K + +G VA+KV LQ G F + E ++K + H NI+ +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 65 CSNEEFKALVLEYMPHGSLEKY-------LHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+E LV EY+ H L +Y LH N L ++Q L L Y+H Y
Sbjct: 72 IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY 123
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE 172
++H DLKP N+L+ D L+DFG+A+ + S + + T+ Y P+
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 71/291 (24%), Positives = 133/291 (45%), Gaps = 33/291 (11%)
Query: 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFK----SFDV-ECEMMKSIHH 55
F + ++G+GGFG V ++ G A K L+ R+ K S + E ++++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLH 114
+ ++ + + ++ LVL M G L+ ++++ N + + L ++ LE LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG 174
++ DLKP N+LLDD +SD G+A + + +I+ + + T+GYMAPE
Sbjct: 120 ---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGR-VGTVGYMAPEVL 173
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234
R + + D + G ++ E + P F G K V +E VD +L
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP----FRGR---KEKVK-------REEVDRRVLE 219
Query: 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLRN 285
E+++ + + + + + P+QR+ +E VK R RN
Sbjct: 220 TEEVYSAKFSEEAKSICKMLL---TKDPKQRLGCQEEGAGEVK-RHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNIIKVISS 64
IG G +G V+KAR G VA+K L+ V + E ++K ++H NI++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 65 CSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+E LV E++ L+KY+ S LD + + + + Y H S +V+H
Sbjct: 67 VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAK---LLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
DLKP N+L+D L+DFG+A+ + R T + T+ Y APE R
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVR-----TYTHEVVTLWYRAPEILLGSRQY 177
Query: 181 ANG-DVYSFGIMLIETFTRK------KPTDEIF 206
+ D++S G + E R+ D++F
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 52/266 (19%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVI---- 62
+G G G VF A D VAVK L + K E ++++ + H NI+KV
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 63 --SSCSNEEFKAL--------VLEYMP---HGSLEKYLHSSNYI-LDIYQRLNIMIDVAS 108
S E+ +L V EYM LE+ S + L +YQ L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTRE-DISTIQTQTLATI 166
L+Y+H SA V+H DLKP+NV ++ +++V + DFG+A+++ ++ L T
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 167 GYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNG--EMTLKHWVN 217
Y +P Y K D+++ G + E T K +F G E+ +
Sbjct: 183 WYRSPRLLLSPNNYTKA------IDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLIL 232
Query: 218 DWLPISTKEIVDPNLLSREDIHFVAK 243
+ +P+ +E D N L FV
Sbjct: 233 ESVPVVREE--DRNELLNVIPSFVRN 256
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-11
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISS 64
+G+G +G V R DG + +K NL+ R K+ + E +++ + H NI+ S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 65 CSNEE-FKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
E+ +V+ + G L L +L Q + + +A L+YLH ++
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSAN 182
H DLK NV L + + D GIA++L E+ + + + T YM+PE +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 183 GDVYSFGIMLIETFTRK 199
DV++ G + E T K
Sbjct: 183 SDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-11
Identities = 38/112 (33%), Positives = 52/112 (46%), Gaps = 25/112 (22%)
Query: 102 IMIDVASTLEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158
+ + + L YL H VIH D+KPSN+LLD + L DFGI+ L S
Sbjct: 119 MTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKA 170
Query: 159 QTQTLATIGYMAPEYGKEGRVSAN---------GDVYSFGIMLIETFTRKKP 201
+T++ YMAPE R+ DV+S GI L+E T + P
Sbjct: 171 KTRSAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-11
Identities = 63/260 (24%), Positives = 108/260 (41%), Gaps = 68/260 (26%)
Query: 8 IGRGGFGSVFK--ARLGDGMEVAVKVFNL--QYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
+G G + +V+K +R+ +G VA+KV ++ + G F + E ++K + H NI+ +
Sbjct: 13 LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 64 SCSNEEFKALVLEYMPHGSLEKY-------LHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
+E V EYM H L +Y LH N L ++Q L L Y+H
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIH-- 120
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT----LATIGYMAP- 171
++H DLKP N+L+ L+DFG+A+ +I +QT + T+ Y P
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSEVVTLWYRPPD 173
Query: 172 ------EYGKEGRVSANGDVYSFGIMLIETFTRKK---------------------PTDE 204
+Y S+ D++ G + IE + PT++
Sbjct: 174 VLLGATDY------SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227
Query: 205 IFNGEMTLKHWVNDWLPIST 224
+ G L ++ +W
Sbjct: 228 TWPGVSKLPNYKPEWFLPCK 247
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVK---VFNLQYGRVFKSFDVECEMMKSIHHRNIIK--- 60
+G G FG V+KAR + G VA+K + N + G + E +++K + H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74
Query: 61 -VISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
+ + K +V YM H L L + + L Q M+ + + YLH
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH- 132
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ----------TQTLAT 165
++H D+K +N+L+D+ + ++DFG+A+ + T + T
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLARPYD-GPPPNPKGGGGGGTRKYTNLVVT 189
Query: 166 IGYMAPEY--GKEGRVSANGDVYSFGIMLIETFTRK 199
Y PE G E R + D++ G + E FTR+
Sbjct: 190 RWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS- 64
+IGRGGFG V+ R D G A+K + K ++ +++ R ++ ++S+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54
Query: 65 ------CSNEEFKA-----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL 113
C F +L+ M G L +L + R ++ LE++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173
H + V++ DLKP+N+LLD++ +SD G+A +++ ++ T GYMAPE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEV 166
Query: 174 GKEGRV-SANGDVYSFGIMLIETFTRKKP 201
++G ++ D +S G ML + P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 32/234 (13%)
Query: 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFD---VECEMMKSIHHRN 57
F +G G FG V A+ G G A+K + K E ++ + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS----NYILDIYQRLNIMIDVASTLEYL 113
I+ ++ S +E +LE++ G L +L + N + Y ++ EYL
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAPE 172
H S +I+ DLKP N+LLD+ ++DFG AK + +T TL T Y+APE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE 185
Query: 173 YGKEGRVSANGDVYSFGIMLIETFTRKKP---------TDEIFNGEMTLKHWVN 217
+ D ++ G++L E P ++I G + +W +
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMMK------SIHHRNII 59
++G+G FG V A L EV A+KV L+ + + DV+C M + + H +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ ++ V+EY+ G L + S + R +V L +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
VI+ DLK N+LLD L+DFG+ K ++T T T Y+APE +E
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPDYIAPEILQELEY 173
Query: 180 SANGDVYSFGIMLIETFTRKKP-----TDEIF 206
+ D ++ G+++ E + P D++F
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 8 IGRGGFGSVFKARLGDGME-VAVKVFNL---QYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG G FG+V+ A E VAVK + Q ++ E + ++ + H N I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAST-------LEYLHFG 116
E LV+EY L S++ +L+++++ +++A+ L YLH
Sbjct: 89 CYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-- 138
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY--- 173
S +IH D+K N+LL + L+DFG A S+ + T +MAPE
Sbjct: 139 -SHNMIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILA 191
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFN 207
EG+ DV+S GI IE RK P +FN
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPP---LFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 8 IGRGGFGSVFKARLGDGME-VAVKVFNLQYGRVFKSFDV-ECEMMKSIHHRNIIKVISSC 65
+G G + +V+K R E VA+K +L S + E +MK + H NI+++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 66 SNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
E LV EYM L+KY+ H LD + + L+ + F + +V+H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV-SAN 182
DLKP N+L++ L+DFG+A+ ++T + + T+ Y AP+ R S +
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIP-VNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181
Query: 183 GDVYSFGIMLIETFT 197
D++S G ++ E T
Sbjct: 182 IDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 7 LIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMK------SIHHRNII 59
++G+G FG V ARL G AVKV L+ + + DVEC M + + +H +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
++ + V+E++ G L ++ S + R ++ S L +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+I+ DLK NVLLD L+DFG+ K +T + T Y+APE +E
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAPEILQEMLY 173
Query: 180 SANGDVYSFGIMLIETFTRKKP-----TDEIF----NGEMTLKHWVN 217
+ D ++ G++L E P D++F N E+ W++
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 60/231 (25%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-------HRNII 59
+G G FGSV+ AR G VA+K + F S++ EC ++ + H NI+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 60 K---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLH- 114
K V N+E V EYM G+L + + +I+ + L ++H
Sbjct: 62 KLKEVFRE--NDELY-FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ-----TQTLATIGYM 169
G+ H DLKP N+L+ V ++DFG+A RE I+ T ++T Y
Sbjct: 118 HGF----FHRDLKPENLLVSGPEVVKIADFGLA----RE----IRSRPPYTDYVSTRWYR 165
Query: 170 APE-------YGKEGRVSANGDVYSFGIMLIETFTRKKP-------TDEIF 206
APE Y S+ D+++ G ++ E +T +P D+++
Sbjct: 166 APEILLRSTSY------SSPVDIWALGCIMAELYTL-RPLFPGSSEIDQLY 209
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 16/230 (6%)
Query: 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG G G V A + G VAVK +L+ + + E +M+ H N++++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ +V+E++ G+L + + ++ Q + + V L LH + VIH D+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
K ++LL + LSDFG +++E + + T +MAPE D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 187 SFGIMLIETFTRKKPTDEIFNGEMTLK--HWVNDWLPISTKEI--VDPNL 232
S GIM+IE + P FN E LK + D LP K + V P+L
Sbjct: 201 SLGIMVIEMVDGEPP---YFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSL 246
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFD-----VECEMMKSIHHRNIIKV 61
+G+GGFG V ++ + G A K L R+ K +E E+++ ++ I+ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACK--KLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL 58
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ ++ LV+ M G L+ ++ + L++ + ++ + + +LH S
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
+++ D+KP NVLLDD LSD G+A L +D TI TQ T GYMAPE KE S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL--KDGKTI-TQRAGTNGYMAPEILKEEPYS 172
Query: 181 ANGDVYSFGIMLIETFTRKKP 201
D ++ G + E + P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHH 55
F ++G+GGFG V ++ G A K L+ R+ K E ++++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKQILEKVNS 59
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLH 114
R ++ + + ++ LVL M G L+ ++++ N D + + ++ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG 174
++++ DLKP N+LLDD +SD G+A + + TI+ + + T+GYMAPE
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGR-VGTVGYMAPEVV 173
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKP 201
K R + + D + G ++ E K P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 8 IGRGGFGSVFKARLGDGME-VAVKVFNL-QYGRVFKSFDV-ECEMMKSIHHRNIIKVISS 64
IG G +G V+KAR E +A+K L Q S + E ++K + H NI+++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+E+ LV EY+ L+K++ SS ++ + + + + Y H S +V+H
Sbjct: 70 VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125
Query: 124 CDLKPSNVLLDDNMVA-HLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR-VSA 181
DLKP N+L+D A L+DFG+A+ + T T + T+ Y APE R S
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTF-THEVVTLWYRAPEILLGSRHYST 183
Query: 182 NGDVYSFGIMLIETFTRK 199
D++S G + E +K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 65/225 (28%), Positives = 97/225 (43%), Gaps = 28/225 (12%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEM------MKSIHHRNII 59
+IG+G FG V AR + AVKV LQ + K + + M +K++ H ++
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ S + VL+Y+ G L +L L+ R ++AS L YLH S
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL--ATIGYMAPEYGKEG 177
+++ DLKP N+LLD L+DFG+ K E+I T + T Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 178 RVSANGDVYSFGIMLIETFTRKKP---------TDEIFNGEMTLK 213
D + G +L E P D I N + LK
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 65/233 (27%), Positives = 95/233 (40%), Gaps = 49/233 (21%)
Query: 7 LIGRGGFGSVFKARLGD---GMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIK 60
LIG+GG G V+ A D VA+K + + K F E ++ + H I+
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 61 VISSCSNEEFKALVLEYMPH----------------GSLEKYLHSSNYILDIYQRLNIMI 104
V S CS+ + V MP+ SL K L + L+I
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF---LSIFH 120
Query: 105 DVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-----DIS--- 156
+ +T+EY+H S V+H DLKP N+LL + D+G A E DI
Sbjct: 121 KICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 157 --------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKP 201
TI + + T YMAPE S + D+Y+ G++L + T P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 41/254 (16%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS- 64
+IGRGGFG V+ R D G A+K + K ++ +++ R ++ ++S+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54
Query: 65 ------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL 113
C + F + +L+ M G L +L + R ++ LE++
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHM 113
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ-TLATIGYMAPE 172
H + V++ DLKP+N+LLD++ +SD G+A D S + ++ T GYMAPE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPE 165
Query: 173 YGKEGRV-SANGDVYSFGIMLIE------TFTRKKPTDEIFNGEMTLKHWVNDWLPIS-T 224
++G ++ D +S G ML + F + K D+ MTL + LP S +
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFS 223
Query: 225 KEIVDP--NLLSRE 236
E+ LL R+
Sbjct: 224 PELRSLLEGLLQRD 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 61/197 (30%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDVECEM------MKSIHHRNII 59
+IG+G FG V A R DG AVKV LQ V + + M +K++ H ++
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ S E VL+++ G L +L + R ++AS L YLH S
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SI 115
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL--ATIGYMAPEYGKEG 177
+++ DLKP N+LLD L+DFG+ K E I+ T T T Y+APE ++
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 178 RVSANGDVYSFGIMLIE 194
D + G +L E
Sbjct: 172 PYDNTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-10
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 8 IGRGGFGSVFKA---RLGDG-----MEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII 59
+G+G F +FK +GD EV +KV + + +SF MM + H++++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEY-LHFGYS 118
C + +V EY+ GSL+ YL + +++I +L +VA L + LHF
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL----EVAKQLAWALHFLED 118
Query: 119 AQVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLTREDISTIQTQTLATIGYMA 170
+ H ++ NVLL +D + LSD GI+ + ++I L I ++
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLERIPWVP 172
Query: 171 PEYGKEGR-VSANGDVYSFGIMLIETFT 197
PE + + +S D +SFG L E F+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 68/260 (26%), Positives = 105/260 (40%), Gaps = 74/260 (28%)
Query: 8 IGRGGFGSVFKARLGDGME-------VAVKVFNLQYGRV---FKSFDVECEMMKSI-HHR 56
+GRG FG V +A G+E VAVK+ L+ G +K+ E +++ I HH
Sbjct: 15 LGRGAFGKVIQAS-AFGIEKSASCRTVAVKM--LKEGATASEYKALMTELKILIHIGHHL 71
Query: 57 NIIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQ----RLNIMI------- 104
N++ ++ +C+ +V+ EY G+L YL S Y+ R M
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 105 ---------DVAS--------------------------TLEYLHFGYSAQV-------- 121
AS TLE L YS QV
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDL-ISYSFQVARGMEFLA 190
Query: 122 ----IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG 177
IH DL N+LL +N V + DFG+A+ + ++ + + +MAPE +
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 178 RVSANGDVYSFGIMLIETFT 197
+ DV+SFG++L E F+
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 9/131 (6%)
Query: 72 ALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSN 130
++ +E+M GSL++ L + I +I +++I V L YL + Q++H D+KPSN
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKH--QIMHRDVKPSN 134
Query: 131 VLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGI 190
+L++ L DFG++ L I ++ + T YM+PE + S D++S G+
Sbjct: 135 ILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 191 MLIETFTRKKP 201
L+E + P
Sbjct: 191 SLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 12/195 (6%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKVISSC 65
+G+G +GSV+K G+ +A+K L+ F +E +++ I+ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
E + +EYM GSL+K I + + I A +IH D
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG-- 183
+KP+NVL++ N L DFG++ L ++++ + YMAPE K G + N
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGVSGNL----VASLAKTNIGCQSYMAPERIKSGGPNQNPTY 184
Query: 184 ----DVYSFGIMLIE 194
DV+S G+ ++E
Sbjct: 185 TVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 7 LIGRGGFGSVFKARLGDG--------MEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI 58
++G G +G VF R G M+V K +Q + + E +++ +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 59 IKVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+ + E K L+L+Y+ G + +L+ + + R ++ LE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH--- 122
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTREDISTIQTQTLATIGYMAPEY--G 174
+++ D+K N+LLD L+DFG++K L+ E T TI YMAPE G
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTIEYMAPEIIRG 180
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKP 201
K G A D +S GI++ E T P
Sbjct: 181 KGGHGKAV-DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 8/191 (4%)
Query: 7 LIGRGGFGSVFKARLGDGME-VAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVIS 63
++G G +G V K R + E VA+K F V ++ E +M++++ NI+++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+ LV EY+ LE N + R I ++ +H+ + ++H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDIVH 123
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
D+KP N+L+ N V L DFG A+ L+ E + T+ +AT Y +PE
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 184 DVYSFGIMLIE 194
D++S G +L E
Sbjct: 183 DMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKS----FDVECEMMKSIHHRNIIKVI 62
+IGRG FG V R +V ++ + +S F E ++M + ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ ++ + +V+EYMP G L + SNY + + + R +V L+ +H S
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 163
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY----GKEG 177
IH D+KP N+LLD + L+DFG + +E + T + T Y++PE G +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 222
Query: 178 RVSANGDVYSFGIMLIETFTRKKP 201
D +S G+ L E P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 46/172 (26%), Positives = 88/172 (51%), Gaps = 18/172 (10%)
Query: 8 IGRGGFGSVFKAR--LGDGMEVAVKVFNLQYGRVFKSFDV-ECEMMKSIHHRNIIKVISS 64
+G G + +V+K R L D + VA+K L++ + E ++K + H NI+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
E+ LV EY+ L++YL ++++ N+ + + L L++ + +V+H
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT----LATIGYMAPE 172
DLKP N+L+++ L+DFG+A+ +I T+T + T+ Y P+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNEVVTLWYRPPD 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKS----FDVECEMMKSIHHRNIIKVI 62
+IGRG FG V R +V ++ + +S F E ++M + ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ ++++ +V+EYMP G L + SNY + +V L+ +H S +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGLI 164
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY----GKEGR 178
H D+KP N+LLD + L+DFG + + T + T Y++PE G +G
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDGY 223
Query: 179 VSANGDVYSFGIMLIETFTRKKP 201
D +S G+ L E P
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFN----LQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+IGRG FG V+ R D +V A+KV ++ ++ E +++ I+K+
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQI-AHVRAERDILADADSPWIVKL 66
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH-FGYSAQ 120
S +EE LV+EYMP G L L + + R I V + L+ +H G+
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA-LDSVHKLGF--- 122
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAK 148
IH D+KP N+L+D + L+DFG+ K
Sbjct: 123 -IHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 36/120 (30%), Positives = 62/120 (51%), Gaps = 7/120 (5%)
Query: 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD 134
+E+M GSL++ L + I + I I V L YL + +++H D+KPSN+L++
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKH--KIMHRDVKPSNILVN 134
Query: 135 DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIE 194
L DFG++ L I ++ + T YM+PE + + D++S G+ L+E
Sbjct: 135 SRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 52/203 (25%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 2 FSENNLIGRGGFGSVFK-ARLGDGMEVAVKVFNLQYGRVFKSFDV-ECEMMKSIHHRNII 59
F + + +G G G VFK + G+ +A K+ +L+ ++ + E +++ + I+
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASTLEYLHFGYS 118
+ ++ ++ +E+M GSL++ L + I + Q L + I V L YL +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREKH- 123
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR 178
+++H D+KPSN+L++ L DFG++ L I ++ + T YM+PE +
Sbjct: 124 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTH 178
Query: 179 VSANGDVYSFGIMLIETFTRKKP 201
S D++S G+ L+E + P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 8 IGRGGFGSVFKAR--LGDGMEVAVKVFNLQYGRVFKSFDV-ECEMMKSIHHRNIIKVISS 64
+G G + +VFK R L + + VA+K L++ + E ++K++ H NI+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
E LV EY+ L++YL + ++ ++ M + L Y H +++H
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAK 148
DLKP N+L+++ L+DFG+A+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 22/180 (12%)
Query: 45 VECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGS--LEKYLHSSNYILDIYQRLNI 102
+E ++++++H ++I++ + + +VL PH S L YL + L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162
Query: 103 MIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
+ L YLH + ++IH D+K N+ ++D + D G A+ +
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF----PVVAPAFLG 215
Query: 163 LA-TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK---------PTDEIFNGEMTL 212
LA T+ APE + ++ D++S GI+L E P + + + L
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 8/144 (5%)
Query: 8 IGRGGFGSVFKAR--LGDGMEVAVKVFNLQYGRVFKSFDV-ECEMMKSIHHRNIIKVISS 64
+G G + +VFK R L + + VA+K L++ + E ++K + H NI+ +
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
++ LV EY+ L++Y+ I+ ++ N+ I + L L + + +V+H
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAK 148
DLKP N+L+++ L+DFG+A+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 36/213 (16%)
Query: 7 LIGRGGFGSVFKARLGDGMEV----AVKVFNLQYGRVFKSF--DVECEMMKSIHHRNIIK 60
++G+G FG VF R G + A+KV +V +E +++ ++H I+K
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN--IMI----------DVAS 108
+ + E L+L+++ G D++ RL+ +M ++A
Sbjct: 63 LHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELAL 109
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY 168
L++LH S +I+ DLKP N+LLD+ L+DFG++K D T+ Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEY 164
Query: 169 MAPEYGKEGRVSANGDVYSFGIMLIETFTRKKP 201
MAPE + + D +SFG+++ E T P
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVI-- 62
++G G +G V+K R + G A+KV ++ + +E M+K HHRNI
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81
Query: 63 ----SSCSNEEFKALVLEYMPHGSLEKYLHSS--NYILDIYQRLNIMIDVASTLEYLHFG 116
S +++ LV+E+ GS+ + ++ N + + + I ++ L +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH-- 138
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI--QTQTLATIGYMAPEY- 173
+ +VIH D+K NVLL +N L DFG++ L R T+ + + T +MAPE
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR----TVGRRNTFIGTPYWMAPEVI 193
Query: 174 ----GKEGRVSANGDVYSFGIMLIE 194
+ D++S GI IE
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 39/131 (29%), Positives = 63/131 (48%), Gaps = 7/131 (5%)
Query: 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVL 132
L+L+Y+ G L +L+ + + R+ I ++ L++LH +I+ D+K N+L
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137
Query: 133 LDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY--GKEGRVSANGDVYSFGI 190
LD L+DFG++K E+ + TI YMAPE G G D +S G+
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196
Query: 191 MLIETFTRKKP 201
+ E T P
Sbjct: 197 LTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHH 55
F ++G+GGFG V ++ G A K L+ R+ K E +++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLH 114
R ++ + + ++ LVL M G L+ ++++ N D + + ++ LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG 174
++++ DLKP N+LLDD +SD G+A + + T++ + + T+GYMAPE
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGR-VGTVGYMAPEVI 173
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKP 201
+ + + D + G ++ E + P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 55/262 (20%), Positives = 103/262 (39%), Gaps = 36/262 (13%)
Query: 23 DGMEVAVKVF---NLQYGRVFKSFDVECEMMKSIHHRNIIKV----ISSCSNEEFKALVL 75
+ EV ++ F + + + + E + ++ I NI+K+ I + +L+L
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD 135
EY G L + L L +L++ ID L L+ + + +L + L+ +
Sbjct: 102 EYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTE 158
Query: 136 NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLI 193
N + G+ K+L+ + + Y + + + + D+YS G++L
Sbjct: 159 NYKLKIICHGLEKILSSPPFKNVNF-----MVYFSYKMLNDIFSEYTIKDDIYSLGVVLW 213
Query: 194 ETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNV 253
E FT K P F ++TKEI D L+ ++ C + +
Sbjct: 214 EIFTGKIP----FEN-------------LTTKEIYD--LIINKNNSLKLPLDCPLEIKCI 254
Query: 254 AMECTVESPEQRINAKEIVTKL 275
CT +R N KEI+ L
Sbjct: 255 VEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-09
Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 44/210 (20%)
Query: 8 IGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IG+G FG V++ R D + A+KV + K + E+ +I RNI+ V +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNIL-VRTLLD 53
Query: 67 NEEFKA-------------LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL 113
F LV +YM G L +L + + I ++ LE+L
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTREDISTIQTQTL-ATIGYMAP 171
H +++ DLKP N+LLD L DFG++K LT T T T Y+AP
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT----TNTFCGTTEYLAP 165
Query: 172 E-------YGKEGRVSANGDVYSFGIMLIE 194
E Y K D +S G+++ E
Sbjct: 166 EVLLDEKGYTKH------VDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-09
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 7 LIGRGGFGSVFKARLGDG--------MEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI 58
++G G +G VF R G M+V K +Q + + E ++++ I
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 59 IKVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI-DVASTLEYLHFG 116
+ + + K L+L+Y+ G L + H S Q + I ++ LE+LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLALEHLH-- 122
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY--G 174
+I+ D+K N+LLD N L+DFG++K ED TI YMAP+ G
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKP 201
+G D +S G+++ E T P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 22/162 (13%)
Query: 8 IGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMMKSIH-HRN-------- 57
I RG FG V+ R + ++ AVKV V K+ + M+ + R+
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKV-------VKKADMINKNMVHQVQAERDALALSKSP 64
Query: 58 -IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
I+ + S + LV+EY+ G ++ LH Y D + + +VA L+YLH
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH-- 121
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158
+IH DLKP N+L+ + L+DFG++K+ +++ +
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNI------ 58
L+G G +G V+K R + G A+KV ++ G + E M+K HHRNI
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 59 -IKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASTLEYLHFG 116
IK +++ LV+E+ GS+ + ++ L I ++ L +LH
Sbjct: 72 FIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 128
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI--QTQTLATIGYMAPEY- 173
+VIH D+K NVLL +N L DFG++ L R T+ + + T +MAPE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR----TVGRRNTFIGTPYWMAPEVI 183
Query: 174 ----GKEGRVSANGDVYSFGIMLIE 194
+ D++S GI IE
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVF---NLQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
L+GR + F A R D E V F N + + ++ C + + H I+K
Sbjct: 74 LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHC--LAACDHFGIVKHF 131
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------------IMIDVASTL 110
+++ L++EY G L K I QRL + + L
Sbjct: 132 DDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMA 170
+ +H S +++H DLK +N+ L + L DFG +K + + + T Y+A
Sbjct: 183 DEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 171 PEYGKEGRVSANGDVYSFGIMLIETFTRKKP 201
PE + R S D++S G++L E T +P
Sbjct: 240 PELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 8 IGRGGFGSVF-----KARLGDGMEV--AVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
+G+G FG+V+ KA + ++V + V L ++ + E +++ + H I+K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 61 VISSCSNEEFKALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+S + ++ EY L+ + L + L Q I + + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--- 123
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DISTIQTQTLATIGYMAPEYGKE 176
+++H DLK N+ L +N++ + DFG+++LL D++T T T YM+PE K
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEALKH 179
Query: 177 GRVSANGDVYSFGIMLIE 194
+ D++S G +L E
Sbjct: 180 QGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 8 IGRGGFGSVFK-ARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVI--- 62
IG+G +G V+K DG AVK+ + V + + E +++S+ +H N++K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 63 ---SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASTLEYL 113
+ LVLE GS+ + + +L QRL+ I+ L++L
Sbjct: 89 YKADKLVGGQL-WLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHL 144
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173
H + ++IH D+K +N+LL L DFG++ LT + + ++ T +MAPE
Sbjct: 145 H---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEV 199
Query: 174 -----GKEGRVSANGDVYSFGIMLIE 194
+ A DV+S GI IE
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 24/152 (15%)
Query: 8 IGRGGFGSVFKAR--LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVIS 63
+G G + +V+K R L + VA+K L++ G F + E ++K + H NI+ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 64 SCSNEEFKALVLEYMPHGSLEKY-------LHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
++ LV EY+ L++Y L N L ++Q L L Y H
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH-- 120
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148
+V+H DLKP N+L+ + L+DFG+A+
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKS----FDVECEMMKSIHHR 56
F +IGRG FG V R +V A+K+ + ++ + +S F E ++M +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLH- 114
I+++ + ++++ +V+EYMP G L + SNY I + + R +V L+ +H
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTA-EVVLALDAIHS 160
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-- 172
G+ IH D+KP N+LLD + L+DFG + + T + T Y++PE
Sbjct: 161 MGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVL 215
Query: 173 --------YGKEGRVSANGDVYSFGIMLIE 194
YG+E D +S G+ L E
Sbjct: 216 KSQGGDGYYGRE------CDWWSVGVFLYE 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 38/223 (17%)
Query: 8 IGRGGFGSVFKAR---LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH---HRNIIK- 60
+G+G +G V AR + VA+K + + + E+ H H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 61 -----VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD------IYQRLNIMIDVAST 109
V NE + L E M L + + S + D IYQ L
Sbjct: 68 YDMDIVFPGNFNELY--LYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL-------CG 117
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT--REDISTIQTQTLATIG 167
L+Y+H SA V+H DLKP N+L++ + + DFG+A+ + + + T+ +AT
Sbjct: 118 LKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 168 YMAPEYG-KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
Y APE + DV+S G +L E RK +F G+
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP----VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 62/265 (23%), Positives = 104/265 (39%), Gaps = 78/265 (29%)
Query: 8 IGRGGFGSVFKA------RLGDGMEVAVKVFNLQYGRV---FKSFDVECEMMKSI-HHRN 57
+GRG FG V +A + VAVK+ L+ G ++ E +++ I HH N
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 72
Query: 58 IIKVISSCSNEEFKALVL-EYMPHGSLEKYL------------------HSSNYI----L 94
++ ++ +C+ +V+ E+ G+L YL +
Sbjct: 73 VVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132
Query: 95 DIYQRLNIMIDVAS------------------------------TLEYLHFGYSAQV--- 121
D+ +RL+ + S TLE L YS QV
Sbjct: 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDL-ICYSFQVAKG 191
Query: 122 ---------IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE 172
IH DL N+LL +N V + DFG+A+ + ++ + + +MAPE
Sbjct: 192 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 173 YGKEGRVSANGDVYSFGIMLIETFT 197
+ + DV+SFG++L E F+
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 94 LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153
LD+ L VA +++L S IH D+ NVLL D VA + DFG+A+ + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
++ + +MAPE + + DV+S+GI+L E F+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 8 IGRGGFGSV---FKARLGDGMEVAVKVFNLQYGRVF--KSFDVECEMMKSIHHRNIIKVI 62
+G G +GSV F + G+ VAVK + + + K E ++K + H N+I ++
Sbjct: 25 VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 63 S----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+ S EEF + L ++ L + D Q L + + L+Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH--- 137
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG 177
SA +IH DLKPSN+ ++++ + DFG+A+ E T +AT Y APE
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 192
Query: 178 -RVSANGDVYSFGIMLIETFT 197
+ D++S G ++ E T
Sbjct: 193 MHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 28/198 (14%)
Query: 25 MEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLE 84
++V +KV + + + +F MM+ + H++I+ + C + +V E++ G L+
Sbjct: 33 IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 85 KYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL-------DDNM 137
++H + +L + + +AS L YL ++H ++ N+LL +
Sbjct: 93 LFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGP 149
Query: 138 VAHLSDFGIA-KLLTREDISTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIET 195
LSD GI +L+R+ + + I ++APE ++ + S D +SFG L E
Sbjct: 150 FIKLSDPGIPITVLSRQ-------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
Query: 196 FTRKKPTDEIFNGEMTLK 213
+NGE+ LK
Sbjct: 203 ---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 28/206 (13%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHHRNIIKVI 62
+G G FG V A + V + + ++ K V E +++ I+H + +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSS----NYILDIYQRLNIMIDVASTLEYLHFGYS 118
S +E + LVLE++ G +L + N + Y ++I EYL S
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI-----FEYLQ---S 149
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPEYGK 175
+++ DLKP N+LLD + ++DFG AK+ + T+T G Y+APE
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAPEILL 201
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKP 201
D ++ GI + E P
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 58/303 (19%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRN-IIKVIS 63
IG G +G V+KAR G VA+K L+ + + E +++ + I++++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 64 SCSNEEFKA-----LVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASTLEYLH 114
EE LV EY+ L+K++ S L + M + + + H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 115 FGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173
V+H DLKP N+L+D + ++D G+ + + S T + T+ Y APE
Sbjct: 128 ---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEV 182
Query: 174 GKEGR-VSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTL 212
S D++S G + E ++ PT++++ G L
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242
Query: 213 KHW--VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
+ W W P V P+ LS E + + K ++ P +RI+AK
Sbjct: 243 RDWHEFPQWKPQDLSRAV-PD-LSPEGLDLLQK----MLRYD---------PAKRISAKA 287
Query: 271 IVT 273
+T
Sbjct: 288 ALT 290
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 46 ECEMMKSIHHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH------SSNYI 93
E +MK ++H+NII +++ S EEF+ LV+E M +L + + +Y+
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYL 123
Query: 94 LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153
L YQ L +++LH SA +IH DLKPSN+++ + + DFG+A+
Sbjct: 124 L--YQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 168
Query: 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFG-IM 191
S + T + T Y APE N D++S G IM
Sbjct: 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 46 ECEMMKSIHHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 99
E ++K ++H+NII +++ S EEF+ LV+E M +L + +H LD +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERM 125
Query: 100 LNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159
++ + +++LH SA +IH DLKPSN+++ + + DFG+A+ + +
Sbjct: 126 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMM 179
Query: 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW 215
T + T Y APE N D++S G ++ E IF G + W
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK----GSVIFQGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV--ECEMMKSIHHRNIIKVIS 63
+IG+G +G V A G +VA+K N + V + + E ++++ + H +I+++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 64 ---SCSNEEFKAL--VLEYMPHGSLEKYLHS----------SNYILDIYQRLNIMIDVAS 108
S EFK + V E M E LH ++ +YQ L
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI-QTQTLATIG 167
L+Y+H +A V H DLKP N+L + + + DFG+A++ + + I T +AT
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 168 YMAPEYGKE--GRVSANGDVYSFGIMLIETFTRK 199
Y APE + + D++S G + E T K
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 64/224 (28%), Positives = 94/224 (41%), Gaps = 58/224 (25%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMK 51
+ + +G G FG V AR G VA+K ++ K F E +++K
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELKLLK 64
Query: 52 SIHHRNIIKV----ISSCSNEEFKALVLEYMPH-----GSLEKYLHSSNYILDIYQRLNI 102
+ H NII + IS + F +L H LEK Y L YQ L
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF--IQYFL--YQILR- 119
Query: 103 MIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
L+Y+H SA V+H DLKPSN+L+++N + DFG+A++ + T
Sbjct: 120 ------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGY 165
Query: 163 LATIGYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRK 199
++T Y APE Y E D++S G + E K
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 18/215 (8%)
Query: 2 FSENNLIGRGGFGSVFKAR---LGD--GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHR 56
F +L+GRG FG V R GD M+V K L V F+ E +++ +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETV-SFFEEERDILSISNSP 61
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
I ++ + +++ LV+EY P G L L N D + +A + +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE---- 172
+ +H D+KP NVL+D L+DFG A LT + + T Y+APE
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPDYIAPEVLTT 177
Query: 173 ---YGKEGRVSANGDVYSFGIMLIETFTRKKPTDE 204
GK G D +S G++ E + P E
Sbjct: 178 MNGDGK-GTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165
VA +E+L S + IH DL N+LL +N V + DFG+A+ + ++ +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
+ +MAPE + + DV+SFG++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-08
Identities = 64/291 (21%), Positives = 110/291 (37%), Gaps = 58/291 (19%)
Query: 8 IGRGGFGSVFKARLGDGMEVA-VKVFNLQYGRVFK---SFDVECEMMKSIHHRNIIKVIS 63
IG G FG V + + VA V V L+ K F + + + + H NI++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYIL---DIYQRLNIMIDVASTLEYLHFGYSAQ 120
C LV EY G L+ YL + + + ++A+ + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE---G 177
+H DL N L ++ + D+GI +ED + + ++APE E G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 178 RVSAN----GDVYSFGIMLIETF-TRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232
++A +V++ G+ L E F +P +L
Sbjct: 180 LITAEQTKPSNVWALGVTLWELFENAAQPY---------------------------SHL 212
Query: 233 LSREDIHFVAKEQCVSFV------------FNVAMECTVESPEQRINAKEI 271
RE ++ V K+Q V + V C + SPE+R A+E+
Sbjct: 213 SDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWL-SPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 3/104 (2%)
Query: 94 LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153
LD L+ VA + +L S IH DL N+LL + + DFG+A+ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
++ + +MAPE + DV+S+GI+L E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 46 ECEMMKSIHHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 99
E +MK ++H+NII +++ + EEF+ LV+E M +L + + LD +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 121
Query: 100 LNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159
++ + +++LH SA +IH DLKPSN+++ + + DFG+A+ S +
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175
Query: 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW 215
T + T Y APE N D++S G ++ E K +F G + W
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165
VA+ +E+L S +H DL NVL+ + + + DFG+A+ + R+ + T
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
+ +MAPE + DV+SFGI+L E FT
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 94 LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153
L L+ VA +E+L S +H DL NVLL + + DFG+A+ + +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
+ T + +MAPE + + DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFD------VECEMMKSIHHRNII 59
L+G+G FG V R G A+K+ + V + D E ++K+ H +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKE---VIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ S ++ V+EY+ G L +L + R ++ S L+YLH S
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SG 114
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
++++ DLK N++LD + ++DFG+ K D +T++T T Y+APE ++
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI-TDAATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 180 SANGDVYSFGIMLIETFTRKKP 201
D + G+++ E + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNL--QYGRVFKSFDVECEMMKSIHHRNIIKVISS 64
IG G FG + DG + +K N+ + + E ++ ++ H NI++ S
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYIL-DIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+V++Y G L K +++ +L Q L+ + + L+++H +++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILH 124
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ--TQTLATIGYMAPEYGKEGRVSA 181
D+K N+ L + L DFGIA++L ST++ + T Y++PE + +
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLN----STVELARTCIGTPYYLSPEICENRPYNN 180
Query: 182 NGDVYSFGIMLIETFTRK 199
D+++ G +L E T K
Sbjct: 181 KSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSI-HHRNIIK 60
IG G F V KA+ G A+K + FKS + E + ++ + H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK----KHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 61 VISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+I + + ALV E M +L + + L + + M + +L+++H
Sbjct: 63 LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---R 118
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ--TQTLATIGYMAPE 172
+ H D+KP N+L+ D+++ L+DFG + I + T+ ++T Y APE
Sbjct: 119 NGIFHRDIKPENILIKDDIL-KLADFGSCR-----GIYSKPPYTEYISTRWYRAPE 168
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 57/183 (31%), Positives = 87/183 (47%), Gaps = 30/183 (16%)
Query: 6 NLIGRGGFGSVFKARLGDGME-VAVK--VFNLQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
N+IG G FG V++A D E VA+K + + QY + E +MK+++H NII +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK------NRELLIMKNLNHINIIFLK 125
Query: 63 SSCSNEEFKA--------LVLEYMPHG--SLEKYLHSSNYILDIYQRLNIMIDVASTLEY 112
E FK +V+E++P K+ +N+ L ++ + L Y
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 113 LHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAK--LLTREDISTIQTQTLATIGYM 169
+H S + H DLKP N+L+D N L DFG AK L + +S I ++ Y
Sbjct: 186 IH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YR 237
Query: 170 APE 172
APE
Sbjct: 238 APE 240
|
Length = 440 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 40/184 (21%)
Query: 8 IGRGGFGSV---FKARLGDGMEVAVKVFNLQYGRVFKSF------DVECEMMKSIHHRNI 58
+G G +GSV + RL +VAVK + R F+S E ++K + H N+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 59 IKVIS----SCSNEEFKALVLEYMPHGSLEKYLHSSNYILD------IYQRLNIMIDVAS 108
I ++ + S E F + L G+ + + D IYQ L
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR------- 129
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY 168
L+Y+H SA +IH DLKPSNV ++++ + DFG+A+ E T +AT Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWY 181
Query: 169 MAPE 172
APE
Sbjct: 182 RAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 15/161 (9%)
Query: 46 ECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-----LDIYQRL 100
E +++K+I HR II +I + K+ V MP + + Y+ L + Q +
Sbjct: 136 EIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLF----TYVDRSGPLPLEQAI 188
Query: 101 NIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160
I + L YLH +IH D+K N+ LD+ A L DFG A L +
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245
Query: 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKP 201
T+ +PE A D++S G++L E +
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDV-ECEMMKSIHHRNIIKVIS--- 63
IG+G FG V + R D +++ L+ R K+ V E+ ++ R ++ ++
Sbjct: 1 IGKGSFGKVMQVRKRD----TQRIYALKTIR--KAHIVSRSEVTHTLAERTVLAQVNCPF 54
Query: 64 ------SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
S + E LVL ++ G L +L D+ + ++ LE LH
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH--- 110
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG 177
VI+ DLKP N+LLD L DFG+ KL ++D T T Y+APE
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT--NTFCGTPEYLAPELLLGH 168
Query: 178 RVSANGDVYSFGIMLIETFTRKKP 201
+ D ++ G++L E T P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-07
Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 46 ECEMMKSIHHRNIIKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQR 99
E +MK ++H+NII +++ S EEF+ + V+E M +L + + LD +
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 128
Query: 100 LNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159
++ + +++LH SA +IH DLKPSN+++ + + DFG+A+ S +
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW 215
T + T Y APE N D++S G ++ E +F G + W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 7e-07
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 57/231 (24%)
Query: 7 LIGRGGFGSVFKARL-GDGMEVAVKVFNLQ-------YGRVFKSFDVECEMMKSIHHRNI 58
L+G+G G VF RL G G A+KV + + RV E E++ ++ H +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL----TEQEILATLDHPFL 63
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASTLEYLH-F 115
+ +S E + LV++Y P G L + L + + R +V LEYLH
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLL 122
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT---------------REDISTIQT 160
G ++ DLKP N+LL ++ LSDF ++K R +++I +
Sbjct: 123 GI----VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 161 QTLATIG------------YMAPEYGKEGRVSANG-----DVYSFGIMLIE 194
+T + Y+APE +S +G D ++ GI+L E
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEV-----ISGDGHGSAVDWWTLGILLYE 224
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 15/147 (10%)
Query: 7 LIGR----GGFGSVFKARLGDGMEVAVKVFNL--QYGRVFKSFDVECEMMKSIHHRNIIK 60
LIG+ + K + + + VAVK NL K E + + H NI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL---NIMIDVASTLEYLHFGY 117
++S + +V M +GS E L + + L I+ DV + L+Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH--- 118
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDF 144
S IH +K S++LL + LS
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-07
Identities = 30/147 (20%), Positives = 65/147 (44%), Gaps = 17/147 (11%)
Query: 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECE--MMKSIHHRNII--KVI 62
L+ G V+ D + +K+ + K D E E +++ + + + KV+
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSRE----KGADREREVAILQLLARKGLPVPKVL 59
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+S ++ + L++E++ +L++ + ++ +I +A L LH +
Sbjct: 60 ASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKL 149
H DL P N+L+DD + + D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKS-----IHHRNIIK 60
++G+G FG V A R G A+K+ L+ V + DVEC M++ +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 61 VISSC-SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ SC + V+EY+ G L + + ++ + + A L F +S
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI-STIQTQTL-ATIGYMAPEYGKEG 177
+I+ DLK NV+LD ++DFG+ K E++ + T+T T Y+APE
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 178 RVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEM 210
+ D ++FG++L E + P DE+F M
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFD-VECE---MMKSIHHRNIIKV 61
+IGRG + V RL + A+KV + + D V+ E ++ +H ++ +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
S E V+EY+ G L ++ + + + R +++ L YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
I+ DLK NVLLD L+D+G+ K R +T + T Y+APE +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILRGEDYGF 175
Query: 182 NGDVYSFGIMLIETFTRKKPTD 203
+ D ++ G+++ E + P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 8 IGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSC 65
IG+G +G VFK +G + AVK+ + + + + + E ++K++ H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 66 SNEEFKA-----LVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASTLEYLH 114
++ K LVLE GS+ + L +R+ I+ + L++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY- 173
+ IH D+K +N+LL L DFG++ LT + + ++ T +MAPE
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVI 196
Query: 174 ----GKEGRVSANGDVYSFGIMLIE 194
+ A DV+S GI IE
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 14/239 (5%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFD---VECEMMKSIHHRNIIKVI 62
+IGRG + V RL ++ A+KV + + D E + + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 63 SSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
SC + LV+EY+ G L ++ + + + R ++ L +LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
I+ DLK NVLLD + L+D+G+ K +T + T Y+APE +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STFCGTPNYIAPEILRGEEYGF 175
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIF-NGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
+ D ++ G+++ E + P D I N +M + ++ + I K I P LS + H
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL--FQVILEKPIRIPRFLSVKASH 232
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 56/220 (25%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNLQY-GRVF-KSFDVECEMMKSIHHRNIIKVI- 62
+G G +GSV A G +VA+K + + +F K E ++K + H N+I ++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 63 ---SSCSNEEFKA--LVLEYM---------PHGSLEK--YLHSSNYILDIYQRLNIMIDV 106
S+ S +EF+ LV+ YM S +K YL +YQ L
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL--------VYQML------ 127
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI 166
L+Y+H SA +IH DLKP N+ ++++ + DFG+A+ E T + T
Sbjct: 128 -CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTR 178
Query: 167 GYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRK 199
Y APE Y + D++S G ++ E T K
Sbjct: 179 WYRAPEVILNWMHYNQ------TVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 47/202 (23%), Positives = 83/202 (41%), Gaps = 16/202 (7%)
Query: 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDV------ECEMMKSIHHRNIIK 60
++G G FG + + + + ++ R+ KS E ++ + H NI+
Sbjct: 7 VVGEGSFGRALLVQ----HVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 61 VISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
S + +V+EY G L +K + L + + ++++H
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EK 119
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+V+H D+K N+ L N L DFG A+LLT + T Y+ PE +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAYACTYVGTPYYVPPEIWENMPY 177
Query: 180 SANGDVYSFGIMLIETFTRKKP 201
+ D++S G +L E T K P
Sbjct: 178 NNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 2e-06
Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 17/168 (10%)
Query: 49 MMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 108
+MK + N IK+ S + + L+++Y+ G L L L + I+ +
Sbjct: 64 LMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVE 120
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMV-AHLSDFGIAKLLTREDISTIQTQTL--AT 165
L LH +IH D+K NVL D +L D+G+ K I T + T
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGT 169
Query: 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLK 213
+ Y +PE K + D ++ G++ E T K P E + E+ L+
Sbjct: 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 63/252 (25%), Positives = 106/252 (42%), Gaps = 40/252 (15%)
Query: 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVE---CE-----MMKSIHHRNI 58
+GRG FG V A G A+K L+ G + +VE CE S H +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+ + + E+ V+EY G L ++H+ D++ + A + L + +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ-TQTL-ATIGYMAPEYGKE 176
++++ DLK N+LLD ++DFG+ K E + T T T ++APE E
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEVLTE 175
Query: 177 GRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231
+ D + G+++ E + P +E+F+ VND E+ P
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS------IVND-------EVRYPR 222
Query: 232 LLSREDIHFVAK 243
LSRE I + +
Sbjct: 223 FLSREAISIMRR 234
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFD------VECEMMKSIHHRNII 59
L+G+G FG V R G A+K+ + V + D E ++++ H +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASTLEYLHFGYS 118
+ + + V+EY G L + H S + +R ++ S LEYLH S
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---S 113
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL--ATIGYMAPEYGKE 176
V++ D+K N++LD + ++DFG+ K E IS T T Y+APE ++
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 177 GRVSANGDVYSFGIMLIETFTRKKP 201
D + G+++ E + P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-06
Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVEC-----EMMKSIHHRNIIK 60
+IGRG FG V +L + +V A+K+ N + K + C +++ + ++ I
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNI--MIDVASTLEYLHFGY 117
+ + +E LV++Y G L L + + + R + M+ ++ LH+
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-- 123
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK-- 175
+H D+KP N+L+D N L+DFG + L ED + + + T Y++PE +
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 176 ---EGRVSANGDVYSFGIMLIETFTRKKP 201
+G+ D +S G+ + E + P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKS-----IHHRNIIK 60
++G+G FG V A R G A+K+ L+ V + DVEC M++ +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 61 VISSC-SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ SC + V+EY+ G L ++ + Q + +++ L +LH
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLFFLH---RR 120
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE------Y 173
+I+ DLK NV+LD ++DFG+ K + ++T T Y+APE Y
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT--RTFCGTPDYIAPEIIAYQPY 178
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEM 210
GK + D +++G++L E + P DE+F M
Sbjct: 179 GK------SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 7 LIGRGGFGSVFKARLGDGM----EVAVKVFNLQ----------YGRVFKSFDVECEM-MK 51
LIG GGFG V++ + + K+ NL+ Y ++ + +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 52 SIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL---------NI 102
+I H I K C + + + ++ LEK + ++ +I++R+ NI
Sbjct: 79 NIDHLGIPKYYG-CGSFKRCRMYYRFI---LLEKLVENTK---EIFKRIKCKNKKLIKNI 131
Query: 103 MIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTREDISTIQT 160
M D+ +TLEY+H + H D+KP N+++D N ++ D+GIA ++ + I +
Sbjct: 132 MKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188
Query: 161 QT---LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKP 201
Q T+ Y + V+ GD+ S G +++ K P
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 65/235 (27%), Positives = 98/235 (41%), Gaps = 58/235 (24%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHR--------N 57
++G+G FG V A R G A+K+ L+ + + DVEC M + R
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTM---VEKRVLALPGKPP 61
Query: 58 IIKVISSC-SNEEFKALVLEYMPHGSLE---------KYLHSSNYILDIYQRLNIMIDVA 107
+ + SC + V+EY+ G L K H+ Y +I A
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI----------A 111
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATI 166
L +LH S +I+ DLK NV+LD ++DFG+ K + T+T T
Sbjct: 112 IGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTP 165
Query: 167 GYMAPE------YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEM 210
Y+APE YGK + D ++FG++L E + P DE+F M
Sbjct: 166 DYIAPEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 8 IGRGGFGSVFKARLGDGM---EVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII---KV 61
+GRG +G V+KA+ DG E A+K ++ + S E +++ + H N+I KV
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 62 ISSCSNEEFKALVLEYMPHG--SLEKYLHSSNYILDIYQRLNIMID--VASTLEYLHFGY 117
S S+ + L+ +Y H + K+ +S Q M+ + L+ +H+ +
Sbjct: 67 FLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 118 SAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTR-----EDISTIQTQTLATIGY 168
+ V+H DLKP+N+L+ + ++D G A+L D+ + + T Y
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV----VVTFWY 181
Query: 169 MAPEYGKEGRVSANG-DVYSFGIMLIETFTRK 199
APE R D+++ G + E T +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFN----LQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+IGRG FG V ++ + +V A+K+ N L+ F E +++ + R I +
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET-ACFREERDVLVNGDRRWITNL 66
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNI--MIDVASTLEYLHFGYS 118
+ +E LV++Y G L L + + + R + M+ ++ L +
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY----- 173
+H D+KP NVLLD N L+DFG + L D + + T Y++PE
Sbjct: 124 ---VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKP 201
+GR D +S G+ + E + P
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 28/201 (13%)
Query: 22 GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81
G + V +KV + + + +F +M + H ++ V C +V E++ HG
Sbjct: 42 GRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHG 101
Query: 82 SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH- 140
L+ L + + ++ + +AS L YL ++H ++ N+LL +A
Sbjct: 102 PLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158
Query: 141 ------LSDFGIA-KLLTREDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIML 192
LSD G++ L+RE + + I ++APE G +S D +SFG L
Sbjct: 159 TSPFIKLSDPGVSFTALSRE-------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTL 211
Query: 193 IETFTRKKPTDEIFNGEMTLK 213
+E F+GE+ LK
Sbjct: 212 LEI---------CFDGEVPLK 223
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 20/76 (26%), Positives = 27/76 (35%), Gaps = 6/76 (7%)
Query: 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL--HF-GYSAQVIHCDLKPSN 130
LE+ + R ++ + L L H Q+IH DL P N
Sbjct: 151 RLEWDILEPRALLRLD--LVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDN 208
Query: 131 VLLD-DNMVAHLSDFG 145
VL D D V+ DF
Sbjct: 209 VLFDDDTDVSGFIDFD 224
|
Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFN----LQYGRV--FKS-----FDVECEMMKSIH 54
+IGRG FG V ++ + A+K+ N L+ F+ + +C+ + ++H
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 55 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNI--MIDVASTLE 111
+ + +E + LV++Y G L L + + + R I M+ ++
Sbjct: 68 Y--------AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ-TLATIGYMA 170
LH+ +H D+KP NVLLD N L+DFG L T+Q+ + T Y++
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 171 PEYGKE-----GRVSANGDVYSFGIMLIETFTRKKP 201
PE + G+ D +S G+ + E + P
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 12/148 (8%)
Query: 7 LIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHHRNIIK 60
+IGRG FG V + D G A+K L+ + + V E +++ + ++K
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ S +E + L++EY+P G + L + + R I A T+ + +
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYI----AETILAIDSIHKLG 121
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAK 148
IH D+KP N+LLD LSDFG+
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 9e-05
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 8 IGRGGFGSVFKARLG-DGMEVAVKVFN--LQYGRVFKSFDVECEMMKSIHHRNIIKVI-- 62
+G G +G+V A G +VA+K Q K E ++K + H N+I ++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 63 --SSCSNEEFKA--LVLEYMPH--GSLEKY--LHSSNYILDIYQRLNIMIDVASTLEYLH 114
S + F LV+ +M G L K+ L +YQ L L+Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK-------GLKYIH 135
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG 174
+A +IH DLKP N+ ++++ + DFG+A+ E T + T Y APE
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVI 187
Query: 175 KEG-RVSANGDVYSFGIMLIETFTRK 199
+ D++S G ++ E T K
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFD------VECEMMKSIHHRNII 59
L+G+G FG V + G A+K+ + V + D E ++++ H +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKE---VIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASTLEYLHFGYS 118
+ S + V+EY G L + H S + R ++ S L+YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH--SE 114
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR 178
V++ DLK N++LD + ++DFG+ K + D +T++T T Y+APE ++
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-FCGTPEYLAPEVLEDND 172
Query: 179 VSANGDVYSFGIMLIETFTRKKP 201
D + G+++ E + P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 46 ECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMI 104
E ++++I+H +II++ + + +F L+L P + Y + ++ + I L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 105 DVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164
V ++YLH ++IH D+K N+ ++ L DFG A DI+ + A
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV--DINANKYYGWA 244
Query: 165 -TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
TI APE D++S GI+L E T
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 10/156 (6%)
Query: 2 FSENNLIGRGGFGSVFKARLGD-----GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHR 56
F +IGRG FG V + D M++ K L+ +V E +++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQV-GHIRAERDILVEADSL 61
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
++K+ S ++ L++E++P G + L + + + + I V + G
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152
+ IH D+KP N+LLD LSDFG+ L +
Sbjct: 122 F----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 8 IGRGGFGSVFKARLGDGME---VAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII---KV 61
+GRG +G V+KA+ DG + A+K ++ + S E +++ + H N+I KV
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 62 ISSCSNEEFKALVLEYMPHG--SLEKYLHSSNYILDIYQRLNIMID--VASTLEYLHFGY 117
S ++ + L+ +Y H + K+ +S Q M+ + L+ +H+ +
Sbjct: 67 FLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 118 SAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTR-----EDISTIQTQTLATIGY 168
+ V+H DLKP+N+L+ + ++D G A+L D+ + + T Y
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV----VVTFWY 181
Query: 169 MAPEYGKEGRVSANG-DVYSFGIMLIETFTRK 199
APE R D+++ G + E T +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 47/174 (27%), Positives = 75/174 (43%), Gaps = 18/174 (10%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFN----LQYGRVFKSFDVECEMMKSIHHRNIIKV 61
L+G+G FG V R + A+K+ + V + E ++++ H + +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFLTAL 60
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASTLEYLHFGYSAQ 120
S + V+EY G L + H S + R ++ S L YLH S
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLH---SCD 115
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL--ATIGYMAPE 172
V++ DLK N++LD + ++DFG+ K E IS T T Y+APE
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 10/156 (6%)
Query: 2 FSENNLIGRGGFGSVFKARLGD-----GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHR 56
F +IGRG FG V + D M++ K L+ +V E +++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQV-AHIRAERDILVEADGA 61
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
++K+ S ++ L++E++P G + L + + + + I V + G
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152
+ IH D+KP N+LLD LSDFG+ L +
Sbjct: 122 F----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 28/104 (26%)
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-------------LTREDIS 156
LEYLH + ++H DLKP N+L+ L+DFG++K+ + ++
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 157 TIQTQTLATIGYMAPE------YGKEGRVSANGDVYSFGIMLIE 194
+ Q T Y+APE YGK D ++ GI+L E
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 6/131 (4%)
Query: 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVL 132
V+E++ G L ++ + + + R A L+F + +I+ DLK NVL
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFY----SAEISLALNFLHERGIIYRDLKLDNVL 128
Query: 133 LDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 192
LD L+D+G+ K R +T + T Y+APE + + D ++ G+++
Sbjct: 129 LDAEGHIKLTDYGMCKEGIRPGDTT--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 186
Query: 193 IETFTRKKPTD 203
E + P D
Sbjct: 187 FEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 48/231 (20%), Positives = 79/231 (34%), Gaps = 68/231 (29%)
Query: 11 GGFGSVF--KARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE 68
G FG +F R A + N K CE + + + + NE
Sbjct: 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPK-----CERLIAKRVKAGSRAAIQLENE 213
Query: 69 EFKALVLEYMPHGSLEK-----------YLHSSNYILDIY-----------------QRL 100
L L + H ++ K Y+ + Y D+Y Q
Sbjct: 214 ---ILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR 270
Query: 101 NIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160
IM + +EY+H ++IH D+K N+ L+ + L DFG A +E
Sbjct: 271 AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE----- 322
Query: 161 QTLATIGYMAPEYGKEGRVSANG-------------DVYSFGIMLIETFTR 198
A +YG G V+ N D++S G++L++ +
Sbjct: 323 ---------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 7e-04
Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 21/149 (14%)
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYIL-DIYQRLNIMIDVASTLEYLHF 115
N++ + +E+ LVL++ G L ++ I + +R + VA L+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA--LDALH- 102
Query: 116 GYSAQVIHC-DLKPSNVLLDDNMVAHLSDFG----IAKLLTREDISTIQTQTLATIGYMA 170
+ I C DL P+N+LLDD L+ F + E + + Y A
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM---------YCA 150
Query: 171 PEYGKEGRVSANGDVYSFGIMLIETFTRK 199
PE G + D +S G +L E T K
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 16/44 (36%), Positives = 21/44 (47%), Gaps = 3/44 (6%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMK 51
I V +A L DG EVAVKV Q V K + +++K
Sbjct: 19 IAAASIAQVHRAVLKDGEEVAVKV---QRPGVKKRIRSDLKLLK 59
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 64/290 (22%), Positives = 116/290 (40%), Gaps = 63/290 (21%)
Query: 8 IGRGGFGSVFKARLGDGMEV----AVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG G FG VF + E A+ L+ R +E +M+ + H+NI++ I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYID 79
Query: 64 SCSNEEFKAL--VLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASTLEY 112
N+ + L ++E+ G L + + + I+DI ++L L Y
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALAY 133
Query: 113 LHF----GYSAQVIHCDLKPSNVLLDDNM-----------------VAHLSDFGIAKLLT 151
H +V+H DLKP N+ L + +A + DFG++K +
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI- 192
Query: 152 REDISTIQTQTLATIGYMAPE--YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
I ++ + T Y +PE + D+++ G ++ E + K P F+
Sbjct: 193 --GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP----FHKA 246
Query: 210 MTLKHWVNDW-----LPISTKEIVDPNLLSREDIHFVAKE-----QCVSF 249
+++ LPI K + N+L + ++ AKE QC+ +
Sbjct: 247 NNFSQLISELKRGPDLPIKGKS-KELNILIKNLLNLSAKERPSALQCLGY 295
|
Length = 1021 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 37/146 (25%), Positives = 66/146 (45%), Gaps = 14/146 (9%)
Query: 8 IGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDV-----ECEMMKSIHHRNIIKV 61
IG G FG V R D + A+K L+ V E +++ + ++K+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKT--LRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH-FGYSAQ 120
S +++ V++Y+P G + L + R I ++ +E +H G+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMGF--- 122
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGI 146
IH D+KP N+L+D + L+DFG+
Sbjct: 123 -IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 22/157 (14%)
Query: 2 FSENNLIGRGGFGSV-FKARLGDGMEVAVKVFNLQYGRVFKS-----FDVECEMMKSIHH 55
F +IG+G FG V + G A+K L +FK E +++
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLE----KYLHSSNYILDIYQRLNIMIDVASTLE 111
++ + S + ++ L++E++P G L KY S + Y M + +E
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY-----MAECVLAIE 115
Query: 112 YLH-FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 147
+H G+ IH D+KP N+L+D LSDFG++
Sbjct: 116 AVHKLGF----IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 285 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.63 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.37 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.37 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.25 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.18 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.16 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.0 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.75 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.73 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.68 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.63 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.42 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.38 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.37 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.32 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.29 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.26 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.22 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.19 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.15 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.11 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.1 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.96 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.95 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.85 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.75 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.68 | |
| PLN02236 | 344 | choline kinase | 97.64 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.64 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.55 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.44 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.4 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.15 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.09 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.01 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.93 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.92 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.77 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.75 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.56 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 96.51 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.39 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.38 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.35 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.34 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.34 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-53 Score=353.91 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=211.4
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|..++.||+|+|+.||.++. .+|+.||+|+++.. .....+...+|+++.+.|+|||||+++++|++.+..|+|+|.
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 78899999999999999986 78999999999763 345567888999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
|..++|.++++ .++++++..++.++.||+.||.||| +++|+|||||..|+|++++.+|||+|||+|+.+..+...
T Consensus 100 C~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er- 174 (592)
T KOG0575|consen 100 CHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER- 174 (592)
T ss_pred cCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcccc-
Confidence 99999999987 4556999999999999999999999 999999999999999999999999999999988765322
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
..+.+|||-|.|||++.....+..+||||+||+||.|+.|++||+...-.+ .+... ...+..
T Consensus 175 -k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~I-------k~~~Y~--------- 236 (592)
T KOG0575|consen 175 -KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKI-------KLNEYS--------- 236 (592)
T ss_pred -cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHH-------HhcCcc---------
Confidence 346789999999999999999999999999999999999999997632111 11111 111111
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+...+.++.+||.++|..||.+|||++++|.+
T Consensus 237 ----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 ----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 133456679999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=336.97 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=208.6
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchh-------HHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR-------VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
|.+.+.||+|+||.|-+|. ..+|+.||||+++...-. ......+|+++|++++||+|++++++|..++..|+
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 5678999999999999996 568999999999754311 11234689999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CcEEEeeeccceec
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLL 150 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~---~~~~i~df~~~~~~ 150 (285)
||||++||.|.+.+-.+.. +.+.....++.||+.|+.||| +.||+||||||+|||++.+ ..+||+|||++...
T Consensus 254 VlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 9999999999998866554 778888899999999999999 9999999999999999755 78999999999987
Q ss_pred CcccccceeccccccccccCCcccCCCc---cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEGR---VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
.. .....+.+||+.|.|||++.+.. ++.+.|+||+||++|.+++|.+||.+.........+.
T Consensus 330 g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------------ 394 (475)
T KOG0615|consen 330 GE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------------ 394 (475)
T ss_pred cc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------------
Confidence 64 33456788999999999988765 3457799999999999999999998765544222222
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+.+..++.+..+||.+||..||++|||+.|+|.+
T Consensus 395 ----~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 ----LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ----hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2223333344577889999999999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=326.27 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=207.4
Q ss_pred CCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCc-eEEEEeccC
Q 039392 3 SENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF-KALVLEYMP 79 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e~~~ 79 (285)
+.++.||+|.-|+|+++++ .+++-+|+|++....+ ...+.+.+|+++++..+||+||.+++.|..+.. ..++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 4578899999999999975 5788899999965544 455778999999999999999999999998885 999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+|+|.+++...+. +++...-+++.++++||.|||. +++|+||||||.|+|+++.|.|||+|||.+..+.+. ..
T Consensus 162 gGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 162 GGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred CCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 9999999876644 9999999999999999999993 499999999999999999999999999999876653 44
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcC-CCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP-ISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (285)
....||..|||||-+.+..|+.++||||||+.++|+.+|+.||................... .+.
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP-------------- 300 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP-------------- 300 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC--------------
Confidence 66789999999999999999999999999999999999999987641111111111111111 100
Q ss_pred hhhhhh-HhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 239 HFVAKE-QCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 239 ~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+ +. .+++++.+|+..||+.||.+|||++|++++
T Consensus 301 ~l--P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RL--PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CC--CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 22 478889999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-51 Score=327.79 Aligned_cols=203 Identities=31% Similarity=0.523 Sum_probs=183.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|.+.+.||.|+|++||+|+. .++..||||.+... ..+..+.+..|+.+|+.++|||||.+++++..++.+|+||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 588899999999999999974 46899999999766 466677788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC------CcEEEeeeccceecC
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN------MVAHLSDFGIAKLLT 151 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~------~~~~i~df~~~~~~~ 151 (285)
|.||+|.+++.+.+. +++.+++.++.||+.|+++|| +++|+||||||.|||++.. -.+||.|||+++.+.
T Consensus 91 C~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 91 CNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999999987765 999999999999999999999 9999999999999999754 458999999999988
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccch
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM 210 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~ 210 (285)
+. ......+|++.|||||++..+.|+.++|+||+|+++|+|++|..||+.....+.
T Consensus 167 ~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 167 PG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred ch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 53 344677899999999999999999999999999999999999999987544443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=317.51 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=204.9
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccc-eeccC-CceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVIS-SCSNE-EFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~-~~~~~v~ 75 (285)
+|.++++||.|.||+||++. ..+|..+|.|.+.-. ..++.+....|+.+|++|+||||+++++ .+.+. ..++++|
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 37889999999999999995 678999999987643 2456677889999999999999999999 45444 4489999
Q ss_pred eccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 76 EYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQ-VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 76 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
|+|.+|+|..+++. ..+.+++.++|+++.|++.||..+|+.+.+| ++||||||.||+++.+|.+|++|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999998853 4556999999999999999999999644444 8899999999999999999999999999887
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhh-hhhhhcCCCccccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKH-WVNDWLPISTKEIVDP 230 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 230 (285)
.. ........|||.|++||.+.+..|+.++||||+||++|||...+.||.+..- ..++. ......++
T Consensus 180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--~~L~~KI~qgd~~~-------- 247 (375)
T KOG0591|consen 180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--LSLCKKIEQGDYPP-------- 247 (375)
T ss_pred ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--HHHHHHHHcCCCCC--------
Confidence 64 3344567899999999999999999999999999999999999999987411 11111 11110000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
....-.+..+..+|.-|+..||..||+.-.++..+.
T Consensus 248 ----------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 248 ----------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 001345677999999999999999998544444443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-51 Score=315.19 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=209.3
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|+.+.++|+|++|.|++++++ +|+-||||.+.... +...+.+.+|+.+|++++|+|+|.++++|.....+++|+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 677889999999999999854 79999999985433 344466889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+. ++.+-+.......+...+.+++.|++.|+.|+| +++++||||||+||+|+.+|.+|+||||+|+.+... ...
T Consensus 84 dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~ 157 (396)
T KOG0593|consen 84 DH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDN 157 (396)
T ss_pred ch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--cch
Confidence 77 666666666666999999999999999999999 999999999999999999999999999999988743 345
Q ss_pred eccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC---cc-----cccc
Q 039392 159 QTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS---TK-----EIVD 229 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~~ 229 (285)
++....|.||.|||.+.+ ..|..+.||||+||++.||++|...|.+.+.-+. ............ .. .++.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHHHHHHhccCCcee
Confidence 577889999999999888 5899999999999999999999999877543222 222211111111 00 0000
Q ss_pred ccccC----cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLS----REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
-..++ .++.+. .-...+..+.+++++||.+||.+|+|+++++.+
T Consensus 237 Gv~lP~~~~~epLe~-k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLER-KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhh-hcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00111 111111 123556678999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=337.59 Aligned_cols=254 Identities=31% Similarity=0.487 Sum_probs=220.0
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCC
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGS 82 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 82 (285)
..++.||+|.||.||.|.+....+|++|.+...+ ...+.|.+|+++|+.|+|++|+++++++..++-+++||||++.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3568899999999999999888899999987653 233677899999999999999999999999889999999999999
Q ss_pred HHHhhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecc
Q 039392 83 LEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161 (285)
Q Consensus 83 L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~ 161 (285)
|.++++. .+..+...+.+.++.|||+|++||+ ++++|||||-..||||++++.+||+|||+++...++ .......
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~ 363 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEG 363 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeecCC
Confidence 9999987 5556999999999999999999999 999999999999999999999999999999954433 3334444
Q ss_pred ccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 162 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
..-+..|.|||.+....++.+|||||||++|+|++| |+.||....+.+... .-..+.++
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~--------------------~le~GyRl 423 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE--------------------LLERGYRL 423 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH--------------------HHhccCcC
Confidence 555677999999999999999999999999999999 888887655443321 23445667
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
+.+..||++++++|..||..+|++|||++.+...++++...
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 77889999999999999999999999999999999988753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=327.00 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=213.8
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCC-ceEEEEeccC
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-FKALVLEYMP 79 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~~~ 79 (285)
.+.+.+|+|+||+||+|.+.+...||+|.+.... ....+.+.+|+.+|.+++||||++++|++..+. .+++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3456799999999999998655559999987543 222568999999999999999999999998887 7999999999
Q ss_pred CCCHHHhhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCeeeCCCC-cEEEeeeccceecCccccc
Q 039392 80 HGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSAQ-VIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 80 ~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-~~h~di~~~nili~~~~-~~~i~df~~~~~~~~~~~~ 156 (285)
+|+|.+++.. ....++...++.|+.||+.|++||| +++ ++||||||.|+|++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 9999999977 3556999999999999999999999 888 99999999999999998 99999999998765432
Q ss_pred ceeccccccccccCCcccC--CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 157 TIQTQTLATIGYMAPEYGK--EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......||..|+|||++. ...++.++||||||+++|||+||..||................
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~---------------- 262 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG---------------- 262 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC----------------
Confidence 2223367899999999999 5589999999999999999999999998865533222221111
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
.+...+..+++.+..++.+||..||.+||++.+++..|+.+.....
T Consensus 263 ---~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 263 ---LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ---CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1111133377889999999999999999999999999999987654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=316.57 Aligned_cols=239 Identities=28% Similarity=0.349 Sum_probs=201.7
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.++||+|+||+|+.++ .++++-+|+|++++.. ....+....|..+|..++||+|++++..|++.+.+|+|+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 47899999999999999997 4578999999987543 3345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+.||.|...+++++. +++..+.-++..|+.||.||| +.||+|||+||+|||++.+|+++|+|||++...-.. .
T Consensus 106 ~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~ 179 (357)
T KOG0598|consen 106 YLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--G 179 (357)
T ss_pred ccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC--C
Confidence 9999999999987776 999999999999999999999 999999999999999999999999999999854332 2
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......+||+.|+|||++.+..++.++|.||||+++|+|++|..||.+....+...+.... +
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~-----k------------- 241 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG-----K------------- 241 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC-----c-------------
Confidence 2234578999999999999999999999999999999999999999875433322211100 0
Q ss_pred cchhhh-hhHhHHHHHHhhhcccccCcCCCC
Q 039392 237 DIHFVA-KEQCVSFVFNVAMECTVESPEQRI 266 (285)
Q Consensus 237 ~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp 266 (285)
... +.-.+.+.+++++++|..||++|.
T Consensus 242 ---~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 001 122466799999999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=298.83 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=217.6
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchh--HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|...+.||+|.||.||+|+ ..+|+.||||.+...... .-....+|+..|+.++|+||+.++++|...+.+.+|+||+
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 6778999999999999997 568999999999765432 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+. +|+..++.....++...+..++.+++.|++||| .+.++||||||.|++++++|.+||.|||+++.+........
T Consensus 84 ~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 84 PT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred cc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 66 999999988888999999999999999999999 99999999999999999999999999999999876644433
Q ss_pred eccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc----
Q 039392 159 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL---- 233 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 233 (285)
....|.||.|||.+.+. .|+...||||.||++.||+.|.+-|.+ .++-.+....+.....+....+.+-...
T Consensus 160 --~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG-~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 160 --HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG-DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred --cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC-CchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 33789999999988876 699999999999999999988765554 4455555666555555544443332221
Q ss_pred -----CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 -----SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+....+. .-..+++++.+|+.+|+.+||.+|+|++|+|++
T Consensus 237 ~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111111 123567778999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=328.45 Aligned_cols=265 Identities=21% Similarity=0.273 Sum_probs=211.9
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHH-HHHHHHHHHccCC-CCccccccceeccCC-ceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFK-SFDVECEMMKSIH-HRNIIKVISSCSNEE-FKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~-~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~~v~e 76 (285)
.|.++++||.|.||.||+|. ..+|+.||||.++.+.....+ --.+|+..|++++ ||||+++.+++.+.+ .+++|||
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE 90 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE 90 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence 37788999999999999997 457899999988765444322 2347999999999 999999999998887 9999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+++. +|..+++..+..+++..+..|+.||++||+++| ++|+.|||+||+|||+.....+||.|||+|+.+...
T Consensus 91 ~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--- 163 (538)
T KOG0661|consen 91 FMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK--- 163 (538)
T ss_pred hhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC---
Confidence 9955 999999888888999999999999999999999 999999999999999999999999999999987653
Q ss_pred ceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc-c----
Q 039392 157 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD-P---- 230 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---- 230 (285)
..++....|.||+|||++.. ..|+.+.|||++||+|+|+.+-+..|.+..+-+. ...............+.. .
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHHhCCCccccchhHHHHHH
Confidence 44567789999999997665 5799999999999999999999999987544332 222222222222211111 0
Q ss_pred ------cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 ------NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+....+ .++.++.++|.+||..||.+||||+++|++
T Consensus 243 ~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111112222223 378899999999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=327.56 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=208.5
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|.+++.||.|+|++|++|+ ..+++.+|||++.+.. .........|-++|.+| .||+|++++..|++...+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 58899999999999999997 4579999999986532 22334466788999999 7999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++|.|.++|.+.+. +++.-++.++.+|+.||+||| .+||+||||||+|||++++++++|.|||.|..++....
T Consensus 154 e~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999988765 999999999999999999999 99999999999999999999999999999988765322
Q ss_pred c---------ce--eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc
Q 039392 156 S---------TI--QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST 224 (285)
Q Consensus 156 ~---------~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
. .. .....||..|.+||++.....++++|+|+|||++|+|+.|.+||.+.. +-..++..+.-.+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-eyliFqkI~~l~y---- 304 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-EYLIFQKIQALDY---- 304 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-HHHHHHHHHHhcc----
Confidence 1 11 134679999999999999999999999999999999999999997632 2222222222111
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+.+.++.+.+||+++|..||.+|+|+++|-++
T Consensus 305 ----------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 305 ----------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1234556779999999999999999999988765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=313.73 Aligned_cols=255 Identities=31% Similarity=0.432 Sum_probs=206.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCC--ceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE--FKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~ 77 (285)
+|..++.||+|+||.||++... +|...|+|.+........+.+.+|+.+|++++|||||++++...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3677899999999999999754 48999999987664444677889999999999999999999754444 68899999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeeccceecCc-ccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTR-EDI 155 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~~~~~-~~~ 155 (285)
+++|+|.+++.+.+..+++..++.+.+|+++||.||| ++|++|+||||+|||++. ++.+||.|||.+..... ...
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 9999999999887656999999999999999999999 999999999999999999 79999999999987664 111
Q ss_pred cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccc-cccchhhhhhhhhhcCCCcccccccccc
Q 039392 156 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEI-FNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
........+|+.|+|||++.+. ...+++|||||||++.+|+||..||... ...............
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~------------- 241 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL------------- 241 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC-------------
Confidence 2233456799999999999853 3446999999999999999999999763 111111111111100
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
...+...+.++.+|+++|+..+|.+||||+++|.+-.-
T Consensus 242 ------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 242 ------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 01234467789999999999999999999999987644
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=318.11 Aligned_cols=266 Identities=26% Similarity=0.301 Sum_probs=208.6
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccC--CceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 76 (285)
|+.+++||+|.||.||+|+ ..+|+-||+|.+..+. +.......+|+.+|++|.||||+++.+..... ..+|+|+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 6678899999999999997 5679999999987655 33344566899999999999999999988665 78999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++. +|.-++....-.+++.++.-++.||+.||+||| .+|++|||||..||||+.+|.+||.|||+|+.+.... .
T Consensus 199 YMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~-~ 273 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG-S 273 (560)
T ss_pred cccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC-C
Confidence 9977 898888776666999999999999999999999 9999999999999999999999999999999877644 3
Q ss_pred ceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc-----c-
Q 039392 157 TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV-----D- 229 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~- 229 (285)
...+....|.||.|||++.+. .|+.+.|+||.||||.||+.|+..|.+....+. +...+.-...+....+. .
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-l~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-LHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-HHHHHHHhCCCChhccccccCCcc
Confidence 335677889999999998876 799999999999999999999999987543322 11111111111111111 0
Q ss_pred ccccCccc---chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 230 PNLLSRED---IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 230 ~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
....+... .-...-...+....+|+..+|..||.+|.||.++|.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00000000 001112355777889999999999999999999885
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=322.37 Aligned_cols=248 Identities=27% Similarity=0.366 Sum_probs=213.2
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|+...+||+|+.|.||.+. ..+++.||||.+........+.+.+|+.+|+..+|+|||++++.|...+.+|+||||++|
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 6677899999999999996 557889999999887776678889999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
|+|.+.+.... +++.++..++..+++||+||| .+|++|||||.+||+++.+|.+||+|||++..+..... ...
T Consensus 355 gsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~ 427 (550)
T KOG0578|consen 355 GSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRS 427 (550)
T ss_pred Cchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccc
Confidence 99999987655 999999999999999999999 99999999999999999999999999999988766532 345
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
.-.||+.|+|||+.....|+++.||||||+++.||+.|++||-...+-+. +.. + ......++
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA-lyL-I----------------a~ng~P~l 489 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-I----------------ATNGTPKL 489 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH-HHH-H----------------hhcCCCCc
Confidence 67899999999999999999999999999999999999999865221111 110 0 11112223
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+...++++++|+.+||+.|+.+|+|++|+|++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 3356778889999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=317.40 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=204.5
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeecc----ch-hHHHHHHHHHHHHccCC-CCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQ----YG-RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 73 (285)
+|.+++.||+|+||+|+.|. ..+++.||+|++... .. ...+.+.+|+.+++.++ ||||+++++++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 58899999999999999996 457899999987653 11 23456778999999999 9999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CcEEEeeeccceecCc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTR 152 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~i~df~~~~~~~~ 152 (285)
||||+.||.|.+++.+ .+.+.+..+..++.|++.|++||| ++|++||||||+|++++.+ +++||+|||++....
T Consensus 98 vmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 9999999999999988 455899999999999999999999 9999999999999999998 999999999998773
Q ss_pred ccccceeccccccccccCCcccCCCc-cC-cchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGR-VS-ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~-~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.........+|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||+.......... .....
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-i~~~~----------- 239 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-IRKGE----------- 239 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-HhcCC-----------
Confidence 1123346678999999999999876 64 889999999999999999999987322222111 11100
Q ss_pred cccCcccchhhhhhHh-HHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 231 NLLSREDIHFVAKEQC-VSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
+..+..+ ++++..|+.+||..||.+|+|+.+++.
T Consensus 240 ---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 ---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1112223 677999999999999999999999984
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=305.24 Aligned_cols=260 Identities=24% Similarity=0.321 Sum_probs=214.5
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
.|++..+||.|..++||+|+ .+.++.||||++..+.-. ..+.+.+|++.++.++||||++++..|..+..+|+||+++
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 48889999999999999996 567899999999876533 3578899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
.+||+.+++... ...+++..+..++++++.||.||| ++|.+|||||+.||||+.+|.|+|+|||..-.+.......
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999998653 223999999999999999999999 9999999999999999999999999999765543322111
Q ss_pred -ee-ccccccccccCCcccCCC--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 158 -IQ-TQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 158 -~~-~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.. ....+++.|+|||++..+ .|+.++||||||+.++|+.+|+.||....+.+....+....++....
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t--------- 254 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT--------- 254 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc---------
Confidence 11 456899999999996544 69999999999999999999999999877766655555444433221
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+.......+..+++++..||..||++|||+++++++
T Consensus 255 --~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 255 --SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred --ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111112234455679999999999999999999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=319.06 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=214.7
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
.++..||+|.||+||+|+|-+ .||||++.... ++..+.|++|+.++++-+|.||+-+.|++..+.. .+|+.+|+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 467889999999999999743 59999987654 4567889999999999999999999999999887 899999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
.+|..++.-....+++.+.++|++|+++|+.||| .++|+|+|||..|||+.++++|||+|||+++............
T Consensus 472 sSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~ 548 (678)
T KOG0193|consen 472 SSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE 548 (678)
T ss_pred chhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence 9999999877777999999999999999999999 9999999999999999999999999999998765543334444
Q ss_pred cccccccccCCcccCCC---ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 161 QTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
...+...|+|||++..+ .++.++||||||+++|||++|..||. ..+.+.......++....+.
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~------------- 614 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDL------------- 614 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccc-------------
Confidence 55677789999988765 58999999999999999999999998 44333322222222111111
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
......++.++++|+..||..++++||++.++|..|+++..+
T Consensus 615 --s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 615 --SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred --hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 112356788999999999999999999999999999998874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=314.04 Aligned_cols=259 Identities=23% Similarity=0.390 Sum_probs=203.5
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccC-Cce
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNE-EFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~ 71 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++..+ +||||+++++.+... ...
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 478899999999999999963 235679999986443 23346688999999999 899999999987654 457
Q ss_pred EEEEeccCCCCHHHhhhcCC------------------------------------------------------------
Q 039392 72 ALVLEYMPHGSLEKYLHSSN------------------------------------------------------------ 91 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~------------------------------------------------------------ 91 (285)
+++|||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 89999999999999886431
Q ss_pred -CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccC
Q 039392 92 -YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMA 170 (285)
Q Consensus 92 -~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (285)
..++...+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................++..|+|
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 23667788899999999999999 99999999999999999999999999999976543222222233445678999
Q ss_pred CcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHH
Q 039392 171 PEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSF 249 (285)
Q Consensus 171 PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
||.+.+..++.++||||||+++|+|++ |..||......+.......... ....+..++++
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~ 305 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-------------------RMRAPENATPE 305 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-------------------CCCCCCCCCHH
Confidence 999988899999999999999999997 9999876433222111111000 00012345667
Q ss_pred HHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 250 VFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 250 l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=317.05 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=210.1
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|-+.+.||+|.||.||+|+ ..+.+.||+|.+.+.. .+....+.+|+++++.++||||+.++++|+....+|+|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 47788999999999999996 4578889999987543 34567788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+.| +|..++...+. ++++.+..++.+++.||.||| +.+|.|+|+||.||+++.+|.+|++|||+++..+.. +.
T Consensus 83 a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~ 155 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TS 155 (808)
T ss_pred hhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC--ce
Confidence 977 99999987765 999999999999999999999 999999999999999999999999999999987654 44
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......|||.|+|||+..++.++..+|+|||||++||+++|++||....-.+...... .+...
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~-~d~v~---------------- 218 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL-KDPVK---------------- 218 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh-cCCCC----------------
Confidence 5567789999999999999999999999999999999999999997632222111111 00000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+...+..+.+|++.+|..||.+|.|+.+++.+
T Consensus 219 ----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 ----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 023567779999999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=308.48 Aligned_cols=273 Identities=40% Similarity=0.650 Sum_probs=218.8
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCc-eEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF-KALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e~~~ 79 (285)
||...+.||+|+||.||+|...+|+.||||.+.........+|.+|++++.+++|||+++++|+|.+.+. .++|+||++
T Consensus 76 ~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~ 155 (361)
T KOG1187|consen 76 NFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMP 155 (361)
T ss_pred CCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccC
Confidence 5777889999999999999988889999998776544313459999999999999999999999999884 999999999
Q ss_pred CCCHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 80 HGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 80 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
.|+|.+.+..... .+++.++.+|+.++|.||+|||......++||||||.|||+|++...||+|||++...... ....
T Consensus 156 nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~ 234 (361)
T KOG1187|consen 156 NGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSV 234 (361)
T ss_pred CCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccce
Confidence 9999999876654 6899999999999999999999643446999999999999999999999999999554431 1111
Q ss_pred eccc-cccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCcccc-ccchhhhhhhh-hhcCCCccccccccccCc
Q 039392 159 QTQT-LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIF-NGEMTLKHWVN-DWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 159 ~~~~-~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (285)
... .+|.+|++||+...+..+.++||||||+++.|+++|+.+.+... ..+.....|.. ........+++|+.+...
T Consensus 235 -~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 235 -STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred -eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 111 78999999999999999999999999999999999998887544 22333455542 233335667777765421
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
... ....-..+..+..+|++.+|++||++.++++.|+.+.
T Consensus 314 ~~~----~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 314 EYP----DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCC----hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 111 0033444888999999999999999999999886554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=287.42 Aligned_cols=236 Identities=24% Similarity=0.329 Sum_probs=201.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|+..+.||.|+||.|.+++.+ +|.-+|+|+++... -...+...+|..+|+.+.||+++++++.+.+.+.+|+|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 5788999999999999999854 68889999987543 2345677889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|.+||-|..++++.+. +++..++-++.||+.|++||| ++++++||+||+|||+|++|.+||+|||++..+...
T Consensus 125 yv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred ccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 9999999999987766 999999999999999999999 999999999999999999999999999999887653
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.-..+|||.|+|||++....++.++|-||||+++|||+.|..||.+..+... ....... +..
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-Y~KI~~~-------~v~-------- 259 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-YEKILEG-------KVK-------- 259 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-HHHHHhC-------ccc--------
Confidence 2456899999999999999999999999999999999999999987544221 1111111 111
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI 266 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 266 (285)
.+.-.++++++|++++|+.|-.+|.
T Consensus 260 -----fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 260 -----FPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred -----CCcccCHHHHHHHHHHHhhhhHhhh
Confidence 1334566799999999999999993
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=309.48 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=202.8
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|+.+..||+|+||.||+++ ..+|+-+|+|++++.. ....+....|-.+|....++.||+++..|++...+|+|||
T Consensus 142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 58899999999999999997 5579999999997654 3445667789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc----
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR---- 152 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~---- 152 (285)
|++||++..++.+.+. +++..++.++.+++.|++.|| +.|++||||||+|+|||..|++||+|||++.-+..
T Consensus 222 ylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred ecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 9999999999987765 999999999999999999999 99999999999999999999999999999853211
Q ss_pred ------------------cccc-----------------------ceeccccccccccCCcccCCCccCcchhhHHHHHH
Q 039392 153 ------------------EDIS-----------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 191 (285)
Q Consensus 153 ------------------~~~~-----------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~ 191 (285)
.... ...-...|||-|+|||++.+..++...|.||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0000 00012458999999999999999999999999999
Q ss_pred HHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCC---CH
Q 039392 192 LIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI---NA 268 (285)
Q Consensus 192 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~ 268 (285)
||||+.|.+||.+..+.+ .......+.. ...++....+++++++||.+||. ||.+|. ++
T Consensus 378 myEmLvGyPPF~s~tp~~-T~rkI~nwr~----------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQE-TYRKIVNWRE----------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHhCCCCCCCCCHHH-HHHHHHHHhh----------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 999999999997743332 2222222111 11122233445789999999999 999997 46
Q ss_pred HHHHH
Q 039392 269 KEIVT 273 (285)
Q Consensus 269 ~eil~ 273 (285)
+||-+
T Consensus 440 ~EIK~ 444 (550)
T KOG0605|consen 440 EEIKK 444 (550)
T ss_pred HHHhc
Confidence 66543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=317.98 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=209.6
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|..++-||.|+.|.|-+|++ .+|+.+|||++.... ....+.+.+|+-+|+.+.|||++.+++++++...+|+|+||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 67889999999999999974 589999999997653 23346678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++||-|.+++-+.+. +++..+.+.++||+.|+.|+| ..+|||||+||+|++++..+++||.|||+|....++ .
T Consensus 94 v~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---k 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---K 166 (786)
T ss_pred cCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC---c
Confidence 999999999877765 888889999999999999999 999999999999999999999999999999876553 3
Q ss_pred eeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+|+++|++||++.+..| ..++||||.|++||.+++|+.||++. +-+..+.+..
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-Nir~LLlKV~-------------------- 225 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-NIRVLLLKVQ-------------------- 225 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-cHHHHHHHHH--------------------
Confidence 3456789999999999998865 78899999999999999999999852 2111111111
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
...+..+..+++++.+|+++||..||.+|+|.+||+++-
T Consensus 226 ~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 226 RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 112223567788899999999999999999999999873
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=326.94 Aligned_cols=255 Identities=31% Similarity=0.521 Sum_probs=220.8
Q ss_pred CCCceecccCceEEEEEEe------CCCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 3 SENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
...+.||+|+||+||+|.. +..+.||||.++..... .+++|.+|++++..++|||||+++|++.+++-+++|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 4578999999999999963 33567999998876655 7889999999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcC---------C----CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEe
Q 039392 76 EYMPHGSLEKYLHSS---------N----YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS 142 (285)
Q Consensus 76 e~~~~~~L~~~~~~~---------~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~ 142 (285)
||+..|+|.+|+... + .+++..+.+.|+.||+.|+.||- ++.+|||||-+.|.+|.++-.|||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEec
Confidence 999999999998642 1 12778899999999999999999 9999999999999999999999999
Q ss_pred eeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcC
Q 039392 143 DFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLP 221 (285)
Q Consensus 143 df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 221 (285)
|||+++.....+.........-+.+|||||.+...+++..|||||+|++|||+++ |..||.+..+.+.....
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i------- 718 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI------- 718 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH-------
Confidence 9999998776665655556778899999999999999999999999999999998 88898886655443221
Q ss_pred CCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 222 ISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
..+.-+..+++||.++++||.+||+.+|++|||++||-.+|++.-+
T Consensus 719 -------------~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 719 -------------RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -------------HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 1111245578999999999999999999999999999999998754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=300.39 Aligned_cols=268 Identities=19% Similarity=0.229 Sum_probs=202.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||+||+++.. +++.+|+|++.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5899999999999999999864 68899999986532 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++.+..+. .....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (287)
T cd07848 82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-A 156 (287)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-c
Confidence 9886665544 33445889999999999999999999 99999999999999999999999999999987643221 1
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC------------cc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS------------TK 225 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~ 225 (285)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+... .......+.+ ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF-TIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhhCCCCHHHHHhhhccchhc
Confidence 1223457888999999988889999999999999999999999997643222111 1100000000 00
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+................+.++.+++++||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000111111123467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=303.11 Aligned_cols=244 Identities=24% Similarity=0.328 Sum_probs=201.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++.+.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6899999999999999999754 68999999986532 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.... .+++..++.++.|++.||+||| ++|++|+||+|+||+++.+|.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 82 YVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 999999999987654 4889999999999999999999 9999999999999999999999999999987654321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ........
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~----------------- 214 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-YEKILAGK----------------- 214 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCC-----------------
Confidence 234578899999999988899999999999999999999999975332111 11111000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
...+...+..+.+++++||+.||.+||+ +++++++
T Consensus 215 ---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ---LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0012233567899999999999999995 8888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=302.87 Aligned_cols=268 Identities=21% Similarity=0.275 Sum_probs=201.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+++++.++||||+++++++......++|||++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 5889999999999999999754 689999999865432 22245678999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
. ++|.+++......++...+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 159 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HT 159 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--cc
Confidence 5 5888887766556889999999999999999999 9999999999999999999999999999987543321 12
Q ss_pred eccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc--------cc
Q 039392 159 QTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI--------VD 229 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 229 (285)
.....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+......................+ ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 234557889999998765 458899999999999999999999997654332222222111111100000 00
Q ss_pred ccc----cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNL----LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+.. ..............++++.+|+.+||+.||++|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 000000001111234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=301.42 Aligned_cols=267 Identities=20% Similarity=0.259 Sum_probs=202.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||.|+||+||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++......++|||++
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 588999999999999999975 4789999999865432 23356778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++ +|.+++......++...+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~ 159 (288)
T cd07871 86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KT 159 (288)
T ss_pred Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--cc
Confidence 75 899888766656889999999999999999999 9999999999999999999999999999987654322 11
Q ss_pred eccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc--------ccccc
Q 039392 159 QTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST--------KEIVD 229 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 229 (285)
.....+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||.+....+... ........... .....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH-LIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChHHhhccccchhhh
Confidence 233457888999998765 468999999999999999999999997643322211 11111100000 00000
Q ss_pred ccccCcc--cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSRE--DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+.. ..........+.++.+|+.+||..||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00011123456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=278.99 Aligned_cols=258 Identities=23% Similarity=0.301 Sum_probs=207.9
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCC-----ceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-----FKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~ 75 (285)
|++.+.||+|+|+.|+++. ..+++.+|+|.+...+.+..+...+|++..++++|||++++++....+. ..|+++
T Consensus 23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 8899999999999999997 5678999999998888788899999999999999999999999875443 489999
Q ss_pred eccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCcEEEeeeccceec
Q 039392 76 EYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150 (285)
Q Consensus 76 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~di~~~nili~~~~~~~i~df~~~~~~ 150 (285)
+|+..|+|.+.++. .+..+++.+++.|+.+++.||.+|| ... ++|+||||.||++++++.+++.|||.++..
T Consensus 103 Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999998864 3445999999999999999999999 777 999999999999999999999999999764
Q ss_pred Cccccc-------ceeccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhc
Q 039392 151 TREDIS-------TIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL 220 (285)
Q Consensus 151 ~~~~~~-------~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 220 (285)
.-+-.. ..-....+|..|.|||.+. +...+.++|||||||++|.|+.|..||+.....-.+
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS--------- 250 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS--------- 250 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe---------
Confidence 321111 0011345788899999775 456899999999999999999999999754321110
Q ss_pred CCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 221 PISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
..-.+ ......++.....+..+.+++++||+.||.+||++.+++++++++.
T Consensus 251 ---laLAv-----~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 ---LALAV-----QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---EEEee-----eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 00000 0111222223346777999999999999999999999999998874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=292.36 Aligned_cols=266 Identities=26% Similarity=0.320 Sum_probs=208.4
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchh--HHHHHHHHHHHHccCCCCc-cccccceeccCC------ce
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRN-IIKVISSCSNEE------FK 71 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~ 71 (285)
|...++||+|++|+||+|+ ..+|+.||+|.+...... .-....+|+.+++.++|+| |+.+.+++...+ .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 5567789999999999997 457899999999876542 2345678999999999999 999999997766 89
Q ss_pred EEEEeccCCCCHHHhhhcCC---CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 72 ALVLEYMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
++|+|++.. +|..++.... ...+...++.++.||+.|++||| +++|+||||||.|++|+++|.+||+|||+++
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 999999955 9999987765 34777899999999999999999 9999999999999999999999999999999
Q ss_pred ecCcccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 149 LLTREDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
...-+ .........|.+|+|||++.+. .|+...||||+||+++||+++...|.+... .......+.....+....+
T Consensus 169 a~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 169 AFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCccCC
Confidence 66533 2335667889999999999888 799999999999999999999998887554 2333333333322222222
Q ss_pred ccccccCcccchhhh-------h---hHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDPNLLSREDIHFVA-------K---EQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~-------~---~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+.....+.. . ....++..+++.+||+.+|.+|.|++.++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 222211111111100 0 1223578999999999999999999999987
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=293.01 Aligned_cols=267 Identities=26% Similarity=0.309 Sum_probs=205.9
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEee--ccchhHHHHHHHHHHHHccCCCCccccccceecc-----CCceEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFN--LQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN-----EEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~ 73 (285)
|...+.||+|++|.|+.+. ..+|+.||||.+. .......++..+|+.+|+.++|+||+.+.+++.. -+..|+
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 4457899999999999996 4579999999987 4445566778899999999999999999998854 457899
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|+|++ +.+|...++++.. ++...+..++.|++.||.|+| +.+++|||+||.|++++.+..+||+|||+|+.....
T Consensus 104 V~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 104 VFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred ehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeecccc
Confidence 99999 5599999976654 899999999999999999999 999999999999999999999999999999988654
Q ss_pred cccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc--cc-
Q 039392 154 DISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI--VD- 229 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~- 229 (285)
......+....|.||.|||++.. ..|+.+.||||+||++.||++|+..|.+...-. +..........++...+ +.
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~-Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH-QLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH-HHHHHHHhcCCCCHHHHHHhcc
Confidence 33334466788999999997654 579999999999999999999999987643221 11111111111111000 00
Q ss_pred -------ccccCcccchhh-hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 -------PNLLSREDIHFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 -------~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+-......+. .-..+++++.+|+.+||..||.+|+|++|+|++
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001111111111 113678889999999999999999999999875
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=297.56 Aligned_cols=259 Identities=29% Similarity=0.484 Sum_probs=209.2
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|.+.+.||+|+||+||++.. .++..+++|.+..........+.+|++++++++|+|++++++++......+++
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578899999999999999963 23456899988766566667788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCC------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEe
Q 039392 75 LEYMPHGSLEKYLHSSN------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS 142 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~ 142 (285)
+|++++++|.+++.... ..+++..++.++.|++.||+||| ++|++|+||+|+||+++.++.++++
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEec
Confidence 99999999999986432 23889999999999999999999 9999999999999999999999999
Q ss_pred eeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcC
Q 039392 143 DFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLP 221 (285)
Q Consensus 143 df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 221 (285)
|||++................++..|+|||.+.+..++.++|+||||+++++|++ |..||......+.. ........
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~-~~i~~~~~- 240 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-ECITQGRV- 240 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCc-
Confidence 9999876543322222233445678999999998899999999999999999998 88888654322211 11110000
Q ss_pred CCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 222 ISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...+..++.++.+++.+||+.||.+|||++++++.|+++.++.
T Consensus 241 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 241 ------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 0001234567999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=297.61 Aligned_cols=246 Identities=22% Similarity=0.302 Sum_probs=200.1
Q ss_pred ceecccCceEEEEEEeCCCcEEEEEEeeccch---hHHHHHHHHHHHHccCCCCccccccceecc----CCceEEEEecc
Q 039392 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKVISSCSN----EEFKALVLEYM 78 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~ 78 (285)
..+|+|+++.||+|.. +|+.||+|.+..... ...+.+.+|+.++++++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6789999999999987 688999999875432 235678899999999999999999998865 45788999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++.+.. .++....+.++.|++.|+.+|| + .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999997654 4888899999999999999999 6 488999999999999999999999999987654321
Q ss_pred eeccccccccccCCcccCC--CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 158 IQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+. ..........
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~~~-------------- 240 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLIINKNNS-------------- 240 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcCCC--------------
Confidence 23456788999999876 6789999999999999999999999976432221 1111100000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
+..+..+++++.+++.+||+.||.+|||++++++.|+.++.
T Consensus 241 ----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 ----LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ----CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 01122457789999999999999999999999999998864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=297.64 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=201.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++|++++++.+.+...+..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 588999999999999999974 579999999986443 1223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
++++++|.+.+... ...+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999998877543 335889999999999999999999 9999999999999999999999999999998754321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... .........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~------------- 220 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE-EVDRRVKED------------- 220 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH-HHHHHhhcc-------------
Confidence 1234467899999999999999999999999999999999999997643321110 000000000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
....+...+.++.+|+++||+.||.+||+ +++++++
T Consensus 221 ---~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 ---QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00012235667899999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=301.43 Aligned_cols=247 Identities=28% Similarity=0.407 Sum_probs=209.2
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|+..+.||+|.||.||+|. ..+++.||+|++..+.. ..++.+..|+.+|.+++++||.++++.+..+..++++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 6778999999999999996 45789999999987764 445778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
||++.+.++.... +++..+.-++++++.|+.||| .++.+|+|||+.||++..+|.+|+.|||.+...++.....
T Consensus 95 gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-- 168 (467)
T KOG0201|consen 95 GGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-- 168 (467)
T ss_pred CcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc--
Confidence 9999999976653 578888889999999999999 9999999999999999999999999999998776654332
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
.+..||+.|||||++....|+.++||||||+++++|.+|.+|+....+....+ .+....-+.
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------------lIpk~~PP~---- 230 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------------LIPKSAPPR---- 230 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------------eccCCCCCc----
Confidence 67789999999999998899999999999999999999999987754422111 111100000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+++.+++||..||..||+.||||.++|++
T Consensus 231 --L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 --LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 022456679999999999999999999999975
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=299.15 Aligned_cols=260 Identities=23% Similarity=0.419 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEeC-----------------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCcccccc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-----------------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVI 62 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-----------------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 62 (285)
.|++.+.||+|+||.||++... ++..||+|++.... ......+.+|++++..++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 4788999999999999999642 23469999987543 33456788999999999999999999
Q ss_pred ceeccCCceEEEEeccCCCCHHHhhhcCC------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 039392 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSN------------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124 (285)
Q Consensus 63 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~ 124 (285)
+++...+..+++|||+++++|.+++.... ..++...++.++.||+.||.||| +.|++|+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 99999999999999999999999885431 13567788999999999999999 9999999
Q ss_pred CCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh--CCCCC
Q 039392 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT--RKKPT 202 (285)
Q Consensus 125 di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~ 202 (285)
||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999986644332222233445778999999888889999999999999999987 55677
Q ss_pred ccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 203 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
......+. .............. .....+..++..+.+++.+||..+|.+|||++++.+.|+
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 243 GELTDEQV-IENAGEFFRDQGRQ------------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CcCCHHHH-HHHHHHHhhhcccc------------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 65332211 11111100000000 000112345677999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=287.90 Aligned_cols=267 Identities=23% Similarity=0.265 Sum_probs=207.5
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHH--HHHHHHHHHHccCCCCccccccceec--cCCceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVF--KSFDVECEMMKSIHHRNIIKVISSCS--NEEFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e 76 (285)
|+.++.|++|.||.||+|++ .+++-||+|.++.+....- -...+|+.+|.+.+||||+.+..+.. +-+..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 67888999999999999975 4788999999876543211 12457999999999999999999864 4467999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
||+. +|..++.....++....+.-++.|++.|++||| .+.|+|||+||+|++++..|.+||+|||+|+.++.+ .
T Consensus 158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~ 231 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--L 231 (419)
T ss_pred HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC--c
Confidence 9977 999999888888999999999999999999999 999999999999999999999999999999988776 3
Q ss_pred ceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhh-------hhhcCCCccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWV-------NDWLPISTKEIV 228 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 228 (285)
...+....|.||.|||++.+. .|+.+.||||+||++.+|+++.+.|.+....+.....+. ..|+..+.-...
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 345667889999999998887 699999999999999999999999887544333222211 011111111111
Q ss_pred cccccCcccchhhhh----hHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DPNLLSREDIHFVAK----EQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........+...... ...+..-.+|+..+|.+||.+|.|+++.|++
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111111111111 1145788999999999999999999999864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=306.24 Aligned_cols=244 Identities=21% Similarity=0.276 Sum_probs=200.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++.+...+..++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 578899999999999999975 468999999987542 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+.+++|.+++.+... +++..+..++.|++.||+||| ++|++|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 99 FVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred CCCCChHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 9999999999876543 888899999999999999999 9999999999999999999999999999998764422
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+. ........
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~----------------- 231 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-YEKILAGR----------------- 231 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-HHHHhcCC-----------------
Confidence 234578899999999998999999999999999999999999965322111 11110000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
...+..++..+.+++++||+.||.+||+ +++++.+
T Consensus 232 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 ---LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0001224566889999999999999996 6888765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=307.30 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=204.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5899999999999999999854 68999999987543 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.... .+++..++.++.||+.||.||| ++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999997654 3889999999999999999999 99999999999999999999999999999976543
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+. ............. + ....
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~-----~-~~~~- 224 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYWKETLQR-----P-VYDD- 224 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHhccccccC-----C-CCCc-
Confidence 22345688999999999988999999999999999999999999976432221 1111100000000 0 0000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....++.++.+++.+||..+|.+|||+++++++
T Consensus 225 -----~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 -----PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -----cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 012456779999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=304.02 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=196.8
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+.||+|+||.||++.. .+|+.+|+|++.... ......+.+|+.+++.++||||+++.+.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999975 578999999987542 233456778999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecc
Q 039392 82 SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161 (285)
Q Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~ 161 (285)
+|.+++.... .+++..+..++.||+.||+||| +.|++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 9999887654 4899999999999999999999 9999999999999999999999999999987532211 11233
Q ss_pred ccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhh
Q 039392 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241 (285)
Q Consensus 162 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (285)
..+++.|+|||.+.+..++.++|||||||++|+|++|..||......... ..... .. ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~----~~----------------~~ 213 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILM----EE----------------IR 213 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-HHHHc----CC----------------CC
Confidence 45889999999999999999999999999999999999999653221111 10000 00 00
Q ss_pred hhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 242 AKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
.+...+.++.+++.+||+.||++|| ++++++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1223567799999999999999999 79998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=305.81 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=202.3
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||.||+|.+ .++..||+|++.... ....+.+.+|+.+++.+ +||||+++++.+......+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 478899999999999999852 346689999986443 23445678899999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCC-------------------------------------------------------------
Q 039392 73 LVLEYMPHGSLEKYLHSSN------------------------------------------------------------- 91 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~------------------------------------------------------------- 91 (285)
+||||+++|+|.+++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999998885421
Q ss_pred -------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 92 -------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 92 -------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
..++...++.++.||+.||.||| +.|++|+||||+||+++.++.++|+|||++...........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 13677888999999999999999 99999999999999999999999999999986654322222
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....++..|+|||.+.+..++.++|+||||+++++|++ |..||..................
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------- 335 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR----------------- 335 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc-----------------
Confidence 223334567999999999999999999999999999998 88888654332221111111100
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
...+...+.++.+++.+||+.||++|||++++++.|++.
T Consensus 336 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 --MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 001123356799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=306.77 Aligned_cols=257 Identities=24% Similarity=0.396 Sum_probs=203.1
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||.||++.+ .++..||+|.+.... ......+.+|+++++.+ +|+||+++++.+......+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 478899999999999999863 234579999986543 33446688899999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCC-------------------------------------------------------------
Q 039392 73 LVLEYMPHGSLEKYLHSSN------------------------------------------------------------- 91 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~------------------------------------------------------------- 91 (285)
+||||+++++|.+++....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 9999999999998875321
Q ss_pred --------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecccc
Q 039392 92 --------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163 (285)
Q Consensus 92 --------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~ 163 (285)
..++...++.++.|++.||.||| ++|++||||||+||+++.++.++|+|||++................
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 13677888999999999999999 9999999999999999999999999999997654332222222333
Q ss_pred ccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhh
Q 039392 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVA 242 (285)
Q Consensus 164 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
++..|+|||.+.+..++.++||||||+++|+|++ |..||................. . ...
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-~------------------~~~ 336 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-Q------------------MSR 336 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-C------------------ccC
Confidence 5567999999988899999999999999999997 9999876433222111111000 0 000
Q ss_pred hhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 243 KEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
+...++++.+++.+||+.||.+|||++++++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1224567999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=291.24 Aligned_cols=254 Identities=21% Similarity=0.367 Sum_probs=203.5
Q ss_pred CCCCCceecccCceEEEEEEe----CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|.. ..+..+++|.+.... ......+.+|+..+++++||||+++++.+...+..++||
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 85 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT 85 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence 478899999999999999964 246789999987543 334466889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++++|.+++......++...++.++.|++.||+||| +.|++|+||+|.||+++.++.++++|||..........
T Consensus 86 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 86 EYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 999999999998776556899999999999999999999 99999999999999999999999999998765432211
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......++..|+|||.+.+..++.++||||||++++++++ |..||......+. .......
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~-~~~~~~~---------------- 224 (266)
T cd05064 163 -YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-IKAVEDG---------------- 224 (266)
T ss_pred -hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-HHHHHCC----------------
Confidence 11112334567999999988899999999999999999775 9999865432211 1110000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
...+.+..++..+.+++.+||+.+|.+|||++++++.|.++
T Consensus 225 ---~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ---FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00111234667799999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=303.20 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=214.6
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCc-eEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF-KALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e 76 (285)
+|..++.+|+|+||.++.++ ..+++.+|+|.+.... ....+.+..|+.++.++.||||+.+.+.|..++. ++++|+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 58899999999999999996 4467899999986543 3344577889999999999999999999999888 999999
Q ss_pred ccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+||++.+.+.+.. ..+++++++.|+.|++.|+.||| ++.++|||||+.|||+++++.|+|+|||++...+...
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999999987665 56999999999999999999999 9999999999999999999999999999999887653
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......||+.|+.||++.+..|+.++|||||||++|+|++-+.+|.+........+.....
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~----------------- 222 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL----------------- 222 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----------------
Confidence 23456789999999999999999999999999999999999999998865544433322111
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
-.+.+...+.++..+|..||..+|..||++.++|.+
T Consensus 223 ---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111245667889999999999999999999999987
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=289.11 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=205.9
Q ss_pred CCCCCceecccCceEEEEEEeC----CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|.+. +...+++|.+.... ......+.+|+.+++.++|+||+++++.+...+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 5889999999999999999753 24578999886543 334466888999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.|+.+|| +++++|+||+|.||+++.++.++++|||++........
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999999776656899999999999999999999 99999999999999999999999999999987753221
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.........+..|+|||.+.+..++.++|+||||++++++++ |..||......+.. ........
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~--~~~~~~~~------------- 226 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI--KAVEDGYR------------- 226 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH--HHHHcCCC-------------
Confidence 211222334567999999998899999999999999999998 99998653322211 11100000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
...+..++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 227 -----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 -----LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=298.27 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=204.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 5889999999999999999754 68889999987653 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++..... +++..+..++.|++.||.||| +. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 86 DGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred CCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 99999999876543 889999999999999999999 64 69999999999999999999999999987654321
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcC---------CCcc---
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP---------ISTK--- 225 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~--- 225 (285)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||......+.. ........ ....
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE--AIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHhcccccccccCCccccCccccc
Confidence 23345788999999999889999999999999999999999999654322111 11000000 0000
Q ss_pred --cccccc-ccC--------------cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 226 --EIVDPN-LLS--------------REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 226 --~~~~~~-~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
...... ... ............++++.+|+.+||..||++|||+++++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000 000 00000000123567899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=293.24 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=207.7
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|++.+.||+|.+|+|-+|+ ...|+.||||.+..+. .+..-.+.+|++++..++||||+.++.+|++.+...+||||
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence 7788899999999999997 4689999999986543 34455688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
..+|.|.+++...+. +++..++.+++||+.|+.|+| +++++|||+|.+||++|.++++||.|||++..+... .
T Consensus 135 aS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~---k 207 (668)
T KOG0611|consen 135 ASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK---K 207 (668)
T ss_pred cCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc---c
Confidence 999999999977665 999999999999999999999 999999999999999999999999999999887764 3
Q ss_pred eeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+|++.|.+||++.+..| .+..|.||||+++|.+..|..||++.+-.... ...... ...
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv-----rQIs~G---aYr-------- 271 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV-----RQISRG---AYR-------- 271 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH-----HHhhcc---ccc--------
Confidence 4467789999999999998865 68899999999999999999999874322211 111111 111
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
....+..+.-||++||..||++|.|++++.+++.
T Consensus 272 ------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 ------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1112344667999999999999999999998864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=292.82 Aligned_cols=253 Identities=32% Similarity=0.502 Sum_probs=203.5
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
.|.+.+.||+|+||.||+|... +++.+++|.+...... ..+.+.+|+++++.++|+||+++++.+......++
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence 3778899999999999999642 3578999998755443 45788899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC-------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEE
Q 039392 74 VLEYMPHGSLEKYLHSSN-------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH 140 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~ 140 (285)
+||++++++|.+++.... ..++...+..++.|++.++.+|| +.|++|+||+|+||+++.++.++
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeEE
Confidence 999999999999986532 23778889999999999999999 99999999999999999999999
Q ss_pred EeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhh
Q 039392 141 LSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDW 219 (285)
Q Consensus 141 i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 219 (285)
|+|||++................++..|+|||.+.+..++.++||||||+++++|++ |..||......+.... .....
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~-~~~~~ 241 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC-ITQGR 241 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCC
Confidence 999999876533221122233345678999999999999999999999999999998 9999865433221111 00000
Q ss_pred cCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
.. ..+..++..+.+++++||..||.+|||++|+++.|+
T Consensus 242 -------------~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 242 -------------LL------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -------------cC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 001235667999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=290.47 Aligned_cols=253 Identities=27% Similarity=0.488 Sum_probs=208.5
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||.|++|.||+|...++..+++|++..........+.+|+.+++.++|+|++++++++......+++||++++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 47889999999999999998777899999998876665567788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++.+. ...++...++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~ 161 (261)
T cd05148 87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--S 161 (261)
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--c
Confidence 9999998763 334888999999999999999999 999999999999999999999999999999765433211 1
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|++||.+.+..++.++|+||||+++++|++ |..||......+. ....... .
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~-~~~~~~~-------------------~ 221 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV-YDQITAG-------------------Y 221 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH-HHHHHhC-------------------C
Confidence 23345667999999988889999999999999999998 8999865432211 1111100 0
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+..++.++.+++.+||..||++|||++++++.|+++
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0011234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=307.77 Aligned_cols=240 Identities=23% Similarity=0.308 Sum_probs=200.0
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|+++++||+|.||+|+++. ..+++.+|||++++.. +...+..+.|..+++..+ ||++++++..|+..+++|+||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 57889999999999999997 4568899999998654 456677888999988886 999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+.||++..++.. ..+++..+.-++..|+.||.||| ++||+|||||.+||++|.+|.+||.|||++...-..
T Consensus 449 ey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-- 521 (694)
T KOG0694|consen 449 EYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-- 521 (694)
T ss_pred EecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC--
Confidence 99999995544432 34999999999999999999999 999999999999999999999999999999754322
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
....++.+||+.|+|||++.++.|+.+.|.||||++||+|+.|..||.+..+++.-.+ .. .++.
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds-I~-------~d~~-------- 585 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS-IV-------NDEV-------- 585 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-Hh-------cCCC--------
Confidence 2234678899999999999999999999999999999999999999987544332111 11 1111
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINA 268 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 268 (285)
..+..++.+..++++++|..+|++|.-+
T Consensus 586 -----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 -----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1144567779999999999999999844
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=292.10 Aligned_cols=254 Identities=29% Similarity=0.526 Sum_probs=204.8
Q ss_pred CCCCCceecccCceEEEEEEeCC------CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLGD------GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~------~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|++|.||+|...+ ...+++|.+.... ......+.+|+++++.++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 47889999999999999996432 2578999886443 3345668899999999999999999999999899999
Q ss_pred EEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc
Q 039392 74 VLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV 138 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~ 138 (285)
++|++++++|.+++.... ..++...++.++.|++.||.||| ++|++|+||+|+||+++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCc
Confidence 999999999999886531 34788889999999999999999 999999999999999999999
Q ss_pred EEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhh
Q 039392 139 AHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVN 217 (285)
Q Consensus 139 ~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 217 (285)
++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+. ......
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~-~~~i~~ 241 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV-IEMIRS 241 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHc
Confidence 99999999876543322222334456778999999988889999999999999999998 9999876433221 111000
Q ss_pred hhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 218 DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
. . ....+..++.++.+++.+||+.||.+||++++++++|++
T Consensus 242 ----~---------~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 242 ----R---------Q------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----C---------C------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0 0 001134567889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=298.99 Aligned_cols=242 Identities=21% Similarity=0.280 Sum_probs=196.4
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999975 478999999987542 233456678999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecc
Q 039392 82 SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161 (285)
Q Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~ 161 (285)
+|..++.... .+++..++.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence 9988886654 4889999999999999999999 9999999999999999999999999999987532221 11223
Q ss_pred ccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhh
Q 039392 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241 (285)
Q Consensus 162 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (285)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... ..... ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~-~~~~~--------------------~~ 213 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-ILMEE--------------------IR 213 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-HhcCC--------------------CC
Confidence 4688899999999988999999999999999999999999965332211111 10000 00
Q ss_pred hhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 242 AKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
.+..+++++.+++.+||+.||++|+ ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1224567789999999999999998 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=287.22 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=206.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|.. .+++.+++|.+... .......+.+|+++++.++|||++++++.+...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 689999999999999999975 47899999987532 23444567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 77 YMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 77 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++++++|.+++.. ....++...++.++.|++.|+.||| +++++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988753 2334788999999999999999999 999999999999999999999999999998876543
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.. ......++..|+|||.+.+..++.++|+||+|+++++|++|..||....................
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 226 (267)
T cd08228 160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP----------- 226 (267)
T ss_pred hH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC-----------
Confidence 21 11234577789999999888899999999999999999999999865332211111111100000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
. ......+..+.+++.+||..+|++|||++++++.++.++
T Consensus 227 -~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 -P-----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -C-----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 002234567999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=312.38 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=202.7
Q ss_pred CCCCceecccCceEEEEEEeC-C-CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARLG-D-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~-~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++.+...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 678899999999999999643 3 67889998766655555677889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 80 HGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 80 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+++|.+++... ...+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||++.........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999877532 334888999999999999999999 999999999999999999999999999999876543222
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......+++.|+|||.+.+..++.++|||||||++|+|++|..||......+.... .......
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~-~~~~~~~--------------- 289 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ-VLYGKYD--------------- 289 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhCCCC---------------
Confidence 223345689999999999988999999999999999999999999865332111111 0000000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..++.++.+++.+||..+|++|||+++++..
T Consensus 290 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 ----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0022345679999999999999999999999753
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=288.09 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=202.7
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|+.++.||+|..|+||+++.. ++..+|+|++.... .....++..|.+||..+.||.++.+++.|+.+...|++|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 456789999999999999854 46889999998654 34455677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc---
Q 039392 78 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE--- 153 (285)
Q Consensus 78 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~--- 153 (285)
|+||+|..+.+++. +.+++..++-++..++-||+||| ..|||+|||||+||||.++|++.|+||+++......
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 99999999987654 45999999999999999999999 999999999999999999999999999987532110
Q ss_pred -----------------------------c-cc---------------------ceeccccccccccCCcccCCCccCcc
Q 039392 154 -----------------------------D-IS---------------------TIQTQTLATIGYMAPEYGKEGRVSAN 182 (285)
Q Consensus 154 -----------------------------~-~~---------------------~~~~~~~~~~~~~~PE~~~~~~~~~~ 182 (285)
. .. .......||-.|+|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 00 00112357889999999999999999
Q ss_pred hhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCc
Q 039392 183 GDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESP 262 (285)
Q Consensus 183 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 262 (285)
.|.|+||+++|||+.|..||.+..+.+.- ..... .+..++.....+.++++||+++|..||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl-~NIv~------------------~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETL-RNIVG------------------QPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhH-HHHhc------------------CCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 99999999999999999999885544332 21111 112222334667789999999999999
Q ss_pred CCCCC----HHHHH
Q 039392 263 EQRIN----AKEIV 272 (285)
Q Consensus 263 ~~Rps----~~eil 272 (285)
++|.- ++||-
T Consensus 377 ~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhccccchHHhh
Confidence 99987 66654
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=292.22 Aligned_cols=258 Identities=30% Similarity=0.493 Sum_probs=208.0
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|.+.+.||+|+||.||++.. .++..+++|.+..........+.+|+++++.++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 467789999999999999963 23556889988766665567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcE
Q 039392 75 LEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVA 139 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~ 139 (285)
||++++++|.+++.... ..++...++.++.||+.|+++|| ++|++|+||+|.||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 99999999999986532 23788899999999999999999 9999999999999999999999
Q ss_pred EEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhh
Q 039392 140 HLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVND 218 (285)
Q Consensus 140 ~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 218 (285)
+++|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ......
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~ 241 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-ECITQG 241 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhCC
Confidence 9999999876543322222233456778999999988899999999999999999998 99998654332211 100000
Q ss_pred hcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 219 WLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
. ... ....++..+.+++.+||+.+|.+|||++++++.|+++.+.
T Consensus 242 ~-------------~~~------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 242 R-------------VLE------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred C-------------CCC------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0 000 0123456789999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=307.71 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=201.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||++.. .+++.||+|++.... ......+.+|+++++.++|+||+++++.+......++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 689999999999999999975 468999999987532 2334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999987654 4899999999999999999999 999999999999999999999999999998754321100
Q ss_pred c------------------------------------eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCC
Q 039392 157 T------------------------------------IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK 200 (285)
Q Consensus 157 ~------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 200 (285)
. ......+|+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 0012358899999999999999999999999999999999999
Q ss_pred CCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC---HHHHHHH
Q 039392 201 PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN---AKEIVTK 274 (285)
Q Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~~ 274 (285)
||......+.. ........ ...++.....++++.+++.+|+. +|.+|++ +++++++
T Consensus 238 Pf~~~~~~~~~-~~i~~~~~----------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETY-RKIINWKE----------------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHH-HHHHcCCC----------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99754322111 11110000 00001112346678999999997 9999997 9998874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=302.42 Aligned_cols=244 Identities=21% Similarity=0.268 Sum_probs=199.7
Q ss_pred CCCCCceecccCceEEEEEEeC-C-CcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-D-GMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~-~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|... + +..||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 5888999999999999999643 3 4689999986432 233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++++|.+++.+... +++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++.......
T Consensus 111 Ey~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~- 185 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT- 185 (340)
T ss_pred eCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-
Confidence 99999999999976554 889999999999999999999 9999999999999999999999999999997654321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ .........
T Consensus 186 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~i~~~~~--------------- 245 (340)
T PTZ00426 186 ----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-YQKILEGII--------------- 245 (340)
T ss_pred ----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-HHHHhcCCC---------------
Confidence 234678899999999988899999999999999999999999975322111 111110000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
..+...+..+.+++++||+.||.+|+ |+++++++
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00123456688999999999999995 89998875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=304.74 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=197.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||++.. .+++.+|+|++.... ......+.+|+.++.+++|++|+++++.+.+...+++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 689999999999999999974 468999999987532 2334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.+.. .+++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999987654 4899999999999999999999 999999999999999999999999999998754321100
Q ss_pred ---------------------------------ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCc
Q 039392 157 ---------------------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTD 203 (285)
Q Consensus 157 ---------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 203 (285)
.......||+.|+|||.+.+..++.++|+|||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00113468999999999999999999999999999999999999997
Q ss_pred cccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcC---CCCCHHHHHHH
Q 039392 204 EIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPE---QRINAKEIVTK 274 (285)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~---~Rps~~eil~~ 274 (285)
.....+. .......... ..++....++.++.+++.+|+. +|. .||++++++++
T Consensus 238 ~~~~~~~-~~~i~~~~~~----------------~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQET-YKKVMNWKET----------------LIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHH-HHHHHcCcCc----------------ccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 5432221 1111110000 0011112345668888888765 344 46899999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=287.05 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=201.0
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
|++.+.||+|+||.||++.+.++..+++|.+... ....+.+.+|+++++.++||||+++++++......+++|||++++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 7788999999999999998877788999987643 223456788999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecc
Q 039392 82 SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161 (285)
Q Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~ 161 (285)
+|.+++......++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++++|||.+......... ....
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05114 85 CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSG 160 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCC
Confidence 999998765455889999999999999999999 999999999999999999999999999998765432211 1122
Q ss_pred ccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 162 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
..++..|+|||.+.+..++.++|+||||++++++++ |..||......+.... ...... .
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~-i~~~~~------~------------- 220 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM-ISRGFR------L------------- 220 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCC------C-------------
Confidence 234567999999988889999999999999999999 8899865432221111 111000 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
..+...+.++.+++.+||+.+|++|||++++++.|
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00112345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=304.66 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=203.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|.+.+.||+|+||+||++.. .+++.+|+|++.... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 689999999999999999975 478999999987543 2344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.+....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999877556999999999999999999999 999999999999999999999999999999876543211
Q ss_pred ceeccccccccccCCcccC------CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGK------EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
......+++.|+|||++. ...++.++||||||+++|+|++|..||........ ....... .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~~---~-------- 225 (330)
T cd05601 159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNIMNF---Q-------- 225 (330)
T ss_pred -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HHHHHcC---C--------
Confidence 223346788999999876 45678999999999999999999999975432211 1111100 0
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....++.....+.++.+++.+||. +|.+|||+++++++
T Consensus 226 -----~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 -----RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000111122456778999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=306.08 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=204.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|++++..++|+||+++++.+...+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5899999999999999999754 68999999987542 2344667889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc--
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED-- 154 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~-- 154 (285)
|+++++|.+++.+. ..++...++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999998766 34899999999999999999999 9999999999999999999999999999987654432
Q ss_pred -------------------------ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccc
Q 039392 155 -------------------------ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209 (285)
Q Consensus 155 -------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 209 (285)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 0011234568899999999999999999999999999999999999997643221
Q ss_pred hhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC-HHHHHHH
Q 039392 210 MTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN-AKEIVTK 274 (285)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~eil~~ 274 (285)
.. ..... +. ....++....+++++.++|.+||. +|.+||+ +++++++
T Consensus 238 ~~-~~i~~-~~---------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TY-NKIIN-WK---------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-HHHhc-cC---------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 11110 00 000011111256779999999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=299.43 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=199.0
Q ss_pred CCCCCceecccCceEEEEEEe----CCCcEEEEEEeeccc----hhHHHHHHHHHHHHccCC-CCccccccceeccCCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY----GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 71 (285)
+|++.+.||+|+||.||+++. .+++.+|+|++.... ....+.+.+|+.+++.++ |++|+++++.+...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 689999999999999999864 368899999986432 223456778999999994 99999999999999999
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++||||+++++|.+++.+... +++..++.++.||+.||.||| ++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999998866543 889999999999999999999 9999999999999999999999999999987654
Q ss_pred cccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
..... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||......... ...........
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~------- 227 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILKCD------- 227 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHhcCC-------
Confidence 32211 11234588999999998765 4789999999999999999999999643221111 11111000000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
...+...++.+.+++.+||+.||++|| ++++++++
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 ---------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 001223566789999999999999999 77888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=295.29 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=205.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCc----EEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGM----EVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~----~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|+||.||+|.+. +++ .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v 86 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 86 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence 5889999999999999999742 333 48999986543 34456788999999999999999999998765 46799
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
++++++|+|.+++......++...++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 9999999999999876656888999999999999999999 9999999999999999999999999999998765433
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
..........+..|++||.+.+..++.++||||||+++|++++ |..||.+....+. .......
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--~~~~~~~-------------- 227 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSILEKG-------------- 227 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHhCC--------------
Confidence 2222223334667999999999999999999999999999998 9999875432211 1111100
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
..+..+..++.++.+++.+||..+|.+|||+.+++..+.++.++
T Consensus 228 ----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 228 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00011223455688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=296.10 Aligned_cols=264 Identities=21% Similarity=0.301 Sum_probs=201.6
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||++... ++..+++|.+.... ......+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (333)
T cd06650 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (333)
T ss_pred hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecC
Confidence 5899999999999999999754 68889999887543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++.... .++...+..++.|++.|+.||| . .+++|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---- 157 (333)
T cd06650 86 DGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (333)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence 9999999987654 3888999999999999999999 6 47999999999999999999999999998755332
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc-c-------cc-
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK-E-------IV- 228 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-------~~- 228 (285)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||......... ............ . ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccccccCcccCCcc
Confidence 112345788999999999888999999999999999999999999754322111 000000000000 0 00
Q ss_pred ------cccccCc------------ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 ------DPNLLSR------------EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ------~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+...+. ...........+.++.+|+.+||+.||.+|||+++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000 000000001245678999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=291.47 Aligned_cols=249 Identities=34% Similarity=0.557 Sum_probs=196.2
Q ss_pred CCceecccCceEEEEEEeC-----CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 4 ENNLIGRGGFGSVFKARLG-----DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~-----~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+.+.||.|.||.||+|.+. .+..|+||.+.... ......+.+|++.+++++||||+++++++...+..++|+|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999754 36789999996543 33467899999999999999999999999988889999999
Q ss_pred cCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+++++|.+++... ...++...++.|+.|++.||.||| +++++|++|++.||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 455999999999999999999999 899999999999999999999999999999877433333
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
...........|+|||.+.+..++.++||||||++++++++ |..||......+.. .....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~-~~~~~------------------ 220 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII-EKLKQ------------------ 220 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH-HHHHT------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc------------------
Confidence 33344556778999999988889999999999999999999 67887654222211 11100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
......+..++..+.+++.+||..+|.+|||++++++.|
T Consensus 221 -~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 -GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011111334567799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=302.96 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=204.0
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccch-hHHHHHHHHHHHHccCC-CCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 72 (285)
+|++++.||+|+||.||+|... ++..||+|++..... ...+.+.+|+++++.+. ||||+++++++......+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 4778999999999999999642 234699999875433 33467889999999996 999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCC-------------------------------------------------------------
Q 039392 73 LVLEYMPHGSLEKYLHSSN------------------------------------------------------------- 91 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~------------------------------------------------------------- 91 (285)
+||||+++++|.+++....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999999999998875421
Q ss_pred ----------------------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 039392 92 ----------------------------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM 137 (285)
Q Consensus 92 ----------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~ 137 (285)
..++...++.++.|++.||+||| +.+++|+||+|+||+++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCC
Confidence 12667778899999999999999 99999999999999999999
Q ss_pred cEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhh
Q 039392 138 VAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWV 216 (285)
Q Consensus 138 ~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 216 (285)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||..............
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~ 354 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence 999999999986644322222233345677999999988889999999999999999997 8899865432221111110
Q ss_pred hhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 217 NDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
.. .....+..++.++.+++.+||+.+|++|||+.++.+.|+++..
T Consensus 355 ~~-------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 355 SG-------------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred cC-------------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00 0011123456779999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=298.28 Aligned_cols=242 Identities=21% Similarity=0.300 Sum_probs=196.5
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++.+.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999975 468999999987542 234456778999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecc
Q 039392 82 SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161 (285)
Q Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~ 161 (285)
+|.+.+.... .+++..++.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9998886654 4889999999999999999999 9999999999999999999999999999987533211 11233
Q ss_pred ccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhh
Q 039392 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241 (285)
Q Consensus 162 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (285)
..+++.|+|||.+.+..++.++||||||+++|+|++|..||......+.... . .... ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~-~----~~~~----------------~~ 213 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-I----LMED----------------IK 213 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH-h----ccCC----------------cc
Confidence 4688999999999988999999999999999999999999965322111100 0 0000 00
Q ss_pred hhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 242 AKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
.+...+.++.+++.+||..||.+|+ ++++++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1223566789999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=287.77 Aligned_cols=253 Identities=24% Similarity=0.438 Sum_probs=204.4
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.++||+|++|.||+|...++..+++|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++++|++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 478899999999999999987778889999876543 2346788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++.+. ...++...++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 161 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AR 161 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-cc
Confidence 9999998653 344788889999999999999999 999999999999999999999999999999876542211 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ ........
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-~~~~~~~~------------------- 221 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV-MSALQRGY------------------- 221 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH-HHHHHcCC-------------------
Confidence 22334567999999988889999999999999999998 9999865322211 11110000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.......++.++.+++.+||..+|++|||++++++.|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011123456689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=271.62 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=206.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++++.||+|.||.||.|+. .++--||+|++.... ......+.+|+++-..|+||||++++++|.+....|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 588999999999999999974 467778999986543 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|.++|.+...+... ...+++...+.+..|++.|+.|+| ..+++||||||+|++++..|.+||.|||-+......
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~-- 177 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN-- 177 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC--
Confidence 99999998887633 334999999999999999999999 999999999999999999999999999998765422
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.....++|..|++||+..+...+...|+|++|++.|+++.|..||......+.... ... .
T Consensus 178 --kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr-I~k-------~---------- 237 (281)
T KOG0580|consen 178 --KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR-IRK-------V---------- 237 (281)
T ss_pred --CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH-HHH-------c----------
Confidence 23456789999999999999999999999999999999999999987543222211 111 1
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
+...+..++..+.++|.+|+..+|.+|.+..|++.+-.
T Consensus 238 ---~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 238 ---DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ---cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11113445667999999999999999999999998754
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=302.60 Aligned_cols=262 Identities=20% Similarity=0.200 Sum_probs=197.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|.+.+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++++|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 589999999999999999975 468899999643 2345689999999999999999999999999999999995
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|..++.... .++...++.++.|++.||.||| ++|++||||||+||+++.++.++|+|||++....... ....
T Consensus 167 -~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~ 240 (391)
T PHA03212 167 -TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKY 240 (391)
T ss_pred -CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccc
Confidence 58888876554 3889999999999999999999 9999999999999999999999999999986543221 1112
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCcccccc------chhhhhhhhhhcCCCcccccc----
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNG------EMTLKHWVNDWLPISTKEIVD---- 229 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~---- 229 (285)
....+|+.|+|||++.+..++.++||||||+++|+|++|..||...... ..............+.....+
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 2346899999999999889999999999999999999999886532211 111111111111000000000
Q ss_pred -----------ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 -----------PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..........+......+.++.+++.+||+.||.+|||++|+|++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000001111223457789999999999999999999999863
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=296.46 Aligned_cols=240 Identities=25% Similarity=0.294 Sum_probs=194.0
Q ss_pred ecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 8 IGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 8 lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999754 68899999986432 33445677899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecccc
Q 039392 84 EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163 (285)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~ 163 (285)
.+++..... +++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 999876543 889999999999999999999 9999999999999999999999999999987543221 1123346
Q ss_pred ccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhh
Q 039392 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243 (285)
Q Consensus 164 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
+++.|+|||.+.+..++.++||||||+++|+|++|..||......+.. .... ... ...+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-~~~~----~~~----------------~~~~ 213 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-RKIL----QEP----------------LRFP 213 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-HHHH----cCC----------------CCCC
Confidence 889999999999999999999999999999999999999753222111 1100 000 0112
Q ss_pred hHhHHHHHHhhhcccccCcCCCCC---HHHHHHH
Q 039392 244 EQCVSFVFNVAMECTVESPEQRIN---AKEIVTK 274 (285)
Q Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps---~~eil~~ 274 (285)
...++++.+++.+||..||.+||+ +++++.+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 345677899999999999999975 6676654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=284.04 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=197.6
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
+.||+|+||.||+|.. .+++.+++|.+.... ......+.+|+++++.++||||+++++++......++|+|++++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4799999999999975 478999999876433 33456788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecccc
Q 039392 84 EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163 (285)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~ 163 (285)
.+++......+++..++.++.|++.||.||| ++|++|+||+|+||+++.++.++++|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9998765555889999999999999999999 9999999999999999999999999999987544321111111122
Q ss_pred ccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhh
Q 039392 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVA 242 (285)
Q Consensus 164 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
.+..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .... .. .. ....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~~~-~~--~~----------------~~~~ 217 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-REAI-EQ--GV----------------RLPC 217 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-HHHH-Hc--CC----------------CCCC
Confidence 3456999999988889999999999999999998 8888865322111 1100 00 00 0011
Q ss_pred hhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 243 KEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
+..++..+.+++.+||+.+|++|||++++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2234667999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=305.17 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=198.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
.|++++.||+|+||+||+|.. .+++.+|+|++.... ....+.+.+|+++++.++|+||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 488899999999999999974 568899999986532 2344668889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc-
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI- 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~- 155 (285)
|+++++|.+++.+... +++..+..++.||+.||.||| +.|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999876554 888899999999999999999 99999999999999999999999999998754311000
Q ss_pred --------------------------------------------cceeccccccccccCCcccCCCccCcchhhHHHHHH
Q 039392 156 --------------------------------------------STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 191 (285)
Q Consensus 156 --------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~ 191 (285)
........+|+.|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000113468899999999988889999999999999
Q ss_pred HHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhccc--ccCcCCCCCHH
Q 039392 192 LIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECT--VESPEQRINAK 269 (285)
Q Consensus 192 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~~p~~Rps~~ 269 (285)
+|+|++|..||......+..... ..... ....+....+++++.+++.+|+ ..+|..|++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i-~~~~~----------------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKV-INWEN----------------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHH-Hcccc----------------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999764332221111 00000 0001112235677889999855 44555699999
Q ss_pred HHHHH
Q 039392 270 EIVTK 274 (285)
Q Consensus 270 eil~~ 274 (285)
+++.+
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=299.85 Aligned_cols=267 Identities=21% Similarity=0.307 Sum_probs=197.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccC-----CceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE-----EFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 72 (285)
.|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 488999999999999999975 468999999886432 23345678899999999999999999987432 3579
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+|||++. ++|.+++..... +++..+..++.||+.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD-LTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhccc-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 589888866544 889999999999999999999 99999999999999999999999999999976433
Q ss_pred ccc-cceeccccccccccCCcccCC--CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 153 EDI-STIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 153 ~~~-~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
... ........+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+...... ...... ...........
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-~~~~~~-~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLITD-LLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHH-HhCCCCHHHHH
Confidence 221 112234568899999998765 5789999999999999999999999965432111 000000 00000000000
Q ss_pred c-----------cccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 P-----------NLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~-----------~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ......+..+ ......++++.+++.+||..||++|||+++++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0000000000 0012346778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=306.24 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=198.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++++.||+|+||+||++.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++.+......++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 689999999999999999974 578999999986432 2334667889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.... .+++..++.++.|++.||+||| +.|++||||||+||+++.++.++|+|||+++........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999987654 4889999999999999999999 999999999999999999999999999998633210000
Q ss_pred -----------c----------------------------------eeccccccccccCCcccCCCccCcchhhHHHHHH
Q 039392 157 -----------T----------------------------------IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 191 (285)
Q Consensus 157 -----------~----------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~ 191 (285)
. ......+++.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0012358889999999998899999999999999
Q ss_pred HHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCC---CCH
Q 039392 192 LIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQR---INA 268 (285)
Q Consensus 192 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~ 268 (285)
+|+|++|..||......+. .......... ..++.....+.++.+++.+||. +|.+| +|+
T Consensus 238 l~elltG~~Pf~~~~~~~~-~~~i~~~~~~----------------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 238 MFECLIGWPPFCSENSHET-YRKIINWRET----------------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhcCCCCCCCCCHHHH-HHHHHccCCc----------------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 9999999999975432211 1111110000 0011112345678999999998 67765 599
Q ss_pred HHHHHH
Q 039392 269 KEIVTK 274 (285)
Q Consensus 269 ~eil~~ 274 (285)
.+++.+
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=286.11 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=202.0
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|++|.||.+...++..+++|.+.... ...+.+.+|+.++++++||||+++++++......+++||++.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 478899999999999999987777779999876443 2346688899999999999999999999988889999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++......+++..++.++.|++.||.||| +.|++|+||+|.||+++.++.++|+|||.+........ ....
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~ 159 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSV 159 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecC
Confidence 9999998765556899999999999999999999 99999999999999999999999999999876543321 1112
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...++..|++||...+..++.++|+||||+++|+|++ |..||......+.... .......
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~------------------ 220 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK-VSQGLRL------------------ 220 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HhcCCCC------------------
Confidence 2334567999999988889999999999999999998 9999865432221111 1000000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
..+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001123566899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=286.04 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=201.9
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|++|.||++.+.++..+++|++..... ....+.+|+++++.++|+||+++++++...+..++++|++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4788999999999999999877777899999764322 234677899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++......++...++.++.|++.|+++|| +.|++|+||+|+||+++.++.++|+|||.++...+.... ...
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~ 159 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQ 159 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccC
Confidence 9999998765556899999999999999999999 999999999999999999999999999998765432211 111
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+..|+|||.+.+..++.++|+||||+++|++++ |..||......+.. ....... .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~-------------------~ 219 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ESVSAGY-------------------R 219 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHHHcCC-------------------c
Confidence 2223457999999998899999999999999999999 78888654322211 1100000 0
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
...+..++.++.+++.+||..+|++|||++++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011223567799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=285.18 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=204.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|++|.||+|.. .+++.+++|.+..+ ......+.+|+++++.++|+|++++++.+......+++||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 367788999999999999975 45888999998644 3345678889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 80 HGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 80 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+++|.+++.... ..++...++.++.|++.+|++|| ++|++|+||+|+||++++++.++|+|||++......... .
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~ 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-A 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-c
Confidence 999999986543 34888899999999999999999 999999999999999999999999999999876543211 1
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......+..|+|||.+.+..++.++||||||+++|+|++ |..||......+ .........
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~------------------ 222 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGY------------------ 222 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCC------------------
Confidence 112233567999999988899999999999999999998 888886532211 111111000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+..++.++.+++.+||..+|++|||+.++++.|+++
T Consensus 223 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011234567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=284.69 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=204.1
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|++|.||+|...+++.|++|.+.... ...+.+.+|++++++++|+|++++++++...+..+++||++++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 477889999999999999987777889999986543 2345678899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++.... ..++...+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~ 161 (261)
T cd05068 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AR 161 (261)
T ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-cc
Confidence 99999986643 45889999999999999999999 999999999999999999999999999999876532111 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
.....+..|+|||.+.+..++.++|+||||+++++|++ |+.||.+...... ........ .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~-~----------------- 222 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-LQQVDQGY-R----------------- 222 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCC-C-----------------
Confidence 11223457999999998899999999999999999999 9999865332211 11111100 0
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
......++..+.+++.+|++.+|.+||+++++++.|+++
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 001123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=295.02 Aligned_cols=243 Identities=25% Similarity=0.347 Sum_probs=195.6
Q ss_pred CceecccCceEEEEEEe----CCCcEEEEEEeeccc----hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 5 NNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY----GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
++.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 46899999999999964 357899999987532 2233456789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.+.. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 81 YLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 999999999887654 3788888999999999999999 9999999999999999999999999999987543221
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ....... ..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~~~~----~~------------- 216 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDKILK----GK------------- 216 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-HHHHHHc----CC-------------
Confidence 11223468899999999998889999999999999999999999997532211 1111110 00
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
...+..+++++.+++.+||+.+|++|| ++++++++
T Consensus 217 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 ---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 011223466789999999999999999 88888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=303.18 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=199.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+......++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 478899999999999999975 468899999986432 2233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++... .+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||++........
T Consensus 124 y~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~- 197 (370)
T cd05596 124 YMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM- 197 (370)
T ss_pred CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence 99999999988654 3788889999999999999999 99999999999999999999999999999986643221
Q ss_pred ceeccccccccccCCcccCCC----ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKEG----RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||....... ..........
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~------------ 264 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMDHKN------------ 264 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHHcCCC------------
Confidence 112345689999999987653 47899999999999999999999997533211 1111111000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCC--CCCHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~~ 274 (285)
...++.....+.++.+++.+||..+|++ |+|+++++.+
T Consensus 265 ----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0011112235677999999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=288.18 Aligned_cols=253 Identities=29% Similarity=0.471 Sum_probs=203.2
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.++||+|+||.||++.. .++..+++|.+..........+.+|+++++.++|+||+++++++......+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 477889999999999999953 23567889988766666667889999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCC--------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEE
Q 039392 75 LEYMPHGSLEKYLHSSN--------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH 140 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~ 140 (285)
+|++++++|.+++.... ..++...++.++.|++.|++||| +.|++|+||+|+||++++++.++
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEE
Confidence 99999999999986542 23788899999999999999999 99999999999999999999999
Q ss_pred EeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhh
Q 039392 141 LSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDW 219 (285)
Q Consensus 141 i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 219 (285)
|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... .....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~ 241 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC-ITQGR 241 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-HHcCc
Confidence 999999876543221122223334678999999988899999999999999999998 8888865332211111 00000
Q ss_pred cCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
....+..+++.+.+++.+||..||.+||+++++++.|+
T Consensus 242 -------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 -------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00112245667999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=304.93 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=197.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
.|++++.||+|+||+||+|.. .+++.+|+|++.... ......+.+|++++++++|+||+++++.+...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 478899999999999999974 568899999986532 2344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc-
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI- 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~- 155 (285)
|+++++|.+++.+.. .+++..+..++.||+.||.||| +.|++||||||+||+++.+|.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999987654 4888999999999999999999 99999999999999999999999999999753211000
Q ss_pred --------------------------------------------cceeccccccccccCCcccCCCccCcchhhHHHHHH
Q 039392 156 --------------------------------------------STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 191 (285)
Q Consensus 156 --------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~ 191 (285)
........+|+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112357899999999999999999999999999
Q ss_pred HHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC---H
Q 039392 192 LIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN---A 268 (285)
Q Consensus 192 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~ 268 (285)
+|+|++|..||......+.... ...... ....+.....++++.+++.+|+ .+|.+|++ +
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~-i~~~~~----------------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMK-VINWQT----------------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHH-HHccCC----------------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999976432221111 110000 0001112234667888998876 59999987 8
Q ss_pred HHHHHH
Q 039392 269 KEIVTK 274 (285)
Q Consensus 269 ~eil~~ 274 (285)
++++.+
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=295.17 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=194.5
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHH---ccCCCCccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMM---KSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|..++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999975 468999999987542 22334555665554 566799999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
|||+++++|...+... .+++..++.++.||+.||+||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999998887543 4899999999999999999999 9999999999999999999999999999986432211
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.. .......
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~-~~i~~~~--------------- 217 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF-DSIVNDE--------------- 217 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCC---------------
Confidence 1123456788999999999989999999999999999999999999754322111 1110000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
...+..++..+.+++.+||..||.+|| ++++++++
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 001223466788999999999999999 57777764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=284.13 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=202.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-----hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-----GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
||.+.+.||+|++|.||.+.. .+++++++|.+.... ....+.+.+|++++++++||||+++++++......+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 689999999999999999974 468999999886432 12345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
+|++++++|.+++.... .++...+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 83 MEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999887654 3888899999999999999999 9999999999999999999999999999987654321
Q ss_pred ccce-eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTI-QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.... .....++..|+|||.+.+..++.++|+||||+++|++++|+.||............ .. ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~---~~----------- 223 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-AT---QP----------- 223 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH-hc---cC-----------
Confidence 1111 12344677899999999888999999999999999999999998654222111110 00 00
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+..++..+.+++.+||..+|.+|||+++++++
T Consensus 224 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0001123456678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=306.52 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=198.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++++.||+|+||.||+++. .+++.||+|++.... ......+.+|++++++++|+||+++++.+...+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 589999999999999999974 468999999986432 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc--
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED-- 154 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~-- 154 (285)
|+++++|.+++.+.. .+++..+..++.||+.||+||| +.|++||||||+||+++.++.++|+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999987654 3888899999999999999999 9999999999999999999999999999975321000
Q ss_pred ---------------------------------------ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHH
Q 039392 155 ---------------------------------------ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIET 195 (285)
Q Consensus 155 ---------------------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l 195 (285)
.........+++.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001124688999999999999999999999999999999
Q ss_pred hhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCC---CHHHHH
Q 039392 196 FTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI---NAKEIV 272 (285)
Q Consensus 196 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~eil 272 (285)
++|+.||......+.... ... +. . .........+++++.+++.+|+ .+|.+|+ |+.+++
T Consensus 238 l~G~~Pf~~~~~~~~~~~-i~~-~~---~------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 238 LVGQPPFLADTPAETQLK-VIN-WE---T------------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhCCCCCCCCCHHHHHHH-Hhc-cC---c------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999976433221111 000 00 0 0001112235667888999976 5999999 899998
Q ss_pred HH
Q 039392 273 TK 274 (285)
Q Consensus 273 ~~ 274 (285)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=297.25 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=193.2
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|+..+.||+|+||+||++.. .+++.||+|++..... .....+.+|+++++.++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 67788999999999999975 4689999999865433 344678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.... ..++..+..++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 156 ~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 225 (353)
T PLN00034 156 GGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPC 225 (353)
T ss_pred CCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccc
Confidence 99986532 2566778889999999999999 9999999999999999999999999999998664321 112
Q ss_pred ccccccccccCCcccCC-----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 160 TQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
....++..|+|||.+.. ...+.++||||||+++|+|++|..||.......... ........
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~~~~------------ 291 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS--LMCAICMS------------ 291 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH--HHHHHhcc------------
Confidence 33468889999998743 234578999999999999999999997322211110 00000000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........++.++.++|.+||..||++|||++|++++
T Consensus 292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000123456779999999999999999999999975
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=295.15 Aligned_cols=247 Identities=21% Similarity=0.259 Sum_probs=196.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCC-CccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHH-RNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|.+++..+.| ++|+++++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 689999999999999999975 467899999987542 2344567788899988875 56888999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++++|.+++..... +++..+..++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 99999999998876554 889999999999999999999 9999999999999999999999999999986532211
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+++.|+|||++.+..++.++|+||+|+++|+|++|..||......+.... ... ..
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~-i~~----~~------------ 217 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS-IME----HN------------ 217 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-HHc----CC------------
Confidence 112334578999999999998999999999999999999999999975432211111 100 00
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCH-----HHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~eil~~ 274 (285)
...+...+.++.+++.+||..||.+|++. ++++++
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00112345678899999999999999976 566653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=289.21 Aligned_cols=266 Identities=24% Similarity=0.341 Sum_probs=195.7
Q ss_pred CCCCCceecccCceEEEEEEe--CCCcEEEEEEeeccch--hHHHHHHHHHHHHccC---CCCccccccceec-----cC
Q 039392 1 GFSENNLIGRGGFGSVFKARL--GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSI---HHRNIIKVISSCS-----NE 68 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~--~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~ 68 (285)
+|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 589999999999999999975 3468899998864332 2223455677666655 6999999999874 34
Q ss_pred CceEEEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccc
Q 039392 69 EFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 147 (285)
Q Consensus 69 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~ 147 (285)
..+++++|++. ++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999996 48988886543 34889999999999999999999 999999999999999999999999999999
Q ss_pred eecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+....+.. ..............+
T Consensus 158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~i~~~~~~~~~~~~ 233 (290)
T cd07862 158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDW 233 (290)
T ss_pred EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhc
Confidence 766543 1223456788999999998888999999999999999999999999764332221 111111100000000
Q ss_pred c------cccccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 V------DPNLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~------~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ...........+ .....++..+.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 000000000000 0112456778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=292.79 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=202.4
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceecc-CCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSN-EEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~ 71 (285)
.|++.+.||+|+||.||+|.. .+++.|++|++.... ......+..|+++++++ +|+||+++++.+.. ....
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 378899999999999999952 235789999986433 23345677899999999 79999999998754 4568
Q ss_pred EEEEeccCCCCHHHhhhcCC------------------------------------------------------------
Q 039392 72 ALVLEYMPHGSLEKYLHSSN------------------------------------------------------------ 91 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~------------------------------------------------------------ 91 (285)
++++||+++++|.+++....
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999998875321
Q ss_pred CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCC
Q 039392 92 YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171 (285)
Q Consensus 92 ~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~P 171 (285)
..++...+..++.|++.||+||| ++|++|+||||.||+++.++.++|+|||++..+.............++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 14788889999999999999999 999999999999999999999999999999876433222222334456679999
Q ss_pred cccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHH
Q 039392 172 EYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFV 250 (285)
Q Consensus 172 E~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 250 (285)
|.+.+..++.++|||||||++++|++ |..||......+.......... . ...+...++++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~------------------~~~~~~~~~~~ 305 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-R------------------MRAPEYATPEI 305 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC-C------------------CCCCccCCHHH
Confidence 99999999999999999999999998 9999865332221111100000 0 00122345678
Q ss_pred HHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 251 FNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 251 ~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.+++.+||+.+|.+|||+++++++|.++.+.
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=285.73 Aligned_cols=253 Identities=27% Similarity=0.355 Sum_probs=201.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|+||.||+|.. .+++.+++|++..........+.+|+.++++++||||+++++.+......++++|+++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 589999999999999999975 5688999999876555555667889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++.... .++...+..++.|++.|+.||| +.|++|+|++|+||+++.++.++|+|||++....... ...
T Consensus 90 ~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~ 163 (267)
T cd06646 90 GGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKR 163 (267)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--ccc
Confidence 999999886544 4889999999999999999999 9999999999999999999999999999998654321 111
Q ss_pred ccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 160 TQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....++..|+|||.+. ...++.++|+||+|+++++|++|..||....+.+........ ....
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~--------~~~~------- 228 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS--------NFQP------- 228 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC--------CCCC-------
Confidence 2345678899999874 345788999999999999999999998643322111100000 0000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
..+......+..+.+++++||..+|++|||++++++++
T Consensus 229 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 -PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00001123456799999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=281.55 Aligned_cols=257 Identities=22% Similarity=0.342 Sum_probs=206.6
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|++|.||+|... +|+.+++|.++.. .....+.+.+|++++++++|++++++++.+...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 5899999999999999999765 7899999987632 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 77 YMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 77 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|+++++|.+++.. ....++...++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998854 2344889999999999999999999 999999999999999999999999999998765432
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
... .....++..|+|||.+.+..++.++|+||||+++++|++|..||......... ........ ..
T Consensus 160 ~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~---------~~ 225 (267)
T cd08224 160 TTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKKIEKC---------DY 225 (267)
T ss_pred Ccc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH---HHhhhhcC---------CC
Confidence 211 12335677899999998888999999999999999999999998643211111 10000000 00
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
.. ......+..+.+++.+||..+|++|||+.++++.++.++
T Consensus 226 ~~-----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PP-----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CC-----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 001245667899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=283.24 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=205.7
Q ss_pred CCCCCceecccCceEEEEEEeCC----CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLGD----GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~----~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|++|.||+|...+ ...+++|...... ....+.+.+|+.+++.+.|+|++++++++... ..+++|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEE
Confidence 47788999999999999997432 3468999887654 44556788999999999999999999988764 467999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.||.+|| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999999776556899999999999999999999 99999999999999999999999999999876654321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
. .......+..|+|||.+....++.++|+||||++++++++ |..||......+.... ....
T Consensus 163 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~---------------- 224 (270)
T cd05056 163 Y-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-IENG---------------- 224 (270)
T ss_pred e-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcC----------------
Confidence 1 1122334567999999888889999999999999999986 9999876543322111 1000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.....+..++.++.+++.+|+..+|.+|||+.++++.|++++++
T Consensus 225 ---~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 ---ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00011234567799999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=296.70 Aligned_cols=242 Identities=21% Similarity=0.285 Sum_probs=195.5
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+++++.++||||+++.+.+......++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999974 578999999987542 233456678999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 82 SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
+|..++.... .+++..++.++.||+.||.||| + .|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence 9998886654 4899999999999999999999 7 799999999999999999999999999987533221 1122
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||......... ..... .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-~~i~~----~~----------------~ 213 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILM----EE----------------I 213 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-HHHhc----CC----------------C
Confidence 345889999999998889999999999999999999999999653221111 10000 00 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
..+...++++.+++.+||+.||++|+ ++++++++
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01223466789999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=283.04 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=206.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|++|.||++.. .+++.+++|.+.... ......+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 588999999999999999974 578999999876422 2344678889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 77 YMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 77 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++++++|.+++.. ....+++..++.++.|++.|+.||| ++|++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998763 2334889999999999999999999 999999999999999999999999999998765433
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.. ......++..|+|||.+.+..++.++|+||||+++++|++|..||.................. .+
T Consensus 160 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~--- 226 (267)
T cd08229 160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--------YP--- 226 (267)
T ss_pred Cc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--------CC---
Confidence 21 112345778899999998888999999999999999999999998653222111111110000 00
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
.......+.++.+++.+||..+|++|||++++++.+.++.
T Consensus 227 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 ------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0001235667999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=300.58 Aligned_cols=245 Identities=25% Similarity=0.412 Sum_probs=207.3
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCHH
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLE 84 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 84 (285)
++-||+|++|.||+|+.. ++.||||.+..- -..+++.|++|+|+||+.|.++|.....+|+|||||..|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 456899999999999984 688999976422 124788899999999999999999999999999999999999
Q ss_pred HhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccc
Q 039392 85 KYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164 (285)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~ 164 (285)
..++..+. +.......|..+|+.|++||| .+.|+|||||.-||||+.+..|||+|||-..-.... ...-...|
T Consensus 201 ~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 201 EVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred HHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 99976665 888889999999999999999 999999999999999999999999999998766543 22234678
Q ss_pred cccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhh
Q 039392 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKE 244 (285)
Q Consensus 165 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (285)
|..|+|||++.+...+++.||||||++||||+||..||.+...... +- -.....+.++.+.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----------------Iw--GVGsNsL~LpvPs 334 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----------------IW--GVGSNSLHLPVPS 334 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----------------EE--eccCCcccccCcc
Confidence 9999999999999999999999999999999999999876332111 00 0122334566678
Q ss_pred HhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 245 QCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
.|+.-+.-|++.||+-.|..|||+.++|.+|+-...+++
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 889999999999999999999999999999987765554
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=294.37 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=193.4
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||+||++.. .+++.||+|++.... ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999975 468899999987532 23345566788888766 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++.+... +++..++.++.|++.||.||| ++|++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~i~~~~~-l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSRR-FDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 999998876544 889999999999999999999 9999999999999999999999999999987543221 1123
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+. ........ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~~~-------~------------- 213 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEAILNDE-------V------------- 213 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHHhcCC-------C-------------
Confidence 34688999999999988999999999999999999999999976432211 11111000 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCH------HHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINA------KEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~------~eil~~ 274 (285)
..+...+.++.+++++||+.||.+||++ ++++.+
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0012345678999999999999999998 666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=286.60 Aligned_cols=268 Identities=25% Similarity=0.394 Sum_probs=203.4
Q ss_pred CCCCceecccCceEEEEEE-----eCCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceecc--CCceEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-----LGDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-----~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 73 (285)
|.+.+.||+|+||+||++. ..+++.+|+|.+..... .....+.+|+++++.++||||+++++++.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 4788999999999998864 24578899999875432 345677889999999999999999998754 346889
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
+||++++++|.+++.... ++...++.++.|++.|+.+|| +++++|+||+|+||+++.++.++|+|||++......
T Consensus 86 v~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999987643 899999999999999999999 999999999999999999999999999998766543
Q ss_pred cccc-eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 154 DIST-IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 154 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.... ......++..|+|||.+.+..++.++|+||||+++++|++|..||............... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~-- 236 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ--GQMTVVRLIEL-- 236 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccc--cccchhhhhhh--
Confidence 2111 112233456699999998888999999999999999999999998654322111100000 00000000000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
.........+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 237 -~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 -LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred -hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000111123456788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=286.06 Aligned_cols=253 Identities=23% Similarity=0.409 Sum_probs=198.7
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|++|.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 4788999999999999998642 35679999875432 2334567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC---------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 74 VLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
+||++++++|.+++.+.. ...+...+..++.|++.||.||| +.|++|+||+|.||++++++.++++||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999986532 12567788899999999999999 999999999999999999999999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ...........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~-- 240 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-VLRFVMEGGLL-- 240 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCcC--
Confidence 99876543222211222345678999999988889999999999999999999 678886532211 11111110000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 241 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 241 -----------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 002234567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=294.15 Aligned_cols=242 Identities=22% Similarity=0.302 Sum_probs=194.2
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4799999999999975 468899999987542 23345566788888765 799999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|...+..... +++..+..++.||+.||.||| ++|++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT 154 (321)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence 999988876544 888999999999999999999 9999999999999999999999999999987543221 1123
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ........ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~i~~~~-------~------------- 213 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-FESILHDD-------V------------- 213 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-HHHHHcCC-------C-------------
Confidence 34578899999999988999999999999999999999999976432221 11111000 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCC-------CHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRI-------NAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rp-------s~~eil~~ 274 (285)
..+..++.++.+++.+||..||++|| ++++++++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00122456788999999999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=280.94 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=203.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|++|.||++.. .+++.+++|.+... .......+.+|+++++.++|||++++++.+...+..++++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 688999999999999999975 46899999998643 234456788899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+++++|.+++... ...++...++.++.|++.|+.||| +.|++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999998764 345889999999999999999999 99999999999999999999999999999887654321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......+++.|+|||+..+..++.++|+||||+++++|++|..||........... ...... .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~-------------~-- 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK-IIRGVF-------------P-- 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCC-------------C--
Confidence 11234567889999999988899999999999999999999999975432211111 000000 0
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+.++.+++.+||+.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=286.46 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=201.9
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||.|++|.||+|... +++.+++|.+..........+.+|+.+++.++|+|++++.+.+...+..++|||+++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4889999999999999999754 588999999987766667788899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|..++.+....++...++.++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~ 167 (292)
T cd06644 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRR 167 (292)
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cccc
Confidence 99998887665556899999999999999999999 999999999999999999999999999998754322 1112
Q ss_pred ccccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 160 TQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
....++..|+|||.+. ...++.++|+||||+++|+|++|..||......... ........ .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~---~---------- 233 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKSEP---P---------- 233 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH-HHHhcCCC---c----------
Confidence 2345677899999874 334688999999999999999999998653321111 11100000 0
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+...+.++.+++.+||..+|++||++++++++
T Consensus 234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 ----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 001122345568899999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=306.42 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=200.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCC--------
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-------- 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 69 (285)
+|++.+.||+|+||+||+++. .+++.||+|++.... ......+.+|+..+..++|+|++++...+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 488899999999999999974 578999999986542 344566788999999999999999887764322
Q ss_pred ceEEEEeccCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecc
Q 039392 70 FKALVLEYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 146 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~ 146 (285)
..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 367999999999999988542 335889999999999999999999 99999999999999999999999999999
Q ss_pred ceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 147 AKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
+................+++.|+|||.+.+..++.++||||||+++|+|++|..||......+. ...... ...
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-~~~~~~----~~~-- 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-MHKTLA----GRY-- 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhc----CCC--
Confidence 9766543222223345688999999999998999999999999999999999999965322111 110000 000
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+..+++++.+++.+||+.||.+|||+.+++.+
T Consensus 263 -------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 -------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00123456779999999999999999999999875
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=286.50 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=204.2
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||.||+|... +...+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5889999999999999999642 23568888876543 2344678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 039392 74 VLEYMPHGSLEKYLHSSN-----------------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSN 130 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~n 130 (285)
++|++.+++|.+++.... ..++...++.++.|++.||.+|| +.+++|+||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999875421 23778889999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccc
Q 039392 131 VLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGE 209 (285)
Q Consensus 131 ili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~ 209 (285)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++++|++ |..||.+....+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876543322212223345667999999888889999999999999999998 999986532211
Q ss_pred hhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 210 MTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
. ....... .....+..++.++.+++.+||+.+|.+||+++++++.|+++..+
T Consensus 238 ~--~~~~~~~------------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 L--FNLLKTG------------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred H--HHHHhCC------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1 1111000 00111234556799999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=300.14 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=198.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 4888999999999999999754 68899999986422 2233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++... .+++..+..++.||+.||+||| ++|++||||||+||+++.++.+||+|||++....... .
T Consensus 124 y~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~ 197 (370)
T cd05621 124 YMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M 197 (370)
T ss_pred CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence 99999999998654 3788899999999999999999 9999999999999999999999999999998764322 1
Q ss_pred ceeccccccccccCCcccCCC----ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKEG----RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.......+|+.|+|||++.+. .++.++|+||+|+++|+|++|..||....... ..........
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~~~~~------------ 264 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIMDHKN------------ 264 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCc------------
Confidence 122345689999999988654 37899999999999999999999997543211 1111111000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCC--CCCHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~~ 274 (285)
...++.....+..+.+++.+||..++.+ |+|+++++++
T Consensus 265 ----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0011112235677889999999866554 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=281.17 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=206.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||.|++|.||++.. .+++.+++|++........+.+.+|+++++.++|||++++++.+.....++++||+++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 588899999999999999975 4678899999987666666788899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++......+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 158 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKR 158 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hcc
Confidence 99999998776456899999999999999999999 9999999999999999999999999999987654321 111
Q ss_pred ccccccccccCCcccCCC---ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 160 TQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....++..|++||.+.+. .++.++|+||||+++++|++|..||......+............
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~--------------- 223 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--------------- 223 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------------
Confidence 234577789999998776 78999999999999999999999987643222211111000000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+.++.+++++||..+|.+|||+++++.+
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 -PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0011123456779999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=298.04 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=199.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCC-----ceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-----FKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 72 (285)
+|++++.||+|+||.||++.. .+++.||+|.+.... ......+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999975 478999999886432 233456788999999999999999999998766 789
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+|+|++. ++|.+.+.... .++...++.++.||+.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 47888775544 4899999999999999999999 99999999999999999999999999999986543
Q ss_pred ccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc----
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI---- 227 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 227 (285)
.. ........++..|+|||.+.+. .++.++||||+||++++|++|+.||.+...... ................
T Consensus 156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhh
Confidence 22 1122334568889999988775 479999999999999999999999976432211 1111110000000000
Q ss_pred ------c-c-ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 ------V-D-PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ------~-~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. . .................+.++.+++.+||+.||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0 000000000001122346779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=285.27 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=201.2
Q ss_pred CCCCCceecccCceEEEEEEe-----CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-----GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|+||.||+|.. .++..+++|.+.... ......+.+|+++++.++||||+++++++......+++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 477889999999999999963 246789999886433 33446788899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcC----------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc
Q 039392 75 LEYMPHGSLEKYLHSS----------------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV 138 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~ 138 (285)
||++++++|.+++... ...++...++.++.|++.||+||| ++|++|+||+|+||+++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCc
Confidence 9999999999988422 123678888999999999999999 999999999999999999999
Q ss_pred EEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhh
Q 039392 139 AHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVN 217 (285)
Q Consensus 139 ~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 217 (285)
++++|||++................++..|+|||.+.+..++.++|+||||+++++|++ |..||.+..... . .....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-~-~~~~~ 240 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-V-IEMVR 240 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-H-HHHHH
Confidence 99999999986644322222233344667999999988889999999999999999998 888886532211 1 11111
Q ss_pred hhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 218 DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
.... +..+..++..+.+++.+||+.||.+||++.+++++|.+
T Consensus 241 ~~~~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQL------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCc------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000 01123456778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=285.94 Aligned_cols=270 Identities=28% Similarity=0.420 Sum_probs=204.0
Q ss_pred CCCCCceecccCceEEEEEEe-----CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc--CCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-----GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 73 (285)
.|++.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+++++.++|||++++.+++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 478899999999999999863 3578999999876666666788899999999999999999997643 456889
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++||+++++|.+++......++...++.++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999998766555889999999999999999999 999999999999999999999999999999876543
Q ss_pred ccccee-ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC-cccccccc
Q 039392 154 DISTIQ-TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS-TKEIVDPN 231 (285)
Q Consensus 154 ~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (285)
...... .....+..|+|||.+.+..++.++|+||||+++++|++|..|+...... ............. ......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-- 237 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQMIVYHLIE-- 237 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccccchHHHHH--
Confidence 221111 1122344599999998888999999999999999999988765432111 0000000000000 000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.......+.....++.++.+++.+||..+|++|||++++++.|+++
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 -LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred -HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000011112345667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=291.38 Aligned_cols=267 Identities=20% Similarity=0.278 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|.+.+.||+|+||+||+|... +++.+|+|.+..... .....+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4888999999999999999754 688899999875432 22345678999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++ +|.+++......++...++.++.|++.||.||| ++|++||||+|+||+++.++.++|+|||++........ .
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 160 (309)
T cd07872 87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--T 160 (309)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--c
Confidence 75 888887766656889999999999999999999 99999999999999999999999999999876543221 1
Q ss_pred eccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhc--------CCCcc-ccc
Q 039392 159 QTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL--------PISTK-EIV 228 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~-~~~ 228 (285)
.....++..|+|||.+.+ ..++.++||||||+++++|++|..||......+. ......... ..... ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 223456788999998765 4689999999999999999999999976433221 111111000 00000 000
Q ss_pred cccccCcccc-hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DPNLLSREDI-HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......... .......++.++.+++.+||+.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000 011123457788999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=281.11 Aligned_cols=248 Identities=33% Similarity=0.538 Sum_probs=203.3
Q ss_pred ceecccCceEEEEEEeCC----CcEEEEEEeeccchhH-HHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARLGD----GMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~----~~~~~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||++.... +..+++|.+....... .+.+.+|++.++.++|+|++++++++......+++||++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999997543 7889999987654433 57788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcC--------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 81 GSLEKYLHSS--------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 81 ~~L~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
++|.+++... ...+++..++.++.|++.|+++|| +++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999775 356899999999999999999999 99999999999999999999999999999987654
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
...........++..|+|||.+....++.++|+||||+++++|++ |..||......+.. .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~-------------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-EYLRK-------------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHc--------------
Confidence 332222334456778999999988889999999999999999999 68998765222111 11000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
......+..++.++.+++.+||..+|++|||+++++++|+
T Consensus 223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011112344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=294.95 Aligned_cols=247 Identities=20% Similarity=0.282 Sum_probs=194.1
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999975 468899999987532 23345677899999888 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++.+.. .+++..++.++.|++.||.||| ++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 99998886554 4899999999999999999999 9999999999999999999999999999986422111 1123
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh---hhhhh-hhhcCCCccccccccccCcc
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT---LKHWV-NDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (285)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||+........ ...+. ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------------- 220 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-------------- 220 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------------
Confidence 346788999999999999999999999999999999999999643211100 00000 000000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCC------HHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRIN------AKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~eil~~ 274 (285)
....+..++.++.+++.+||+.||.+|+| +++++++
T Consensus 221 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 --QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 00112335667899999999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=282.82 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=202.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCc----EEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGM----EVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~----~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
.|++.+.||+|+||.||+|.+. +++ .+++|.+.... ......+..|+..+..+.||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 3788999999999999999753 344 47778765433 2334567778888999999999999998764 457789
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
+|++++++|.+++......+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999776666899999999999999999999 9999999999999999999999999999998765433
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.........++..|++||.+.+..++.++|+||||+++|++++ |..||.+..... .......-...
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~----------- 230 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGERL----------- 230 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCcC-----------
Confidence 2222334456678999999988889999999999999999998 999986542211 11111100000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
..+..++.++.+++.+|+..+|.+|||++|+++.|..+.++.
T Consensus 231 -------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 231 -------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 001124456889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=283.89 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=204.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCc----EEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGM----EVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~----~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|+||+||+|.+ .+++ .||+|++.... ......+.+|+.+++.++|+||+++++.+... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEE
Confidence 377889999999999999974 3444 47999886543 33456788899999999999999999998764 46799
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
++++++++|.+++......++...++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999999998766556899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
..........+..|+|||...+..++.++||||||+++|++++ |..||........ .........
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~~~~~~~------------ 229 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI--PDLLEKGER------------ 229 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHCCCc------------
Confidence 2222222344567999999988899999999999999999998 8888865332111 111110000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...+..++.++.+++.+||..||.+|||+.++++.|.++.++.
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 ------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0011234567899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=282.08 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=196.7
Q ss_pred CCCCceecccCceEEEEEEeCC-Cc--EEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceecc------CCc
Q 039392 2 FSENNLIGRGGFGSVFKARLGD-GM--EVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSN------EEF 70 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~-~~--~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 70 (285)
+.+++.||+|+||.||+|.... ++ .+|+|.++.. .....+.+.+|+++++.++|+||+++++.+.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678999999999999997543 33 5899987643 24445778889999999999999999987632 235
Q ss_pred eEEEEeccCCCCHHHhhhc-----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeec
Q 039392 71 KALVLEYMPHGSLEKYLHS-----SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 145 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~ 145 (285)
.++++||+++++|.+++.. ....++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999887632 2234788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCc
Q 039392 146 IAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIST 224 (285)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
++.................+..|++||...+..++.++|+||||+++|+|++ |..||......+. ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~-~--- 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI-YDYLRQGN-R--- 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHcCC-C---
Confidence 9987644322111222345667999999998899999999999999999999 7888865322111 11110000 0
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
......++..+.+++.+||+.+|++|||++++++.|+++
T Consensus 233 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 ---------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001123456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=285.72 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=200.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch---hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||++.. .+++.||+|++..... .....+.+|+++++.++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 689999999999999999975 4689999999865321 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|+++++|.+++... ...++...+..++.|++.|+.||| +.|++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999887543 334889999999999999999999 9999999999999999999999999999987654322
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+..... .............
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~------------ 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRVKEDQ------------ 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHHhhhcc------------
Confidence 1123457889999999988889999999999999999999999997532211 1111111000000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
...+...+..+.+++.+||..||++|| ++++++++
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 ----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001223566789999999999999999 88898765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=285.46 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=201.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCc--EEEEEEeecc-chhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGM--EVAVKVFNLQ-YGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~--~~~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|... ++. .+++|.++.. .....+.+.+|++++.++ +||||+++++.+......++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 5899999999999999999753 333 4688877642 233446788899999999 6999999999999999999999
Q ss_pred eccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEE
Q 039392 76 EYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH 140 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~ 140 (285)
|++++++|.+++.... ..++...++.++.|++.||++|| ++|++|+||+|+||+++.++.++
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEE
Confidence 9999999999986432 23778899999999999999999 99999999999999999999999
Q ss_pred EeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhh
Q 039392 141 LSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDW 219 (285)
Q Consensus 141 i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 219 (285)
|+|||++...... ........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. .....
T Consensus 160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-~~~~~-- 233 (297)
T cd05089 160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-EKLPQ-- 233 (297)
T ss_pred ECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhc--
Confidence 9999998643211 11111223456999999988889999999999999999997 99998654322211 11000
Q ss_pred cCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
.. ....+..++.++.+++.+||..+|.+|||++++++.|.++.++.
T Consensus 234 -~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 234 -GY----------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -CC----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 00012345677999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=287.95 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=203.3
Q ss_pred CCCCCceecccCceEEEEEEeC--------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG--------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEF 70 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~--------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 70 (285)
+|.+.+.||+|+||.||++... +...+|+|.+.... ......+.+|+++++.+ +|+||+++++.+.....
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3778899999999999999642 23569999987542 33445677899999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 039392 71 KALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~ 135 (285)
.+++||++++++|.+++.... ..++...++.++.|++.||+||| ++|++|+||+|+||+++.
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE 175 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEcC
Confidence 999999999999999986532 23778889999999999999999 999999999999999999
Q ss_pred CCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhh
Q 039392 136 NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 136 ~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 214 (285)
++.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+ ...
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-~~~- 253 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFK- 253 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-HHH-
Confidence 99999999999876543211111112234467999999988889999999999999999998 888875432211 111
Q ss_pred hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 215 WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...... ....+..++.++.+++.+||..+|++|||++++++.|+++...-
T Consensus 254 ~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 254 LLKEGH------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHcCC------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 100000 00112345677999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=281.27 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=201.5
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.++||+|++|.||+|...++..+++|.+..... ..+.+.+|+++++.++|+||+++++.+.. ...+++||++++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence 4789999999999999999876667799999874322 33567889999999999999999998754 457899999999
Q ss_pred CCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++.+. ...++...++.++.|++.||.+|| +.+++|+||+|.||+++.++.++|+|||.+......... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~ 160 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-AR 160 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-cc
Confidence 9999998753 234788999999999999999999 999999999999999999999999999999766543211 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||...+..++.++|+||||+++|++++ |..||......+.. ..... ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-~~~~~---~~---------------- 220 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVER---GY---------------- 220 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-HHHhc---CC----------------
Confidence 23345567999999988889999999999999999999 88888654322111 10000 00
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
.......++..+.+++.+|++.+|.+|||++++++.|++..
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 00012245667899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=294.26 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=192.7
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||+||++.. .+++.+|+|++... .......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 5799999999999975 46889999998753 233445677888888776 799999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|..++.... .+++..++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence 99988876554 4899999999999999999999 9999999999999999999999999999987532211 1123
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh---hhhh-hhhhcCCCccccccccccCcc
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT---LKHW-VNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (285)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ...+ .......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------------- 220 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------------- 220 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------------
Confidence 346788999999999999999999999999999999999999642211110 0000 0000000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCH------HHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINA------KEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~eil~~ 274 (285)
....+...+..+.+++.+||+.||++|||+ ++++++
T Consensus 221 --~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 --QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 001123456678899999999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=284.77 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=200.7
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.+.||+|++|.||++... ++..+++|.+........+.+.+|+++++.++|+|++++++.+...+..++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 577889999999999999754 5788899998766666667788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|..++.+....+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++++|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 9998887665556899999999999999999999 9999999999999999999999999999987653321 1123
Q ss_pred cccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 161 QTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
...++..|+|||.+. +..++.++|+||+|+++++|++|..||......+.... .......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~-------------- 226 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSEPP-------------- 226 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH-HhhcCCC--------------
Confidence 345788899999874 34578899999999999999999999875432221111 1100000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+..++.++.+++.+||+.+|.+|||+++++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 ---TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000122345678999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=305.93 Aligned_cols=256 Identities=22% Similarity=0.323 Sum_probs=205.0
Q ss_pred CCCCceecccCceEEEEEEeCCC-cEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccce-ecc------CCceE
Q 039392 2 FSENNLIGRGGFGSVFKARLGDG-MEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISS-CSN------EEFKA 72 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~------~~~~~ 72 (285)
+++.+.|.+|+|+.||.|....+ ..||+|.+-.......+...+|++++++|+ |+|||.+++. ... .-...
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 46789999999999999986554 999999988777788899999999999997 9999999993 211 12356
Q ss_pred EEEeccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 73 LVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++||||.|++|.++++.. ...+++..+++|+.++++|+++||++ +-.++|||||-+||||+.+|..||||||.++-..
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 899999999999998742 22399999999999999999999943 4459999999999999999999999999997543
Q ss_pred ccccc-------ceeccccccccccCCccc---CCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcC
Q 039392 152 REDIS-------TIQTQTLATIGYMAPEYG---KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221 (285)
Q Consensus 152 ~~~~~-------~~~~~~~~~~~~~~PE~~---~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (285)
..... ...-....|+.|++||++ .+..+++++|||+|||+||-|+....||+..-...
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------------ 265 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------------ 265 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------------
Confidence 22100 001123468899999964 57789999999999999999999999998631110
Q ss_pred CCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 222 ISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
+-.....++.....+..+.+||+.||+.||.+||++-++++.+.+|++.
T Consensus 266 -----------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 -----------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -----------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111122222356788899999999999999999999999999998854
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=281.08 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=199.4
Q ss_pred CCCCceecccCceEEEEEEeC----CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCc-----
Q 039392 2 FSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF----- 70 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 70 (285)
|.+.+.||+|+||.||+|... .+..+|+|.+.... ......+.+|++.++.++|+|++++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678999999999999999642 24779999987532 3345678899999999999999999998755443
Q ss_pred -eEEEEeccCCCCHHHhhhcC-----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 71 -KALVLEYMPHGSLEKYLHSS-----NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 71 -~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
.++++||+++++|..++... ...++...++.++.|++.||.||| +.+++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999998887432 234888999999999999999999 999999999999999999999999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++.................+..|++||.+.+..++.++|+||||+++++|++ |..||.+..+.+.. .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~-~~~~~~~---- 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY-DYLRHGN---- 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCC----
Confidence 99986644322211122334567999999988889999999999999999999 88888654332211 1110000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+..++.++.+++.+||+.||++|||+.++++.|+++
T Consensus 233 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 ---------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001234566799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=276.96 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=204.2
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++-+.||+|+|+.|++.. ..+|+.+++|++..+. ....+.+.+|+.+-+.++||||+++.+.++.....|+|+|.
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 36778899999999999985 5579999999886543 23457788999999999999999999999999999999999
Q ss_pred cCCCCHHH-hhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCcEEEeeeccceecCcc
Q 039392 78 MPHGSLEK-YLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 78 ~~~~~L~~-~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~i~df~~~~~~~~~ 153 (285)
++|+.|-. +.++ ...++..+-..++||+++|.|+| .++|+|||+||.|+++. .+.-+|++|||++..++.+
T Consensus 92 m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 92 VTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred ccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99998854 4444 33888888999999999999999 99999999999999995 3456999999999988743
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
. .-....|+|.|+|||++....++..+|||+-|+++|-++.|.+||.+....+.... .+.+
T Consensus 167 ~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~-I~~g--------------- 227 (355)
T KOG0033|consen 167 E---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ-IKAG--------------- 227 (355)
T ss_pred c---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH-Hhcc---------------
Confidence 2 23456799999999999999999999999999999999999999976433322211 1111
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....-..++.++++.++|+++||..||.+|+|+.|+|.+
T Consensus 228 -~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 228 -AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111112256778889999999999999999999999875
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=280.29 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=205.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|++|.||+|... +++.+++|.+..... .+.+.+|+++++.++|+|++++++.+......++++|+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 5889999999999999999865 488999999875533 5788899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++......++...++.++.|++.|+.+|| +.+++|+||+|.||+++.++.++|+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~ 156 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KR 156 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--cc
Confidence 99999999776666899999999999999999999 99999999999999999999999999999886654321 12
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....++..|+|||.+.+..++.++|+||||+++++|++|..||............ .. .....
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-----~~-------------~~~~~ 218 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-----PN-------------KPPPT 218 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-----cc-------------CCCCC
Confidence 2344677899999998889999999999999999999999998754332211110 00 00001
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+..+...+.++.+++.+||+.+|++|||+++++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11123456679999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=291.81 Aligned_cols=248 Identities=24% Similarity=0.298 Sum_probs=210.8
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch---hHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|++.+.||.|.||.||++... +|+.+|+|++..... .......+|+.+|+++. ||||+.+.+.++.....++|||
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 788899999999999999754 599999999976543 24467889999999998 9999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----CCcEEEeeeccceecCc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD----NMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~----~~~~~i~df~~~~~~~~ 152 (285)
++.||.|.+.+... . +++..+..++.|++.++.||| ..|++|||+||+|+++.. ++.++++|||++.....
T Consensus 117 L~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred ecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999999988766 3 999999999999999999999 999999999999999953 35799999999998776
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.......+||+.|+|||++....++...||||+|+++|.|++|..||.+............
T Consensus 192 ---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~---------------- 252 (382)
T KOG0032|consen 192 ---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR---------------- 252 (382)
T ss_pred ---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc----------------
Confidence 2344667899999999999999999999999999999999999999977543333221111
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+.-..+..++..+.+++++||..||.+|+|+.++|++
T Consensus 253 -~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 253 -GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122222356678889999999999999999999999986
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=286.47 Aligned_cols=256 Identities=29% Similarity=0.452 Sum_probs=202.7
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|++|.||++... +...+++|.+.... ......+.+|+++++++ +|+||+++++++...+..+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 3678899999999999999642 24678999886532 33445688899999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 039392 73 LVLEYMPHGSLEKYLHSS---------------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM 137 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~ 137 (285)
++|||+++++|.+++... ...++...++.++.|++.||+||| +.+++|+||+|+||+++.++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCC
Confidence 999999999999998532 234888899999999999999999 99999999999999999999
Q ss_pred cEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhh
Q 039392 138 VAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWV 216 (285)
Q Consensus 138 ~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 216 (285)
.++++|||++................++..|+|||.+.+..++.++||||||+++|++++ |..||......+.... ..
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~ 248 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-LK 248 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH-HH
Confidence 999999999986654322222222334567999999988899999999999999999997 8888865332221111 00
Q ss_pred hhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 217 NDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
.. . ....+..++..+.+++.+||..||++|||++++++.|+++.
T Consensus 249 ~~-~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 249 EG-Y------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred cC-C------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 00 0 00012234567899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=286.21 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=204.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||.|++|.||++.. .+++.+++|++........+.+.+|+++++.++|+|++++++.+......+++||+++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 588999999999999999975 4689999999987766666788899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++......+++..++.++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~ 160 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KR 160 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--cc
Confidence 99999998776666999999999999999999999 99999999999999999999999999998865543211 11
Q ss_pred ccccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 160 TQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
....++..|++||.+. ...++.++|+||||+++|+|++|..||......+.. ........
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-------------- 225 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-LKILKSEP-------------- 225 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-HHHhcCCC--------------
Confidence 2345778899999864 334778999999999999999999998764322211 11100000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..+...+.++.+++.+||..+|.+|||+++++++
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ---PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011123456678999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=283.98 Aligned_cols=245 Identities=24% Similarity=0.293 Sum_probs=194.2
Q ss_pred ecccCceEEEEEEe-CCCcEEEEEEeeccch---hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 8 lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
||+|+||+||++.. .+++.+|+|.+..... ...+.+..|+++++.++|+||+++.+.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999974 4788999999864322 2335567899999999999999999999999999999999999999
Q ss_pred HHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 84 EKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 84 ~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
...+.. ....+++..++.++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 887643 2334889999999999999999999 99999999999999999999999999999876543221 122
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... ........ ..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~----------------~~ 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-LKQRILND----------------SV 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH-HHHhhccc----------------CC
Confidence 34678899999999999999999999999999999999999965322111110 00000000 00
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
..+...+.++.+++.+||+.||++|| ++++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11234567799999999999999999 77888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=278.51 Aligned_cols=248 Identities=31% Similarity=0.493 Sum_probs=199.8
Q ss_pred ceecccCceEEEEEEeCCCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCHH
Q 039392 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLE 84 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 84 (285)
++||+|++|.||++...+++.+++|.+...... ....+.+|++++++++|+||+++++++......++++|++++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999998766999999988755433 5567889999999999999999999999999999999999999999
Q ss_pred HhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccc
Q 039392 85 KYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164 (285)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~ 164 (285)
+++......++...+..++.+++.++.+|| +++++|+||+|+||+++.++.++|+|||++.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 998765556889999999999999999999 99999999999999999999999999999876543221111112223
Q ss_pred cccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhh
Q 039392 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243 (285)
Q Consensus 165 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
+..|+|||.+.+..++.++|+||||+++++|++ |..||........... ..... ....+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~--~~~~~------------------~~~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER--IESGY------------------RMPAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH--HhcCC------------------CCCCC
Confidence 556999999988889999999999999999999 7888765432211111 00000 00112
Q ss_pred hHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 244 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
..++.++.+++.+||..+|++|||++++++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 334667999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=287.44 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=198.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--------------hHHHHHHHHHHHHccCCCCcccccccee
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--------------RVFKSFDVECEMMKSIHHRNIIKVISSC 65 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 65 (285)
.|++++.||+|.+|.|-+|+. .+++.||||++..... ...+...+|+.+|+++.|+|||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 489999999999999999985 4689999999975321 1345788999999999999999999998
Q ss_pred cc--CCceEEEEeccCCCCHHHhhhcCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEe
Q 039392 66 SN--EEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS 142 (285)
Q Consensus 66 ~~--~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~ 142 (285)
.+ .+.+|+|+|||..|.+... ...++ +++.++++++.+++.||+||| .+|++||||||.|+|++++|++||+
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred cCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEee
Confidence 65 4689999999988877542 22333 899999999999999999999 9999999999999999999999999
Q ss_pred eeccceecCcc---cccceeccccccccccCCcccCCC----ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhh
Q 039392 143 DFGIAKLLTRE---DISTIQTQTLATIGYMAPEYGKEG----RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW 215 (285)
Q Consensus 143 df~~~~~~~~~---~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~ 215 (285)
|||.+..+... ..........|||-|+|||...+. ..+.+.||||+|+++|.|+.|..||-+...-+.. ..
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~-~K- 330 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF-DK- 330 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH-HH-
Confidence 99999866322 111122346799999999977663 2578899999999999999999999653222111 11
Q ss_pred hhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 216 VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
+...++.++.......++.+||.+||+.||++|.++.++-.+..
T Consensus 331 -----------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 331 -----------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -----------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 11122222233356677999999999999999999999876543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=280.73 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=201.8
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccc------hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY------GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+++++.++|+||+++.+++......+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 589999999999999999987788999999876432 23345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
+|++++++|.+++.+.. .++...+..++.|++.|+++|| +.+++|+||+|.||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999987654 3788999999999999999999 9999999999999999999999999999987543211
Q ss_pred ----ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 155 ----ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 155 ----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.........++..|+|||.+.+..++.++|+||||++++++++|..||........... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~--------- 226 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-IGAHRGL--------- 226 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-hhhccCC---------
Confidence 01111234577889999999988899999999999999999999999965322111110 0000000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
. ...+...+.++.+++++||..+|.+||+++++++
T Consensus 227 --~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 --M------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --C------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0012345677899999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=280.52 Aligned_cols=252 Identities=24% Similarity=0.441 Sum_probs=202.2
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.++||+|+||.||+|...+++.+++|.+..... ....+.+|+.+++.++|+|++++++++. .+..++++|++.+
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 4788999999999999999987889999999875433 3356788999999999999999999874 4568899999999
Q ss_pred CCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++... +..++...+..++.|++.||++|| +.|++|+||+|+||+++.++.++++|||.+........ ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccc
Confidence 9999988653 335888899999999999999999 99999999999999999999999999999876653221 111
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||.+....++.++|+||||++++++++ |..||.+....+.. .......
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~------------------- 220 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-QNLERGY------------------- 220 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-HHHHcCC-------------------
Confidence 22334567999999988889999999999999999998 99998754322211 1110000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+...+.++.+++.+||+.+|++|||++++++.|+++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 0011223456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=280.72 Aligned_cols=255 Identities=26% Similarity=0.463 Sum_probs=204.0
Q ss_pred CCCCCceecccCceEEEEEEeC----CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++++++||||+++++++...+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4788999999999999999742 23478999886543 334567888999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999776656899999999999999999999 99999999999999999999999999999987654321
Q ss_pred cce-eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 156 STI-QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
... ......+..|++||.+.+..++.++|+||||++++++++ |..||......+. ........
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-~~~~~~~~-------------- 226 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEGY-------------- 226 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH-HHHHhCCC--------------
Confidence 111 111223457999999988889999999999999999886 9999865432211 11111000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.......++..+.+++.+|++.+|.+|||++++++.|+++
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011223466789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=290.74 Aligned_cols=242 Identities=21% Similarity=0.268 Sum_probs=194.1
Q ss_pred ceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||+||++... +++.||+|++.... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999754 68899999987542 23345567788888877 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|...+.+.. .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence 99998887654 3899999999999999999999 9999999999999999999999999999986432211 1112
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .... ... .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-~~i~----~~~----------------~ 213 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-QSIL----EDE----------------V 213 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-HHHH----cCC----------------C
Confidence 345788999999999999999999999999999999999999753321111 1000 000 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCH-----HHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~eil~~ 274 (285)
..+..++.++.+++.+||..||.+|||+ .+++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0122346678999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=291.67 Aligned_cols=246 Identities=20% Similarity=0.265 Sum_probs=196.0
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|... +++.+|+|++.... .........|..++..+ +|++++++.+++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 6899999999999999999754 67899999987543 22234456677777776 5899999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++++|.+.+..... +++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 99999999998866544 889999999999999999999 9999999999999999999999999999987543221
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|..||........ ........
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i~~~~---------------- 217 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSIMEHN---------------- 217 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-HHHHHhCC----------------
Confidence 112345678999999999999999999999999999999999999976432211 11111100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCH-----HHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVT 273 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~eil~ 273 (285)
...+...+.++.+++.+||+.+|.+|+++ +++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 00122346678999999999999999985 56554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=284.89 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=203.5
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 72 (285)
+|.+.+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|+.+++++ +|+||+++++.+...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 367889999999999999963 234578999886543 33456788999999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 73 LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++||++++++|.+++.... ..++..++..++.|++.||.||| +.+++|+||+|.||+++.++.++++|||++....
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999986543 33789999999999999999999 9999999999999999999999999999987654
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
............++..|+|||.+.+..++.++||||+|++++++++ |..||.................
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~----------- 261 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY----------- 261 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC-----------
Confidence 3322222223345678999999988889999999999999999998 9999865433222111110000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+...+.++.+++.+||..+|++|||+.++++.|+++
T Consensus 262 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 --------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0001123356799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=285.70 Aligned_cols=265 Identities=24% Similarity=0.337 Sum_probs=201.3
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccC--C---ceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--E---FKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~---~~~~v~ 75 (285)
|+..+++|.|+||.||.|.. .++++||||.+-.+.+ --.+|+++|+.+.||||+++..+|... . .+.+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 55678999999999999974 4579999998765432 223699999999999999999888432 1 445899
Q ss_pred eccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeeccceecC
Q 039392 76 EYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLT 151 (285)
Q Consensus 76 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~~~~ 151 (285)
||++. +|.+.++. .+..++...++-+..||..||.||| ..|+|||||||.|+++|. .|.+||+|||.|..+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99976 89888863 2445888888999999999999999 999999999999999995 5999999999999876
Q ss_pred cccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc----
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE---- 226 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 226 (285)
....+ ....++..|+|||.+.+. +|+.+.||||.||++.||+-|++.|.+.+ +..+....+......+..+
T Consensus 178 ~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 178 KGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred cCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHhhc
Confidence 65433 445688899999988876 79999999999999999999999998733 3333333333222221111
Q ss_pred ------cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH--HHHHH
Q 039392 227 ------IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK--LVKIR 279 (285)
Q Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~--l~~l~ 279 (285)
...+........+ ......+++..+|+.++|.++|.+|.++.|++.+ ++.++
T Consensus 254 n~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred CcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 1111111111111 2345678889999999999999999999999853 45444
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=280.55 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=202.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|++|.||++.. .+++.+++|.+... .....+.+.+|+.+++.++|+|++++.+.+...+.+++++|++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 588999999999999999975 46889999998643 2344567788999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++... ...++...++.++.|++.|+.+|| ++|++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999887653 344889999999999999999999 99999999999999999999999999999976644321
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......++..|+|||.+.+..++.++|+||||+++++|++|..||........... .......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~---------------- 218 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK-VCQGSYK---------------- 218 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH-HhcCCCC----------------
Confidence 12234577889999999888899999999999999999999999975322111111 0000000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+...+..+.+++.+||+.||.+|||+++++..
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0012345568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=290.40 Aligned_cols=240 Identities=22% Similarity=0.298 Sum_probs=190.5
Q ss_pred ceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||+|... +|+.||+|++.... .........|..++... +||+|+++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999754 68899999987542 22344556677777654 899999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|..++.... .++...+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++...... .....
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCcee
Confidence 99999887654 3889999999999999999999 999999999999999999999999999998643221 11223
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||......+. ........ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-~~~~~~~~-------~------------- 213 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-FESIRVDT-------P------------- 213 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCC-------C-------------
Confidence 45678999999999999999999999999999999999999975432211 11110000 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHH-HHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAK-EIV 272 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~-eil 272 (285)
..+..++.++.+++.+||..||.+||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00122456688999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=281.39 Aligned_cols=255 Identities=24% Similarity=0.432 Sum_probs=202.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CC---cEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DG---MEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~---~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
.|++.+.||+|+||.||+|... ++ ..|++|.+... .......+..|+.+++.++||||+++.+.+......++++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 3678899999999999999743 23 36999998754 2444567889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.|+.+|| +.|++|+||+|.||+++.++.++++|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999998776666899999999999999999999 99999999999999999999999999999876543221
Q ss_pred cceec-ccc--ccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 156 STIQT-QTL--ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 156 ~~~~~-~~~--~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
..... ... .+..|++||.+.+..++.++|+||+|++++++++ |..||......+. ........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~--~~~i~~~~----------- 228 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--INAIEQDY----------- 228 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH--HHHHHcCC-----------
Confidence 11111 111 2346999999988899999999999999999886 9999865332211 11111000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+..++..+.+++.+||..+|.+||+++++++.|+++
T Consensus 229 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111234566789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=289.38 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=190.2
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHcc-CCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKS-IHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||+|.. .+++.||+|++.... ....+....|..++.. .+||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999975 468899999987542 2223444556666654 4799999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|..++.... .+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999887654 4899999999999999999999 9999999999999999999999999999997643322 1223
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||.+....+.. ....... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-~~i~~~~--------------------~ 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-DSILNDR--------------------P 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCC--------------------C
Confidence 456889999999999888999999999999999999999999754321111 1110000 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHH-HHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAK-EIVT 273 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~-eil~ 273 (285)
..+..++.++.+++.+||..||.+||++. +++.
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 01223456688999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=285.79 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=201.0
Q ss_pred CCCCceecccCceEEEEEEeC------CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
|++.+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+.++..++||||+++++.+......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 677889999999999999742 257899999875443 3346688899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcE
Q 039392 75 LEYMPHGSLEKYLHSS---------------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVA 139 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~ 139 (285)
+|++.+++|.+++... ...++...++.++.|++.||.||| ++|++|+||||.||+++.++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 9999999999887421 123778888999999999999999 9999999999999999999999
Q ss_pred EEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhh
Q 039392 140 HLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVND 218 (285)
Q Consensus 140 ~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 218 (285)
+|+|||++................+++.|+|||.+.+..++.++|+||||+++++|++ |..||.+....+. ....
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~i--- 239 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-IEMI--- 239 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHH---
Confidence 9999999876543322222233445678999999988889999999999999999998 7778765322111 1110
Q ss_pred hcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 219 WLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
..... ...+..++..+.+++.+||+.+|.+|||++++++.|+.
T Consensus 240 -~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 -RNRQV---------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HcCCc---------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 00000 01123567779999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=279.65 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=200.6
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|++|.||++...++..+++|.+..... ..+.+.+|+.++++++|++++++++++.. ...+++||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence 4789999999999999999877788899999875433 23568899999999999999999998854 457899999999
Q ss_pred CCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++... ...++...++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++......... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 160 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-AR 160 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cc
Confidence 9999998654 234889999999999999999999 999999999999999999999999999999866432211 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||...+..++.++|+||||+++++|++ |..||......+ ........ .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~-~------------------ 220 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-VLEQVERG-Y------------------ 220 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcC-C------------------
Confidence 12234567999999888889999999999999999999 888886532221 11111100 0
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
....+...+.++.+++.+||..+|++|||++++.+.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001123445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=285.66 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=203.9
Q ss_pred CCCCCceecccCceEEEEEEe--------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCc
Q 039392 1 GFSENNLIGRGGFGSVFKARL--------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEF 70 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~--------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 70 (285)
+|.+.+.||+|+||.||++.. .++..+++|.+.... ......+.+|+.+++.+ +||||+++++.+.....
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 478899999999999999963 124578999886432 34456788999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 039392 71 KALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~ 135 (285)
.+++||++++++|.+++.+.. ..++...+..++.|++.||.||| ++|++|+||+|+||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~ 172 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTE 172 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEcC
Confidence 999999999999999986532 23677888999999999999999 999999999999999999
Q ss_pred CCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhh
Q 039392 136 NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 136 ~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 214 (285)
++.++|+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..||......+.. ..
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~ 251 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-KL 251 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-HH
Confidence 99999999999987654322222223345567999999988889999999999999999998 77887653221111 10
Q ss_pred hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 215 WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
..... ....+..++.++.+++.+||..+|++|||+.++++.|.++...
T Consensus 252 -~~~~~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 252 -LKEGH------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHcCC------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 00000 0001224567799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=297.17 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=198.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|..+++.++||||+++++.+......++|||
T Consensus 44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (371)
T cd05622 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 123 (371)
T ss_pred hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 5889999999999999999754 68899999986432 2233557789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.... +++..+..++.||+.||.||| ++|++||||||+||+++.++.++|+|||++....... .
T Consensus 124 y~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~ 197 (371)
T cd05622 124 YMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M 197 (371)
T ss_pred CCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-c
Confidence 999999999986543 788889999999999999999 9999999999999999999999999999998765322 1
Q ss_pred ceeccccccccccCCcccCCC----ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKEG----RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.......+|+.|+|||++.+. .++.++||||||+++|+|++|..||....... .........
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~------------- 263 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHK------------- 263 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC-------------
Confidence 122345689999999988654 37899999999999999999999997532211 111111100
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCC--CCCHHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTKL 275 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~~l 275 (285)
....++.....+.++.+++.+||..++.+ |+++++++++.
T Consensus 264 ---~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 ---NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00111112345677899999999844443 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=285.99 Aligned_cols=249 Identities=27% Similarity=0.328 Sum_probs=202.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.|++.+.||+|++|.||+|.. .+++.+++|.+..........+.+|+.+++.+.|+|++++++.+......++|+||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 478889999999999999975 4688999999876655556778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++... .++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 101 ~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~ 173 (296)
T cd06654 101 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 173 (296)
T ss_pred CCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--ccc
Confidence 99999998653 3788899999999999999999 9999999999999999999999999999987654321 111
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+++.|+|||.+.+..++.++|+||||+++++|++|..||............. . .... .
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~-~---~~~~--------------~ 235 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-T---NGTP--------------E 235 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh-c---CCCC--------------C
Confidence 23457788999999988889999999999999999999999996543211111100 0 0000 0
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+...+..+.+++.+||..+|++|||+++++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00122345668899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=282.72 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=204.8
Q ss_pred CCCCCceecccCceEEEEEEeCC-----CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceecc-CCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLGD-----GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSN-EEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-----~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~ 73 (285)
+|.+.+.||+|+||.||+|.... +..|++|.+.... ......+.+|+.+++.++|+|++++++++.. +...++
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 86 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV 86 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence 47888999999999999997544 6888999876442 3445668889999999999999999998655 567889
Q ss_pred EEeccCCCCHHHhhhcCC-------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecc
Q 039392 74 VLEYMPHGSLEKYLHSSN-------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 146 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~ 146 (285)
+++++++++|.+++.... ..++...++.++.|++.||.||| +.+++|+||+|.||++++++.++++|||+
T Consensus 87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 999999999999986532 34889999999999999999999 99999999999999999999999999999
Q ss_pred ceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 147 AKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
++.+.............++..|+|||.+.+..++.++||||||++++++++ |..||......+ .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~----- 236 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAAYLKDGY----- 236 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHHHHHcCC-----
Confidence 976543322222223345667999999988889999999999999999999 999986542211 111111000
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.+.....++.++.+++.+||..+|++|||+.++++.|+++...
T Consensus 237 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 -------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0001223456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=293.00 Aligned_cols=263 Identities=24% Similarity=0.247 Sum_probs=194.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCC------ce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE------FK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 71 (285)
+|++.+.||+|+||.||++.. .+|+.+|+|++... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 488899999999999999975 46899999998643 2334456778999999999999999999886443 47
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+++||++++ ++...+.. .++...+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++....
T Consensus 102 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 102 YLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred EEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 899999965 66665532 3778889999999999999999 9999999999999999999999999999987543
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc-------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST------- 224 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 224 (285)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|..||.+...... .............
T Consensus 175 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 TN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCcHHHHHHHH
Confidence 22 112334678889999999999999999999999999999999999976432111 1111000000000
Q ss_pred -------------cccccccccCc--ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 -------------KEIVDPNLLSR--EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 -------------~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........... .+.........++++.+|+.+||..||++|||++|++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 000000112335678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=315.48 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=218.0
Q ss_pred CCCceecccCceEEEEEEe--CCCc----EEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 3 SENNLIGRGGFGSVFKARL--GDGM----EVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~--~~~~----~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+.++.||+|+||.||.|.. .+|. .|++|.+.... .+....|.+|+.++..++||||++++|++......++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 4578999999999999953 2343 37888876543 456678999999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcC------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 76 EYMPHGSLEKYLHSS------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 76 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
||++||+|..+++.. ...++....+.++.||+.|++||+ +++++||||...|.|++....+||.|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999877 556899999999999999999999 99999999999999999999999999999996
Q ss_pred cCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
..............-+..|+|||.+..+.++.++||||||+++||++| |..||.+..+.+....
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~--------------- 916 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD--------------- 916 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH---------------
Confidence 655544444444456678999999999999999999999999999999 8889876544332111
Q ss_pred cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
....+ ++..+..|+..++++|..||+.+|++||++..+++.+.++.+.++
T Consensus 917 ----~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 917 ----VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ----HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 11111 555678899999999999999999999999999999999887665
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=284.03 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=200.1
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHH--HHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFK--SFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|++++.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678999999999999999864 5678999999876543322 3456999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++++|.+++.... .++...++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NEN 154 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSE
T ss_pred ccccccccccccc-cccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc--ccc
Confidence 9989999997433 3899999999999999999999 999999999999999999999999999999864221 223
Q ss_pred eccccccccccCCcccC-CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGK-EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....++..|+|||.+. +..++.++|+||||+++++|++|..||....... .......... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~-------------~~~~ 220 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-QLEIIEKILK-------------RPLP 220 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-HHHHHHHHHH-------------THHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchh-hhhhhhhccc-------------cccc
Confidence 34566788999999988 7889999999999999999999999987641111 0000000000 0000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+.++.+++.+||..||++|||+++++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011123679999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=280.03 Aligned_cols=252 Identities=29% Similarity=0.492 Sum_probs=203.8
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|++|.||++...+++.+++|.+..... ..+.+.+|+.+++.++|+|++++++.+......++++|++++
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 4788999999999999999877778899999875432 346688899999999999999999999988899999999999
Q ss_pred CCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++.... ..++...+..++.|++.|+.+|| +++++|+||+|+||+++.++.++++|||.+........ ...
T Consensus 86 ~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 161 (261)
T cd05034 86 GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAR 161 (261)
T ss_pred CCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-hhh
Confidence 99999987643 35889999999999999999999 99999999999999999999999999999887653211 111
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
.....+..|+|||.+.+..++.++|+||+|++++++++ |+.||.+..... .........
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~------------------- 221 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGY------------------- 221 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCC-------------------
Confidence 12234567999999988889999999999999999998 999986532211 111111100
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
....+...+.++.+++.+||..+|++||+++++.+.|++
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001122335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=299.06 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=198.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||++.. .+++.||+|++.... ......+.+|..++..++|++|+++++.+...+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 588999999999999999975 468999999987432 2344667789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.+... +++..++.++.|++.||.||| +.|++||||||+||+++.+|.++|+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999876544 889999999999999999999 999999999999999999999999999998654321100
Q ss_pred ---------------------------------ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCc
Q 039392 157 ---------------------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTD 203 (285)
Q Consensus 157 ---------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 203 (285)
.......+|+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00112458899999999999999999999999999999999999997
Q ss_pred cccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC---HHHHHHH
Q 039392 204 EIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN---AKEIVTK 274 (285)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~~ 274 (285)
........ ...... . ....++.....+.++.+++.+|+ .||.+|++ +++++++
T Consensus 238 ~~~~~~~~-~~i~~~----~------------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETY-RKVMNW----K------------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHH-HHHHcC----C------------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 64322211 111100 0 00001111234567889999977 49999985 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=296.43 Aligned_cols=255 Identities=29% Similarity=0.426 Sum_probs=209.8
Q ss_pred CCCceecccCceEEEEEEe--CCC---cEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 3 SENNLIGRGGFGSVFKARL--GDG---MEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~--~~~---~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
...++||+|+||.||+|.. .++ ..||+|..... ....+..+.+|++++++++||||++++|+.....-+++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 3568999999999999963 222 23899987752 356778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
||+|+||+|.+++++....++..+...++.+.+.||+||| +++++||||-..|.|++.++.+||+|||+++.-..-
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~- 315 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY- 315 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcce-
Confidence 9999999999999988777999999999999999999999 999999999999999999999999999998754411
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.........+..|+|||.+....++.++||||||+++||+++ |..||.+....+...... .
T Consensus 316 -~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~-~---------------- 377 (474)
T KOG0194|consen 316 -VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV-K---------------- 377 (474)
T ss_pred -eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-h----------------
Confidence 111112346778999999999999999999999999999999 888987754432222211 1
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
...+...+...+.++..++.+|+..+|++|||+.++.+.++.+...
T Consensus 378 --~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 378 --NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred --cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 1111122335677799999999999999999999999999998764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=281.71 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=200.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|.+.+.||+|+||.||+|.. .+++.+++|++..........+.+|+.+++.++||||+++++.+...+..++++|+++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 477889999999999999974 4689999999876655555667889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++.... .+++..++.++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 90 ~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~ 163 (267)
T cd06645 90 GGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKR 163 (267)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--ccc
Confidence 999999886654 4899999999999999999999 9999999999999999999999999999987654321 112
Q ss_pred ccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 160 TQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....++..|+|||.+. ...++.++|+||||+++|+|++|..||....+............. ....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~--------- 231 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---PPKL--------- 231 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC---CCcc---------
Confidence 3345788999999874 445889999999999999999999998653322211111000000 0000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+..+.+++.+||..+|++|||+++++++
T Consensus 232 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 ----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0011234568899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=288.63 Aligned_cols=241 Identities=24% Similarity=0.324 Sum_probs=190.4
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHcc-CCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKS-IHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||+||+|.. .+++.||+|++.... ....+....|..++.. ++||||+++++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999975 468899999987542 2233445567777765 4899999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++.... .++...+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence 99999987654 3888999999999999999999 9999999999999999999999999999987532211 1123
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...++..|+|||.+.+..++.++|+||+|+++|+|++|..||......+. ...... .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~i~~-~~------~------------- 213 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-FQSIRM-DN------P------------- 213 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh-CC------C-------------
Confidence 34578899999999988999999999999999999999999976432211 111000 00 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHH-HHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAK-EIVT 273 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~-eil~ 273 (285)
..+...+.++.+++.+||+.||++||++. +++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 00112455688999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=282.24 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=198.9
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|.+.+.||+|++|.||+|... .+..+++|.+.... ......+.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 4788899999999999999753 45678999876443 3344568889999999999999999999988888999
Q ss_pred EEeccCCCCHHHhhhcCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---cEEEeee
Q 039392 74 VLEYMPHGSLEKYLHSSN------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHLSDF 144 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~i~df 144 (285)
+||++++++|.+++.... ..+++..++.++.||+.|++||| +++++|+||+|+||+++.++ .++++||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999986543 23788999999999999999999 99999999999999998654 5899999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++.................+..|+|||.+.+..++.++||||||+++++|++ |..||......... . .......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-~-~~~~~~~-- 239 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-E-FVTGGGR-- 239 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H-HHHcCCc--
Confidence 99986643221111122233567999999988889999999999999999997 99998754322211 1 1000000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
...+..++..+.+++.+||+.+|++|||+.+++++|+
T Consensus 240 ----------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 ----------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0012234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=284.15 Aligned_cols=269 Identities=24% Similarity=0.409 Sum_probs=203.4
Q ss_pred CCCCceecccCceEEEEEEe-----CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccC--CceEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-----GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 73 (285)
|.+.+.||+|+||.||++.. .++..|++|.+.... ......+.+|+++++.++|+|++++.+++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 67899999999999999862 357889999987543 34456788999999999999999999988764 57889
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
+|||+++++|.+++.+....++...++.++.|++.||++|| ++|++|+||+|+||+++.++.++|+|||++......
T Consensus 86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 99999999999998766555889999999999999999999 999999999999999999999999999999876543
Q ss_pred ccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 154 DIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 154 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
... .......++..|+|||.+.+..++.++||||||+++++++++..|......... ..................
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-- 238 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL--KMIGPTHGQMTVTRLVRV-- 238 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh--hhcccccccccHHHHHHH--
Confidence 221 112234456679999998888899999999999999999998766432211000 000000000000000000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.........+..++..+.+++.+||+.+|++|||++++++.++++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 -LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000011112334677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=288.10 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceecc-CCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSN-EEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~ 71 (285)
+|++.+.||+|+||.||+|.+ .+++.||+|.+.... ......+.+|+.++.++ +|+||+++++.+.. ....
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 488999999999999999962 357889999987543 23446688899999999 68999999998754 4567
Q ss_pred EEEEeccCCCCHHHhhhcCC------------------------------------------------------------
Q 039392 72 ALVLEYMPHGSLEKYLHSSN------------------------------------------------------------ 91 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~------------------------------------------------------------ 91 (285)
+++|||+++++|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 89999999999999885421
Q ss_pred ------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecccccc
Q 039392 92 ------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165 (285)
Q Consensus 92 ------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~ 165 (285)
..++...+..++.|++.||+||| ++|++|+||||.||+++.++.++|+|||++................++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 12567778899999999999999 999999999999999999999999999998765332222222233455
Q ss_pred ccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhh
Q 039392 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKE 244 (285)
Q Consensus 166 ~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (285)
..|+|||.+.+..++.++|+||||++++++++ |..||................. ....+.
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~ 305 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-------------------RMRAPD 305 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-------------------CCCCCC
Confidence 67999999988889999999999999999997 8889865432211111110000 000011
Q ss_pred HhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 245 QCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
..++++.+++.+||+.+|++|||+.+++++|+.+.+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 2345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=285.19 Aligned_cols=249 Identities=28% Similarity=0.337 Sum_probs=203.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||.|++|.||+|.. .+++.+++|.+........+.+.+|+.+++.++|+|++++++.+......++|+|+++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 478889999999999999974 5789999999876555556778889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|..++... .++...+..++.|++.++++|| +.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 100 ~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~ 172 (296)
T cd06655 100 GGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KR 172 (296)
T ss_pred CCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cC
Confidence 99999988654 3889999999999999999999 99999999999999999999999999999876543221 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....++..|+|||.+.+..++.++|+||||+++|++++|..||............. ... .. .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~-~~~-~~----------------~ 234 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNG-TP----------------E 234 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcC-Cc----------------c
Confidence 23457788999999988889999999999999999999999997643322111100 000 00 0
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+..+..+++.+.+++++||..+|.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 01123456678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=293.33 Aligned_cols=239 Identities=24% Similarity=0.321 Sum_probs=192.4
Q ss_pred CceecccCceEEEEEEe----CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 5 NNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
++.||+|+||.||+++. .+|+.+|+|++..... .....+.+|++++++++||||+++++.+......++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 46899999999999863 3688999999875432 23345678999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++++|.+++.+.. .+++..++.++.||+.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154 (318)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence 9999999886654 4899999999999999999999 9999999999999999999999999999987654321 11
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+.. ..... ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~i~~----~~--------------- 214 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM-TMILK----AK--------------- 214 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH-HHHHc----CC---------------
Confidence 22346788999999998888999999999999999999999999753321111 11100 00
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e 270 (285)
...+...++++.+++++||+.||.+|||+.+
T Consensus 215 -~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 -LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0012234667899999999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=285.65 Aligned_cols=248 Identities=27% Similarity=0.326 Sum_probs=202.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++.+......++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 488999999999999999975 5789999999876655555678889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++.+. .++...+..++.|++.+|.+|| +.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 100 ~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 172 (297)
T cd06656 100 GGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (297)
T ss_pred CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--Cc
Confidence 99999998653 3788899999999999999999 99999999999999999999999999999876543321 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+++.|++||.+.+..++.++|+||||+++|++++|..||................ ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~------------------~~~ 234 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG------------------TPE 234 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC------------------CCC
Confidence 23457788999999998889999999999999999999999996532211111000000 000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
...+...+..+.+++.+||..+|.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0012334566889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=280.83 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=205.1
Q ss_pred CCCCceecccCceEEEEEEeC-CCc----EEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGM----EVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~----~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
|++.+.||+|+||.||+|.+. +|+ .+++|....... .....+.+|+++++.++|+|++++++++.. ...++++
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 678899999999999999743 333 589998765543 344678889999999999999999999887 6788999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++.+....+++..++.++.|++.|++||| +++++|+||+|+||+++.++.++|+|||.+........
T Consensus 88 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 88 QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999999876666899999999999999999999 99999999999999999999999999999987654322
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.........+..|++||.+....++.++|+||||++++++++ |..||......+.. .......
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~-------------- 228 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP--DLLEKGE-------------- 228 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH--HHHhCCC--------------
Confidence 222222233567999999888889999999999999999998 99998764322211 1110000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
....+..++..+.+++.+||..+|.+|||+.++++.|.++.++-
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 229 ----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 00112224456889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=276.87 Aligned_cols=248 Identities=30% Similarity=0.501 Sum_probs=203.3
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||.|++|.||++... |+.+++|.+..... ..+.+.+|+.+++.++|+|++++++.+......+++||++++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4788999999999999999864 78899999876544 456788899999999999999999999989999999999999
Q ss_pred CCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++.... ..++...++.++.|++.|+.||| ++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----- 156 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----- 156 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc-----
Confidence 99999986554 24899999999999999999999 9999999999999999999999999999997664321
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
.....+..|+|||.+....++.++|+||||++++++++ |..||........ ........
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~------------------- 216 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPHVEKGY------------------- 216 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHhcCC-------------------
Confidence 12234556999999988889999999999999999997 9999865422111 11110000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+..+++++.+++++||..+|++|||++++++.|+++
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0001223467799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=290.21 Aligned_cols=237 Identities=26% Similarity=0.316 Sum_probs=187.5
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccch---hHHHHHHHHHH-HHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG---RVFKSFDVECE-MMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||+||+|.. .+|+.||+|++..... .....+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999975 4789999999875421 22233444444 56788999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|..++.... .+++..+..++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 99999887654 4889999999999999999999 9999999999999999999999999999986532211 1223
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||......+. ...... .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~----~~----------------~ 213 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-YDNILN----KP----------------L 213 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-HHHHHc----CC----------------C
Confidence 34578899999999998999999999999999999999999975322111 111100 00 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
......+.++.+++.+||+.||.+||+++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 01123466789999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=282.42 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=198.9
Q ss_pred CCCCCceecccCceEEEEEEeCC---------------CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccce
Q 039392 1 GFSENNLIGRGGFGSVFKARLGD---------------GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISS 64 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---------------~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 64 (285)
+|++.+.||+|+||.||++...+ ...||+|.+.... ....+.+.+|++++++++|+|+++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 48899999999999999986421 2348999987543 3345678899999999999999999999
Q ss_pred eccCCceEEEEeccCCCCHHHhhhcCC-----------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 039392 65 CSNEEFKALVLEYMPHGSLEKYLHSSN-----------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL 133 (285)
Q Consensus 65 ~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili 133 (285)
+......++|||++.+++|.+++.... ..++...++.++.|++.|+.||| +.|++|+||+|+||++
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill 162 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLV 162 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEE
Confidence 999999999999999999999885432 12677888999999999999999 9999999999999999
Q ss_pred CCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh--CCCCCccccccchh
Q 039392 134 DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT--RKKPTDEIFNGEMT 211 (285)
Q Consensus 134 ~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~~~~~~~~ 211 (285)
+.++.++++|||++................++..|+|||...+..++.++|+||||+++++|++ +..||......+..
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 9999999999999876543322222223344678999999988889999999999999999998 56677653322211
Q ss_pred hhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 212 LKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
............. .. ...+...++.+.+++++|+..+|++|||++++++.|+
T Consensus 243 -~~~~~~~~~~~~~------~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 243 -ENTGEFFRNQGRQ------IY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHhhhhcccc------cc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1110000000000 00 0012234567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=282.74 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=201.1
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
.|++.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++|+|++++++.+......++
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV 86 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 4788999999999999998532 24579999876443 2233457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC---------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 74 VLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
+|||+++++|.+++.... ...+...+..++.|++.||.||| +++++|+||+|+||+++.++.++++||
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcC
Confidence 999999999999986421 22456778899999999999999 999999999999999999999999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|+++...............++..|+|||.+.+..++.++|+||||+++++|++ |..||......+.. .......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~---- 238 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL-KFVMDGG---- 238 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCC----
Confidence 99876543222111222334667999999988889999999999999999998 78888653322211 1100000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
. ...+..++..+.+++.+||+.+|++|||+.++++.|.+....+
T Consensus 239 ~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 239 Y---------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred C---------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 0 0011234567999999999999999999999999998865443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=275.68 Aligned_cols=247 Identities=30% Similarity=0.466 Sum_probs=198.2
Q ss_pred ceecccCceEEEEEEeCCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCHH
Q 039392 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLE 84 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 84 (285)
+.||+|++|.||+|...+++.+++|.+..... .....+.+|+++++.++|||++++++++......+++||++++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47899999999999877888999999865543 33356888999999999999999999999999999999999999999
Q ss_pred HhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccc
Q 039392 85 KYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164 (285)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~ 164 (285)
+++......++...+..++.|++.+|.++| ++|++|+||+|+||+++.++.++++|||++........ ........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 998765555889999999999999999999 99999999999999999999999999999875433211 11112233
Q ss_pred cccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhh
Q 039392 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243 (285)
Q Consensus 165 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
+..|+|||.+.+..++.++|+||||++++++++ |..||......... ...... .. ...+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-~~~~~~-~~------------------~~~~ 216 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-EQVEKG-YR------------------MSCP 216 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-HHHHcC-CC------------------CCCC
Confidence 566999999988889999999999999999998 88898653222111 111000 00 0012
Q ss_pred hHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 244 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
..++..+.+++.+|+..+|++|||+.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 234567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=278.22 Aligned_cols=255 Identities=27% Similarity=0.487 Sum_probs=203.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CC---cEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DG---MEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~---~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|+..+.||+|++|.||+|... ++ ..+++|.+.... ....+.+..|+++++.++|+|++++.+++...+..+++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 4778899999999999999753 23 368999886543 344567888999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++++|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999998766556889999999999999999999 99999999999999999999999999999876643221
Q ss_pred ccee-ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 156 STIQ-TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 ~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.... .....+..|++||.+.+..++.++|+||||+++|++++ |..||......+ ....... ..
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-~~~~i~~-~~------------- 227 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-VMKAIND-GF------------- 227 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhc-CC-------------
Confidence 1111 11223457999999988889999999999999999997 999986533211 1111100 00
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
..+....++.++.+++.+||..+|++||+++++++.|+++
T Consensus 228 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001223466789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=283.28 Aligned_cols=264 Identities=21% Similarity=0.289 Sum_probs=202.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||++.. .++..+++|.+.... ......+.+|++++++++||||+++++.+..++..++++||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 589999999999999999975 468889999886543 334466888999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++.+.. .++...+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 82 DGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence 9999999997664 4889999999999999999999 6 68999999999999999999999999998654322
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcC-CCcccc-ccccc---
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP-ISTKEI-VDPNL--- 232 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~--- 232 (285)
......++..|+|||.+.+..++.++|+||||+++++|++|..||........ ......... ...... .....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL--EAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH--HHhhcCccccccccCCcccccCCCC
Confidence 11234577889999999888899999999999999999999999865332111 111110000 000000 00000
Q ss_pred ---------------cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 233 ---------------LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 233 ---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
....... ......+.++.+++.+||..+|++|||+++++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccchhhHHHHHHHHhcCCCcc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000 00112566799999999999999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=283.60 Aligned_cols=268 Identities=25% Similarity=0.287 Sum_probs=200.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
.|++.+.||+|++|.||+|.. .+|+.+++|.+..... .....+.+|++++++++|+|++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488999999999999999975 4689999999865322 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++ +|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R 154 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence 965 888887665556899999999999999999999 9999999999999999999999999999987654321 1
Q ss_pred eeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc------ccccc
Q 039392 158 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK------EIVDP 230 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 230 (285)
......++..|+|||.+.+. .++.++|+||||+++++|++|..|+....................... ...+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234567889999987665 478999999999999999999998654333322222211111110000 00000
Q ss_pred cccCcccc--h-hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDI--H-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~--~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........ . .......++++.+++++||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000 0 01112456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=276.79 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=199.5
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|++|.||++....+..+++|.+.... ...+.+.+|+.+++.++|+|++++++++.. ...+++||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 377889999999999999987766779999876433 234567889999999999999999988754 567899999999
Q ss_pred CCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++.... ..++...+..++.|++.||.||| +.|++|+||+|+||++++++.++|+|||.+......... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~ 160 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-AR 160 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-cc
Confidence 99999986543 34788899999999999999999 999999999999999999999999999999766432211 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+. ........ ..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~-~~---------------- 222 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LEQVERGY-RM---------------- 222 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCC-CC----------------
Confidence 22335567999999988889999999999999999999 8899875332211 11111100 00
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
..+...+..+.+++.+||..||.+||+++++++.|++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0122345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=281.12 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=200.7
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 4788999999999999999642 34789999986543 2334567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC---------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 74 VLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
+||++++++|.+++.... ..++...++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCc
Confidence 999999999999886432 12677889999999999999999 999999999999999999999999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++................++..|+|||.+.+..++.++|+||||++++++++ |..||......+. ...... ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~----~~ 238 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-LKFVID----GG 238 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-HHHHhc----CC
Confidence 99876544322222233445678999999988889999999999999999998 8888865332211 111110 00
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
....+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 239 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 ---------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00012234667999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=284.75 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=199.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCc--EEEEEEeecc-chhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGM--EVAVKVFNLQ-YGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~--~~~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|++++.++ +|+||+++++++...+..++++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 5788899999999999999753 454 3577766532 233446788899999999 8999999999999999999999
Q ss_pred eccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEE
Q 039392 76 EYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH 140 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~ 140 (285)
||+++++|.+++.... ..++...++.++.|++.|++||| ++|++|+||+|+||+++.++.++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEE
Confidence 9999999999986432 24788999999999999999999 99999999999999999999999
Q ss_pred EeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhh
Q 039392 141 LSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDW 219 (285)
Q Consensus 141 i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 219 (285)
|+|||++...... ........+..|+|||.+.+..++.++||||||+++++|++ |..||......+.. . ...
T Consensus 165 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~-~~~-- 237 (303)
T cd05088 165 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-E-KLP-- 237 (303)
T ss_pred eCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH-H-HHh--
Confidence 9999998632211 11111223556999999888889999999999999999998 99998653322111 1 000
Q ss_pred cCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.. .....+..+++++.+++.+||..+|++|||+++++..|.++...
T Consensus 238 -~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 238 -QG---------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred -cC---------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00001123456789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=275.90 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=204.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||.|++|.|+.++. .+++.+++|.+.... ......+.+|++++++++|+||+++++++.....+++++|+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999999974 468899999876542 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+++++|.+++.+. ...++...+..++.|++.++.+|| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999998765 345889999999999999999999 99999999999999999999999999999987654321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......+++.|+|||...+..++.++|+||||+++++|++|..||......+.... ... ... .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~-~~~----~~~---------~-- 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK-IVQ----GNY---------T-- 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHc----CCC---------C--
Confidence 22344578889999999888899999999999999999999999865332221111 110 000 0
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
.....++.++.+++.+||+.+|.+|||+++++++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 00134466789999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=282.45 Aligned_cols=267 Identities=24% Similarity=0.313 Sum_probs=199.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|++|.||+|.. .+++.|++|.+.... ......+.+|+.+++.++|||++++++.+..+...++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 689999999999999999975 468999999986432 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 78 MPHGSLEKYLHSSN--YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 78 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
++ ++|.+++.... ..++...++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 48888875432 45889999999999999999999 9999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc-------
Q 039392 156 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI------- 227 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 227 (285)
.......+++.|+|||.+.+. .++.++|+||||+++++|++|..||.+........... ..........+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIF-RILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-HHhCCCChhhhhcchhhH
Confidence 112233567889999987654 57899999999999999999999997643322111110 00000000000
Q ss_pred -ccccccC-cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 -VDPNLLS-REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 -~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....... ...........+++++.+++++||+.||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 0000001122467788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=275.68 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=200.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceecc-CCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSN-EEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 76 (285)
||++.+.||+|++|.||++.. .+++.+++|.+.... ....+.+.+|++++++++|+|++++.+.+.. ...+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 799999999999999999975 457889999986543 2344567889999999999999999988764 446789999
Q ss_pred ccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
++++++|.+++... ...+++.+++.++.|++.++.+|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999988653 334899999999999999999999 9999999999999999999999999999987664322
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+++.|+|||.+.+..++.++|+||||++++++++|..||........... ......+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~-------------- 220 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR-IIEGKLP-------------- 220 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhcCCC--------------
Confidence 112334577889999999988999999999999999999999999865332111111 1110000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+...++++.+++.+|++.+|.+|||+++++++
T Consensus 221 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 -----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0122356679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=284.25 Aligned_cols=267 Identities=20% Similarity=0.247 Sum_probs=200.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||.|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 488899999999999999975 4688999999865432 22345678999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++ +|.+++......++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 87 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 160 (301)
T cd07873 87 DK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 160 (301)
T ss_pred cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--c
Confidence 64 898888766656889999999999999999999 99999999999999999999999999999875443221 1
Q ss_pred eccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc---cccccc----
Q 039392 159 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST---KEIVDP---- 230 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---- 230 (285)
.....+++.|+|||.+.+. .++.++||||||+++++|++|..||......+. ............. ......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhcccccc
Confidence 1233467889999987654 578999999999999999999999976433211 1111111000000 000000
Q ss_pred -cccCccc--chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 -NLLSRED--IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 -~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....... ........+++.+.+++.+||+.||.+|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 0011123457789999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=283.56 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=202.2
Q ss_pred CCCCceecccCceEEEEEEeC--------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCce
Q 039392 2 FSENNLIGRGGFGSVFKARLG--------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFK 71 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~--------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 71 (285)
|.+.+.||+|++|.||++... ....+++|.+.... ......+.+|+++++++ .||||+++++++......
T Consensus 14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (314)
T cd05099 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL 93 (314)
T ss_pred eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence 678899999999999999631 24568999876443 34456788899999999 599999999999988899
Q ss_pred EEEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 039392 72 ALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN 136 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~ 136 (285)
++++||+++++|.+++.... ..++...+..++.|++.||.||| ++|++|+||+|+||+++.+
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTED 170 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCC
Confidence 99999999999999986532 23788889999999999999999 9999999999999999999
Q ss_pred CcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhh
Q 039392 137 MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHW 215 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 215 (285)
+.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||......+ .....
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-~~~~~ 249 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-LFKLL 249 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH
Confidence 9999999999976543221111112233456999999988889999999999999999999 888886532211 11110
Q ss_pred hhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 216 VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
.. .. ....+..++.++.+++.+||..+|++|||++++++.|.++....
T Consensus 250 ~~-~~------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 250 RE-GH------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred Hc-CC------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 00 00 00012344667889999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=292.19 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=201.7
Q ss_pred CCCCceecccCceEEEEEEeC------CCcEEEEEEeeccch-hHHHHHHHHHHHHccCC-CCccccccceeccCCceEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 73 (285)
|.+++.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++.++. ||||+++++.+......++
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 667899999999999999742 356899999875432 33456888999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC--------------------------------------------------------------
Q 039392 74 VLEYMPHGSLEKYLHSSN-------------------------------------------------------------- 91 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-------------------------------------------------------------- 91 (285)
|+||+++++|.+++....
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 999999999999885431
Q ss_pred -----------------------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 039392 92 -----------------------------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN 136 (285)
Q Consensus 92 -----------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~ 136 (285)
..++...++.++.|++.||.||| +.+++|+||+|.||+++.+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCC
Confidence 12456678889999999999999 9999999999999999999
Q ss_pred CcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhh
Q 039392 137 MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHW 215 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 215 (285)
+.++++|||++................++..|++||.+.+..++.++|+||||+++++|++ |..||......+......
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~ 355 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence 9999999999976543221111223345678999999988889999999999999999998 888986543322211111
Q ss_pred hhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 216 VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
.... ....+..++.++.+++.+||+.+|.+||++++++..|+++.
T Consensus 356 ~~~~-------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 356 KRGY-------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HcCC-------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1100 00112235677999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=275.62 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=195.9
Q ss_pred ceecccCceEEEEEEe---CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL---GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~---~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||+|.+ .++..+++|++.... ....+.+.+|+.+++.+.|+||+++++++.. ...+++||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 3689999999999953 357889999986443 3345678899999999999999999998764 457899999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce-e
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI-Q 159 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~-~ 159 (285)
++|.+++.... .+++..+..++.|++.|+.+|| ++|++|+||+|.||+++.++.++|+|||++........... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999986554 4889999999999999999999 99999999999999999999999999999987654322111 1
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||.+....++.++|+||||+++|+|++ |..||......+. .. ......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~-~i~~~~------------------ 215 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-TQ-MIESGE------------------ 215 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH-HHHCCC------------------
Confidence 12233567999999988889999999999999999998 9999875422211 11 111000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+..+++++.++|.+||+.||++|||+.+|.+.|++.
T Consensus 216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0011234667799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=308.74 Aligned_cols=259 Identities=26% Similarity=0.355 Sum_probs=203.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 5889999999999999999754 68999999986432 2344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcC----------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecc
Q 039392 77 YMPHGSLEKYLHSS----------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 146 (285)
Q Consensus 77 ~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~ 146 (285)
+++|++|.+++.+. ....+...++.++.||+.||+||| +.|++||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999988542 112456678899999999999999 99999999999999999999999999999
Q ss_pred ceecCcccc----------------cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccch
Q 039392 147 AKLLTREDI----------------STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM 210 (285)
Q Consensus 147 ~~~~~~~~~----------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~ 210 (285)
+........ ........+|+.|+|||.+.+..++.++||||||+++++|++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 986621110 0011224589999999999998999999999999999999999999865322111
Q ss_pred hhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCC-CHHHHHHHHHHHHH
Q 039392 211 TLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLVKIRD 280 (285)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~eil~~l~~l~~ 280 (285)
..... ... +........+++.+.+++.+||..||++|| +++++++.|+...+
T Consensus 240 ~~~~~-----------i~~-------P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYRDV-----------ILS-------PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh-----------ccC-------hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11100 000 000111234567789999999999999996 67778887777654
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=275.40 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=196.1
Q ss_pred eecccCceEEEEEEe---CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCC
Q 039392 7 LIGRGGFGSVFKARL---GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGS 82 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~---~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 82 (285)
.||+|+||.||+|.+ .++..+++|++..... ...+.+.+|+.++++++|+||+++++++.. ...++|||++++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 489999999999964 2456799999875543 334668899999999999999999998864 46889999999999
Q ss_pred HHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce-ecc
Q 039392 83 LEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI-QTQ 161 (285)
Q Consensus 83 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~-~~~ 161 (285)
|.+++......+++..++.++.|++.|+.+|| ++|++|+||+|+||+++.++.++++|||++........... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99998765556899999999999999999999 99999999999999999999999999999876543321111 111
Q ss_pred ccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 162 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
..++..|+|||.+.+..++.++|+||||+++|++++ |..||......+. ....... . ..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~-~------------------~~ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-MSFIEQG-K------------------RL 217 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-HHHHHCC-C------------------CC
Confidence 223567999999988889999999999999999996 9999875432211 1100000 0 00
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
..+..+++++.+++.+||..+|++||++.++.+.|+++
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=287.36 Aligned_cols=254 Identities=22% Similarity=0.256 Sum_probs=198.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|..++..++|+||+++++.+...+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 589999999999999999975 468999999986422 2334557789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.+....+++..+..++.||+.||+||| +++++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT- 157 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-
Confidence 99999999999775556899999999999999999999 99999999999999999999999999999876543221
Q ss_pred ceeccccccccccCCcccCC-----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.......+++.|+|||++.. ..++.++|+||+|+++|+|++|..||......+.... ... .....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~-i~~---~~~~~------ 227 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-IMN---HKEHF------ 227 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH-HHc---CCCcc------
Confidence 11122458889999998863 4578899999999999999999999975332221111 100 00000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCC--CCCHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~~ 274 (285)
.... ....++.++.+++++||..++.+ |+++++++++
T Consensus 228 ~~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 QFPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 01235677899999988664443 7899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=291.20 Aligned_cols=263 Identities=23% Similarity=0.237 Sum_probs=194.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccC------Cce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE------EFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 71 (285)
+|++.+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 478899999999999999975 468899999986432 23345677899999999999999999987543 357
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+++||++++ ++...+.. .++...++.++.|++.||.||| ++|++||||||+||+++.++.++|+|||++....
T Consensus 98 ~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 98 YLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred EEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 899999965 67666643 3788889999999999999999 9999999999999999999999999999997654
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcC----------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP---------- 221 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 221 (285)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....... .........
T Consensus 171 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred Ccc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhhc
Confidence 321 123346788999999999889999999999999999999999999754321111 000000000
Q ss_pred ----------CCccccccccccCcc--cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 222 ----------ISTKEIVDPNLLSRE--DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 222 ----------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........+...... +.........+.++.+++.+||..||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000000 00011122335678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=277.36 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=199.2
Q ss_pred ceecccCceEEEEEEeC--CC--cEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARLG--DG--MEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~--~~--~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|++|.||+|.+. ++ ..+++|.+..... ...+.+.+|+.++++++|+||+++++.+.. ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 47899999999999743 23 3689999877655 566788899999999999999999999988 889999999999
Q ss_pred CCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc-ce
Q 039392 81 GSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TI 158 (285)
Q Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~-~~ 158 (285)
++|.+++.... ..++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999987654 45889999999999999999999 999999999999999999999999999999876542211 11
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....++..|+|||.+....++.++|+||||+++++|++ |..||......+.. ...... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~--~---------------- 217 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL-KKIDKE--G---------------- 217 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHhc--C----------------
Confidence 123445678999999988899999999999999999998 99998654322211 111100 0
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
..+..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000012234567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=294.39 Aligned_cols=194 Identities=25% Similarity=0.394 Sum_probs=170.3
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-C-----CccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-H-----RNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~~v 74 (285)
|.+.+.||+|+||.|.++. ..+++.||||+++. ..........|+.+|..++ | -|+|+++++|...+++|+|
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 6789999999999999996 56799999999874 3555667778999999997 3 4899999999999999999
Q ss_pred EeccCCCCHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCcEEEeeeccceecC
Q 039392 75 LEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLT 151 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~--~~~~~i~df~~~~~~~ 151 (285)
+|.+ ..+|.++++.+.. .++...++.++.||+.||.+|| +.+|+|+||||+|||+.. ...||++|||+++...
T Consensus 267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9999 5599999977643 3899999999999999999999 999999999999999963 3479999999999776
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEI 205 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 205 (285)
... .....+..|+|||++.+..|+.+.|||||||+++||++|.+.|.+.
T Consensus 343 q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 343 QRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred Ccc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 532 2566788999999999999999999999999999999998887764
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=289.39 Aligned_cols=239 Identities=25% Similarity=0.293 Sum_probs=188.0
Q ss_pred ceecccCceEEEEEEeC-CCcEEEEEEeeccch---hHHHHHHHH-HHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG---RVFKSFDVE-CEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||+||++... +++.+|+|++..... .....+..| ..+++.++|+||+++++.+...+..++|||++++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999754 678899999875321 122233333 4457888999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++..... +++..+..++.||+.||.||| ++|++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~ 154 (325)
T cd05602 81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS 154 (325)
T ss_pred CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence 999998876543 788889999999999999999 9999999999999999999999999999987543221 1123
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||......+.. ..... .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~----~~----------------~ 213 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-DNILN----KP----------------L 213 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-HHHHh----CC----------------c
Confidence 456889999999999999999999999999999999999999753322111 11100 00 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEI 271 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ei 271 (285)
......+..+.+++.+||+.+|.+||++.+.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 0122456678999999999999999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=297.28 Aligned_cols=261 Identities=24% Similarity=0.325 Sum_probs=191.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc--------CCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN--------EEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~ 71 (285)
+|++++.||+|+||.||+|.. .+++.||||.+.... ....+|+.+++.++|+||+++.+++.. ...+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 378899999999999999975 468999999875432 223469999999999999999887632 2246
Q ss_pred EEEEeccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CcEEEeeeccc
Q 039392 72 ALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIA 147 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~i~df~~~ 147 (285)
++||||+++ ++.+++.. ....+++..++.++.||+.||.||| ++|++||||||+||+++.+ +.+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 789999975 77766642 3445899999999999999999999 9999999999999999865 47999999999
Q ss_pred eecCcccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc--
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-- 224 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 224 (285)
........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.. ............
T Consensus 219 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 219 KNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL-VRIIQVLGTPTEDQ 294 (440)
T ss_pred hhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHH
Confidence 86543221 1234578899999987654 6899999999999999999999999764332221 111111111000
Q ss_pred --------cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 --------KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+. ..........+...+.++.+|+.+||..||.+|||+.|++++
T Consensus 295 ~~~~~~~~~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 295 LKEMNPNYADIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHhchhhhcccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000 011111222233467789999999999999999999999954
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=297.54 Aligned_cols=263 Identities=19% Similarity=0.199 Sum_probs=196.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
||.+.+.||+|+||.||++... +++.|++|.... ..+.+|++++++++|+||+++++++...+..+++++++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 5889999999999999999754 578899996322 335679999999999999999999999999999999995
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++............
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 5888888665556999999999999999999999 999999999999999999999999999999866433222222
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCcccccc------chhhhhhhhhhcCCCcccccc----
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNG------EMTLKHWVNDWLPISTKEIVD---- 229 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~---- 229 (285)
....+|..|+|||.+.+..++.++|||||||++|+|++|..|+...... .......+..... ....+..
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~-~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV-HVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc-ccccCCCCcch
Confidence 3356899999999999989999999999999999999988765332111 0111111111000 0000000
Q ss_pred -----------c-cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 -----------P-NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 -----------~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. .........+......+..+.+||.+||..||.+|||++|+|++
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000000111112345678999999999999999999999975
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=275.61 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=198.0
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcccccccee-ccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC-SNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~~ 79 (285)
+|.+.+.||+|++|.||++... ++.+++|.+.... ..+.+.+|+.++++++|++++++++.+ ......++++|+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4788999999999999999764 7889999876432 346688899999999999999999875 55667899999999
Q ss_pred CCCHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 80 HGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 80 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+++|.+++..... .++...++.++.|++.||++|| ++|++|+||+|+||+++.++.++++|||++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 9999999876433 4788899999999999999999 9999999999999999999999999999987543321
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ........
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-~~~~~~~~------------------ 216 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPRVEKGY------------------ 216 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhcCC------------------
Confidence 22234567999999988889999999999999999997 8988864321111 00000000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.......+++.+.+++.+||+.+|++|||++++++.|+++
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 -KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0001234567799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=281.31 Aligned_cols=266 Identities=24% Similarity=0.307 Sum_probs=194.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccC---CCCccccccceecc-----CC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSI---HHRNIIKVISSCSN-----EE 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 69 (285)
.|++.+.||+|+||+||+|.. .+++.+|+|.+.... ......+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 589999999999999999975 468999999886432 11223345666666655 69999999998754 34
Q ss_pred ceEEEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 70 FKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
..++++|++.+ +|.+++.... ..++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 8888876543 34889999999999999999999 9999999999999999999999999999997
Q ss_pred ecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc
Q 039392 149 LLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228 (285)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
...... ......++..|+|||.+.+..++.++||||+|+++|+|++|..||........ ...............+.
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCCCChhhCc
Confidence 664321 11234568889999999888999999999999999999999999865433221 11111111000000000
Q ss_pred ------cccccCcccch-hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 ------DPNLLSREDIH-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........... ......++.++.+++.+||+.||++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 01112456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=286.84 Aligned_cols=241 Identities=20% Similarity=0.268 Sum_probs=192.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999974 468999999987542 233355667888888775 577888999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++++|.+++..... +++..++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 99999999998876544 899999999999999999999 9999999999999999999999999999987543221
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+++.|+|||.+.+..++.++|+||+|+++++|++|..||........ ........
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i~~~~---------------- 217 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-FQSIMEHN---------------- 217 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCC----------------
Confidence 112334578899999999988899999999999999999999999976432211 11111000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINA 268 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 268 (285)
...+..++.++.+++.+||+.+|.+|++.
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 00112345668899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=277.88 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=191.4
Q ss_pred ecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 8 lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
||+|+||.||++.. .+|+.+++|.+.... ......+..|++++++++||||+++.+.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999975 468999999986432 12233455699999999999999999999999999999999999999
Q ss_pred HHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccc
Q 039392 84 EKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162 (285)
Q Consensus 84 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~ 162 (285)
.+++.... ..++...++.++.|++.|++||| +.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 88875433 34888889999999999999999 9999999999999999999999999999987665422 12334
Q ss_pred cccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhh
Q 039392 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVA 242 (285)
Q Consensus 163 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..||......... ........... . . . .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~---~------~-----~-~ 218 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTLEDE---V------K-----F-E 218 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhhccc---c------c-----c-c
Confidence 5788999999998888999999999999999999999998653221111 11111000000 0 0 0 0
Q ss_pred hhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 243 KEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
....+.++.+++.+||+.||.+||+++|+++
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 1235667899999999999999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=296.38 Aligned_cols=264 Identities=22% Similarity=0.177 Sum_probs=198.3
Q ss_pred CCCCCceecccCceEEEEEEe---CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL---GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
.|.+.+.||+|+||.||++.. .++..|++|.+... ....+|+++++.++||||+++++.+......+++||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 378899999999999999863 24678999987543 2345799999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+. ++|.+++... ..++...++.++.||+.||.||| ++|++||||||+||+++.++.++|+|||++..........
T Consensus 168 ~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 168 YK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred cC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 95 5888888544 34899999999999999999999 9999999999999999999999999999997665433222
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccc--hhhhhhhhhhcCCCcccccc------
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE--MTLKHWVNDWLPISTKEIVD------ 229 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~------ 229 (285)
......++..|+|||++.+..++.++||||||+++|+|++|..||.+..... ....................
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 2234568899999999998899999999999999999999999997643321 11111111111000000000
Q ss_pred --------ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 --------PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.................+.++.++|++||..||++|||+.+++.+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000011112345678899999999999999999999875
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=280.96 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=200.7
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||.||++... ++..+++|.+.... ......+.+|+.+++.++|||++++++++..+...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 5889999999999999999742 46789999986543 3344668889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC---------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 039392 74 VLEYMPHGSLEKYLHSSN---------------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVL 132 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~---------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nil 132 (285)
++|++++++|.+++.... ..++...++.++.|++.||.+|| ..+++|+||+|.||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheE
Confidence 999999999999886321 23677888999999999999999 999999999999999
Q ss_pred eCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchh
Q 039392 133 LDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMT 211 (285)
Q Consensus 133 i~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~ 211 (285)
++.++.++++|||++.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~- 241 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV- 241 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999876543221111222334567999999988889999999999999999997 7778754322211
Q ss_pred hhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 212 LKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
.... ..... +..+..++.++.+++.+||+.+|++|||++|+++.|++
T Consensus 242 ~~~~----~~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 IYYV----RDGNV---------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH----hcCCC---------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1100 00000 00122356779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=280.64 Aligned_cols=260 Identities=22% Similarity=0.400 Sum_probs=199.9
Q ss_pred CCCCCceecccCceEEEEEEeC-----------------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCcccccc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-----------------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVI 62 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-----------------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 62 (285)
+|++.+.||+|+||.||++... ++..+++|++.... ....+.+.+|+++++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4889999999999999998532 23468999887543 33456788999999999999999999
Q ss_pred ceeccCCceEEEEeccCCCCHHHhhhcCC----------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 039392 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSN----------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVL 132 (285)
Q Consensus 63 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nil 132 (285)
+++......+++||++++++|.+++.... ..++...++.++.|++.|+++|| +.|++|+||+|+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEE
Confidence 99999999999999999999999886532 12667789999999999999999 999999999999999
Q ss_pred eCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh--CCCCCccccccch
Q 039392 133 LDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT--RKKPTDEIFNGEM 210 (285)
Q Consensus 133 i~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~~~~~~~ 210 (285)
++.++.++++|||++............+....+..|++||...+..++.++|+||||+++|+|++ |..||......+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999876543221122222334567999998888889999999999999999998 7788765332221
Q ss_pred hhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 211 TLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
. ............ ......+..+++.+.+++.+||+.||.+|||++++++.|+
T Consensus 243 ~-~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 243 I-ENTGEFFRDQGR------------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H-HHHHHHHhhccc------------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111000000000 0001112335677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=270.75 Aligned_cols=248 Identities=27% Similarity=0.384 Sum_probs=202.8
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc--------hhHHHHHHHHHHHHccCC-CCccccccceeccCCce
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--------GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFK 71 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 71 (285)
|.-.+.||.|..+.|-++. ..+|..+++|++.... ....+.-..|+++|+++. ||+|+++.++++.+...
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 5666789999999888875 5578899999886422 223455667999999996 99999999999999999
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++|+|.++.|-|.|++.+... +++...+++++|+.+|++||| .++|||||+||+||+++++-+++|+|||+++.+.
T Consensus 99 FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999977654 999999999999999999999 9999999999999999999999999999999887
Q ss_pred cccccceeccccccccccCCcccCC------CccCcchhhHHHHHHHHHHhhCCCCCccccccchh-hhhhhhhhcCCCc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE------GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT-LKHWVNDWLPIST 224 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 224 (285)
... .....+|||+|+|||.+.. ..|+...|+|+.|++||.++.|..||--.- +.. +...+.
T Consensus 175 ~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlMLR~Ime------- 242 (411)
T KOG0599|consen 175 PGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLMLRMIME------- 242 (411)
T ss_pred Cch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHHHHHHh-------
Confidence 643 2356789999999997753 358899999999999999999999984210 000 011111
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+.-+.+.+.+.+.++||.+||+.||++|.|++|+|.+
T Consensus 243 ---------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 243 ---------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ---------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11112223366778889999999999999999999999975
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=279.90 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=204.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||.|++|.||+|.. .+|+.+++|.+.... ......+.+|+.++++++|+|++++++++......++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999975 468999999987554 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+ +++|.+++......+++..++.++.|++.+|++|| +.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999998766666999999999999999999999 99999999999999999999999999999987654321 1
Q ss_pred eeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc------cccc--
Q 039392 158 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST------KEIV-- 228 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~-- 228 (285)
......++..|+|||.+.+. .++.++||||+|+++++|++|..||...... ............... ....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchh
Confidence 22344678889999987654 4689999999999999999998777543321 111111111110000 0000
Q ss_pred cccccC-cccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DPNLLS-REDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~~~~~-~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...... .....+ ......+.++.+++++||..+|.+|||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000000 0112346789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=280.28 Aligned_cols=260 Identities=24% Similarity=0.400 Sum_probs=202.1
Q ss_pred CCCCCceecccCceEEEEEEeCC-----------------CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCcccccc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGD-----------------GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVI 62 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-----------------~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 62 (285)
.|++.+.||+|+||.||++.... +..+++|.+.... ....+.+.+|++++++++|||+++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 48899999999999999986432 3468999987543 34456788999999999999999999
Q ss_pred ceeccCCceEEEEeccCCCCHHHhhhcCC----------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 039392 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSN----------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVL 132 (285)
Q Consensus 63 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nil 132 (285)
+++......++++|++.+++|.+++.... ..++...++.++.|++.||.||| +.+++|+||+|+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhcee
Confidence 99999899999999999999999986543 24889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh--CCCCCccccccch
Q 039392 133 LDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT--RKKPTDEIFNGEM 210 (285)
Q Consensus 133 i~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~~~~~~~ 210 (285)
++.++.++++|||++................++..|+|||.+.+..++.++||||||+++|+|++ +..||......+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~- 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ- 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence 99999999999999876543322222233445678999999888889999999999999999998 667775432211
Q ss_pred hhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 211 TLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
.............. ......+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGHFFRDDGR------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhccccccc------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111110000000 0000112235567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=279.65 Aligned_cols=269 Identities=25% Similarity=0.420 Sum_probs=205.5
Q ss_pred CCCCceecccCceEEEEEEe-----CCCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceecc--CCceEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-----GDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-----~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 73 (285)
|++.+.||+|+||.||++.. .+++.+|+|++...... ....+.+|+++++.++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 67889999999999999973 24788999998765543 45778899999999999999999998876 567899
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++|++++++|.+++......++...++.++.|++.||++|| +.|++|+||+|.||+++.++.++++|||.+......
T Consensus 86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 99999999999999776656899999999999999999999 999999999999999999999999999999876533
Q ss_pred cccce-eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 154 DISTI-QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 154 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
..... ......+..|++||.+.+..++.++|+||||+++++|++|..|+.......... ................ .
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~ 239 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM--IGIAQGQMIVTRLLEL-L 239 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc--cccccccccHHHHHHH-H
Confidence 22111 112234456999999988889999999999999999999999976532211100 0000000000000000 0
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
........+..++.++.+++.+||..+|++|||++++++.|+++
T Consensus 240 --~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 --KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred --HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00011111234567799999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=275.42 Aligned_cols=252 Identities=25% Similarity=0.441 Sum_probs=201.2
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||.||++...++..+++|.+.... ...+.+.+|+++++.++|+|++++.+.+.. ...+++||++++
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 478899999999999999987777889999876543 334678889999999999999999999887 778999999999
Q ss_pred CCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++... ....+...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++++|||.+........ ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 160 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR 160 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccc
Confidence 9999998653 334788889999999999999999 99999999999999999999999999999876543221 111
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||.+....++.++|+||||++++++++ |..||......... ........
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~--~~~~~~~~----------------- 221 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI--RALERGYR----------------- 221 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHhCCCC-----------------
Confidence 22334567999999988889999999999999999998 89998653322111 11100000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.......+.++.+++.+|++.+|++||++.++++.|+++
T Consensus 222 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 222 -MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 001123456799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=275.93 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|++|.||++.+.++..+++|.+..... ....+.+|++++++++||+++++++.+......++++|++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 3678899999999999999876688899998764322 235678899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++......++...++.++.|++.++++|| +.+++|+||+|.||+++.++.++|+|||.+........ ....
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 159 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSST 159 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cccC
Confidence 9999998766556889999999999999999999 99999999999999999999999999999876543221 1112
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+..|+|||.+.+..++.++|+||||+++|++++ |..||........... .... ..
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~-------------------~~ 219 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-INAG-------------------FR 219 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HhCC-------------------CC
Confidence 2234567999999988889999999999999999998 8999865332211111 0000 00
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
...+...+.++.+++.+||+.+|++|||++++++.|
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 000122356799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=283.06 Aligned_cols=195 Identities=23% Similarity=0.308 Sum_probs=159.1
Q ss_pred CceecccCceEEEEEEeC---CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc--CCceEEEEeccC
Q 039392 5 NNLIGRGGFGSVFKARLG---DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKALVLEYMP 79 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~ 79 (285)
+++||+|+||+||+|... +++.+|+|.+..... ...+.+|+.++++++||||+++++.+.. ....++++|++.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 578999999999999743 567899998864322 2456789999999999999999998843 456889999995
Q ss_pred CCCHHHhhhcC--------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCcEEEeeeccc
Q 039392 80 HGSLEKYLHSS--------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIA 147 (285)
Q Consensus 80 ~~~L~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~i~df~~~ 147 (285)
+ +|.+++... ...++...++.++.||+.||.||| +.|++|+||||+||++ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 888876432 124888999999999999999999 9999999999999999 45688999999999
Q ss_pred eecCcccc-cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccc
Q 039392 148 KLLTREDI-STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEI 205 (285)
Q Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~ 205 (285)
........ ........+++.|+|||.+.+. .++.++||||+||++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87654321 1122345678899999988764 5899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=278.46 Aligned_cols=248 Identities=27% Similarity=0.359 Sum_probs=202.6
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+++++.++|+|++++.+.+..+..+++++|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4888999999999999999754 68999999987553 344466788999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++++|.+++... .++...++.++.|++.++.+|| +.+++|+||+|+||++++++.++++|||++....... ..
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 154 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SK 154 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cc
Confidence 999999998765 4889999999999999999999 9999999999999999999999999999998765432 11
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ..... . + ...
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~-~--------~-~~~---- 219 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNN-P--------P-SLE---- 219 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-hhhcC-C--------C-CCc----
Confidence 2234567789999999888899999999999999999999999865432211110 00000 0 0 000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...++.++.+++.+||..+|++|||+++++++
T Consensus 220 ----~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 ----GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11156678999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=274.69 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=193.7
Q ss_pred ceecccCceEEEEEEeC----CCcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceec-cCCceEEEEeccC
Q 039392 6 NLIGRGGFGSVFKARLG----DGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCS-NEEFKALVLEYMP 79 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~ 79 (285)
+.||+|+||.||+|... .+..+++|.+... .....+.+.+|+.+++.++|||++++++.+. .++..++++|++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 47899999999999642 2457899987543 2344567888999999999999999999764 4566889999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc--
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST-- 157 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~-- 157 (285)
+++|.+++.+.....+...+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++..........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999998765555677788889999999999999 9999999999999999999999999999987654322111
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCC-CCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRK-KPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......++..|+|||.+.+..++.++||||||+++++|++|. .||......+ ....... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~---~--------------- 218 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-ITVYLLQ---G--------------- 218 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhc---C---------------
Confidence 111234566799999998888999999999999999999954 5554321111 1111000 0
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
.....+..+++.+.+++.+||..+|++||++.++++.|+++.+
T Consensus 219 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 219 -RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0001122345679999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=286.55 Aligned_cols=242 Identities=21% Similarity=0.272 Sum_probs=190.5
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||+||++.. .+++.+|+|++.... ....+.+.+|..++.++ +||+|+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999975 468899999987542 23445677899988888 599999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|..++.... .+++..++.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence 99998886554 3899999999999999999999 9999999999999999999999999999987532211 1123
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccch-hhhhh-hhhhcCCCccccccccccCcccc
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM-TLKHW-VNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... ....... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~- 219 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------------P- 219 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------------C-
Confidence 35688899999999999999999999999999999999999964322111 00000 0000000 0
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
...+...+..+.+++.+||+.||++|++++
T Consensus 220 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 220 -IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 001223456688999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=287.76 Aligned_cols=261 Identities=20% Similarity=0.239 Sum_probs=193.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
||++++.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++......++|+|++.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 6899999999999999999754 5788999975432 22458999999999999999999999999999999995
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+ +|.+++......++...++.++.||+.||.||| ++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 141 ~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~ 213 (357)
T PHA03209 141 S-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AF 213 (357)
T ss_pred C-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---cc
Confidence 4 888888766666899999999999999999999 9999999999999999999999999999987533211 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCC-cccccc-ch-------hhhhhhhhhc--CCCcc---
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPT-DEIFNG-EM-------TLKHWVNDWL--PISTK--- 225 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~-~~~~~~-~~-------~~~~~~~~~~--~~~~~--- 225 (285)
....++..|+|||.+.+..++.++||||||+++|+|+++..|+ ...... .. .......... +....
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 2345788999999999989999999999999999999866554 322111 00 0001111000 00000
Q ss_pred --c----ccc---ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 --E----IVD---PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 --~----~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. +.. .................+.++.++|.+||+.||.+|||++|+|.+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 000 000000000111122446677889999999999999999999875
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=289.38 Aligned_cols=263 Identities=21% Similarity=0.208 Sum_probs=195.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccC------Cce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE------EFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 71 (285)
+|++.+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 478899999999999999975 468899999986432 33445677899999999999999999987543 357
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++|||++++ +|...+.. .++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....
T Consensus 105 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 105 YIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 899999965 77777643 2778889999999999999999 9999999999999999999999999999997654
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc-------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST------- 224 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 224 (285)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+...... .............
T Consensus 178 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred CCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhhh
Confidence 321 12334678899999999999999999999999999999999999976432211 1111110000000
Q ss_pred -------------cccccccccCc--ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 -------------KEIVDPNLLSR--EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 -------------~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........... ...........+.++.+++.+||+.||.+|||++++|++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 000001111234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=287.87 Aligned_cols=261 Identities=23% Similarity=0.275 Sum_probs=194.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccC------Cce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNE------EFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 71 (285)
+|++.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|+++++.++|+||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 488999999999999999974 5688999999865432 2334567899999999999999999987533 356
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+++++++ +++|.+++... .++...++.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++....
T Consensus 96 ~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 96 YLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 8999988 67998887543 3899999999999999999999 9999999999999999999999999999998654
Q ss_pred cccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.. .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+. ............. .....
T Consensus 170 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~-~~~~~ 242 (343)
T cd07878 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-LKRIMEVVGTPSP-EVLKK 242 (343)
T ss_pred CC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCCH-HHHHh
Confidence 32 123457889999998876 4689999999999999999999999965322111 1111111100000 00000
Q ss_pred -----------cccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 -----------NLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 -----------~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+ ......++.+.+++.+||..||.+|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0012345668899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=284.00 Aligned_cols=258 Identities=29% Similarity=0.430 Sum_probs=202.5
Q ss_pred CCCCCceecccCceEEEEEEeC--------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG--------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEF 70 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~--------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 70 (285)
.|++++.||+|+||.||++... ++..+++|.+.... ....+.+.+|+++++++ +|+||+++++.+.....
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 3788999999999999999631 12368999876433 33456788999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 039392 71 KALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~ 135 (285)
.++++|++++++|.+++.+.. ..++...+..++.|++.||+||| ++|++|+||+|+||+++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcC
Confidence 999999999999999986432 23677888999999999999999 999999999999999999
Q ss_pred CCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhh
Q 039392 136 NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 136 ~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 214 (285)
++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......+. ...
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~ 248 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-FKL 248 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-HHH
Confidence 99999999999976644321211222334567999999999899999999999999999998 8888865322111 111
Q ss_pred hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 215 WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
. .... ....+..++.++.+++.+||+.+|.+|||+.++++.|+++...
T Consensus 249 ~----~~~~---------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 249 L----KEGH---------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred H----HcCC---------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 0 0000 0001224456799999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=277.50 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=197.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.++||+|++|.||+|.. .+++.+++|.+.... ......+.+|++++.+++|||++++++.+...+..++++|++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 478899999999999999974 578899999986543 334466889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++++|..+. .++...+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---- 149 (279)
T cd06619 82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---- 149 (279)
T ss_pred CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence 999886542 2678888999999999999999 9999999999999999999999999999987654321
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhh--hhhhhhhcCCCccccccccccCcc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL--KHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ............ .
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~------ 218 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----P------ 218 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----C------
Confidence 223467889999999998899999999999999999999999986533221110 000000000000 0
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......++++.+++.+||+.+|.+||++++++++
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 ---VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00012245668999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=273.04 Aligned_cols=248 Identities=29% Similarity=0.425 Sum_probs=196.1
Q ss_pred ceecccCceEEEEEEeC----CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARLG----DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.+++.+.|+|++++++++.. +..++++|++.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 57999999999999632 236899999875543 344678889999999999999999998764 467899999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce-e
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI-Q 159 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~-~ 159 (285)
++|.+++.... .+++..++.++.|++.++.+|| ..+++|+||+|+||+++.++.++|+|||++........... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997655 4889999999999999999999 99999999999999999999999999999886643321111 1
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||...+..++.++|+||||++++++++ |..||......+. .........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~--~~~~~~~~~----------------- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV--IAMLESGER----------------- 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHHcCCc-----------------
Confidence 11223456999999988899999999999999999998 9999876433211 111110000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
...+..++..+.+++.+||..+|.+|||+.++++.|+++
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011233556799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=275.96 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=200.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch---------hHHHHHHHHHHHHccCCCCccccccceeccCCc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG---------RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF 70 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 70 (285)
.|.+...||+|++|.||+|.. .+++.+++|.+..... ...+.+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478999999999999999975 4688999998864321 233567889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceec
Q 039392 71 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~ 150 (285)
.++++|++++++|.+++.... .++...+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997654 4888899999999999999999 999999999999999999999999999998766
Q ss_pred Cccccc----ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 151 TREDIS----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 151 ~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
...... .......++..|+|||.+.+..++.++|+||+|+++++|++|..||........... ... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~---~----- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-IGE---N----- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH-Hhc---c-----
Confidence 532111 111223467789999999888899999999999999999999999976432211111 000 0
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ....+...+.++.+++++||+.+|.+||++.+++++
T Consensus 228 -----~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 -----A------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----C------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 000122356678999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=278.12 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=199.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
.|+..+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|+++++.++|++++++.+.+...+..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 478899999999999999975 468899999986542 2223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
++++++|.+++... ...++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999998887543 235899999999999999999999 9999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......++..|+|||.+.+..++.++|+||||++++++++|..||......... ............
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-~~~~~~~~~~~~----------- 222 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-EEVDRRVLETEE----------- 222 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhhhcccc-----------
Confidence 112346788999999998888999999999999999999999999754322111 111110000000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
......+.++.+++.+||..||++||+ +++++.+
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 -----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 012234566889999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=277.48 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=201.4
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||.||+|+.. +.+.+++|.+...... ..+.+.+|++++++++|+|++++++++......++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence 4788999999999999999743 3567899988654443 55778899999999999999999999999899999
Q ss_pred EEeccCCCCHHHhhhcCC--------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeec
Q 039392 74 VLEYMPHGSLEKYLHSSN--------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 145 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~ 145 (285)
+||++++++|.+++.... ..++...+..++.|++.+|.||| +.+++|+||+|+||+++.++.++++|||
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999986544 14889999999999999999999 9999999999999999999999999999
Q ss_pred cceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCc
Q 039392 146 IAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIST 224 (285)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
++....... ........++..|++||.+.+...+.++|+||||++++++++ |..||........ .......
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-~~~~~~~------ 234 (275)
T cd05046 163 LSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-LNRLQAG------ 234 (275)
T ss_pred cccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-HHHHHcC------
Confidence 986543221 111223345667999999888889999999999999999998 7788854322211 1110000
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
...+.....++..+.+++.+||..+|.+|||+.++++.|.
T Consensus 235 ------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 ------------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0001112345667999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=283.45 Aligned_cols=269 Identities=19% Similarity=0.255 Sum_probs=196.8
Q ss_pred CCCceeccc--CceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 3 SENNLIGRG--GFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 3 ~~~~~lg~G--~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+++++||+| +|++||++.. .+|+.||+|.+.... ......+.+|+++++.++||||+++++++..++..++|+|+
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 7889999964 578999999987542 33445677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+++++|.+++... ...++...++.++.|++.||.||| +++++|+||||+||+++.++.+++.||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999998653 234889999999999999999999 999999999999999999999999999865433221110
Q ss_pred -----ceeccccccccccCCcccCC--CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCC------C
Q 039392 157 -----TIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI------S 223 (285)
Q Consensus 157 -----~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------~ 223 (285)
.......++..|+|||.+.+ ..++.++||||||+++++|++|..||.................... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 01122345667999999875 4689999999999999999999999975433222111111000000 0
Q ss_pred cccc------------c-cccc------cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 TKEI------------V-DPNL------LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 ~~~~------------~-~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+. . .... ..............++++.+++.+||+.||.+|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 0 0000 000000011123456789999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=274.40 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=202.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
.|+..+.||.|++|.||+|.+. +++.+++|++.... ......+.+|+.+++.+.|+|++++++.+..+...++|||++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3778899999999999999754 68899999987543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++++|.+++... .++...+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||++........ .
T Consensus 85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06640 85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence 999999988653 3788889999999999999999 99999999999999999999999999999976544221 1
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||........... . ....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~------------~~~~------ 217 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL--I------------PKNN------ 217 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh--h------------hcCC------
Confidence 1233567789999999888899999999999999999999999865322111100 0 0000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......++..+.+++.+||+.+|++||++++++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 001123456779999999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=288.32 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=203.0
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeec--cchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNL--QYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|+++++||+|+.+.||++...+.+-+|+|.+.. ...+...-+.+|+.+|.+|+ |.+|++++++-..++.+|+|||+-
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 789999999999999999987778888876543 33566678999999999996 999999999999999999999998
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+- +|..++++.....+...+..+..||++|+.++| ++||||.||||.|+++ -.|.+||+|||.|.....+.....
T Consensus 443 d~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 443 DI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred cc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechhcccCcccccee
Confidence 44 999999887665665688889999999999999 9999999999999998 567999999999999988887777
Q ss_pred eccccccccccCCcccCCC-----------ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 159 QTQTLATIGYMAPEYGKEG-----------RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~-----------~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
...-.||+.|++||.+... ..++++|||||||++|+|+.|+.||....+....+......-+. +
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~-----I 592 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE-----I 592 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc-----c
Confidence 7888999999999965422 26899999999999999999999997644322222111110011 1
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+.. .-..++.++++.||..||++|||+.++|++
T Consensus 593 efp~~------------~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 593 EFPDI------------PENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cccCC------------CCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11100 112228899999999999999999999864
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=274.69 Aligned_cols=256 Identities=26% Similarity=0.330 Sum_probs=204.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||.|++|+||+|.. .++..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++++|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 689999999999999999974 468899999986543 335577889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 79 PHGSLEKYLHSSN--YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 79 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++|.+++.... ..+++..+..++.|++.|+.+|| +.|++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999999986542 34889999999999999999999 999999999999999999999999999998766543222
Q ss_pred c--eeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 157 T--IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 157 ~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
. ......++..|++||.+... .++.++|+||||+++++|++|+.||......+........... ..
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~ 227 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP-----------SL 227 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC-----------Cc
Confidence 1 12334577889999988777 7899999999999999999999999765433221111111000 00
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
... ......++++.+++.+||..||++|||+++++++
T Consensus 228 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETG----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCc----cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 0023456778999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=287.31 Aligned_cols=237 Identities=26% Similarity=0.325 Sum_probs=187.3
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHH-HHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVEC-EMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||+||++.. .+|+.+|+|++.... ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4799999999999974 478999999986542 22223444444 357788999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|...+.... .+++..++.++.||+.||.||| +.|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence 99988886554 4899999999999999999999 9999999999999999999999999999986532211 1123
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||......+. ...... .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~~~~----~~----------------~ 213 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-YDNILH----KP----------------L 213 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-HHHHHc----CC----------------c
Confidence 44688899999999999999999999999999999999999975332211 111110 00 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
......+..+.+++++||..+|.+||+++
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 01123456688999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=272.32 Aligned_cols=250 Identities=32% Similarity=0.568 Sum_probs=201.0
Q ss_pred CCCCceecccCceEEEEEEeCC-----CcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLGD-----GMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~-----~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+++.+.||.|+||.||++.... +..+++|.+...... ....+..|++.++.++|+|++++++.+...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678999999999999997543 488999998755433 5677889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 76 EYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
|++++++|.+++...... ++...+..++.|++.++++|| +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998765544 899999999999999999999 9999999999999999999999999999998765442
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.... ....++..|++||.+.+..++.++|+||+|+++++|++ |..||........ ........ .
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~-~~~~~~~~-~------------ 222 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV-LEYLKKGY-R------------ 222 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhcCC-C------------
Confidence 2111 12235678999999988889999999999999999998 7788765222111 11100000 0
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
.......+.++.+++.+||..+|++|||+.++++.|
T Consensus 223 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 001122567799999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=282.74 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=208.2
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|...+.||+|.|..|-+|+ .-+|+.||||++....- .....+..|+..++.++||||++++++......+|+|+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 7788999999999999996 34899999999976542 33356778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
.+|+|.++|.++...+.+..+.+++.||+.|+.|+| +..+||||+||+|+.+. +-|-||+.|||+...+.+..
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--- 173 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--- 173 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence 999999999998888999999999999999999999 99999999999999874 78999999999998877643
Q ss_pred eeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+|+.-|.|||++.+..| .++.||||||+++|-+.+|+.||+.....+ .+...+ ++..
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-TLTmIm------------DCKY---- 236 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-TLTMIM------------DCKY---- 236 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-hhhhhh------------cccc----
Confidence 2355678888999999999876 578899999999999999999998643222 222111 2111
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+.-++.++++||.+||..||++|.|.+||...
T Consensus 237 ----tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 ----TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1245567889999999999999999999998753
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=286.76 Aligned_cols=254 Identities=20% Similarity=0.243 Sum_probs=198.9
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|..++..++|++|+++++.+......++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5889999999999999999754 57889999986422 2233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.+....+++..+..++.||+.|+.||| +++++||||||+||+++.++.++|+|||++....... .
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~ 157 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-T 157 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-c
Confidence 99999999999876556899999999999999999999 9999999999999999999999999999987653322 1
Q ss_pred ceeccccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.......+++.|+|||++. ...++.++|+||||+++|+|++|+.||......+.... ........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~-i~~~~~~~--------- 227 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-IMNHKERF--------- 227 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH-HhCCCccc---------
Confidence 1122346889999999876 34578999999999999999999999975432221111 10000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCC--CCCHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~~ 274 (285)
..+ .....++.++.+++++||..++.+ |+++++++++
T Consensus 228 ~~p------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFP------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCC------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 001345777999999999765555 6899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=272.95 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=196.9
Q ss_pred CCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCC
Q 039392 4 ENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGS 82 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 82 (285)
....||+|+||.||+|.. .++..+++|.+........+.+.+|+++++.++|+||+++++++..++..++++|++++++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 446899999999999974 4678899999877666666788899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCcc--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeeccceecCccccccee
Q 039392 83 LEKYLHSSNYIL--DIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 83 L~~~~~~~~~~~--~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
|.+++......+ +...+..++.|++.|++||| +.|++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~ 166 (268)
T cd06624 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CT 166 (268)
T ss_pred HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cc
Confidence 999987654334 78888899999999999999 999999999999999975 77999999999876543211 11
Q ss_pred ccccccccccCCcccCCC--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 160 TQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
....++..|+|||.+.+. .++.++|+||+|++++++++|..||............. ....
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~--~~~~---------------- 228 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV--GMFK---------------- 228 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh--hhhc----------------
Confidence 223467889999987654 37899999999999999999999986532211111100 0000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+..+++++.+++.+||..+|++|||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0001123456779999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=274.59 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=203.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||.|++|.||++... +++.+++|.+.... ......+.+|+++++.++||||+++++.+...+.+++++|++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5788999999999999999764 68899999987654 344567888999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++......+++..+..++.|++.++++|| + .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 989999999876556899999999999999999999 8 9999999999999999999999999999865533211
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
....++..|+|||.+.+..++.++|+||||++++++++|..||......................
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 221 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------------- 221 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------------
Confidence 11556778999999988899999999999999999999999986543211111111111100000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
... .....+.++.++|.+||..+|++|||+.+++.+
T Consensus 222 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRL-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCC-ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000 011256779999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=277.78 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=199.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
.|++.+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++++++|++++++.+.+...+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 378899999999999999974 468999999886532 2223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
++++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999998885432 34888999999999999999999 9999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......... ...........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~~------------ 221 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEVQ------------ 221 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhhh------------
Confidence 112346788999999999889999999999999999999999999753321110 00000000000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
......+++++.+++.+||+.||.+||| +++++++
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 ----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0012234667899999999999999999 8898874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=271.92 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=202.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-----hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-----GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
.|+..+.||+|++|.||+|... +++.+++|.+.... ......+.+|+++++.++|+|++++++.+.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4889999999999999999865 78999999986543 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
+|++++++|.+++.+.. .++...++.++.|++.++++|| +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999987654 3888999999999999999999 9999999999999999999999999999987764432
Q ss_pred ccceeccccccccccCCcccCCCc-cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
......++..|++||.+.... ++.++|+||||++++++++|..||........... ... ... .
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~-~~~--~--------- 220 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGR-SKE--L--------- 220 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHh-ccc--C---------
Confidence 123345778899999887766 89999999999999999999999876432111111 000 000 0
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ..+..++..+.+++.+||..+|.+||++++++.+
T Consensus 221 ~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 P------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred C------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0 0122345678899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=272.03 Aligned_cols=239 Identities=21% Similarity=0.364 Sum_probs=188.7
Q ss_pred ceecccCceEEEEEEeCC-------------CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceE
Q 039392 6 NLIGRGGFGSVFKARLGD-------------GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~-------------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 72 (285)
+.||+|+||.||+|...+ ...+++|++..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999996421 2358899887665555667888999999999999999999999888899
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc-------EEEeeec
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV-------AHLSDFG 145 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~-------~~i~df~ 145 (285)
++||++++++|..++......++...++.++.|++.|+.||| +.+++|+||+|+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999888766556899999999999999999999 999999999999999986664 8999999
Q ss_pred cceecCcccccceeccccccccccCCcccC-CCccCcchhhHHHHHHHHHHh-hCCCCCccccccchhhhhhhhhhcCCC
Q 039392 146 IAKLLTREDISTIQTQTLATIGYMAPEYGK-EGRVSANGDVYSFGIMLIETF-TRKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
++...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+. ..... ..
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~----~~ 225 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFYE----GQ 225 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHHh----cC
Confidence 88654321 2234567799999876 457899999999999999998 57787754221111 00000 00
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
. ......+.++.+++.+||+.||.+||++++++..+
T Consensus 226 ~----------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 C----------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c----------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 00112245688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=275.90 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=198.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|++|.||++... +++.+|+|.+... .......+.+|++++++++|+||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4889999999999999999864 7899999988654 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcC--CCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 79 PHGSLEKYLHSS--NYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 79 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
++++|..++... ...+++..+..++.|++.|+.||| . .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999888664 224899999999999999999999 5 59999999999999999999999999998765322
Q ss_pred cceeccccccccccCCcccCCC------ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 156 STIQTQTLATIGYMAPEYGKEG------RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
......++..|+|||.+.+. .++.++|+||||+++++|++|..||........ ...........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~------- 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQLSAIVDGD------- 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHHHHHHhhcC-------
Confidence 11233467789999987544 358899999999999999999999865322111 11100000000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+..++.++.+++.+||+.+|++||++++++.+
T Consensus 227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 ---------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 000122356778999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=279.23 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=201.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCc----EEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGM----EVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~----~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|+..+.||+|+||.||+|.+ .++. .+++|.+..... .....+.+|+.+++.++||||+++++.+... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 367788999999999999974 3444 578888765433 3334678899999999999999999988754 45689
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
++++++++|.+++......++...++.++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++.......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 9999999999998776556889999999999999999999 9999999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.........++..|++||.+.+..++.++||||||+++|++++ |..||.+..... ..........
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~------------ 229 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEKGER------------ 229 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHCCCC------------
Confidence 2222223345668999999988899999999999999999997 889986532211 1111110000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
+..+..++..+.+++.+|+..+|.+||+++++++.|.++.++
T Consensus 230 ------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 ------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001122455688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=271.34 Aligned_cols=248 Identities=24% Similarity=0.407 Sum_probs=201.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|+..+.||+|++|.||++.. .+++.+++|.+.... ......+.+|+++++.++|+|++++++.+...+..++|+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 589999999999999999974 478899999986542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CcEEEeeeccceecCcccc
Q 039392 78 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 78 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~i~df~~~~~~~~~~~ 155 (285)
+++++|.+++... ...+++..+..++.|++.++++|| ++|++|+||+|+||+++.+ +.++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999998764 334888999999999999999999 9999999999999999854 5689999999987654321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.....++..|+|||.+.+..++.++|+||||+++++|++|+.||................ .
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-----~----------- 218 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-----F----------- 218 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC-----C-----------
Confidence 123456778999999988889999999999999999999999986543322211110000 0
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+...+.++.+++.+||..+|.+|||+++++++
T Consensus 219 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 ----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00122356679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=293.50 Aligned_cols=244 Identities=26% Similarity=0.394 Sum_probs=209.9
Q ss_pred eecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCHHH
Q 039392 7 LIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEK 85 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 85 (285)
+||+|.+|+||.|++. +...+|||-++.......+.+.+|+.+.++++|.||++++|.+.+++.+-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999864 566789999988877788899999999999999999999999999999989999999999999
Q ss_pred hhhcCCCcc--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeeeccceecCcccccceeccc
Q 039392 86 YLHSSNYIL--DIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQT 162 (285)
Q Consensus 86 ~~~~~~~~~--~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df~~~~~~~~~~~~~~~~~~ 162 (285)
+++..=+++ ++.++--+.+||++||.||| +..|||||||-+|++|+ -.|.+||+|||-+..+..- +......
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence 998765555 78888889999999999999 99999999999999996 7899999999998776532 3334566
Q ss_pred cccccccCCcccCCC--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 163 LATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 163 ~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
.||..|+|||++..+ .|..++|||||||.+.||.||++||....+++..+-..... ....
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy------------------KvHP 798 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY------------------KVHP 798 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce------------------ecCC
Confidence 799999999999866 59999999999999999999999998877766654432221 1122
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
+.+...+.++..+|.+|+.++|.+|||++++|.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 236677888999999999999999999999985
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=284.52 Aligned_cols=237 Identities=25% Similarity=0.302 Sum_probs=186.2
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHH-HHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVEC-EMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||+|.. .+++.+|+|++.... ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999975 468899999986532 12223344444 467889999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|...+.... .+++..+..++.||+.||.||| +.|++|+||||+||+++.+|.++|+|||++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 99988876544 3888889999999999999999 9999999999999999999999999999987532211 1123
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ..... ... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~----~~~----------------~ 213 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDNIL----HKP----------------L 213 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HHHHh----cCC----------------C
Confidence 34578899999999888899999999999999999999999965322111 11110 000 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
..+...+.++.+++.+||+.+|.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01223456688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=273.91 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=202.6
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
||++.+.||.|+||.||++... +++.+++|++.... ....+.+.+|++++++++||||+++++.+..+...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 6999999999999999999754 68999999987543 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++.+++|.+++... ..++...+..++.|++++|.+|| +.+++|+||+|.||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998766 35889999999999999999999 9999999999999999999999999999988765432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..........
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~-------------- 217 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR--DQIRAKQETA-------------- 217 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH--HHHHHHhccc--------------
Confidence 12334567789999999888899999999999999999999999876543211 1110000000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCH--HHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINA--KEIVT 273 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~eil~ 273 (285)
....+...+..+.+++.+||..||.+||++ ++++.
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 218 --DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred --cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 000122345778999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=286.33 Aligned_cols=254 Identities=19% Similarity=0.241 Sum_probs=198.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|.+.+.||+|+||.||+++. .+++.+|+|++.... ......+.+|..++..++|++|+++++.+...+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 589999999999999999975 468889999986432 2233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 157 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT- 157 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence 99999999999875556899999999999999999999 99999999999999999999999999999976654321
Q ss_pred ceeccccccccccCCcccCC-----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+.. ...........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-~~i~~~~~~~~-------- 228 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-GKIMNHEERFQ-------- 228 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH-HHHHcCCCccc--------
Confidence 11223468899999998765 45788999999999999999999999753322111 11100000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCC--CCCHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~~ 274 (285)
.+. ....++.++.+++.+||...+++ |+++++++++
T Consensus 229 -~p~------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 -FPS------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -CCC------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 01234667999999999876655 4688888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=277.03 Aligned_cols=244 Identities=23% Similarity=0.282 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|++|.||++... +++.+++|++.... ......+.+|++++++++||||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 6899999999999999999754 68999999986432 2344668889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++.... .++...+..++.|++.||.+|| +.|++|+||+|.||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999987664 4899999999999999999999 999999999999999999999999999998766543
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+++.|++||.+.+...+.++|+||||+++++|++|..||........ .........
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~---------------- 215 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-YEKILEGKV---------------- 215 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCc----------------
Confidence 2234578889999999888889999999999999999999999875432111 111110000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
..+...+..+.+++.+||..||.+|+ ++++++.+
T Consensus 216 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 ----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 01122356688999999999999999 78888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=277.93 Aligned_cols=268 Identities=21% Similarity=0.280 Sum_probs=197.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|++|.||+|... +++.|++|.+..... .....+.+|+++++.++|+||+++++++......++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 5889999999999999999754 689999999865432 22244668999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
.+ +|.+++......++...++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 86 ~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~ 159 (291)
T cd07844 86 DT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KT 159 (291)
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--cc
Confidence 75 899988766556889999999999999999999 9999999999999999999999999999987543221 11
Q ss_pred eccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc--------
Q 039392 159 QTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD-------- 229 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (285)
.....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...........................
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122345778999998765 45889999999999999999999999654322222111111111000000000
Q ss_pred ccccCc-ccchh-hhhhHhH--HHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSR-EDIHF-VAKEQCV--SFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~-~~~~~-~~~~~~~--~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...... ..... ....... .++.+++.+||+.+|.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 00000 0001122 668899999999999999999998863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=272.92 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=195.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-----hhHHHHHHHHHHHHccCCCCccccccceecc--CCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-----GRVFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 72 (285)
||++.+.||+|++|.||+|.. .++..+++|.+.... ......+.+|+.+++.++||||+++++.+.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 689999999999999999975 468899999876432 2334568889999999999999999998765 46788
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+++|++++++|.+++..... ++...++.++.|++.|+++|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 99999999999999876543 788889999999999999999 99999999999999999999999999999876543
Q ss_pred ccc-cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 153 EDI-STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 153 ~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
... ........++..|+|||.+.+..++.++|+||+|++++++++|..||............ .. ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~-~~---~~--------- 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-AT---QP--------- 225 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH-hc---CC---------
Confidence 111 11112234678899999998888999999999999999999999998754222111110 00 00
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+...+..+.+++ +||..+|++|||+++++++
T Consensus 226 ------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 ------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00011223456677888 6777899999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=275.89 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=199.1
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|+..+.||+|++|.||+|.. .+++.+|+|.+.... ....+.+.+|+++++.++|+||+++++.+......++|+|+++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 56678899999999999974 468899999987443 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++... .++...+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++........ ..
T Consensus 86 ~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06642 86 GGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hh
Confidence 99999988643 3888999999999999999999 99999999999999999999999999999876543221 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....++..|+|||.+.+..++.++|+||||+++++|++|..|+........... . ... ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~---~~~---------~~~----- 219 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL--I---PKN---------SPP----- 219 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh--h---hcC---------CCC-----
Confidence 223567789999999888899999999999999999999999865332211100 0 000 000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....++.++.+++.+||..+|.+|||+.+++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 -TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0112345668899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=273.10 Aligned_cols=248 Identities=29% Similarity=0.483 Sum_probs=193.9
Q ss_pred ceecccCceEEEEEEeC-CCc--EEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARLG-DGM--EVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~-~~~--~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||+|... ++. .+++|.+.... ....+.+.+|++++.++ +||||+++++.+...+..+++||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999753 343 46888876432 34456788899999999 799999999999999999999999999
Q ss_pred CCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeec
Q 039392 81 GSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 145 (285)
Q Consensus 81 ~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~ 145 (285)
++|.+++.... ..++...++.++.|++.|++||| +.|++|+||+|+||+++.++.++++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 23778899999999999999999 9999999999999999999999999999
Q ss_pred cceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCc
Q 039392 146 IAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIST 224 (285)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
++...... ........+..|+|||.+....++.++|+||||+++++|++ |..||......+. .... ....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~----~~~~- 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKL----PQGY- 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-HHHH----hCCC-
Confidence 98532211 11111223556999999988889999999999999999997 9999865322211 1100 0000
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
....+..++.++.+++.+|+..+|.+|||+.+++..|.++.
T Consensus 229 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 --------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00011234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=274.92 Aligned_cols=249 Identities=29% Similarity=0.495 Sum_probs=196.0
Q ss_pred ceecccCceEEEEEEeCC-------CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 6 NLIGRGGFGSVFKARLGD-------GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~-------~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+.||+|++|.||+|...+ ++.+++|.+.... ......+.+|+++++.++||||+++++++......+++||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999996432 3578999875443 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcC------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-----cEEEeeecc
Q 039392 78 MPHGSLEKYLHSS------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-----VAHLSDFGI 146 (285)
Q Consensus 78 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-----~~~i~df~~ 146 (285)
+++++|.+++... ...++...+..++.|++.|+.||| +.+++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999988642 223778889999999999999999 99999999999999999877 899999999
Q ss_pred ceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 147 AKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
+.................+..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~--~~~--~---- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH--VTA--G---- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH--Hhc--C----
Confidence 876543322222223345677999999998899999999999999999998 9999865432221110 000 0
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
..+.....++..+.+++.+||..+|++||+++++++.|++
T Consensus 230 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 ------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0011123456778999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=271.82 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=201.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
.|++.+.||+|+||.+|.+.. .+++.+++|.+.... ......+.+|+.+++.++|+|++++.+.+...+..++++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 489999999999999999974 468899999986432 33446788899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+.+++|.+.+.... ..++...++.++.|++.|+.+|| +++++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999886542 34788999999999999999999 99999999999999999999999999999976644221
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......++..|+|||...+...+.++|+||||++++++++|..||......+.... ......
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~-~~~~~~---------------- 218 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK-IIRGSY---------------- 218 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH-HhcCCC----------------
Confidence 11233467789999999888899999999999999999999999865322111111 100000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00122346679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=272.80 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=201.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc------hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY------GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|+..+.||+|++|.||++.. .+++.+++|++.... ......+.+|+..+++++|+|++++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 699999999999999999974 578999999986433 2245678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-cEEEeeeccceecCc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTR 152 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~i~df~~~~~~~~ 152 (285)
|+|++++++|.+++.+.. .+++..++.++.|++.||.+|| ++|++|+||+|.||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999987654 4888999999999999999999 99999999999999998765 699999999876654
Q ss_pred cccc--ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 153 EDIS--TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 153 ~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.... .......++..|+|||.+.+..++.++|+||+|++++++++|..||........... ... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~-~~~~~------- 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFK-IASAT------- 227 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHH-HhccC-------
Confidence 3111 111234567789999999888899999999999999999999999864322111110 000 00000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+...++++.+++.+||..+|.+|||+.+++.+
T Consensus 228 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 -------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0001123456779999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=271.53 Aligned_cols=245 Identities=28% Similarity=0.485 Sum_probs=196.8
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||.||++.. +++.+++|.+.... ....+.+|+.+++.++|||++++++.+... ..+++||++.+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 478899999999999999875 67889999986542 235678899999999999999999998665 47899999999
Q ss_pred CCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++.... ..++...++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~ 154 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----V 154 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----C
Confidence 99999986543 34788899999999999999999 999999999999999999999999999998754321 1
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
.....+..|+|||.+.+..++.++|+||||+++++|++ |..||......+... ... .. .
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~--~~~---~~---------------~ 214 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE--CVE---KG---------------Y 214 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH--HHh---CC---------------C
Confidence 22234567999999988889999999999999999998 899986543221111 000 00 0
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
.......++.++.+++.+||+.+|.+||+++++++.|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 000123456778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=275.06 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=200.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|++|.||+|... +++.+++|.+.... ....+.+.+|+++++.++|+|++++++.+......++++|+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5889999999999999999764 68999999886432 22335577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++.|..++.... .+++..++.++.|++.+|.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 82 CDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred cCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 99887777665443 4899999999999999999999 99999999999999999999999999999987654321
Q ss_pred eeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhh--hhhhhcCC-----Ccccccc
Q 039392 158 IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKH--WVNDWLPI-----STKEIVD 229 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~ 229 (285)
......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.+....+..... ........ +......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1123346778999998765 45789999999999999999999999764433221110 00000000 0000000
Q ss_pred ccccCc----ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSR----EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...... .+.. ......+..+.+++.+||..+|++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000 0000 0112446789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=276.39 Aligned_cols=249 Identities=27% Similarity=0.329 Sum_probs=202.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.|.+.+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+|+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 478899999999999999974 4688999999876555555678889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++.+.. ++...+..++.|++.|+.+|| ++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 100 ~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (293)
T cd06647 100 GGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (293)
T ss_pred CCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence 999999986543 788889999999999999999 99999999999999999999999999998876543221 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+++.|++||.+....++.++|+||||++++++++|..||.............. .....
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~------------------~~~~~ 234 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------------NGTPE 234 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc------------------CCCCC
Confidence 234577789999999888899999999999999999999999965322111000000 00000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+......+..+.+++++||..+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123456678999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=275.94 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=201.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchh-----HHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGR-----VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|++|.||+|.. .+++.|++|.+...... ....+.+|+++++.++|+|++++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999975 46899999998754322 335567899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
||++ +++|.+++......++...++.++.||+.||.+|| ++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999999766545899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc--------
Q 039392 155 ISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK-------- 225 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 225 (285)
. ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||....... ...............
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccc
Confidence 1 1122345678999998754 457899999999999999999977776533221 111111111000000
Q ss_pred -ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 -EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
............. .......+.++.+++.+||..+|++|||+++++.+
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 00112346779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=273.47 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=199.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch----------hHHHHHHHHHHHHccCCCCccccccceeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG----------RVFKSFDVECEMMKSIHHRNIIKVISSCSNEE 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 69 (285)
.|.+.+.||+|++|.||+|.. .+++.+++|.+..... ...+.+.+|+++++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478899999999999999974 4688999998753211 12346778999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 70 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
..++|+|++++++|.+++.... .++...+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999987764 4888999999999999999999 99999999999999999999999999999876
Q ss_pred cCcccccceeccccccccccCCcccCCCc--cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGR--VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
..............++..|+|||.+.... ++.++|+||||++++++++|..||............ .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~-~~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL----GNKR-SAPP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh----hccc-cCCc
Confidence 54322111122345678899999887654 889999999999999999999998643222111110 0000 0000
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ......++.++.+++.+||..+|++|||+++++++
T Consensus 233 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IP----------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CC----------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 00122456779999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=272.81 Aligned_cols=238 Identities=22% Similarity=0.342 Sum_probs=187.4
Q ss_pred eecccCceEEEEEEeC-------------------------CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccc
Q 039392 7 LIGRGGFGSVFKARLG-------------------------DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~~-------------------------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 61 (285)
.||+|+||.||+|... ....|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998631 124588998876655555678889999999999999999
Q ss_pred cceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----
Q 039392 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM---- 137 (285)
Q Consensus 62 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~---- 137 (285)
++++......++||||+++++|..++......++...+..++.|++.||+||| +.+++|+||+|.||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998765556889999999999999999999 99999999999999997643
Q ss_pred ---cEEEeeeccceecCcccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHh-hCCCCCccccccchhh
Q 039392 138 ---VAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETF-TRKKPTDEIFNGEMTL 212 (285)
Q Consensus 138 ---~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll-~g~~p~~~~~~~~~~~ 212 (285)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||......+..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence 4799999987543221 12345677999998765 56899999999999999985 688888654322211
Q ss_pred hhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 213 KHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
........ .+...++.+.+++.+||+.+|++|||++++++.|
T Consensus 232 -~~~~~~~~--------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 -RFYEKKHR--------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHHHhccC--------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11000000 0111234588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=271.09 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=190.1
Q ss_pred ceecccCceEEEEEEeC---CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 6 NLIGRGGFGSVFKARLG---DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.++++++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999643 346789998765432 33356788999999999999999999999988999999999999
Q ss_pred CHHHhhhcCC----CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 82 SLEKYLHSSN----YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 82 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+|.+++.... ...+...+..++.|++.|++||| +.+++|+||||+||+++.++.++++|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 23566778889999999999999 9999999999999999999999999999986543322222
Q ss_pred eeccccccccccCCcccCCC-------ccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 158 IQTQTLATIGYMAPEYGKEG-------RVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~-------~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
......++..|+|||.+.+. .++.++|+||||+++++|++ |..||....+.+........... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----KLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----CCCC
Confidence 22234456779999987642 35789999999999999996 99999764333221111110000 0000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
+. .....++.+.+++.+|+ .+|++|||+++++..|+
T Consensus 233 ~~----------~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PR----------LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred Cc----------cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00 01234556888999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=268.75 Aligned_cols=250 Identities=30% Similarity=0.404 Sum_probs=205.9
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.|++.+.||+|++|.||++... +++.+++|.+..........+.+|++.++.++|++++++.+.+......++++|+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4889999999999999999764 688999999876655566788899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++......++...++.++.|++.++.+|| ..|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999998776456899999999999999999999 99999999999999999999999999999887655321 2
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....++..|++||.+.....+.++|+||||+++++|++|..||.............. ......
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~------------ 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-----NGPPGL------------ 217 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-----cCCCCc------------
Confidence 344577889999999888899999999999999999999999875432211111000 000000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+..+.+++.+||..||++|||+.+++++
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 -RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011135668999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=279.10 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=199.1
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|+....||+|+||.||++.. .+++.+++|.+........+.+.+|+.+++.+.|||++++++.+..++..++++|++++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44556899999999999975 46899999998765545556788899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|..++... .++...++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 175 (297)
T cd06659 103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 175 (297)
T ss_pred CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence 9999887553 3889999999999999999999 9999999999999999999999999999986543321 1112
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...++..|+|||.+.+..++.++|+||||+++++|++|..||......+. ...... .... .+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----~~~~-------------~~ 237 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRLRD----SPPP-------------KL 237 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhc----cCCC-------------Cc
Confidence 34577889999999888899999999999999999999999865322111 111100 0000 00
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+..+.+++++||+.+|++|||+++++++
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0112345668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=279.54 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=201.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch---hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|++|+||++... +++.+++|.+..... .....+.+|+++++.++|+||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5889999999999999999754 589999999875432 244568889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
++.+++|.+++... ...+++..++.++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998754 345899999999999999999999 99999999999999999999999999999865432111
Q ss_pred c---------------------------ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCcccccc
Q 039392 156 S---------------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNG 208 (285)
Q Consensus 156 ~---------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 208 (285)
. .......++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 0111235677899999998888999999999999999999999999754332
Q ss_pred chhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC----HHHHHHH
Q 039392 209 EMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN----AKEIVTK 274 (285)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~eil~~ 274 (285)
..... ..... ..+......+.++.+++.+||..+|++||| +++++.+
T Consensus 239 ~~~~~-~~~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSN-ILKKE------------------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHH-HhcCC------------------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 21111 10000 001111225677999999999999999999 8888874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=277.01 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=197.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|.+.+.||+|+||.||++... +++.|++|.+.... ......+.+|+++++.++||||+++++.+......++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6899999999999999999754 68899999987543 2334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc-
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI- 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~- 155 (285)
++++++|.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|.||+++.++.++++|||++........
T Consensus 82 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999997654 4889999999999999999999 99999999999999999999999999998763211000
Q ss_pred ------------cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC
Q 039392 156 ------------STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 156 ------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
........++..|+|||.+.+..++.++|+||||++++++++|..||.+....+. ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 236 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIEWP 236 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCC
Confidence 0011123457789999999888899999999999999999999999865322211 111111000000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
. ....++.++.+++.+||+.+|++||+..++++.++
T Consensus 237 ~-----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 237 E-----------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred C-----------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 0 01135667899999999999999998655544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=284.67 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=216.8
Q ss_pred CCceecccCceEEEEEE--eC-CCc--EEEEEEeec-cchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 4 ENNLIGRGGFGSVFKAR--LG-DGM--EVAVKVFNL-QYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~--~~-~~~--~~~iK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
..+.||.|.||.||.|. .. .|+ .||||..+. ......+.|..|+.+++.+.||||++++|++.+.. .|+|||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEEec
Confidence 45789999999999995 22 344 478888765 33455788999999999999999999999998765 6899999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++-|-|.++++.+...++..+...++.||+.+|+||| +..+|||||-..||++.+...||++|||+++...++....
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999999999988888999999999999999999999 9999999999999999999999999999999988765433
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
. +...-+.-|+|||.+.-..++.++|||.||++|||+++ |..||.+-.+.+. ...-+.
T Consensus 549 a-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------------------I~~iEn 607 (974)
T KOG4257|consen 549 A-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------------------IGHIEN 607 (974)
T ss_pred c-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------------------EEEecC
Confidence 3 34455677999999999999999999999999999998 8899987433322 123345
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
+.+++.++.||+.++.++.+||.++|.+||.+.++...|.++++
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 66777889999999999999999999999999999999998876
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=269.80 Aligned_cols=238 Identities=23% Similarity=0.409 Sum_probs=188.1
Q ss_pred ceecccCceEEEEEEeCC-C----------cEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 6 NLIGRGGFGSVFKARLGD-G----------MEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~-~----------~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+.||+|+||.||+|.... + ..+++|++...... ...+.+|+.+++.++|+||+++++.+.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 479999999999997543 3 25788877654433 5778899999999999999999999877 778899
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-------cEEEeeeccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-------VAHLSDFGIA 147 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-------~~~i~df~~~ 147 (285)
+|++++++|.+++......++...+..++.|++.||.||| ++|++|+||+|+||+++.++ .++++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999776546889999999999999999999 99999999999999999887 7999999998
Q ss_pred eecCcccccceeccccccccccCCcccCCC--ccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCc
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIST 224 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
...... ....++..|+|||.+... .++.++|+||||++++++++ |..||......+. ...+ ....
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~~-~~~~---- 223 (259)
T cd05037 156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFY-QDQH---- 223 (259)
T ss_pred cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHHH-hcCC----
Confidence 765431 223355679999998776 78999999999999999999 5777755432111 1111 0000
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
.. +......+.+++.+||..+|.+|||+.++++.|+
T Consensus 224 -------~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -------RL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------CC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0001156889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=305.40 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=194.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceecc--CCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 75 (285)
+|++++.||+|+||+||++.. .++..+++|++... .......+..|+.+++.++||||++++++|.. ...+|+||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 488999999999999999975 45778899988643 23345678889999999999999999998844 45789999
Q ss_pred eccCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCC----CCCeeecCCCCCCeeeCC-------------
Q 039392 76 EYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGY----SAQVIHCDLKPSNVLLDD------------- 135 (285)
Q Consensus 76 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~----~~~~~h~di~~~nili~~------------- 135 (285)
||+++++|.+++... ...+++..++.|+.||+.||.|||... ..+|+|+||||+|||++.
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 999999999988652 235899999999999999999999311 145999999999999964
Q ss_pred ----CCcEEEeeeccceecCcccccceeccccccccccCCcccCC--CccCcchhhHHHHHHHHHHhhCCCCCccccccc
Q 039392 136 ----NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209 (285)
Q Consensus 136 ----~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 209 (285)
.+.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred ccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 3358999999997654322 1234568999999998854 458899999999999999999999996533222
Q ss_pred hhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 210 MTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........ .. ... ....+.++.+||.+||..+|.+|||+.++|.+
T Consensus 251 qli~~lk~----~p--------~lp--------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 251 QLISELKR----GP--------DLP--------IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHhc----CC--------CCC--------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 11111100 00 000 11235678999999999999999999999853
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=275.38 Aligned_cols=268 Identities=21% Similarity=0.244 Sum_probs=197.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||+|.. .+++.+++|.+...... ....+.+|+++++.++|+||+++.+++......++|+|++
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 588999999999999999974 46889999998654322 2235678999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
. +++.+++......++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 159 (291)
T cd07870 86 H-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--T 159 (291)
T ss_pred c-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--C
Confidence 5 5777776554445778888999999999999999 99999999999999999999999999999875433211 1
Q ss_pred eccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC------------cc
Q 039392 159 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS------------TK 225 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~ 225 (285)
.....++..|+|||.+.+. .++.++|+||||+++++|++|..||+.................... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 1233467889999988754 5788999999999999999999999765433222221111000000 00
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....................+.++.+++.+|+..||.+|||+++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000111235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=276.43 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=198.7
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|.....||+|+||.||++.. .++..++||.+........+.+.+|+.+++.++|+|++++++.+...+..++++|++++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34456799999999999975 46889999998765555566788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++... .++...++.++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 176 (292)
T cd06658 104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK 176 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence 9999988543 3788999999999999999999 9999999999999999999999999999987543321 1112
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...++..|+|||...+..++.++|+||||+++++|++|..||........ ....... .... .
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~-~~~~----------------~ 238 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRIRDN-LPPR----------------V 238 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc-CCCc----------------c
Confidence 34577889999999888899999999999999999999999865322111 1111000 0000 0
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+..+.+++.+||..||.+|||+++++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0012345568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=269.70 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=205.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|++|.||++... +++.+++|.+..... .....+.+|+..+..++|+|++++++.+.....+++++|++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5889999999999999999755 599999999876544 44577889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++.... .+++..++.++.|++.++.+|| + .+++|+||+|+||+++.++.++++|||.+.........
T Consensus 82 ~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 82 DGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999999997653 4899999999999999999999 8 99999999999999999999999999998876543221
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .............
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~------------- 220 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAICDGPP------------- 220 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHHhcCCC-------------
Confidence 123456778999999988899999999999999999999999987654211 0111110000000
Q ss_pred chhhhhhH-hHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQ-CVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...... .+..+.+++.+||..+|++|||+++++++
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 --PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000112 56679999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=285.52 Aligned_cols=241 Identities=22% Similarity=0.255 Sum_probs=186.0
Q ss_pred ecccCceEEEEEEe-CCCcEEEEEEeeccch---hHHHHHHHHHHHHccC---CCCccccccceeccCCceEEEEeccCC
Q 039392 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSI---HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 8 lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
||+|+||+||+|.. .+++.||+|++..... ........|..++... .||+|+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999975 4689999999864321 2223344566666554 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++.+.. .+++..++.++.||+.||+||| ++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence 99998887654 4899999999999999999999 9999999999999999999999999999986533221 1123
Q ss_pred cccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...++..|+|||.+.+. .++.++||||||+++|+|++|..||......+.. ......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~~-----------~~----- 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-RNIAFGKVR-----------FP----- 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-HHHHcCCCC-----------CC-----
Confidence 45688899999988754 5899999999999999999999998653322111 111000000 00
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCC----CHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRI----NAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rp----s~~eil~~ 274 (285)
....+.++.+++++||..||.+|| ++++++++
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 112456688999999999999998 57777653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=268.71 Aligned_cols=252 Identities=28% Similarity=0.385 Sum_probs=202.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
.|.+.+.||+|++|.||++.. .+++.+++|++..... ...+.+.+|+++++.++|+||+++++.+...+..++++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999975 4688999999876544 3667889999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++++|.+++.... ..+...+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999987654 3788889999999999999999 9999999999999999999999999999988765432211
Q ss_pred e--eccccccccccCCcccCCCc---cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 158 I--QTQTLATIGYMAPEYGKEGR---VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 158 ~--~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
. .....++..|+|||.+.... .+.++|+||||++++++++|..||............. .. ..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~-~~--~~---------- 223 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV-GA--GH---------- 223 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH-hc--CC----------
Confidence 1 12345677899999987765 8999999999999999999999997543221111100 00 00
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
...++....++..+.+++.+||+.+|.+|||+++++.
T Consensus 224 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ----KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001112234666889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=273.53 Aligned_cols=250 Identities=29% Similarity=0.346 Sum_probs=203.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|++|.||++... +++.+++|++..... ..+.+.+|++.++.++|+|++++++.+......++++|+++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 4788899999999999999765 688999999876544 45677889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++......++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 173 (286)
T cd06614 99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KR 173 (286)
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hh
Confidence 99999999876545899999999999999999999 99999999999999999999999999998865543221 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....++..|++||.+.+..++.++|+||||+++|+|++|..||....+...... ...... ..
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~-~~~~~~-----------------~~ 235 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL-ITTKGI-----------------PP 235 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCC-----------------CC
Confidence 223467789999999888899999999999999999999999865322211111 000000 00
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......++.++.+++.+||+.+|.+|||+.+++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122356679999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=270.01 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=196.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-----hhHHHHHHHHHHHHccCCCCccccccceeccC--CceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-----GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 72 (285)
+|++.+.||+|+||.||++.. .+++.|++|.+.... ......+.+|+++++.+.|+||+++++.+... ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 689999999999999999975 468999999875321 23346788899999999999999999988653 5678
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+++|++++++|.+++.+... ++...++.++.|++.+|.+|| +.+++|+||+|.||+++.++.++|+|||.+.....
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEecCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 99999999999999876543 788889999999999999999 99999999999999999999999999999876543
Q ss_pred cccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 153 EDIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 153 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.... .......++..|+|||.+.+..++.++|+||||+++|++++|..||......... ...... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~--~---------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIATQ--P---------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-HHHhcC--C----------
Confidence 2111 1112234677899999998888999999999999999999999998653221111 110000 0
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+...+..+.+++.+|+. +|.+||++++++++
T Consensus 226 ------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 ------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0011133455668899999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=268.87 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=201.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceec--cCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCS--NEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 75 (285)
+|++.+.||.|++|.||++.. .+++.+++|.+.... ....+.+.+|+++++.++|+|++++++.+. .....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 589999999999999999964 568899999886432 344566788999999999999999999774 345688999
Q ss_pred eccCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeeCCCCcEEEeeeccceec
Q 039392 76 EYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGY--SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150 (285)
Q Consensus 76 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~~~~h~di~~~nili~~~~~~~i~df~~~~~~ 150 (285)
|++++++|.+++... ...++...++.++.|++.||.+||..+ +.+++|+||+|+||+++.++.++++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 345889999999999999999999443 678999999999999999999999999999876
Q ss_pred CcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
..... ......++..|++||.+.+..++.++|+||||+++++|++|..||........ ..... ...
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~---~~~------- 226 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL--ASKIK---EGK------- 226 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH--HHHHh---cCC-------
Confidence 54321 12234578889999999888899999999999999999999999976432211 11110 000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ..+...+..+.+++.+||+.+|.+|||+++++++
T Consensus 227 --~~------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 --FR------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CC------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0122445679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=273.15 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=194.0
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccC------CceEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNE------EFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~~ 73 (285)
|++.+.||+|+||.||+|.. .+++.+++|.+.... .....+..|+.+++++ +|+|++++.+.+... ...++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 78889999999999999975 468899999986543 3335677899999888 699999999988542 45889
Q ss_pred EEeccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 74 VLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
++|++++++|.+++... ...+++..+..++.|++.|++||| +++++|+||+|+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 99999999999988764 335889999999999999999999 99999999999999999999999999999876543
Q ss_pred ccccceeccccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
.. .......++..|+|||.+. ...++.++|+||+|+++++|++|..||............ ....
T Consensus 164 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~~~~----- 232 (272)
T cd06637 164 TV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNP----- 232 (272)
T ss_pred cc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----hcCC-----
Confidence 21 1123345778899999875 335788999999999999999999998653221111110 0000
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........++.++.+++.+||..+|.+|||+++++++
T Consensus 233 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 ----------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ----------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0000112345678999999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=272.56 Aligned_cols=247 Identities=26% Similarity=0.321 Sum_probs=199.3
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|+|++++++.+...+..++++|++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 45567999999999999974 46889999998765555556788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++.. ..++...+..++.|++.++++|| +.|++|+||+|.||+++.++.++++|||.+....... ....
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~ 173 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK 173 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence 999999876 34888999999999999999999 9999999999999999999999999999876544321 1112
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...++..|+|||.+.+..++.++|+||||+++++|++|..||......... ...... ... ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~-~~~~~~-~~~----------------~~ 235 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-KRIRDN-LPP----------------KL 235 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH-HHHHhc-CCC----------------CC
Confidence 345788899999998888999999999999999999999998653221111 111000 000 00
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
.....++..+.+++.+||..+|++|||++++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 001224567999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=272.66 Aligned_cols=239 Identities=25% Similarity=0.373 Sum_probs=189.1
Q ss_pred ceecccCceEEEEEEeC-C-------CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 6 NLIGRGGFGSVFKARLG-D-------GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~-~-------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+.||.|+||.||+|... . ..++++|.+........+.+.+|+.+++.++|||++++++.+..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 47999999999999642 2 335888887665555567788899999999999999999999998899999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc--------EEEeeecccee
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV--------AHLSDFGIAKL 149 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--------~~i~df~~~~~ 149 (285)
+++++|..++......++...++.++.|++.|++||| ++|++|+||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999776656889999999999999999999 999999999999999987664 68999998865
Q ss_pred cCcccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCC-CCCccccccchhhhhhhhhhcCCCcccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRK-KPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
.... ....++..|+|||.+.+. .++.++|+||||+++|++++|. .|+....... ... .....
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~~-~~~~~-------- 221 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KLQ-FYEDR-------- 221 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HHH-HHHcc--------
Confidence 4321 223467789999998764 5799999999999999999985 5544322111 110 00000
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
...+...+.++.+++.+||+.+|++|||++++++.|
T Consensus 222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 001122345688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=271.49 Aligned_cols=250 Identities=26% Similarity=0.325 Sum_probs=196.9
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCC------ceE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEE------FKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~ 72 (285)
+|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++++ .|+||+++++.+.... ..+
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 5899999999999999999864 678899999876543 346788999999998 6999999999986544 589
Q ss_pred EEEeccCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 73 LVLEYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
++||++++++|.+++... ...++...++.++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 999999999999987643 345889999999999999999999 99999999999999999999999999999876
Q ss_pred cCcccccceeccccccccccCCcccCC-----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST 224 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
..... .......++..|+|||.+.. ..++.++||||||+++++|++|..||........... .....
T Consensus 163 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~----- 234 (275)
T cd06608 163 LDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-IPRNP----- 234 (275)
T ss_pred cccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH-hhccC-----
Confidence 54321 11233457788999997653 3467889999999999999999999865322211111 10000
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..........+.++.+++.+||..||++|||+++++++
T Consensus 235 ------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 235 ------------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ------------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00111123356779999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=268.65 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=199.2
Q ss_pred CCCCCceecccCceEEEEEEeC--CCcEEEEEEeecc----------chhHHHHHHHHHHHHcc-CCCCccccccceecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG--DGMEVAVKVFNLQ----------YGRVFKSFDVECEMMKS-IHHRNIIKVISSCSN 67 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 67 (285)
||++.+.||+|+||.||++... +++.+++|.+... .......+..|+.++.. ++|||++++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 6999999999999999999754 3788999987532 12234556678887764 789999999999999
Q ss_pred CCceEEEEeccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEee
Q 039392 68 EEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSD 143 (285)
Q Consensus 68 ~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~d 143 (285)
.+..++++||+++++|.+++.. ....++...++.++.|++.++.+|| . .+++|+||+|.||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3345889999999999999999999 6 6899999999999999999999999
Q ss_pred eccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC
Q 039392 144 FGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 144 f~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
||.+....... ......++..|++||...+..++.++|+||||+++|++++|..||........... ......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~-~~~~~~--- 230 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK-IVEAVY--- 230 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH-HhhccC---
Confidence 99998765432 22345577889999999888899999999999999999999999865322111110 000000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
.+ ......+.++.+++.+||+.||++|||+.|+.+++.
T Consensus 231 ---------~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 ---------EP------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---------Cc------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 001134567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=269.33 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=187.7
Q ss_pred ceecccCceEEEEEEeC---CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 6 NLIGRGGFGSVFKARLG---DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+.||+|+||.||+|... ....+++|.+..... .....+.+|++.++.++|+||+++++.+......++|||+++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 46999999999999643 245688887654432 33456788999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCC----ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 82 SLEKYLHSSNY----ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 82 ~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+|.+++..... ..+...++.++.||+.|++||| +.+++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999866432 2456778899999999999999 9999999999999999999999999999986543322111
Q ss_pred eeccccccccccCCcccC-------CCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 158 IQTQTLATIGYMAPEYGK-------EGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~-------~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
......++..|+|||++. ...++.++||||||+++|+|++ |..||....+.+............. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL-----PK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC-----CC
Confidence 112334566799999764 3457889999999999999999 7788765432221111111110000 00
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
+ ......+..+.+++..|+ .||++|||++++++.|.
T Consensus 233 ~----------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 P----------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred C----------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 012234566778888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=275.95 Aligned_cols=264 Identities=20% Similarity=0.259 Sum_probs=187.1
Q ss_pred CceecccCceEEEEEEeC---CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceec--cCCceEEEEeccC
Q 039392 5 NNLIGRGGFGSVFKARLG---DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS--NEEFKALVLEYMP 79 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~ 79 (285)
+++||+|+||+||+|... ++..+|+|.+..... ...+.+|+++++.++||||+++++++. .....++++|++.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999743 457899998864422 245678999999999999999999874 4567889999996
Q ss_pred CCCHHHhhhcC--------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCcEEEeeeccc
Q 039392 80 HGSLEKYLHSS--------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIA 147 (285)
Q Consensus 80 ~~~L~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~i~df~~~ 147 (285)
+ +|.+++... ...++...++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 787776421 123788899999999999999999 9999999999999999 46689999999999
Q ss_pred eecCccccc-ceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccch--------hhhhhhh
Q 039392 148 KLLTREDIS-TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM--------TLKHWVN 217 (285)
Q Consensus 148 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~--------~~~~~~~ 217 (285)
......... .......++..|+|||.+.+. .++.++||||||+++++|++|..||........ .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 876543211 122334578889999988764 589999999999999999999999975332111 0000010
Q ss_pred hhcCCCcccc---------------ccccccCcccch-hh--hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 218 DWLPISTKEI---------------VDPNLLSREDIH-FV--AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 218 ~~~~~~~~~~---------------~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+ ............ .. .....+..+.+++.+||..||.+|||++|+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 000000000000 00 011224568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=267.02 Aligned_cols=252 Identities=28% Similarity=0.360 Sum_probs=206.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccC--CceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 75 (285)
+|.+.+.||+|++|.||+|... +++.+++|++..... ...+.+.+|++++++++|+|++++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999865 789999999876542 4567788999999999999999999999888 8899999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++.+.. .++...++.++.|++.++++|| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999987765 5899999999999999999999 99999999999999999999999999999987765432
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
........++..|++||.+.....+.++|+||||++++++++|..||.............. ..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~-------------- 219 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG---SS-------------- 219 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc---cc--------------
Confidence 1112345577889999999888899999999999999999999999876441111111000 00
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+...+..+.+++.+|+..+|.+||++.+++.+
T Consensus 220 -~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 -GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00001122336779999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=272.80 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=193.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceec-----cCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCS-----NEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~~ 73 (285)
+|++.+.||+|++|.||++.. .+++.+++|++..... ....+.+|+.+++.+ +|+|++++++.+. .+...++
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 588999999999999999975 4688999998764322 235567899999998 6999999999873 4467899
Q ss_pred EEeccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceec
Q 039392 74 VLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~ 150 (285)
+|||+++++|.+++.. ....+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999988753 2334788899999999999999999 999999999999999999999999999998765
Q ss_pred CcccccceeccccccccccCCcccCC-----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
.... .......++..|+|||.+.. ..++.++|+||+|+++++|++|..||........... ... ..
T Consensus 175 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~----~~-- 245 (286)
T cd06638 175 TSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPR----NP-- 245 (286)
T ss_pred ccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-ccc----cC--
Confidence 4321 11223457888999998753 4578999999999999999999999865432111110 000 00
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
.. ....+...+..+.+++.+||+.||++|||+++++++.
T Consensus 246 ---~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 246 ---PP--------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---CC--------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0001112345688999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=273.61 Aligned_cols=267 Identities=24% Similarity=0.334 Sum_probs=200.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+++++.++||||+++++++......++++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5889999999999999999864 689999998754332 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++++|..+..... .++...++.++.|++.++.||| +.+++|+||+|+||++++++.++++|||++....... .
T Consensus 82 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~ 155 (286)
T cd07846 82 VDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--E 155 (286)
T ss_pred CCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--c
Confidence 99988887765443 3889999999999999999999 9999999999999999999999999999987654432 1
Q ss_pred eeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCC--Cccc------cc
Q 039392 158 IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI--STKE------IV 228 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~------~~ 228 (285)
......++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+.. .......... .... ..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL-YHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH-HHHHHHhCCCchhhHHHhccchHh
Confidence 1223456788999998765 45788999999999999999999998654322111 1110000000 0000 00
Q ss_pred cccccCc---ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DPNLLSR---EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....... ..........++..+.+++.+||..+|.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000 000011123567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=267.83 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=205.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||.|++|.||++... +++.+++|.+..... .....+.+|+++++.++|+|++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999754 689999999876533 4556788899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 78 MPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 78 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
+++++|.+++.+. ...++...++.++.+++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999988764 356899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......+++.|+|||......++.++|+||+|+++++|++|..||......+...... .....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~--------- 221 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-----KGQYP--------- 221 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-----cCCCC---------
Confidence 12233467888999999888889999999999999999999999986543222111110 00000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+...+.++.+++.+||..+|++|||+++++++
T Consensus 222 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 ------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0012345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=273.26 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=201.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|++|+||++.. .+++.+++|++.... ......+.+|+++++.++||||+++++.+.....+++|+||+
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 478889999999999999975 468899999876543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++.... .++...+..++.+++.++.||| + .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 86 DCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 9999999886644 4889999999999999999999 5 689999999999999999999999999986543221
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh------hhhhhhhhcCCCcccccccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT------LKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 231 (285)
.....++..|+|||.+.+..++.++|+||||++++++++|..||......... ............
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-------- 229 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--------
Confidence 12345788899999988889999999999999999999999999754332110 000100000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
...+ ....++.++.+++.+|+..||.+|||++|++++.
T Consensus 230 -----~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -----PPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -----CCCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000 0112566789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.62 Aligned_cols=262 Identities=19% Similarity=0.237 Sum_probs=186.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC------CCccccccceeccC-CceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH------HRNIIKVISSCSNE-EFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~-~~~~ 72 (285)
+|++.+.||+|+||+||+|.. .+++.||||++.... ........|+++++.+. |.+++++.+++... ...+
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 377888999999999999975 468889999986432 22334455666666664 44588888887654 5688
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCC--------------
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNM-------------- 137 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~-------------- 137 (285)
+||+++ +++|.+++.+.+ .++...+..++.||+.||.||| . .|++||||||+||+++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 999988 668988886654 4889999999999999999999 7 5999999999999998665
Q ss_pred --cEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhh
Q 039392 138 --VAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW 215 (285)
Q Consensus 138 --~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~ 215 (285)
.+||+|||.+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+.. ...
T Consensus 284 ~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~~i 357 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL-HLM 357 (467)
T ss_pred CceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHH
Confidence 4999999987643221 23456889999999999999999999999999999999999999764432111 111
Q ss_pred hhhhcCCCc-----------cccccc------cccCccc-----chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 216 VNDWLPIST-----------KEIVDP------NLLSRED-----IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 216 ~~~~~~~~~-----------~~~~~~------~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
.......+. ...... ....... ..........+.+.+||.+||+.||++|||++|+|+
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 110000000 000000 0000000 000001112456789999999999999999999997
Q ss_pred H
Q 039392 274 K 274 (285)
Q Consensus 274 ~ 274 (285)
+
T Consensus 438 H 438 (467)
T PTZ00284 438 H 438 (467)
T ss_pred C
Confidence 4
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=269.21 Aligned_cols=270 Identities=21% Similarity=0.269 Sum_probs=202.3
Q ss_pred CCCCCceecccCceEEEEEEe-C--C--CcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceecc-CCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-G--D--GMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSN-EEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~--~--~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 72 (285)
.|+....||+|.+|.||+|.. + + ..++|||.++..++ ..-..+-+|+.+++.++|+|++.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 478899999999999999942 2 2 33789999875532 222456679999999999999999999977 78899
Q ss_pred EEEeccCCCCHHHhhhcC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC----CcEEEeee
Q 039392 73 LVLEYMPHGSLEKYLHSS----NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN----MVAHLSDF 144 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~----~~~~i~df 144 (285)
+++||.+. +|+.+|.-+ .+.++...+..+++||+.|+.||| ++=+.|||+||.||++..+ |.|||.||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999977 899988533 234889999999999999999999 8999999999999999877 99999999
Q ss_pred ccceecCcccccc-eeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccc-----h---hhhh
Q 039392 145 GIAKLLTREDIST-IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGE-----M---TLKH 214 (285)
Q Consensus 145 ~~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-----~---~~~~ 214 (285)
|+++.+.+.-... ..+....|.||.|||.+.+. .|+.+.|||++||++.||++.++.|.+....- . ....
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999988765444 33456789999999998887 69999999999999999999998886532110 0 1111
Q ss_pred hhhhhcCCCccccccccccCcc-------c----ch--hh----hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 215 WVNDWLPISTKEIVDPNLLSRE-------D----IH--FV----AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~-------~----~~--~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+.....++...+.+-...++. . .+ +. ....-++...+|+.+||++||.+|.|+++++++
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1111112222222111111110 0 00 00 011234558899999999999999999999875
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=272.34 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=211.1
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|.++.+||+|++|.||++. ..+|+.+|||.++.++ ..+.+.+|+.++++...|+++++++.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 4577899999999999995 4579999999987654 457888999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
|++.++++..++++++..+..+++.-+.||+||| ...-+|||||..||+++-+|..|+.|||.+..+.+. .....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRN 187 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhC
Confidence 9999999988888999999999999999999999 888899999999999999999999999999876653 22335
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...||+.|+|||++..-.|+..+||||||+...+|..|++||.+.-+....+. +++.++ .-|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM--IPT~PP----------------PTF 249 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM--IPTKPP----------------PTF 249 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe--ccCCCC----------------CCC
Confidence 67899999999999999999999999999999999999999977544322111 111111 112
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..-++++.+++++||-.+|++|.|+-+++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2244556779999999999999999999999876
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=271.48 Aligned_cols=248 Identities=28% Similarity=0.351 Sum_probs=191.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch-hHHHHHHHHHHH-HccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG-RVFKSFDVECEM-MKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||.||++... +|+.||+|.+..... .....+..|... ++..+|||++++++.+......++++|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 5889999999999999999754 699999999875432 222344445554 6667899999999999999999999999
Q ss_pred cCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 78 MPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 78 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++ ++|.+++.. ....+++..++.++.|++.|++||| ++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 96 488777643 2335899999999999999999999 76 9999999999999999999999999998765432
Q ss_pred cccceeccccccccccCCcccCC----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKE----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
. ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||....................
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 227 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ------- 227 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCC-------
Confidence 1 1122356778999998764 4568899999999999999999999865332222111111100000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
. ....++.++.+++.+||..+|++|||++++++
T Consensus 228 ---~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 ---L--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---C--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01124667999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=268.88 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=196.7
Q ss_pred CCCCceecccCceEEEEEEe----CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCC------
Q 039392 2 FSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE------ 69 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 69 (285)
|.+.+.||+|++|.||+|.. .++..+++|++.... ....+.+.+|+++++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 77899999999999999963 247889999886542 344567888999999999999999999875432
Q ss_pred ceEEEEeccCCCCHHHhhhcC-----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 70 FKALVLEYMPHGSLEKYLHSS-----NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
..+++++++.+++|.+++... ...++...++.++.|++.|++||| ++|++|+||+|+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 246888999999998876422 123788889999999999999999 999999999999999999999999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++................++..|++||.+.+..++.++||||||+++|+|++ |..||........ ...... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~-~~~-- 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI-YNYLIK-GNR-- 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH-HHHHHc-CCc--
Confidence 99886543321112222334567999999988889999999999999999999 8888765332111 111110 000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.......+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 234 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 ----------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000123456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=274.45 Aligned_cols=267 Identities=21% Similarity=0.252 Sum_probs=199.0
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccC--CceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 75 (285)
+|++.+.||.|++|.||+|... +++.+++|.++.... .....+.+|+.++++++||||+++.+++... ...++++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5889999999999999999764 688999999875432 2223466799999999999999999988776 8899999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++ +|.+++......++...++.++.|++.||+||| +.|++|+||+|+||+++.++.++++|||++.......
T Consensus 86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99975 999988766556899999999999999999999 9999999999999999999999999999988765432
Q ss_pred cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc----------
Q 039392 156 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST---------- 224 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 224 (285)
.......++..|+|||.+.+. .++.++|+||+|+++++|++|..||........ .............
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccc
Confidence 112234467789999987654 468999999999999999999999976433211 1111111100000
Q ss_pred -cccccccccCcccchhhhhhH-hHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 -KEIVDPNLLSREDIHFVAKEQ-CVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 -~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..................+.. .++.+.+++++||+.+|++|||++|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000000001111 46778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=272.02 Aligned_cols=265 Identities=25% Similarity=0.313 Sum_probs=198.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
||+..+.||.|++|.||+|.. .+++.+++|.+.... ......+.+|++++++++||||+++++++...+..+++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 699999999999999999975 468899999886543 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+. ++|.+++... ...++...++.++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 96 5888887553 334889999999999999999999 9999999999999999999999999999987554321
Q ss_pred ceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc------cc--
Q 039392 157 TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK------EI-- 227 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~-- 227 (285)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... ........... ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-IFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCChhhhhhhhHHHH
Confidence 111233457789999987664 468899999999999999999999865332221111 11111100000 00
Q ss_pred ---ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 ---VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+. ...... ......++.++.++|.+||+.||++|||+++++++
T Consensus 234 ~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPK-WARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhccc-ccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 000000 00112356778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=272.70 Aligned_cols=268 Identities=22% Similarity=0.278 Sum_probs=201.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|++|.||+|... +++.|++|.+.... ......+.+|+++++.++|+||+++++.+...+..++++|+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5889999999999999999754 68899999886432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++.+..+..+ ...++...++.++.|++.|+.+|| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 988666555544 344889999999999999999999 99999999999999999999999999999887654332 1
Q ss_pred eeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc---cccc-----
Q 039392 158 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST---KEIV----- 228 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~----- 228 (285)
......++..|+|||.+.+. .++.++|+||||+++++|++|..||......+.. ............ ....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL-YLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHhhhcccCccc
Confidence 12334567889999998887 8899999999999999999999998754322211 111110000000 0000
Q ss_pred cc----cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DP----NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ............+..++.++.+++++||..+|++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00000000001122347889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=268.49 Aligned_cols=246 Identities=27% Similarity=0.388 Sum_probs=199.7
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+.+|+.+++.++|+|++++++.+..+...++|+|+++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 67889999999999999975 468899999876443 3344678889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++.+. .++...+..++.|++.++.+|| +.|++|+||+|.||+++.++.++++|||++........ ..
T Consensus 86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06641 86 GGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hh
Confidence 99999988653 3889999999999999999999 99999999999999999999999999999876544321 11
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....++..|+|||.+.+..++.++|+||||++++++++|..||........... .. .... .
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~---~~~~---------~----- 219 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL--IP---KNNP---------P----- 219 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH--Hh---cCCC---------C-----
Confidence 234567789999999888889999999999999999999999865322111100 00 0000 0
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....++.++.+++.+||..+|.+||++++++++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 -TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0122346678999999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=269.14 Aligned_cols=258 Identities=25% Similarity=0.287 Sum_probs=198.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceecc--CCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e 76 (285)
+|+..+.||.|++|.||++.. .+++.+++|.+..... .....+.+|+++++.++||||+++++.+.. ...++++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 578899999999999999975 4688999999875433 344668889999999999999999998754 447899999
Q ss_pred ccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 77 YMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 77 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++++++|.+++.. ....++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999887643 2344788899999999999999999 999999999999999999999999999998654332
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
. .....++..|++||.+.+..++.++|+||||+++|+|++|..||............................
T Consensus 159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (287)
T cd06621 159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE--- 231 (287)
T ss_pred c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccC---
Confidence 1 123346778999999988899999999999999999999999997653211111111111111000000000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......++++.+++.+||..+|.+|||+.|++++
T Consensus 232 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 ------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00011235678999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=274.88 Aligned_cols=267 Identities=24% Similarity=0.266 Sum_probs=197.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccC--CceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 75 (285)
+|++.+.||.|++|.||+|.. .+|+.||+|.+..... .......+|+.++++++|+|++++++++... +..++|+
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 588999999999999999975 4689999999865432 1123456799999999999999999998654 5689999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++.+ +|.+++......++...++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 88 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 88 EYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred ecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99965 898888765566899999999999999999999 99999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc-------
Q 039392 156 STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI------- 227 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 227 (285)
. ......+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||....... ................+
T Consensus 164 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 164 P--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred C--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhhhccc
Confidence 1 122345677999998765 468999999999999999999999997643222 11111111110000000
Q ss_pred -ccccccCcccchhh--hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 -VDPNLLSREDIHFV--AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 -~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.............. .....++++.++|.+||+.||++|||+++++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000000 011246778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=295.34 Aligned_cols=255 Identities=24% Similarity=0.456 Sum_probs=219.3
Q ss_pred CCCceecccCceEEEEEEeC----CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 3 SENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
.+.++||.|.||.|++|+.+ ....||||-++.... +.+..|..|+.||-++.||||+++.++....+-..+|.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 36789999999999999743 245689999887654 4567899999999999999999999999999988999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++.|+|..|++.+...+...++.-|++.|+.|++||. +.++|||||...|||++.+..+|++|||+++.+.++....
T Consensus 712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 9999999999998888999999999999999999999 9999999999999999999999999999999886654222
Q ss_pred -eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 158 -IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 158 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......-+.+|.|||.+...+++.++||||+|++|||.++ |..||=+..+-+... .-+
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk--------------------aIe 848 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK--------------------AIE 848 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH--------------------HHH
Confidence 2223345678999999999999999999999999999987 999986544432211 123
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
++.+++.+.+||..+++||..||++|-.+||.+.+|+..|+++-.
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 455666788999999999999999999999999999999988764
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=286.86 Aligned_cols=246 Identities=29% Similarity=0.398 Sum_probs=204.0
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeec---cchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNL---QYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|.-++.||.|+||.||.+++ .+.+.||||.+.- .+.+.|+.+.+|+..|++++|||++.+.++|....+.|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 45578999999999999975 4677889998763 3457789999999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
| -||-.|++.-..+++.+..+..|..+.++||+||| +.+.+|||||..||++++.|.||+.|||.+....+
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 9 45999999888888999999999999999999999 99999999999999999999999999999976554
Q ss_pred eeccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 158 IQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.....|||.|+|||++. .+.|+-+.||||||++..++...++|+........ +..+. .. ..+.+.
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-LYHIA---QN------esPtLq- 246 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIA---QN------ESPTLQ- 246 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-HHHHH---hc------CCCCCC-
Confidence 35678999999999875 56799999999999999999999999754321111 11110 00 011111
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
...-+..+.+|+..||+.-|.+|||.++++++--
T Consensus 247 --------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 247 --------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred --------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 2233566889999999999999999999998643
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=269.69 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||.|++|.||+|... +|+.+++|.+..... .....+.+|++++++++|+|++++++.+...+..++|+|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 6899999999999999999864 689999999875432 23456678999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 79 PHGSLEKYLHSSN--YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 79 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++ +|.+++.... ..+++..+..++.|++.||.+|| +.|++|+||+|+||++++++.++++|||++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 75 8888876543 34889999999999999999999 9999999999999999999999999999987554321
Q ss_pred ceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc---c----
Q 039392 157 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI---V---- 228 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 228 (285)
.......++..|++||.+.+ ..++.++|+|+||++++++++|..||......+... .............. .
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL-KIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCChhhHHHHhcCch
Confidence 11123346778999998765 457899999999999999999999997654332211 11111100000000 0
Q ss_pred -cccccCc-ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 -DPNLLSR-EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 -~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....... ..........++..+.+++.+||+.||.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 000001112457789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=271.67 Aligned_cols=245 Identities=27% Similarity=0.357 Sum_probs=195.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
.|++.+.||+|++|+||+|... +++.|++|.+.... ....+.+.+|+++++.++|||++++.+++......++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3788899999999999999754 68999999886432 2344568889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++.+ ++.+++......++...+..++.|++.||.||| +.+++|+||+|.||+++.++.++|+|||++......
T Consensus 96 ~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9964 788877655556899999999999999999999 999999999999999999999999999998755432
Q ss_pred ceeccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
....++..|+|||.+. ...++.++||||||+++|+|++|..||........... ... ... + .
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-~~~---~~~------~-~- 233 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQ---NDS------P-T- 233 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-Hhc---CCC------C-C-
Confidence 2335677899999874 35688999999999999999999999865322111111 000 000 0 0
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+.++.+++.+||..+|++||++++++.+
T Consensus 234 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 -------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0012345679999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=274.27 Aligned_cols=270 Identities=21% Similarity=0.281 Sum_probs=198.4
Q ss_pred CCCCCceecccCceEEEEEEeC---CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccC--CceE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG---DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 72 (285)
+|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++.+... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5889999999999999999753 57899999987633 33345677899999999999999999999887 7899
Q ss_pred EEEeccCCCCHHHhhhcC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----CCcEEEeee
Q 039392 73 LVLEYMPHGSLEKYLHSS----NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD----NMVAHLSDF 144 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~----~~~~~i~df 144 (285)
+|+|++++ ++.+++... ...+++..++.++.|++.|++||| +.+++|+||+|+||+++. ++.++|+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 777766432 225889999999999999999999 999999999999999999 999999999
Q ss_pred ccceecCcccc-cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccc--------hhhhh
Q 039392 145 GIAKLLTREDI-STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGE--------MTLKH 214 (285)
Q Consensus 145 ~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~--------~~~~~ 214 (285)
|++........ ........++..|+|||.+.+. .++.++|+||||+++++|++|..||....... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99887644322 1112234567889999987664 57899999999999999999999997543322 00111
Q ss_pred hhhhhcCCCc------------cc---cccccccCcccchhhhh--hHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 215 WVNDWLPIST------------KE---IVDPNLLSREDIHFVAK--EQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 215 ~~~~~~~~~~------------~~---~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+........ .. ................. ...+.++.+++.+||..||++|||+++++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1110000000 00 00000000000000011 1456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=265.44 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=185.4
Q ss_pred ceecccCceEEEEEEeCC---CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 6 NLIGRGGFGSVFKARLGD---GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~---~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+.||+|+||.||++...+ ...+++|.+.... ....+.+.+|+.+++.++|||++++++.+......+++|||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 469999999999996433 3346677665443 334567889999999999999999999999999999999999999
Q ss_pred CHHHhhhcCC---CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 82 SLEKYLHSSN---YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+|.+++.+.. ...+...++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999986532 23566778899999999999999 99999999999999999999999999999764322111111
Q ss_pred eccccccccccCCcccCC-------CccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 159 QTQTLATIGYMAPEYGKE-------GRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.....++..|+|||.+.. ..++.++||||||+++|+|++ |..||......+. ......... .....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~----~~~~~~ 232 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-LNHVIKDQQ----VKLFKP 232 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhhcc----cccCCC
Confidence 223456778999998743 245789999999999999997 4567754322211 111111000 000011
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
.. ....+..+.+++..|+ .+|++|||++++++.|+
T Consensus 233 ~~----------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QL----------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cc----------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 00 1123456788999998 78999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=279.41 Aligned_cols=261 Identities=23% Similarity=0.417 Sum_probs=217.0
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
.+.++||+|.||+|.++...++..||+|.++..... ....|.+|+.+|.+++||||+.++++|..++-+++|+||++.|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 478899999999999998777899999999876644 4488999999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 82 SLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 82 ~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
+|..++..+..+ ........|+.||+.|++||. +.++|||||.+.|+|++.++++||+|||+++.+..+......+
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 999999887543 355667789999999999999 9999999999999999999999999999999777666666666
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh--CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT--RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
...-+.+|+|+|.+..++++.++|+|+||+++||+++ ...||......+.. .+......... ...
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-en~~~~~~~~~------------~~~ 764 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-ENAGEFFRDQG------------RQV 764 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-HhhhhhcCCCC------------cce
Confidence 6777889999999999999999999999999999886 67888654332221 11111111111 111
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
-+..+..|+..++++|.+||..+..+|||++++..+|++.-
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 23346788999999999999999999999999999988753
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=268.75 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=198.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCC---CCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIH---HRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~ 75 (285)
.|++.+.||+|++|.||+|.. .+++.+++|.+.... ....+.+.+|+.+++.+. |||++++++.+......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 378899999999999999975 578999999986543 334566778999998886 999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++... .++...++.++.|++.++.+|| +.|++|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998654 4889999999999999999999 99999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 156 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... .... ..+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-----~~~~-----~~~---- 220 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-----IPKS-----KPP---- 220 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-----cccC-----CCC----
Confidence 12234577889999987654 578999999999999999999999975422111100 0000 000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+ .....+.++.+++.+||+.||++||++.+++++
T Consensus 221 ----~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 ----RL-EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----CC-CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00 011245679999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=263.40 Aligned_cols=247 Identities=29% Similarity=0.398 Sum_probs=203.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|+|++++.+++...+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999754 688999999876543 4557788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++++|.+++.... .+++..++.++.|++.++.+|| +.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 99999999987664 4899999999999999999999 999999999999999999999999999999877653321
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....++..|++||...+...+.++|+|++|++++++++|..||........... .. ...
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~---~~~--------------- 215 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IV---QDD--------------- 215 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-Hh---ccC---------------
Confidence 2334577889999998887889999999999999999999999865432111111 00 000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
....+...+..+.+++.+||..+|++|||++++++
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00012234667899999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=269.43 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=193.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccC-----CceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNE-----EFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~~ 73 (285)
+|.+.+.||+|++|.||++.. .+++.+++|++.... .....+.+|+.+++.+ +|||++++++++... ...++
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 588899999999999999975 568899999986432 2235566788899888 799999999988643 35889
Q ss_pred EEeccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceec
Q 039392 74 VLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~ 150 (285)
|+||+++++|.+++.. ....+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 9999999999988753 2345889999999999999999999 999999999999999999999999999998765
Q ss_pred CcccccceeccccccccccCCcccCCC-----ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEG-----RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
..... ......++..|+|||.+... .++.++|+||||+++++|++|..||........... ... ....
T Consensus 179 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~----~~~~ 251 (291)
T cd06639 179 TSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPR----NPPP 251 (291)
T ss_pred ccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH-Hhc----CCCC
Confidence 43221 11234567889999987543 368999999999999999999999865432211111 100 0000
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ...+...+..+.+++.+||+.+|++|||+++++++
T Consensus 252 ~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 252 T-------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred C-------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 00112334568999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=268.15 Aligned_cols=266 Identities=25% Similarity=0.285 Sum_probs=198.4
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|++.+.||.|++|.||+|.. .+|+.|++|++..... .....+.+|+++++.++|+|++++++.+......++++|++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78899999999999999975 4799999999875432 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+ ++|.+++.... ..+++..++.++.|++.||++|| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 58998886554 34899999999999999999999 99999999999999999999999999999875543211
Q ss_pred eeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc---------cc
Q 039392 158 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK---------EI 227 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 227 (285)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ .............. ..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchhh
Confidence 11223457789999987654 578999999999999999999999875432211 11111111110000 00
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...................+.++.+++.+||+.+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000001123455779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=264.03 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=202.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||.|++|.||++.. .+++.+++|.+.... ......+.+|+++++.++|+||+++.+.+......++++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 689999999999999999964 468899999986532 33445677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 78 MPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 78 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
+++++|.+++... ...++...++.++.|++.|+.+|| +.|++|+||+|.||+++.++.++++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 234888999999999999999999 999999999999999999999999999999776543
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
......++..|++||.+.+..++.++|+||||++++++++|..||......+..... .. . ...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~----~---------~~~ 219 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QR----G---------KYP 219 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hc----C---------CCC
Confidence 122345678899999998888999999999999999999999998754322211110 00 0 000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+.++.+++.+||..+|.+|||+++++++
T Consensus 220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0122456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=286.49 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=208.6
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|.++..||-|+||.||+|..+ ++-..|.|++...+....+.+.-|+++|..+.||+|+++++.|...+.+|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 567788999999999999765 3455688999888888889999999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
|-+..++-.-+..+.+.++..++.|++.||+||| +..|+|||+|..||+++-+|.+++.|||.+-..... ....+
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRD 188 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--Hhhhc
Confidence 9998888776777999999999999999999999 999999999999999999999999999997654322 23346
Q ss_pred cccccccccCCccc-----CCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 161 QTLATIGYMAPEYG-----KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 161 ~~~~~~~~~~PE~~-----~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
..+|||+|+|||+. ....|+.++||||||+.+.+|.-+.+|.....+....++.-...
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe----------------- 251 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE----------------- 251 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-----------------
Confidence 78899999999964 45679999999999999999999999987654443333321111
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+.-+..+.--+..+.+++.+||..||..||++.+++++
T Consensus 252 -PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 -PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11111233345668999999999999999999999975
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=270.79 Aligned_cols=267 Identities=20% Similarity=0.237 Sum_probs=194.8
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+++.+|.|+++.++++.. +++.+|+|++... .......+.+|+++++.++|+||+++++.+......+++||+++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 444445555555555444 6899999998754 3445577889999999999999999999999999999999999999
Q ss_pred CHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc-----
Q 039392 82 SLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI----- 155 (285)
Q Consensus 82 ~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~----- 155 (285)
+|.+++... ...+++..+..++.|++.||+||| +++++|+||+|+||+++.++.+++.||+.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999998753 334888999999999999999999 99999999999999999999999999998865532211
Q ss_pred cceeccccccccccCCcccCC--CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCC---C-----cc
Q 039392 156 STIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI---S-----TK 225 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~-----~~ 225 (285)
........++..|+|||.+.. ..++.++|+||+|+++++|++|..||.................... . ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 111123345667999998865 3588999999999999999999999976443322221111000000 0 00
Q ss_pred ccc-----cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIV-----DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
... ..................+.++.+++++||+.||++|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000111112222334556789999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=269.43 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=193.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceecc------CCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSN------EEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~ 72 (285)
.|++.+.||+|+||.||+|.. .+++.+++|++.... .....+..|+.+++++ +|+|++++++.+.. ....+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 378889999999999999975 468899999986543 3345677888888888 69999999998842 45789
Q ss_pred EEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 73 LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++||++++++|.+++.... ..+++..++.++.|++.|+.||| +.+++|+||+|.||+++.++.++|+|||++....
T Consensus 96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 9999999999999886532 34788889999999999999999 9999999999999999999999999999987553
Q ss_pred cccccceeccccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
... .......++..|+|||.+. ...++.++|+||||+++|+|++|..||........... . .....
T Consensus 173 ~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~-~~~~~----- 243 (282)
T cd06636 173 RTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-I-PRNPP----- 243 (282)
T ss_pred ccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-H-hhCCC-----
Confidence 211 1122345778899999875 34578899999999999999999999865322111110 0 00000
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......++.++.++|++||..||.+|||+.+++++
T Consensus 244 ------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 244 ------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000122456779999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=265.36 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=199.6
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|++|.||++... +|..+++|.+.... ....+.+.+|+++++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999754 68889999986542 13345677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-cEEEeeeccceecCcccc
Q 039392 78 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 78 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~i~df~~~~~~~~~~~ 155 (285)
+++++|.+++.... ..+++..+..++.|++.|+.||| ..+++|+||+|.||++++++ .++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999886543 34788999999999999999999 99999999999999998875 469999999877654321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......++..|+|||...+..++.++|+||||++++++++|..||......+.... ... ... .
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~----~~~---------~- 220 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK-ICQ----GYF---------A- 220 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-Hhc----ccC---------C-
Confidence 12234577889999998888899999999999999999999999865332221111 100 000 0
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+.++.+++.+||..+|++|||+++++++
T Consensus 221 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0012345669999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=279.18 Aligned_cols=247 Identities=26% Similarity=0.347 Sum_probs=208.6
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|.+.+.||+|.|++|.+++ ..++..||||.++... ....+.+.+|++++..++||||++++.+......+|+||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 58899999999999999997 4579999999997654 34446688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+.++.+.+++.+++. ..+..+..++.|++.|++||| +++++|||||++|++++.+.++||+|||+...+.. ..
T Consensus 137 a~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---~~ 209 (596)
T KOG0586|consen 137 ASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY---GL 209 (596)
T ss_pred ccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc---cc
Confidence 999999999988876 555889999999999999999 99999999999999999999999999999998874 33
Q ss_pred eeccccccccccCCcccCCCc-cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 158 IQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....++++.|+|||++.+.. ..+..|+|++|+++|.+.+|..||++..-. ..-.+.+....
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----------------~Lr~rvl~gk~ 272 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----------------ELRPRVLRGKY 272 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-----------------cccchheeeee
Confidence 446778999999999998875 578999999999999999999999863211 11111111111
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
. .+.-++-++.++|+++|-.+|.+|++++++.+.-
T Consensus 273 r----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 273 R----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred c----ccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 1 1233455688999999999999999999998764
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=266.39 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=203.1
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|++.+.||.|++|.||++.. .+++.+++|.+..... .....+.+|+++++.++|++++++++.+..+...++++|++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 78889999999999999975 4689999998865433 24466778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++ ++.+++......++...++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 65 888888765556899999999999999999999 9999999999999999999999999999998765532 11
Q ss_pred eccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc---ccccc---cc
Q 039392 159 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST---KEIVD---PN 231 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~ 231 (285)
.....++..|+|||.+.+. .++.++|+||||++++++++|+.||......+. ............. ..... ..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhhhh
Confidence 2234567789999988776 789999999999999999999999865433221 1111111111000 00000 00
Q ss_pred --ccCc--ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 232 --LLSR--EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 232 --~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.... ..........++.++.+++.+||..||.+||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 000011124567889999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=267.05 Aligned_cols=267 Identities=25% Similarity=0.328 Sum_probs=201.6
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccC--CceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 76 (285)
|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+++++.++|+|++++.+++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 778999999999999999765 58899999987653 33445677899999999999999999999887 88999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++ +|.+++......+++..++.++.|++.|+++|| +.|++|+||+|.||++++++.++|+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 899888766556899999999999999999999 99999999999999999999999999999987654321
Q ss_pred ceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc------
Q 039392 157 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD------ 229 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (285)
.......++..|+|||.+.+ ..++.++|+||||+++++|++|..||....... ...................
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccchh
Confidence 11223445778999997664 467899999999999999999999997644321 1222211111111000000
Q ss_pred -ccccCccc----chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 -PNLLSRED----IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 -~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........ ..-.....++.++.+++++||..+|.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000 0000011137789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=264.50 Aligned_cols=239 Identities=20% Similarity=0.273 Sum_probs=199.2
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|+++++||+|.||+|.+++ ..+++.+|+|+++.+. ....+.-..|-++|+..+||.+..+...|+..+.+|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 47789999999999999997 4579999999987653 3445566678899999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|..||.|.-.+.+... +++...+-+...|+.||.||| ++++|+||+|.+|.++|++|++||.|||++.--... .
T Consensus 249 yanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--g 322 (516)
T KOG0690|consen 249 YANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--G 322 (516)
T ss_pred EccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc--c
Confidence 9999999887766554 899999999999999999999 999999999999999999999999999999643221 2
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......+|||.|+|||++....|.++.|.|++|++||+|++|+.||..-..... +...+..
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-----------------FeLIl~e-- 383 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-----------------FELILME-- 383 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-----------------HHHHHhh--
Confidence 234567899999999999999999999999999999999999999976332211 1111111
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI 266 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 266 (285)
++..+...++++..|+..+|..||++|.
T Consensus 384 --d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 --DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1112456678899999999999999996
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=269.37 Aligned_cols=246 Identities=27% Similarity=0.365 Sum_probs=196.7
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|...+.||+|+||.||++.. .++..+++|.+... .......+.+|+++++.++|+|++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66788999999999999975 46889999998643 233446788899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+.+ ++.+.+......++...+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 975 788877665556899999999999999999999 999999999999999999999999999988654322
Q ss_pred eeccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 158 IQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
....++..|+|||.+. ...++.++|+||||+++++|++|..||........... .......
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~------------- 242 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESP------------- 242 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHhccCC-------------
Confidence 2345677899999873 45688999999999999999999999865322211111 1100000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
.......++.+.+++.+||+.+|.+||++.+++++..
T Consensus 243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 0001234566899999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=274.75 Aligned_cols=261 Identities=23% Similarity=0.256 Sum_probs=194.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccC------Cce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE------EFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 71 (285)
+|++.+.||+|+||.||++.. .+++.+|+|.+... .......+.+|+.+++.++|+|++++++++... ...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 478899999999999999975 47899999998642 233345677899999999999999999987543 357
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++|+|++.+ +|.+.+... ++...+..++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 97 ~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 97 YLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 899999955 888877543 788889999999999999999 9999999999999999999999999999998664
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC--------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS-------- 223 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 223 (285)
.... .....++..|+|||.+.+..++.++|+||||+++++|++|..||........ ............
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhh
Confidence 4221 2233567889999999999999999999999999999999999975432111 111100000000
Q ss_pred -----------------ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 -----------------TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.............. .......+.++.+++.+||+.||++|||++|+|.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDS--ESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCccc--ccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000000 00012346678999999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=262.82 Aligned_cols=241 Identities=26% Similarity=0.327 Sum_probs=195.1
Q ss_pred ecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 8 IGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 8 lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
||.|++|.||++... +++.+++|++.... ....+.+.+|+.+++.++||||+++++.+..+...++++|++++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999754 58999999986533 23446788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecccc
Q 039392 84 EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163 (285)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~ 163 (285)
.+++.+... ++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcCC-CCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 999876543 889999999999999999999 9999999999999999999999999999998765432 112335
Q ss_pred ccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh-hhhhhhhhcCCCccccccccccCcccchhhh
Q 039392 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT-LKHWVNDWLPISTKEIVDPNLLSREDIHFVA 242 (285)
Q Consensus 164 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
++..|++||.+.+..++.++|+||+|+++|++++|..||......... ...... .. .....
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~---------------~~~~~ 215 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK---GN---------------GKLEF 215 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---cC---------------CCCCC
Confidence 678899999988888999999999999999999999999765421111 111000 00 00011
Q ss_pred hhHhHHHHHHhhhcccccCcCCCCC-----HHHHHH
Q 039392 243 KEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT 273 (285)
Q Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~ 273 (285)
+...+.++.+++.+||+.+|.+||+ ++|+++
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2223667999999999999999999 888876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=268.31 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=196.7
Q ss_pred CceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 5 NNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
...||+|++|.||++.. .+++.+++|.+..........+.+|+.+++.++|+|++++++.+...+..+++||++++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 45799999999999975 57899999998765555567788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecccc
Q 039392 84 EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163 (285)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~ 163 (285)
.+++... .++...++.++.|++.++++|| +.|++|+||+|.||+++.++.++|+|||++....... .......
T Consensus 105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 9887543 3788899999999999999999 9999999999999999999999999999987654321 1112345
Q ss_pred ccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhh
Q 039392 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243 (285)
Q Consensus 164 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
++..|++||.+.+..++.++|+||+|+++++|++|..||........ .... ....+. .+...
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-~~~~-~~~~~~----------------~~~~~ 239 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMI-RDNLPP----------------KLKNL 239 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HhhCCc----------------ccCCc
Confidence 67889999998888889999999999999999999999865322111 1100 000000 00011
Q ss_pred hHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 244 EQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+..+.+++.+||..+|.+||++++++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 2345668899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=265.28 Aligned_cols=243 Identities=27% Similarity=0.355 Sum_probs=193.7
Q ss_pred ecccCceEEEEEEeC-CCcEEEEEEeeccch---hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 8 IGRGGFGSVFKARLG-DGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 8 lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
||+|++|.||++... +++.+++|++..... ...+.+.+|++++++++|+|++++++.+......++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999865 589999999865443 4456788899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc------cc
Q 039392 84 EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI------ST 157 (285)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~------~~ 157 (285)
.+++.+.. .+++..++.++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99987655 4899999999999999999999 99999999999999999999999999999875433211 11
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......++..|++||.......+.++|+||||++++++++|..||......+.... . .....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~----~~~~~------------- 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN-I----LNGKI------------- 218 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-H----hcCCc-------------
Confidence 22334567789999998888899999999999999999999999865432211111 0 00000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCH---HHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINA---KEIVT 273 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~---~eil~ 273 (285)
.+......+.++.+++.+||+.+|++|||+ .++++
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000011136778999999999999999999 55543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=265.34 Aligned_cols=262 Identities=20% Similarity=0.242 Sum_probs=193.8
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCC-CCccccccceeccC--CceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNE--EFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v~e 76 (285)
|++.+.||+|++|.||+|.. .+++.+++|.+.... ........+|+..++++. |+|++++++++... +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 78899999999999999974 468899999886532 222233446888888885 99999999999877 88999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++ ++.+.+......+++..++.++.|++.||.+|| +.|++|+||+|+||+++. +.++|+|||++........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9965 888877665555899999999999999999999 999999999999999999 9999999999976643221
Q ss_pred ceeccccccccccCCcccC-CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCC-----------Cc
Q 039392 157 TIQTQTLATIGYMAPEYGK-EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI-----------ST 224 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~ 224 (285)
.....++..|+|||.+. +..++.++|+||+|+++++|++|..||......+.. .......... ..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI-AKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH-HHHHHHcCCCCHHHHHhhccccc
Confidence 12234678899999764 455789999999999999999999999654322111 1110000000 00
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+...... . .......+.++.+++.+||..+|.+|||+++++.+
T Consensus 232 ~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTG-L-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCccccccc-H-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000 0 01122457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=266.26 Aligned_cols=249 Identities=27% Similarity=0.419 Sum_probs=202.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeecc---chhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|.+.+.||+|++|.||++... +++.+++|++... .......+.+|+++++++. |+||+++++++...+..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 6889999999999999999754 7899999998653 2334466788999999998 999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++.+.. .++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999997765 4999999999999999999999 99999999999999999999999999999886654321
Q ss_pred c------------------ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhh
Q 039392 156 S------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN 217 (285)
Q Consensus 156 ~------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 217 (285)
. .......++..|++||......++.++|+||||++++++++|..||........ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~ 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKILK 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHh
Confidence 1 112233467789999998888899999999999999999999999876432111 111000
Q ss_pred hhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCH----HHHHHH
Q 039392 218 DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINA----KEIVTK 274 (285)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~eil~~ 274 (285)
.....+...+..+.+++.+||..+|.+|||+ ++++++
T Consensus 237 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 237 --------------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred --------------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0000112336668999999999999999999 888753
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=287.74 Aligned_cols=267 Identities=17% Similarity=0.179 Sum_probs=186.9
Q ss_pred CCCCCceecccCceEEEEEEeC--CCcEEEEE------------------EeeccchhHHHHHHHHHHHHccCCCCcccc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG--DGMEVAVK------------------VFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~--~~~~~~iK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 60 (285)
+|++++.||+|+||+||++... ++...+.| .+. ........+.+|+++++.++|+||++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 4889999999999999998532 22222222 111 11223456778999999999999999
Q ss_pred ccceeccCCceEEEEeccCCCCHHHhhhcCC----CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 039392 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN----YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN 136 (285)
Q Consensus 61 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~ 136 (285)
+++++...+..+++++++.+ +|.+++.... .......++.++.||+.||.||| ++|++||||||+||+++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence 99999999999999999954 6766654321 12345677889999999999999 9999999999999999999
Q ss_pred CcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccc--cchhhhh
Q 039392 137 MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFN--GEMTLKH 214 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~--~~~~~~~ 214 (285)
+.++|+|||++..+...... ......++..|+|||++.+..++.++|||||||++|+|++|..++..... .......
T Consensus 304 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999876543211 12234688999999999999999999999999999999998864432111 1111111
Q ss_pred hhhhhcCCCcccc----------ccccc---cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 215 WVNDWLPISTKEI----------VDPNL---LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 215 ~~~~~~~~~~~~~----------~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........ ..++ +.... .......+......+..+.+++.+||+.||.+|||++|+|++
T Consensus 383 ~~~~~~~~-~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVC-DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccC-hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111000 0000 00000 000111111222345668889999999999999999999874
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.20 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=204.2
Q ss_pred CCceecccCceEEEEEEe-CCCcEEE---EEEee-ccchhHHHHHHHHHHHHccCCCCccccccceeccCCc--eEEEEe
Q 039392 4 ENNLIGRGGFGSVFKARL-GDGMEVA---VKVFN-LQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF--KALVLE 76 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~-~~~~~~~---iK~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~v~e 76 (285)
+..+||+|+|-+||+|.+ .+|-.|| +|.-. ..++...+++..|+++|+.|+|+||++++..|.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 456899999999999964 3566665 33211 1234456889999999999999999999999976544 779999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df~~~~~~~~~~~ 155 (285)
.+..|+|..++++.+. .+...+..|++||+.||.|||.+ .=.|+|||||-+||||+ ..|.|||+|+|+|+......
T Consensus 124 L~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 9999999999988876 88999999999999999999943 44699999999999997 57999999999999876532
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.....|||.|||||+.. ..|++..||||||.+|.||.|+..||....++...++....+..+..+.+..
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~------- 269 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK------- 269 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC-------
Confidence 23378999999999886 7899999999999999999999999998888777777766666665554443
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.++++++|.+|+.. ..+|||+.|+|..
T Consensus 270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 -----------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 34588999999999 9999999999863
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=265.30 Aligned_cols=244 Identities=22% Similarity=0.282 Sum_probs=192.4
Q ss_pred ecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 8 lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
||+|+||+||++.. .+|+.+++|.+.... ......+.+|+++++.++|||++++.+.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999964 468999999986432 22334567899999999999999999999999999999999999999
Q ss_pred HHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccc
Q 039392 84 EKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162 (285)
Q Consensus 84 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~ 162 (285)
.+++.+.. ..+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99886644 34899999999999999999999 9999999999999999999999999999987654321 11234
Q ss_pred cccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhh
Q 039392 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVA 242 (285)
Q Consensus 163 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
.++..|++||.+.+..++.++|+||||+++++|++|+.||......... ......... .....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~----------------~~~~~ 217 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-EELKRRTLE----------------MAVEY 217 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-HHHHhcccc----------------ccccC
Confidence 4667899999988888999999999999999999999998654321110 000000000 00011
Q ss_pred hhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 243 KEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
+...++.+.+++.+||+.+|.+|| ++.+++.+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 233467799999999999999999 77777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=264.94 Aligned_cols=242 Identities=22% Similarity=0.287 Sum_probs=186.9
Q ss_pred eecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHH---HccCCCCccccccceeccCCceEEEEeccC
Q 039392 7 LIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEM---MKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~---l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.||+|+||.||++.. .+++.+|+|.+.... ......+.+|..+ +...+|++++.+.+.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999975 468999999886432 1111223344433 334479999999999998899999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++..... +++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 9999998876544 899999999999999999999 9999999999999999999999999999987554321 1
Q ss_pred ccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||...+ ..++.++|+||+|+++++|++|..||............ ......
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~---------------- 214 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLTV---------------- 214 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH--HHhhcC----------------
Confidence 23457889999998764 56899999999999999999999999754322211100 000000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
....+...+.++.+++.+||..||++|| |+++++++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011234567799999999999999999 69999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=267.75 Aligned_cols=267 Identities=22% Similarity=0.260 Sum_probs=195.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCC-CCccccccceeccCCc-----e
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEF-----K 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----~ 71 (285)
+|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.+. |+|++++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 588999999999999999975 4689999998765432 22356778999999995 6999999998876655 8
Q ss_pred EEEEeccCCCCHHHhhhcC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeecc
Q 039392 72 ALVLEYMPHGSLEKYLHSS----NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGI 146 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~ 146 (285)
+++||++++ +|.+++... ...+++..++.++.||+.||.||| ..|++|+||+|+||+++. ++.++|+|||.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999976 888877543 234789999999999999999999 999999999999999998 89999999999
Q ss_pred ceecCcccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 147 AKLLTREDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........... ...........
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (295)
T cd07837 158 GRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTPTEQ 234 (295)
T ss_pred ceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHHhCCCChh
Confidence 8765432111 122345778999998765 4578999999999999999999999875433222111 11111100000
Q ss_pred ccccc---c---ccCc-ccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIVDP---N---LLSR-EDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~~~---~---~~~~-~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..... . .... ..... ......+.++.++|.+||..||.+|||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0 0000 00000 0112467789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=262.98 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=197.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc-----chhHHHHHHHHHHHHccCCCCccccccceeccC--CceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ-----YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 72 (285)
+|++.+.||+|++|.||+|.. .+++.+++|.+... .......+.+|++++++++|+||+++++.+... ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 689999999999999999975 46899999987532 234456788999999999999999999988653 4688
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+++|++++++|.+++.+... ++...++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 99999999999998876543 788889999999999999999 99999999999999999999999999999976533
Q ss_pred cccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 153 EDIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 153 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.... .......++..|+|||.+.+..++.++|+||||++++++++|..||........... .. ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~----~~~-------- 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK-IA----TQP-------- 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH-HH----cCC--------
Confidence 1111 111234577889999999888899999999999999999999999865322211111 00 000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+...++++.+++.+||. +|.+|||+.+++.+
T Consensus 226 ------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 ------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0011134566779999999999 57999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=269.94 Aligned_cols=269 Identities=22% Similarity=0.308 Sum_probs=193.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCC--------
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-------- 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 69 (285)
+|++.+.||+|++|.||+|.. .+++.+|+|.+..... .....+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 488899999999999999975 4689999998764322 22234567999999999999999999875543
Q ss_pred ceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 70 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
..++++|++.+ +|.+.+......+++..++.++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 45899999965 888887766556899999999999999999999 99999999999999999999999999999976
Q ss_pred cCccccc--ceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc-
Q 039392 150 LTREDIS--TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK- 225 (285)
Q Consensus 150 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 225 (285)
....... .......++..|+|||.+.+. .++.++|+||||+++++|++|..||........ ...........+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-LTLISQLCGSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhh
Confidence 6432211 111233467789999987654 478899999999999999999999875432211 11100000000000
Q ss_pred -------ccccccccCcccc----hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 -------EIVDPNLLSREDI----HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 -------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+......... ........+..+.++|.+||..||.+|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000000 000011124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=269.31 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=195.9
Q ss_pred Cceeccc--CceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 5 NNLIGRG--GFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 5 ~~~lg~G--~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
...||+| ++|+||++.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..+...++++|++.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 8999999975 479999999986532 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc--
Q 039392 80 HGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-- 156 (285)
Q Consensus 80 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~-- 156 (285)
++++.+++.+.. ..+++..+..++.|++.||+||| +.|++|+||||+||+++.++.+++.||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999887542 34888999999999999999999 999999999999999999999999999765433221100
Q ss_pred c---eeccccccccccCCcccCCC--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhc-CCCc------
Q 039392 157 T---IQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL-PIST------ 224 (285)
Q Consensus 157 ~---~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~------ 224 (285)
. ......++..|++||.+.+. .++.++||||+|+++++|++|..||.................. +...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0 01112245569999998763 5789999999999999999999999765433222111110000 0000
Q ss_pred -ccc-----------ccc-------cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 -KEI-----------VDP-------NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 -~~~-----------~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
... ... ...............+++.+.+|+++||+.||.+|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 000 00111112222344577889999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=266.46 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=195.9
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||.|++|+||+|... +++.+++|.+..... .....+.+|+++++.++|+|++++++++......++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 5889999999999999999754 689999998864322 2335677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeeccceecCcccc
Q 039392 78 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 78 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~~~~~~~~ 155 (285)
+++ +|.+.+.... ...+...++.++.||+.||++|| +++++|+||+|+||+++. ++.++|+|||++.......
T Consensus 83 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 83 LDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred ccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 964 7877765433 23678888999999999999999 999999999999999985 5679999999997654321
Q ss_pred cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc---c--
Q 039392 156 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV---D-- 229 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 229 (285)
.......++..|+|||.+.+. .++.++|+||+|+++++|++|..||......+.... ............+. .
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK-IFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChhhccccccch
Confidence 111233457789999987664 578999999999999999999999975432221111 11110000000000 0
Q ss_pred --ccccCc--ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 --PNLLSR--EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 --~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...... ...........++++.+++.+||..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000001123456778999999999999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=272.42 Aligned_cols=267 Identities=23% Similarity=0.297 Sum_probs=195.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccC-----CceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE-----EFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~ 73 (285)
+|++.+.||+|++|.||+|.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 588999999999999999974 578999999986432 33445677899999999999999999876543 35789
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++|++.+ +|.+.+... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 86 v~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 86 VQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred Eehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 9999965 888777543 3889999999999999999999 999999999999999999999999999998765432
Q ss_pred cccc-eeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc---c
Q 039392 154 DIST-IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI---V 228 (285)
Q Consensus 154 ~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 228 (285)
.... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.+..... ................. .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhh
Confidence 2111 1123457888999997654 568999999999999999999999996532211 11111111110000000 0
Q ss_pred cc-------cccCcccchhh-hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DP-------NLLSREDIHFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~-------~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. .........+. .....+.++.+++.+||+.+|.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00000000000 012346779999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=272.59 Aligned_cols=267 Identities=24% Similarity=0.324 Sum_probs=198.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceecc----CCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSN----EEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 73 (285)
+|++.+.||+|++|.||+|.. .+++.|++|.+.... ......+.+|+.++++++||||+++.+++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 588999999999999999974 469999999987543 2344567789999999999999999998753 356889
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|+|++. ++|.+++..... ++...++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 86 v~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 86 VMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 999995 589888865544 899999999999999999999 999999999999999999999999999998765432
Q ss_pred cc--cceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 154 DI--STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 154 ~~--~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.. ........++..|+|||.+.+ ..++.++|+||||+++++|++|..||........ ...... ............
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~~~~~-~~g~~~~~~~~~ 238 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LKLILS-VLGSPSEEVLNR 238 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HHHHHH-HhCCChhHhhhh
Confidence 21 111223467888999998765 4689999999999999999999999965432211 111100 000000000000
Q ss_pred -----------cccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 -----------NLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 -----------~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+ ......+.++.+++.+||+.+|.+|||+++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 0112357789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=272.74 Aligned_cols=270 Identities=24% Similarity=0.279 Sum_probs=199.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccC-----CceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE-----EFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 72 (285)
.|.+.+.||+|++|+||++.. .+++.|++|.+... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 378899999999999999974 57899999988643 223345567899999999999999999987543 3579
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+++|++. ++|.+++.... .+++..++.++.|++.||.+|| +++++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 9999995 58988886654 4899999999999999999999 99999999999999999999999999999976643
Q ss_pred ccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc-----
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE----- 226 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 226 (285)
.. .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.+.... .................
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcC
Confidence 32 11223456788999998765 46899999999999999999999999653221 11111111110000000
Q ss_pred ------cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH--HHHH
Q 039392 227 ------IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK--LVKI 278 (285)
Q Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~--l~~l 278 (285)
...................+++++.+++++||+.+|.+|||+++++++ +..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000000011123567889999999999999999999999987 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=260.63 Aligned_cols=241 Identities=20% Similarity=0.244 Sum_probs=188.2
Q ss_pred CCCCcee--cccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLI--GRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~l--g~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|++.+.+ |+|+||.||++.. .++..+++|.+........ |......+ +|+|++++++.+...+..++||||
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 5566666 9999999999974 5688899999865422211 22222222 699999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-cEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~i~df~~~~~~~~~~~~ 156 (285)
+++++|.+++.... .+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 91 IKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 99999999997665 5899999999999999999999 99999999999999999888 9999999998765432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....++..|+|||.+.+..++.++|+||+|+++++|++|..||............+.....
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 224 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ---------------- 224 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc----------------
Confidence 1234678899999998888999999999999999999999999754332221111111100
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCC-HHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRIN-AKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~eil~~ 274 (285)
.........++.+.+++.+||+.+|.+||+ +++++++
T Consensus 225 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 -KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000112246677999999999999999995 6998853
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=270.64 Aligned_cols=273 Identities=25% Similarity=0.298 Sum_probs=206.0
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCC-----ceE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-----FKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 72 (285)
+|++.+.||.|++|.||+|... +++.+++|.+.... ....+.+.+|+++++.++|+|++++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999854 58999999887543 334467888999999999999999999987765 789
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
++++++++ +|.+++.+.. .+++..++.++.|++.||++|| +.|++|+||+|.||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999964 8988886655 5899999999999999999999 99999999999999999999999999999987655
Q ss_pred cccc-ceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc--
Q 039392 153 EDIS-TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV-- 228 (285)
Q Consensus 153 ~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 228 (285)
.... .......++..|+|||.+.+. .++.++|+||||+++++|++|..||......+. .................
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhhc
Confidence 4210 112334567889999998887 899999999999999999999999976543221 11111111111100000
Q ss_pred cc--------cccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH--HHHHH
Q 039392 229 DP--------NLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK--LVKIR 279 (285)
Q Consensus 229 ~~--------~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~--l~~l~ 279 (285)
.. .........+ ......+.++.+++++||+.+|.+|||+++++.+ ++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00 0000000000 0112357789999999999999999999999985 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=266.78 Aligned_cols=252 Identities=27% Similarity=0.307 Sum_probs=193.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|...+.||+|+||.||++.. .+++.+++|.+.... ......+.+|+.++.++. |+||+++++.+..+...+++||+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 466778999999999999975 468999999986543 234456788999999986 99999999999888899999999
Q ss_pred cCCCCHHHhhh----cCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 78 MPHGSLEKYLH----SSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 78 ~~~~~L~~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+.. ++.++.. .....+++..+..++.|++.||+||| + .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 854 6665432 12345889999999999999999999 5 5999999999999999999999999999875543
Q ss_pred ccccceeccccccccccCCcccCCC---ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
.. ......++..|+|||.+.+. .++.++|+||+|+++++|++|+.||............... ...
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~------ 228 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK---GDP------ 228 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC---CCC------
Confidence 21 11223467789999988766 6899999999999999999999998754311111111100 000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+... ...+..++.++.+|+.+||..+|.+|||+++++++
T Consensus 229 ~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILS------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCC------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00112356779999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=265.38 Aligned_cols=257 Identities=20% Similarity=0.269 Sum_probs=184.5
Q ss_pred CCCCCceecccCceEEEEEEeCC----CcEEEEEEeeccchhHH-----------HHHHHHHHHHccCCCCcccccccee
Q 039392 1 GFSENNLIGRGGFGSVFKARLGD----GMEVAVKVFNLQYGRVF-----------KSFDVECEMMKSIHHRNIIKVISSC 65 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~----~~~~~iK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~~~~ 65 (285)
.|.+.+.||+|+||+||+|...+ +..+++|+......... .....+...+..+.|++++++++.+
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 47889999999999999997543 45667776443322111 1112233455667899999999876
Q ss_pred ccCC----ceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEE
Q 039392 66 SNEE----FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL 141 (285)
Q Consensus 66 ~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i 141 (285)
.... ..+++++.+. .++.+.+.... ..+...++.++.|++.|++||| +.+++||||||+||+++.++.++|
T Consensus 93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEE
Confidence 5433 3467788773 47777665433 2577888999999999999999 999999999999999999999999
Q ss_pred eeeccceecCccccc-----ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhh
Q 039392 142 SDFGIAKLLTREDIS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWV 216 (285)
Q Consensus 142 ~df~~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 216 (285)
+|||+++........ .......+|+.|+|||...+..++.++||||||+++++|++|..||..............
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999999876432111 111234588999999999999999999999999999999999999976532221111110
Q ss_pred -hhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 217 -NDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 217 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
.........+. ....++.++.++++.|+..+|++||+++++++.++
T Consensus 248 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 248 CDFIKRLHEGKI--------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHhhhhhh--------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00000000000 02245677999999999999999999999998763
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=264.75 Aligned_cols=243 Identities=27% Similarity=0.309 Sum_probs=192.8
Q ss_pred CCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 3 SENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
...+.||+|++|+||+|.. .+++.+++|.+.... ......+.+|+++++.++|+|++++.+++......+++||++
T Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 103 (313)
T cd06633 24 VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC 103 (313)
T ss_pred hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecC
Confidence 4457899999999999975 468899999986432 234456788999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
.+ ++.+++......++...++.++.|++.++.||| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 104 ~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------ 173 (313)
T cd06633 104 LG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ 173 (313)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC------
Confidence 65 788877665556889999999999999999999 99999999999999999999999999998864322
Q ss_pred eccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 159 QTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.....++..|+|||.+. ...++.++|+||||+++++|++|..||................... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------~--- 240 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT----------L--- 240 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------C---
Confidence 12345778899999874 4568889999999999999999999986543222111110000000 0
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 241 ------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011234558899999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.02 Aligned_cols=266 Identities=23% Similarity=0.276 Sum_probs=195.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccC-----------
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE----------- 68 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----------- 68 (285)
.|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+++++.++|||++++++.+...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 478899999999999999975 46899999998766555567788899999999999999999876543
Q ss_pred ---CceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeee
Q 039392 69 ---EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDF 144 (285)
Q Consensus 69 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df 144 (285)
...++++|++++ +|.+++... .+++..++.++.|++.||.||| +.|++|+||+|+||+++ .++.++++||
T Consensus 86 ~~~~~~~lv~e~~~~-~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 86 TELNSVYIVQEYMET-DLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccceEEEEeecccc-cHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 357899999964 898887543 3889999999999999999999 99999999999999997 5567899999
Q ss_pred ccceecCccccc-ceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCC
Q 039392 145 GIAKLLTREDIS-TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI 222 (285)
Q Consensus 145 ~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (285)
|.+......... .......++..|+|||.+.. ..++.++|+||||+++++|++|..||........... ........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~ 238 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL-ILESVPVV 238 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCC
Confidence 999765432111 11122346778999997654 5688999999999999999999999975433222111 11111000
Q ss_pred Cc---cccc----c----ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 223 ST---KEIV----D----PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 223 ~~---~~~~----~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. .... . .......+. .......+.++.+++.+||+.||.+|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPL-RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCH-HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 0000 0 000000000 00112356778999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=264.22 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=193.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|++|.||+|... +++.+++|.+.... ......+.+|+.++.+.. |+||+++++++......+++||+
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 5788999999999999999865 48999999987543 223345566776666664 99999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+++ ++.+++......++...+..++.|++.|+.||| + .|++|+||+|+||++++++.++|+|||++........
T Consensus 96 ~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 96 MST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred cCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 854 788877665556889999999999999999999 6 5999999999999999999999999999876543221
Q ss_pred ceeccccccccccCCcccCCCc----cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGR----VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.....++..|+|||.+.+.. ++.++|+||||+++++|++|+.||...................
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 237 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP----------- 237 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC-----------
Confidence 12234667899999887553 7889999999999999999999986532221111111110000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
.......++.++.+++.+||..||.+||++++++.+-
T Consensus 238 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 238 ------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0000113456789999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=259.04 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=186.0
Q ss_pred ceecccCceEEEEEEe-CCCcEEEEEEeeccch---hHHHHHHHHHHH-HccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG---RVFKSFDVECEM-MKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||.|++|.||+|.. .+++.+|+|.+..... .....+..|..+ ....+|+|++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 6799999999999975 4688999999864321 122233344443 4455899999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++.... .++...+..++.|++.||.||| +.+++|+||+|.||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999987654 3889999999999999999999 99999999999999999999999999999875433 12
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...++..|++||.+.+..++.++|+||||++++++++|..||........ ...... .... . ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~-------~-----~~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILS----RRIN-------W-----PE 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHh----cccC-------C-----CC
Confidence 33467789999998888889999999999999999999999865332211 111100 0000 0 00
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHH---HHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAK---EIVT 273 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~---eil~ 273 (285)
.....++.++.+++.+||..+|++|||+. |+++
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 01124567799999999999999999664 5544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=264.48 Aligned_cols=268 Identities=25% Similarity=0.289 Sum_probs=196.6
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCC--------
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-------- 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 69 (285)
+|++.+.||+|++|.||+|... +++.|++|.+.... ......+.+|+++++.++|||++++++++....
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 4889999999999999999754 68899999986543 223345678999999999999999999886554
Q ss_pred --ceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccc
Q 039392 70 --FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 147 (285)
Q Consensus 70 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~ 147 (285)
.+++++|++++ ++...+......++...++.++.|++.||.||| +.|++|+||+|.||+++.++.++|+|||++
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999976 777777665555899999999999999999999 999999999999999999999999999999
Q ss_pred eecCcccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc-
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK- 225 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 225 (285)
........ ........+..|++||.+.+. .++.++|+||||+++++|++|+.||...... ................
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhh
Confidence 86654321 111222346679999987653 5789999999999999999999998753221 1111111111111000
Q ss_pred --cccccccc-----Cccc--chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 --EIVDPNLL-----SRED--IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 --~~~~~~~~-----~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+...... .... .........+..+.+++.+||..+|.+|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 0000 0000112357789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=261.58 Aligned_cols=265 Identities=24% Similarity=0.321 Sum_probs=195.6
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch--hHHHHHHHHHHHHccC---CCCccccccceeccCCc-----
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG--RVFKSFDVECEMMKSI---HHRNIIKVISSCSNEEF----- 70 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 70 (285)
|++.+.||+|++|.||+|... +++.+++|.+..... .....+.+|+.+++++ +|+|++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 778999999999999999865 589999999864322 2223455677766655 59999999999987766
Q ss_pred eEEEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 71 KALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
.++++|++.+ +|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999965 8988876543 24889999999999999999999 99999999999999999999999999999877
Q ss_pred cCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc-
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV- 228 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 228 (285)
...... .....++..|+|||.+.+..++.++|+||||+++++|++|..||......+. .................
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCChHhcCC
Confidence 644321 1223467789999999888899999999999999999999999875433222 22221111100000000
Q ss_pred c----ccccCcc-cch-hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 D----PNLLSRE-DIH-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~----~~~~~~~-~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ....... ... .......+..+.+++.+||+.||++||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0000000 000 11112456778999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=262.08 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=196.2
Q ss_pred CCCCCceecccCceEEEEEEe----CCCcEEEEEEeeccc----hhHHHHHHHHHHHHccC-CCCccccccceeccCCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY----GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 71 (285)
+|++.+.||+|+||.||++.. .+|+.+++|++.... ....+.+.+|+.+++++ +|+||+++.+.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 689999999999999999974 368899999986432 12335677899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++++|++++++|.+++.... .++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999987654 3888999999999999999999 9999999999999999999999999999987654
Q ss_pred cccccceeccccccccccCCcccCCC--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
..... ......++..|++||.+... .++.++|+||||+++++|++|..||...... ..............
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~------ 228 (290)
T cd05613 157 EDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE------ 228 (290)
T ss_pred ccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccC------
Confidence 32211 11234467789999988653 4788999999999999999999998632111 11111111000000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
...+..+++.+.+++.+||..+|.+|| ++++++.+
T Consensus 229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 001223556788999999999999997 77887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=265.83 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=194.9
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|...+.||+|++|.||+|+. .+++.+++|.+... .......+.+|+++++.++|+|++++.+++......++|+|+
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 56678999999999999975 46888999987642 233445677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+. +++.+++......++...+..++.|++.|+.+|| +.+++|+||+|.||+++.++.++++|||++......
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 96 5888877655556889999999999999999999 999999999999999999999999999998765432
Q ss_pred eeccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 158 IQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
....++..|+|||.+. ....+.++||||||+++++|++|..||......... ........
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~-------------- 231 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNES-------------- 231 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-HHHhhcCC--------------
Confidence 2234677899999864 346788999999999999999999998653221111 11110000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
........+..+.+++.+||..+|.+||++++++++-.
T Consensus 232 ----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 ----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00012234566889999999999999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=261.98 Aligned_cols=254 Identities=20% Similarity=0.254 Sum_probs=196.6
Q ss_pred CCCCCceecccCceEEEEEEe----CCCcEEEEEEeeccc----hhHHHHHHHHHHHHccC-CCCccccccceeccCCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY----GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 71 (285)
+|++.+.||+|++|.||++.. .+++.+++|++.... ......+.+|+++++++ +|++++++.+.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 688999999999999999863 357889999986432 22335577899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++||||+++++|.+++.... .++...++.++.|++.+|.+|| +.+++|+||+|.||+++.++.++++|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999886554 3888899999999999999999 9999999999999999999999999999987654
Q ss_pred cccccceeccccccccccCCcccCCCc--cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGR--VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
..... ......++..|++||...+.. .+.++|+||||+++++|++|..||....... ............
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~------- 227 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS------- 227 (288)
T ss_pred ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc-------
Confidence 32211 112234678899999887654 7889999999999999999999985321111 111111100000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
....+..++..+.+++.+||+.+|++|||++++.+.|.
T Consensus 228 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 ---------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred ---------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 00112234567899999999999999999877766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=233.58 Aligned_cols=266 Identities=24% Similarity=0.271 Sum_probs=203.6
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchh--HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|.-.++||+|.+|+||+|++ .+++-||+|.+..+... .-....+|+-+++.++|.||++++++...++.+.+|+|+|
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 56678999999999999985 46888999998765432 2256778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
..+|..+..+-++.++.+.++.++.|++.|+.++| ++++.|||+||.|.+|+.+|.+|+.|||+++.++-+ ..-
T Consensus 84 -dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip--vrc 157 (292)
T KOG0662|consen 84 -DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRC 157 (292)
T ss_pred -hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEe
Confidence 45999999888888999999999999999999999 999999999999999999999999999999987653 233
Q ss_pred eccccccccccCCcccCCCc-cCcchhhHHHHHHHHHHhhCCCC-CccccccchhhhhhhhhhcCCCccccccccc----
Q 039392 159 QTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLIETFTRKKP-TDEIFNGEMTLKHWVNDWLPISTKEIVDPNL---- 232 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (285)
.+....|.||.+|.++.+.. |+.+.|+||.||++.|+.....| |.+.. ...+....+........+.+..-..
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 45567899999999998874 89999999999999999985544 54432 2233333322222221111111111
Q ss_pred --cCcccchhhh---hhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 233 --LSREDIHFVA---KEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 233 --~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+..+.-... -+.....-+++++++|.-+|.+|+|+++++++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111100000 12233445789999999999999999998864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=268.91 Aligned_cols=266 Identities=26% Similarity=0.321 Sum_probs=196.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeecc--chhHHHHHHHHHHHHccC-CCCccccccceecc--CCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSI-HHRNIIKVISSCSN--EEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 74 (285)
+|++.+.||+|++|.||+|... +++.+++|.+... .......+.+|+.+++++ +|+||+++++++.. ...+++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 4788899999999999999754 6889999987532 223345567899999999 99999999998754 3468999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
+|++.+ +|..++... .++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 88 FEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred eccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 999965 998888665 4788888999999999999999 9999999999999999999999999999987664432
Q ss_pred cc---ceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC-------
Q 039392 155 IS---TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS------- 223 (285)
Q Consensus 155 ~~---~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 223 (285)
.. .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||....+..... ..........
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE-KIIEVIGPPSAEDIESI 240 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHHHHHH
Confidence 11 12223457888999997755 467899999999999999999999997644332211 1111100000
Q ss_pred ----ccccccccccCcccch-hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 ----TKEIVDPNLLSREDIH-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 ----~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....... ........ ......++.++.+++.+||+.+|.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDS-LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhh-cccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 00000000 00112257789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=276.18 Aligned_cols=275 Identities=25% Similarity=0.349 Sum_probs=207.6
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccC------CceEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE------EFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~ 73 (285)
|...+.||+|+||.||+|+ ..+|+.||||.+.... ....+.-.+|++++++++|+|||+++++-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3456789999999999998 5589999999987543 34446667899999999999999999986543 35679
Q ss_pred EEeccCCCCHHHhhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCC--cEEEeeeccc
Q 039392 74 VLEYMPHGSLEKYLHSSN--YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD--DNM--VAHLSDFGIA 147 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~--~~~--~~~i~df~~~ 147 (285)
+||||.||+|...+++.. ..+++...+.++.+++.|+.||| ++||+||||||.||++. .+| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999997632 23999999999999999999999 99999999999999984 333 4699999999
Q ss_pred eecCcccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
+.+.++. ......||..|++||+... ..++...|.||||+++|++.||..||.....+..............+...
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9887754 4567789999999999985 78999999999999999999999999766555432222211112221111
Q ss_pred cccccccCcccchhh--------hhhHhHHHHHHhhhcccccCcCCCC--CHHHHHHHHHHHHHHH
Q 039392 227 IVDPNLLSREDIHFV--------AKEQCVSFVFNVAMECTVESPEQRI--NAKEIVTKLVKIRDSL 282 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp--s~~eil~~l~~l~~~~ 282 (285)
.+....-...+.++. ........+...+..+|..+|.+|- ...+.-..+.++++..
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 111111111121111 1223334455778889999999998 8888888888877654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=268.75 Aligned_cols=261 Identities=23% Similarity=0.276 Sum_probs=194.2
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCC------ce
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE------FK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 71 (285)
+|++.+.||+|++|.||++. ..+++.||+|.+.... ......+.+|++++++++|+||+++.+++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 47889999999999999997 4478999999885432 233456778999999999999999999886543 35
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++|++++ +++|.+++... .+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++++|||++....
T Consensus 96 ~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 8999999 67998888643 3889999999999999999999 9999999999999999999999999999987654
Q ss_pred cccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC-------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS------- 223 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 223 (285)
... ....++..|++||.+.+ ..++.++|+||||++++++++|..||........... .........
T Consensus 170 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 170 SEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME-IMKVTGTPSKEFVQKL 243 (343)
T ss_pred cCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCCHHHHHhh
Confidence 321 22346778999998766 4588999999999999999999999975432211111 111100000
Q ss_pred ----ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 224 ----TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 224 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
...............-......+++++.+++.+||+.||++|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000112356777999999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=260.65 Aligned_cols=266 Identities=26% Similarity=0.307 Sum_probs=200.4
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|++.+.||+|.+|.||+|... +++.+++|++.... ....+.+..|+++++.++|+|++++.+++......++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 678899999999999999754 58999999987653 333456778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++ +|.+++.+....++...++.++.|++.+|++|| +.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 74 999999876445999999999999999999999 99999999999999999999999999999876644321 1
Q ss_pred eccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc--------cc
Q 039392 159 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI--------VD 229 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 229 (285)
......+..|+|||.+.+. .++.++|+||||++++++++|..||........ ................ ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhccccccc
Confidence 2233456779999988766 789999999999999999999999865332211 1111110000000000 00
Q ss_pred ccccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........... ......+..+.+++++||..+|++||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000 0011236779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=266.79 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=199.8
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|+.-++||+|+||.||-+. ..+|+.+|.|.+..+. ..-..-..+|.++|++++.++||.+-..|+..+.+|+|+..
T Consensus 187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence 5677899999999999985 5689999999875432 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++||+|.-.|.+.+. .+++..++-++.+|+.||.+|| ..+||+||+||+|||+|+.|+++|+|+|+|..+....
T Consensus 267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~-- 341 (591)
T KOG0986|consen 267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK-- 341 (591)
T ss_pred ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC--
Confidence 999999988877653 3999999999999999999999 9999999999999999999999999999999876542
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......||.+|+|||++.+..|+.+.|.|||||++|+|+.|+.||...-.... . +.++..... .
T Consensus 342 -~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--~------------eEvdrr~~~-~ 405 (591)
T KOG0986|consen 342 -PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--R------------EEVDRRTLE-D 405 (591)
T ss_pred -ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--H------------HHHHHHHhc-c
Confidence 33445899999999999999999999999999999999999999965221110 0 001110100 0
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
+. ..+...+++++++.+.+|..||.+|.-+.
T Consensus 406 ~~--ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 406 PE--EYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hh--hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 01 11356788899999999999999997554
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=258.62 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=186.3
Q ss_pred eecccCceEEEEEEe-CCCcEEEEEEeeccch---hHHHHHHHHH---HHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 7 LIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG---RVFKSFDVEC---EMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.||+|+||.||++.. .+++.||+|.+..... .....+..|. ..++...||+++++.+.+...+..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999974 4689999999865321 1111223333 34445579999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
|++|..++.+.. .+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 999998886554 4899999999999999999999 9999999999999999999999999999987553321 1
Q ss_pred ccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||.+.+. .++.++|+||+|+++++|++|..||.............. ... .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~----------------~ 214 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLT----------------M 214 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--hhc----------------c
Confidence 234578889999998754 689999999999999999999999976422211100000 000 0
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
....+...+.++.+++++||..+|.+|| ++++++++
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0011223467799999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=265.21 Aligned_cols=269 Identities=20% Similarity=0.272 Sum_probs=193.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchh--HHHHHHHHHHHHccCCCCccccccceeccC--------C
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGR--VFKSFDVECEMMKSIHHRNIIKVISSCSNE--------E 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~ 69 (285)
+|++.+.||+|++|.||+|... +++.+++|.+...... ....+.+|+++++.++|+||+++++.+... .
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 5889999999999999999754 6889999988654321 223567899999999999999999987443 3
Q ss_pred ceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 70 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
.++++++|+.+ ++...+......++...+..++.|++.||.||| +.|++|+||+|+||++++++.++|+|||++..
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 46899999965 777777655556999999999999999999999 99999999999999999999999999999976
Q ss_pred cCcccccce---------eccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhh
Q 039392 150 LTREDISTI---------QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDW 219 (285)
Q Consensus 150 ~~~~~~~~~---------~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 219 (285)
......... .....+++.|+|||.+.+. .++.++|+||||+++++|++|..||.+...... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence 543221111 1123456779999987654 578999999999999999999999875433211 11111111
Q ss_pred cCCCcc---------ccccccccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 220 LPISTK---------EIVDPNLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 220 ~~~~~~---------~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...... ..............+ .......+.+.+++.+||+.||.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000 000000000000000 0112234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.40 Aligned_cols=261 Identities=24% Similarity=0.299 Sum_probs=195.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCCc------e
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF------K 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~ 71 (285)
+|++.+.||+|++|.||+|... +++.|++|++... .......+.+|+.+++.++|+|++++.+++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 5888999999999999999754 6889999987643 22334567789999999999999999998865544 8
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++++|++ +++|.+++... .+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 96 YLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 8999999 66999988653 3899999999999999999999 9999999999999999999999999999997654
Q ss_pred cccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.. .....++..|+|||.+.+. .++.++|+||||++++++++|..||....... .......... .....+...
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~-~~~~~~~~~ 242 (343)
T cd07851 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVG-TPDEELLQK 242 (343)
T ss_pred cc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcC-CCCHHHHhh
Confidence 32 1233567789999987653 67899999999999999999999997543221 1111111110 000000000
Q ss_pred c-----------ccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 N-----------LLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~-----------~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. .......++ ......+.++.+++.+||+.+|++|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 000000000 0112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=261.72 Aligned_cols=263 Identities=20% Similarity=0.285 Sum_probs=201.8
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CC-----ccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HR-----NIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~~v 74 (285)
|.+...+|+|.||.|..+- ..++..||||+++ ......+...-|+++|+++. +. -++.+.++|...++.|+|
T Consensus 91 y~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik-~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCiv 169 (415)
T KOG0671|consen 91 YEIVDLLGEGTFGKVVECWDRETKEHVALKIIK-NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIV 169 (415)
T ss_pred eehhhhhcCCcccceEEEeecCCCceehHHHHH-HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEE
Confidence 7889999999999999985 3457899999986 44566677788999999994 22 467788889999999999
Q ss_pred EeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC------------------
Q 039392 75 LEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD------------------ 135 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~------------------ 135 (285)
+|.+ |.|+.+++..++ .+++...++.|+.|+++++++|| +.+++|.|+||+||++.+
T Consensus 170 fell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 170 FELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred Eecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 9999 669999997754 45999999999999999999999 999999999999999832
Q ss_pred --CCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccch-hh
Q 039392 136 --NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM-TL 212 (285)
Q Consensus 136 --~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~ 212 (285)
+..++++|||.|+...... .....|..|.|||++.+..++..+||||+|||++|+.+|...|+...+.+. .+
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred CCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 3358999999998765443 456788999999999999999999999999999999999999988665443 23
Q ss_pred hhhhhhhcCCCc------cccccccccC----------------cccch--hhhhhHhHHHHHHhhhcccccCcCCCCCH
Q 039392 213 KHWVNDWLPIST------KEIVDPNLLS----------------REDIH--FVAKEQCVSFVFNVAMECTVESPEQRINA 268 (285)
Q Consensus 213 ~~~~~~~~~~~~------~~~~~~~~~~----------------~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 268 (285)
.+.+.+..+... .+.+....+. ..+.+ ....+....++.+|+++||..||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 332222111110 0011110000 00000 11123445669999999999999999999
Q ss_pred HHHHHH
Q 039392 269 KEIVTK 274 (285)
Q Consensus 269 ~eil~~ 274 (285)
.|+|.+
T Consensus 401 ~EAL~H 406 (415)
T KOG0671|consen 401 REALSH 406 (415)
T ss_pred HHHhcC
Confidence 999874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=265.56 Aligned_cols=265 Identities=21% Similarity=0.232 Sum_probs=194.2
Q ss_pred CCceecccCceEEEEEEeC-CCcEEEEEEeeccchhH--------------HHHHHHHHHHHccCCCCccccccceeccC
Q 039392 4 ENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRV--------------FKSFDVECEMMKSIHHRNIIKVISSCSNE 68 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 68 (285)
+.+.||.|++|+||+|... +++.||+|.+....... ...+.+|+++++.++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4577999999999999754 68999999986432211 12466899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 69 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 69 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
+..+++||++. ++|.+++.... .++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++++|||.+.
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcccee
Confidence 99999999996 48998886544 3889999999999999999999 9999999999999999999999999999997
Q ss_pred ecCcccc------------cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhh
Q 039392 149 LLTREDI------------STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW 215 (285)
Q Consensus 149 ~~~~~~~------------~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~ 215 (285)
....... ........++..|+|||.+.+. .++.++|+||||+++++|++|..||......+. ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~i 246 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-LGRI 246 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 6652110 1111223457789999988765 468999999999999999999999875433221 1111
Q ss_pred hhhhcCCCcccccc--------ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 216 VNDWLPISTKEIVD--------PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 216 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...........+.. +................+.++.+++++||..+|++|||+++++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11110000000000 000000000001112346778999999999999999999999864
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=257.33 Aligned_cols=265 Identities=20% Similarity=0.249 Sum_probs=196.0
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch-hHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|++.+.||+|++|+||+|... +++.+++|.+..... .......+|+..+++++ |+|++++++.+......++|||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 788999999999999999864 588899998765432 12233456889999998 999999999999999999999999
Q ss_pred CCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++|.+.+.... ..++...+..++.|++.+|.||| +++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 678988876654 45899999999999999999999 9999999999999999999999999999997664422
Q ss_pred eeccccccccccCCcccC-CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc---------c
Q 039392 158 IQTQTLATIGYMAPEYGK-EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE---------I 227 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 227 (285)
......++..|+|||.+. +..++.++|+||||+++++|++|+.||......+. ............... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhcc
Confidence 112345677899999774 44689999999999999999999999865432211 111111111100000 0
Q ss_pred ccccccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDPNLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
............. ......+..+.+++++||+.+|.+|||++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000 0011225779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=298.27 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=205.2
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|..+..||.|.||.||.+. ..+|+-.|+|-+... .........+|..+++.++|||+++++++-...+..++.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 5567899999999999997 457888999976543 2344566778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc--cc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED--IS 156 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~--~~ 156 (285)
++|+|.+.++..+ ..++.....+..|++.|++||| +.|||||||||+||+++.+|.+|.+|||.|..+.+.. ..
T Consensus 1317 ~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred ccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999986544 3777777888999999999999 9999999999999999999999999999999876642 12
Q ss_pred ceeccccccccccCCcccCCC---ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.......||+-|+|||++.+. ....++|||||||+..||+||+.||...++.-..+.+...+-.+.
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq----------- 1461 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ----------- 1461 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC-----------
Confidence 222356799999999998875 478899999999999999999999987655433333322221111
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+...+++-++|+..||..||++|.++.|++++
T Consensus 1462 --------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 --------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 133477889999999999999999999988865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=288.66 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=185.9
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceeccC----------
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE---------- 68 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---------- 68 (285)
+|+.++.||+|+||.||+++++ +|+.||||.+... +......+.+|+..|.+++|||||+++..+.+.
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~ 559 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV 559 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence 3667889999999999999865 8999999998765 455567788999999999999999876643100
Q ss_pred --------------------------------------------------------------------------------
Q 039392 69 -------------------------------------------------------------------------------- 68 (285)
Q Consensus 69 -------------------------------------------------------------------------------- 68 (285)
T Consensus 560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~ 639 (1351)
T KOG1035|consen 560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS 639 (1351)
T ss_pred ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence
Q ss_pred -----------------------------CceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 039392 69 -----------------------------EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119 (285)
Q Consensus 69 -----------------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 119 (285)
..+|+-||||+...+.+++.++...-.....|+++++|++||.|+| +.
T Consensus 640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---~~ 716 (1351)
T KOG1035|consen 640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---DQ 716 (1351)
T ss_pred cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---hC
Confidence 0246778888876666666655432246778999999999999999 99
Q ss_pred CeeecCCCCCCeeeCCCCcEEEeeeccceecC----c--c----------cccceeccccccccccCCcccCCCc---cC
Q 039392 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT----R--E----------DISTIQTQTLATIGYMAPEYGKEGR---VS 180 (285)
Q Consensus 120 ~~~h~di~~~nili~~~~~~~i~df~~~~~~~----~--~----------~~~~~~~~~~~~~~~~~PE~~~~~~---~~ 180 (285)
|++||||||.|||+++.+.|||+|||+++... . . ......+...||..|.|||++.+.. |+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999998721 0 0 0011234567899999999887654 99
Q ss_pred cchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhccccc
Q 039392 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVE 260 (285)
Q Consensus 181 ~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 260 (285)
.+.||||||++++||+.- |...-..-...........+.+ ..+ ..+..+.-.++|++|++.
T Consensus 797 ~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP~~-~~f---------------~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIPEP-ADF---------------FDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred chhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCCCC-ccc---------------ccccchHHHHHHHHHhcC
Confidence 999999999999999853 4432222222222221111111 000 112233356899999999
Q ss_pred CcCCCCCHHHHHH
Q 039392 261 SPEQRINAKEIVT 273 (285)
Q Consensus 261 ~p~~Rps~~eil~ 273 (285)
||.+||||.|+|.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999985
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=251.75 Aligned_cols=245 Identities=20% Similarity=0.240 Sum_probs=195.2
Q ss_pred ceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceecc----CCceEEEEeccC
Q 039392 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSN----EEFKALVLEYMP 79 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~~v~e~~~ 79 (285)
++||-|-.|.|-.+. ..+++.+|+|++... ..+++|+++.-+. .|+|||.+++++.+ ...+.+|||.++
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 589999999999886 457999999997532 4456788765555 49999999999854 456789999999
Q ss_pred CCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCcEEEeeeccceecCcccc
Q 039392 80 HGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 80 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~i~df~~~~~~~~~~~ 155 (285)
||.|...++..+ ..+++..+..|+.||+.|+.||| ..+|.||||||+|+|.+ .+..+|++|||+|.....
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--- 216 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--- 216 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC---
Confidence 999998887654 46999999999999999999999 99999999999999996 466799999999986553
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+.|+.|.|||++....++.+.|+||+|++||-|++|.+||...-... .+- ....+.....
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--isp-----------gMk~rI~~gq 283 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISP-----------GMKRRIRTGQ 283 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CCh-----------hHHhHhhccC
Confidence 223356678999999999999999999999999999999999999997522110 000 0001111122
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+.-+.+..++.+.+++|+++|..+|.+|.|+++++.+
T Consensus 284 y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 223334478899999999999999999999999998864
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=252.37 Aligned_cols=239 Identities=28% Similarity=0.345 Sum_probs=193.9
Q ss_pred ecccCceEEEEEEeC-CCcEEEEEEeeccch---hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 8 IGRGGFGSVFKARLG-DGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 8 lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
||+|++|.||++... +++.+++|++..... .....+.+|+++++.++|+|++++++.+..+...+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999754 588999999875432 2456788899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecccc
Q 039392 84 EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163 (285)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~ 163 (285)
.+++..... ++...++.++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||.+....... .......
T Consensus 81 ~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEGR-FSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 999976653 889999999999999999999 9999999999999999999999999999997764432 1123445
Q ss_pred ccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhh
Q 039392 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243 (285)
Q Consensus 164 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
++..|++||...+...+.++|+|+||++++++++|..||......... ..... ..+..+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-~~~~~--------------------~~~~~~ 213 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY-EKILK--------------------DPLRFP 213 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhc--------------------CCCCCC
Confidence 677899999998888999999999999999999999999654321111 11000 001112
Q ss_pred hHhHHHHHHhhhcccccCcCCCCCH---HHHHH
Q 039392 244 EQCVSFVFNVAMECTVESPEQRINA---KEIVT 273 (285)
Q Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~---~eil~ 273 (285)
...+..+.+++++||..||++|||+ +++++
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 2235668999999999999999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=270.73 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=212.8
Q ss_pred CCCceecccCceEEEEEEeCC-CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 3 SENNLIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
...++||.|.+|.||.|.|+. .--||||-++.+ ....++|..|+.+++.++|||+++++++|..+.-+|+|+||+..|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 356799999999999999875 345788887643 456788999999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 82 SLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 82 ~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
+|.++++..+. ..+....+.|+.||..|++||. +++++||||-..|.|+.++..||+.|||+++....+... .+.
T Consensus 349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AHA 424 (1157)
T KOG4278|consen 349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AHA 424 (1157)
T ss_pred cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-ccc
Confidence 99999987654 3777788899999999999999 999999999999999999999999999999988765422 222
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...-+.-|.|||.+....++.++|||+||+++|++.| |-.||.+..-.+.. -+-+.+.+
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY--------------------~LLEkgyR 484 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------------------GLLEKGYR 484 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH--------------------HHHhcccc
Confidence 2333556999999999999999999999999999998 66787664322211 01233444
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
...+.+|++.+++||+.||+.+|.+||++.|+-+.++.+..+
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 555789999999999999999999999999999999998744
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=263.21 Aligned_cols=261 Identities=26% Similarity=0.311 Sum_probs=193.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceecc-CCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSN-EEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 76 (285)
+|++.+.||.|+||.||++.. .+++.+++|.+.... ....+.+.+|+++++.++|||++++.+++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 588899999999999999974 478999999875322 2334667789999999999999999998865 567889999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++ +++|.+++... .++...+..++.|++.||.+|| +.+++|+||+|.||+++.++.++|+|||.+.......
T Consensus 91 ~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-- 162 (328)
T cd07856 91 LL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-- 162 (328)
T ss_pred hh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence 99 55898887643 3788888899999999999999 9999999999999999999999999999987543211
Q ss_pred ceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhc-----------CCCc
Q 039392 157 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL-----------PIST 224 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~ 224 (285)
....++..|+|||.+.+ ..++.++|+||||+++++|++|..||....... .......... ....
T Consensus 163 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 163 ---TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ---CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhccchhh
Confidence 22345778999998765 568999999999999999999999986532211 1110000000 0000
Q ss_pred cccccccccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+.... ......... ......+.++.++|.+||+.+|++|||+++++.+
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000000 0112356789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=293.65 Aligned_cols=261 Identities=28% Similarity=0.476 Sum_probs=199.4
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+...+.||+|+||.||+|.. .++..||+|.+...... ...|++.+++++||||+++++++......++||||+++
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 45667899999999999975 57899999987643221 12468889999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++.. ++...+..++.|++.|++|||...+.+++||||||+||+++.++..++. ++....... ..
T Consensus 768 g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~ 836 (968)
T PLN00113 768 KNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DT 836 (968)
T ss_pred CcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CC
Confidence 999999853 7788899999999999999995546699999999999999988887765 554432211 12
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcC-CCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP-ISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (285)
...++..|+|||.+.+..++.++||||||+++|||++|+.||+...........|...... .......++.....
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 912 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD---- 912 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC----
Confidence 2356788999999999899999999999999999999999986543333333333332211 11122222222111
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.........++.+++.+|++.+|++|||++|+++.|+++.+.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 111233455788999999999999999999999999998763
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=263.12 Aligned_cols=268 Identities=23% Similarity=0.259 Sum_probs=192.5
Q ss_pred CCCCCceecccCceEEEEEEeC-C--CcEEEEEEeeccc--hhHHHHHHHHHHHHccC-CCCccccccceec----cCCc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-D--GMEVAVKVFNLQY--GRVFKSFDVECEMMKSI-HHRNIIKVISSCS----NEEF 70 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~--~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~----~~~~ 70 (285)
+|++.+.||+|+||.||++... + +..+|+|.+.... ....+.+.+|+++++++ +|+||+++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 6899999999999999999753 4 7789999876432 22345677899999998 5999999998643 2345
Q ss_pred eEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceec
Q 039392 71 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~ 150 (285)
.+++++++. ++|.+++.... .++...++.++.||+.||.||| +.|++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 778889885 58988886544 4889999999999999999999 999999999999999999999999999999765
Q ss_pred Cccccc--ceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc--
Q 039392 151 TREDIS--TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK-- 225 (285)
Q Consensus 151 ~~~~~~--~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 225 (285)
...... .......++..|+|||.+.+ ..++.++|+||+|++++++++|..||....... ...............
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 432211 11123457888999997655 468999999999999999999999987533211 111111110000000
Q ss_pred -cc-------ccccccCcccchhh-hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 -EI-------VDPNLLSREDIHFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 -~~-------~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ............+. .....+..+.+++.+||+.||.+|||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 00000000000000 112346779999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=253.55 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=191.3
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeecc-----chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQ-----YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
|.+.+.||+|++|.||++... .+..+++|+.+.. .......+..|+.+++.++|||++++++.+......++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 788999999999999999754 3445555554421 1122334667899999999999999999999999999999
Q ss_pred eccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 76 EYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 76 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
||+++++|.+++.. ....+++..++.++.|++.|+.+|| +.|++|+||+|+||+++. +.++++|||.+.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999988753 3345899999999999999999999 999999999999999975 5699999999876543
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.. .......++..|++||...+..++.++|+||||++++++++|..||........... ... ..
T Consensus 158 ~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~-~~~---~~---------- 221 (260)
T cd08222 158 SC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR-IVE---GP---------- 221 (260)
T ss_pred Cc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHc---CC----------
Confidence 22 112234467789999998888889999999999999999999999864321111111 000 00
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+..++.++.+++.+||..+|++||++.+++++
T Consensus 222 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 ------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 000123456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=264.92 Aligned_cols=262 Identities=24% Similarity=0.297 Sum_probs=191.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccC------Cce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE------EFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 71 (285)
+|++.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+++++.++|+||+++.+++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 478889999999999999974 578999999986533 22345677899999999999999999987532 346
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+++++++ +++|.+++... .++...++.++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 98 ~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 98 YLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred EEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 7788877 77998887654 3889999999999999999999 9999999999999999999999999999987543
Q ss_pred cccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc---cc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK---EI 227 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 227 (285)
.. .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||........ .............. ..
T Consensus 172 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 172 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHhhc
Confidence 22 123456778999998766 4688999999999999999999999865332211 11111111000000 00
Q ss_pred ccc---c----ccCcccchhh-hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDP---N----LLSREDIHFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~---~----~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
... . ........+. .....+.++.++|.+||+.||.+|||+.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 0 0000000000 011346678999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=245.45 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=201.5
Q ss_pred CCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEeccCC
Q 039392 4 ENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
++..||.|..|.||+++. .+|.-+|||.+..... +...++...+.+...-+ +|+|++.+++|..+...++.||.+ +
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 456799999999999974 5689999999876543 44456777777766554 899999999999998888999998 4
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
..++.++.+..+++++..+-++...++.||.||.. ++|++|||+||.||++|..|++|++|||.+..+.+ +....
T Consensus 175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAht 249 (391)
T KOG0983|consen 175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHT 249 (391)
T ss_pred HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---ccccc
Confidence 47788887777789999999999999999999996 88999999999999999999999999999987765 33445
Q ss_pred cccccccccCCcccCC---CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 161 QTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
...|-+-|+|||-+.. ..|+.++||||||+.++|+.||..||.+...+-..+.......+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP----------------- 312 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP----------------- 312 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-----------------
Confidence 5566777999998764 46899999999999999999999999886555444444333211
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
-.+....+.++.+.+|+..||..|+.+||...++|++
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1122233467789999999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=270.85 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=206.4
Q ss_pred CCceecccCceEEEEEEeC--CCc--EEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 4 ENNLIGRGGFGSVFKARLG--DGM--EVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~--~~~--~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
..++||+|.||.|++|.|. +|+ .||||.+...... +...|.+|+.+|.+|+|+++++++++..+ ...-+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4578999999999999753 344 5799998776644 66889999999999999999999999987 4455999999
Q ss_pred CCCCHHHhhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+.|+|.+.+.+ ....+.......++.||+.|+.||. .+++||||+-..|+++.....|||+|||+.+.+.......
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999877 3445888899999999999999999 9999999999999999999999999999999887644333
Q ss_pred ee-ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 158 IQ-TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 158 ~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.. .......-|+|||.+....++-++|+|++|+.+|||++ |+.||.+....+. .. .+.
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI-----------------L~--~iD- 329 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI-----------------LK--NID- 329 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH-----------------HH--hcc-
Confidence 22 23344556999999999999999999999999999998 8889876332211 11 111
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
...++..++.|+..+++++..||..+|.+|||+..|.+.+-
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 44556678899999999999999999999999999975443
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=263.02 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=193.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccC------Cce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE------EFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 71 (285)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++... ...
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 477889999999999999975 468999999886432 22335677899999999999999999988644 346
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++++|++.. +|..+.. ..++...+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 96 ~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 96 YLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 899999854 7776652 23888999999999999999999 9999999999999999999999999999987543
Q ss_pred cccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST------ 224 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 224 (285)
.. .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.+...... .............
T Consensus 169 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 169 AE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHh
Confidence 21 122345778999998766 4688999999999999999999999976432111 1111110000000
Q ss_pred -----ccccc-ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH--HHHHH
Q 039392 225 -----KEIVD-PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK--LVKIR 279 (285)
Q Consensus 225 -----~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~--l~~l~ 279 (285)
..... .......... ......+..+.+++.+||+.||.+||++++++.+ ++..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cccchHHHHhhcCCcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000 0000000000 0012356678999999999999999999999965 55544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=248.35 Aligned_cols=260 Identities=21% Similarity=0.321 Sum_probs=201.0
Q ss_pred CceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEeccCCCC
Q 039392 5 NNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYMPHGS 82 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 82 (285)
.+.||+|+++.|-.+. ..+|.++|||++.+.......+..+|++++.+.+ |+||++++++|+++..+|+|||-+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3579999999999885 6789999999998887788889999999999996 9999999999999999999999999999
Q ss_pred HHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc---EEEeeeccceecC--ccc---
Q 039392 83 LEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLT--RED--- 154 (285)
Q Consensus 83 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~i~df~~~~~~~--~~~--- 154 (285)
|...|.+... +++..+..+..+|+.||.+|| .+||.|||+||+||+-.+... +||+||.+..-.. .+-
T Consensus 163 lLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 163 LLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999877665 999999999999999999999 999999999999999975544 7999998875321 111
Q ss_pred ccceeccccccccccCCcccC---C--CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc-ccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGK---E--GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK-EIV 228 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~---~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 228 (285)
.........|+..|||||+.. + ..|+.+.|.||||+++|-|++|..||.+....+.. |.++..-.... +++
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---WdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---WDRGEVCRVCQNKLF 315 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---ccCCCccHHHHHHHH
Confidence 112223567888999999542 3 35899999999999999999999999875332111 11111111000 011
Q ss_pred cccccCcccchhh--hhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 229 DPNLLSREDIHFV--AKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 229 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
.... +...+|+ -+-.++.+..+++..+|..++.+|.++.+++.
T Consensus 316 esIQ--EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 ESIQ--EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHh--ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1101 1111111 24467889999999999999999999998876
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=287.12 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=202.9
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|.++++||+|+||.|..++ ..+++-||+|+++.- .....+-|.+|-.+|-.-+.+=|++++..|++++++|+|||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 58899999999999999997 457888999998652 23334567888889988889999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++||+|..++.+.. .+++..++-++..|+.||..|| +.|+|||||||+|||+|..|++|+.|||.|-....+. .
T Consensus 156 Y~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~ 230 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-T 230 (1317)
T ss_pred cccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCC-c
Confidence 999999999998888 6999999999999999999999 9999999999999999999999999999998877543 3
Q ss_pred ceeccccccccccCCcccCC-----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.......|||-|.+||++.. +.|++..|.||+|+++|+|+.|..||.+..-.+...+.. .
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm-~-------------- 295 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM-N-------------- 295 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh-c--------------
Confidence 34456789999999998763 458999999999999999999999998743322222211 1
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC---HHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN---AKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~~ 274 (285)
-...+.|+....++.++.+||.+.+. +|..|.. ++++-.+
T Consensus 296 --hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 296 --HKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred --hhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 01112222234477889999998886 4556665 7776543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=267.12 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=202.3
Q ss_pred CceecccCceEEEEEE-eCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 5 NNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
.+.||+|.||+||-|. .++|+.||||++.+-. ......+++|+.+|+.+.||.|+.+...|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4689999999999996 5689999999997532 223367889999999999999999999999999999999999775
Q ss_pred CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CcEEEeeeccceecCcccccce
Q 039392 82 SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~---~~~~i~df~~~~~~~~~~~~~~ 158 (285)
-|+-++.+....+++....-+..||+.||.||| -++|+|+|+||+||++.+. -++||+|||+|+..... ..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---sF 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---SF 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh---hh
Confidence 555566666666999999999999999999999 9999999999999999643 47999999999998764 34
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
.....||+-|+|||++.+..|+.+.||||+|+++|.-++|..||.....-....+ ....-.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ-------------------NAaFMy 783 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ-------------------NAAFMY 783 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh-------------------cccccc
Confidence 4567899999999999999999999999999999999999999865211111111 111111
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
....+..++.++.+||..+|+..-.+|.|....+++-
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 1222667888899999999999999999999887653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=247.55 Aligned_cols=269 Identities=21% Similarity=0.339 Sum_probs=196.1
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceecc--------CCc
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSN--------EEF 70 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~ 70 (285)
|.-..++|+|.||.||+|+. ++|+.|++|.+..+.. ..-....+|+.+|+.++|+|++.+++.+.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 34456899999999999974 4678888886543221 112345679999999999999999998743 245
Q ss_pred eEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceec
Q 039392 71 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~ 150 (285)
+|+||++|+. +|.-++......++...+.+++.++.+||.|+| ...|+|||+|++|++|+.+|.++|.|||+++.+
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 8999999977 888888776566999999999999999999999 999999999999999999999999999999776
Q ss_pred Cccc--ccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchh--hhh-----hhhhhc
Q 039392 151 TRED--ISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT--LKH-----WVNDWL 220 (285)
Q Consensus 151 ~~~~--~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~--~~~-----~~~~~~ 220 (285)
.... ....+.....|.+|++||.+.+. .++++.|||+.||+|.+|+++.+.+++..+-+.. .+. ....|+
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 5432 22334456679999999988776 7999999999999999999999988764332110 111 111222
Q ss_pred CCCccccccccc---cCcccchhh----hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 221 PISTKEIVDPNL---LSREDIHFV----AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 221 ~~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+.-.+..... .+....+.. .+-.-.++..+|+.++|..||.+|+.+.+++.+
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 221111100000 111111100 011124577899999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=263.38 Aligned_cols=238 Identities=23% Similarity=0.261 Sum_probs=192.6
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
.|.+...+|.|+|+.|-.+. ..+++..++|++...... ..+|+.++... +|||++++.+++......|+|||.+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 36777889999999998885 557888999998765222 22456554444 6999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-CCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili-~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
.|+-+.+.+..... +. ..+..|+.+|+.|+.||| .+|++|||+||+|||+ +..|+++|+|||.+......
T Consensus 399 ~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred cccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 98877776655443 33 667789999999999999 9999999999999999 59999999999999877654
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
....+-|..|.|||++..+.+++++|+||||+++|+|++|..||...+.+....... ...+.
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~------------- 531 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKF------------- 531 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCcc-------------
Confidence 345567888999999999999999999999999999999999998765552211111 00000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...++.++++|+..||+.||.+|+++.+++.+
T Consensus 532 -----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 -----SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 15678889999999999999999999999764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.87 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=217.0
Q ss_pred CCceecccCceEEEEEEe-CC----CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 4 ENNLIGRGGFGSVFKARL-GD----GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~-~~----~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
..++||+|+||+||+|.+ .+ +-+|+||++.... .++-.++.+|+-++..+.|||++++++++.... +-+|+++
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 467999999999999964 33 4467999875433 445577889999999999999999999998776 6689999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++|.|.++++.++..+.....+.|..||++|+.||| ++++|||||-..|||+.+-..+||.|||++.....+....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999988888999999999999999999999 9999999999999999999999999999999987766554
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
........+-|+|-|.+....++.++||||+|+..||++| |..|+++.+..+... .-+.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d--------------------lle~ 915 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD--------------------LLEK 915 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH--------------------HHhc
Confidence 4455556777999999999999999999999999999999 999998754433211 1123
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
+.++..+..|+.+++.++.+||..|+..||+++++...+..+.+..
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 3346667889999999999999999999999999999999887543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=274.77 Aligned_cols=144 Identities=29% Similarity=0.433 Sum_probs=129.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|.+.++||+|+||+||+|... +++.||+|++.... ......+..|+.++..++|+||++++..+......++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 5889999999999999999754 68999999986432 2334667889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
|+.+++|.+++.... .+++..++.++.||+.||.||| .++++|+||||+|||++.++.++|+|||++.
T Consensus 85 y~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999987654 3888999999999999999999 8999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=243.70 Aligned_cols=219 Identities=19% Similarity=0.144 Sum_probs=174.4
Q ss_pred cCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCHHHhhhc
Q 039392 11 GGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS 89 (285)
Q Consensus 11 G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 89 (285)
|.+|.||++.+ .+++.+|+|.+..... ..+|...+....|||++++++.+......+++||++++++|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999975 4789999999875432 22344444455699999999999999999999999999999998876
Q ss_pred CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecccccccccc
Q 039392 90 SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169 (285)
Q Consensus 90 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (285)
... ++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++++|||.+....... ....++..|+
T Consensus 79 ~~~-l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~ 149 (237)
T cd05576 79 FLN-IPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC 149 (237)
T ss_pred hcC-CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence 543 889999999999999999999 9999999999999999999999999999876554321 2233456799
Q ss_pred CCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHH
Q 039392 170 APEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSF 249 (285)
Q Consensus 170 ~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
|||...+..++.++|+||+|+++++|++|..|+........ . ...+..+..+++.
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~-------~~~~~~~~~~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------T-------HTTLNIPEWVSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------c-------ccccCCcccCCHH
Confidence 99999888889999999999999999999987643211000 0 0000112335667
Q ss_pred HHHhhhcccccCcCCCCCH
Q 039392 250 VFNVAMECTVESPEQRINA 268 (285)
Q Consensus 250 l~~li~~~l~~~p~~Rps~ 268 (285)
+.+++.+||+.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 8999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=268.43 Aligned_cols=256 Identities=29% Similarity=0.442 Sum_probs=208.2
Q ss_pred CCCceecccCceEEEEEEe----CC----CcEEEEEEeeccch-hHHHHHHHHHHHHccC-CCCccccccceeccCCceE
Q 039392 3 SENNLIGRGGFGSVFKARL----GD----GMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~----~~----~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 72 (285)
.+.+.||+|+||.|++|.. .. ...||+|..+.... ...+.+..|+++++.+ +|+||+.+.+.+...+.++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 4566999999999999952 11 45689998765433 4557788999999999 4999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 039392 73 LVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM 137 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~ 137 (285)
+|.||+..|+|.+++...+ ..++....+.++.||+.|++||+ +.+.+|||+-..||+++++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence 9999999999999997766 34788899999999999999999 99999999999999999999
Q ss_pred cEEEeeeccceecCccccccee-ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhh
Q 039392 138 VAHLSDFGIAKLLTREDISTIQ-TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHW 215 (285)
Q Consensus 138 ~~~i~df~~~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 215 (285)
.+||+|||+++........... +...-+..|+|||.+....++.++||||+|+++||+++ |..||.+.........
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-- 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-- 533 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH--
Confidence 9999999999976554333211 11114556999999999999999999999999999999 8888866321111111
Q ss_pred hhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 216 VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
....+.+...+..|+++++++|+.||+.+|++||++.++.+.++.+..
T Consensus 534 -----------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 534 -----------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -----------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 122333444467788999999999999999999999999999999654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=243.51 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=200.4
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHc--cCCCCccccccceeccC----CceEEEEe
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMK--SIHHRNIIKVISSCSNE----EFKALVLE 76 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~~~----~~~~~v~e 76 (285)
++.+.||+|.||+||+|++. |+.||||+|....+. ...+|.++.+ .++|+||+.+++.-..+ ..+|+|++
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 34678999999999999985 899999999765443 3445666554 56899999999976444 36889999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhc-----CCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF-----GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-----~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
|.+.|||.|++.+. .++....++++..++.||++||. +++-.|.|||||+.||++.++|.+.|.|+|+|....
T Consensus 290 YHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 290 YHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred cccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 99999999999874 38899999999999999999994 223469999999999999999999999999998776
Q ss_pred ccc--ccceeccccccccccCCcccCCCc------cCcchhhHHHHHHHHHHhhC----------CCCCccccccchhhh
Q 039392 152 RED--ISTIQTQTLATIGYMAPEYGKEGR------VSANGDVYSFGIMLIETFTR----------KKPTDEIFNGEMTLK 213 (285)
Q Consensus 152 ~~~--~~~~~~~~~~~~~~~~PE~~~~~~------~~~~~Di~slG~~l~~ll~g----------~~p~~~~~~~~~~~~ 213 (285)
... .........||.+|+|||++...- --..+||||||.++||+... ..||.+..+.+.++.
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 543 223445678999999999887542 12458999999999999842 257766555554444
Q ss_pred hhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 214 HWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
+.....-..... +.. -+.+....+-..+.++|+.||..||.-|.|+=.+-+.|.++.+
T Consensus 448 eMrkVVCv~~~R--------P~i-pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 448 EMRKVVCVQKLR--------PNI-PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHhcceeecccC--------CCC-CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 443322222211 111 1122244566778899999999999999999999999888874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=247.37 Aligned_cols=270 Identities=27% Similarity=0.347 Sum_probs=198.2
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHcc--CCCCccccccceeccCC----ceEEEEe
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKS--IHHRNIIKVISSCSNEE----FKALVLE 76 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~~v~e 76 (285)
...+.+|+|.||.||+|... ++.||||+++.... +.+.+|-++.+. ++|+||+++++.-.... .+++|++
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 45678999999999999874 59999999975543 556666666654 47999999999865544 7899999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC------CCCCeeecCCCCCCeeeCCCCcEEEeeeccceec
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG------YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~------~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~ 150 (285)
|.+.|+|.+++..+. ++.....+++..++.||+|||.- ++-.|+|||||+.|||+..++...|+|||++-.+
T Consensus 289 fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 999999999998765 88999999999999999999962 2447999999999999999999999999999988
Q ss_pred CcccccceeccccccccccCCcccCCC-ccC-----cchhhHHHHHHHHHHhhCCCCCcc--ccccchhhhhhhhhhcCC
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEG-RVS-----ANGDVYSFGIMLIETFTRKKPTDE--IFNGEMTLKHWVNDWLPI 222 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~-----~~~Di~slG~~l~~ll~g~~p~~~--~~~~~~~~~~~~~~~~~~ 222 (285)
.........-...||.+|+|||++.+. +.. .+.||||+|.++||+++...-++. ..+-+..+..-+...+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP-- 444 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP-- 444 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC--
Confidence 754433333346799999999998765 222 458999999999999987654431 1111112221111111
Q ss_pred Ccccccccc---ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 223 STKEIVDPN---LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 223 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
+..+..+.. .......+......-...+.+.+..||..||+-|.|+.=+-+++.++..
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 111111110 1111111122223445678899999999999999999999999988763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=237.23 Aligned_cols=238 Identities=30% Similarity=0.373 Sum_probs=193.0
Q ss_pred CceEEEEEEeC-CCcEEEEEEeeccchhH-HHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCHHHhhhc
Q 039392 12 GFGSVFKARLG-DGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS 89 (285)
Q Consensus 12 ~~~~v~~~~~~-~~~~~~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 89 (285)
+||.||+|... +++.+++|++....... ...+.+|++.+++++|++++++.+.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57999999865 58999999987655443 67888999999999999999999999998999999999998899999876
Q ss_pred CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceecccccccccc
Q 039392 90 SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169 (285)
Q Consensus 90 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (285)
... ++...++.++.+++.++.+|| +.+++|+||+|.||+++.++.++++|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 554 888999999999999999999 9999999999999999999999999999998765532 223345677899
Q ss_pred CCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHH
Q 039392 170 APEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSF 249 (285)
Q Consensus 170 ~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
+||...+..++.++|+|++|++++++++|..||...................... ....++.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~ 216 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-----------------PEWKISPE 216 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-----------------ccccCCHH
Confidence 9999988888999999999999999999999986632222211111110000000 00014567
Q ss_pred HHHhhhcccccCcCCCCCHHHHHH
Q 039392 250 VFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 250 l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=251.35 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=199.9
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-------hhHHHHHHHHHHHHccCCCCccccccceec-cCCceE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-------GRVFKSFDVECEMMKSIHHRNIIKVISSCS-NEEFKA 72 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~ 72 (285)
|-.+.+||+|+|+.||++.+ ...+-||+|+-..+. ......+.+|..+.+.|.||.||+++++|. +...+|
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 45678999999999999964 456778888754332 122345668999999999999999999995 456788
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCcEEEeeecccee
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKL 149 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~i~df~~~~~ 149 (285)
-|+|||+|.+|..+++.+. .+++..++.|..||+.||.||..- +-.|+|.|+||.||++- .-|.+||.|||++..
T Consensus 545 TVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 9999999999998887665 489999999999999999999832 45799999999999994 457899999999988
Q ss_pred cCccccc-----ceeccccccccccCCcccCC----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhc
Q 039392 150 LTREDIS-----TIQTQTLATIGYMAPEYGKE----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL 220 (285)
Q Consensus 150 ~~~~~~~-----~~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 220 (285)
...+... .......||-||++||++.- ..++.+.||||+|+++|+++.|+.||.....-+..
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--------- 693 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--------- 693 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH---------
Confidence 7664322 23345678999999997653 35889999999999999999999999753322221
Q ss_pred CCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHH
Q 039392 221 PISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272 (285)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil 272 (285)
+.....+......|+.++.+++++.+||++||++.-.+|....++.
T Consensus 694 ------LqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 ------LQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ------HhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1122233344445666778899999999999999999999888765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=246.16 Aligned_cols=241 Identities=21% Similarity=0.257 Sum_probs=195.0
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|.++.+||+|+||+|-++. ..+.+.+|||+++.+. +...+--+.|-++|... +.|.++++...|+.-+.+|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 47788999999999999995 5567889999987543 22223344577777665 4788899999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+.||+|-..+++-++ +.+..+.-++..|+-||-+|| ++||++||+|.+||+++.+|.+||.|||++..--..
T Consensus 430 EyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-- 503 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-- 503 (683)
T ss_pred EEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC--
Confidence 99999999888877665 888888889999999999999 999999999999999999999999999998643222
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+||+-|+|||++..+.|+.+.|.||+|+++|||+.|+.||++.++.+.-......
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------------------ 565 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------------------ 565 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc------------------
Confidence 22234678999999999999999999999999999999999999999986554432221100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINA 268 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 268 (285)
+-..+...+.++.+++...|...|.+|..+
T Consensus 566 ---nvsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 566 ---NVSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred ---cCcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 111144567778899999999999999643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=256.61 Aligned_cols=240 Identities=21% Similarity=0.278 Sum_probs=197.9
Q ss_pred CCCCceecccCceEEEEEEeCCCc-EEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGM-EVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~-~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
...+..||-|+||.|-++...... -+|+|++++. .....+....|-.+|.....|+|++++..|.+....|++||.
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 345678999999999999754333 3777877543 244556777899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
|-||.||.+++..+. ++..++.-+...+++|++||| .+||++||+||+|.+++.+|-+||.|||+|........+
T Consensus 502 ClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT- 576 (732)
T KOG0614|consen 502 CLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT- 576 (732)
T ss_pred hcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce-
Confidence 999999999977665 899999999999999999999 999999999999999999999999999999988765443
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
-+.+||+.|.|||++.+...+.+.|.||||+++||+++|.+||.+..+...... ... ..+
T Consensus 577 --wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-ILk----------------Gid- 636 (732)
T KOG0614|consen 577 --WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-ILK----------------GID- 636 (732)
T ss_pred --eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-HHh----------------hhh-
Confidence 346799999999999999999999999999999999999999987654332211 111 111
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCC
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRIN 267 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 267 (285)
.+..++.++....+||++++..+|.+|.-
T Consensus 637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 -KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11123455666889999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=236.87 Aligned_cols=251 Identities=25% Similarity=0.262 Sum_probs=194.8
Q ss_pred CCceecccCceEEEEEE-eCCCcEEEEEEeeccch-hHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 4 ENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
-+..||.|+||+|++.. ..+|+..|+|.+..... ....++..|.+...+- +.|||+++++..-.++.+|+-||.+ .
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence 34679999999999996 55799999999987654 4556677777765444 6999999999999999999999999 5
Q ss_pred CCHHHhhhc----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 81 GSLEKYLHS----SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
.||..+.+. ....+++..+-.+....+.||.||.. +..++|||+||+||+++..|.+|++|||.+..+.+.
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--- 221 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--- 221 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH---
Confidence 588765432 22238888888888899999999985 678999999999999999999999999998765442
Q ss_pred ceeccccccccccCCcccCCC--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 157 TIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
...+...|-..|+|||-+... .++.++|+||||++|+|+.||..||..+.+--.+........+++-. .+
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~--------~~ 293 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL--------FD 293 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec--------Cc
Confidence 222334455669999987654 48999999999999999999999999887654444444333322211 11
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+ ....+..+..+|..||..|-..||+..+++++
T Consensus 294 ~~------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KE------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cc------ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 11234558899999999999999999998764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=227.89 Aligned_cols=260 Identities=19% Similarity=0.310 Sum_probs=195.0
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceecc--CCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSN--EEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e 76 (285)
+|++.+++|+|.++.||.|. ..+++.++||++++... +.+.+|+.+|+.+. ||||++++++..+ ...+.+|+|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 58899999999999999996 45688999999876533 56778999999997 9999999999865 457889999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df~~~~~~~~~~~ 155 (285)
+++..++..+... ++...+...+.+++.||.|+| +.||+|||+||.|++|+ ..-.++++|+|+|....+...
T Consensus 116 ~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 116 YVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 9988888766532 777788899999999999999 99999999999999998 456799999999998766432
Q ss_pred cceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhh-----------c---
Q 039392 156 STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDW-----------L--- 220 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------~--- 220 (285)
..-...+..|--||.+.. +.++.+.|+|||||++..|+..+.||........++-...... .
T Consensus 189 ---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 189 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred ---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 234456778999997764 5689999999999999999999999854333222221111100 0
Q ss_pred -CCCccccccccccCcccchhhh---hhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 221 -PISTKEIVDPNLLSREDIHFVA---KEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+.....+..... .....+|.. ....++++.+|+.++|..|.++|+|++|++.+
T Consensus 266 Ldp~~~~i~~~~~-rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 266 LDPQFEDILGRHS-RKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CChhHhhHhhccc-cccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 001111111100 000011111 12336889999999999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=251.99 Aligned_cols=262 Identities=20% Similarity=0.241 Sum_probs=178.1
Q ss_pred CCCCCceecccCceEEEEEEe-----------------CCCcEEEEEEeeccchhHHHHHH--------------HHHHH
Q 039392 1 GFSENNLIGRGGFGSVFKARL-----------------GDGMEVAVKVFNLQYGRVFKSFD--------------VECEM 49 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-----------------~~~~~~~iK~~~~~~~~~~~~~~--------------~e~~~ 49 (285)
+|++.++||+|+||+||+|.. .+++.||||.+........+.+. .|+..
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 588999999999999999853 23567999998654433223332 35556
Q ss_pred HccCCCCcc-----ccccceecc--------CCceEEEEeccCCCCHHHhhhcCC-----------------------Cc
Q 039392 50 MKSIHHRNI-----IKVISSCSN--------EEFKALVLEYMPHGSLEKYLHSSN-----------------------YI 93 (285)
Q Consensus 50 l~~l~h~~i-----~~~~~~~~~--------~~~~~~v~e~~~~~~L~~~~~~~~-----------------------~~ 93 (285)
+.+++|.++ +++++++.. .+..++|+||+++++|.+++.... ..
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 666655443 566666532 356789999999999998875321 11
Q ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcc
Q 039392 94 LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173 (285)
Q Consensus 94 ~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~ 173 (285)
++...++.++.|++.+|.||| +.+++|+||||+||+++.++.++|+|||++....... .........++.|++||.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhh
Confidence 355678889999999999999 9999999999999999999999999999987554321 111122334788999998
Q ss_pred cCCCc----------------------cCcchhhHHHHHHHHHHhhCCC-CCccccccchhhhhhhhhhcCCCccccccc
Q 039392 174 GKEGR----------------------VSANGDVYSFGIMLIETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 174 ~~~~~----------------------~~~~~Di~slG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
+.... .....|+||+||++++|+++.. |+................... +.
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~-----~r-- 454 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR-----WR-- 454 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH-----HH--
Confidence 75432 1234699999999999999886 654321111111110000000 00
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCc---CCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESP---EQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~eil~~ 274 (285)
.......++......++..++|+.+||..+| .+|+|++|+|++
T Consensus 455 -~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 455 -MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0011112223345567889999999999866 689999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=260.61 Aligned_cols=262 Identities=19% Similarity=0.223 Sum_probs=167.0
Q ss_pred CCCCCceecccCceEEEEEEeC-C----CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccce------eccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-D----GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS------CSNEE 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~----~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~~~ 69 (285)
+|.+.+.||+|+||.||+|... + +..||+|.+...... +...++ .++...+.++..+... .....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 5788899999999999999753 4 789999987543221 111111 1122222233332222 24556
Q ss_pred ceEEEEeccCCCCHHHhhhcCCCc-------------------cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 039392 70 FKALVLEYMPHGSLEKYLHSSNYI-------------------LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSN 130 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~n 130 (285)
..++|+||+.+++|.+++...... .....+..++.|++.||.||| +++++||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHH
Confidence 789999999999999988654321 123446689999999999999 9999999999999
Q ss_pred eeeCC-CCcEEEeeeccceecCcccccceeccccccccccCCcccCCC----------------------ccCcchhhHH
Q 039392 131 VLLDD-NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG----------------------RVSANGDVYS 187 (285)
Q Consensus 131 ili~~-~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----------------------~~~~~~Di~s 187 (285)
||++. ++.+||+|||++....... ........+++.|+|||.+... +++.++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99985 6899999999997654321 1222345678899999955322 2345569999
Q ss_pred HHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc---cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCC
Q 039392 188 FGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE---IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQ 264 (285)
Q Consensus 188 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 264 (285)
+||++|+|+++..+++... ..+...... ...+... .............+...+......++|+.+||+.||.+
T Consensus 365 lGviL~el~~~~~~~~~~~---~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNL---IQFNRQLKR-NDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHhCcCCCchHH---HHHHHHHHh-cCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999877644210 011000000 0000000 00000000000011111223445679999999999999
Q ss_pred CCCHHHHHHH
Q 039392 265 RINAKEIVTK 274 (285)
Q Consensus 265 Rps~~eil~~ 274 (285)
|||++++|++
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=231.55 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=195.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|+.+++||+|++++|..++. ++.+-+|+|+++++ .++.+.....|..+.++. +||+++-+..+|+.+..+++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 478899999999999999974 46778899998743 345556666788877777 5999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||++||+|--.+++.++ ++++.++-+...|+.||+||| ++||++||+|.+|++++.+|.+|+.|+|++..--.+
T Consensus 331 eyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~-- 404 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-- 404 (593)
T ss_pred EEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC--
Confidence 99999999877776665 999999999999999999999 999999999999999999999999999998643222
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCcc--ccccchhhhhhhhhhcCCCcccccccccc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDE--IFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
....+..++||.|.|||++.+..|..+.|.|+||++|++|+.|+.||+- ..+++..-..+.....-. +
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-------k--- 474 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-------K--- 474 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-------h---
Confidence 2234567899999999999999999999999999999999999999973 333332222111111100 0
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINA 268 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 268 (285)
. .-.+...+..+..+++..|+.||++|..+
T Consensus 475 ---q--iriprslsvkas~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 475 ---Q--IRIPRSLSVKASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred ---c--ccccceeehhhHHHHHHhhcCCcHHhcCC
Confidence 0 00122334446678899999999998643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=243.55 Aligned_cols=264 Identities=22% Similarity=0.284 Sum_probs=199.5
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC------CCccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH------HRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~~v 74 (285)
|.+....|+|-|++|.+|.+ ..|..||||++..+ ......=..|+++|++|+ .-++++++..|...+++|+|
T Consensus 434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClV 512 (752)
T KOG0670|consen 434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLV 512 (752)
T ss_pred eEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEE
Confidence 66777889999999999974 35889999999744 333455667999999996 34789999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCc--cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeeccceecC
Q 039392 75 LEYMPHGSLEKYLHSSNYI--LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLT 151 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~~~~ 151 (285)
+|.+ ..+|.+++++.+.. +....+..++.|+..||..|. ++|++|.||||+|||+++ ...+||||||.|...+
T Consensus 513 FE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 513 FEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred ehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccccccc
Confidence 9999 66999999875433 777889999999999999999 999999999999999985 5678999999998877
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhh----------------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW---------------- 215 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---------------- 215 (285)
....+ ....+..|.|||++.+..|+...|+||+||++|++.||+..|.+..+..+..-.+
T Consensus 589 eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 589 ENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred ccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 64432 2345667999999999999999999999999999999999998866554321110
Q ss_pred hhhhcCCCccccc---cc--------cccCccc-chhh-----------hhhHhHHHHHHhhhcccccCcCCCCCHHHHH
Q 039392 216 VNDWLPISTKEIV---DP--------NLLSRED-IHFV-----------AKEQCVSFVFNVAMECTVESPEQRINAKEIV 272 (285)
Q Consensus 216 ~~~~~~~~~~~~~---~~--------~~~~~~~-~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil 272 (285)
...-...+...+. +. ......+ .++. -....-.++.+|+.+||..||++|.|++++|
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 1111111110000 00 0000000 0000 0123457789999999999999999999998
Q ss_pred HH
Q 039392 273 TK 274 (285)
Q Consensus 273 ~~ 274 (285)
++
T Consensus 745 ~H 746 (752)
T KOG0670|consen 745 KH 746 (752)
T ss_pred cC
Confidence 75
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=245.52 Aligned_cols=205 Identities=22% Similarity=0.348 Sum_probs=171.8
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|..++.||-|+||+|.+++ ..+...+|.|-+.+.. .......+.|-.||....++-||+++..|++.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 4467899999999999996 4567778999775433 23345567788999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC------
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT------ 151 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~------ 151 (285)
++||++-.++-+.+- +++..++-++..+..|++++| +.|++||||||+|||||.+|.+||.|||+|+-+.
T Consensus 711 IPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred cCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999888766553 889999999999999999999 9999999999999999999999999999996321
Q ss_pred ---ccc-------------------------------ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh
Q 039392 152 ---RED-------------------------------ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197 (285)
Q Consensus 152 ---~~~-------------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~ 197 (285)
... .........||+-|+|||++....++...|.|+.|++||+|+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 000 0011123568999999999999999999999999999999999
Q ss_pred CCCCCccccccch
Q 039392 198 RKKPTDEIFNGEM 210 (285)
Q Consensus 198 g~~p~~~~~~~~~ 210 (285)
|+.||-+..+.+.
T Consensus 867 g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 867 GQPPFLADTPGET 879 (1034)
T ss_pred CCCCccCCCCCcc
Confidence 9999977555544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=234.43 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=209.5
Q ss_pred CCceecccCceEEEEEEeC------CCcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceec-cCCceEEEE
Q 039392 4 ENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCS-NEEFKALVL 75 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~ 75 (285)
...++-+|.||.||.|.+. +.+.|.+|-++.. ++-....+..|.-.+..+.|||++.+.++.. +...+++++
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 3456789999999999532 3445566655422 2334456778888999999999999999874 457888999
Q ss_pred eccCCCCHHHhhhcC-------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 76 EYMPHGSLEKYLHSS-------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 76 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
++...|+|..++... ....+..+...++.|++.|+++|| ++|++|.||-..|-+|++..++||+|=.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhcc
Confidence 999999999998722 223677788999999999999999 9999999999999999999999999999998
Q ss_pred ecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 149 LLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
.+=+.+..+-.+....+..|++||.+.+..++.++|+||||++||||+| |+.|+.+.++.+..-.
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-------------- 510 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-------------- 510 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--------------
Confidence 7766555555566667788999999999999999999999999999999 8899887655444221
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHhc
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~~ 284 (285)
-..+.++..+.+||++++.+|..||...|++|||++++...|.+..-.+.|
T Consensus 511 ------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~ 561 (563)
T KOG1024|consen 511 ------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR 561 (563)
T ss_pred ------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence 123344555778999999999999999999999999999999988766543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=247.06 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=199.0
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceec-----cCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCS-----NEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-----~~~~~~~v 74 (285)
|++.+.+|.|.+|.||+++ ..+++..|+|+.....+. .+++..|.++|+... |||++.+++++- .++.+|+|
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 5788999999999999997 457888899987765543 245667888998884 999999999883 46789999
Q ss_pred EeccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 75 LEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
||+|.|||..|+++.- +..+.++.+.-|++.++.|+.+|| ...++|||||-.||+++.+|.||++|||....++..
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 9999999999998653 345888999999999999999999 999999999999999999999999999998765543
Q ss_pred cccceeccccccccccCCcccCCC-----ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEG-----RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
. .......||+.|+|||++... .|+.++|+||||++..||--|.+|+...-+....+. ..
T Consensus 177 ~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~----Ip--------- 241 (953)
T KOG0587|consen 177 V--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IP--------- 241 (953)
T ss_pred c--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----CC---------
Confidence 2 223567899999999987643 478889999999999999999999865433221111 00
Q ss_pred cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+..+..+..=+.++.++|..||..|-.+||+..++|++
T Consensus 242 -----RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 -----RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11112222344556779999999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=218.97 Aligned_cols=240 Identities=19% Similarity=0.278 Sum_probs=189.9
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccce-eccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISS-CSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~~~~v~e~~ 78 (285)
|++++.||+|.||.+-++. .++++.+|+|.++... ...+.|.+|...--.|. |.||+.-+++ |+..+.+.+++|++
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 7889999999999999997 4578899999987553 34578888988766664 9999988876 67778888999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCcEEEeeeccceecCccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+.|+|.+-+..++ +.+.....++.|+++|+.|+| ++++||||||.+||||- ...++|++|||+.+..+....
T Consensus 105 P~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~- 178 (378)
T KOG1345|consen 105 PRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK- 178 (378)
T ss_pred ccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCceeh-
Confidence 9999998776655 888889999999999999999 99999999999999994 455899999999987654321
Q ss_pred ceeccccccccccCCcccCC---C--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKE---G--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~---~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.......|.+||.... . ...+++|+|.||+++|.+++|..||+..+..+.....|...........+.
T Consensus 179 ----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~--- 251 (378)
T KOG1345|consen 179 ----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK--- 251 (378)
T ss_pred ----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch---
Confidence 2223445888885432 2 368999999999999999999999998777777777776655544332111
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCC
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQR 265 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 265 (285)
.. ...++.+..+.++-|..+|++|
T Consensus 252 ----~F------~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 252 ----KF------NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred ----hh------cccCHHHHHHHHHhcCCccccc
Confidence 10 1224447789999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=215.04 Aligned_cols=211 Identities=36% Similarity=0.569 Sum_probs=183.5
Q ss_pred ecccCceEEEEEEeC-CCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCHHH
Q 039392 8 IGRGGFGSVFKARLG-DGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEK 85 (285)
Q Consensus 8 lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 85 (285)
||+|.+|.||++... +++.+++|++...... ..+.+.+|++.++.+.|++++++++.+......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999864 4899999998765443 34678899999999999999999999999899999999999899999
Q ss_pred hhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeeccceecCcccccceeccccc
Q 039392 86 YLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDISTIQTQTLA 164 (285)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~~~~~~~~~~~~~~~~~ 164 (285)
++......++...++.++.+++.++.+|| +.|++|+||+|.||+++. ++.++|+||+.+........ .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 98766345889999999999999999999 999999999999999998 89999999999987654321 1233456
Q ss_pred cccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhh
Q 039392 165 TIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243 (285)
Q Consensus 165 ~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
...|++||..... ..+.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7779999988877 889999999999999999
Q ss_pred hHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 244 EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
..+.+++.+|+..+|.+||+++++++.+
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2378899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=228.95 Aligned_cols=128 Identities=27% Similarity=0.386 Sum_probs=108.4
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC--------CCcccccccee----ccC
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH--------HRNIIKVISSC----SNE 68 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~----~~~ 68 (285)
|-+.++||+|.|+|||++. ..+.+.||+|+++.. ....+....|+++|++++ ...||++++.| .++
T Consensus 80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG 158 (590)
T KOG1290|consen 80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG 158 (590)
T ss_pred EEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence 6688999999999999996 457888999998643 344566778999999884 24789999988 456
Q ss_pred CceEEEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 039392 69 EFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL 133 (285)
Q Consensus 69 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili 133 (285)
.+.|+|+|++ |.+|..+|...+ +.++...+..|+.||+.||.|||+ +.||+|.||||+|||+
T Consensus 159 ~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 159 QHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred cEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 7899999999 668988887654 349999999999999999999997 8999999999999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=223.22 Aligned_cols=266 Identities=23% Similarity=0.314 Sum_probs=194.0
Q ss_pred CCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCC-----ceEEE
Q 039392 3 SENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-----FKALV 74 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v 74 (285)
+-.+.||.|+||.||.+.+ .+|+.|++|.+..-.. ...+.+.+|..+|+-++|.|++..++..+... .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4568999999999999975 4799999998764332 34467889999999999999999988876543 45678
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
+|.+.. +|..+|-+.. .++...+.-++.||+.||+||| +.+|.||||||.|.+++++..+||+|||+++....+.
T Consensus 136 TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 888854 7888775544 4888888999999999999999 9999999999999999999999999999999776543
Q ss_pred ccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc--------
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK-------- 225 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 225 (285)
.........|..|.|||++.+. .|+.+.||||+||++.|++..+..|+.-.+-+. .....+-....+..
T Consensus 211 -~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ-L~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 211 -RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ-LQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred -hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH-HHHHHHHhCCCcHHHHHHHhhh
Confidence 3333456678899999998887 699999999999999999999988876322111 11110000000000
Q ss_pred ---ccccccc-cCccc--chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 226 ---EIVDPNL-LSRED--IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 226 ---~~~~~~~-~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
....... .+... ..+..+.....+...++.+++..||.+|.+.++++.+.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0000000 00000 00111223345677889999999999999999988764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=247.55 Aligned_cols=241 Identities=25% Similarity=0.397 Sum_probs=186.5
Q ss_pred CCceecccCce-EEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCCC
Q 039392 4 ENNLIGRGGFG-SVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 4 ~~~~lg~G~~~-~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
-.+.+|.|+.| .||+|.. .|++||||.+-.. -...+.+|+..|+.- .||||+++++.-++....|+..|.|.-
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 34678899887 5688876 5889999976533 234566899999887 499999999999999999999999965
Q ss_pred CHHHhhhcCCCc---cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCcEEEeeeccceecCcc
Q 039392 82 SLEKYLHSSNYI---LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 82 ~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-----~~~~~i~df~~~~~~~~~ 153 (285)
+|.+++...... ......+.++.|++.||++|| +.+||||||||.||||+. ..+++|+|||++..+...
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999999874211 111345788999999999999 999999999999999975 257899999999988765
Q ss_pred cccc-eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhC-CCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 154 DIST-IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 154 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.... ......||.+|+|||.+.....+.+.|||||||++|+.++| ..||......+...-
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl------------------ 726 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL------------------ 726 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh------------------
Confidence 4322 23567799999999999999889999999999999999996 789876543322111
Q ss_pred ccCcccchhhhh-hHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 232 LLSREDIHFVAK-EQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 232 ~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
..........+ ..+ ++.+||.+|++++|..||+|.++|.
T Consensus 727 -~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 727 -TGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -cCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00000000111 111 7889999999999999999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=204.00 Aligned_cols=212 Identities=27% Similarity=0.328 Sum_probs=172.5
Q ss_pred CceecccCceEEEEEE-eCCCcEEEEEEeeccch-hHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCCC
Q 039392 5 NNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+..||+|++|.|-+.+ ..+|+-.|+|.+..... +..++..+|+.+..+. .+|+++.+++........|+.||.+ ..
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 5679999999998886 45899999998865443 3445667788765554 5999999999999999999999999 44
Q ss_pred CHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 82 SLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 82 ~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
||..+-.. .+...++..+-+++..++.||.+||. +..++|||+||.||||+..|++|+||||.+..+.+.-..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-- 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-- 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH--
Confidence 88776532 34559999999999999999999996 678999999999999999999999999999877653222
Q ss_pred eccccccccccCCcccCC----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCC
Q 039392 159 QTQTLATIGYMAPEYGKE----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI 222 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (285)
+-..|-..|+|||.+.. ..|+.++||||||+.+.||.+++.||+.+.++-..+++.+....+.
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 21234456999997653 3699999999999999999999999999988887777776655544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=219.44 Aligned_cols=255 Identities=25% Similarity=0.311 Sum_probs=190.7
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCC------ceE
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE------FKA 72 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~ 72 (285)
|..++.+|.|+. .|..+. .-.+++|++|.....- ...+.+..+|..++..++|+||++++.+|...+ ..|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 556778889988 666664 3468999999865432 234466778999999999999999999985443 567
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+|||++.. +|...+.. .++-.++..++.|++.|+.+|| +.||+||||||+||++..++.+||.|||+++..+.
T Consensus 98 ~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 98 LVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCc
Confidence 99999954 88887762 2777889999999999999999 99999999999999999999999999999986554
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhh---------------
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN--------------- 217 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--------------- 217 (285)
. ...+....+..|.|||++.+..+.+..||||+||++.+|++|...|.+. ....+|..
T Consensus 171 ~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 171 D---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred c---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHHHHHH
Confidence 3 3445667888999999999999999999999999999999999987652 11111110
Q ss_pred ------hh-------cCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 218 ------DW-------LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 218 ------~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ...+..+.+....+.. ....+..-+..+++++.+||-.||++|.|++++|.+
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~---~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPV---VLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccc---cccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 0001111111111110 011112235668899999999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=232.44 Aligned_cols=196 Identities=22% Similarity=0.349 Sum_probs=168.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhH-----HHHHHHHHHHHccCC---CCccccccceeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRV-----FKSFDVECEMMKSIH---HRNIIKVISSCSNE 68 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~-----~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 68 (285)
+|+..+++|.|+||.|+++.. .+...|+||.+.++. +.+ .-...-|+++|..++ |+||++++++|++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 488899999999999999964 457789999886532 111 122446999999997 99999999999999
Q ss_pred CceEEEEecc-CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccc
Q 039392 69 EFKALVLEYM-PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 147 (285)
Q Consensus 69 ~~~~~v~e~~-~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~ 147 (285)
+.+|+++|.. +|.+|.++|..... +++..+..|+.|++-|+++|| +.||+|||||-+|+.++.+|.+||+|||.+
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccch
Confidence 9999999975 56789999977665 899999999999999999999 999999999999999999999999999999
Q ss_pred eecCcccccceeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCcc
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDE 204 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~ 204 (285)
...... ..+...||..|+|||++.+..| ...-|||+||+++|.+.....||..
T Consensus 718 a~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 776543 3456679999999999998875 6778999999999999999999854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=207.73 Aligned_cols=199 Identities=31% Similarity=0.450 Sum_probs=172.3
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|++.+.||.|++|.||++... +++.+++|.+...... ..+.+.+|++.++.++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 678899999999999999865 4889999998766544 56788899999999999999999999999899999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++......++...++.++.+++.++.+|| +.+++|+|++|.||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999998765543788899999999999999999 899999999999999999999999999998876543200 11
Q ss_pred ccccccccccCCccc-CCCccCcchhhHHHHHHHHHHhhCCCCCcc
Q 039392 160 TQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLIETFTRKKPTDE 204 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 204 (285)
....++..|++||.. ....++.++|+|+||++++++++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 233466779999988 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=219.10 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=194.8
Q ss_pred CCCCceecccCceEEEEEEeC----CCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|..+++||.|.|++||++... ..+.||+|.+...+.. ..+.+|++.|..+. +.||+++.+.+..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 678899999999999999532 4778999988765544 55778999999996 8999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeeeccceecCccc-
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTRED- 154 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df~~~~~~~~~~- 154 (285)
|++.....++... ++...+...++.++.||.++| ..||+||||||.|++.+ ..++-.|+|||++.......
T Consensus 116 ~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred ccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9999999888764 668889999999999999999 99999999999999998 56788999999997211100
Q ss_pred -----------------------------------------ccceeccccccccccCCcccCCC-ccCcchhhHHHHHHH
Q 039392 155 -----------------------------------------ISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIML 192 (285)
Q Consensus 155 -----------------------------------------~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l 192 (285)
.........||++|.|||++... ..+.+.||||.|+++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00011123489999999987654 689999999999999
Q ss_pred HHHhhCCCCCccccccchhhhhhhhhhc-----------CC------Cc-----------cccccccccC-ccc-chhh-
Q 039392 193 IETFTRKKPTDEIFNGEMTLKHWVNDWL-----------PI------ST-----------KEIVDPNLLS-RED-IHFV- 241 (285)
Q Consensus 193 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----------~~------~~-----------~~~~~~~~~~-~~~-~~~~- 241 (285)
..++++..||.....+-....+....+. .. +. .........+ ... ....
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 9999999998664433222222111000 00 00 0000000000 010 0111
Q ss_pred hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+-.+..+.+|+++||..||.+|.|++++|++
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 112234578999999999999999999999975
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=231.16 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=201.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|+....+|+|.+|.||++++ .+++..|+|+++.......+-...|+-+++..+||||+.+++.+.....+|+.||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 478899999999999999985 4789999999998777777777889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
||+|.++-.-. .++++-++..+.+..+++++||| ..|=+|||||-.||++++.|.+|+.|||.+-..+.. ....
T Consensus 96 ggslQdiy~~T-gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~Kr 169 (829)
T KOG0576|consen 96 GGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKR 169 (829)
T ss_pred CCcccceeeec-ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--hhhh
Confidence 99999876433 34889999999999999999999 999999999999999999999999999998655432 1222
Q ss_pred ccccccccccCCccc---CCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 160 TQTLATIGYMAPEYG---KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~---~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....||+.|+|||+. ....+...+|+|++|+...++-.-+.|....-+.+..+-.....+.++ ...++.
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp---~lkDk~----- 241 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP---TLKDKT----- 241 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC---cccCCc-----
Confidence 456899999999964 456799999999999999999887777543322222221111111111 122222
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
.-++.+.+|++.+|..+|++|||++.+|.
T Consensus 242 --------kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 242 --------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22445889999999999999999998875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=200.50 Aligned_cols=261 Identities=18% Similarity=0.179 Sum_probs=209.4
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|+++++||+|+||..+.|. .-++++||||.-+..++. ..+..|....+.|. .++|..++.+.+.+..-.+|+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 58999999999999999997 457999999997665543 55667888888775 789999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCcEEEeeeccceecCcc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-----~~~~~i~df~~~~~~~~~ 153 (285)
|.||+|++.-++..++..++..++.|++.-++++| ++.+++|||||+|+||.. ...+.++|||+|..+.+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 88999999888888999999999999999999999 999999999999999964 345899999999877654
Q ss_pred cc-----cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh--hhhhhhhhcCCCccc
Q 039392 154 DI-----STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT--LKHWVNDWLPISTKE 226 (285)
Q Consensus 154 ~~-----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 226 (285)
.. ........||.+|++-....+...+++.|+-|||.++++++-|..||++.-.+... ...+.......+.
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i-- 260 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI-- 260 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH--
Confidence 32 12233567999999999999999999999999999999999999999986443221 1111110000000
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
-....+.|.++..-++-.-..+-.+-|..+-+.+.+.++++.+
T Consensus 261 -------------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 261 -------------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred -------------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 0113456777888888888888888999998888888887654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=190.02 Aligned_cols=171 Identities=21% Similarity=0.219 Sum_probs=131.9
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
|+|.+++...+..+++..++.++.|++.||.||| +.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence 5899999876666999999999999999999999 766 999999999999999 9998765432
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||++.+..++.++||||||+++|+|++|..||........................ .
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------~ 129 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-------------R 129 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-------------c
Confidence 125788999999999999999999999999999999999998654333222222222111111000 0
Q ss_pred hhhhHhHH--HHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 241 VAKEQCVS--FVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 241 ~~~~~~~~--~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
......+. ++.+++.+||..+|.+|||+.++++++..+..+.
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 01122233 6899999999999999999999999998876553
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=202.19 Aligned_cols=261 Identities=21% Similarity=0.243 Sum_probs=196.1
Q ss_pred CCCCCceecccCceEEEEEEeCC--CcEEEEEEeeccchhHHHHHHHHHHHHccCC----CCcccccccee-ccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLGD--GMEVAVKVFNLQYGRVFKSFDVECEMMKSIH----HRNIIKVISSC-SNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~~ 73 (285)
+|.+.+.||+|+||.||.+...+ ...+|+|+...........+..|..++..+. ..++..+++.+ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 48899999999999999997544 3578999876543332235667888888876 25888889888 57778899
Q ss_pred EEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-----CcEEEeeeccc
Q 039392 74 VLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN-----MVAHLSDFGIA 147 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~-----~~~~i~df~~~ 147 (285)
||+.+ |.+|.++..... ..++..++..++.|++.+|.+|| +.|++||||||.|+.+... -.+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999 889999886554 66999999999999999999999 9999999999999999754 46899999999
Q ss_pred e--ecCcccc-----cce-eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhh
Q 039392 148 K--LLTREDI-----STI-QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDW 219 (285)
Q Consensus 148 ~--~~~~~~~-----~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 219 (285)
+ ....... ... .....||..|+++....+...+++.|+||++.++.++..|..||......... .......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-SKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-HHHHHHh
Confidence 8 3322111 111 23355999999999999999999999999999999999999999664432221 1110000
Q ss_pred cCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
..... .. .....+.++.++...+-..+..++|....+...++.+..+
T Consensus 254 ~~~~~----~~-----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKLLT----DR-----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhcc----cc-----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00000 00 1122345566677777779999999999999998877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=187.14 Aligned_cols=261 Identities=18% Similarity=0.189 Sum_probs=203.0
Q ss_pred CCCCCceecccCceEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
.|.++++||+|+||.+|.|. ..+|+.||||+-+.... ...+..|..+.+.++ ...|+.+..++.+...-.+||+.+
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 37889999999999999995 56799999999654432 245667888888886 567888888888988899999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCcEEEeeeccceecCcccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~i~df~~~~~~~~~~~ 155 (285)
|.||+++++-+...++..+++.++.|++.-++|+| .++++||||||+|+++. ...++.++|||++..+-+...
T Consensus 94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 88999999877777999999999999999999999 99999999999999996 456789999999987654221
Q ss_pred -----cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhh-hhhhhh-hcCCCccccc
Q 039392 156 -----STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL-KHWVND-WLPISTKEIV 228 (285)
Q Consensus 156 -----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~-~~~~~~~~~~ 228 (285)
........||.+|++-....+...+.+.|+-|+|.++.++--|..||++........ .+.+.. ....+.
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i---- 245 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI---- 245 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH----
Confidence 112234568999999998888889999999999999999999999999864433221 111110 000000
Q ss_pred cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
-....+.|.++.-.+.-|-..--.+-|...-+-+.+.-|.+++
T Consensus 246 -----------e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 246 -----------EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred -----------HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 0113455667777788888888888888888877777776654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=231.43 Aligned_cols=196 Identities=15% Similarity=0.222 Sum_probs=137.3
Q ss_pred CCC-Ccccccccee-------ccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 039392 53 IHH-RNIIKVISSC-------SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124 (285)
Q Consensus 53 l~h-~~i~~~~~~~-------~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~ 124 (285)
++| .||+++++.+ .....+.+++|++ +++|.+++......++...++.++.||+.||+||| ++||+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 345 5777777776 2334567788887 55999999765556999999999999999999999 9999999
Q ss_pred CCCCCCeeeCCCCcEEE-------------------eeeccceecCcccc--------------cceeccccccccccCC
Q 039392 125 DLKPSNVLLDDNMVAHL-------------------SDFGIAKLLTREDI--------------STIQTQTLATIGYMAP 171 (285)
Q Consensus 125 di~~~nili~~~~~~~i-------------------~df~~~~~~~~~~~--------------~~~~~~~~~~~~~~~P 171 (285)
||||+|||++..|.+++ +|||+++....... ........+|++|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999976555554 45555432110000 0000113468889999
Q ss_pred cccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHH
Q 039392 172 EYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVF 251 (285)
Q Consensus 172 E~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (285)
|++.+..++.++|||||||++|||++|..|+..... .......... +.. .....+...
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~-------------~~~------~~~~~~~~~ 242 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVL-------------PPQ------ILLNWPKEA 242 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhc-------------Chh------hhhcCHHHH
Confidence 999999999999999999999999998887643211 1111100000 000 001123356
Q ss_pred HhhhcccccCcCCCCCHHHHHHH
Q 039392 252 NVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 252 ~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.++.+||+.+|.+|||++|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 78899999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=185.83 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=194.7
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+.-+|.+...|..|+|+++ |..+++|++.... ...-..|.+|.-.|+.+.||||+++++.+..+..+.+|..|++.+
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456778889999999986 5677778876443 334467889999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 82 SLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 82 ~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
+|...+..... ..+..++.+++.+++.|++|||+. +.-+.---+++..++|+++...+|.- +-+. .+....
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~k------fsfqe~ 344 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTK------FSFQEV 344 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccce------eeeecc
Confidence 99998865433 367788999999999999999942 22233345889999999988877741 1111 111122
Q ss_pred cccccccccCCcccCCCc---cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 161 QTLATIGYMAPEYGKEGR---VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....+-|++||.++... .-+++|+|||.+++||+-|...||.+.++.+..++ +..++
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-------------------ialeg 405 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-------------------IALEG 405 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-------------------hhhcc
Confidence 334567799999887653 45779999999999999999999998877666544 23445
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
.+...++++++.+-+|+.-|++.||.+||.+..++-.|++++
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 555567788889999999999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-26 Score=188.67 Aligned_cols=162 Identities=20% Similarity=0.185 Sum_probs=123.8
Q ss_pred CCCCCceecccCceEEEEEEeC--CCcEEEEEEeecc-----chhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG--DGMEVAVKVFNLQ-----YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||+||+|... +++.+|||.+... .......+.+|+++|++++|+|+++.+..+ +..++
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~L 95 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDGL 95 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcEE
Confidence 5899999999999999999753 5777899986532 223456688999999999999998533222 35789
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeeCCCCcEEEeeeccceecCc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL-KPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di-~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
||||++|++|... .. .. ...++.|++++|.+|| ++|++|||| ||+||+++.++.++|+|||++..+..
T Consensus 96 VmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 96 VRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 9999999999632 11 11 1457889999999999 999999999 99999999999999999999987755
Q ss_pred ccccce------eccccccccccCCcccCC
Q 039392 153 EDISTI------QTQTLATIGYMAPEYGKE 176 (285)
Q Consensus 153 ~~~~~~------~~~~~~~~~~~~PE~~~~ 176 (285)
...... .....++..|.+||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 321111 123445667889997654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=206.33 Aligned_cols=253 Identities=21% Similarity=0.219 Sum_probs=187.5
Q ss_pred CCceecccCceEEEEEEe-CCCcEEEEEEe-----eccchhHH-HHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 4 ENNLIGRGGFGSVFKARL-GDGMEVAVKVF-----NLQYGRVF-KSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~-----~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
..+.+|.|++|.|+.+.. ...+....|.+ +....... ..+..|+-+-..++|+|++.....+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 467889999997776642 22333333332 22222222 225567777788899999988888877766666699
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
||++ +|..++..... +....+--++.|++.|++|+| ..|+.|||+|++|++++.+|.+||+|||.+..+......
T Consensus 402 ~~~~-Dlf~~~~~~~~-~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGK-LTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhcccc-cchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 99999877633 777778889999999999999 999999999999999999999999999999887665444
Q ss_pred --ceeccccccccccCCcccCCCccC-cchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 157 --TIQTQTLATIGYMAPEYGKEGRVS-ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 157 --~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.......++..|+|||++.+..|. +..||||.|++++.|.+|+.||......+..+. ........
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------------~~~~~~~~ 544 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------------TNNYSDQR 544 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------------hhcccccc
Confidence 455667889999999999988765 557999999999999999999976444333220 00000011
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
.............+.+.+.+|.+||+.+|.+|.|+++|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1111112224456778899999999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-23 Score=175.22 Aligned_cols=257 Identities=32% Similarity=0.436 Sum_probs=197.2
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchh---HHHHHHHHHHHHccCCCC-ccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR---VFKSFDVECEMMKSIHHR-NIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|..+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999875 78899988755432 467788999999999988 799999999777778999999
Q ss_pred cCCCCHHHhhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-cEEEeeeccceecCccc
Q 039392 78 MPHGSLEKYLHSSN--YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTRED 154 (285)
Q Consensus 78 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~i~df~~~~~~~~~~ 154 (285)
+.++++.+++.... ..++......++.|++.++.++| ..+++|||+||+||+++..+ .+++.|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776554 24888999999999999999999 99999999999999999888 79999999998655433
Q ss_pred ccc----eeccccccccccCCcccCC---CccCcchhhHHHHHHHHHHhhCCCCCcccccc---chhhhhhhhhhcCCCc
Q 039392 155 IST----IQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLIETFTRKKPTDEIFNG---EMTLKHWVNDWLPIST 224 (285)
Q Consensus 155 ~~~----~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~ 224 (285)
... ......++..|.+||.+.+ ...+...|+|++|++++++++|..||...... ............+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 221 2356778999999999887 57899999999999999999999997665431 1111111111111 00
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..... ... .......+.+++.+++..+|..|.+..+....
T Consensus 236 ~~~~~----~~~------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLS----PSN------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccC----ccc------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000 000 02223568899999999999999988877654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=169.26 Aligned_cols=228 Identities=21% Similarity=0.267 Sum_probs=146.1
Q ss_pred CCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCC----------Ccccccccee----
Q 039392 4 ENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHH----------RNIIKVISSC---- 65 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~---- 65 (285)
.++.||.|+++.||.+.+ .+++++++|++.... ...++.+.+|.-....+.+ -.++..++..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 467899999999999975 469999999986443 3345666666655544322 1222222221
Q ss_pred -----cc---CC-----ceEEEEeccCCCCHHHhhhc---CC---CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 039392 66 -----SN---EE-----FKALVLEYMPHGSLEKYLHS---SN---YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126 (285)
Q Consensus 66 -----~~---~~-----~~~~v~e~~~~~~L~~~~~~---~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di 126 (285)
.. .+ ..+++|+.+.+ +|.+++.. .. ..........+..|++..+++|| ..|++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEeccc
Confidence 11 11 33578888844 88877532 11 12334445667789999999999 999999999
Q ss_pred CCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCC--------CccCcchhhHHHHHHHHHHhhC
Q 039392 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE--------GRVSANGDVYSFGIMLIETFTR 198 (285)
Q Consensus 127 ~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~l~~ll~g 198 (285)
+|+|++++.+|.+.++||+.....+... .. ...+..|.|||.... ..++.+.|.|+||+++|.++++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999887665421 11 234466889985432 2578999999999999999999
Q ss_pred CCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCC
Q 039392 199 KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQR 265 (285)
Q Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 265 (285)
..||+.......... ++....+.|..+..||+.+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~-------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999975432211100 222344778889999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=199.52 Aligned_cols=247 Identities=20% Similarity=0.229 Sum_probs=176.8
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccch-hHHHHH---HHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG-RVFKSF---DVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+...+.||++.|=+|.+|++.+|. |++|++-...+ -....+ .+|++ ...+++||++++.-+....+..|+|-+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 456789999999999999988888 99999854432 112222 33444 4556899999999998888888899999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC-----c
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-----R 152 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~-----~ 152 (285)
... +|.|.+..... +......-++.|++.|+..+| +.|++|||||.+||||++=+.+.|.||..-...- +
T Consensus 103 vkh-nLyDRlSTRPF-L~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPF-LVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccchH-HHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 966 89988855443 666667779999999999999 9999999999999999999999999997653221 1
Q ss_pred ccccceeccccccccccCCcccCC-----------CccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKE-----------GRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWL 220 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 220 (285)
.......++...-.-|.|||-+.. ...+++.||||+||+++|+++ |.+||.-..- -.+...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----~aYr~~-- 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----LAYRSG-- 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----HhHhcc--
Confidence 222333344444455999995432 115788999999999999998 6777653210 000000
Q ss_pred CCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 221 PISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
. ....+.....-....+++++..|++.||.+|.||++.|+..
T Consensus 251 -----~--------~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 251 -----N--------ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred -----C--------ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 0 00001111111223488999999999999999999999873
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=169.29 Aligned_cols=168 Identities=13% Similarity=0.134 Sum_probs=129.0
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHH---HH------HHHHHHHHccCCCCccccccceeccC---
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVF---KS------FDVECEMMKSIHHRNIIKVISSCSNE--- 68 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~---~~------~~~e~~~l~~l~h~~i~~~~~~~~~~--- 68 (285)
.|+..++||.|+||.||++.. ++..+|+|++.+...... +. +.+|+..+.++.|++|..+.+++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 478899999999999999765 577899999975443222 22 57899999999999999998875432
Q ss_pred -----CceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEee
Q 039392 69 -----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD 143 (285)
Q Consensus 69 -----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~d 143 (285)
+..+++|||++|.+|.++.. .+. ..+.+++.++..+| ..|++|+|++|+||+++.+| ++++|
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999988732 333 24568999999999 99999999999999999888 99999
Q ss_pred eccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHh
Q 039392 144 FGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETF 196 (285)
Q Consensus 144 f~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll 196 (285)
||........... ........+..++|+|+||+.+..+.
T Consensus 178 fg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9987644321111 00233344667899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=163.26 Aligned_cols=142 Identities=17% Similarity=0.160 Sum_probs=109.3
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeeccchh--H------------------------HHHHHHHHHHHccCCCCc
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR--V------------------------FKSFDVECEMMKSIHHRN 57 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~ 57 (285)
+...||+|++|.||+|...+|++||+|++...... . ......|++++..+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 35789999999999998778999999998754211 0 012235889999998777
Q ss_pred cccccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCCeeeCCC
Q 039392 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL-HFGYSAQVIHCDLKPSNVLLDDN 136 (285)
Q Consensus 58 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~~~~~~h~di~~~nili~~~ 136 (285)
+......... ..++|||+++|+++....... ..++...+..++.|++.+|.++ | ..|++|+||||+||+++ +
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence 6443332222 237999999887665543222 3488899999999999999999 7 89999999999999998 5
Q ss_pred CcEEEeeeccceecCc
Q 039392 137 MVAHLSDFGIAKLLTR 152 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~ 152 (285)
+.++++|||++.....
T Consensus 154 ~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 GKLYIIDVSQSVEHDH 169 (190)
T ss_pred CcEEEEEccccccCCC
Confidence 7899999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=156.13 Aligned_cols=141 Identities=23% Similarity=0.269 Sum_probs=110.4
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeeccchh--------------------------HHHHHHHHHHHHccCCCCc
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR--------------------------VFKSFDVECEMMKSIHHRN 57 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~ 57 (285)
+.+.||+|++|.||+|...+|+.||+|++...... ......+|.+.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 46789999999999998768999999998754211 0122357889999998888
Q ss_pred cccccceeccCCceEEEEeccCCCCHHHh-hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCC
Q 039392 58 IIKVISSCSNEEFKALVLEYMPHGSLEKY-LHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 58 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~-~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~ 135 (285)
+.....+.... .++|||+++|+++... +.. ..++......++.|++.++.++| . .|++|+||||+||+++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence 75444333322 4799999988755332 332 23778888999999999999999 8 9999999999999998
Q ss_pred CCcEEEeeeccceecCc
Q 039392 136 NMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 136 ~~~~~i~df~~~~~~~~ 152 (285)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-21 Score=146.91 Aligned_cols=185 Identities=15% Similarity=0.108 Sum_probs=137.3
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccch----hHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEec
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG----RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
.+...|++|.||+|+.+.. .+.+++.+.+..... .....+.+|+++|+++. ++++++++++ +..+++|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3577899999999998866 678888777654332 12235789999999995 5788888886 346899999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL-KPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di-~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+.|.+|...... ....++.|++.++.++| ..|++|+|| +|.||+++.+|.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999888654321 11346789999999999 999999999 799999999999999999999865543210
Q ss_pred ----ce-------eccccccccccCCcccCCC-ccC-cchhhHHHHHHHHHHhhCCCCCc
Q 039392 157 ----TI-------QTQTLATIGYMAPEYGKEG-RVS-ANGDVYSFGIMLIETFTRKKPTD 203 (285)
Q Consensus 157 ----~~-------~~~~~~~~~~~~PE~~~~~-~~~-~~~Di~slG~~l~~ll~g~~p~~ 203 (285)
.. ......++.+++|+...-. ..+ .+.+.++.|+.+|.++|+..+.-
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 00 0122345667777743332 233 66788999999999999998853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-23 Score=175.82 Aligned_cols=225 Identities=24% Similarity=0.299 Sum_probs=179.3
Q ss_pred eecccCceEEEEEE----eCCCcEEEEEEeeccch--hHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEeccC
Q 039392 7 LIGRGGFGSVFKAR----LGDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 7 ~lg~G~~~~v~~~~----~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.+|.|++|.|++++ ...+..+++|+...... ........|-.++...+ ||.++++...++.+..+++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999874 33477788888764432 11124445777787776 9999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
|+.+...+..... +.+.........++-+++.+| +.+++|+|+|++||+++.+|.+++.|||+....-.....
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 9888877765554 777777778889999999999 999999999999999999999999999998765543322
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
+|+..|+|||++. ....+.|.||+|+++++|++|..||.. .... ......
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~--------------------~Il~~~ 203 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMK--------------------RILKAE 203 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHH--------------------HHhhhc
Confidence 7899999999987 678899999999999999999999875 0000 011112
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINA 268 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 268 (285)
+..+...+..+.++++.++..+|..|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 33356677889999999999999999754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.6e-21 Score=172.69 Aligned_cols=192 Identities=25% Similarity=0.305 Sum_probs=155.0
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC---CCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH---HRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|.|-+.+|+|++|+||.|...+|+.+|||+-++... |+ |.--.+++.+|+ -+.|..+...+.-.+...+|++|.
T Consensus 700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~ 776 (974)
T KOG1166|consen 700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WE-FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS 776 (974)
T ss_pred EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--ee-eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence 456789999999999999877799999999765432 11 111123333443 345677777777788888999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-------CCCcEEEeeeccceecC
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-------DNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-------~~~~~~i~df~~~~~~~ 151 (285)
+.|+|.++++. .+..++..+..+..|++..++.|| ..+|+|+||||+|+++. ..--++|+|||.+....
T Consensus 777 ~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 777 PYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred ccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999999984 445889999999999999999999 99999999999999993 23458999999987765
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCC
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK 200 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 200 (285)
...........++|..+--+|+..|..|+...|.|+|..+++.|+.|+.
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 5443444556778888999999999999999999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=164.07 Aligned_cols=219 Identities=26% Similarity=0.380 Sum_probs=163.9
Q ss_pred HccCCCCccccccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 039392 50 MKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPS 129 (285)
Q Consensus 50 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~ 129 (285)
|+.+.|.|+.++++.+.++...+.|.++|..|+|.+.+......++......+.++++.|+.|+|. +...+|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 467889999999999999999999999999999999998877678888899999999999999994 222399999999
Q ss_pred CeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCc-------cCcchhhHHHHHHHHHHhhCCCCC
Q 039392 130 NVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR-------VSANGDVYSFGIMLIETFTRKKPT 202 (285)
Q Consensus 130 nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-------~~~~~Di~slG~~l~~ll~g~~p~ 202 (285)
|-+++....+|+.|||+.....................|.|||.+.... .+.+.|+||+|++++++++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999987764311111122223445699999877631 477799999999999999999999
Q ss_pred ccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 203 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
+........ .+.+..... .......+.... ....++++..++..||..+|.+||+++.+-..+..+..
T Consensus 159 ~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~~--------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDP-DEIILRVKK-GGSNPFRPSIEL--------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCCh-HHHHHHHHh-cCCCCcCcchhh--------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 875443332 111111000 000011111110 11344578899999999999999999999999887765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=146.45 Aligned_cols=136 Identities=15% Similarity=0.306 Sum_probs=105.6
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccC-----CCCccccccceeccCC---c-eEE
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-----HHRNIIKVISSCSNEE---F-KAL 73 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~~ 73 (285)
.-.++||+|++|.||. ...++.. +||++........+.+.+|+.+++.+ .||||++++++++++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4567999999999996 3334444 69998765444456788999999999 5799999999998764 3 336
Q ss_pred EEec--cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCCeeeCC----CCcEEEee-ec
Q 039392 74 VLEY--MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTL-EYLHFGYSAQVIHCDLKPSNVLLDD----NMVAHLSD-FG 145 (285)
Q Consensus 74 v~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l-~~lh~~~~~~~~h~di~~~nili~~----~~~~~i~d-f~ 145 (285)
|+|+ +.+++|.+++++.. +++. ..++.|++.++ +||| +++++|+||||+||+++. ++.++|+| ||
T Consensus 83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 45789999997642 5555 35677888777 9999 999999999999999974 34799999 45
Q ss_pred cc
Q 039392 146 IA 147 (285)
Q Consensus 146 ~~ 147 (285)
..
T Consensus 156 ~~ 157 (210)
T PRK10345 156 ES 157 (210)
T ss_pred Cc
Confidence 43
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=149.31 Aligned_cols=142 Identities=19% Similarity=0.187 Sum_probs=109.9
Q ss_pred CCCCceecccCceEEEEEE--eCCCcEEEEEEeeccchh------------------------HHHHHHHHHHHHccCCC
Q 039392 2 FSENNLIGRGGFGSVFKAR--LGDGMEVAVKVFNLQYGR------------------------VFKSFDVECEMMKSIHH 55 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~--~~~~~~~~iK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h 55 (285)
|.+.+.||+|++|.||+|. ..+|+.||+|++...... ....+.+|++++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7789999999999999998 568999999998753210 11235679999999875
Q ss_pred Cc--cccccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCee
Q 039392 56 RN--IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ-VIHCDLKPSNVL 132 (285)
Q Consensus 56 ~~--i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-~~h~di~~~nil 132 (285)
.. ++++++. . ..++|||+++|.+|........ ......+..++.|++.++.+|| ..| ++|+||+|+||+
T Consensus 110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIl 181 (237)
T smart00090 110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNIL 181 (237)
T ss_pred cCCCCCeeeEe---c-CceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEE
Confidence 32 3333432 2 3479999999988766543322 3566667889999999999999 999 999999999999
Q ss_pred eCCCCcEEEeeeccceecCc
Q 039392 133 LDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 133 i~~~~~~~i~df~~~~~~~~ 152 (285)
++ ++.++++|||.+.....
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 88999999999875443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.4e-20 Score=148.25 Aligned_cols=197 Identities=19% Similarity=0.253 Sum_probs=141.0
Q ss_pred CCCccccccceec---------------------------cCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHH
Q 039392 54 HHRNIIKVISSCS---------------------------NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV 106 (285)
Q Consensus 54 ~h~~i~~~~~~~~---------------------------~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l 106 (285)
+||||+++.+.|. ++.++|+||..+.. +|..++-... .+......++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 5999999988762 23478899999855 8998886544 6677788899999
Q ss_pred HHHHHHHhcCCCCCeeecCCCCCCeeeC--CCC--cEEEeeeccceecCccc----ccceeccccccccccCCcccCCC-
Q 039392 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLD--DNM--VAHLSDFGIAKLLTRED----ISTIQTQTLATIGYMAPEYGKEG- 177 (285)
Q Consensus 107 ~~~l~~lh~~~~~~~~h~di~~~nili~--~~~--~~~i~df~~~~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~- 177 (285)
++|+.+|| ++|+.|||+|++||++. .++ .+.+.|||.+-.-.... ......+..|..-.+|||+....
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 99999999999999994 343 46889999764322211 11122234566678999976532
Q ss_pred --c---cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHH
Q 039392 178 --R---VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFN 252 (285)
Q Consensus 178 --~---~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (285)
. .-.++|.|+.|.+.||+++...||..--..-.....+ . +..-...+..+++.+.+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y------------q-------e~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY------------Q-------ESQLPALPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh------------h-------hhhCCCCcccCChHHHH
Confidence 1 2467899999999999999999997621111111100 0 00111225678889999
Q ss_pred hhhcccccCcCCCCCHHHHHHHH
Q 039392 253 VAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 253 li~~~l~~~p~~Rps~~eil~~l 275 (285)
++...|+.||.+|+|..-+...|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999987665544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=142.07 Aligned_cols=135 Identities=23% Similarity=0.311 Sum_probs=112.2
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccch--------hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG--------RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
.+.||+|++|.||+|.. .|..+++|+...... .....+.+|++++..+.|+++.....++......+++||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36899999999999987 677899998654321 112356789999999999988877777767777889999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
+++|++|.+++.... . ....++.+++.++.++| +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999886432 1 67889999999999999 99999999999999999 88999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=139.85 Aligned_cols=137 Identities=23% Similarity=0.195 Sum_probs=107.5
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchh----------------------HHHHHHHHHHHHccCCCCc--
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR----------------------VFKSFDVECEMMKSIHHRN-- 57 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~-- 57 (285)
|.+.+.||+|+||.||++...+|+.+++|++...... .......|+.++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 6788999999999999998878999999987643210 1123567888888887764
Q ss_pred cccccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 039392 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM 137 (285)
Q Consensus 58 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~ 137 (285)
++..++ ....+++||+++|++|..+... .....++.+++.++.++| +.|++|+||+|+||+++.++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCC
Confidence 333333 2345899999999998765431 234568889999999999 99999999999999999999
Q ss_pred cEEEeeeccceecCc
Q 039392 138 VAHLSDFGIAKLLTR 152 (285)
Q Consensus 138 ~~~i~df~~~~~~~~ 152 (285)
.++++|||.+.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=136.81 Aligned_cols=130 Identities=19% Similarity=0.313 Sum_probs=104.8
Q ss_pred eecccCceEEEEEEeCCCcEEEEEEeeccch--------hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYG--------RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
.||+|++|.||+|.. ++.++++|+...... .....+.+|+++++.+.|+++.....++......+++||++
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 578899998643221 11255678999999998877655555555566678999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
+|++|.+++..... .++.+++.++.++| +.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754321 67889999999999 99999999999999999 89999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-19 Score=160.91 Aligned_cols=207 Identities=23% Similarity=0.276 Sum_probs=145.6
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
||+.++.+.-|++|.||.++++ +.+++++|+-+ +.- +.+. +++....|.++
T Consensus 84 df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----ilRn--ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 84 DFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----ILRN--ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred ccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----hhhc--cccccCCccee--------------------
Confidence 6788999999999999999865 46778875422 111 1111 23333344333
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc-------
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR------- 152 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~------- 152 (285)
|+-...++..+. ++.. ++.+++|+| ..|++|+|+||+|.+|+.-|++|+.|||+...-..
T Consensus 136 -gDc~tllk~~g~-lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLKNIGP-LPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhcccCCC-Ccch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 455555554433 3332 277899999 99999999999999999999999999998753211
Q ss_pred -ccc-----cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 153 -EDI-----STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 153 -~~~-----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
... -......++|+.|.|||++..+.|....|.|++|+++|+++.|.+||.+..+. ..+..++.+.....-
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-elfg~visd~i~wpE-- 279 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIEWPE-- 279 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-HHHhhhhhhhccccc--
Confidence 000 01112457999999999999999999999999999999999999999874333 333333332222211
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCC
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI 266 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 266 (285)
+ ....++++.+++.++|..+|..|.
T Consensus 280 ---------~------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 280 ---------E------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---------c------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 1 234467799999999999999996
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.9e-18 Score=152.64 Aligned_cols=134 Identities=21% Similarity=0.274 Sum_probs=107.8
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--------hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--------GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
|...+.||+|+||+||++...+. .+++|+..... ....+.+.+|+++++.++|++++....+.......++
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34578999999999999976443 44444322111 1123557789999999999999887777666667889
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
||||+++++|.+++. ....++.+++.++.+|| +.|++|||++|+||++ .++.++++|||++..
T Consensus 414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999998875 34568899999999999 9999999999999999 678999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=152.15 Aligned_cols=171 Identities=25% Similarity=0.402 Sum_probs=128.3
Q ss_pred ceEEEEeccCCCCHHHhhhcC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccc
Q 039392 70 FKALVLEYMPHGSLEKYLHSS--NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 147 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~ 147 (285)
.+++.|++|.-.+|.+++... ....+....+.++.|++.++.| ++.+|+|++|.||+...+..++|.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999533 3347778889999999999988 78999999999999999999999999999
Q ss_pred eecCccc----ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCC
Q 039392 148 KLLTRED----ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPI 222 (285)
Q Consensus 148 ~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (285)
+...... .........+|.+|++||.+.++.++.++|||+||+++++++. -..+++. ...+........+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip- 478 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIP- 478 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCC-
Confidence 8776544 2334456779999999999999999999999999999999997 3333221 1111111110000
Q ss_pred CccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 223 STKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
+. -..-.++-+.|+.+++.+.|.+||++.
T Consensus 479 -------~~-----------~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 479 -------PE-----------FLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred -------hH-----------HhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 00 001123356899999999999999443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-19 Score=160.62 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=193.0
Q ss_pred CCCCceecccCceEEEEEEeC--CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARLG--DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|.+.+.||+|+++.|-..... ....++.|.+.... .........|..+-..++ |.|++.+++........+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 778899999999998887643 33445555554332 222344455777777777 9999999999999999999999
Q ss_pred ccCCCCHHHhh-hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-cEEEeeeccceecCc-c
Q 039392 77 YMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTR-E 153 (285)
Q Consensus 77 ~~~~~~L~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~i~df~~~~~~~~-~ 153 (285)
+..|+++.+.+ .......+...+-..+.|+..++.|+|. ..+++|+|++|+|.+++..+ ..++.|||+++.+.. .
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 99999998887 4443235666677789999999999995 78999999999999999999 999999999998877 4
Q ss_pred cccceeccccc-cccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 154 DISTIQTQTLA-TIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 154 ~~~~~~~~~~~-~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
..........+ ++.|.+||...+. ...+..|+||.|+++..+++|..||+...........|....
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~------------ 247 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK------------ 247 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc------------
Confidence 44444555667 8999999998884 568889999999999999999999987655443222221111
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil 272 (285)
.......+........+++.+++..+|..|.+.+++-
T Consensus 248 ----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 ----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ----cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0111122345566688899999999999999988763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=127.12 Aligned_cols=138 Identities=23% Similarity=0.259 Sum_probs=96.3
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeeccchhHH--HH----------------------HHHHHHHHccCCCCc--
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVF--KS----------------------FDVECEMMKSIHHRN-- 57 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~~-- 57 (285)
+.+.||+|+||+||+|...+++.||+|++........ .. ...|.+.+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 4678999999999999877899999999875432111 10 123444444443322
Q ss_pred cccccceeccCCceEEEEeccCCCCHHH-hhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCC
Q 039392 58 IIKVISSCSNEEFKALVLEYMPHGSLEK-YLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 58 i~~~~~~~~~~~~~~~v~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~ 135 (285)
+.+.++. ...+++||+++++.+.. .+.... .. ..+..++.+++.++.++| . .+++|+||+|+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence 2333322 23589999998844321 111111 11 557789999999999999 7 9999999999999999
Q ss_pred CCcEEEeeeccceecCc
Q 039392 136 NMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 136 ~~~~~i~df~~~~~~~~ 152 (285)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 99999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.4e-17 Score=120.33 Aligned_cols=135 Identities=20% Similarity=0.255 Sum_probs=111.4
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCC--CccccccceeccCCceEEEEeccCCC
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHH--RNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.+.+ ..+++++......+..++++|++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56889999999999998754 7899999765433 4567789999998876 58888888888778899999999887
Q ss_pred CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 82 SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
++..+ +......++.+++.++..+|.....+++|+|++|.||+++..+.++++||+.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77554 4455667888999999999943335899999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-16 Score=126.46 Aligned_cols=135 Identities=19% Similarity=0.244 Sum_probs=103.6
Q ss_pred Cceec-ccCceEEEEEEeCCCcEEEEEEeeccc-------------hhHHHHHHHHHHHHccCCCCcc--ccccceeccC
Q 039392 5 NNLIG-RGGFGSVFKARLGDGMEVAVKVFNLQY-------------GRVFKSFDVECEMMKSIHHRNI--IKVISSCSNE 68 (285)
Q Consensus 5 ~~~lg-~G~~~~v~~~~~~~~~~~~iK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 68 (285)
...|| .|+.|+||.+... +..+|||.+.... ......+.+|++++..+.|+++ +..++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45787 8999999999874 6789999875321 1223457789999999988775 5566554332
Q ss_pred -C---ceEEEEeccCC-CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEee
Q 039392 69 -E---FKALVLEYMPH-GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD 143 (285)
Q Consensus 69 -~---~~~~v~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~d 143 (285)
. ..++|+|+++| .+|.+++... .++.. .+.+++.++.+|| +.|++|+||+|.||+++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999987 6898887653 24443 3568999999999 99999999999999999989999999
Q ss_pred ecccee
Q 039392 144 FGIAKL 149 (285)
Q Consensus 144 f~~~~~ 149 (285)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-15 Score=131.61 Aligned_cols=173 Identities=17% Similarity=0.227 Sum_probs=135.2
Q ss_pred EEE-E-EeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCHHHhhhcCCCc
Q 039392 16 VFK-A-RLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI 93 (285)
Q Consensus 16 v~~-~-~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~ 93 (285)
+|. | +..++.+|.+.+.+...........+.++.|+.++||+|+++++.++..++.|+|+|.+ .+|...+++.+
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-- 102 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH--
Confidence 453 3 45578899998887766655566778899999999999999999999999999999998 47888886633
Q ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcc
Q 039392 94 LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173 (285)
Q Consensus 94 ~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~ 173 (285)
...+.--+.||+.||.+||+ +.+++|++++...|+++..|.+||++|.++........ .......-..|..|+.
T Consensus 103 --~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 103 --KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 45556678999999999985 78999999999999999999999999999876544321 1111222334667775
Q ss_pred cCCCccCcchhhHHHHHHHHHHhhCCC
Q 039392 174 GKEGRVSANGDVYSFGIMLIETFTRKK 200 (285)
Q Consensus 174 ~~~~~~~~~~Di~slG~~l~~ll~g~~ 200 (285)
+.... .+.|.|.||++.++++.|..
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCccc
Confidence 54333 45799999999999999943
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.3e-15 Score=130.02 Aligned_cols=142 Identities=23% Similarity=0.276 Sum_probs=98.2
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHH----------------------------------------HHH
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFK----------------------------------------SFD 44 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~----------------------------------------~~~ 44 (285)
.+.||+|++|.||+|+..+|+.||||+..+....... .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4689999999999999889999999998764321110 133
Q ss_pred HHHHHHccCC----CCcccccccee-ccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHH-HHHHHhcCCC
Q 039392 45 VECEMMKSIH----HRNIIKVISSC-SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS-TLEYLHFGYS 118 (285)
Q Consensus 45 ~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~-~l~~lh~~~~ 118 (285)
+|+..+.++. +.+-+.+-.++ ...+..++||||++|.+|.++........+ ...++.+++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence 3444444442 22222222222 223456799999999999887643211122 2345555555 467889 9
Q ss_pred CCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 119 ~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
.|++|+|++|.||+++.+|.++++|||++..++.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.8e-13 Score=111.05 Aligned_cols=265 Identities=13% Similarity=0.114 Sum_probs=169.7
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccce-------eccCCceEEEE
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISS-------CSNEEFKALVL 75 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-------~~~~~~~~~v~ 75 (285)
.++.||+|+-+.+|..-. -...|.|++........+....| |... .||-+-.-+.+ ........++|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 467899999998887631 22356788876554433332222 2222 35533221221 12333477889
Q ss_pred eccCCCC-HHHhhhc-----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 76 EYMPHGS-LEKYLHS-----SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 76 e~~~~~~-L~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
+.+.+.. +.++.+. +.........+..++.++.+.+.|| ..|.+.+|++++|+|+++++.|.+.|-+.-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 9887642 3333321 2223677889999999999999999 99999999999999999999999998665544
Q ss_pred cCcccccceeccccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhC-CCCCccccccch---hhh-hhhhhh
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEM---TLK-HWVNDW 219 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~---~~~-~~~~~~ 219 (285)
..+. ..+....+.+.|.+||.-. +-.-+...|.|.||+++++++.| ..||.+...... ... ......
T Consensus 167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 4332 2334567888999999543 34567889999999999999986 889987533211 111 111110
Q ss_pred cCCCccccccccccCcccchhhhhhHhHHHHHHhhhccccc--CcCCCCCHHHHHHHHHHHHHHHh
Q 039392 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVE--SPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
.....+ ..+.. ...+..++ ....++.+..+..+|+.. +++-|||++-++..|..+++++.
T Consensus 244 f~ya~~--~~~g~-~p~P~~~P-~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 244 FAYASD--QRRGL-KPPPRSIP-LSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeechh--ccCCC-CCCCCCCC-hhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 000000 00000 00111111 234577788999999965 46789999999999999998863
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.6e-14 Score=113.96 Aligned_cols=200 Identities=18% Similarity=0.271 Sum_probs=138.3
Q ss_pred HccCCCCccccccceeccC-----CceEEEEeccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 039392 50 MKSIHHRNIIKVISSCSNE-----EFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121 (285)
Q Consensus 50 l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~ 121 (285)
+-++-|.|++++..++.+. ....++.||+..|++..++++ +...+....-.+|+.||+.||.|||.+ .-.+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 4455699999999988543 456799999999999999865 344577888899999999999999954 5579
Q ss_pred eecCCCCCCeeeCCCCcEEEeeeccceecCcc---cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhC
Q 039392 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE---DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR 198 (285)
Q Consensus 122 ~h~di~~~nili~~~~~~~i~df~~~~~~~~~---~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g 198 (285)
+|+++..+.|++..+|-+|+.--.- ..+... ..........+.++|.+||.-...+.+-++|||++|.++.+|..+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999999852111 111100 001111223467789999988888889999999999999999988
Q ss_pred CCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 199 KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..........-.... .+....+..+ ...-+.++.+|++-.|..||++++++-+
T Consensus 279 Eiq~tnseS~~~~ee-------------~ia~~i~~le----------n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEE-------------NIANVIIGLE----------NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhh-------------hhhhheeecc----------CccccCcCcccccCCCCCCcchhhhhcC
Confidence 875322111000000 0000000000 0112358889999999999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-14 Score=123.82 Aligned_cols=247 Identities=24% Similarity=0.284 Sum_probs=179.5
Q ss_pred CCCCceecc--cCceEEEEEEe---CCCcEEEEEEee--ccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEE
Q 039392 2 FSENNLIGR--GGFGSVFKARL---GDGMEVAVKVFN--LQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~--G~~~~v~~~~~---~~~~~~~iK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 73 (285)
+.+.+.+|. |.+|.+|.++. .++..+++|.-+ ...+..-..-.+|+...+.++ |++.++....+...+.+++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 345678899 99999999965 357778888732 222222233345666666664 9999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCCeeeCCC-CcEEEeeeccce
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS----TLEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAK 148 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~----~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~i~df~~~~ 148 (285)
-+|.+ +.+|..+...-...++...++..+.+... |+..+| ..+++|-|++|.||+...+ ...+++||++..
T Consensus 196 qtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 196 QTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcceeE
Confidence 99999 56888887666555888889999999999 999999 9999999999999999988 889999999999
Q ss_pred ecCcccccceec---cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 149 LLTREDISTIQT---QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 149 ~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
............ ...+...|++||.. +.-++.++|+|++|.++.+..++..++....+. . |...+..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----~----W~~~r~~ 341 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-----S----WSQLRQG 341 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-----C----ccccccc
Confidence 887765332222 22566779999975 456788999999999999998887664322111 0 1111000
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
.+..+ .....+.++...+..|+..+|..|++++.+..
T Consensus 342 ------~ip~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 ------YIPLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------cCchh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 01100 11223444666889999999999999987764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.2e-14 Score=122.75 Aligned_cols=141 Identities=22% Similarity=0.257 Sum_probs=89.6
Q ss_pred CCCCceecccCceEEEEEEeCC-CcEEEEEEeeccchhH----------------------------------HHHHHHH
Q 039392 2 FSENNLIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRV----------------------------------FKSFDVE 46 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~----------------------------------~~~~~~e 46 (285)
|+. +.||+|++|.||+|+..+ |+.||||+..+..... .+.+.+|
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 443 789999999999999766 9999999997643111 1112223
Q ss_pred HHHHccCCCCccccccceecc-------------CCceEEEEeccCCCCHHHhh--hcCCCccCHHHHHHHHHHHH-HHH
Q 039392 47 CEMMKSIHHRNIIKVISSCSN-------------EEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVA-STL 110 (285)
Q Consensus 47 ~~~l~~l~h~~i~~~~~~~~~-------------~~~~~~v~e~~~~~~L~~~~--~~~~~~~~~~~~~~~~~~l~-~~l 110 (285)
+...+.. +|+.++...+.+ ....++||||++|+++.++- ...+ .+.... +...+ ..+
T Consensus 201 lD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~~l---a~~~v~~~~ 273 (537)
T PRK04750 201 LDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMKLL---AERGVEVFF 273 (537)
T ss_pred hCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHHHH---HHHHHHHHH
Confidence 3222222 233333332222 33456999999999998742 2222 222211 11111 123
Q ss_pred HHHhcCCCCCeeecCCCCCCeeeCCCC----cEEEeeeccceecCcc
Q 039392 111 EYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTRE 153 (285)
Q Consensus 111 ~~lh~~~~~~~~h~di~~~nili~~~~----~~~i~df~~~~~~~~~ 153 (285)
.-+. ..|++|+|++|.||+++.+| +++++|||++..++..
T Consensus 274 ~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3345 68999999999999999888 9999999999887653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.5e-14 Score=106.70 Aligned_cols=128 Identities=21% Similarity=0.189 Sum_probs=94.5
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccc-cccceeccCCceEEEEeccCCCCH
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII-KVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
++.|+.|.++.||++... +..+++|+....... ...+.+|+.+++.+.+.+++ +++.... ...++|||+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 467899999999999864 778999997654321 23456788888888655544 4444332 234799999999877
Q ss_pred HHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 84 EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ-----VIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-----~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
... . .. ....+.+++.++..|| ..+ ++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~-----~-~~---~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE-----D-FS---DPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----c-cc---CHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 543 0 11 1235678999999999 666 59999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1e-12 Score=100.41 Aligned_cols=137 Identities=22% Similarity=0.229 Sum_probs=98.1
Q ss_pred CceecccCceEEEEEEeCC-------CcEEEEEEeeccc----------------------hhHHHH----HHHHHHHHc
Q 039392 5 NNLIGRGGFGSVFKARLGD-------GMEVAVKVFNLQY----------------------GRVFKS----FDVECEMMK 51 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~-------~~~~~iK~~~~~~----------------------~~~~~~----~~~e~~~l~ 51 (285)
...||.|.-+.||.|...+ +..+|+|++.... ...... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4678999999999997442 5789999886311 001122 337899998
Q ss_pred cCCC--CccccccceeccCCceEEEEeccCCCCHH-HhhhcCCCccCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCC
Q 039392 52 SIHH--RNIIKVISSCSNEEFKALVLEYMPHGSLE-KYLHSSNYILDIYQRLNIMIDVASTLEYL-HFGYSAQVIHCDLK 127 (285)
Q Consensus 52 ~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~~L~-~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~~~~~~h~di~ 127 (285)
++.. -++++++++ ...++|||++.+..+. ..++.. .++......+..+++.++..+ | +.|++|+|++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 8863 345555654 3456999999664332 122221 245556677889999999988 8 9999999999
Q ss_pred CCCeeeCCCCcEEEeeeccceecC
Q 039392 128 PSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 128 ~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+.||+++ ++.+.++||+.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999996 5789999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.1e-11 Score=91.91 Aligned_cols=131 Identities=20% Similarity=0.293 Sum_probs=98.0
Q ss_pred ceecccCceEEEEEEeCCCcEEEEEEeeccc--------hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--------GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
..+++|+-+.++.+.+. |.++++|.=.++. .--..+..+|+.++.++.--.+....=+..++....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999763 4557777532221 11224456799999888765665555555566666699999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
++|..|.+.+.... ..++..+-.-+.-|| ..|++|+|+.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~--------~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEAR--------PDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcc--------hHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998887652 345666777788999 99999999999999997665 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.37 E-value=9.7e-12 Score=98.50 Aligned_cols=143 Identities=19% Similarity=0.199 Sum_probs=106.4
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCC--ccccccceeccC---CceEEEEecc
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHR--NIIKVISSCSNE---EFKALVLEYM 78 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~~v~e~~ 78 (285)
.+.|+.|..+.+|++...+|+.+++|....... .....+..|+++++.+.+. ++++++.+.... +..+++||++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 467899999999999876678999999754332 1345677899999998753 456677766553 3668999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY----------------------------------------- 117 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----------------------------------------- 117 (285)
+|.++.+.+.. ..++......++.+++.++..||...
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888765532 22566666677777888887777421
Q ss_pred ------------CCCeeecCCCCCCeeeCC--CCcEEEeeecccee
Q 039392 118 ------------SAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKL 149 (285)
Q Consensus 118 ------------~~~~~h~di~~~nili~~--~~~~~i~df~~~~~ 149 (285)
...++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 67789999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-10 Score=99.03 Aligned_cols=213 Identities=15% Similarity=0.146 Sum_probs=150.0
Q ss_pred eEEEEEE-eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceec----cCCceEEEEeccCC-CCHHHhh
Q 039392 14 GSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS----NEEFKALVLEYMPH-GSLEKYL 87 (285)
Q Consensus 14 ~~v~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~~v~e~~~~-~~L~~~~ 87 (285)
.+.|++. .-+|..|++|.+..........-..-++.++++.|.|++++.++|. .+..+++|++|+++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5788885 5579999999985443333333445688899999999999999886 34578899999875 4565542
Q ss_pred -hc-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 88 -HS-------------SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 88 -~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
.. .+...++..+|.++.|+..||.++| +.|+...-+.+.+|+++.+-+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 11 2334788999999999999999999 999999999999999998889999988887765543
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
. . +.+ .-..+.|.=.||.++..+.+|...--........
T Consensus 447 ~--------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s---------------------- 485 (655)
T KOG3741|consen 447 P--------------T--EPL---ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSS---------------------- 485 (655)
T ss_pred C--------------C--cch---hHHhhhhHHHHHHHHHHHhhcccccccccchHHH----------------------
Confidence 2 0 111 1234679999999999999996531110000000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
..-......+.++++++.-....++.+ -++++++.++
T Consensus 486 ----~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 486 ----HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ----HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 000113445666777777777777776 5677766554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.6e-11 Score=87.89 Aligned_cols=142 Identities=18% Similarity=0.194 Sum_probs=101.8
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeeccc--------hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--------GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
....+.+|+-+.|+++.+ .|+.++||.=..+. .-...+..+|+.+|.++.--.|.-..-++.+...-.+.|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 356788999999999987 47888888532211 223355667888888876545544444555555666889
Q ss_pred eccCC-CCHHHhhhcCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---cEEEeeecccee
Q 039392 76 EYMPH-GSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHLSDFGIAKL 149 (285)
Q Consensus 76 e~~~~-~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~i~df~~~~~ 149 (285)
|+++| .++.+++...... ........++.++-+.+.-|| ..+++|+|+.++||++..+| .+.++|||+...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 3677776543322 233333678889999999999 99999999999999996443 358999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.2e-12 Score=109.09 Aligned_cols=245 Identities=20% Similarity=0.150 Sum_probs=167.2
Q ss_pred CCCCceecccCceEEEEEEe--CCCcEEEEEEeeccchhHHH--HHHHHHHHHccC-CCCccccccceeccCCceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARL--GDGMEVAVKVFNLQYGRVFK--SFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~--~~~~~~~iK~~~~~~~~~~~--~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|..+..||.|.|+.|+.... .++..+++|-....-..... ....|+.+...+ .|.+++.....+...+..++-.|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 55678899999999988742 46777888865433221111 223455555555 38888888888877777789999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~i~df~~~~~~~~~~~ 155 (285)
+|.++++...+.-. ..+++...+++..|++.++.++| +..++|+|++|.||++..+ +..+++||+.+..+...
T Consensus 347 ~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred hhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccccee--
Confidence 99988876655222 22667778899999999999999 9999999999999999875 77889999988653221
Q ss_pred cceecccccccccc--CCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 156 STIQTQTLATIGYM--APEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 ~~~~~~~~~~~~~~--~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.....+..++. ++.......+..+.|+++||.-+.+.+++.+.-....... . +....
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-----------~------i~~~~- 479 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-----------T------IRSGD- 479 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-----------e------eeccc-
Confidence 12222333444 4445555678999999999999999999876432211000 0 00000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
.+...+...++..+.+.+...++..||++.++..+.+-.+
T Consensus 480 ------~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 480 ------TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 1111222355667888899999999999988876655443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.3e-11 Score=93.50 Aligned_cols=135 Identities=22% Similarity=0.210 Sum_probs=101.4
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccc----------------------hhHHHHHHHHHHHHccCCCC--cc
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY----------------------GRVFKSFDVECEMMKSIHHR--NI 58 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--~i 58 (285)
.++..||-|.-|.||.|..++|.++++|.=.... ......+.+|.++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4678999999999999999899999999643211 11234567899999998744 56
Q ss_pred ccccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc
Q 039392 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV 138 (285)
Q Consensus 59 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~ 138 (285)
++.+++- ..++|||+++|..|...- ++....-.++..|+..+.-+- ..|++|+|+++-||+++++|.
T Consensus 174 P~P~~~n----RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAWN----RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCccccc----cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCC
Confidence 6666553 356999999987665432 123334456666777777777 799999999999999999999
Q ss_pred EEEeeeccceec
Q 039392 139 AHLSDFGIAKLL 150 (285)
Q Consensus 139 ~~i~df~~~~~~ 150 (285)
+.++||.-+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999776543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-10 Score=88.72 Aligned_cols=126 Identities=25% Similarity=0.305 Sum_probs=82.0
Q ss_pred EEEEEEeCCCcEEEEEEeeccc--------------------------hhHHHHHHHHHHHHccCCCC--ccccccceec
Q 039392 15 SVFKARLGDGMEVAVKVFNLQY--------------------------GRVFKSFDVECEMMKSIHHR--NIIKVISSCS 66 (285)
Q Consensus 15 ~v~~~~~~~~~~~~iK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 66 (285)
.||.|...+|..+|+|+..... ........+|++.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899988889999999886311 01224466899999999865 455555442
Q ss_pred cCCceEEEEeccC--CCCHHHhhhcCCCccCHHHHHHHHHHHHH-HHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEee
Q 039392 67 NEEFKALVLEYMP--HGSLEKYLHSSNYILDIYQRLNIMIDVAS-TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD 143 (285)
Q Consensus 67 ~~~~~~~v~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~~l~~-~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~d 143 (285)
...+||||++ |..+..+.... ++......++.+++. ....+| ..|++|+|+++.||+++.+ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 2359999998 65554433222 112234456777777 444568 9999999999999999877 999999
Q ss_pred eccceecC
Q 039392 144 FGIAKLLT 151 (285)
Q Consensus 144 f~~~~~~~ 151 (285)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.6e-10 Score=89.76 Aligned_cols=138 Identities=17% Similarity=0.135 Sum_probs=96.7
Q ss_pred eecccCceEEEEEEeCCCcEEEEEEeeccchh-HHH----------HHHHHHHHHccCCCCccc--cccceecc-----C
Q 039392 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR-VFK----------SFDVECEMMKSIHHRNII--KVISSCSN-----E 68 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~~i~--~~~~~~~~-----~ 68 (285)
.+-......|.++.. +|+.++||........ ... .+.+|...+.++...+|. ++++++.. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333444666655 5788999976433211 111 367888888888544443 33444432 2
Q ss_pred CceEEEEeccCCC-CHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-------CCcE
Q 039392 69 EFKALVLEYMPHG-SLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-------NMVA 139 (285)
Q Consensus 69 ~~~~~v~e~~~~~-~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-------~~~~ 139 (285)
...++|+|++++. +|.+++... ....+......++.+++..+..|| ..|++|+|+++.||+++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 3467999999875 798887532 223556677789999999999999 999999999999999975 4688
Q ss_pred EEeeeccce
Q 039392 140 HLSDFGIAK 148 (285)
Q Consensus 140 ~i~df~~~~ 148 (285)
.++||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-11 Score=112.36 Aligned_cols=246 Identities=23% Similarity=0.270 Sum_probs=161.9
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+.+.+.+.+|.++.++.+.- ..|.-..+|+.... ....++....+-.++-...+|.++.....+.-....++++++
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~ 885 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY 885 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence 45566778889998888752 23433333332211 011111111122222122346666555555556678899999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc----
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE---- 153 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~---- 153 (285)
+.+++|...+...+. .+.+........+.+++++|| ...+.|+|++|.|.++..+|..++.+|+.......-
T Consensus 886 ~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 886 LNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 999999888876653 555556667778899999999 787999999999999999999999998743322110
Q ss_pred -----------------c--------ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCcccccc
Q 039392 154 -----------------D--------ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNG 208 (285)
Q Consensus 154 -----------------~--------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 208 (285)
. .........+++.|.+||...+......+|.|++|+++++.++|..||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 001123456889999999999999999999999999999999999998764332
Q ss_pred chhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 209 EMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
+. +... ...+..... .+...+.+..+++.+.+..+|.+|..+.
T Consensus 1042 ~~-f~ni----~~~~~~~p~-------------g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QI-FENI----LNRDIPWPE-------------GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh-hhcc----ccCCCCCCC-------------CccccChhhhhhhhhhhccCchhccCcc
Confidence 21 1111 111111011 1334456688899999999999998765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.5e-11 Score=106.06 Aligned_cols=151 Identities=17% Similarity=0.212 Sum_probs=105.0
Q ss_pred HHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec-------cccccccccCCcccCC
Q 039392 104 IDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT-------QTLATIGYMAPEYGKE 176 (285)
Q Consensus 104 ~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~-------~~~~~~~~~~PE~~~~ 176 (285)
.+++.|+.++|+ ..++||++|.|++|.++..|.+||+.|+++............. .......|.+||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999996 7899999999999999999999999999887655422211111 1123445999999999
Q ss_pred CccCcchhhHHHHHHHHHHhhCCCC-CccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhh
Q 039392 177 GRVSANGDVYSFGIMLIETFTRKKP-TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAM 255 (285)
Q Consensus 177 ~~~~~~~Di~slG~~l~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 255 (285)
...+.++|+||+|+++|.+..|..+ +.+. .......... .......+-....+++++.+-+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~~~~~~~~~----------------~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GGLLSYSFSR----------------NLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhcc-CCcchhhhhh----------------cccccccccccccCcHHHHHHHH
Confidence 8899999999999999999955544 3321 1111111000 00011111123577889999999
Q ss_pred cccccCcCCCCCHHHHHH
Q 039392 256 ECTVESPEQRINAKEIVT 273 (285)
Q Consensus 256 ~~l~~~p~~Rps~~eil~ 273 (285)
+++..++.-||++.+++.
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999997776653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.6e-09 Score=93.34 Aligned_cols=142 Identities=20% Similarity=0.202 Sum_probs=92.4
Q ss_pred ceecccCceEEEEEEeCCCcEEEEEEeeccchhHH----------------------------------HH------HHH
Q 039392 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVF----------------------------------KS------FDV 45 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~----------------------------------~~------~~~ 45 (285)
..|+.++.|.||+|+..+|+.||||+..++-.+.. +. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67899999999999999999999999876432111 01 222
Q ss_pred HHHHHccCC-----CCccccccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHH-HHHHHhcCCCC
Q 039392 46 ECEMMKSIH-----HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS-TLEYLHFGYSA 119 (285)
Q Consensus 46 e~~~l~~l~-----h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~-~l~~lh~~~~~ 119 (285)
|+..+.++. .+++.-..-+++..+.-.++|||++|..+.++........+...+. ..+++ .+.-+- ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia---~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELA---ELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHH---HHHHHHHHHHHH---hc
Confidence 333333331 2222111112233445569999999999988743222225533332 22222 233444 68
Q ss_pred CeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 120 ~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|++|+|..|.||+++.+|++.+.|||+....+..
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999999877653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-08 Score=78.94 Aligned_cols=133 Identities=16% Similarity=0.166 Sum_probs=83.8
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHH---------HHHHHHccCCC---Cccccccce-----
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFD---------VECEMMKSIHH---RNIIKVISS----- 64 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~---------~e~~~l~~l~h---~~i~~~~~~----- 64 (285)
|...+.+-......|.+... +|..+++|.........++.+. +.+..+..+.. .....++.+
T Consensus 33 ~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~ 111 (229)
T PF06176_consen 33 YKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI 111 (229)
T ss_pred ceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence 45555666666666666655 4688999987655433333222 23333333321 222222222
Q ss_pred eccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 65 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
+......+++|||++|..|.+... +++ .+...+.+++.-+| +.|++|+|.+|.|++++.++ ++++|+
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred ccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 223345568999999988876532 222 24456778899999 99999999999999998555 899999
Q ss_pred ccce
Q 039392 145 GIAK 148 (285)
Q Consensus 145 ~~~~ 148 (285)
+...
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 7654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.6e-08 Score=77.76 Aligned_cols=135 Identities=24% Similarity=0.297 Sum_probs=89.4
Q ss_pred eecccCceEEEEEEeCCCcEEEEEEeeccchh------------------------HHHHHHHHHHHHccCCCC--cccc
Q 039392 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR------------------------VFKSFDVECEMMKSIHHR--NIIK 60 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~--~i~~ 60 (285)
.|.+|.-+.||+|...++..+|+|++...... ......+|+..|+++... .+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 56788889999998888999999998643210 011133455555555322 2222
Q ss_pred ccceeccCCceEEEEeccCCCC-HHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCc
Q 039392 61 VISSCSNEEFKALVLEYMPHGS-LEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMV 138 (285)
Q Consensus 61 ~~~~~~~~~~~~~v~e~~~~~~-L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~ 138 (285)
.+.+.. -.+|||++.... -...++... .....+..+..++++.+.-|- . .++||+||+.-|||+. ++.
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~--~e~~e~~~~~~~~v~~~~~l~---~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLKDVP--LELEEAEGLYEDVVEYMRRLY---KEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCcccCC--cCchhHHHHHHHHHHHHHHHH---HhcCcccccchhhheEEE-CCe
Confidence 333222 238999985431 111122211 233356677888888888887 5 9999999999999999 889
Q ss_pred EEEeeeccceecC
Q 039392 139 AHLSDFGIAKLLT 151 (285)
Q Consensus 139 ~~i~df~~~~~~~ 151 (285)
+.|+|++-+....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999887554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.8e-08 Score=78.78 Aligned_cols=106 Identities=24% Similarity=0.292 Sum_probs=81.2
Q ss_pred HHHHHHHHHHccCCCCcc--ccccceeccC----CceEEEEeccCC-CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHH
Q 039392 41 KSFDVECEMMKSIHHRNI--IKVISSCSNE----EFKALVLEYMPH-GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL 113 (285)
Q Consensus 41 ~~~~~e~~~l~~l~h~~i--~~~~~~~~~~----~~~~~v~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 113 (285)
..+.+|...+..+...+| ++++++.... ...++|+|.+++ .+|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 456678887777753333 4455555432 245799999987 479998876433 55666788999999999999
Q ss_pred hcCCCCCeeecCCCCCCeeeCCCC---cEEEeeeccceec
Q 039392 114 HFGYSAQVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLL 150 (285)
Q Consensus 114 h~~~~~~~~h~di~~~nili~~~~---~~~i~df~~~~~~ 150 (285)
| ..|++|+|+++.|||++.++ .+.++||+-+...
T Consensus 135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9 99999999999999998877 8999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.84 E-value=7e-08 Score=76.40 Aligned_cols=137 Identities=11% Similarity=0.138 Sum_probs=84.0
Q ss_pred ceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc--cccccceeccCCceEEEEeccCCCC-
Q 039392 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN--IIKVISSCSNEEFKALVLEYMPHGS- 82 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~~~~- 82 (285)
.+||+|..+.||+. .+..+++|....... .....+|.++++.+...+ +.+++.+....+...++|++++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 255688998765332 244678999998886433 4677777777777889999998863
Q ss_pred HHHhh--------------hc-----CC---CccCHHHHHH-HHHH----------HHHH-HHHHhc-CCCCCeeecCCC
Q 039392 83 LEKYL--------------HS-----SN---YILDIYQRLN-IMID----------VAST-LEYLHF-GYSAQVIHCDLK 127 (285)
Q Consensus 83 L~~~~--------------~~-----~~---~~~~~~~~~~-~~~~----------l~~~-l~~lh~-~~~~~~~h~di~ 127 (285)
+...+ .+ +. ...+...... +..+ +... ..+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 11 00 0011111000 0000 0011 111110 113357899999
Q ss_pred CCCeeeCCCCcEEEeeeccce
Q 039392 128 PSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 128 ~~nili~~~~~~~i~df~~~~ 148 (285)
|.||+++.++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999998875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.9e-07 Score=71.89 Aligned_cols=135 Identities=17% Similarity=0.131 Sum_probs=96.7
Q ss_pred cccCceEEEEEEeCCCcEEEEEEeecc-c-----hhHHHHHHHHHHHHccCCCCc--cccccceec-c----CCceEEEE
Q 039392 9 GRGGFGSVFKARLGDGMEVAVKVFNLQ-Y-----GRVFKSFDVECEMMKSIHHRN--IIKVISSCS-N----EEFKALVL 75 (285)
Q Consensus 9 g~G~~~~v~~~~~~~~~~~~iK~~~~~-~-----~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~-~----~~~~~~v~ 75 (285)
|+|+-+-|++.... |+.+.+|..... . +--...+.+|+..++++...+ ++++. ++. . ...-++|+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 55778888888654 446888875410 0 223467889999998886333 34444 222 1 12356899
Q ss_pred eccCC-CCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc--EEEeeeccce
Q 039392 76 EYMPH-GSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV--AHLSDFGIAK 148 (285)
Q Consensus 76 e~~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--~~i~df~~~~ 148 (285)
|-+++ .+|.+++.... .+.+......++.+++.++.-|| ..|+.|+|+.+.||+++.+|. +.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 58888875532 23567777889999999999999 999999999999999986667 8999997665
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.3e-08 Score=71.26 Aligned_cols=129 Identities=19% Similarity=0.224 Sum_probs=92.9
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcccc-ccceeccCCceEEEEeccCCC
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK-VISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~v~e~~~~~ 81 (285)
++.+.|++|.+|.||++.+. |..+++|+-..+++ ...+..|+++|+.+..-++.+ ++.+..+ ++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 35678999999999999985 56899998665544 477888999999988666543 3333222 2459999998
Q ss_pred CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC-CCCeeeCCCCcEEEeeecccee
Q 039392 82 SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLK-PSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~-~~nili~~~~~~~i~df~~~~~ 149 (285)
+|.+..... +.. -...+++...-|. ..||-|+.|+ |...++..++.+.|+||..|+.
T Consensus 98 ~L~~~~~~~----~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG----DRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc----cHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887764321 222 2335666766777 8899999987 5666666666999999999873
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=9.1e-08 Score=83.65 Aligned_cols=140 Identities=21% Similarity=0.303 Sum_probs=89.7
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchh-------------------------------HHHH------HHHHH
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR-------------------------------VFKS------FDVEC 47 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-------------------------------~~~~------~~~e~ 47 (285)
.+.||..+.|.|++|+..+|+.||||+-++.-.. .... |.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 3688999999999999989999999998753211 1111 22233
Q ss_pred HHHcc----CCCCc------cccccceeccCCceEEEEeccCCCCHHHh--hhcCCCccCHHHHHHHHHHHHHHHHHHhc
Q 039392 48 EMMKS----IHHRN------IIKVISSCSNEEFKALVLEYMPHGSLEKY--LHSSNYILDIYQRLNIMIDVASTLEYLHF 115 (285)
Q Consensus 48 ~~l~~----l~h~~------i~~~~~~~~~~~~~~~v~e~~~~~~L~~~--~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 115 (285)
+..++ +.|-+ |++++- .....-.++|||++|..+.+. +.+.+ ++...+ +..+.++...+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i---~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDI---LNKLVEAYLEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHH---HHHHHHHHHHHHH
Confidence 32222 22333 222322 223345699999999887665 33333 555533 3344443322211
Q ss_pred CCCCCeeecCCCCCCeeeC----CCCcEEEeeeccceecCcc
Q 039392 116 GYSAQVIHCDLKPSNVLLD----DNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 116 ~~~~~~~h~di~~~nili~----~~~~~~i~df~~~~~~~~~ 153 (285)
..|++|+|-.|.||++. .++.+.+.|||+.......
T Consensus 319 --~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 --KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred --hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 67899999999999998 3678999999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.4e-07 Score=72.96 Aligned_cols=141 Identities=19% Similarity=0.277 Sum_probs=81.9
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCC--cccccccee---ccCCceEEEEeccC
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHR--NIIKVISSC---SNEEFKALVLEYMP 79 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~~v~e~~~ 79 (285)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+++++... ......+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4689999999999998866 68999997654 3445666788888777533 345555533 23345789999999
Q ss_pred CCCHHH----------------hhhc---C--C-CccCHH---------HHHHH------------HHHHHH-HHHHHhc
Q 039392 80 HGSLEK----------------YLHS---S--N-YILDIY---------QRLNI------------MIDVAS-TLEYLHF 115 (285)
Q Consensus 80 ~~~L~~----------------~~~~---~--~-~~~~~~---------~~~~~------------~~~l~~-~l~~lh~ 115 (285)
|.++.. .+.. . . ...... ..... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887766 1110 0 0 000000 00000 011111 2222221
Q ss_pred ----CCCCCeeecCCCCCCeeeC-CCCcEEEeeeccce
Q 039392 116 ----GYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAK 148 (285)
Q Consensus 116 ----~~~~~~~h~di~~~nili~-~~~~~~i~df~~~~ 148 (285)
.....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1256799999999999999 66777899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.3e-07 Score=72.51 Aligned_cols=138 Identities=15% Similarity=0.113 Sum_probs=83.0
Q ss_pred eecccCc-eEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEeccCCCCHH
Q 039392 7 LIGRGGF-GSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYMPHGSLE 84 (285)
Q Consensus 7 ~lg~G~~-~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 84 (285)
.|..|.. +.||+.... +..+++|...... .....+|+++++.+. +-.+++++......+..++||++++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444555 789999764 4788999875442 234567888888774 344556777776666788999999997776
Q ss_pred Hhhh----------------c-CC-----CccCHH--HHHHHHH--------------------HHHHHHHHHhc----C
Q 039392 85 KYLH----------------S-SN-----YILDIY--QRLNIMI--------------------DVASTLEYLHF----G 116 (285)
Q Consensus 85 ~~~~----------------~-~~-----~~~~~~--~~~~~~~--------------------~l~~~l~~lh~----~ 116 (285)
.... + +. ..+... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0 00 001000 0000000 01111122210 0
Q ss_pred CCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 117 ~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
....++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13458999999999999998888899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.3e-05 Score=61.40 Aligned_cols=102 Identities=25% Similarity=0.298 Sum_probs=79.8
Q ss_pred HHHHHHccCCC-CccccccceeccCCceEEEEeccCCCCHHHh---hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 039392 45 VECEMMKSIHH-RNIIKVISSCSNEEFKALVLEYMPHGSLEKY---LHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120 (285)
Q Consensus 45 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~ 120 (285)
+|.-+++.+++ +++++++|.+- .+++.|+...+++... +..- ...+...+.+++.++++.+.++++.....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47777888875 68999999984 3578999976655422 1111 12678889999999999999999655566
Q ss_pred eeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 121 ~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+...|++++|+-++++|+++++|.+.+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.2e-06 Score=66.88 Aligned_cols=74 Identities=9% Similarity=0.150 Sum_probs=46.2
Q ss_pred CceecccCce-EEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCC---ccccccceeccC---CceEEEEec
Q 039392 5 NNLIGRGGFG-SVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHR---NIIKVISSCSNE---EFKALVLEY 77 (285)
Q Consensus 5 ~~~lg~G~~~-~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~~v~e~ 77 (285)
++.++.|+.. .||+. +..+++|+.... .....+.+|+++++.+... .+.++++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 4567766665 58876 235788875532 2234677899998877532 334444444332 245789999
Q ss_pred cCCCCHH
Q 039392 78 MPHGSLE 84 (285)
Q Consensus 78 ~~~~~L~ 84 (285)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9887663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.37 E-value=1e-05 Score=62.39 Aligned_cols=129 Identities=21% Similarity=0.313 Sum_probs=89.0
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeeccc----------------hhHHHHHHHHHHHHccCC------CCccccc
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY----------------GRVFKSFDVECEMMKSIH------HRNIIKV 61 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~ 61 (285)
-...||+|+.-.||.-- +....+||+..... ........+|+.....+. +..|.++
T Consensus 5 ~~~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35689999999888753 34557889887655 112344445555444443 7889999
Q ss_pred cceeccCCceEEEEeccCC------CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 039392 62 ISSCSNEEFKALVLEYMPH------GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 62 ~~~~~~~~~~~~v~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~ 135 (285)
+|+.+++..+.+|+|.+.. .+|.+++.... ++. . +...+-....+|- +.+|+.+|++|.||++..
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~---~~~~L~~f~~~l~---~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-E---LRQALDEFKRYLL---DHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-H---HHHHHHHHHHHHH---HcCCeecCCCcccEEEEe
Confidence 9999999999999998632 36778875443 544 3 3334445666777 888999999999999953
Q ss_pred --CC--cEEEee
Q 039392 136 --NM--VAHLSD 143 (285)
Q Consensus 136 --~~--~~~i~d 143 (285)
++ .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 22 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.1e-07 Score=83.19 Aligned_cols=183 Identities=20% Similarity=0.219 Sum_probs=131.7
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc-cccccceeccCCceEEEEeccCCC-C
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN-IIKVISSCSNEEFKALVLEYMPHG-S 82 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e~~~~~-~ 82 (285)
-+.+++|+.+++++.+....+....+++... ....-++++|.+++||| .+..++-++.+...++.++++.++ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 3457888999999987544555556665433 33445889999999999 666677777788899999999776 3
Q ss_pred HHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccc
Q 039392 83 LEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162 (285)
Q Consensus 83 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~ 162 (285)
...........+...+...+.+.-+.+++++| +..-+|+| ||+.+ ++..+..+|+....++... .....
T Consensus 322 ~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~---~~~t~ 390 (829)
T KOG0576|consen 322 SALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM---KPRTA 390 (829)
T ss_pred ccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----ccccc-ccccccccccCCcccCccc---ccccC
Confidence 33322222222445555566666677899999 65557777 55554 4778899999887665532 33556
Q ss_pred cccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCc
Q 039392 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTD 203 (285)
Q Consensus 163 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 203 (285)
.+++.+++||+.....+...-|.|++|.-..++--|..|-.
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 78999999999999999999999999988778877777643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.4e-05 Score=75.25 Aligned_cols=78 Identities=15% Similarity=0.298 Sum_probs=55.3
Q ss_pred CceecccCceEEEEEEeCCC---cEEEEEEeeccch-hHHHHHHHHHHHHccCC-CCcc--ccccceeccC---CceEEE
Q 039392 5 NNLIGRGGFGSVFKARLGDG---MEVAVKVFNLQYG-RVFKSFDVECEMMKSIH-HRNI--IKVISSCSNE---EFKALV 74 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~---~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~~v 74 (285)
.+.++.|.++.+|+....++ ..+++|..+.... .....+.+|+++++.+. |.++ ++++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56788899999999875443 4688887654321 12345778999999885 5654 6667776554 467899
Q ss_pred EeccCCCC
Q 039392 75 LEYMPHGS 82 (285)
Q Consensus 75 ~e~~~~~~ 82 (285)
||+++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998854
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.1e-06 Score=66.87 Aligned_cols=137 Identities=12% Similarity=0.150 Sum_probs=77.8
Q ss_pred eecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc-ccccceeccCCceEEEEeccCCCCHHH
Q 039392 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI-IKVISSCSNEEFKALVLEYMPHGSLEK 85 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~~L~~ 85 (285)
.+..|-.+.+|+... +++.+++|..........-...+|.++++.+...++ ++++.... -++|+++++|.++..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456688889999874 567899998654332221234678888888864433 33333322 258999998866532
Q ss_pred h--------------hhc---C---CCccCHH-HHHHHHHHH---------HHHHHHHhc-----CCCCCeeecCCCCCC
Q 039392 86 Y--------------LHS---S---NYILDIY-QRLNIMIDV---------ASTLEYLHF-----GYSAQVIHCDLKPSN 130 (285)
Q Consensus 86 ~--------------~~~---~---~~~~~~~-~~~~~~~~l---------~~~l~~lh~-----~~~~~~~h~di~~~n 130 (285)
. +.+ . ...++.. .+..+..++ ...+..+-. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 110 0 1111111 111111111 111222210 012358999999999
Q ss_pred eeeCCCCcEEEeeecccee
Q 039392 131 VLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 131 ili~~~~~~~i~df~~~~~ 149 (285)
|+++.++ +.++||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.2e-05 Score=64.32 Aligned_cols=74 Identities=16% Similarity=0.227 Sum_probs=48.5
Q ss_pred CceecccCceEEEEEEeCC--CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc-ccccceeccCCceEEEEeccCCC
Q 039392 5 NNLIGRGGFGSVFKARLGD--GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI-IKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
++.|..|-...+|+....+ ++.+++|+........ ....+|+.+++.+...++ ++++.... + .+++||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence 4577888889999997654 6789999876433221 223468888888753333 44444332 2 3799999886
Q ss_pred CH
Q 039392 82 SL 83 (285)
Q Consensus 82 ~L 83 (285)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.5e-05 Score=66.07 Aligned_cols=139 Identities=18% Similarity=0.169 Sum_probs=92.9
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeeccc------------------------h--hHHHHHHHHHHHHccCCCCc
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY------------------------G--RVFKSFDVECEMMKSIHHRN 57 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~------------------------~--~~~~~~~~e~~~l~~l~h~~ 57 (285)
+...|..|.-+.||.+...+|..+|||+++..- + ...-.+..|+..|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345677888999999988889999999886310 1 11122446777788877666
Q ss_pred cccccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 039392 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM 137 (285)
Q Consensus 58 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~ 137 (285)
|+-.--.... ...+||+++.. +=+..-.-....++...+..+-.|++..+..|-+ .+++||.||+--|+++ .+|
T Consensus 228 IP~PePIlLk--~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 228 IPCPEPILLK--NHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY-HDG 301 (520)
T ss_pred CCCCCceeee--cceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE-ECC
Confidence 4332222222 23489999943 3322211122236666777888888888888764 8899999999999998 567
Q ss_pred cEEEeeeccce
Q 039392 138 VAHLSDFGIAK 148 (285)
Q Consensus 138 ~~~i~df~~~~ 148 (285)
.+.|+|.+-+.
T Consensus 302 ~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 KLYIIDVSQSV 312 (520)
T ss_pred EEEEEEccccc
Confidence 88888876654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.3e-05 Score=62.70 Aligned_cols=76 Identities=11% Similarity=0.014 Sum_probs=54.1
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCC---Cccccccceecc---CCceEEEEecc
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHH---RNIIKVISSCSN---EEFKALVLEYM 78 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~~v~e~~ 78 (285)
.+.||+|..+.||+....++ .+++|+.+.... ...+..|++.|+.+.. -.++++++.+.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSFST--PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEeccccc--chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 45789999999999976555 477787543111 2466788988888853 356777876643 46689999999
Q ss_pred CCCCH
Q 039392 79 PHGSL 83 (285)
Q Consensus 79 ~~~~L 83 (285)
+|.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 88654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.5e-06 Score=67.99 Aligned_cols=137 Identities=20% Similarity=0.216 Sum_probs=95.3
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccc------------------hh----HHHHHHHHHHHHccCC-CC-c
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY------------------GR----VFKSFDVECEMMKSIH-HR-N 57 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~------------------~~----~~~~~~~e~~~l~~l~-h~-~ 57 (285)
+.+++.||-|.-+-+|.+...+|++.++|.=.... .. ..-...+|+..|+.+. |. .
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 46789999999999999999899999998532211 01 0112445777777774 22 2
Q ss_pred cccccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 039392 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM 137 (285)
Q Consensus 58 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~ 137 (285)
+++.+++ +..++|||.+.|.+|...-.- .+..+ +...+...+--|. .+|++|+|++--||+++.++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHH---HcCceecccchheeEEecCC
Confidence 3333333 346799999999887543211 22333 4445666677787 89999999999999999999
Q ss_pred cEEEeeeccceecCc
Q 039392 138 VAHLSDFGIAKLLTR 152 (285)
Q Consensus 138 ~~~i~df~~~~~~~~ 152 (285)
.++++||.-+...+.
T Consensus 240 ~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 240 KIVVIDFPQMVSTSH 254 (465)
T ss_pred CEEEeechHhhccCC
Confidence 999999987655443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.5e-05 Score=74.77 Aligned_cols=198 Identities=22% Similarity=0.249 Sum_probs=129.6
Q ss_pred HHHHHHHHHHccCCCCccccccceeccCCce----EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC
Q 039392 41 KSFDVECEMMKSIHHRNIIKVISSCSNEEFK----ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116 (285)
Q Consensus 41 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 116 (285)
.....|.+.+....|+|+..++.+..+.... .+..+++...++...+...+. .+..+.+.+..++..|+.++|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~-i~~~~~r~~~~~~~~GL~~~h-- 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS-IPLETLRILHQKLLEGLAYLH-- 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc-cCHHHHHHHHHHHhhhHHHHH--
Confidence 3344566677777899999999887554322 244567777777777755443 888899999999999999999
Q ss_pred CCCCeeecCCCCC---CeeeCCCCcEEEe--eeccceecCcccccceeccccccccccCCcccCCCcc--CcchhhHHHH
Q 039392 117 YSAQVIHCDLKPS---NVLLDDNMVAHLS--DFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV--SANGDVYSFG 189 (285)
Q Consensus 117 ~~~~~~h~di~~~---nili~~~~~~~i~--df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~Di~slG 189 (285)
.....|.-+... +.-++.++.+.++ ||+......+.... .....+..+-+||....... ....|+|.+|
T Consensus 304 -~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 304 -SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred -HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 654444433333 3344566677776 88877665543211 22233444667776665544 4457999999
Q ss_pred HHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 190 IMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 190 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
.+...+..|..+-....... .+. ...+..+..+...+|+..++++|+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~~~----------------~~l--------------~~~~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVPV----------------SLL--------------DVLSTSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHhhhhhcCcccccccchh----------------hhh--------------ccccchhhhhhhhhhcchhhhhccchh
Confidence 99999998876522110000 000 001111466788899999999999999
Q ss_pred HHHHHH
Q 039392 270 EIVTKL 275 (285)
Q Consensus 270 eil~~l 275 (285)
+++.+.
T Consensus 430 ~ll~~~ 435 (1351)
T KOG1035|consen 430 ELLTHP 435 (1351)
T ss_pred hhhhch
Confidence 998753
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.10 E-value=0.00011 Score=62.85 Aligned_cols=75 Identities=23% Similarity=0.205 Sum_probs=52.2
Q ss_pred CceecccCceEEEEEEeCCC-cEEEEEEeeccc-------hhHHHHHHHHHHHHccCC---CCccccccceeccCCceEE
Q 039392 5 NNLIGRGGFGSVFKARLGDG-MEVAVKVFNLQY-------GRVFKSFDVECEMMKSIH---HRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~-~~~~iK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~ 73 (285)
.+.||.|.+..||++...+| +.++||.-.+.. +...++...|.+.|+.+. ...+++++.+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 46889999999999987766 589999854211 223456677888888763 234566666633 44679
Q ss_pred EEeccCCC
Q 039392 74 VLEYMPHG 81 (285)
Q Consensus 74 v~e~~~~~ 81 (285)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00016 Score=59.84 Aligned_cols=141 Identities=16% Similarity=0.115 Sum_probs=81.4
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc--cccccce------eccCCceEEEEe
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN--IIKVISS------CSNEEFKALVLE 76 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~~v~e 76 (285)
.+.+..|....+|+....+ ..+++|+.... ....+..|+++++.+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987644 46889987642 2234556777777664322 3343332 123456789999
Q ss_pred ccCCCCHHH-----------hhhc-------CCCc----cCHHHHH------------HHHHHHHHHHHHHhc----CCC
Q 039392 77 YMPHGSLEK-----------YLHS-------SNYI----LDIYQRL------------NIMIDVASTLEYLHF----GYS 118 (285)
Q Consensus 77 ~~~~~~L~~-----------~~~~-------~~~~----~~~~~~~------------~~~~~l~~~l~~lh~----~~~ 118 (285)
+++|.++.. .+.+ .... ....-.. .....+..++..+.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998866421 1100 0000 0000000 011112233344431 113
Q ss_pred CCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 119 ~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
.+++|+|+.|.|++++.++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999887788999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.8e-05 Score=62.32 Aligned_cols=75 Identities=21% Similarity=0.306 Sum_probs=48.2
Q ss_pred CceecccCceEEEEEEeCC-------CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc-ccccceeccCCceEEEEe
Q 039392 5 NNLIGRGGFGSVFKARLGD-------GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI-IKVISSCSNEEFKALVLE 76 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e 76 (285)
++.+..|-...+|+....+ ++.+++|+....... .....+|.++++.+...++ .+++..+.. ..|++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-LIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 4567778888999987554 578999997654322 2345678888887753333 344554432 25788
Q ss_pred ccCCCCHH
Q 039392 77 YMPHGSLE 84 (285)
Q Consensus 77 ~~~~~~L~ 84 (285)
+++|.++.
T Consensus 78 ~i~G~~l~ 85 (302)
T cd05156 78 FIPSRTLT 85 (302)
T ss_pred eeCCCcCC
Confidence 88776553
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00027 Score=59.27 Aligned_cols=140 Identities=18% Similarity=0.216 Sum_probs=74.8
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc--cccccce------eccCCceEEEEe
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN--IIKVISS------CSNEEFKALVLE 76 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~~v~e 76 (285)
.+.++.|....+|+....+| .+++|++..... +....+..+++.+...+ +.+++.. ....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34566787789999876555 688998752111 22333445554443212 2333321 123456789999
Q ss_pred ccCCCCHH-----------Hhhhc-----CC------CccCH---HHH------------HHHHHH-HHHHHHHHhc---
Q 039392 77 YMPHGSLE-----------KYLHS-----SN------YILDI---YQR------------LNIMID-VASTLEYLHF--- 115 (285)
Q Consensus 77 ~~~~~~L~-----------~~~~~-----~~------~~~~~---~~~------------~~~~~~-l~~~l~~lh~--- 115 (285)
+++|..+. ..+.+ .. ..... ... ...+.+ +...+..+..
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99886431 11111 00 00000 000 001111 1112222220
Q ss_pred -CCCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 116 -GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 116 -~~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
....+++|+|+.|.||+++.+...-++||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 024589999999999999866666899999875
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00025 Score=54.48 Aligned_cols=123 Identities=24% Similarity=0.447 Sum_probs=81.6
Q ss_pred CCCCceecccCc-eEEEEEEeCCCcEEEEEEeec---cch------------------hHHHHHHHHHHHHccCC---CC
Q 039392 2 FSENNLIGRGGF-GSVFKARLGDGMEVAVKVFNL---QYG------------------RVFKSFDVECEMMKSIH---HR 56 (285)
Q Consensus 2 y~~~~~lg~G~~-~~v~~~~~~~~~~~~iK~~~~---~~~------------------~~~~~~~~e~~~l~~l~---h~ 56 (285)
++.++.||.|.- |.||+++. +|+.+|+|++.. ... .....|..|.+..-+++ +.
T Consensus 39 I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e 117 (207)
T PF13095_consen 39 IEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGRE 117 (207)
T ss_pred EeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcccc
Confidence 467889999999 99999988 477999999321 110 12245777888766664 44
Q ss_pred cc--ccccceeccC------------------CceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC
Q 039392 57 NI--IKVISSCSNE------------------EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116 (285)
Q Consensus 57 ~i--~~~~~~~~~~------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 116 (285)
.. ++.+++..-. ....+|.|+.+... .+.... +.+|..-+..+|
T Consensus 118 ~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~~-- 181 (207)
T PF13095_consen 118 GLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKILH-- 181 (207)
T ss_pred CceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHHH--
Confidence 55 7777776211 12245666554422 123333 446667788899
Q ss_pred CCCCeeecCCCCCCeeeCCCCcEEEeeeccc
Q 039392 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 147 (285)
Q Consensus 117 ~~~~~~h~di~~~nili~~~~~~~i~df~~~ 147 (285)
+.||+-+|+++.|.. + -+|+|||.+
T Consensus 182 -k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 182 -KLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred -HCCeeeccCcccccc---C--CEEEecccC
Confidence 999999999999987 2 367788754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.001 Score=55.44 Aligned_cols=141 Identities=21% Similarity=0.225 Sum_probs=79.5
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc--ccccccee------ccCCceEEEEe
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN--IIKVISSC------SNEEFKALVLE 76 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~------~~~~~~~~v~e 76 (285)
++.++.|....+|+....+| .+++|+...... .+....|.++++.+...+ +++++... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 56677788889999876544 688898754211 123345666666663222 33333321 22456789999
Q ss_pred ccCCCCHH-----------Hhhhc-----CC--Cc----cCHH---H--HH----------HHHHHHHHHHHHHhc----
Q 039392 77 YMPHGSLE-----------KYLHS-----SN--YI----LDIY---Q--RL----------NIMIDVASTLEYLHF---- 115 (285)
Q Consensus 77 ~~~~~~L~-----------~~~~~-----~~--~~----~~~~---~--~~----------~~~~~l~~~l~~lh~---- 115 (285)
+++|.++. ..+.+ .. .. .... . .. .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885432 11110 00 00 0000 0 00 001112334444431
Q ss_pred CCCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 116 ~~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
....+++|+|+.+.|++++.++.+.++||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 124789999999999999988877899998875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00063 Score=56.30 Aligned_cols=140 Identities=16% Similarity=0.155 Sum_probs=83.7
Q ss_pred CCceecccCceEEEEEEeCCCcEEEEEEeec--cchhHHHHHHHHHHHHccCCC--CccccccceeccCC--ceEEEEec
Q 039392 4 ENNLIGRGGFGSVFKARLGDGMEVAVKVFNL--QYGRVFKSFDVECEMMKSIHH--RNIIKVISSCSNEE--FKALVLEY 77 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~~v~e~ 77 (285)
+.+.+..|.-..+|..... +++++++ .+. ..-.......+|+++++.+.. -.+...++.+.++. ..|+||++
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3444444444455555443 7889998 332 112334556678888887653 22334455555544 78999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHH-HHHHHHHHHHhcC----------------------------------------
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIM-IDVASTLEYLHFG---------------------------------------- 116 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~-~~l~~~l~~lh~~---------------------------------------- 116 (285)
++|..+.+...... .+ ...+ ..+...|..||.-
T Consensus 107 veGe~~~~~~~~~~--~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 107 VEGEVVWSALPPES--LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred ecceeccCcCCccc--ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 98854433221111 00 0111 2444445555530
Q ss_pred ---------------CCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 117 ---------------YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 117 ---------------~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
....++|+|+.+.|++++.++-+-++||+++..-.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 12368999999999999988889999999987543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00054 Score=57.54 Aligned_cols=74 Identities=18% Similarity=0.230 Sum_probs=45.6
Q ss_pred ceecccCceEEEEEEeCCC-cEEEEEEeec-------cchhHHHHHHHHHHHHccCC--CCccccccceeccCCceEEEE
Q 039392 6 NLIGRGGFGSVFKARLGDG-MEVAVKVFNL-------QYGRVFKSFDVECEMMKSIH--HRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~-~~~~iK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+.+|.|....||++..++| +.++||.-.+ ..+....+..-|.+.|+... .|..++-+-.+ +++...++|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vM 79 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVM 79 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehH
Confidence 3679999999999987654 6899996432 11333455566778887654 34333332223 333444888
Q ss_pred eccCC
Q 039392 76 EYMPH 80 (285)
Q Consensus 76 e~~~~ 80 (285)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 88743
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0005 Score=58.20 Aligned_cols=138 Identities=17% Similarity=0.230 Sum_probs=79.9
Q ss_pred ceecccCceEEEEEEeCC-----CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc-ccccceeccCCceEEEEeccC
Q 039392 6 NLIGRGGFGSVFKARLGD-----GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI-IKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+.|..|-...+|++...+ ++.+++|+........+++ ..|..+++.+...++ .++++.+..+ .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345567788999986432 3689999887654433333 568888888864444 3455655432 5788887
Q ss_pred CCCHHHh--------------hhc---CC----C-ccCHHHHHHHHHHHH-----------------HHHHH----Hhc-
Q 039392 80 HGSLEKY--------------LHS---SN----Y-ILDIYQRLNIMIDVA-----------------STLEY----LHF- 115 (285)
Q Consensus 80 ~~~L~~~--------------~~~---~~----~-~~~~~~~~~~~~~l~-----------------~~l~~----lh~- 115 (285)
+.++... +++ .. . ......+..++.++. ..+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7655311 000 00 0 011122333332221 11111 111
Q ss_pred CCCCCeeecCCCCCCeeeCC-CCcEEEeeeccce
Q 039392 116 GYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAK 148 (285)
Q Consensus 116 ~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~ 148 (285)
.....++|+|+++.||+++. ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11347899999999999986 5789999998875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00098 Score=54.56 Aligned_cols=31 Identities=32% Similarity=0.609 Sum_probs=25.7
Q ss_pred CCeeecCCCCCCeeeCCCCc-EEEeeecccee
Q 039392 119 AQVIHCDLKPSNVLLDDNMV-AHLSDFGIAKL 149 (285)
Q Consensus 119 ~~~~h~di~~~nili~~~~~-~~i~df~~~~~ 149 (285)
..++|+|++|.||+++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0018 Score=53.22 Aligned_cols=73 Identities=23% Similarity=0.288 Sum_probs=45.7
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccC---CCCccccccceeccCCceEEEEeccCCC
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI---HHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
.+.++.|....+|+.. .+++.+++|+-... ....+..|++-|+.+ ..-.+++++++....+..++++|+++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4578889999999987 56788999986622 224455677666666 3556778899887777789999998665
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0027 Score=54.40 Aligned_cols=73 Identities=10% Similarity=0.038 Sum_probs=48.9
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccch-------hHHHHHHHHHHHHccCC---CCccccccceeccCCceEEE
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG-------RVFKSFDVECEMMKSIH---HRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v 74 (285)
.+.||.|....||+...+ +..++||.-.+... ....+...|++.|+.+. ...+++++.+..+. .+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence 457899999999999864 45699997652111 13344445677776653 24677788877743 4578
Q ss_pred EeccCC
Q 039392 75 LEYMPH 80 (285)
Q Consensus 75 ~e~~~~ 80 (285)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999966
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0013 Score=55.40 Aligned_cols=73 Identities=16% Similarity=0.262 Sum_probs=45.3
Q ss_pred ceecccCceEEEEEEeCC----CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc-ccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARLGD----GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI-IKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.|..|=...+|+....+ +..+++|+........+ ...+|..+++.+...++ +++++++.. . +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeCC--c--EeehhhcC
Confidence 455557778889886432 34899998865544322 23468888888865444 345555532 2 57888877
Q ss_pred CCH
Q 039392 81 GSL 83 (285)
Q Consensus 81 ~~L 83 (285)
.++
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0024 Score=54.43 Aligned_cols=74 Identities=18% Similarity=0.252 Sum_probs=46.5
Q ss_pred CceecccCceEEEEEEeCC-CcEEEEEEeec------cchhHHHHHHHHHHHHccCC--CCccc-cccceeccCCceEEE
Q 039392 5 NNLIGRGGFGSVFKARLGD-GMEVAVKVFNL------QYGRVFKSFDVECEMMKSIH--HRNII-KVISSCSNEEFKALV 74 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~------~~~~~~~~~~~e~~~l~~l~--h~~i~-~~~~~~~~~~~~~~v 74 (285)
.+.||.|....||++...+ ++.++||.-.+ +-+...++..-|.+.|+... .|..+ +++.+ . +....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D-~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-D-SVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-C-cHHhhHH
Confidence 5689999999999998643 56799986432 11334456667888888764 34333 34433 2 3334477
Q ss_pred EeccCC
Q 039392 75 LEYMPH 80 (285)
Q Consensus 75 ~e~~~~ 80 (285)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 777643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.017 Score=48.24 Aligned_cols=31 Identities=23% Similarity=0.300 Sum_probs=28.2
Q ss_pred CCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 118 ~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
..++||+|+.+.|++++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4589999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.005 Score=51.54 Aligned_cols=113 Identities=15% Similarity=0.160 Sum_probs=74.5
Q ss_pred cCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecc
Q 039392 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 146 (285)
Q Consensus 67 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~ 146 (285)
+....|++|++. |+++.. +. ....+++..++++.+..+.-+.. +..+-||++.-.||+|+ +|+|.|+||.+
T Consensus 297 e~~y~yl~~kdh-gt~is~-ik----~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-IK----ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CceEEEEEEecC-Cceeee-ee----cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence 344566777776 556643 21 14456788889998888888873 45688999999999999 99999999999
Q ss_pred ceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCC
Q 039392 147 AKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRK 199 (285)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~ 199 (285)
++.-..+... .-.+.-.|..+.| ..+.+-+||- +|--|+.|.
T Consensus 368 sRl~~~q~~i-------sy~rldhp~lF~G-~dd~QFeIYr---lMr~l~~g~ 409 (488)
T COG5072 368 SRLSYSQGII-------SYNRLDHPDLFNG-VDDYQFEIYR---LMRRLLKGR 409 (488)
T ss_pred eecccCCcee-------eccccCchhhhcC-ccceeeeHHH---HHHHHhcCc
Confidence 9854433211 1122334555543 3366777776 344444444
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.015 Score=48.70 Aligned_cols=137 Identities=24% Similarity=0.307 Sum_probs=76.4
Q ss_pred ecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc---cc---ccc----eeccCCceEEEEec
Q 039392 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI---IK---VIS----SCSNEEFKALVLEY 77 (285)
Q Consensus 8 lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i---~~---~~~----~~~~~~~~~~v~e~ 77 (285)
|.+ .-..+|+....+|+. ++|+.... .....+..|...+..+.-.++ ++ .-| ....+...+-++++
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456788888766665 99998765 223455567777776632222 11 111 12222377789999
Q ss_pred cCCCCHHH-h-----------hh-------cCC--Cc-------cC--HHH---------HHHHHHHHHHHHHHHhc---
Q 039392 78 MPHGSLEK-Y-----------LH-------SSN--YI-------LD--IYQ---------RLNIMIDVASTLEYLHF--- 115 (285)
Q Consensus 78 ~~~~~L~~-~-----------~~-------~~~--~~-------~~--~~~---------~~~~~~~l~~~l~~lh~--- 115 (285)
++|..+.. . +. ... ++ .. ... -.....++...+..+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99877762 1 10 000 00 00 000 01112223333333331
Q ss_pred -CCCCC---eeecCCCCCCeeeCCCCc-EEEeeeccce
Q 039392 116 -GYSAQ---VIHCDLKPSNVLLDDNMV-AHLSDFGIAK 148 (285)
Q Consensus 116 -~~~~~---~~h~di~~~nili~~~~~-~~i~df~~~~ 148 (285)
....+ ++|+|+.|.||+++.+.. +-++||+.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11234 999999999999998874 8899999875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.018 Score=48.08 Aligned_cols=30 Identities=27% Similarity=0.288 Sum_probs=25.9
Q ss_pred CCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 118 ~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
..+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 368999999999999987 678899998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0021 Score=50.37 Aligned_cols=30 Identities=33% Similarity=0.508 Sum_probs=21.8
Q ss_pred CCeeecCCCCCCeee-CCCCcEEEeeeccce
Q 039392 119 AQVIHCDLKPSNVLL-DDNMVAHLSDFGIAK 148 (285)
Q Consensus 119 ~~~~h~di~~~nili-~~~~~~~i~df~~~~ 148 (285)
..++|+|+.|.||++ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 468999999999999 899999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.045 Score=46.06 Aligned_cols=71 Identities=10% Similarity=0.075 Sum_probs=41.8
Q ss_pred cCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc--ccccc---c--eeccCCceEEEEeccCCCC
Q 039392 11 GGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN--IIKVI---S--SCSNEEFKALVLEYMPHGS 82 (285)
Q Consensus 11 G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~---~--~~~~~~~~~~v~e~~~~~~ 82 (285)
+.-..||+....+++.+++|+..... .....+..|.+.+..+.... ++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34567899987778889999976432 12344556777666653211 22211 1 1222456778899987754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.016 Score=45.27 Aligned_cols=87 Identities=16% Similarity=0.114 Sum_probs=58.6
Q ss_pred HHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 039392 41 KSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120 (285)
Q Consensus 41 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~ 120 (285)
..+.++..++.+++ .|+++..- +.....+|+|.|.-... .....+. . =+..|...|+. ..+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~~N~i~---a-gi~~L~~fH~~-~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------NFSNFIT---A-GIKDLMDFHSE-NQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------chhHHHH---H-hHHHHHHhhcc-CCC
Confidence 44567888888765 46666632 55567799999844211 1111111 1 13457777842 567
Q ss_pred eeecCCCCCCeeeCCCCcEEEeeecc
Q 039392 121 VIHCDLKPSNVLLDDNMVAHLSDFGI 146 (285)
Q Consensus 121 ~~h~di~~~nili~~~~~~~i~df~~ 146 (285)
..|+|-.|+||+-|+.|.+||.|-+.
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999998654
|
The function of this family is unknown. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.016 Score=46.66 Aligned_cols=81 Identities=17% Similarity=0.210 Sum_probs=54.4
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc-CCC
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM-PHG 81 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~-~~~ 81 (285)
+....+..|..+.|+.++..+|++.++|+..+..... .+ ......|+..+-...+++++.-...+ .+++|.+ ++.
T Consensus 5 ~~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E-~~g~~~L~~w~G~GaVrll~~d~~~~--AlLLErl~~g~ 80 (253)
T PF04655_consen 5 TPDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HE-ARGEAALRWWNGRGAVRLLAADPERG--ALLLERLDPGR 80 (253)
T ss_pred ccCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hh-hhHHhHhheeCCCCceeeeccccccc--hhhhhhccCCC
Confidence 3445566789999999998899999999976443211 11 11225577778778888888764443 3778887 555
Q ss_pred CHHHhh
Q 039392 82 SLEKYL 87 (285)
Q Consensus 82 ~L~~~~ 87 (285)
+|.+.-
T Consensus 81 ~L~~~~ 86 (253)
T PF04655_consen 81 SLASLP 86 (253)
T ss_pred chhhcc
Confidence 665544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.03 Score=48.06 Aligned_cols=74 Identities=20% Similarity=0.288 Sum_probs=43.8
Q ss_pred ceecccCceEEEEEEeCCC--cE-----EEEEEeeccchhHHHHHHHHHHHHccCCCCcc-ccccceeccCCceEEEEec
Q 039392 6 NLIGRGGFGSVFKARLGDG--ME-----VAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI-IKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~--~~-----~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~ 77 (285)
+.|..|-...+|++...++ .. |++++........+ ...+|.++++.+...++ .++++.+.. +++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 4555687889999864332 22 44444322222122 23458888888865444 456666653 488999
Q ss_pred cCCCCHH
Q 039392 78 MPHGSLE 84 (285)
Q Consensus 78 ~~~~~L~ 84 (285)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9886653
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.00053 Score=66.74 Aligned_cols=156 Identities=12% Similarity=-0.049 Sum_probs=111.5
Q ss_pred HHHHHccCCCCccccccceecc--CCceEEEEeccCCCCHHHhhhcCCC---ccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 039392 46 ECEMMKSIHHRNIIKVISSCSN--EEFKALVLEYMPHGSLEKYLHSSNY---ILDIYQRLNIMIDVASTLEYLHFGYSAQ 120 (285)
Q Consensus 46 e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~~ 120 (285)
|...++...|+++......... ....+..++++.+|.+.+.+-++.. ..+..-+.....+.+.+...+|.+...|
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 3334455678888776665533 3455678899999999988865432 2334444444444466777777543333
Q ss_pred --eeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhC
Q 039392 121 --VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR 198 (285)
Q Consensus 121 --~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g 198 (285)
-+|+++++.|.+|..+..+++.++|+.+..++. ....+...+++.|+.|+....-.++.++|+|..|+.+|....|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 679999999999999999999999999844332 2233455677788999988888899999999999999988877
Q ss_pred CCCCc
Q 039392 199 KKPTD 203 (285)
Q Consensus 199 ~~p~~ 203 (285)
..+|-
T Consensus 1437 n~~fi 1441 (2724)
T KOG1826|consen 1437 NAYFI 1441 (2724)
T ss_pred cHHHH
Confidence 76653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.011 Score=51.72 Aligned_cols=164 Identities=18% Similarity=0.240 Sum_probs=90.1
Q ss_pred HHHHHHHHHccCCCCccccccceecc-CCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 039392 42 SFDVECEMMKSIHHRNIIKVISSCSN-EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120 (285)
Q Consensus 42 ~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~ 120 (285)
.+....+.++.+.|++....+.+-.. ..+..+|+|++ +.|+++....... ..... + -| +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l--~~~s~------~------~~-----~ 87 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL--KDESL------L------AH-----G 87 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc--chhhh------c------cc-----c
Confidence 34556788888999999988887644 34566889999 5699998765431 11110 0 11 2
Q ss_pred eeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCC
Q 039392 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK 200 (285)
Q Consensus 121 ~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 200 (285)
+.|- | .++++| .+++.. |- ...+++|||++|.++.++..|..
T Consensus 88 ~~~~-----~-------~~~~td-~~~t~~--------------------~~-----~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 88 VLHL-----N-------IIYITD-HFLTKY--------------------PS-----PIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ccee-----h-------hhhccc-cccccC--------------------CC-----CCCcchhhhhHHHHHHHHHHhhH
Confidence 2111 1 122222 111100 00 01149999999999999999987
Q ss_pred CCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHH
Q 039392 201 PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272 (285)
Q Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil 272 (285)
.+....+.+... ........+.. ...-..+......++.....+..+|+...|..||...+..
T Consensus 130 l~~~~~~s~~l~--~i~k~~~~d~~-------~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 130 LEAELTESEYLE--ILLKYYTDDQE-------LLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHH--HHHHhccCchh-------HHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 765432222111 11111111110 0000111133446667778899999999999888655443
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.039 Score=48.33 Aligned_cols=74 Identities=18% Similarity=0.275 Sum_probs=46.0
Q ss_pred CceecccCceEEEEEEeCC---------CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccc-cccceeccCCceEEE
Q 039392 5 NNLIGRGGFGSVFKARLGD---------GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII-KVISSCSNEEFKALV 74 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~v 74 (285)
++.|..|=...+|++...+ ++.|++++........+ ....|..+++.+...++- ++++.+.. +.|
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~g----g~I 184 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFSG----GRI 184 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeCC----CEE
Confidence 3456667777888886431 46899999876655544 334577777777544443 44554431 257
Q ss_pred EeccCCCCH
Q 039392 75 LEYMPHGSL 83 (285)
Q Consensus 75 ~e~~~~~~L 83 (285)
.+|++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 888877533
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.055 Score=52.56 Aligned_cols=32 Identities=44% Similarity=0.497 Sum_probs=26.8
Q ss_pred CCCeeecCCCCCCeeeCCCC--cEE-Eeeecccee
Q 039392 118 SAQVIHCDLKPSNVLLDDNM--VAH-LSDFGIAKL 149 (285)
Q Consensus 118 ~~~~~h~di~~~nili~~~~--~~~-i~df~~~~~ 149 (285)
..+++|+|+.+.||+++.++ ++. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 56899999999999998775 454 999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 285 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-29 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-22 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-22 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-15 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-12 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 4e-79
Identities = 88/280 (31%), Positives = 141/280 (50%), Gaps = 14/280 (5%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
F LIG G FG V+K L DG +VA+K + + + F+ E E + H +++
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASTLEYLHFGY 117
+I C L+ +YM +G+L+++L+ S+ + QRL I I A L YLH
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR- 158
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG 177
+IH D+K N+LLD+N V ++DFGI+K T D + + T T+GY+ PEY +G
Sbjct: 159 --AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG 216
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIF-NGEMTLKHWVNDWLPIST-KEIVDPNLLSR 235
R++ DVYSFG++L E + + + L W + ++IVDPNL +
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276
Query: 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
+ K + A++C S E R + +++ KL
Sbjct: 277 IRPESLRK------FGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-76
Identities = 96/285 (33%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNII 59
FS N++GRGGFG V+K RL DG VAVK + + + F E EM+ HRN++
Sbjct: 31 NFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 90
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLH---SSNYILDIYQRLNIMIDVASTLEYLHFG 116
++ C + LV YM +GS+ L S LD +R I + A L YLH
Sbjct: 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176
++IH D+K +N+LLD+ A + DFG+AKL+ +D + + T TIG++APEY
Sbjct: 151 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLST 209
Query: 177 GRVSANGDVYSFGIMLIETFTRKKPTDEIF---NGEMTLKHWVNDWLPISTK---EIVDP 230
G+ S DV+ +G+ML+E T ++ D + ++ L WV + K +VD
Sbjct: 210 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--KGLLKEKKLEALVDV 267
Query: 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
+L ++ V + VA+ CT SP +R E+V L
Sbjct: 268 DLQGNYK------DEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 5e-70
Identities = 80/297 (26%), Positives = 132/297 (44%), Gaps = 31/297 (10%)
Query: 1 GFSE------NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKS------FDVECE 48
F E N +G GGFG V+K + + VAVK L + FD E +
Sbjct: 26 NFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK--LAAMVDITTEELKQQFDQEIK 82
Query: 49 MMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDV 106
+M H N+++++ S+ + LV YMP+GSL L + L + R I
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI 166
A+ + +LH IH D+K +N+LLD+ A +SDFG+A+ + + + ++ + T
Sbjct: 143 ANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199
Query: 167 GYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK- 225
YMAPE G ++ D+YSFG++L+E T DE L +
Sbjct: 200 AYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDIKEEIEDEEKTI 257
Query: 226 -EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
+ +D + D + E +VA +C E +R + K++ L ++ S
Sbjct: 258 EDYIDKKM---NDADSTSVEAMY----SVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 7e-64
Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 26/297 (8%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+ RG FG V+KA+L VAVK+F +Q + ++ + E + + H NI++
Sbjct: 26 LQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQF 83
Query: 62 ISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH--- 114
I + L+ + GSL +L ++ + +I +A L YLH
Sbjct: 84 IGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 115 ----FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMA 170
G+ + H D+K NVLL +N+ A ++DFG+A + + T YMA
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 171 PEYGKEGRVSANG------DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWV--NDWLPI 222
PE EG ++ D+Y+ G++L E +R D + M
Sbjct: 202 PEVL-EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260
Query: 223 STKEIVDPNLLSREDI-HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+E+V R + + K ++ + EC E R++A + ++ ++
Sbjct: 261 DMQEVVVHKKK-RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-59
Identities = 73/286 (25%), Positives = 125/286 (43%), Gaps = 40/286 (13%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQ-------YGRVFKSFDVECEMMKSIHHRNII 59
IG+GGFG V K R + D VA+K L F+ F E +M +++H NI+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
K+ N +V+E++P G L L + + +L +M+D+A +EY+ +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 120 QVIHCDLKPSNVLLD-----DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-- 172
++H DL+ N+ L + A ++DFG+++ + L +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETI 198
Query: 173 YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232
+E + D YSF ++L T + P DE G++ + + + L
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-----------REEGL 247
Query: 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
R I E C + NV C P++R + IV +L ++
Sbjct: 248 --RPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 7e-59
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 8/202 (3%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSC 65
IG G FG+V +A G +VAVK+ Q F E +MK + H NI+ + +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSN--YILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+ ++V EY+ GSL + LH S LD +RL++ DVA + YLH + ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
+LK N+L+D + DFG+++L +S+ T +MAPE ++ +
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 184 DVYSFGIMLIETFTRKKPTDEI 205
DVYSFG++L E T ++P +
Sbjct: 221 DVYSFGVILWELATLQQPWGNL 242
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-58
Identities = 79/280 (28%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
+GRG FG V KA+ +VA+K + K+F VE + ++H NI+K+ +C N
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 68 EEFKALVLEYMPHGSLEKYLHSSN--YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
LV+EY GSL LH + ++ + + + YLH +IH D
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 126 LKPSNVLLDDNM-VAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGD 184
LKP N+LL V + DFG A DI T T + +MAPE + S D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 185 VYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL--PISTKEIVDPNLLSREDIHFVA 242
V+S+GI+L E TR+KP DEI + V++ P+
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI------------------- 226
Query: 243 KEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
+ + ++ C + P QR + +EIV + +
Sbjct: 227 -KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-57
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSC 65
IG G FG+V+K + +VAVK+ N+ + ++F E +++ H NI+ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
+ + A+V ++ SL +LH+S ++ + ++I A ++YLH + +IH D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE---YGKEGRVSAN 182
LK +N+ L ++ + DFG+A +R S Q +I +MAPE S
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 183 GDVYSFGIMLIETFTRKKP 201
DVY+FGI+L E T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-57
Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+ G ++K R G ++ VKV ++ R + F+ EC ++ H N++ V+ +C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 66 SNEEFK--ALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ L+ +MP+GSL LH +N+++D Q + +D+A + +LH +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE---YGKEGRV 179
L +V++D++M A +S + + ++APE E
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTN 188
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
+ D++SF ++L E TR+ P ++ N E+ +K + L R I
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-------------VALEGL--RPTI- 232
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
V + C E P +R IV L K++D
Sbjct: 233 ---PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-56
Identities = 67/288 (23%), Positives = 115/288 (39%), Gaps = 34/288 (11%)
Query: 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
+G+G FG K G + +K ++F E ++M+ + H N++K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
++ + EY+ G+L + S + QR++ D+AS + YLH S +IH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDIST---------IQTQTLATIG---YMAPEYG 174
N L+ +N ++DFG+A+L+ E + + +G +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234
DV+SFGI+L E R D+LP + ++
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADP--------------DYLPRTMDFGLNVRGFL 240
Query: 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
C F + + C PE+R + ++ L +R L
Sbjct: 241 DRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-55
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQ----YGRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG GGFG V++A G EVAVK + ++ E ++ + H NII +
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
C E LV+E+ G L + L + +N + +A + YLH +IH
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 124 CDLKPSNVLLD--------DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK 175
DLK SN+L+ N + ++DFG+A RE T + +MAPE +
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIR 187
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKPTDEI 205
S DV+S+G++L E T + P I
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-54
Identities = 79/318 (24%), Positives = 120/318 (37%), Gaps = 43/318 (13%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMK--SIHHRNII 59
LIGRG +G+V+K L D VAVKVF+ ++F E + + + H NI
Sbjct: 15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIA 70
Query: 60 KVISSC-----SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
+ I LV+EY P+GSL KYL + D + V L YLH
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 115 ------FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA---- 164
Y + H DL NVL+ ++ +SDFG++ LT + + A
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 165 --TIGYMAPEY-------GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT---- 211
TI YMAPE D+Y+ G++ E F R TD +
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TDLFPGESVPEYQM 246
Query: 212 -LKHWV-NDWLPISTKEIVDPNLLSREDI--HFVAKEQCVSFVFNVAMECTVESPEQRIN 267
+ V N + +V R + V + +C + E R+
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQ-RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305
Query: 268 AKEIVTKLVKIRDSLLRN 285
A+ ++ ++ RN
Sbjct: 306 AQXAEERMAELMMIWERN 323
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-54
Identities = 68/299 (22%), Positives = 115/299 (38%), Gaps = 30/299 (10%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEM--MKSIHHRNIIKVIS 63
IG+G +G V+ + G +VAVKVF S+ E E+ + H NI+ I+
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98
Query: 64 SCSNEEFK----ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH----- 114
+ L+ +Y +GSL YL + LD L + S L +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDISTIQTQTLATIGYMAPE 172
+ H DLK N+L+ N ++D G+A ++ + T YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 173 ------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS--T 224
+ D+YSFG++L E R + ++ V
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 225 KEIVDPNLLSREDI-HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
+ + L R + + ++C+ + + EC +P R+ A + L K+ +S
Sbjct: 277 EIVCIKKL--RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-54
Identities = 45/210 (21%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVIS 63
LIG+G FG V+ R EVA+++ +++ K+F E + H N++ +
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+C + A++ +L + + +LD+ + I ++ + YLH + ++H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA---TIGYMAPEYGKEGRVS 180
DLK NV D+ V ++DFG+ + + + + ++APE ++
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 181 ANG---------DVYSFGIMLIETFTRKKP 201
DV++ G + E R+ P
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-53
Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 30/295 (10%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEM--MKSIHHRNIIKVIS 63
+G+G +G V++ G VAVK+F+ + KS+ E E+ + H NI+ I+
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69
Query: 64 SCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH----- 114
S + L+ Y GSL YL LD L I++ +AS L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDISTIQTQTLATIGYMAPE 172
+ H DLK N+L+ N ++D G+A + + + + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 173 ------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS--T 224
D+++FG++L E R + + + V +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 225 KEIVDPNLLSREDI-HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
K + R +I + + ++ + + EC ++P R+ A I L KI
Sbjct: 248 KVVCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-50
Identities = 70/303 (23%), Positives = 121/303 (39%), Gaps = 40/303 (13%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEM--MKSIHHRNIIKVIS 63
IG+G FG V++ + G EVAVK+F+ + +S+ E E+ + H NI+ I+
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103
Query: 64 SCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH----- 114
+ + + LV +Y HGSL YL+ Y + + + + + AS L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDISTIQTQTLATIGYMAPE 172
+ H DLK N+L+ N ++D G+A + I + T YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 173 ------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226
K D+Y+ G++ E R + ++ V S +E
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV--PSDPSVEE 279
Query: 227 IVD--------PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+ PN+ +R + + + + EC + R+ A I L ++
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSC-----EALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 279 RDS 281
Sbjct: 335 SQQ 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-42
Identities = 82/281 (29%), Positives = 121/281 (43%), Gaps = 38/281 (13%)
Query: 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSC 65
IGRG FG VF RL D VAVK + F E ++K H NI+++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
+ ++ +V+E + G +L + L + L ++ D A+ +EYL S IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
L N L+ + V +SDFG+++ + + + APE GR S+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 186 YSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK-- 243
+SFGI+L ETF+ G P PNL +++ FV K
Sbjct: 299 WSFGILLWETFS---------LGAS----------PY-------PNLSNQQTREFVEKGG 332
Query: 244 -----EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
E C VF + +C P QR + I +L IR
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 72/290 (24%), Positives = 129/290 (44%), Gaps = 29/290 (10%)
Query: 8 IGRGGFGSVFKARL-----GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
+G+G FGSV R G VAVK + F+ E E++KS+ H NI+K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 63 SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
C + + L++EY+P+GSL YL +D + L + +EYL + +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATIGYMAPEYGKEGRV 179
IH DL N+L+++ + DFG+ K+L + ++ ++ + I + APE E +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
S DV+SFG++L E FT + + M + ++ I
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI-----------GNDKQGQMIVFHLIE 274
Query: 240 FVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
+ + C ++ + EC + QR + +++ ++ +IRD +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-41
Identities = 72/290 (24%), Positives = 130/290 (44%), Gaps = 29/290 (10%)
Query: 8 IGRGGFGSVFKARL-----GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
+G+G FGSV R G VAVK + F+ E E++KS+ H NI+K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 63 SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
C + + L++EY+P+GSL YL +D + L + +EYL + +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATIGYMAPEYGKEGRV 179
IH DL N+L+++ + DFG+ K+L + ++ ++ + I + APE E +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
S DV+SFG++L E FT + + M + ++ I
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI-----------GNDKQGQMIVFHLIE 243
Query: 240 FVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
+ + C ++ + EC + QR + +++ ++ +IRD++
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-41
Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 32/286 (11%)
Query: 6 NLIGRGGFGSVFKARL----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
+IGRG FG V+ L G + AVK N F E +MK H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 61 VISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
++ C E L VL YM HG L ++ + + + + + VA ++YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SK 147
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT--IGYMAPEYGKEG 177
+ +H DL N +LD+ ++DFG+A+ + ++ ++ +T A + +MA E +
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 178 RVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236
+ + DV+SFG++L E TR P ++ ++ T ++ L +
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------------TVYLLQGRRLLQ- 253
Query: 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
E C ++ V ++C E R + E+V+++ I +
Sbjct: 254 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-41
Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 54/299 (18%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKV 61
+G G FGSV + L G ++VAVK L R + F E MK H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 62 ISSCSNEEFKA-----LVLEYMPHGSLEKYL-----HSSNYILDIYQRLNIMIDVASTLE 111
+ C + ++L +M +G L YL + + + L M+D+A +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
YL + +H DL N +L D+M ++DFG++K + D + ++A
Sbjct: 162 YLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 172 EYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230
E + ++ DV++FG+ + E TR P + N EM
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-------------------- 258
Query: 231 NLLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
++ E C+ ++ + C P R + +L K+ +SL
Sbjct: 259 -------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-40
Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 28/276 (10%)
Query: 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS 64
+ +G G +G V++ + VAVK V + F E +MK I H N+++++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
C+ E ++ E+M +G+L YL N + L + ++S +EYL IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
+L N L+ +N + ++DFG+++L+T D T I + APE + S
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 184 DVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVA 242
DV++FG++L E T P I ++ + + P
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------P------------ 441
Query: 243 KEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
E C V+ + C +P R + EI +
Sbjct: 442 -EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 63/293 (21%), Positives = 123/293 (41%), Gaps = 35/293 (11%)
Query: 8 IGRGGFGSVFKARL-----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG V R G +VAVK + G E E++++++H NI+K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 62 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
C+ + L++E++P GSL++YL + +++ Q+L + + ++YL S
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATIGYMAPEYGKEGR 178
Q +H DL NVL++ + DFG+ K + ++ T++ + + + APE + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 179 VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238
DV+SFG+ L E T + I + +
Sbjct: 206 FYIASDVWSFGVTLHELLTY---------CDSDSSPMALFLKMIGPTH---GQMTVTRLV 253
Query: 239 HFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284
+ + + C V+ + +C P R + + ++ ++LL+
Sbjct: 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF----EALLK 302
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 67/298 (22%), Positives = 124/298 (41%), Gaps = 52/298 (17%)
Query: 6 NLIGRGGFGSVFKARL----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
+IGRG FG V+ L G + AVK N F E +MK H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 61 VISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL---HFG 116
++ C E L VL YM HG L ++ + + + + + VA +++L F
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT--IGYMAPEYG 174
+H DL N +LD+ ++DFG+A+ + ++ ++ +T A + +MA E
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 175 KEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233
+ + + DV+SFG++L E TR P ++ ++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------------- 305
Query: 234 SREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284
++ + E C ++ V ++C E R + E+V+++ I + +
Sbjct: 306 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 70/293 (23%), Positives = 130/293 (44%), Gaps = 41/293 (13%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVF--NLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G+G FGSV +A+L G ++VAVK+ ++ + F E MK H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 62 ISSCSNEEFKA------LVLEYMPHGSLEKYLHSS-----NYILDIYQRLNIMIDVASTL 110
+ K ++L +M HG L +L +S + L + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMA 170
EYL S IH DL N +L ++M ++DFG+++ + D + + ++A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 171 PEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229
E + + + DV++FG+ + E TR + P I N E+ ++
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-------------YNYLIG 254
Query: 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
N L + +C+ V+++ +C P+QR + + +L I L
Sbjct: 255 GNRLKQ-------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 33/290 (11%)
Query: 8 IGRGGFGSVFKARL-----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG V G G VAVK G + + E +++++++H +IIK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 62 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
C + + LV+EY+P GSL YL + + + Q L + + YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATIGYMAPEYGKEGR 178
IH DL NVLLD++ + + DFG+AK + + ++ + + + APE KE +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 179 VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238
DV+SFG+ L E T + + I +
Sbjct: 214 FYYASDVWSFGVTLYELLTH---------CD---SSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 239 HFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
+ + ++C + V+++ C R + ++ L + +
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 67/296 (22%), Positives = 129/296 (43%), Gaps = 44/296 (14%)
Query: 4 ENNLIGRGGFGSVFKARLGDG----MEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNI 58
+ +IG+G FG V+ D ++ A+K + + ++F E +M+ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 59 IKVISSCSNEE-FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+ +I E ++L YM HG L +++ S + ++ + VA +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT--IGYMAPEYGK 175
+ +H DL N +LD++ ++DFG+A+ + + ++Q A + + A E +
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235
R + DV+SFG++L E TR G P ++
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTR---------GAP----------PY-------RHIDPF 235
Query: 236 EDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284
+ HF+A+ E C ++ V +C P R + +V ++ +I +LL
Sbjct: 236 DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-39
Identities = 63/274 (22%), Positives = 106/274 (38%), Gaps = 33/274 (12%)
Query: 5 NNLIGRGGFGSVFKAR-LGDGMEVAVKVFNL--QYGRVFKSFDVECEMMKSIHHRNIIKV 61
+ IGRG F +V+K +EVA + F E EM+K + H NI++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 62 ISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
S + LV E M G+L+ YL ++ I + + L++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 118 SAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176
+ +IH DLK N+ + + D G+A L + T +MAPE +E
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYEE 204
Query: 177 GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236
+ DVY+FG+ ++E T + P E N + + P S + E
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-----FDKVAIPE 258
Query: 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
+ C ++ ++R + K+
Sbjct: 259 VKEIIEG-------------CIRQNKDERYSIKD 279
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 63/281 (22%), Positives = 114/281 (40%), Gaps = 39/281 (13%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSI--HHRNIIKV 61
IG GG VF+ A+K NL+ + S+ E + + H II++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+++ +V+E + L +L +D ++R + ++ + +H +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--------- 172
+H DLKP+N L+ D M+ L DFGIA + + S ++ + T+ YM PE
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 173 --YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230
+ ++S DV+S G +L K P +I N L ++ EI P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----PNHEIEFP 243
Query: 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
++ ++ + C P+QRI+ E+
Sbjct: 244 DIPEKDLQDVLKC-------------CLKRDPKQRISIPEL 271
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 68/290 (23%), Positives = 113/290 (38%), Gaps = 32/290 (11%)
Query: 8 IGRGGFGSVFKARL-----GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
+G+G FGSV R G VAVK + F E +++K++H I+K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 63 SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
++ LV+EY+P G L +L LD + L + +EYL S +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDISTIQTQTLATIGYMAPEYGKEGRV 179
+H DL N+L++ ++DFG+AKLL +D ++ + I + APE +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 180 SANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238
S DV+SFG++L E FT K + +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS-------------CSPSAEFLRMMGCERDVPALSRLL 254
Query: 239 HFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
+ + C + V + C SP+ R + + +L +
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 7 LIGRGGFGSVFKA---RLGDGMEVAVKVFNLQYGR--VFKS-FDVECEMMKSIHHRNIIK 60
+G GG +V+ A L ++VA+K + F+ E + H+NI+
Sbjct: 18 KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+I ++ LV+EY+ +L +Y+ S + L + +N + +++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPEYGKEG 177
++H D+KP N+L+D N + DFGIAK L+ T TQT +G Y +PE K
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS----ETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGE----MTLKHWVNDWLPISTKEIVDPNLL 233
D+YS GI+L E + P FNGE + +KH + D +P T ++ ++
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDV-RKDIP 241
Query: 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQR-INAKEIVTKLVKIRDSLLRN 285
NV + T + R +E+ L + N
Sbjct: 242 QSLS--------------NVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
IG G FG V + +VA+K + F E E+M + H ++++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 68 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLK 127
+ LV E+M HG L YL + + L + +DV + YL A VIH DL
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 128 PSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 187
N L+ +N V +SDFG+ + + +D T T T + + +PE R S+ DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 188 FGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK--- 243
FG+++ E F+ K P + N E+ + ++
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEV---------------------------VEDISTGFR 223
Query: 244 ----EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283
+ V+ + C E PE R ++ +L +I +S L
Sbjct: 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 63/281 (22%), Positives = 114/281 (40%), Gaps = 39/281 (13%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSI--HHRNIIKV 61
IG GG VF+ A+K NL+ + S+ E + + H II++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+++ +V+E + L +L +D ++R + ++ + +H +
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--------- 172
+H DLKP+N L+ D M+ L DFGIA + + S ++ + T+ YM PE
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 173 --YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230
+ ++S DV+S G +L K P +I N L ++ EI P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----PNHEIEFP 262
Query: 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
++ ++ + C P+QRI+ E+
Sbjct: 263 DIPEKDLQDVLKC-------------CLKRDPKQRISIPEL 290
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-39
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 11/209 (5%)
Query: 8 IGRGGFGSVFKARLGDGME-----VAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG+V+K E VA+K + K E +M S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ C + L+ + MP G L Y+ + LN + +A + YL ++
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+H DL NVL+ ++DFG+AKLL E+ I +MA E +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 182 NGDVYSFGIMLIETFTR-KKPTDEIFNGE 209
DV+S+G+ + E T KP D I E
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-39
Identities = 70/286 (24%), Positives = 112/286 (39%), Gaps = 32/286 (11%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIK 60
+G G FG V + G + VAVK F E M S+ HRN+I+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ K +V E P GSL L + + VA + YL S +
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATIGYMAPEYGKEGRV 179
IH DL N+LL + + DFG+ + L + +D +Q + APE K
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201
Query: 180 SANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238
S D + FG+ L E FT ++P W+ ++ +I+ + +E
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILH--KIDKEGE 242
Query: 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284
E C ++NV ++C PE R + L++ + + +R
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-39
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 8 IGRGGFGSVFKARL-----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG+V K + V +KV + G + F++ + S+ H +I+++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ C + LV +Y+P GSL ++ L LN + +A + YL +
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+H +L NVLL ++DFG+A LL +D + ++ I +MA E G+ +
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196
Query: 182 NGDVYSFGIMLIETFTR-KKPTDEIFNGEM 210
DV+S+G+ + E T +P + E+
Sbjct: 197 QSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 28/275 (10%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G+G FG V+ VA+K ++F E ++MK + H ++++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
S E +V EYM GSL +L L + Q +++ +AS + Y+ +H
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGD 184
DL+ +N+L+ +N+V ++DFG+A+L+ ++ T + I + APE GR + D
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 185 VYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243
V+SFGI+L E T+ + P + N E+ + +P P
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------P------------- 486
Query: 244 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+C + ++ +C + PE+R + + L
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 39/281 (13%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHH--RNIIKV 61
IG GG VF+ A+K NL+ + S+ E + + II++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+++ +V+E + L +L +D ++R + ++ + +H +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 176
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--------- 172
+H DLKP+N L+ D M+ L DFGIA + + S ++ + + YM PE
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 173 --YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230
+ ++S DV+S G +L K P +I N L ++ EI P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----PNHEIEFP 290
Query: 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
++ ++ + C P+QRI+ E+
Sbjct: 291 DIPEKDLQDVLKC-------------CLKRDPKQRISIPEL 318
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 28/275 (10%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G+G FG V+ VA+K ++F E ++MK + H ++++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
S E +V EYM GSL +L L + Q +++ +AS + Y+ +H
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGD 184
DL+ +N+L+ +N+V ++DFG+A+L+ ++ T + I + APE GR + D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 185 VYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243
V+SFGI+L E T+ + P + N E+ + +P P
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------P------------- 403
Query: 244 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+C + ++ +C + PE+R + + L
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-38
Identities = 60/281 (21%), Positives = 117/281 (41%), Gaps = 38/281 (13%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
+G G FG V + +VA+K+ F E ++M ++ H ++++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 68 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLK 127
+ ++ EYM +G L YL + Q L + DV +EYL S Q +H DL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 128 PSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 187
N L++D V +SDFG+++ + +D T + + + PE + S+ D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 188 FGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK---- 243
FG+++ E ++ G+M P + E +A+
Sbjct: 207 FGVLMWEIYSL---------GKM----------PY-------ERFTNSETAEHIAQGLRL 240
Query: 244 ---EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
V+ + C E ++R K +++ ++ + D
Sbjct: 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-38
Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 38/280 (13%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
+G G FG V + +VAVK+ F E + M + H ++K CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 68 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLK 127
E +V EY+ +G L YL S L+ Q L + DV + +L S Q IH DL
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 128 PSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 187
N L+D ++ +SDFG+ + + +D T + + APE + S+ DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 188 FGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK---- 243
FGI++ E F+ G+M P + E + V++
Sbjct: 191 FGILMWEVFSL---------GKM----------PY-------DLYTNSEVVLKVSQGHRL 224
Query: 244 ---EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
++ + C E PE+R +++++ + +R+
Sbjct: 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-38
Identities = 42/213 (19%), Positives = 83/213 (38%), Gaps = 30/213 (14%)
Query: 7 LIGRGGFGSVFKA---RLGDGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNIIKVI 62
I GG G ++ A + +G V +K ++ E + + + H +I+++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 63 -----SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+ + +V+EY+ SL++ L + + + ++++ L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT-LATIGYMAPEYGKE 176
S +++ DLKP N++L + + L D G + T G+ APE +
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRIN-------SFGYLYGTPGFQAPEIVR- 250
Query: 177 GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
+ D+Y+ G L NG
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 38/281 (13%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
IG+G FG V G +VAVK ++ ++F E +M + H N+++++
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 68 EEFKA-LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
E+ +V EYM GSL YL S +L L +DV +EYL +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
L NVL+ ++ VA +SDFG+ K + S+ Q + + APE +E + S DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 186 YSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVND--WLPISTKEIVDPNLLSREDIHFVA 242
+SFGI+L E ++ + P I + + V + P
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKMDA-------P------------ 408
Query: 243 KEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283
+ C V++V C R ++ +L IR L
Sbjct: 409 -DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 11/209 (5%)
Query: 8 IGRGGFGSVFKARLGDGME-----VAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG+V+K E VA+K + K E +M S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ C + L+ + MP G L Y+ + LN + +A + YL ++
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+H DL NVL+ ++DFG+AKLL E+ I +MA E +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 182 NGDVYSFGIMLIETFTR-KKPTDEIFNGE 209
DV+S+G+ + E T KP D I E
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 68/280 (24%), Positives = 114/280 (40%), Gaps = 40/280 (14%)
Query: 8 IGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G +G V++ + VAVK V + F E +MK I H N+++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
E ++ E+M +G+L YL N + L + ++S +EYL IH D
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 126 LKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDV 185
L N L+ +N + ++DFG+++L+T D T I + APE + S DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 186 YSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK-- 243
++FG++L E T G P P + + + K
Sbjct: 196 WAFGVLLWEIATY---------GMS----------PY-------PGIDLSQVYELLEKDY 229
Query: 244 -----EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
E C V+ + C +P R + EI +
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 58/271 (21%), Positives = 97/271 (35%), Gaps = 34/271 (12%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS 64
+GRG FG V + + G + AVK L+ E + I+ + +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGA 118
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
+ + +E + GSL + + L + L + LEYLH + +++H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHG 174
Query: 125 DLKPSNVLLDDN-MVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPEYGKEGRVS 180
D+K NVLL + A L DFG A L + + G +MAPE
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD-PNLLSREDIH 239
A D++S M++ P + F G + LK + I + P +
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK------IASEPPPIREIPPSCAPLTAQ 288
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
+ + + P R +A E
Sbjct: 289 AIQE-------------GLRKEPVHRASAME 306
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 7 LIGRGGFGSVFKA---RLGDGMEVAVKVFNLQYGR--VFKS-FDVECEMMKSIHHRNIIK 60
L+GRGG G V++A VA+K+ + VF++ E + +++
Sbjct: 41 LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ + + + + L L L + + I+ + S L+ H +A
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPEYGKEG 177
H D+KP N+L+ + A+L DFGIA T TQ T+G YMAPE E
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT----DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGE---MTLKH 214
+ D+Y+ +L E T P + G+ + H
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP----YQGDQLSVMGAH 246
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 52/193 (26%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G G FG V+ A +VAVK V ++F E +MK++ H ++K+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
+ E ++ E+M GSL +L S + + ++ +A + ++ IH
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGD 184
DL+ +N+L+ ++V ++DFG+A+++ ++ T + I + APE G + D
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 185 VYSFGIMLIETFT 197
V+SFGI+L+E T
Sbjct: 368 VWSFGILLMEIVT 380
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 58/300 (19%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
+G G FG V++ ++ ++VAVK + F +E ++ +H+NI++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSS------NYILDIYQRLNIMIDVASTLEYL- 113
I + +++E M G L+ +L + L + L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 114 --HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY 168
HF IH D+ N LL VA + DFG+A+ + R + + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 169 MAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228
M PE EG ++ D +SFG++L E F+ G M P
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PY------ 246
Query: 229 DPNLLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
P+ ++E + FV + C V+ + +C PE R N I+ ++
Sbjct: 247 -PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 60/301 (19%), Positives = 121/301 (40%), Gaps = 52/301 (17%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIK 60
+G+G FG V++ VA+K N R F E +MK + ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSS---------NYILDIYQRLNIMIDVASTLE 111
++ S + +++E M G L+ YL S + + + + ++A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
YL+ + + +H DL N ++ ++ + DFG+ + + D + L + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 172 EYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231
E K+G + DV+SFG++L E T E P
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATL---------AEQ----------PY-------QG 243
Query: 232 LLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284
L + + + FV + + C +F + C +P+ R + EI++ + + + R
Sbjct: 244 LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303
Query: 285 N 285
Sbjct: 304 E 304
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-37
Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
++G+G +G V+ R L + + +A+K + R + E + K + H+NI++ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL--NIMIDVASTLEYLHFGYSAQVIH 123
S F + +E +P GSL L S L ++ + L+YLH Q++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 124 CDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSAN 182
D+K NVL++ + V +SDFG +K L I+ T+ YMAPE +G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 183 G--DVYSFGIMLIETFTRKKPTDEIFNGEMTL-KHWVNDWLPISTKEIVDPNLLSREDIH 239
D++S G +IE T K P E+ + + K + P EI P +S E
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP----EI--PESMSAEAKA 257
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
F+ K C P++R A +
Sbjct: 258 FILK-------------CFEPDPDKRACAND 275
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-37
Identities = 69/292 (23%), Positives = 123/292 (42%), Gaps = 43/292 (14%)
Query: 7 LIGRGGFGSVFKA---RLGDGMEVAVKVFNLQYGR--VFKS-FDVECEMMKSIHHRNIIK 60
++G GG V A R +VAVKV R F F E + +++H I+
Sbjct: 19 ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 61 VISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
V + E +V+EY+ +L +H+ + + + ++ D L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSH-- 133
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT-LATIGYMAPEYGK 175
+IH D+KP+N+++ + DFGIA+ + S QT + T Y++PE +
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE----MTLKHWVNDWLPISTKEIVDPN 231
V A DVYS G +L E T + P F G+ + +H V + + + P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQH-VRE-------DPIPP- 239
Query: 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQR-INAKEIVTKLVKIRDSL 282
++ + + V ++ ++PE R A E+ LV++ +
Sbjct: 240 ---SARHEGLSAD-----LDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-37
Identities = 69/300 (23%), Positives = 120/300 (40%), Gaps = 58/300 (19%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
+G G FG V++ ++ ++VAVK + F +E ++ +H+NI++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSS------NYILDIYQRLNIMIDVASTLEYL- 113
I + ++LE M G L+ +L + L + L++ D+A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 114 --HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY 168
HF IH D+ N LL VA + DFG+A+ + R + + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 169 MAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228
M PE EG ++ D +SFG++L E F+ G M P
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PY------ 287
Query: 229 DPNLLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
P+ ++E + FV + C V+ + +C PE R N I+ ++
Sbjct: 288 -PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 80/302 (26%), Positives = 124/302 (41%), Gaps = 57/302 (18%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG VF A D M VAVK K F E E++ ++ H +I+K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMIDV 106
C + + +V EYM HG L K+L + L + Q L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI 166
AS + YL S +H DL N L+ N++ + DFG+++ + D + T+ I
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 167 GYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226
+M PE + + DV+SFG++L E FT G+ P
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTY---------GKQ----------PW---- 236
Query: 227 IVDPNLLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
L + E I + + C V++V + C P+QR+N KEI L +
Sbjct: 237 ---FQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293
Query: 280 DS 281
+
Sbjct: 294 KA 295
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 46/285 (16%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
IG+G FG V G +VAVK ++ ++F E +M + H N+++++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 66 SNEEFKA-LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
E+ +V EYM GSL YL S +L L +DV +EYL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
DL NVL+ ++ VA +SDFG LT+ + S+ Q + + APE +E + S
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFG----LTK-EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 184 DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243
DV+SFGI+L E ++ G + P P + ++ + V K
Sbjct: 196 DVWSFGILLWEIYSF---------GRV----------PY-------PRIPLKDVVPRVEK 229
Query: 244 -------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
+ C V+ V C R + ++ +L I+
Sbjct: 230 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 7/191 (3%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
+G G FG V+ +VAVK +F E +MK + H+ ++++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 68 EEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
E ++ EYM +GSL +L + + L I + L++ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 127 KPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVY 186
+ +N+L+ D + ++DFG+A+L+ ++ T + I + APE G + DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 187 SFGIMLIETFT 197
SFGI+L E T
Sbjct: 195 SFGILLTEIVT 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 68/291 (23%), Positives = 125/291 (42%), Gaps = 46/291 (15%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVI 62
+G G FG V RL + VA+K + Y + + F E +M H NII++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ + +V EYM +GSL+ +L + + Q + ++ +AS ++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYV 169
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDISTIQTQTLATIGYMAPEYGKEGRVSA 181
H DL N+L++ N+V +SDFG+ ++L + + I + +PE + ++
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
DV+S+GI+L E + GE N ++ I V
Sbjct: 230 ASDVWSYGIVLWEVMSY---------GERPYWEMSN-----------------QDVIKAV 263
Query: 242 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLRN 285
+ C + ++ + ++C + R ++IV+ L D L+RN
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL----DKLIRN 310
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-36
Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 42/284 (14%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVI 62
IG G G V RL + VA+K Y R + F E +M H NII++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ +V EYM +GSL+ +L + + I Q + ++ V + + YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYV 173
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDISTIQTQTLATIGYMAPEYGKEGRVSA 181
H DL NVL+D N+V +SDFG++++L D + T I + APE S+
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
DV+SFG+++ E GE + N R+ I V
Sbjct: 234 ASDVWSFGVVMWEVLAY---------GERPYWNMTN-----------------RDVISSV 267
Query: 242 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+ C + + ++C + QR +IV+ L +
Sbjct: 268 EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-36
Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 50/298 (16%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG VF A D M VAVK + F E E++ + H++I++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYL--------------HSSNYILDIYQRLNIMIDVA 107
C+ +V EYM HG L ++L + L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 108 STLEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164
+ + YL HF +H DL N L+ +V + DFG+++ + D + +T+
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPIS 223
I +M PE + + DV+SFG++L E FT K+P ++ N E +
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-IDC--------- 272
Query: 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
I L R C V+ + C P+QR + K++ +L + +
Sbjct: 273 ---ITQGRELER-------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-36
Identities = 48/210 (22%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMK-SIHHRNIIK 60
F +++G G G++ + D +VAVK + F D E ++++ S H N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ + +F+ + +E +L++Y+ ++ + + ++ S L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 121 VIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEY- 173
++H DLKP N+L+ + A +SDFG+ K L S + + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 174 --GKEGRVSANGDVYSFGIMLIETFTRKKP 201
+ + D++S G + +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 63/293 (21%), Positives = 119/293 (40%), Gaps = 54/293 (18%)
Query: 8 IGRGGFGSVFKARL---GDGMEVAVKVFNLQYGRVFKS---FDVECEMMKSIHHRNIIKV 61
+G G FGSV + ++VA+KV L+ G E ++M + + I+++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL---HFGYS 118
I C E LV+E G L K+L + + ++ V+ ++YL +F
Sbjct: 76 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATIGYMAPEYGKEG 177
+H DL NVLL + A +SDFG++K L + T ++ + + APE
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 178 RVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236
+ S+ DV+S+G+ + E + +KP ++ E
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---------------------------PE 221
Query: 237 DIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
+ F+ + +C ++ + +C + E R + + ++ SL
Sbjct: 222 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 62/288 (21%), Positives = 110/288 (38%), Gaps = 53/288 (18%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
F E LIG GGFG VFKA+ DG +K + + E + + + H NI+
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 61 VISSCSNEEFKA----------------LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIM 103
++ + +E+ G+LE+++ LD L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 104 IDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163
+ ++Y+H S ++I+ DLKPSN+ L D + DFG+ L + +T++
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSK 182
Query: 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223
T+ YM+PE D+Y+ G++L E E
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------------FFTD 230
Query: 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
++ + ++ +++ + K + PE R N EI
Sbjct: 231 LRDGIISDIFDKKEKTLLQK-------------LLSKKPEDRPNTSEI 265
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 45/287 (15%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVI 62
IG G FG V + + VA+K V + F E M+ H +I+K+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ +++E G L +L Y LD+ + +++ L YL S + +
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSAN 182
H D+ NVL+ N L DFG+++ + ++ I +MAPE R ++
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSA 197
Query: 183 GDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
DV+ FG+ + E KP + N ++ I +
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNNDV---------------------------IGRI 230
Query: 242 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
C ++++ +C P +R E+ +L I +
Sbjct: 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-35
Identities = 61/284 (21%), Positives = 110/284 (38%), Gaps = 45/284 (15%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVI 62
+G G FG V++ G+ + VAVK + F E +MK++ H +I+K+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
E +++E P+G L YL + L + + + + + YL S +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSAN 182
H D+ N+L+ L DFG+++ + ED + T I +M+PE R +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTA 194
Query: 183 GDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
DV+ F + + E + K+P + N ++ I +
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFFWLEN---------------------------KDVIGVL 227
Query: 242 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
K + C ++ + C P R E+V L +
Sbjct: 228 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-35
Identities = 70/285 (24%), Positives = 124/285 (43%), Gaps = 43/285 (15%)
Query: 8 IGRGGFGSVFKARL-----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKV 61
IG G FG V+K L + VA+K Y + F E +M H NII++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
S + ++ EYM +G+L+K+L + + Q + ++ +A+ ++YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNY 168
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ-TLATIGYMAPEYGKEGRVS 180
+H DL N+L++ N+V +SDFG++++L + +T T I + APE + +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240
+ DV+SFGI++ E T GE N E +
Sbjct: 229 SASDVWSFGIVMWEVMTY---------GERPYWELSN-----------------HEVMKA 262
Query: 241 VAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+ C S ++ + M+C + +R +IV+ L K+
Sbjct: 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 8 IGRGGFGSVFKARL---GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVIS 63
+G G FGSV + ++VA+KV + E ++M + + I+++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL---HFGYSAQ 120
C E LV+E G L K+L + + ++ V+ ++YL +F
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT--IGYMAPEYGKEGR 178
+H +L NVLL + A +SDFG++K L +D S ++ + + APE +
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 515
Query: 179 VSANGDVYSFGIMLIETFTR-KKPTDEIFNGE 209
S+ DV+S+G+ + E + +KP ++ E
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-35
Identities = 59/282 (20%), Positives = 92/282 (32%), Gaps = 50/282 (17%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE---MMKSIHHRN 57
F + +G G +G VFK R DG AVK + E K H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+++ + L E SL+++ + L Q + D L +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPE---- 172
S ++H D+KP+N+ L L DFG+ L + + YMAPE
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG----TAGAGEVQEGDPRYMAPELLQG 230
Query: 173 -YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD-- 229
YG DV+S G+ ++E + GE W + +
Sbjct: 231 SYGTA------ADVFSLGLTILEVACNMELP---HGGE--------GWQQLRQGYLPPEF 273
Query: 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
LS E + P+ R A+ +
Sbjct: 274 TAGLSSELRSVLVM-------------MLEPDPKLRATAEAL 302
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 62/305 (20%), Positives = 124/305 (40%), Gaps = 64/305 (20%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIK 60
+G FG V+K L VA+K + G + + F E + + H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSS---------------NYILDIYQRLNIMID 105
++ + ++ +++ Y HG L ++L L+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 106 VASTLEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
+A+ +EYL H +H DL NVL+ D + +SD G+ + + D + +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI 222
L I +MAPE G+ S + D++S+G++L E F+ G P
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY---------GLQ----------PY 231
Query: 223 STKEIVDPNLLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
+++ + + + C ++V+ + +EC E P +R K+I ++L
Sbjct: 232 -------CGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 276 VKIRD 280
+
Sbjct: 285 RAWGN 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 8 IGRGGFGSVFKARL---GDGMEVAVKVFNLQYG----RVFKSFDVECEMMKSIHHRNIIK 60
+G G FG+V K VAVK+ L+ + E +M+ + + I++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+I C E + LV+E G L KYL + + + + ++ V+ ++YL +
Sbjct: 83 MIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESN 137
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATIGYMAPEYGKEGRV 179
+H DL NVLL A +SDFG++K L E+ QT + + APE +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 180 SANGDVYSFGIMLIETFTR-KKPTDEIFNGE 209
S+ DV+SFG+++ E F+ +KP + E
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 10/195 (5%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVI 62
IG G FG V + M VA+K V + F E M+ H +I+K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ +++E G L +L + LD+ + +++ L YL S + +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSAN 182
H D+ NVL+ N L DFG+++ + ++ I +MAPE R ++
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSA 572
Query: 183 GDVYSFGIMLIETFT 197
DV+ FG+ + E
Sbjct: 573 SDVWMFGVCMWEILM 587
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 66/311 (21%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIK 60
IG G FG VF+AR VAVK+ + + F E +M + NI+K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSS-----------------------NYILDIY 97
++ C+ + L+ EYM +G L ++L S L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 98 QRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157
++L I VA+ + YL + +H DL N L+ +NMV ++DFG+++ + D
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN 217
I +M PE R + DV+++G++L E F+ G
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY---------GLQ------- 275
Query: 218 DWLPISTKEIVDPNLLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKE 270
P + E I++V E C ++N+ C + P R +
Sbjct: 276 ---PY-------YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325
Query: 271 IVTKLVKIRDS 281
I L ++ +
Sbjct: 326 IHRILQRMCER 336
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 27/212 (12%)
Query: 8 IGRGGFGSVFKARL--------GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNII 59
+G+G F +FK EV +KV + + +SF MM + H++++
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
C + LV E++ GSL+ YL + ++I +L + +A+ + +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---EN 132
Query: 120 QVIHCDLKPSNVLLD--------DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
+IH ++ N+LL + LSD GI+ + +DI I ++ P
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI------LQERIPWVPP 186
Query: 172 EYGKEGRV-SANGDVYSFGIMLIETFTR-KKP 201
E + + + D +SFG L E + KP
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-34
Identities = 72/296 (24%), Positives = 123/296 (41%), Gaps = 53/296 (17%)
Query: 8 IGRGGFGSVFKARL--------GDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSI-HH 55
+G G FG V A + + VAVK+ L+ + E EMMK I H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRL 100
+NII ++ +C+ + +++EY G+L +YL + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 101 NIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160
+ +A +EYL S + IH DL NVL+ +N V ++DFG+A+ + D T
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDW 219
+ +MAPE + + DV+SFG+++ E FT P I E+
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--------- 314
Query: 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
K + + + + + C + ++ + +C P QR K++V L
Sbjct: 315 ----FKLLKEGHRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-34
Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 61/303 (20%)
Query: 8 IGRGGFGSVFKARL--------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRN 57
+G G FG V A + + VAVK+ + E EMMK I H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 102
II ++ +C+ + +++EY G+L +YL + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 103 MIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
+A +EYL S + IH DL NVL+ +N V ++DFG+A+ + D T
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI 222
+ +MAPE + + DV+SFG+++ E FT G P
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---------GGS----------PY 260
Query: 223 STKEIVDPNLLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
P + E + + C + ++ + +C P QR K++V L
Sbjct: 261 -------PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
Query: 276 VKI 278
+I
Sbjct: 314 DRI 316
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-34
Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 11/200 (5%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG G FG + DG + +K N+ + + E ++ ++ H NI++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
S +V++Y G L K +++ + Q L+ + + L+++H +++
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYGKEGRVSA 181
H D+K N+ L + L DFGIA++L + + T Y++PE + +
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNS---TVELARACIGTPYYLSPEICENKPYNN 204
Query: 182 NGDVYSFGIMLIETFTRKKP 201
D+++ G +L E T K
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 60/310 (19%), Positives = 110/310 (35%), Gaps = 76/310 (24%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
F E ++G+G FG V KAR D A+K ++ + E ++ S++H+ +++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVVR 66
Query: 61 VISSCSNEEFKA-------------LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA 107
++ + +EY +G+L +HS N + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA--- 164
L Y+H S +IH DLKP N+ +D++ + DFG+AK + R
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 165 ---------TIGYMAPE-------YGKEGRVSANGDVYSFGIMLIE-------TFTRKKP 201
T Y+A E Y ++ D+YS GI+ E R
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 202 TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVES 261
++ + + +D K+I+ L+
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIR-LLIDH-------------------------D 271
Query: 262 PEQRINAKEI 271
P +R A+ +
Sbjct: 272 PNKRPGARTL 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVK---VFNLQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
IGRG F V++A L DG+ VA+K +F+L + E +++K ++H N+IK
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYL---HSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+S + +VLE G L + + ++ + + S LE++H S
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYGKEGR 178
+V+H D+KP+NV + V L D G+ + + T +L T YM+PE E
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPYYMSPERIHENG 212
Query: 179 VSANGDVYSFGIMLIETFTRKKP 201
+ D++S G +L E + P
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 61/309 (19%), Positives = 118/309 (38%), Gaps = 68/309 (22%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIK 60
+G G FG V KA VAVK+ + E ++K ++H ++IK
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYL-----------------------HSSNYILDIY 97
+ +CS + L++EY +GSL +L H L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 98 QRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157
++ ++ ++YL +++H DL N+L+ + +SDFG+++ + ED
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWV 216
++Q + +MA E + + DV+SFG++L E T P
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-------------- 253
Query: 217 NDWLPISTKEIVDPNLLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAK 269
P + + + + C ++ + ++C + P++R
Sbjct: 254 -------------PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300
Query: 270 EIVTKLVKI 278
+I L K+
Sbjct: 301 DISKDLEKM 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-33
Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 28/213 (13%)
Query: 6 NLIGRGGFGSVFKARL---GDGMEVAVKVFNLQYGRV-FKSFDVECEMMKSI-HHRNIIK 60
++IG G FG V KAR+ G M+ A+K + + F E E++ + HH NII
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMID 105
++ +C + + L +EY PHG+L +L +S+ L Q L+ D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLA 164
VA ++YL Q IH DL N+L+ +N VA ++DFG L+R +++ +T
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG----LSRGQEVYVKKTMGRL 203
Query: 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
+ +MA E + N DV+S+G++L E +
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-33
Identities = 62/297 (20%), Positives = 111/297 (37%), Gaps = 48/297 (16%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNII 59
+G G FG V +A M VAVK+ ++ E +++ + +H NI+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYL-----------------HSSNYILDIYQRLNI 102
++ +C+ ++ EY +G L +L LD+ L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 103 MIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
VA + +L S IH DL N+LL + + DFG+A+ + + ++
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLP 221
+ +MAPE + DV+S+GI L E F+ P + K
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------- 260
Query: 222 ISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
I + + E + ++++ C P +R K+IV + K
Sbjct: 261 -----IKEGFRMLS-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 62/296 (20%), Positives = 114/296 (38%), Gaps = 47/296 (15%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNII 59
+GRG FG V +A VAVK+ ++ E +++ I HH N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 60 KVISSCSNEEFKALV-LEYMPHGSLEKYL---------------HSSNYILDIYQRLNIM 103
++ +C+ +V +E+ G+L YL L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 104 IDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163
VA +E+L S + IH DL N+LL + V + DFG+A+ + ++ +
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPI 222
+ +MAPE + + DV+SFG++L E F+ P + E +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 263
Query: 223 STKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+ + + + ++ ++C P QR E+V L +
Sbjct: 264 ----LKEGTRMRA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 63/294 (21%), Positives = 105/294 (35%), Gaps = 45/294 (15%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G GGF V L DG A+K + + E +M + +H NI+++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 66 SNEEFKA----LVLEYMPHGSLEKYL---HSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
E L+L + G+L + L Q L +++ + LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-------TIGYMAP 171
H DLKP+N+LL D L D G + Q TL TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 172 E------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225
E + + DV+S G +L + P D +F ++ V +
Sbjct: 213 ELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-----NQL 264
Query: 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
I S + P QR + ++++L ++
Sbjct: 265 SIPQSPRHSSALWQLLNS-------------MMTVDPHQRPHIPLLLSQLEALQ 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-32
Identities = 55/214 (25%), Positives = 82/214 (38%), Gaps = 18/214 (8%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG G +G K R DG + K + + E +++ + H NI++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 64 SCSNEEFKAL--VLEYMPHGSLEKYL---HSSNYILDIYQRLNIMIDVASTLEYLH--FG 116
+ L V+EY G L + LD L +M + L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYGK 175
V+H DLKP+NV LD L DFG+A++L T +T T YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---DTSFAKTFVGTPYYMSPEQMN 189
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
+ D++S G +L E P F
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 75/303 (24%), Positives = 121/303 (39%), Gaps = 61/303 (20%)
Query: 8 IGRGGFGSVFKARL--------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRN 57
+G G FG V A +VAVK+ + E EMMK I H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 102
II ++ +C+ + +++EY G+L +YL H+ L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 103 MIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
VA +EYL S + IH DL NVL+ ++ V ++DFG+A+ + D T
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI 222
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL---------GGS----------PY 294
Query: 223 STKEIVDPNLLSREDIHFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
P + E + + C + ++ + +C P QR K++V L
Sbjct: 295 -------PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347
Query: 276 VKI 278
+I
Sbjct: 348 DRI 350
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-32
Identities = 47/214 (21%), Positives = 91/214 (42%), Gaps = 29/214 (13%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISS 64
+GRGGFG VF+A+ D A+K L + E + + + H I++ ++
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 65 CSNEEFKA------------LVLEYMPHGSLEKYLHSSNYI--LDIYQRLNIMIDVASTL 110
+ + ++ +L+ +++ I + L+I + +A +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED-------ISTIQTQTL 163
E+LH S ++H DLKPSN+ + V + DFG+ + +++ +
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 164 ATIG---YMAPEYGKEGRVSANGDVYSFGIMLIE 194
+G YM+PE S D++S G++L E
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 6 NLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSI-HH 55
+G G FG V +A ++VAVK+ L+ ++ E ++M + H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LKSTAHADEKEALMSELKIMSHLGQH 109
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYL-------------HSSNYILDIYQRLNI 102
NI+ ++ +C++ ++ EY +G L +L +N L+
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 103 MIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
VA + +L S IH D+ NVLL + VA + DFG+A+ + + ++
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
+ +MAPE + + DV+S+GI+L E F+
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 60/307 (19%), Positives = 107/307 (34%), Gaps = 67/307 (21%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECE-MMKSIHHRNIIK 60
++G G G+V G VAVK + + +E + + +S H N+I+
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVASTLEYLH 114
S + + F + LE +L+ + S N + + +++ +AS + +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 115 FGYSAQVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLTREDISTIQTQ 161
S ++IH DLKP N+L+ +N+ +SDFG+ K L S
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 162 TLA--TIGYMAPEYGKEGRVSANG-------DVYSFGIMLIETFTRKKP--------TDE 204
T G+ APE +E D++S G + ++ K
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 205 IFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQ 264
I G +L L E +++ P +
Sbjct: 250 IIRGIFSLDEMKCLH----------DRSLIAEATDLISQ-------------MIDHDPLK 286
Query: 265 RINAKEI 271
R A ++
Sbjct: 287 RPTAMKV 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNII 59
+G G FG V A G ++VAVK+ + ++ E +MM + H NI+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYL----------------------HSSNYILDIY 97
++ +C+ L+ EY +G L YL +L
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 98 QRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157
L VA +E+L +H DL NVL+ V + DFG+A+ + +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT 197
++ + +MAPE EG + DV+S+GI+L E F+
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
IG G G V AR G +VAVK+ +L+ + + E +M+ H N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ S E +++E++ G+L + L+ Q + V L YLH +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQG 161
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPEYGKEG 177
VIH D+K ++LL + LSDFG ++++ + ++L +G +MAPE
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSL--VGTPYWMAPEVISRS 216
Query: 178 RVSANGDVYSFGIMLIE 194
+ D++S GIM+IE
Sbjct: 217 LYATEVDIWSLGIMVIE 233
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-30
Identities = 64/281 (22%), Positives = 120/281 (42%), Gaps = 41/281 (14%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
+ +G G FG V+KA+ G A KV + + + VE E++ + H I+K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
++ + ++ +++E+ P G+++ + + L Q + + L +LH S +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPE----- 172
+IH DLK NVL+ L+DFG++ + + + + IG +MAPE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK---TLQKRDSF--IGTPYWMAPEVVMCE 192
Query: 173 YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE---IVD 229
K+ D++S GI LIE + P E+ + + L I+ + ++
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSDPPTLLT 244
Query: 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
P+ S E F+ ++PE R +A +
Sbjct: 245 PSKWSVEFRDFLKI-------------ALDKNPETRPSAAQ 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
++ IG+G G+V+ A + G EVA++ NLQ + E +M+ + NI+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ S + +V+EY+ GSL + + +D Q + + LE+LH S Q
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYGKEGRV 179
VIH D+K N+LL + L+DFG +T E + T+ T +MAPE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 180 SANGDVYSFGIMLIE 194
D++S GIM IE
Sbjct: 194 GPKVDIWSLGIMAIE 208
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-30
Identities = 77/276 (27%), Positives = 114/276 (41%), Gaps = 38/276 (13%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
F +G G +GSV+KA G VA+K ++ + E +M+ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
S +V+EY GS+ + N L + I+ LEYLH +
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPEYGKEG 177
IH D+K N+LL+ A L+DFG+A LT + + T+ IG +MAPE +E
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD---TMAKRNTV--IGTPFWMAPEVIQEI 200
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK---EIVDPNLLS 234
+ D++S GI IE K P +I H + I T P L S
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADI--------HPMRAIFMIPTNPPPTFRKPELWS 252
Query: 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
FV + C V+SPEQR A +
Sbjct: 253 DNFTDFVKQ-------------CLVKSPEQRATATQ 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-30
Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN-LQYGRVFKSFDVECEMMKSIHHRNIIK---V 61
++G+G +VF+ R G A+KVFN + + R E E++K ++H+NI+K +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ L++E+ P GSL L S+ Y L + L ++ DV + +L
Sbjct: 76 EEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 120 QVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAP 171
++H ++KP N++ D V L+DFG A+ L + ++ Y+ P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------DDEQFVSLYGTEEYLHP 184
Query: 172 EYGKEGRVSANG--------DVYSFGIML 192
+ + + + D++S G+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVI--- 62
+G GGFG V + G +VA+K + + + + +E ++MK ++H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 63 ---SSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+ + L +EY G L KYL + L ++ D++S L YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 118 SAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMA 170
++IH DLKP N++L ++ + D G AK L Q + Y+A
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-------QGELCTEFVGTLQYLA 191
Query: 171 PEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKH 214
PE ++ + + D +SFG + E T +P +
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 32/236 (13%), Positives = 70/236 (29%), Gaps = 45/236 (19%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG---------------------------- 37
++G+ + +A G V V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 38 RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM-PHGSLEKYLH------SS 90
+V F +++K + +I+V + + Y +L+ + S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 91 NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150
+ L + RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 151 TREDISTIQTQTLATIGYMAPE-----YGKEGRVSANGDVYSFGIMLIETFTRKKP 201
+ + A A ++ D ++ G+ + + P
Sbjct: 262 G-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 42/239 (17%), Positives = 80/239 (33%), Gaps = 36/239 (15%)
Query: 2 FSENNLIGRGGFGSVFKARLGD------GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHH 55
++L+G G F V++A GD + +KV F E +K
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSL----EKYLHSSNYILDIYQRLNIMIDVASTLE 111
+K S+ + LV E +G+L Y ++ ++ ++ + + +E
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAH-----------LSDFGIAKLLTREDISTIQT 160
+H ++IH D+KP N +L + + L D G + + TI T
Sbjct: 187 QVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 161 QTLATIGYMAPE------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLK 213
T G+ E + + D + + + GE +
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQ------IDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN-LQYGRVFKSFDVECEMMKSIHHRNIIK---V 61
++G+G +VF+ R G A+KVFN + + R E E++K ++H+NI+K +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ L++E+ P GSL L S+ Y L + L ++ DV + +L
Sbjct: 76 EEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 120 QVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAP 171
++H ++KP N++ D V L+DFG A+ L + ++ Y+ P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------DDEQFVSLYGTEEYLHP 184
Query: 172 EYGKEGRVSANG--------DVYSFGIML 192
+ + + + D++S G+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 39/200 (19%), Positives = 78/200 (39%), Gaps = 16/200 (8%)
Query: 8 IGRG--GFGSVFKAR-LGDGMEVAVKVFNL--QYGRVFKSFDVECEMMKSIHHRNIIKVI 62
IG+G +V AR G V V+ NL + E + K +H NI+
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
++ + +V +M +GS + + + ++ I+ V L+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI--STIQTQTLATIG---YMAPEYGKE 176
+H +K S++L+ + +LS + + ++ +++PE ++
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 177 GRVSANG--DVYSFGIMLIE 194
+ D+YS GI E
Sbjct: 210 NLQGYDAKSDIYSVGITACE 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 28/304 (9%), Positives = 64/304 (21%), Gaps = 59/304 (19%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
+ G VF R + + A+KVF + + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 63 SSCSNEEFKA--------------------------LVLEYMPHGSLEKYLHSSNYI--- 93
L++ LE + +++
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 94 ---LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150
I + + L S ++H P N+ + + L D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 151 TREDISTIQTQTLATIGYMAPEY--GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNG 208
+ Y E+ + + + G+ + + P F
Sbjct: 245 G-TRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGL 295
Query: 209 EMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINA 268
+ S + K + +R+
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT----LI----GRFLNFDRRRRLLP 347
Query: 269 KEIV 272
E +
Sbjct: 348 LEAM 351
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 53/235 (22%), Positives = 103/235 (43%), Gaps = 38/235 (16%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
L+G+G F V++A + G+EVA+K+ + + + + E ++ + H +I+++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ + + LVLE +G + +YL + + + M + + + YLH S ++
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAPE------ 172
H DL SN+LL NM ++DFG+A L + T+ Y++PE
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPH------EKHYTLCGTPNYISPEIATRSA 188
Query: 173 YGKEGRVSANGDVYSFGIMLIETFTRKKPTDE---------IFNGEMTLKHWVND 218
+G E DV+S G M + P D + + + +++
Sbjct: 189 HGLE------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 50/300 (16%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISS 64
++ GGF V++A+ +G G E A+K ++ E MK + H NI++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 65 CS-------NEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASTLEYLHF 115
S + + L+L + G L ++L S L L I ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA----------T 165
+IH DLK N+LL + L DFG A ++ + Q A T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 166 IGYMAPE----YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
Y PE Y + D+++ G +L R+ P F L+
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDGAKLR-------- 260
Query: 222 ISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
I + P ++ S + +PE+R++ E+V +L +I +
Sbjct: 261 IVNGKYSIPPHDTQYT-------VFHSLI----RAMLQVNPEERLSIAEVVHQLQEIAAA 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 54/300 (18%), Positives = 103/300 (34%), Gaps = 65/300 (21%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY-GRVFKSFDV-ECEMMKSI-HHRN 57
F E IG G FGSVFK DG A+K G V + + E + H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---HSSNYILDIYQRLNIMIDVASTLEYLH 114
+++ S+ + ++ + EY GSL + + + ++++ V L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 115 FGYSAQVIHCDLKPSNVLLDDN-------------------MVAHLSDFGIAKLLTREDI 155
S ++H D+KPSN+ + ++ + D G ++
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--- 186
Query: 156 STIQTQTLA-TIGYMAPE--YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL 212
Q ++A E + D+++ + ++ + NG+
Sbjct: 187 ----PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLP---RNGDQ-- 236
Query: 213 KHWVNDWLPISTKEIVD-PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
W I + P +LS+E + PE+R +A +
Sbjct: 237 ------WHEIRQGRLPRIPQVLSQEFTELLKV-------------MIHPDPERRPSAMAL 277
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNII 59
F++ IG+G FG VFK VA+K+ +L+ + E ++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
K S + +++EY+ GS L LD Q I+ ++ L+YLH S
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SE 138
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPEYGKE 176
+ IH D+K +NVLL ++ L+DFG+A LT + I+ T +G +MAPE K+
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTF--VGTPFWMAPEVIKQ 193
Query: 177 GRVSANGDVYSFGIMLIETFTRKKP 201
+ D++S GI IE + P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 35/231 (15%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G+G FG+V+ AR +A+KV L+ V E E+ + H NI+++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ L+LEY P G++ + L + + + ++A+ L Y H S +V
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRV 130
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAPE------YG 174
IH D+KP N+LL ++DFG + + + L T+ Y+ PE +
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHA-----PSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDE---------IFNGEMTLKHWV 216
++ D++S G++ E K P + I E T +V
Sbjct: 186 EK------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKVISSC 65
IG G V A +VA+K NL+ + E + M HH NI+ +S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 66 SNEEFKALVLEYMPHGSL-------EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
++ LV++ + GS+ + +LD I+ +V LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPEYGK 175
IH D+K N+LL ++ ++DFG++ L T +G +MAPE +
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 176 EGRV-SANGDVYSFGIMLIE 194
+ R D++SFGI IE
Sbjct: 200 QVRGYDFKADIWSFGITAIE 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 42/200 (21%), Positives = 81/200 (40%), Gaps = 30/200 (15%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
+G+GGF F+ A K+ L + +E + +S+ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ +F +VLE SL + + + R + + +YLH +VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAPE------ 172
H DLK N+ L++++ + DFG+A + + + + Y+APE
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG------ERKKVLCGTPNYIAPEVLSKKG 217
Query: 173 YGKEGRVSANGDVYSFGIML 192
+ E DV+S G ++
Sbjct: 218 HSFE------VDVWSIGCIM 231
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 42/200 (21%), Positives = 81/200 (40%), Gaps = 30/200 (15%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
+G+GGF F+ A K+ L + +E + +S+ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+ +F +VLE SL + + + R + + +YLH +VI
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAPE------ 172
H DLK N+ L++++ + DFG+A + + + + Y+APE
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG------ERKKVLCGTPNYIAPEVLSKKG 191
Query: 173 YGKEGRVSANGDVYSFGIML 192
+ E DV+S G ++
Sbjct: 192 HSFE------VDVWSIGCIM 205
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 58/302 (19%), Positives = 105/302 (34%), Gaps = 58/302 (19%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFN-----------------LQYGRVFKSFDVECEMM 50
+ +G F + D A+K + + + F E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 51 KSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-------NIM 103
I + + +N + ++ EYM + S+ K+ + Y I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 104 IDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163
V ++ Y+H + H D+KPSN+L+D N LSDFG ++ + + I +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG----SR 211
Query: 164 ATIGYMAPE--YGKEGRVSANGDVYSFGIMLIETFTRKKPTDE----------IFNGEMT 211
T +M PE + A D++S GI L F P I +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 212 L--KHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK 269
+ + K N LS EDI F+ ++P +RI ++
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL-------------FLRKNPAERITSE 318
Query: 270 EI 271
+
Sbjct: 319 DA 320
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 9/202 (4%)
Query: 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNII 59
F + + +G G G VFK G+ +A K+ +L+ + E +++ + I+
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ ++ ++ +E+M GSL++ L + I + + I V L YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSIAVIKGLTYLR--EKH 151
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+++H D+KPSN+L++ L DFG++ L ++ + T YM+PE +
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY 207
Query: 180 SANGDVYSFGIMLIETFTRKKP 201
S D++S G+ L+E + P
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYP 229
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 66/277 (23%), Positives = 109/277 (39%), Gaps = 42/277 (15%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR-VFKSFDVECEM-MKSIHHRNIIKVISS 64
+GRG +G V K R + G +AVK K ++ ++ M+++ + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASTLEYLHFGYS 118
E + +E M SL+K+ ++D Q + I + + LE+LH
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYK---QVIDKGQTIPEDILGKIAVSIVKALEHLHSKL- 129
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPE----Y 173
VIH D+KPSNVL++ + DFGI+ L + A YMAPE
Sbjct: 130 -SVIHRDVKPSNVLINALGQVKMCDFGISGYLV----DDVAKDIDAGCKPYMAPERINPE 184
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233
+ S D++S GI +IE + P D LK V + P +
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL-----PADKF 239
Query: 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
S E + F ++ C ++ ++R E
Sbjct: 240 SAEFVDFTSQ-------------CLKKNSKERPTYPE 263
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 33/242 (13%), Positives = 75/242 (30%), Gaps = 56/242 (23%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG---------------------------- 37
++G+ + +A G V V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 38 RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM-PHGSLEKYLH------SS 90
+V F +++K + +I+V + + Y +L+ + S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 91 NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150
+ L + RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 151 TREDISTIQTQTLATIGYMAPEY-----------GKEGRVSANGDVYSFGIMLIETFTRK 199
+ + G+ PE + ++ + D ++ G+++ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 200 KP 201
P
Sbjct: 311 LP 312
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 58/203 (28%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNL---QYGRVFKSFDVECEMMKSIHHRN 57
FS+ IG G FG+V+ AR + + VA+K + Q ++ E ++ + H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
I+ E LV+EY GS L L + + L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG---YMAPE-- 172
S +IH D+K N+LL + + L DFG A ++ + +G +MAPE
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANSF--VGTPYWMAPEVI 222
Query: 173 -YGKEGRVSANGDVYSFGIMLIE 194
EG+ DV+S GI IE
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIE 245
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 69/276 (25%), Positives = 104/276 (37%), Gaps = 36/276 (13%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR-VFKSFDVECE-MMKSIHHRNIIKVISS 64
IGRG +GSV K G +AVK K ++ + +M+S I++ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASTLEYLHFGYS 118
E + +E M S +K+ +LD + I + L +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLD--DVIPEEILGKITLATVKALNHLKENL- 145
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE----YG 174
++IH D+KPSN+LLD + L DFGI+ L S +T+ YMAPE
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSA 201
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234
DV+S GI L E T + P + + L V P + + S
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS--EEREFS 259
Query: 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
I+FV C + +R KE
Sbjct: 260 PSFINFVNL-------------CLTKDESKRPKYKE 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 53/239 (22%), Positives = 101/239 (42%), Gaps = 53/239 (22%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
+G+G FG+V+ AR + +A+KV L+ V E E+ + H NI+++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYL---------HSSNYILDIYQRLNIMIDVASTLEYL 113
+ + + L+LE+ P G L K L S+ ++ + +A L Y
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---EE-------LADALHYC 130
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAPE 172
H +VIH D+KP N+L+ ++DFG + +++ +T+ T+ Y+ PE
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH-----APSLRRRTMCGTLDYLPPE 182
Query: 173 ------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDE---------IFNGEMTLKHWV 216
+ ++ D++ G++ E P D I N ++ ++
Sbjct: 183 MIEGKTHDEK------VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 60/220 (27%), Positives = 89/220 (40%), Gaps = 46/220 (20%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNII 59
F L+G G +G V+K R + G A+KV ++ G + E M+K HHRNI
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 84
Query: 60 KVISSCSNEEFKA------LVLEYMPHGSLEKYLHSSNYILDIYQRLN-----------I 102
+ + LV+E+ GS+ D+ + I
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----------TDLIKNTKGNTLKEEWIAYI 134
Query: 103 MIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT 162
++ L +LH +VIH D+K NVLL +N L DFG++ L R + + T
Sbjct: 135 CREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR---TVGRRNT 188
Query: 163 LATIG---YMAPEYGKEGRVSANG-----DVYSFGIMLIE 194
IG +MAPE D++S GI IE
Sbjct: 189 F--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 58/271 (21%), Positives = 97/271 (35%), Gaps = 31/271 (11%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR-VFKSFDVECE-MMKSIHHRNIIKVISS 64
+G G G V+K R G +AVK + K ++ + ++KS I++ +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
+ +E M + + I + + + + L YL + VIH
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-KMTVAIVKALYYLKEKH--GVIHR 149
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG- 183
D+KPSN+LLD+ L DFGI+ L + ++ YMAPE +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 184 ----DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
DV+S GI L+E T + P L + + P+ S +
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP----GHMGFSGDFQS 262
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
FV C + +R +
Sbjct: 263 FVKD-------------CLTKDHRKRPKYNK 280
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-24
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 30/199 (15%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
++G G F VF + G A+K S + E ++K I H NI+ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 66 SNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRL--NIMIDVASTLEYLHFGYSAQVI 122
+ LV++ + G L ++ L Y ++ ++ V S ++YLH ++
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVY----TEKDASLVIQQVLSAVKYLH---ENGIV 128
Query: 123 HCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE------Y 173
H DLKP N+L ++N ++DFG++K+ +ST T GY+APE Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA----CGTPGYVAPEVLAQKPY 184
Query: 174 GKEGRVSANGDVYSFGIML 192
K D +S G++
Sbjct: 185 SKA------VDCWSIGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 29/203 (14%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKV-----FNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
IG+G F V + G + AVK+ F G + E + + H +I+++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY---QRLNIMIDVASTLEYLHFGYS 118
+ + S++ +V E+M L + +Y + M + L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 119 AQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--- 172
+IH D+KP VLL +++ L FG+A L + + T +MAPE
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVK 206
Query: 173 ---YGKEGRVSANGDVYSFGIML 192
YGK DV+ G++L
Sbjct: 207 REPYGKP------VDVWGCGVIL 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-23
Identities = 31/204 (15%), Positives = 55/204 (26%), Gaps = 43/204 (21%)
Query: 7 LIGRGGFGSVFKA---RLGDGMEVAVKVFNLQYGR--VFKS-FDVECEMMKSIHHRNIIK 60
G ++A L +VA+ + Q + I + +
Sbjct: 38 FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
V+ +V E++ GSL++ +S + M +A+ + H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
V PS V + + G LA M +
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD-------AN 180
Query: 181 ANGDVYSFGIMLIETFTRKKPTDE 204
D+ G L + P E
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPE 204
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 49/216 (22%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISS 64
++G G V L E AVK+ Q G + E EM+ HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN--------IMIDVASTLEYLHF 115
E+ LV E M GS+ L I++R + ++ DVAS L++LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSI----------LSHIHKRRHFNELEASVVVQDVASALDFLH- 128
Query: 116 GYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATI----G 167
+ + H DLKP N+L + + DF + + D S I T L T
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 168 YMAPE-----------YGKEGRVSANGDVYSFGIML 192
YMAPE Y K D++S G++L
Sbjct: 187 YMAPEVVEAFSEEASIYDKR------CDLWSLGVIL 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 3e-23
Identities = 53/261 (20%), Positives = 98/261 (37%), Gaps = 71/261 (27%)
Query: 8 IGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNII 59
+GRG FG V +A VAVK+ ++ E +++ I HH N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 60 KVISSCSNEEFKALV-LEYMPHGSLEKYLHS----------------------SNYILDI 96
++ +C+ +V +E+ G+L YL S +D+
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 97 YQRLNIMI------------------------------DVASTLEYLHFGY--------- 117
+RL+ + D + + + +
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 118 -SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176
S + IH DL N+LL + V + DFG+A+ + ++ + + +MAPE +
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269
Query: 177 GRVSANGDVYSFGIMLIETFT 197
+ DV+SFG++L E F+
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFS 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 26/197 (13%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV--ECEMMKSIHHRNIIKVISS 64
+G G +G V R +E A+K+ + + E ++K + H NI+K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 65 CSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
++ LV+E G L ++ +H + + I+ V S + YLH ++H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAAVIIKQVLSGVTYLH---KHNIVH 159
Query: 124 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-----YGK 175
DLKP N+LL + + + + DFG++ + + + L T Y+APE Y +
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRKKYDE 216
Query: 176 EGRVSANGDVYSFGIML 192
+ DV+S G++L
Sbjct: 217 K------CDVWSIGVIL 227
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-23
Identities = 60/278 (21%), Positives = 99/278 (35%), Gaps = 68/278 (24%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVK-----VFNLQYGRVFKSFDV------ECEMMKSIHHR 56
I G +G+V +G+ VA+K V + + + + E ++ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 57 NIIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD-------IYQRLNIMI 104
NI+ + LV E M L + +H ++ +Y L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILL--- 145
Query: 105 DVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164
L LH A V+H DL P N+LL DN + DF +A+ T + T +
Sbjct: 146 ----GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVT 195
Query: 165 TIGYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN 217
Y APE + K D++S G ++ E F RK +F G
Sbjct: 196 HRWYRAPELVMQFKGFTK------LVDMWSAGCVMAEMFNRK----ALFRGSTFYNQL-- 243
Query: 218 DWLPISTKEIVDPNLL---SREDIHFVAKEQCVSFVFN 252
+IV+ ++ ED+ + ++ N
Sbjct: 244 -------NKIVE--VVGTPKIEDVVMFSSPSARDYLRN 272
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-23
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 38/209 (18%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSI-HHR 56
+GRG V + E AVK+ ++ G F + +V E ++++ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
NII++ + F LV + M G L YL + + R IM + + LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIMRALLEVICALH-- 141
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPE--- 172
++H DLKP N+LLDD+M L+DFG + L + + + T Y+APE
Sbjct: 142 -KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIE 196
Query: 173 ---------YGKEGRVSANGDVYSFGIML 192
YGKE D++S G+++
Sbjct: 197 CSMNDNHPGYGKE------VDMWSTGVIM 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-23
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 27/198 (13%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
+G+G FG V + G E AVKV + ++ +S E +++K + H NI+K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 64 SCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
++ + LV E G L ++ + + I+ V S + Y+H +++
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGITYMH---KNKIV 148
Query: 123 HCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-----YG 174
H DLKP N+LL + + DFG++ + T Y+APE Y
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGTYD 205
Query: 175 KEGRVSANGDVYSFGIML 192
++ DV+S G++L
Sbjct: 206 EK------CDVWSTGVIL 217
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-23
Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 58/212 (27%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE---MMKSIHHRNIIKVIS 63
IG G + + ME AVK+ + D E +++ H NII +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN--------IMIDVASTLEYLH 114
+ ++ +V E M G L LD I ++ ++ + T+EYLH
Sbjct: 84 VYDDGKYVYVVTELMKGGEL----------LDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 115 FGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDISTIQTQTLATI---- 166
+ V+H DLKPSN+L + + DFG AK L E+ L T
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN------GLLMTPCYTA 184
Query: 167 GYMAPE------YGKEGRVSANGDVYSFGIML 192
++APE Y D++S G++L
Sbjct: 185 NFVAPEVLERQGYDAA--C----DIWSLGVLL 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 1e-22
Identities = 37/175 (21%), Positives = 74/175 (42%), Gaps = 15/175 (8%)
Query: 42 SFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI--LDIYQR 99
+ V+ M +N + + S + + + ++ +L+ +++ + +
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 100 LNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED----- 154
L+I I +A +E+LH S ++H DLKPSN+ + V + DFG+ + +++
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 155 -----ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDE 204
T + T YM+PE S D++S G++L E E
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-07
Identities = 18/91 (19%), Positives = 33/91 (36%), Gaps = 2/91 (2%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNII 59
F +GRGGFG VF+A+ D A+K L + E + + + H I+
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSS 90
+ ++ + E ++
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 26/197 (13%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISS 64
+G+G FG V K + E AVKV N + + E E++K + H NI+K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 65 CSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+ +V E G L ++ + + + I+ V S + Y+H ++H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 124 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-----YGK 175
DLKP N+LL + + + DFG++ + + T Y+APE Y +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGTYDE 201
Query: 176 EGRVSANGDVYSFGIML 192
+ DV+S G++L
Sbjct: 202 K------CDVWSAGVIL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV-------------ECEMMK 51
+G G +G V + E A+KV + D E ++K
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 52 SIHHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASTL 110
S+ H NIIK+ ++++ LV E+ G L E+ ++ + D NIM + S +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDAANIMKQILSGI 159
Query: 111 EYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIG 167
YLH ++H D+KP N+LL + + + DFG++ +++ L T
Sbjct: 160 CYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAY 213
Query: 168 YMAPE-----YGKEGRVSANGDVYSFGIML 192
Y+APE Y ++ DV+S G+++
Sbjct: 214 YIAPEVLKKKYNEK------CDVWSCGVIM 237
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 52/209 (24%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSC 65
+G G F K AVK+ + R+ + E +K H NI+K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN--------IMIDVASTLEYLHFG 116
++ LV+E + G L + I ++ + IM + S + ++H
Sbjct: 76 HDQLHTFLVMELLNGGEL----------FERIKKKKHFSETEASYIMRKLVSAVSHMH-- 123
Query: 117 YSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYM 169
V+H DLKP N+L +DN+ + DFG A+L ++ Q L T Y
Sbjct: 124 -DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN------QPLKTPCFTLHYA 176
Query: 170 APE------YGKEGRVSANGDVYSFGIML 192
APE Y + D++S G++L
Sbjct: 177 APELLNQNGYDES------CDLWSLGVIL 199
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-22
Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 58/214 (27%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE---MMKSIHHRNIIKVI 62
++G G G V + G + A+K+ S E ++ +I+ ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 63 ----SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN----------IMIDVA 107
+ + +++E M G L I +R + IM D+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164
+ +++LH S + H D+KP N+L + + V L+DFG AK T+ + T
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP----CY 191
Query: 165 TIGYMAPE------YGKEGRVSANGDVYSFGIML 192
T Y+APE Y K D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-22
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 50/210 (23%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV--ECEMMKSIHHRNIIKVISS 64
+G+G F V + + G E A + N + + E + + + H NI+++ S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQR--------LNIMIDVASTLEYLHF 115
S E L+ + + G L + I R + + + + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGEL----------FEDIVAREYYSEADASHCIQQILEAVLHCH- 127
Query: 116 GYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GY 168
V+H +LKP N+LL L+DFG+A + E Q GY
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ------QAWFGFAGTPGY 179
Query: 169 MAPE------YGKEGRVSANGDVYSFGIML 192
++PE YGK D+++ G++L
Sbjct: 180 LSPEVLRKDPYGKP------VDLWACGVIL 203
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 8e-22
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 26/201 (12%)
Query: 7 LIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVEC-----EMMKSIHHRNIIK 60
++G G F +V AR E A+K+ ++ + K V ++M + H +K
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ + ++E L Y +G L KY+ + R ++ S LEYLH
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH---GKG 150
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAPE------Y 173
+IH DLKP N+LL+++M ++DFG AK+L+ + + + T Y++PE
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFVGTAQYVSPELLTEKSA 209
Query: 174 GKEGRVSANGDVYSFGIMLIE 194
K D+++ G ++ +
Sbjct: 210 CKS------SDLWALGCIIYQ 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-21
Identities = 68/300 (22%), Positives = 116/300 (38%), Gaps = 68/300 (22%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECE-----------MMKSIHHR 56
+G G +G V+KA+ G VA+K L D E E ++K +HH
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRL---------DAEDEGIPSTAIREISLLKELHHP 79
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
NI+ +I +E LV E+M L+K L + L Q + + + + H
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH-- 136
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--YG 174
+++H DLKP N+L++ + L+DFG+A+ T + T+ Y AP+ G
Sbjct: 137 -QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMG 193
Query: 175 KEGRVSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTLKH 214
+ + S + D++S G + E T K P + L
Sbjct: 194 SK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 215 WVND----WLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
W + I+ P +E I ++ F+ P +RI+A++
Sbjct: 253 WKQRTFQVFEKKPWSSII-PGF-CQEGIDLLSN----MLCFD---------PNKRISARD 297
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-21
Identities = 65/297 (21%), Positives = 107/297 (36%), Gaps = 60/297 (20%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNL-QYGRVFKSFDV-ECEMMKSIHHRNIIKVISS 64
IG G +G VFK R G VA+K F + V K + E M+K + H N++ ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
+ LV EY H ++ L + + +I + + H IH
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-------YGKEG 177
D+KP N+L+ + V L DFG A+LLT S +AT Y +PE YG
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGDTQYGPP- 183
Query: 178 RVSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTLKHWVN 217
V DV++ G + E + T +++
Sbjct: 184 -V----DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 218 ----DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
D + E+ PN +S + + + P +R+ ++
Sbjct: 239 VKIPDPEDMEPLELKFPN-ISYPALGLLKG----CLHMD---------PTERLTCEQ 281
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE-----------MMKSIHH 55
IG G +G+VFKA+ VA+K L D + E ++K + H
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRL---------DDDDEGVPSSALREICLLKELKH 60
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
+NI+++ +++ LV E+ L+KY S N LD + + + L + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH- 118
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--Y 173
S V+H DLKP N+L++ N L++FG+A+ + + T+ Y P+ +
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLF 174
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
G + S + D++S G + E +P +F G
Sbjct: 175 GAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-21
Identities = 56/242 (23%), Positives = 85/242 (35%), Gaps = 66/242 (27%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHHRNIIKV 61
IG+G +G V A A+K+ N R DV E +MK +HH NI ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL--------------------- 100
+E++ LV+E G L L+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 101 ------------------NIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL- 141
NIM + S L YLH + + H D+KP N L N +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 142 -SDFGIAKLLTREDISTIQ--TQTLATIGYMAPE--------YGKEGRVSANGDVYSFGI 190
DFG++K + + T T ++APE YG + D +S G+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK------CDAWSAGV 264
Query: 191 ML 192
+L
Sbjct: 265 LL 266
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-21
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 30/199 (15%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISS 64
+G+G FG V K + E AVKV N + + E E++K + H NI+K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 65 CSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQR--LNIMIDVASTLEYLHFGYSAQV 121
+ +V E G L ++ + + + I+ V S + Y+H +
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRF----SEHDAARIIKQVFSGITYMH---KHNI 142
Query: 122 IHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-----Y 173
+H DLKP N+LL + + + DFG++ + + T Y+APE Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGTY 199
Query: 174 GKEGRVSANGDVYSFGIML 192
++ DV+S G++L
Sbjct: 200 DEK------CDVWSAGVIL 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFN--LQYGRVFKSFDVECEMMKSIHHRNIIKVISS 64
+G+G F V + G+E A K+ N R F+ + E + + + H NI+++ S
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
E F LV + + G L + + + + + + + + ++ Y H S ++H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-HCIQQILESIAYCH---SNGIVHR 152
Query: 125 DLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAPE----- 172
+LKP N+LL L+DFG+A + ++ GY++PE
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLAIEVN-------DSEAWHGFAGTPGYLSPEVLKKD 205
Query: 173 -YGKEGRVSANGDVYSFGIML 192
Y K D+++ G++L
Sbjct: 206 PYSKP------VDIWACGVIL 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 4e-21
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 45/207 (21%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISS 64
+G+G F V + G+E A K+ N + R F+ + E + + + H NI+++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQR--------LNIMIDVASTLEYLHF 115
E F LV + + G L + I R + + + ++ Y H
Sbjct: 74 IQEESFHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQILESIAYCH- 122
Query: 116 GYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAP 171
S ++H +LKP N+LL L+DFG+A + + A T GY++P
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSP 176
Query: 172 E------YGKEGRVSANGDVYSFGIML 192
E Y K D+++ G++L
Sbjct: 177 EVLKKDPYSKP------VDIWACGVIL 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 49/213 (23%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDV-----ECEMMKSIHHRNI 58
+G G G V A +VA+++ + G ++ E E++K ++H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASTLEY 112
IK+ + E++ +VLE M G L + ++ +RL + ++Y
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGEL------FDKVVG-NKRLKEATCKLYFYQMLLAVQY 254
Query: 113 LHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGY 168
LH +IH DLKP NVLL +++ + ++DFG +K+L + +TL T Y
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL----MRTLCGTPTY 307
Query: 169 MAPE---------YGKEGRVSANGDVYSFGIML 192
+APE Y + V D +S G++L
Sbjct: 308 LAPEVLVSVGTAGYNRA--V----DCWSLGVIL 334
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-21
Identities = 57/197 (28%), Positives = 82/197 (41%), Gaps = 28/197 (14%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
IGRG +G V A G + A K + F E E+MKS+ H NII++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 67 NEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQR--LNIMIDVASTLEYLHFGYSAQVIH 123
+ LV+E G L E+ +H + + IM DV S + Y H V H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVF----RESDAARIMKDVLSAVAYCH---KLNVAH 129
Query: 124 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-----YGK 175
DLKP N L + L DFG+A + + T Y++P+ YG
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGLYGP 186
Query: 176 EGRVSANGDVYSFGIML 192
E D +S G+M+
Sbjct: 187 E------CDEWSAGVMM 197
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 70/225 (31%), Positives = 106/225 (47%), Gaps = 49/225 (21%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVF--KSFDV-ECEMMKSIHHRNIIKVI- 62
IG G FG V++A+L D G VA+K +V K F E ++M+ + H NI+++
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIK-------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 63 -----SSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
+E + LVL+Y+P + Y + + IY +L M + +L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH 173
Query: 115 FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDIST--IQTQTLATIGYMAP 171
S + H D+KP N+LLD D V L DFG AK L R + + I + Y AP
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-----CSRYYRAP 225
Query: 172 E-------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
E Y +++ DV+S G +L E +P IF G+
Sbjct: 226 ELIFGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-21
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 48/224 (21%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVF--KSFDV-ECEMMKSIHHRNIIK---- 60
IG G FG VF+A+L + EVA+K +V K F E ++M+ + H N++
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIK-------KVLQDKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 61 VISSCSNEEFKA--LVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
S+ ++ LVLEY+P + + Y + + +L M + +L Y+H
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSLAYIH- 158
Query: 116 GYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDIST--IQTQTLATIGYMAPE 172
S + H D+KP N+LLD + V L DFG AK+L + + I + Y APE
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI-----CSRYYRAPE 211
Query: 173 -------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
Y + N D++S G ++ E +P +F GE
Sbjct: 212 LIFGATNY------TTNIDIWSTGCVMAELMQG-QP---LFPGE 245
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 7e-21
Identities = 62/299 (20%), Positives = 113/299 (37%), Gaps = 67/299 (22%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECE-----------MMKSIHHR 56
IG G +G V+KA+ G A+K L + E E ++K + H
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRL---------EKEDEGIPSTTIREISILKELKHS 60
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
NI+K+ ++ LV E++ L+K L L+ + ++ + + + Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--YG 174
+V+H DLKP N+L++ ++DFG+A+ T + T+ Y AP+ G
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMG 174
Query: 175 KEGRVSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTLKH 214
+ + S D++S G + E P + + L
Sbjct: 175 SK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 215 WVND---WLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
+ + + P+ + + L I ++K + P QRI AK+
Sbjct: 234 YDPNFTVYEPLPWESFL-KG-LDESGIDLLSK----MLKLD---------PNQRITAKQ 277
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-21
Identities = 66/299 (22%), Positives = 108/299 (36%), Gaps = 60/299 (20%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNL-QYGRVFKSFDV-ECEMMKSIHHRNIIKVI 62
L+G G +G V K R G VA+K F ++ K + E +++K + H N++ ++
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
C ++ LV E++ H ++ L LD + + + + + H S +I
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-------YGK 175
H D+KP N+L+ + V L DFG A+ L + +AT Y APE YGK
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 176 EGRVSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTLKHW 215
V DV++ G ++ E F + +
Sbjct: 205 A--V----DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258
Query: 216 VN----DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
+ E P LS I K C P++R E
Sbjct: 259 AGVRLPEIKEREPLERRYPK-LSEVVIDLAKK-------------CLHIDPDKRPFCAE 303
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-21
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 61/220 (27%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNL--------QYGRVFKSFDVECEMMKSIH-HRN 57
IGRG V + G E AVK+ + Q V ++ E +++ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRL--------NIMIDVAS 108
II +I S + F LV + M G L D + +++ +IM +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL----------FDYLTEKVALSEKETRSIMRSLLE 211
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI-- 166
+ +LH + ++H DLKP N+LLDDNM LSDFG + L + L +
Sbjct: 212 AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-------PGEKLRELCG 261
Query: 167 --GYMAPE------------YGKEGRVSANGDVYSFGIML 192
GY+APE YGKE D+++ G++L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKE------VDLWACGVIL 295
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 8e-21
Identities = 56/261 (21%), Positives = 104/261 (39%), Gaps = 45/261 (17%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEM-----MKSIHH 55
F + ++G+GGFG V ++ ++ A K L+ R+ K + ++ ++
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMID---------- 105
R ++ + + ++ LVL M G L H IY
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDL--KFH-------IYHMGQAGFPEARAVFYAAE 294
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA- 164
+ LE LH ++++ DLKP N+LLDD+ +SD G+A + +
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVG 347
Query: 165 TIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT---------RKKPTDEIFNGEMTLKHW 215
T+GYMAPE K R + + D ++ G +L E +K +E+ +
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 216 VNDWLPISTKEIVDPNLLSRE 236
++ + + LL ++
Sbjct: 408 YSERFSPQARSLCS-QLLCKD 427
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-21
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 43/220 (19%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN--------------------LQYGRVFKSFDV 45
IG+G +G V A D A+KV + G +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 46 ------ECEMMKSIHHRNIIK---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDI 96
E ++K + H N++K V+ + + +V E + G + + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKP--LSE 136
Query: 97 YQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156
Q D+ +EYLH ++IH D+KPSN+L+ ++ ++DFG++ D
Sbjct: 137 DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-- 191
Query: 157 TIQTQTLA-TIGYMAPEYGKEGRVSANG---DVYSFGIML 192
T +MAPE E R +G DV++ G+ L
Sbjct: 192 -ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 8e-21
Identities = 44/188 (23%), Positives = 82/188 (43%), Gaps = 9/188 (4%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V + G K N Y + E +M +HH +I + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
++ L+LE++ G L + + +Y + + +N M L+++H ++H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 127 KPSNVLLDDNMVAHL--SDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGD 184
KP N++ + + + DFG+A L + I T AT + APE V D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTD 232
Query: 185 VYSFGIML 192
+++ G++
Sbjct: 233 MWAIGVLG 240
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-21
Identities = 64/265 (24%), Positives = 116/265 (43%), Gaps = 61/265 (23%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVEC-----EMMKSIHHRNIIK 60
IG+G FG V + D ++ A+K N Q + + +V ++M+ + H ++
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ--KCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 61 VISSCSNEEFKALVLEYMPHGSL----EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
+ S +EE +V++ + G L ++ +H + ++ + ++ L+YL
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-----ICELVMALDYLQ-- 132
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPE--- 172
+ ++IH D+KP N+LLD++ H++DF IA +L RE Q T+A T YMAPE
Sbjct: 133 -NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKPYMAPEMFS 187
Query: 173 ------YGKEGRVSANGDVYSFGIMLIETFTRKKP--------TDEIFNGEMTLKHWVND 218
Y V D +S G+ E ++P + EI +
Sbjct: 188 SRKGAGYSFA--V----DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---------- 231
Query: 219 WLPISTKEIVDPNLLSREDIHFVAK 243
T + P+ S+E + + K
Sbjct: 232 ---FETTVVTYPSAWSQEMVSLLKK 253
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFK-SFDV----ECEMMKSIHHRNIIKV 61
+G G F +V+KAR VA+K L + K + E ++++ + H NII +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ + ++ +LV ++M LE + ++ +L M+ LEYLH +
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--YGKEGRV 179
+H DLKP+N+LLD+N V L+DFG+AK + T + T Y APE +G
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGAR-MY 190
Query: 180 SANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTLKHWVN-- 217
D+++ G +L E R PT+E + +L +V
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250
Query: 218 DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
+ I I + + + F+FN P RI A +
Sbjct: 251 SFPGIPLHHIF-SA-AGDDLLDLIQG----LFLFN---------PCARITATQ 288
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 36/207 (17%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN----LQYGRVFKSFDVECEMMKSIHHRNIIKV 61
L+G G +G V + AVK+ + + E ++++ + H+N+I++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 62 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------STLE 111
+ NEE + +V+EY G E + + + +R + A LE
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML----DSVPE--KRFPV--CQAHGYFCQLIDGLE 123
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----G 167
YLH S ++H D+KP N+LL +S G+A+ L T T
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA----ADDTCRTSQGSPA 176
Query: 168 YMAPE--YGKEGRVSANGDVYSFGIML 192
+ PE G + D++S G+ L
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 39/188 (20%), Positives = 75/188 (39%), Gaps = 9/188 (4%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
+G G FG V + G A K + ++ E + M + H ++ + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
++ ++ E+M G L + + + + + + M V L ++H +H DL
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDL 281
Query: 127 KPSNVLLDDNMVAHL--SDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGD 184
KP N++ L DFG+ L + + T T + APE + V D
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTD 338
Query: 185 VYSFGIML 192
++S G++
Sbjct: 339 MWSVGVLS 346
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 41/234 (17%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN----LQYGRVFKSFDV--ECEMMKSIHHR--N 57
L+G GGFGSV+ + D + VA+K +G + V E ++K +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 58 IIKVISSCSNEEFKALVLEY-MPHGSLEKYLHSSNYILDIYQRLN------IMIDVASTL 110
+I+++ + L+LE P L ++ L V +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAV 162
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
+ H + V+H D+K N+L+D N L DFG LL + T Y
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYS 215
Query: 170 APEY--GK--EGRVSANGDVYSFGIMLIETFTRKKP---TDEIFNGEMTLKHWV 216
PE+ GR + V+S GI+L + P +EI G++ + V
Sbjct: 216 PPEWIRYHRYHGRSA---AVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 49/213 (23%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDV-----ECEMMKSIHHRNI 58
+G G G V A +VA+K+ + G ++ E E++K ++H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVASTLEY 112
IK+ + E++ +VLE M G L + ++ +RL + ++Y
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGEL------FDKVVG-NKRLKEATCKLYFYQMLLAVQY 129
Query: 113 LHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGY 168
LH +IH DLKP NVLL +++ + ++DFG +K+L + +TL T Y
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL----MRTLCGTPTY 182
Query: 169 MAPE---------YGKEGRVSANGDVYSFGIML 192
+APE Y + V D +S G++L
Sbjct: 183 LAPEVLVSVGTAGYNRA--V----DCWSLGVIL 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 47/227 (20%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVF--KSFDV----ECEMMKSIHHRNIIK 60
G+G FG+V + GM VA+K +V F + + +HH NI++
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIK-------KVIQDPRFRNRELQIMQDLAVLHHPNIVQ 83
Query: 61 ---VISSCSNEEFK----ALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASTL 110
+ + + +V+EY+P H Y I ++ + + ++
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSI 142
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
LH S V H D+KP NVL++ + L DFG AK L+ + + + + Y
Sbjct: 143 GCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYR 198
Query: 170 APE-------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
APE Y + D++S G + E +P IF G+
Sbjct: 199 APELIFGNQHY------TTAVDIWSVGCIFAEMMLG-EP---IFRGD 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-20
Identities = 45/217 (20%), Positives = 79/217 (36%), Gaps = 65/217 (29%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE---MMKSIHHRNIIKVI- 62
+G G G V + + A+K+ E ++ +I++++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122
Query: 63 ---SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN----------IMIDVAS 108
+ + + +V+E + G L I R + IM +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165
++YLH S + H D+KP N+L N + L+DFG AK T +L T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-------NSLTT 222
Query: 166 I----GYMAPE------YGKEGRVSANGDVYSFGIML 192
Y+APE Y K D++S G+++
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-20
Identities = 60/236 (25%), Positives = 93/236 (39%), Gaps = 43/236 (18%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN----LQYGRVFKSFDV--ECEMMKSIH----H 55
L+G+GGFG+VF L D ++VA+KV L + + S E ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 56 RNIIKVISSCSNEEFKALVLEY-MPHGSLEKYLHSSNYILDIYQRL------NIMIDVAS 108
+I+++ +E LVLE +P L Y+ L V +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVA 150
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIG 167
+++ H S V+H D+K N+L+D A L DFG LL E + T
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRV 203
Query: 168 YMAPEY--GK--EGRVSANGDVYSFGIMLIETFTRKKP---TDEIFNGEMTLKHWV 216
Y PE+ + V+S GI+L + P EI E+ V
Sbjct: 204 YSPPEWISRHQYHALPA---TVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-20
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 41/204 (20%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHHRNIIK 60
+GRG V++ + G A+KV K+ D E ++ + H NIIK
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 61 VISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQR--LNIMIDVASTLEYLHFGY 117
+ +LVLE + G L ++ + Y +R + + + + YLH
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYY----SERDAADAVKQILEAVAYLH--- 165
Query: 118 SAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-- 172
++H DLKP N+L + ++DFG++K++ + + T GY APE
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEIL 222
Query: 173 ----YGKEGRVSANGDVYSFGIML 192
YG E D++S GI+
Sbjct: 223 RGCAYGPE------VDMWSVGIIT 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-20
Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 25/198 (12%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKVISSC 65
+G G FG V G+E +K N +V + + E E++KS+ H NIIK+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIY---QRLNIMIDVASTLEYLHFGYSAQVI 122
+ +V+E G L + + S+ +M + + L Y H S V+
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 123 HCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-----YG 174
H DLKP N+L + + DFG+A+L ++ T T YMAPE
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFKRDVT 203
Query: 175 KEGRVSANGDVYSFGIML 192
+ D++S G+++
Sbjct: 204 FK------CDIWSAGVVM 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-20
Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 49/230 (21%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSIHHRN 57
IG G G V A VA+K ++ + F E +MK ++H+N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIK-------KLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 58 IIKV----ISSCSNEEFKA--LVLEYMPHGSLEKYLHSS------NYILDIYQRLNIMID 105
II + S EEF+ +V+E M +L + + +Y+L YQ L
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLL--YQMLC---- 138
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165
+++LH SA +IH DLKPSN+++ + + DFG+A+ + T + T
Sbjct: 139 ---GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVT 189
Query: 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW 215
Y APE N D++S G ++ E +F G + W
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 235
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 8e-20
Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 32/256 (12%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEM-----MKSIHH 55
F + ++GRGGFG VF ++ ++ A K L R+ K + M + +H
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY--QRLNIMI-DVASTLEY 112
R I+ + + + LV+ M G + ++++ + + R + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 113 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAP 171
LH +I+ DLKP NVLLDD+ +SD G+A L T+ A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAP 358
Query: 172 EYGKEGRVSANGDVYSFGIMLIETFT---------RKKPTDEIFNGEMTLKHWVN--DWL 220
E + D ++ G+ L E K E+ + L+ V D
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--QRVLEQAVTYPDKF 416
Query: 221 PISTKEIVDPNLLSRE 236
++K+ + LL ++
Sbjct: 417 SPASKDFCE-ALLQKD 431
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 27/246 (10%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVEC--------EMMKS 52
FS + +IGRGGFG V+ R D ++ A+K L R+ ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248
Query: 53 IHHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEY 112
I+ + + + + +L+ M G L +L + R ++ LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307
Query: 113 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAP 171
+H + V++ DLKP+N+LLD++ +SD G+A D S + T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAP 359
Query: 172 E-YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230
E K ++ D +S G ML + P F T D + T + P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRM-TLTMAVELP 414
Query: 231 NLLSRE 236
+ S E
Sbjct: 415 DSFSPE 420
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 39/196 (19%), Positives = 78/196 (39%), Gaps = 39/196 (19%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSIHHRN 57
IG G +G V +A + VA+K ++ + F+ E ++ ++H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIK-------KILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 58 IIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD------IYQRLNIMIDV 106
++K ++ E+F +VLE +K + Y+ + +Y L
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLV----- 167
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI 166
++Y+H SA ++H DLKP+N L++ + + DFG+A+ + + Q
Sbjct: 168 --GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 167 GYMAPEYGKEGRVSAN 182
M +
Sbjct: 223 DDMNLVTFPHTKNLKR 238
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-19
Identities = 59/296 (19%), Positives = 113/296 (38%), Gaps = 60/296 (20%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVKVFNLQY--GRVFKSFDV----ECEMMKSIHHRNIIK 60
+G G + +V+K + VA+K L++ G E ++K + H NI+
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-----APCTAIREVSLLKDLKHANIVT 64
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ E+ LV EY+ L++YL I++++ + + L Y H +
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--YGKEGR 178
V+H DLKP N+L+++ L+DFG+A+ + + + T+ Y P+ G
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGST-D 177
Query: 179 VSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTLKHWVN- 217
S D++ G + E T + PT+E + G ++ + +
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237
Query: 218 ---DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
+ + P L + + K F RI+A++
Sbjct: 238 NYPKYRAEALLSHA-PR-LDSDGADLLTK----LLQFE---------GRNRISAED 278
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 67/274 (24%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVK---VF-NLQYG-RVFKSFDVECEMMKSIHHRNIIK- 60
IG G +G V A + + VA+K F + Y R + E +++ H NII
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 61 --VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSN-------YILDIYQRLNIMIDVAST 109
+I + + E+ K +V + M L K L + + Y L YQ L
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFL--YQILR-------G 140
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ-TQTLATIGY 168
L+Y+H SA V+H DLKPSN+LL+ + DFG+A++ + T T+ +AT Y
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 169 MAPE-------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
APE Y K + D++S G +L E + + IF G+ L
Sbjct: 198 RAPEIMLNSKGYTK------SIDIWSVGCILAEMLSNR----PIFPGKHYLDQL------ 241
Query: 222 ISTKEIVDPNLL---SREDIHFVAKEQCVSFVFN 252
I+ +L S+ED++ + + +++ +
Sbjct: 242 ---NHILG--ILGSPSQEDLNCIINLKARNYLLS 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
S+ ++G G FG V K G+++A K+ + + + E +M + H N+I+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ + ++ LV+EY+ G L + +Y L + M + + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMY 207
Query: 121 VIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR 178
++H DLKP N+L + + DFG+A+ R T ++APE
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNFGTPEFLAPEVVNYDF 264
Query: 179 VSANGDVYSFGIML 192
VS D++S G++
Sbjct: 265 VSFPTDMWSVGVIA 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-19
Identities = 56/242 (23%), Positives = 94/242 (38%), Gaps = 43/242 (17%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQ-----YGRVFKSFDVECEMMKSIHHRNIIK 60
+G G +G V A VAVK+ +++ + K E + K ++H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 61 ---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------ST 109
N ++ L LEY G L + I + A +
Sbjct: 70 FYGHRRE-GNIQY--LFLEYCSGGEL------FDRIEP-DIGMPE--PDAQRFFHQLMAG 117
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
+ YLH + H D+KP N+LLD+ +SDFG+A + + + + T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 170 APE-YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN------DWLPI 222
APE + + DV+S GI+L + P D+ + W W I
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 223 ST 224
+
Sbjct: 235 DS 236
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 62/227 (27%), Positives = 94/227 (41%), Gaps = 60/227 (26%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVK---VF-NLQYG-RVFKSFDVECEMMKSIHHRNIIK- 60
+G G +G V A G VA+K F + R + E +++K H NII
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 61 --VISSCSNEEFKA--LVLEYMPHGSLEKYLH---SSNYILD------IYQRLNIMIDVA 107
+ S E F ++ E M + LH S+ + D IYQ L
Sbjct: 75 FNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLR------ 123
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ-------- 159
++ LH + VIH DLKPSN+L++ N + DFG+A+++ +
Sbjct: 124 -AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 160 TQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRK 199
+ +AT Y APE Y + DV+S G +L E F R+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSR------AMDVWSCGCILAELFLRR 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 52/231 (22%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE-----------MMKSIHH 55
IG+G FG VFKAR G +VA+K +V + E E +++ + H
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALK-------KVL--MENEKEGFPITALREIKILQLLKH 75
Query: 56 RNIIK---VISSCSNEEFKA-----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA 107
N++ + + ++ + LV ++ H L L + + + +M +
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ--TQTLAT 165
+ L Y+H +++H D+K +NVL+ + V L+DFG+A+ + S T + T
Sbjct: 135 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 166 IGYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
+ Y PE YG + D++ G ++ E +TR P I G
Sbjct: 192 LWYRPPELLLGERDYGPP--I----DLWGAGCIMAEMWTR-SP---IMQGN 232
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 63/305 (20%), Positives = 112/305 (36%), Gaps = 73/305 (23%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE-----------MMKSIHH 55
+G G +G V+KA VA+K L + E E ++K + H
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRL---------EHEEEGVPGTAIREVSLLKELQH 92
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
RNII++ S + L+ EY + L+KY+ + + + + + + + + + H
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH- 149
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAH-----LSDFGIAKLLTREDISTIQTQTLATIGYMA 170
S + +H DLKP N+LL + + + DFG+A+ T + T+ Y
Sbjct: 150 --SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRP 205
Query: 171 PE--YGKEGRVSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNG 208
PE G S + D++S + E + P D + G
Sbjct: 206 PEILLGSR-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264
Query: 209 EMTLKHWVND---WLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQR 265
L W + + K ++ LL E + + + P +R
Sbjct: 265 VTALPDWKQSFPKFRGKTLKRVL-GALLDDEGLDLLTA----MLEMD---------PVKR 310
Query: 266 INAKE 270
I+AK
Sbjct: 311 ISAKN 315
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-19
Identities = 58/326 (17%), Positives = 111/326 (34%), Gaps = 79/326 (24%)
Query: 4 ENNLIGRGGFGSVFKAR---LGDGMEVAVKVFNLQYGRVFKSFDVE--CEM--MKSIHHR 56
E +GRG +G V+KA+ D + A+K + E+ ++ + H
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSACREIALLRELKHP 78
Query: 57 NIIK---VISSCSNEEFKALVLEYMPHGSLEKYLHS--------SNYILDIYQRLNIMID 105
N+I V S ++ + L+ +Y H L + L +++
Sbjct: 79 NVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTREDIS-TIQT 160
+ + YLH + V+H DLKP+N+L+ ++D G A+L
Sbjct: 137 ILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 161 QTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRK-------------- 199
+ T Y APE Y K + D+++ G + E T +
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKA--I----DIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 200 ---------------KPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKE 244
P D+ + + + +L+ + H V +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 245 QCVSFVFNVAMECTVESPEQRINAKE 270
S F++ + P +RI +++
Sbjct: 308 ---SKAFHLLQKLLTMDPIKRITSEQ 330
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-19
Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 35/232 (15%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEM----------MKSIHHR 56
+G G FG V+ A EV VK + +V + +E + + H
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKE--KVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASTL 110
NIIKV+ N+ F LV+E G L+ + +I D + RL+ I + S +
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSG-LDLF----AFI-DRHPRLDEPLASYIFRQLVSAV 143
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMA 170
YL +IH D+K N+++ ++ L DFG A L R + T TI Y A
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL--FYT-FCGTIEYCA 197
Query: 171 PE-YGKEGRVSANGDVYSFGIMLIETFTRKKP---TDEIFNGEMTLKHWVND 218
PE +++S G+ L + P +E + + V+
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSK 249
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-19
Identities = 56/242 (23%), Positives = 94/242 (38%), Gaps = 43/242 (17%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQ-----YGRVFKSFDVECEMMKSIHHRNIIK 60
+G G +G V A VAVK+ +++ + K E + K ++H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 61 ---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------ST 109
N ++ L LEY G L + I + A +
Sbjct: 70 FYGHRRE-GNIQY--LFLEYCSGGEL------FDRIEP-DIGMPE--PDAQRFFHQLMAG 117
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
+ YLH + H D+KP N+LLD+ +SDFG+A + + + + T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 170 APE-YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN------DWLPI 222
APE + + DV+S GI+L + P D+ + W W I
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 223 ST 224
+
Sbjct: 235 DS 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 58/266 (21%), Positives = 101/266 (37%), Gaps = 60/266 (22%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSIHHRN 57
+G G +GSV A G +VA+K ++ + F E ++K + H N
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIK-------KLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 58 IIK----VISSCSNEEFKA--LVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVAS 108
+I + S F LV+ +M + +YQ L
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK------- 137
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY 168
L+Y+H SA V+H DLKP N+ ++++ + DFG+A+ T + T Y
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWY 189
Query: 169 MAPE-YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227
APE + D++S G ++ E T K +F G+ L +I
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLDQL---------TQI 236
Query: 228 VDPNLL---SREDIHFVAKEQCVSFV 250
+ + E + + + S++
Sbjct: 237 LK--VTGVPGTEFVQKLNDKAAKSYI 260
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-18
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 26/198 (13%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIK-- 60
+G G FG V G +VAVK+ N ++ V E + +K H +IIK
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 61 -VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
VIS+ + F +V+EY+ G L Y+ + ++ + + + S ++Y H
Sbjct: 78 QVIST-PTDFF--MVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCH---RH 130
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAPE-YG 174
V+H DLKP NVLLD +M A ++DFG++ +++ + L T Y APE
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-------LRTSCGSPNYAAPEVIS 183
Query: 175 KEGRVSANGDVYSFGIML 192
D++S G++L
Sbjct: 184 GRLYAGPEVDIWSCGVIL 201
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 63/268 (23%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSIHHRN 57
+G G +GSV A G+ VAVK ++ + F E ++K + H N
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVK-------KLSRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 58 IIKV----ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD-----IYQRLNIMIDV 106
+I + + S EEF LV M L + D IYQ L
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR----- 143
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI 166
L+Y+H SA +IH DLKPSN+ ++++ + DFG+A+ + T +AT
Sbjct: 144 --GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATR 193
Query: 167 GYMAPE-YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225
Y APE + D++S G ++ E T + +F G + K
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTDHIDQL---------K 240
Query: 226 EIVDPNLL---SREDIHFVAKEQCVSFV 250
I+ L+ E + ++ E +++
Sbjct: 241 LILR--LVGTPGAELLKKISSESARNYI 266
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSIHHRN 57
IG G G V A VA+K ++ + F E +MK ++H+N
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIK-------KLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 58 IIKVI----SSCSNEEFKA--LVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVAS 108
II ++ + EEF+ LV+E M ++ L +YQ L
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC------- 175
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGY 168
+++LH SA +IH DLKPSN+++ + + DFG+A+ + T + T Y
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYY 229
Query: 169 MAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW 215
APE N D++S G ++ E K +F G + W
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQW 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 33/200 (16%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFN------LQYGRVFKSFDVECEMMKSIHHRNIIK 60
IG+G F V AR + G EVA+K+ + ++F+ E +MK ++H NI+K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ E+ L++EY G + YL + + + + + S ++Y H +
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH---QKR 134
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAPE--YG 174
++H DLK N+LLD +M ++DFG + T L Y APE G
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-------GKLDAFCGAPPYAAPELFQG 187
Query: 175 K--EGRVSANGDVYSFGIML 192
K +G DV+S G++L
Sbjct: 188 KKYDGPEV---DVWSLGVIL 204
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 40/191 (20%), Positives = 72/191 (37%), Gaps = 39/191 (20%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSIHHRN 57
IGRG +G V+ A VA+K +V + F+ E ++ +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIK-------KVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 58 IIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD------IYQRLNIMIDV 106
II+ +I +F +VLE L+K + ++ + +Y L
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL----- 140
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI 166
++H + +IH DLKP+N LL+ + + DFG+A+ + E + I
Sbjct: 141 --GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 167 GYMAPEYGKEG 177
+
Sbjct: 196 EPGPHNKNLKK 206
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 66/245 (26%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVK--VF-NLQYG-RVFKSFDVECEMMKSIHHRNIIKVI 62
+G GG G VF A VA+K V + Q + E ++++ + H NI+KV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 63 ------------SSCSNEEFKA--LVLEYMPHGSLEKYLH---SSNYILD------IYQR 99
S E + +V EYM E L +L+ +YQ
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQL 129
Query: 100 LNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTI 158
L L+Y+H SA V+H DLKP+N+ ++ +++V + DFG+A+++
Sbjct: 130 LR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 159 Q-TQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM 210
++ L T Y +P Y K D+++ G + E T K +F G
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTK------AIDMWAAGCIFAEMLTGK----TLFAGAH 229
Query: 211 TLKHW 215
L+
Sbjct: 230 ELEQM 234
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 45/213 (21%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVEC-----EMMKSIHHRNIIK 60
+IGRG FG V +L + +V A+K+ L + K + C +++ + + I
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-----IYQRLNIMIDVASTLEYLHF 115
+ + ++ LV++Y G L L L Y + ++ ++ +H
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVH- 192
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDISTIQTQTL-ATIGYMAPE 172
+H D+KP N+L+D N H L+DFG L + T+Q+ T Y++PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPE 246
Query: 173 -----------YGKEGRVSANGDVYSFGIMLIE 194
YG E D +S G+ + E
Sbjct: 247 ILQAMEGGKGRYGPE------CDWWSLGVCMYE 273
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 59/276 (21%), Positives = 111/276 (40%), Gaps = 79/276 (28%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSIHHRN 57
+G G +G+V A G +VA+K ++++ F E ++K + H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIK-------KLYRPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 58 IIKVI----SSCSNEEFKA--LVLEYMPHGSLEKYLHSSN-------YILDIYQRLNIMI 104
+I ++ + ++F LV+ +M L K + ++ +YQ L
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL--VYQMLK--- 139
Query: 105 DVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA 164
L Y+H +A +IH DLKP N+ ++++ + DFG+A+ + T +
Sbjct: 140 ----GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----ADSEMTGYVV 187
Query: 165 TIGYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN 217
T Y APE Y + D++S G ++ E T K +F G L
Sbjct: 188 TRWYRAPEVILNWMRYTQ------TVDIWSVGCIMAEMITGK----TLFKGSDHLDQL-- 235
Query: 218 DWLPISTKEIVDPNLL---SREDIHFVAKEQCVSFV 250
KEI+ + E + + ++ +++
Sbjct: 236 -------KEIMK--VTGTPPAEFVQRLQSDEAKNYM 262
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 64/303 (21%), Positives = 115/303 (37%), Gaps = 65/303 (21%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDV----ECEMMKSIHHRNIIK 60
+G G + +V+K G+ VA+K L G E +MK + H NI++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG-----TPSTAIREISLMKELKHENIVR 67
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-----LDIYQRLNIMIDVASTLEYLHF 115
+ E LV E+M + L+KY+ S L++ + L + H
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH- 125
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--Y 173
+++H DLKP N+L++ L DFG+A+ + + T+ Y AP+
Sbjct: 126 --ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--VNTFSSEVVTLWYRAPDVLM 181
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRK--------------------KPTDEIFNGEMTLK 213
G S + D++S G +L E T K P + ++ L
Sbjct: 182 GSR-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240
Query: 214 HWVND---WLPISTKEIVDPNL---LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN 267
+ + P ++++ P+ L + F+ N P+ R++
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHG----LLQLN---------PDMRLS 287
Query: 268 AKE 270
AK+
Sbjct: 288 AKQ 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-18
Identities = 38/194 (19%), Positives = 77/194 (39%), Gaps = 22/194 (11%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS 66
+GRG FG V + K ++ E ++ HRNI+ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDL 126
+ E ++ E++ + + +++S + L+ + ++ + V L++LH S + H D+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128
Query: 127 KPSNVLLDDNMVAHL--SDFGIAKLLTREDISTIQTQTLATIGYMAPE------YGKEGR 178
+P N++ + + +FG A+ L D Y APE
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTA-- 183
Query: 179 VSANGDVYSFGIML 192
D++S G ++
Sbjct: 184 ----TDMWSLGTLV 193
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 48/213 (22%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVEC-----EMMKSIHHRNIIK 60
+IGRG FG V R +V A+K+ + + K D ++M + +++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------STLEY 112
+ + ++ + +V+EYMP G L + ++ A L+
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAEVVLALDA 183
Query: 113 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAP 171
+H S IH D+KP N+LLD + L+DFG + +E ++ T T Y++P
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISP 238
Query: 172 E----------YGKEGRVSANGDVYSFGIMLIE 194
E YG+E D +S G+ L E
Sbjct: 239 EVLKSQGGDGYYGRE--C----DWWSVGVFLYE 265
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 45/196 (22%), Positives = 78/196 (39%), Gaps = 18/196 (9%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFN------LQYGRVFKSFDVECEMMKSIHHRNIIK 60
+G G F V K R G+E A K + G + + E +++ + H NII
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ N L+LE + G L +L + + + + + + YLH + +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQILDGVNYLH---TKK 135
Query: 121 VIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176
+ H DLKP N++L L DFG+A + T ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 177 GRVSANGDVYSFGIML 192
+ D++S G++
Sbjct: 193 EPLGLEADMWSIGVIT 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 56/204 (27%), Positives = 82/204 (40%), Gaps = 40/204 (19%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKVI 62
IG G FG R VAVK V + E +S+ H NI++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------STLEYLH 114
A+++EY G L + + + R + D A S + Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICN-------AGRFSE--DEARFFFQQLLSGVSYCH 133
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLTREDISTIQTQTLATIGYMAPE 172
S Q+ H DLK N LLD + L DFG +K S ++ T+ T Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKS-TVGTPAYIAPE 187
Query: 173 --YGKE--GRVSANGDVYSFGIML 192
+E G+++ DV+S G+ L
Sbjct: 188 VLLRQEYDGKIA---DVWSCGVTL 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV-----ECEMMKSIHHRNIIK 60
+G G FG V + G +VAVK+ N Q ++ V E + +K H +IIK
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 61 ---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
VIS+ ++ F +V+EY+ G L Y+ N LD + + + S ++Y H
Sbjct: 81 LYQVIST-PSDIF--MVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH--- 133
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAPE- 172
V+H DLKP NVLLD +M A ++DFG++ +++ + L T Y APE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-------DGEFLRTSCGSPNYAAPEV 186
Query: 173 YGKEGRVSANGDVYSFGIML 192
D++S G++L
Sbjct: 187 ISGRLYAGPEVDIWSSGVIL 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 53/212 (25%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVEC-----EMMKSIHHRNIIK 60
+G G FG V R A+KV L+ V + VE M+ + H II+
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTLE 111
+ + + + ++++Y+ G L L S Y ++ LE
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----------CLALE 120
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDISTIQTQTL-ATIGY 168
YLH S +I+ DLKP N+LLD N H ++DFG AK T TL T Y
Sbjct: 121 YLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK----YVPDV--TYTLCGTPDY 169
Query: 169 MAPE------YGKEGRVSANGDVYSFGIMLIE 194
+APE Y K S D +SFGI++ E
Sbjct: 170 IAPEVVSTKPYNK----SI--DWWSFGILIYE 195
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 44/196 (22%), Positives = 79/196 (40%), Gaps = 18/196 (9%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFN------LQYGRVFKSFDVECEMMKSIHHRNIIK 60
+G G F V K R G+E A K + G + + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ N L+LE + G L +L + + + + + + YLH + +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQILDGVNYLH---TKK 135
Query: 121 VIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176
+ H DLKP N++L L DFG+A + + T ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 177 GRVSANGDVYSFGIML 192
+ D++S G++
Sbjct: 193 EPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-17
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 40/207 (19%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFN------LQYGRVFKSFDVECEMMKSIHHRNIIK 60
+G G F V K R G G E A K + G + + E +++ I H NII
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 61 VISSCSNEEFKALVLEYMPHGSL-----EKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
+ N+ L+LE + G L EK + + + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLKQILDGVHYLH- 125
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
S ++ H DLKP N++L D V + L DFGIA + + T ++AP
Sbjct: 126 --SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNIFGTPEFVAP 180
Query: 172 E------YGKEGRVSANGDVYSFGIML 192
E G E D++S G++
Sbjct: 181 EIVNYEPLGLE------ADMWSIGVIT 201
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 31/201 (15%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVEC-----EMMKSIHHRNIIK 60
+G G FG V + + A+K+ L +V K +E ++++++ ++K
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ S + +V+EY+ G + +L + + R + T EYLH S
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH---SLD 161
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL-ATIGYMAPE------Y 173
+I+ DLKP N+L+D ++DFG AK + +T TL T +APE Y
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIILSKGY 215
Query: 174 GKEGRVSANGDVYSFGIMLIE 194
K V D ++ G+++ E
Sbjct: 216 NKA--V----DWWALGVLIYE 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 55/254 (21%), Positives = 97/254 (38%), Gaps = 75/254 (29%)
Query: 8 IGRGGFGSVFKARLGD-GMEVAVK-VFNLQYGRVFKSFDV-ECEMMKSIHHRNIIKVI-- 62
+G G FG V + + G A+K V + E ++MK + H NIIK++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 63 ------------------------------------SSCSNEEFKALVLEYMP---HGSL 83
+ S ++ +++EY+P H L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 84 EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLS 142
+ ++ S I + + + + ++H S + H D+KP N+L++ + L
Sbjct: 129 KSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 143 DFGIAKLLTREDISTIQTQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLIET 195
DFG AK L + S + + Y APE Y + + D++S G + E
Sbjct: 185 DFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGEL 235
Query: 196 FTRKKPTDEIFNGE 209
KP +F+GE
Sbjct: 236 ILG-KP---LFSGE 245
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 39/204 (19%), Positives = 76/204 (37%), Gaps = 36/204 (17%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEM--MKSI-HHRNIIKVIS 63
+GRG F V + G E A K + ++ E+ ++ +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVASTLEYLHFGY 117
N L+LEY G + + ++ + + ++ + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC-----LPELAEMVSENDVIRLIKQILEGVYYLH--- 148
Query: 118 SAQVIHCDLKPSNVLLDDNMVAH---LSDFGIAKLLTREDISTIQTQTLATIGYMAPE-- 172
++H DLKP N+LL + DFG+++ + + + + T Y+APE
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYLAPEIL 205
Query: 173 ----YGKEGRVSANGDVYSFGIML 192
D+++ GI+
Sbjct: 206 NYDPITTA------TDMWNIGIIA 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 48/201 (23%), Positives = 80/201 (39%), Gaps = 28/201 (13%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFN------LQYGRVFKSFDVECEMMKSIHHRNIIK 60
+G G F V K R G++ A K + G + + E ++K I H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 61 VISSCSNEEFKALVLEYMPHGSL-----EKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
+ N+ L+LE + G L EK + + + + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYLH- 131
Query: 116 GYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
S Q+ H DLKP N++L + DFG+A + D T ++AP
Sbjct: 132 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 172 EYGKEGRVSANGDVYSFGIML 192
E + D++S G++
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 47/215 (21%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEM-----MKSIHHRNIIK 60
+IGRG F V ++ +V A+K+ + + K +V C + + R I +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-----IYQRLNIMIDVASTLEYLHF 115
+ + +E + LV+EY G L L + Y + ++ ++ +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIVMAIDSVH- 179
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDISTIQTQTL-ATIGYMAPE 172
+H D+KP N+LLD H L+DFG L + T+++ T Y++PE
Sbjct: 180 --RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG--TVRSLVAVGTPDYLSPE 233
Query: 173 -------------YGKEGRVSANGDVYSFGIMLIE 194
YG E D ++ G+ E
Sbjct: 234 ILQAVGGGPGTGSYGPE--C----DWWALGVFAYE 262
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-16
Identities = 35/168 (20%), Positives = 62/168 (36%), Gaps = 42/168 (25%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE---MMKSIHHRNIIKVI- 62
+G G G V + + A+K+ E ++ +I++++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 63 ---SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN----------IMIDVAS 108
+ + + +V+E + G L I R + IM +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRE 153
++YLH S + H D+KP N+L N + L+DFG AK T E
Sbjct: 129 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 64/257 (24%), Positives = 105/257 (40%), Gaps = 49/257 (19%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMM------KSIHHRNII 59
++G+G FG V + E+ AVK+ L+ V + DVEC M+ +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
++ S + V+EY+ G L ++ + ++A L +L S
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SK 461
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TIQTQTLA-TIGYMAPE----- 172
+I+ DLK NV+LD ++DFG+ K E+I + T+T T Y+APE
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 173 -YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKE 226
YGK V D ++FG++L E + P DE+F I
Sbjct: 518 PYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQS-------------IMEHN 558
Query: 227 IVDPNLLSREDIHFVAK 243
+ P +S+E +
Sbjct: 559 VAYPKSMSKEAVAICKG 575
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-16
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 6 NLIGRGGFGSVFKAR--LGDGMEVAVKVFNLQYGRVFKSFDVECE--------------M 49
IG G +G VFKAR G VA+K + E
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRV---------QTGEEGMPLSTIREVAVLRH 67
Query: 50 MKSIHHRNIIK----VISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIM 103
+++ H N+++ S ++ E K LV E++ L YL + ++M
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 104 IDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL 163
+ L++LH S +V+H DLKP N+L+ + L+DFG+A++ T +
Sbjct: 127 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 180
Query: 164 ATIGYMAPE--YGKEGRVSANGDVYSFGIMLIETFTRK 199
T+ Y APE + D++S G + E F RK
Sbjct: 181 VTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-16
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 44/220 (20%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE---------------- 48
IG G +G+V+KAR G VA+K +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRV---------PNGGGGGGGLPISTVREVALL 65
Query: 49 -MMKSIHHRNIIK----VISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYI-LDIYQRLN 101
+++ H N+++ +S ++ E K LV E++ L YL + L +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 102 IMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161
+M L++LH + ++H DLKP N+L+ L+DFG+A++ T
Sbjct: 125 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTP 178
Query: 162 TLATIGYMAPE--YGKEGRVSANGDVYSFGIMLIETFTRK 199
+ T+ Y APE + D++S G + E F RK
Sbjct: 179 VVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 27/198 (13%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIK-- 60
+G G FG V A +VA+K + L+ + + E +K + H +IIK
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 61 -VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
VI++ + +V+EY G L Y+ + + + +EY H
Sbjct: 76 DVITT-PTDIV--MVIEYA-GGELFDYI-VEKKRMTEDEGRRFFQQIICAIEYCH---RH 127
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI----GYMAPE-YG 174
+++H DLKP N+LLDDN+ ++DFG++ ++T L T Y APE
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-------DGNFLKTSCGSPNYAAPEVIN 180
Query: 175 KEGRVSANGDVYSFGIML 192
+ DV+S GI+L
Sbjct: 181 GKLYAGPEVDVWSCGIVL 198
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-16
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 90/292 (30%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------ECEMMKSIH-HR 56
+G+G +G V+K+ G VAVK ++F +F E ++ + H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVK-------KIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 57 NIIKVISSCSNEEFKA--LVLEYMPHGSLEKYLHSSN-------YILDIYQRLNIMIDVA 107
NI+ +++ + + LV +YM L + ++ Y+ +YQ +
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV--VYQLIK------ 120
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ-------- 159
++YLH S ++H D+KPSN+LL+ ++DFG+++ T
Sbjct: 121 -VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 160 -----------TQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLIETFTRKKP 201
T +AT Y APE Y K + D++S G +L E KP
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG--I----DMWSLGCILGEILCG-KP 229
Query: 202 TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL---SREDIHFVAKEQCVSFV 250
IF G T+ + I+ ++ S ED+ + + +
Sbjct: 230 ---IFPGSSTMNQL---------ERIIG--VIDFPSNEDVESIQSPFAKTMI 267
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 62/265 (23%), Positives = 100/265 (37%), Gaps = 66/265 (24%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMM-----KSIHHRNIIK 60
L+G+G FG V R A+K+ L+ + +V + ++ H +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTLE 111
+ + + V+EY G L +L Y +I S LE
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI----------VSALE 119
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TIQTQTL-ATIGYM 169
YLH S V++ D+K N++LD + ++DFG+ K E IS +T T Y+
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 172
Query: 170 APE------YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWVND 218
APE YG+ V D + G+++ E + P + +F
Sbjct: 173 APEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHERLFEL---------- 216
Query: 219 WLPISTKEIVDPNLLSREDIHFVAK 243
I +EI P LS E +A
Sbjct: 217 ---ILMEEIRFPRTLSPEAKSLLAG 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 65/268 (24%), Positives = 106/268 (39%), Gaps = 71/268 (26%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMM------KSIHHRNII 59
++G+G FG VF A + A+K L+ V DVEC M+ + H +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTL 110
+ + +E V+EY+ G L ++ S + Y +I L
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI----------ILGL 131
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDIS-TIQTQTL-ATI 166
++LH S +++ DLK N+LLD + H ++DFG+ K E++ +T T T
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK----ENMLGDAKTNTFCGTP 182
Query: 167 GYMAPE------YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHW 215
Y+APE Y D +SFG++L E + P +E+F+
Sbjct: 183 DYIAPEILLGQKYNHS------VDWWSFGVLLYEMLIGQSPFHGQDEEELFHS------- 229
Query: 216 VNDWLPISTKEIVDPNLLSREDIHFVAK 243
I P L +E + K
Sbjct: 230 ------IRMDNPFYPRWLEKEAKDLLVK 251
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 58/265 (21%), Positives = 100/265 (37%), Gaps = 65/265 (24%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEM-----MKSIHHRNIIK 60
L+G+G FG V + A+K+ L+ + +V + +++ H +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTLE 111
+ S + V+EY G L +L Y +I S L+
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI----------VSALD 262
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TIQTQTL-ATIGYM 169
YLH + V++ DLK N++LD + ++DFG+ K E I +T T Y+
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYL 316
Query: 170 APE------YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWVND 218
APE YG+ V D + G+++ E + P +++F
Sbjct: 317 APEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---------- 360
Query: 219 WLPISTKEIVDPNLLSREDIHFVAK 243
I +EI P L E ++
Sbjct: 361 ---ILMEEIRFPRTLGPEAKSLLSG 382
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 69/268 (25%), Positives = 102/268 (38%), Gaps = 71/268 (26%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMM------KSIHHRNII 59
+IG+G FG V AR AVKV LQ + K + + M K++ H ++
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTL 110
+ S + VL+Y+ G L +L Y +I AS L
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----------ASAL 152
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDIS-TIQTQTL-ATI 166
YLH S +++ DLKP N+LLD H L+DFG+ K E+I T T T
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK----ENIEHNSTTSTFCGTP 203
Query: 167 GYMAPE------YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHW 215
Y+APE Y + V D + G +L E P T E+++
Sbjct: 204 EYLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------- 250
Query: 216 VNDWLPISTKEIVDPNLLSREDIHFVAK 243
I K + ++ H +
Sbjct: 251 ------ILNKPLQLKPNITNSARHLLEG 272
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-15
Identities = 66/266 (24%), Positives = 105/266 (39%), Gaps = 67/266 (25%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMM------KSIHHRNII 59
++G+G FG V + E+ AVK+ L+ V + DVEC M+ +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTL 110
++ S + V+EY+ G L ++ Y +I A L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI----------AIGL 134
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TIQTQTL-ATIGY 168
+L S +I+ DLK NV+LD ++DFG+ K E+I + T+T T Y
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKTFCGTPDY 187
Query: 169 MAPE------YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWVN 217
+APE YGK V D ++FG++L E + P DE+F
Sbjct: 188 IAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ---------- 231
Query: 218 DWLPISTKEIVDPNLLSREDIHFVAK 243
I + P +S+E +
Sbjct: 232 ---SIMEHNVAYPKSMSKEAVAICKG 254
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-15
Identities = 67/259 (25%), Positives = 104/259 (40%), Gaps = 67/259 (25%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMM------KSIHHRNII 59
++G+G FG V AR+ + ++ AVKV L+ + + DVEC M + +H +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTL 110
++ + V+E++ G L ++ S Y +I S L
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI----------ISAL 137
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TIQTQTL-ATIGY 168
+LH +I+ DLK NVLLD L+DFG+ K E I + T T T Y
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGICNGVTTATFCGTPDY 190
Query: 169 MAPE------YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWVN 217
+APE YG V D ++ G++L E P D++F
Sbjct: 191 IAPEILQEMLYGPA--V----DWWAMGVLLYEMLCGHAPFEAENEDDLFE---------- 234
Query: 218 DWLPISTKEIVDPNLLSRE 236
I E+V P L +
Sbjct: 235 ---AILNDEVVYPTWLHED 250
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 50/222 (22%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNL-QYGRVFKSFDVECEMMKSI-HHRNIIK---- 60
+GRG + VF+A + + +V VK+ + ++ + E ++++++ NII
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILD--IYQRLNIMIDVASTLEYLHFGY 117
V S ALV E++ + ++ + ++Y + +Y+ L L+Y H
Sbjct: 100 VKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCH--- 147
Query: 118 SAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTL--ATIGYMAPE-- 172
S ++H D+KP NV++D ++ L D+G+A E Q + A+ + PE
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-----EFYHPGQEYNVRVASRYFKGPELL 202
Query: 173 -----YGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE 209
Y D++S G ML RK+P F+G
Sbjct: 203 VDYQMYDYS------LDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 8e-14
Identities = 61/267 (22%), Positives = 106/267 (39%), Gaps = 68/267 (25%)
Query: 7 LIGRGGFGSVFKARLGDGMEV----AVKVFNLQYGRVFKSFDVECEM----MKSIHHRNI 58
++G+G FG VF + G + A+KV L+ + V +M + ++H I
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------STL 110
+K+ + E L+L+++ G L + + + + + L
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDL--FTR-------LSKEVMFTEEDVKFYLAELALAL 139
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDISTIQTQTL-ATIG 167
++LH S +I+ DLKP N+LLD+ H L+DFG++K + + T+
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCGTVE 191
Query: 168 YMAPE------YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHWV 216
YMAPE + + SA D +SFG+++ E T P E
Sbjct: 192 YMAPEVVNRRGHTQ----SA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTM-------- 237
Query: 217 NDWLPISTKEIVDPNLLSREDIHFVAK 243
I ++ P LS E +
Sbjct: 238 -----ILKAKLGMPQFLSPEAQSLLRM 259
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-14
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 49/212 (23%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMM------KSIHHRNII 59
+IGRG + V RL + A+KV ++ V D++ ++ +H ++
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTL 110
+ S E V+EY+ G L ++ Y +I + L
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 123
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TIQTQTL-ATIGY 168
YLH +I+ DLK NVLLD L+D+G+ K E + T T T Y
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNY 176
Query: 169 MAPE------YGKEGRVSANGDVYSFGIMLIE 194
+APE YG V D ++ G+++ E
Sbjct: 177 IAPEILRGEDYGFS--V----DWWALGVLMFE 202
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHH-RNIIKVISSC 65
IG G FG + + L VA+K+ ++ +E K + I +V
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 66 SNEEFKALVLEYMPHG-SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
++ A+VLE + G SLE + + L I I + S +EY+H S +I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129
Query: 125 DLKPSNVLL------DDNMVAHLSDFGIAK 148
D+KP N L+ ++ H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 48/215 (22%)
Query: 7 LIGRGGFGSVFKARLGDGMEV----AVKVFNLQYGRVFKSFDVECEMM-KSI-----HHR 56
++G G +G VF R G + A+KV V K+ E + +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT-IVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------S 108
++ + + E L+L+Y+ G L + H + QR
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL--FTH-------LSQRERFTEHEVQIYVGEIVL 170
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDISTIQTQTLA-T 165
LE+LH +I+ D+K N+LLD N H L+DFG++K ++ T
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER--AYDFCGT 223
Query: 166 IGYMAPE------YGKEGRVSANGDVYSFGIMLIE 194
I YMAP+ G + V D +S G+++ E
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYE 254
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 49/212 (23%)
Query: 7 LIGRGGFGSVFKARLGDGMEV-AVKVFNLQYGRVFKSFDVECEMM------KSIHHRNII 59
+IGRG + V RL + A++V ++ V D++ ++ +H ++
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTL 110
+ S E V+EY+ G L ++ Y +I + L
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 166
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TIQTQTL-ATIGY 168
YLH +I+ DLK NVLLD L+D+G+ K E + T T T Y
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNY 219
Query: 169 MAPE------YGKEGRVSANGDVYSFGIMLIE 194
+APE YG V D ++ G+++ E
Sbjct: 220 IAPEILRGEDYGFS--V----DWWALGVLMFE 245
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 60/261 (22%), Positives = 99/261 (37%), Gaps = 68/261 (26%)
Query: 7 LIGRGGFGSVFKARL----GDGMEVAVKVFNLQYGRVFKSFDVECEMM-----KSIHHRN 57
++G+GG+G VF+ R G A+KV V + D + + H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM-IVRNAKDTAHTKAERNILEEVKHPF 82
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------ST 109
I+ +I + L+LEY+ G L ++ + + M D A
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGEL--FMQ-------LEREGIFMEDTACFYLAEISMA 133
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDISTIQTQTLA-TI 166
L +LH +I+ DLKP N++L+ H L+DFG+ K + T T TI
Sbjct: 134 LGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTFCGTI 185
Query: 167 GYMAPE------YGKEGRVSANGDVYSFGIMLIETFTRKKP-----TDEIFNGEMTLKHW 215
YMAPE + + V D +S G ++ + T P + +
Sbjct: 186 EYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPPFTGENRKKTIDK------- 232
Query: 216 VNDWLPISTKEIVDPNLLSRE 236
I ++ P L++E
Sbjct: 233 ------ILKCKLNLPPYLTQE 247
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 42/236 (17%), Positives = 92/236 (38%), Gaps = 38/236 (16%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSIH---------- 54
+G G F +V+ A+ + + VA+K+ + ++ + E ++++ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 55 -HRNIIKVISS----CSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVAS 108
+I+K++ N +V E + +L + + + + I +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 109 TLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH------LSDFGIAKLLTREDISTIQTQT 162
L+Y+H +IH D+KP NVL++ ++D G A ++IQT+
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200
Query: 163 LATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVND 218
Y +PE D++S ++ E T +F + + +D
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPDEGHSYTKDD 247
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-13
Identities = 32/149 (21%), Positives = 58/149 (38%), Gaps = 15/149 (10%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHH-RNIIKVISSC 65
IG G FG +F+ L + +VA+K + E K + I V
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
LV++ + SLE L + + + ++ +H +++ D
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131
Query: 126 LKPSNVLL------DDNMVAHLSDFGIAK 148
+KP N L+ + NM+ ++ DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 47/202 (23%), Positives = 86/202 (42%), Gaps = 22/202 (10%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSIHHR------NI 58
+IG+G FG V KA VA+K+ N + R + E +++ + + N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGY 117
I ++ + + + E + +L + + + + + + L+ LH
Sbjct: 162 IHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217
Query: 118 SAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK 175
++IHCDLKP N+LL + + DFG + + + IQ++ Y APE
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVIL 272
Query: 176 EGRVSANGDVYSFGIMLIETFT 197
R D++S G +L E T
Sbjct: 273 GARYGMPIDMWSLGCILAELLT 294
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 33/166 (19%), Positives = 63/166 (37%), Gaps = 31/166 (18%)
Query: 8 IGRGGFGSVFKAR---------LGDGMEVAVKV-------FNLQ--YGRVFKSFDVECEM 49
R G +++A + ++K+ FN Q + R K V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 50 -MKSIHHRNIIKVISSCSNE-EFKALVLEYMPHG-SLEKYLHSSNY-ILDIYQRLNIMID 105
+ S I + ++ +++ LVL + G SL+ L S +L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 148
+ LE+LH + +H ++ N+ + D + V L+ +G A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 25/153 (16%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKV-------FNLQYGRVFKSFDVECEMMKSIHH-RNI 58
IG G FG ++ + G EVA+K+ L E ++ K + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI---------ESKIYKMMQGGVGI 67
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+ + ++ +V+E + SLE + + + L + + S +EY+H S
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 123
Query: 119 AQVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 148
IH D+KP N L+ + ++ DFG+AK
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-12
Identities = 35/167 (20%), Positives = 69/167 (41%), Gaps = 31/167 (18%)
Query: 7 LIGRGGFGSVFKAR------LGDGMEVAVKVFNLQYGRVF-----------KSFDVECEM 49
IG+GGFG ++ A +G VKV G +F +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 50 MKSIHHRNIIKVISS----CSNEEFKALVLEYMPHG-SLEKYLHSSNYILDIYQRLNIMI 104
+ + + + K S + + ++ ++++ G L+K ++ L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 105 DVASTLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 148
+ LEY+H + +H D+K SN+LL + + V +L D+G+A
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 35/146 (23%), Positives = 66/146 (45%), Gaps = 11/146 (7%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSC 65
IG G FG ++ + EVA+K+ N++ E ++ + + I V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
++ LV++ + SLE + + L + L + + + +E++H S +H D
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 126 LKPSNVLLDDNMVAH---LSDFGIAK 148
+KP N L+ A+ + DFG+AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-11
Identities = 38/165 (23%), Positives = 69/165 (41%), Gaps = 30/165 (18%)
Query: 7 LIGRGGFGSVFKA-RLGDGMEVAVKVFNLQ-------------YGRVFKSFDVECEM-MK 51
IG GGFG ++ A + A V ++ Y RV K ++ + K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 52 SIHHRNIIKVISS----CSNEEFKALVLEYMPHG-SLEKYLHSSNYILDIYQRLNIMIDV 106
+ + I S ++ +V+E + G L+K N L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGIRM 160
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 148
LEY+H + +H D+K +N+LL + + V +L+D+G++
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 5 NNLIGRGGFGSVFKAR-LGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSIHHR------ 56
++LIG+G FG V KA + VA+K+ N + +E +++ ++
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHF 115
I+ + LV E + +L L ++N+ + + + + L +L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA- 174
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173
+IHCDLKP N+LL + + + DFG + L + IQ++ Y +PE
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEV 229
Query: 174 GKEGRVSANGDVYSFGIMLIETFT 197
D++S G +L+E T
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 4e-09
Identities = 34/188 (18%), Positives = 58/188 (30%), Gaps = 52/188 (27%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKV--------FNLQYGRVFKSFDVECEMMKSIHH---- 55
IG G FG VF+ D VA+K+ N + + F+ E + K +
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 56 -----------RNIIKVISSCSNEEFKA------------------------LVLEYMPH 80
++ V S KA +VLE+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH 140
G + + + + + +I+ + ++L + H DL NVLL +
Sbjct: 147 GIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKK 202
Query: 141 LSDFGIAK 148
L K
Sbjct: 203 LHYTLNGK 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-08
Identities = 42/228 (18%), Positives = 83/228 (36%), Gaps = 56/228 (24%)
Query: 7 LIGRGGFGSVFKA--RLGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSIHHR------N 57
+G G FG V + +VA+K+ N+ + ++ +E ++K I +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFL 83
Query: 58 IIKVISS-------CSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVAST 109
+ + C + E + + ++L +N+ + ++ +
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 110 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA---KLLTREDI-------STIQ 159
L +LH Q+ H DLKP N+L ++ L + + K + I +T
Sbjct: 136 LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 160 TQTLATI----GYMAPE------YGKEGRVSANGDVYSFGIMLIETFT 197
+ TI Y PE + + DV+S G +L E +
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 53/232 (22%), Positives = 87/232 (37%), Gaps = 60/232 (25%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSI-----HHRNII 59
+G G FG V + + + AVKV N++ + +S +E +++K I ++ NI+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 60 KVISS-------CSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLE 111
K C L+ E + SL + + +NY I I++ L
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 112 YLHFGYSAQVIHCDLKPSNVLLDDN---------MVAHLSDFGIAKLLTREDI------- 155
YL + H DLKP N+LLDD I
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 156 STIQTQTLATI----GYMAPE------YGKEGRVSANGDVYSFGIMLIETFT 197
+T ++ +I Y APE + + D++SFG +L E +T
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYT 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 44/221 (19%), Positives = 88/221 (39%), Gaps = 42/221 (19%)
Query: 7 LIGRGGFGSVFKA--RLGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSIHHR------N 57
+G G FG V + G VAVK+ N+ R ++ E ++++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFG 116
++++ + +V E + S ++ + ++ + + + ++ +LH
Sbjct: 79 CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH-- 135
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA---KLLTREDI-------STIQTQTLATI 166
S ++ H DLKP N+L + + I + L DI +T + +T+
Sbjct: 136 -SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL 194
Query: 167 ----GYMAPE------YGKEGRVSANGDVYSFGIMLIETFT 197
Y APE + S DV+S G +LIE +
Sbjct: 195 VSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 64/370 (17%), Positives = 118/370 (31%), Gaps = 129/370 (34%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVF-NLQYGRVFKSFDVECEMMKSIH--------HRN 57
+G G F +V+ + + VA+KV + ++ ++ E ++KS+
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT--ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 58 IIKVISSCSNEEFK---------ALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVA 107
+++++ ++FK +V E + H L K++ SNY L + I+ V
Sbjct: 103 VVQLL-----DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 108 STLEYLHFGYSAQVIHCDLKPSNVLL---------------------------------- 133
L+YLH ++IH D+KP N+LL
Sbjct: 157 QGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 134 ---------------DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR 178
+ + ++D G A + + IQT+ Y + E
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSG 269
Query: 179 VSANGDVYSFGIMLIETFT------------------------------------RKKPT 202
+ D++S M E T K +
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 203 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESP 262
E F + LKH + +V+ S+E+ F+ + P
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE-----AAGFTDFL----LPMLELIP 380
Query: 263 EQRINAKEIV 272
E+R A E +
Sbjct: 381 EKRATAAECL 390
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 6e-06
Identities = 32/202 (15%), Positives = 59/202 (29%), Gaps = 41/202 (20%)
Query: 33 NLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG-----SLE--- 84
N+Q + + +F++ C+++ + R +V S + L++
Sbjct: 252 NVQNAKAWNAFNLSCKIL--LTTRF-KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 85 KYLHSSNY-----ILDIYQRLNIMI-----DVASTLE-YLHFGYSA--QVIHCDLKPSNV 131
KYL +L R +I D +T + + H +I L NV
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NV 365
Query: 132 LLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI---------GYMAPEYGKEGRVSAN 182
L + I T L+ I + + K V
Sbjct: 366 LEPAEYRKMFDRLSV----FPPSAH-IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 183 GDVYSFGIMLIETFTRKKPTDE 204
+ I I + K +E
Sbjct: 421 PKESTISIPSIYLELKVKLENE 442
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 285 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.81 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.77 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.64 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.49 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.31 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.13 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.12 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.83 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.79 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.76 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.7 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.68 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.55 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.77 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.42 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.67 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.55 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.78 | |
| 3eps_A | 578 | Isocitrate dehydrogenase kinase/phosphatase; ATP-b | 80.28 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=392.05 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=215.8
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|.+.+.||+|+||+||+|.+. +++.||||+++..+....+.+.+|++++++++||||+++++++.+++.+++|
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3667899999999999999742 4788999999877777778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCC------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEe
Q 039392 75 LEYMPHGSLEKYLHSSN------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS 142 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~ 142 (285)
|||+++|+|.+++.+.+ ..+++..++.++.|++.||+||| +++++||||||+|||+++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEEC
Confidence 99999999999996542 34899999999999999999999 9999999999999999999999999
Q ss_pred eeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcC
Q 039392 143 DFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLP 221 (285)
Q Consensus 143 df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 221 (285)
|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+.. .......
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~-~~i~~~~-- 247 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-ECITQGR-- 247 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHHTC--
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCC--
Confidence 9999987655443333344568999999999999999999999999999999998 89999775433221 1111100
Q ss_pred CCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 222 ISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
....+..+++++.+|+.+||+.||++|||++++++.|+++.+.
T Consensus 248 -----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 248 -----------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0111345678899999999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-60 Score=391.48 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=207.9
Q ss_pred CCCCceecccCceEEEEEEeC------CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+.+.++||+|+||+||+|++. +++.||||+++..+....+.|.+|++++++++||||+++++++.+.+.+++||
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 122 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 445688999999999999753 47889999998777777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCC--------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEE
Q 039392 76 EYMPHGSLEKYLHSSN--------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL 141 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i 141 (285)
||+++|+|.+++.+.. .++++..++.++.|++.||+||| +++++||||||+|||++.++.+||
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEE
Confidence 9999999999986532 34889999999999999999999 999999999999999999999999
Q ss_pred eeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhc
Q 039392 142 SDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWL 220 (285)
Q Consensus 142 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 220 (285)
+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+.. ......
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~-~~i~~g-- 276 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-DCITQG-- 276 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH-HHHHHT--
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcC--
Confidence 99999987655433334445678999999999999999999999999999999999 89999765432221 111110
Q ss_pred CCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 221 PISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.+...+..+++++.+++.+||+.||++|||++|++++|+.+.+.
T Consensus 277 -----------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 277 -----------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -----------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 01112345778899999999999999999999999999998763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=384.48 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=207.5
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+++.+.||+|+||+||+|++.+ .||||+++.. +....+.+.+|++++++++||||+++++++.+ +.+++||||++
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 5678899999999999998643 5999998643 34556789999999999999999999998865 46889999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+|+|.+++......+++..+..++.|++.||+||| +++++||||||+|||+++++.+||+|||+++...........
T Consensus 115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 99999999776667999999999999999999999 999999999999999999999999999999876544333334
Q ss_pred ccccccccccCCcccCCC---ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 160 TQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....||+.|+|||++.+. .++.++|||||||++|||+||+.||.+..+.................
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~------------ 259 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL------------ 259 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS------------
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc------------
Confidence 556799999999988643 58999999999999999999999997654433222222111111110
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...+..+++++.+++.+||+.||++|||++|+++.|+.|+.++
T Consensus 260 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 260 ---SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ---TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ---ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 0113456788999999999999999999999999999988654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-60 Score=393.15 Aligned_cols=248 Identities=24% Similarity=0.299 Sum_probs=210.3
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.++||+|+||+||+|.. .+|+.||||++........+.+.+|+++++.++||||+++++++...+.+|+|||||+|
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 77889999999999999975 47999999999876655556788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
|+|.+++.+. .+++..++.++.||+.||+||| ++||+||||||+|||++.+|.+||+|||++....... ....
T Consensus 156 g~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~ 228 (346)
T 4fih_A 156 GALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 228 (346)
T ss_dssp EEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBC
T ss_pred CcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cccc
Confidence 9999999764 3999999999999999999999 9999999999999999999999999999998775432 2234
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ .......... ..+
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~-----------------~~~ 290 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLP-----------------PRL 290 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSSC-----------------CCC
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCC-----------------CCC
Confidence 5679999999999999999999999999999999999999997643222 1111111110 011
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+++++.+||.+||..||++|||++|++++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1134567889999999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-60 Score=388.09 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=210.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++++.||+|+||+||+|+. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++++.+.+|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 488999999999999999975 579999999997542 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++||+|.+++.+.+. +++..++.++.||+.||+||| ++||+||||||+|||++.+|.+||+|||++..+......
T Consensus 113 y~~gG~L~~~i~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred cCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999977654 999999999999999999999 999999999999999999999999999999987654434
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+. ..........
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~~~~~--------------- 252 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-FAKIIKLEYD--------------- 252 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC---------------
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCC---------------
Confidence 444567899999999999999999999999999999999999999976432221 1111111110
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+..+++++.+||.+||..||++|||++|++.+
T Consensus 253 -----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 -----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -----CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 122456779999999999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-60 Score=392.23 Aligned_cols=249 Identities=20% Similarity=0.339 Sum_probs=203.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+.+|+||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 478899999999999999975 579999999997542 34567789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+||+|.+++.... ..+++..++.++.||+.||+||| ++||+||||||+|||++.+|.+||+|||+++......
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 179 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-- 179 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--
Confidence 99999999996543 34789999999999999999999 9999999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.. ........+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-~~i~~~~~~--------------- 243 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-LKIISGSFP--------------- 243 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHTCCC---------------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-HHHHcCCCC---------------
Confidence 1223457999999999999999999999999999999999999999764332221 111111110
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..+++++.+||.+||+.||.+|||++|+|++
T Consensus 244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0123456779999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=385.52 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=208.3
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.++||+|+||+||+|++ .+|+.||||+++.... ..+|+.+++.++||||+++++++.+++.+|+||||++|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 45567899999999999985 4799999999975432 24699999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-cEEEeeeccceecCccccc---
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDIS--- 156 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~i~df~~~~~~~~~~~~--- 156 (285)
|+|.+++.+.+. +++..++.++.||+.||+||| ++||+||||||+|||++.+| .+||+|||++.........
T Consensus 135 g~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 135 GSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 999999976654 999999999999999999999 99999999999999999887 6999999999877543221
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+..... .....
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-~~~~~---------------- 273 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI-ASEPP---------------- 273 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH-HHSCC----------------
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-HcCCC----------------
Confidence 1223457999999999999999999999999999999999999999765443322211 11000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
.....+..+++++.++|.+||+.||.+|||++|++++|...++..
T Consensus 274 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 274 -PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 000123456788999999999999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-59 Score=394.57 Aligned_cols=248 Identities=24% Similarity=0.315 Sum_probs=210.0
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|+.++||||+++++++...+.+|+|||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 77889999999999999975 47999999999876655567788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
|+|.+++.... +++..+..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||++..+.... ....
T Consensus 233 G~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~ 305 (423)
T 4fie_A 233 GALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 305 (423)
T ss_dssp EEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBC
T ss_pred CcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cccc
Confidence 99999997543 999999999999999999999 9999999999999999999999999999998775432 2234
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+. .......... .+
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~~~~~-----------------~~ 367 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLPP-----------------RL 367 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCC-----------------CC
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCCC-----------------CC
Confidence 56799999999999999999999999999999999999999976432221 1111111100 01
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+++++.+||.+||..||.+|||++|+|++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1123467789999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-59 Score=383.24 Aligned_cols=254 Identities=25% Similarity=0.445 Sum_probs=209.7
Q ss_pred CCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+++.++||+|+||+||+|.+ .+++.||||.++... ....+.|.+|+.++++++||||+++++++..++.+++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 35678999999999999974 246889999986543 33457799999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcE
Q 039392 75 LEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVA 139 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~ 139 (285)
|||+++|+|.+++.... ..+++..++.++.||+.||+||| +++++||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence 99999999999985431 24888999999999999999999 9999999999999999999999
Q ss_pred EEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhh
Q 039392 140 HLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVND 218 (285)
Q Consensus 140 ~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 218 (285)
||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....+.. ......
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~-~~i~~~ 263 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV-EMIRNR 263 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH-HHHHTT
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcC
Confidence 9999999987655443334455678999999999999999999999999999999998 89999765432221 111100
Q ss_pred hcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 219 WLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
...+.+..++.++.+++.+||+.||.+|||++||++.|++.
T Consensus 264 -------------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 264 -------------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01112446788899999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=373.94 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=199.3
Q ss_pred CCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceecc----CCceEEEE
Q 039392 3 SENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSN----EEFKALVL 75 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~ 75 (285)
++.++||+|+||+||+|.+ .++..||+|++.... ....+.+.+|++++++++||||+++++++.. ...+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4566899999999999975 468999999986543 3445778999999999999999999999854 45689999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeC-CCCcEEEeeeccceecCc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~di~~~nili~-~~~~~~i~df~~~~~~~~ 152 (285)
||++||+|.+++.+... +++..++.++.||+.||+||| +++ ++||||||+|||++ .+|.+||+|||+++....
T Consensus 109 Ey~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999976554 999999999999999999999 888 99999999999998 489999999999975433
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..+.............+
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~----------- 248 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------- 248 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-----------
Confidence 2 2234679999999998865 69999999999999999999999997643332222221111100
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+..+++++.+||.+||..||++|||++|++++
T Consensus 249 -------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01123456779999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=370.85 Aligned_cols=245 Identities=23% Similarity=0.372 Sum_probs=192.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 589999999999999999975 579999999987542 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+ +|+|.+++.+.+. +++..++.++.||+.||+||| ++|++||||||+||+++.+|.+||+|||+++......
T Consensus 94 y~-~g~L~~~l~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp CC-CEEHHHHHHHSCS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CC-CCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 99 6699999876654 999999999999999999999 9999999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+..... ...........
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-~~~~i~~~~~~-------------- 230 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGVYT-------------- 230 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC--------------
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCC--------------
Confidence 2234679999999999988875 689999999999999999999997632221 11111111110
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+..+++++.+|+.+||+.||++|||++|++++
T Consensus 231 ------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 ------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 123456779999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-58 Score=375.64 Aligned_cols=247 Identities=24% Similarity=0.311 Sum_probs=197.9
Q ss_pred CCCCCceecccCceEEEEEEe----CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++++.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++.+++.+|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 488999999999999999974 257889999987543 12234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
|||++||+|.+++.+... +++..++.++.||+.||+||| ++|++||||||+|||++.+|.+||+|||+++......
T Consensus 105 mEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp ECCCTTCEEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEcCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999999999977654 999999999999999999999 9999999999999999999999999999998654332
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+. .........
T Consensus 181 --~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~-------------- 243 (304)
T 3ubd_A 181 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-MTMILKAKL-------------- 243 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC--------------
T ss_pred --ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-HHHHHcCCC--------------
Confidence 222456799999999999999999999999999999999999999976433222 111111110
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCH-----HHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~eil~~ 274 (285)
..+..+++++.+||++||+.||++|||+ +|++++
T Consensus 244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0123457789999999999999999984 677753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=372.98 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=212.2
Q ss_pred CCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCC-Cccccccceecc-CCceE
Q 039392 2 FSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHH-RNIIKVISSCSN-EEFKA 72 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~-~~~~~ 72 (285)
|++++.||+|+||+||+|.+. +++.||+|.+.... ....+.+.+|++++.++.| |||+++++++.. ++.++
T Consensus 66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~ 145 (353)
T 4ase_A 66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 145 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence 567889999999999999742 24679999987544 3345678899999999965 899999999865 45689
Q ss_pred EEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 039392 73 LVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM 137 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~ 137 (285)
+|||||++|+|.+++.... ..+++..++.++.||+.||+||| +++++||||||+|||+++++
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCCCC
Confidence 9999999999999996532 23789999999999999999999 99999999999999999999
Q ss_pred cEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhh
Q 039392 138 VAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWV 216 (285)
Q Consensus 138 ~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 216 (285)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....+.......
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~ 302 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999987755443444455678999999999999999999999999999999998 8999977544333222221
Q ss_pred hhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 217 NDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
... ++..+..+++++.+++.+||+.||.+|||+++++++|+++.+.
T Consensus 303 ~g~-------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 303 EGT-------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC-------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 111 1112345677899999999999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=364.35 Aligned_cols=270 Identities=24% Similarity=0.327 Sum_probs=198.9
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCC----ceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE----FKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~ 77 (285)
|.+.+.||+|+||+||+|++ +|+.||||++...... ......|+..+.+++||||+++++++..++ .+++||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 56778999999999999987 5899999998754332 122334566667889999999999987653 57899999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCC--------CeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA--------QVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~--------~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
+++|+|.+++.... ++...+..++.|++.||+||| ++ +++||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 83 HEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999997654 889999999999999999999 55 999999999999999999999999999987
Q ss_pred cCccccc--ceeccccccccccCCcccCCC------ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcC
Q 039392 150 LTREDIS--TIQTQTLATIGYMAPEYGKEG------RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221 (285)
Q Consensus 150 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (285)
....... .......||+.|+|||++.+. .++.++|||||||++|||+||..||......+..........
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~-- 235 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD-- 235 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS--
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc--
Confidence 6543221 122345799999999988754 478899999999999999999887754332222111110000
Q ss_pred CCccc----cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 222 ISTKE----IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 222 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
..... .......+..+ .......++..+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCC-GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhcccCCCCCC-ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 00000 00000000000 1111234667899999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-55 Score=359.31 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=189.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCC---------
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE--------- 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 69 (285)
+|++++.||+|+||+||+|++ .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 478899999999999999975 479999999987544 344567889999999999999999999986543
Q ss_pred ---ceEEEEeccCCCCHHHhhhcCCC--ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 70 ---FKALVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 70 ---~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
.+|+|||||++++|.+++..... ..+...++.++.||+.||+||| ++|++||||||+|||++.+|.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccC
Confidence 37899999999999999976543 2456678899999999999999 999999999999999999999999999
Q ss_pred ccceecCccccc----------ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhh
Q 039392 145 GIAKLLTREDIS----------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 145 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (285)
|+++........ .......||+.|+|||++.+..++.++|||||||++|+|++ ||............
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 999876543211 11233569999999999999999999999999999999996 76542211111111
Q ss_pred hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 215 WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ... . .......++.+.+|+++||+.||++|||++|++++
T Consensus 240 ~~----~~~---------~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 240 VR----NLK---------F------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH----TTC---------C------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Hh----cCC---------C------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 10 000 0 01123445667899999999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=357.85 Aligned_cols=264 Identities=19% Similarity=0.266 Sum_probs=199.0
Q ss_pred CCCCceecccCceEEEEEEe----CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|++.+.||+|+||+||+|+. .+++.||+|.+..... ...+.+|+++++.+ +||||+++++++...+.+|+|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 88999999999999999964 3578899998865433 24577899999988 69999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~i~df~~~~~~~~~~~ 155 (285)
|+++++|.+++. .+++..++.++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 101 ~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 101 YLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred CCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 999999999984 3889999999999999999999 9999999999999999876 8999999999986543221
Q ss_pred c--------------------------ceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCcccccc
Q 039392 156 S--------------------------TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNG 208 (285)
Q Consensus 156 ~--------------------------~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 208 (285)
. .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||....+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 1 112234699999999988775 5899999999999999999999999654433
Q ss_pred chhhhhhhhhhc----------------------CCCccccc------------cccccCcccchhhhhhHhHHHHHHhh
Q 039392 209 EMTLKHWVNDWL----------------------PISTKEIV------------DPNLLSREDIHFVAKEQCVSFVFNVA 254 (285)
Q Consensus 209 ~~~~~~~~~~~~----------------------~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li 254 (285)
............ ........ .................+++++.+|+
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 222222111000 00000000 00000001111122345678899999
Q ss_pred hcccccCcCCCCCHHHHHHH
Q 039392 255 MECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 255 ~~~l~~~p~~Rps~~eil~~ 274 (285)
++||..||++|||++|+|++
T Consensus 334 ~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHTS
T ss_pred HHHCcCChhHCcCHHHHhcC
Confidence 99999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=360.49 Aligned_cols=267 Identities=26% Similarity=0.286 Sum_probs=203.1
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceecc------CCceE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSN------EEFKA 72 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~ 72 (285)
|++++.||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|+++|+.++||||+++++++.. .+.+|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 78889999999999999975 579999999986433 3344668899999999999999999998753 46789
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+||||++ |+|.+++.+.. .+++..++.++.||+.||.||| ++|++||||||+|||++.+|.+||+|||+++.+..
T Consensus 136 ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 9999996 57999987655 4999999999999999999999 99999999999999999999999999999987643
Q ss_pred cc--ccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 153 ED--ISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 153 ~~--~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
.. .........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+....+ ............+......
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCGGGTC-
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCChHHhhh
Confidence 21 12223456899999999998775 57999999999999999999999997643322 2222222221111111000
Q ss_pred c----------cccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 P----------NLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~----------~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ......+..+ .....+++++.+||.+||..||.+|||++|+|++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000000111 0113457889999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=374.97 Aligned_cols=251 Identities=18% Similarity=0.251 Sum_probs=211.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++++.||+|+||+||+|.. .+|+.||+|++........+.+.+|+++|+.++||||+++++++.....+++||||++
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 478899999999999999975 5799999999987666666778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCcEEEeeeccceecCcccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~--~~~~~i~df~~~~~~~~~~~~~ 157 (285)
||+|.+++......+++..+..++.||+.||.||| ++|++||||||+||+++. .+.+||+|||++..+....
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--- 311 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---
Confidence 99999998766666999999999999999999999 999999999999999985 4899999999999876532
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+. ...........
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~~~--------------- 375 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNM--------------- 375 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCCC---------------
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCCCC---------------
Confidence 22345799999999999999999999999999999999999999976433222 11111111100
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+++++.+||++||+.||.+|||++|+|++
T Consensus 376 -~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 -DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011133567789999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=367.33 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHH---HHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFK---SFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++++.||+|+||+||+|+. .+|+.||+|++.... ..... ....++.+++.++||||++++++|++.+.+|+
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 488999999999999999975 479999999996432 11112 22345677888899999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
||||++||+|.+++.+.+. +++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++......
T Consensus 270 VmEy~~GGdL~~~l~~~~~-l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EECCCCSCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999999977654 999999999999999999999 999999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
. ....+||+.|+|||++.. ..++.++|+|||||++|+|++|..||.+....... .........
T Consensus 346 ~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i~~~----------- 409 (689)
T 3v5w_A 346 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTM----------- 409 (689)
T ss_dssp C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHHHHC-----------
T ss_pred C----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhcCC-----------
Confidence 2 234679999999999864 57999999999999999999999999764332221 100000000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
....+..+++++.+||.+||..||.+|++ ++|++++
T Consensus 410 ------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 410 ------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 00112346778999999999999999998 6887654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=332.21 Aligned_cols=271 Identities=33% Similarity=0.529 Sum_probs=221.5
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||+||+|...+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++|||++++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 58899999999999999999888999999998877666678889999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCC---CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 81 GSLEKYLHSSN---YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++|.+++.... ..++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++..........
T Consensus 120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99999986543 24889999999999999999999 9999999999999999999999999999998755433233
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccch-hhhhhhhh-hcCCCccccccccccCc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM-TLKHWVND-WLPISTKEIVDPNLLSR 235 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (285)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+. ....+... ..........++..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 273 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL--- 273 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC---
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh---
Confidence 33445578999999999888999999999999999999999999976543322 11111111 11111111122111
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
.......++..+.+++.+||..||++|||+++++++|+.+++
T Consensus 274 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 274 ---ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp ---TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 111245678889999999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=334.37 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=216.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++++.||+|+||+||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++|||+++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 477889999999999999975 4689999999876666777889999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc--
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST-- 157 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~-- 157 (285)
+++|.+++......++...++.++.|++.||+||| ++|++|+||||+||+++.++.++|+|||++..........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999999886667999999999999999999999 9999999999999999999999999999998765432211
Q ss_pred ----------eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 158 ----------IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 158 ----------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.............
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~------------ 235 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN------------ 235 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC------------
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh------------
Confidence 0114568999999999999999999999999999999999999986533221111000
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
.........+..+++++.+++.+||..||.+|||++++++.|++++..+
T Consensus 236 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 236 ------VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ------HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0000111113455677999999999999999999999999999998765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=330.88 Aligned_cols=249 Identities=27% Similarity=0.326 Sum_probs=209.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||+++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 489999999999999999974 5799999999987666566778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++.... ++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 101 ~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 173 (297)
T 3fxz_A 101 GGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 173 (297)
T ss_dssp TCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CB
T ss_pred CCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--cc
Confidence 999999997653 899999999999999999999 99999999999999999999999999999987654322 22
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+++.|+|||.+.+..++.++||||||+++|+|++|..||.................. .
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------------~ 235 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP------------------E 235 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC------------------C
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------C
Confidence 3457899999999999999999999999999999999999999764332221111111000 0
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+..+..++..+.+++.+||..||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11134567779999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=335.58 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=213.0
Q ss_pred CCCCCceecccCceEEEEEEe--------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCc
Q 039392 1 GFSENNLIGRGGFGSVFKARL--------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEF 70 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~--------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 70 (285)
+|++++.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 367789999999999999974 235679999987543 34457788999999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 039392 71 KALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~ 135 (285)
+++||||+++++|.+++.... ..++...++.++.||+.||.||| ++|++||||||+||+++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECC
Confidence 999999999999999987643 23788999999999999999999 999999999999999999
Q ss_pred CCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhh
Q 039392 136 NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 136 ~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 214 (285)
++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.. ..
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-~~ 317 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-KL 317 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HH
Confidence 99999999999987665433233334556788999999999999999999999999999999 99998764322211 11
Q ss_pred hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 215 WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
..... ....+..++.++.+++.+||..||.+|||++++++.|+++.....
T Consensus 318 ~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 318 LKEGH-------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHTTC-------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HhcCC-------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11000 001123466779999999999999999999999999999987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=330.87 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=210.2
Q ss_pred CCCCceecccCceEEEEEEeC----CCcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|++.+.||+|+||+||+|... .+..||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence 677899999999999999753 3456999998754 34455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++......++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.........
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 99999999999776666999999999999999999999 999999999999999999999999999999877553222
Q ss_pred -ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 157 -TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 157 -~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... .... .
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~~~-~-------------- 271 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEG-Y-------------- 271 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTT-C--------------
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcC-C--------------
Confidence 12223445778999999988899999999999999999999 9999976433222111 1110 0
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
....+..++.++.+++.+||..||.+|||++++++.|+++.++
T Consensus 272 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 ----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0111235667799999999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=330.43 Aligned_cols=272 Identities=24% Similarity=0.313 Sum_probs=209.4
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCC----ceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE----FKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e 76 (285)
+|++.+.||+|+||+||+|... ++.||+|++..... ......+|+.+++.++||||+++++++.... .+++|||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 4788999999999999999875 79999999875433 3344556888999999999999999987644 4689999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCC----------CeeecCCCCCCeeeCCCCcEEEeeecc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA----------QVIHCDLKPSNVLLDDNMVAHLSDFGI 146 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~----------~~~h~di~~~nili~~~~~~~i~df~~ 146 (285)
++++++|.+++.... ++...++.++.|++.||.||| +. |++|+||||+||+++.++.+||+|||+
T Consensus 103 ~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 103 FHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999997644 899999999999999999999 88 999999999999999999999999999
Q ss_pred ceecCcccccceeccccccccccCCcccCC-----CccCcchhhHHHHHHHHHHhhCCCCCccccccchh-hhhhhhhhc
Q 039392 147 AKLLTREDISTIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT-LKHWVNDWL 220 (285)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~ 220 (285)
+................+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......... .......
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-- 255 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ-- 255 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS--
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc--
Confidence 987765443333344678999999998876 35678899999999999999999999764332111 1100000
Q ss_pred CCCcccc---ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 221 PISTKEI---VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 221 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
....... ..................++.++.+++.+||..||++|||++++++.|+++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000 000000011111122345677899999999999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=329.84 Aligned_cols=257 Identities=28% Similarity=0.412 Sum_probs=203.3
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||+||+|.. +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||++
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence 477889999999999999987 58899999986543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCC--ccCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 79 PHGSLEKYLHSSNY--ILDIYQRLNIMIDVASTLEYLHFGYSAQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 79 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
++++|.+++..... .++...++.++.|++.||+||| ++| ++|+||||+||+++.++.++|+|||++.......
T Consensus 117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99999999976542 3889999999999999999999 999 9999999999999999999999999997554321
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+...... ....
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~-------------- 256 (309)
T 3p86_A 194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKCK-------------- 256 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-HSCC--------------
T ss_pred --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCC--------------
Confidence 12234568999999999999999999999999999999999999997643322211110 0000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
....+..+++++.+++.+||..||.+|||++++++.|+.+.++.
T Consensus 257 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 ----RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 00112345677999999999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=323.46 Aligned_cols=257 Identities=27% Similarity=0.426 Sum_probs=213.4
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++......++|||++++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 4778899999999999999988889999999875432 235688999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++......++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 165 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSST 165 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTT
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccccc
Confidence 9999999777667999999999999999999999 9999999999999999999999999999998665432 12223
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+.. ........
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-~~~~~~~~------------------- 225 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFR------------------- 225 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHTTCC-------------------
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH-HHHhcCcc-------------------
Confidence 4456778999999988899999999999999999999 99998764332211 11111000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...+...+.++.+++.+||..||.+|||+++++++|+++.++-
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 0012234667999999999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=339.71 Aligned_cols=257 Identities=30% Similarity=0.451 Sum_probs=212.3
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||+++
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 567889999999999999865 78999999987543 3344678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++......++...++.++.|++.||+||| ++|++||||+|+||+++.++.+||+|||++............
T Consensus 196 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 99999999876666899999999999999999999 999999999999999999999999999999865443222211
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. .......
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~--~~~~~~~------------------ 332 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--EFVEKGG------------------ 332 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH--HHHHTTC------------------
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHcCC------------------
Confidence 22335677999999988899999999999999999998 99998764332211 1111000
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
....+..++.++.+++.+||..||.+|||++++++.|+++++.
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0111334677899999999999999999999999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=323.37 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=212.8
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||.||++...++..||+|++..... ..+.+.+|+++++.++||||+++++++......++|||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 4778899999999999999988888999999875432 336688999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++......++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~ 163 (268)
T 3sxs_A 88 GCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSV 163 (268)
T ss_dssp CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECC
T ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hccc
Confidence 9999999876666999999999999999999999 99999999999999999999999999999987655432 2223
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...+++.|+|||.+.+..++.++||||||+++++|++ |..||............. ....
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~------------------- 223 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHR------------------- 223 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCC-------------------
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCC-------------------
Confidence 4456778999999988899999999999999999999 999987643332221110 0000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
...+...++++.+++.+||..||.+|||++++++.|+.++++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000223456799999999999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=331.26 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=205.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||+
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 588999999999999999985 579999999987542 34556788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++++|.+++..... +++..++.++.|++.||.||| ++|++||||||+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--- 168 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--- 168 (328)
T ss_dssp CTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred CCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence 999999999876554 899999999999999999999 9999999999999999999999999999997665432
Q ss_pred eeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+....+.. .........
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~--------------- 232 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-ERVLRGKYR--------------- 232 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCC---------------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCC---------------
Confidence 2245678999999999988776 48999999999999999999999764322211 111111000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+..+++++.+++++||..||.+|||+++++++
T Consensus 233 -----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 -----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 122346678999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=328.44 Aligned_cols=273 Identities=26% Similarity=0.428 Sum_probs=210.7
Q ss_pred CCCCCceecccCceEEEEEEe-----CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc--CCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-----GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 73 (285)
.|++.+.||+|+||+||+++. .+++.||+|++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 377889999999999999973 3688999999987777777889999999999999999999998854 456899
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|||++++++|.+++......++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 99999999999999877666999999999999999999999 999999999999999999999999999999876543
Q ss_pred ccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc--c
Q 039392 154 DIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD--P 230 (285)
Q Consensus 154 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 230 (285)
... .......++..|+|||.+.+..++.++||||||+++++|++|..|+........ ... .......... .
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMI---GNDKQGQMIVFHL 241 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH---HHH---CTTCCTHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH---hhh---cCccccchhHHHH
Confidence 221 222334567779999999988999999999999999999999999865321100 000 0000000000 0
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
............+..+++++.+++.+||..||.+|||++++++.|+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0000000111224466788999999999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=325.18 Aligned_cols=267 Identities=36% Similarity=0.568 Sum_probs=213.1
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchh-HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|+||+||+|...+++.||+|++...... ....+.+|+++++.++||||+++++++...+..++|||+++
T Consensus 31 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 110 (326)
T 3uim_A 31 NFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 110 (326)
T ss_dssp SSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCT
T ss_pred ccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEecc
Confidence 58999999999999999998878999999998754322 22357889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCC---CccCHHHHHHHHHHHHHHHHHHhcCCCC---CeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 80 HGSLEKYLHSSN---YILDIYQRLNIMIDVASTLEYLHFGYSA---QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 80 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~---~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
+++|.+++.... ..++...++.++.|++.||.||| +. |++|+||||+||+++.++.++|+|||++......
T Consensus 111 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 111 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp TCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence 999999987643 24889999999999999999999 77 9999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccc---cchhhhhhhhhhcC-CCcccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFN---GEMTLKHWVNDWLP-ISTKEIVD 229 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~ 229 (285)
. ........+++.|+|||.+.+..++.++||||||+++|+|++|..||+.... .......+...... .......+
T Consensus 188 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 3uim_A 188 D-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266 (326)
T ss_dssp S-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC
T ss_pred c-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC
Confidence 2 2223445689999999999888899999999999999999999999964221 11122222222111 11111111
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
... ........+..+.+++.+||+.||.+|||+++++++|+.
T Consensus 267 ~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 267 VDL------QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTC------TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhh------ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 111 112245677889999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=328.88 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=206.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|||++
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 5889999999999999999754 789999999865432 23356789999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++++|.+++..... +++..++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++...........
T Consensus 88 ~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 88 SGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp TTEEGGGGSBTTTB-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 99999999876544 999999999999999999999 99999999999999999999999999999987654333333
Q ss_pred eccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||............+......
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 227 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------- 227 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----------------
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----------------
Confidence 345678999999999887765 889999999999999999999997654433333322211110
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......++.++.+|+.+||..||.+|||++|++++
T Consensus 228 --~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01123456778999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=321.76 Aligned_cols=256 Identities=23% Similarity=0.402 Sum_probs=209.9
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||.||++...++..||+|++..... ..+.+.+|+++++.++||||+++++++...+..++|||++++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 3677899999999999999988888999999875432 235688999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++......++...++.++.|++.||.+|| ++|++|+||||+||+++.++.++|+|||++....... .....
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 179 (283)
T 3gen_A 104 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSV 179 (283)
T ss_dssp CBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTT
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccccc
Confidence 9999999875566999999999999999999999 9999999999999999999999999999998665432 11223
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||........... ......
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~------------------- 239 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLR------------------- 239 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCC-------------------
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-HhcccC-------------------
Confidence 3456778999999988889999999999999999998 9999976443222111 111000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
...+...++.+.+++.+||..||.+|||+++++++|+++.++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 001223456789999999999999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=330.35 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=206.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchh------HHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGR------VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
.|++++.||+|+||.||++... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4788999999999999999754 6899999998754321 34678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----cEEEeeecccee
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKL 149 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~i~df~~~~~ 149 (285)
|||++++++|.+++.... .+++..++.++.||+.||.||| +.|++|+||||+||+++.++ .++|+|||++..
T Consensus 93 v~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999999997654 4999999999999999999999 99999999999999998776 799999999987
Q ss_pred cCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+....+. .........
T Consensus 169 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~i~~~~~--------- 235 (361)
T 2yab_A 169 IEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITAVSY--------- 235 (361)
T ss_dssp CCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCC---------
T ss_pred cCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCC---------
Confidence 65432 22345689999999999998999999999999999999999999976332211 111111100
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........++.++.+||.+||..||.+|||+++++++
T Consensus 236 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 -------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111234567789999999999999999999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=326.69 Aligned_cols=250 Identities=19% Similarity=0.281 Sum_probs=208.0
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|+||+||++... +++.+|+|++.... .....+.+|+++++.++||||+++++++...+..++|||+++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4788999999999999999754 68899999987543 344668899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCcEEEeeeccceecCcccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~--~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++|.+++......+++..++.++.|++.||.||| ++|++|+||||+||+++. ++.++|+|||++.......
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--- 158 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---
Confidence 99999999776656999999999999999999999 999999999999999986 7899999999998775432
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+. ..........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~---------------- 221 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNAEYT---------------- 221 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCC----------------
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHHHcCCCC----------------
Confidence 22345688999999999988899999999999999999999999976432221 1111111110
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........++.++.+++.+||..||.+|||++|++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111133567789999999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=321.52 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=206.4
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||+||+|...+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||++
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 378899999999999999998889999999986543 233466789999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++ +|.+.+......+++..++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 102 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~ 175 (311)
T 3niz_A 102 EK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RS 175 (311)
T ss_dssp SE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C-
T ss_pred CC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--cc
Confidence 75 888888776666999999999999999999999 9999999999999999999999999999998765432 22
Q ss_pred eccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc-------
Q 039392 159 QTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP------- 230 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 230 (285)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+.... ................
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK-IFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH-HHHHHCCCCTTTSGGGTTSHHHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHCCCChHHhhhhhccchhh
Confidence 234567999999998876 5689999999999999999999999986544433222 2111111111110000
Q ss_pred --cc-cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 --NL-LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 --~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. .............+++++.+|+.+||..||.+|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 000000111223456789999999999999999999999873
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=322.30 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=213.0
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 367889999999999999964 345889999987543 3455778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 039392 74 VLEYMPHGSLEKYLHSSN-----------------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSN 130 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~n 130 (285)
|||++++++|.+++.... ..++...++.++.||+.||.||| ++|++|+||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchhe
Confidence 999999999999987543 23889999999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccc
Q 039392 131 VLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGE 209 (285)
Q Consensus 131 ili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~ 209 (285)
|+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987755433333344556788999999988889999999999999999999 999987643322
Q ss_pred hhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 210 MTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.. ...... .. ...+..++.++.+++.+||..||.+|||++++++.|+++.++
T Consensus 261 ~~-~~~~~~-~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 261 LF-NLLKTG-HR------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HH-HHHHTT-CC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH-HHhhcC-Cc------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 21 111100 00 001234567799999999999999999999999999998765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=325.01 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=204.9
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 4788999999999999999754 69999999987542 2345667889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.+.. .+++..++.++.||+.||.||| ++|++||||||+||+++.+|.++|+|||++.......
T Consensus 86 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 159 (337)
T 1o6l_A 86 YANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp CCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence 999999999987654 3899999999999999999999 9999999999999999999999999999997543221
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......+|+.|+|||++.+..++.++|+||||+++|+|++|..||........ .........
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~---------------- 222 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEI---------------- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC----------------
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-HHHHHcCCC----------------
Confidence 122345689999999999999999999999999999999999999975332211 111111000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
..+..+++++.++|.+||..||.+|| ++++++++
T Consensus 223 ----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 01224567799999999999999999 89999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=330.31 Aligned_cols=260 Identities=24% Similarity=0.389 Sum_probs=211.8
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCC-ce
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEE-FK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~ 71 (285)
+|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+++++++ +||||+++++++...+ ..
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 102 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 102 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence 377889999999999999962 346889999987543 34456788999999999 7999999999987754 48
Q ss_pred EEEEeccCCCCHHHhhhcCCC-----------------------------------------------------------
Q 039392 72 ALVLEYMPHGSLEKYLHSSNY----------------------------------------------------------- 92 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~----------------------------------------------------------- 92 (285)
++||||+++++|.+++.....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 999999999999999865432
Q ss_pred ------ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccc
Q 039392 93 ------ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATI 166 (285)
Q Consensus 93 ------~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~ 166 (285)
.++...++.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++................+++
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 1888999999999999999999 9999999999999999999999999999998765544333445566788
Q ss_pred cccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhH
Q 039392 167 GYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQ 245 (285)
Q Consensus 167 ~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (285)
.|+|||.+.+..++.++||||||+++|+|++ |..||................... ..+..
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------------~~~~~ 320 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-------------------RAPDY 320 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-------------------CCCTT
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-------------------CCCCC
Confidence 9999999988899999999999999999998 999997654433322222111110 01223
Q ss_pred hHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 246 CVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
+++++.+++.+||..||.+|||+++++++|+++.+..
T Consensus 321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 5667999999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=330.43 Aligned_cols=258 Identities=25% Similarity=0.461 Sum_probs=201.2
Q ss_pred CCCCCceecccCceEEEEEEeC----CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++......++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 4889999999999999999753 57789999987543 344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++........
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999877666999999999999999999999 99999999999999999999999999999987654321
Q ss_pred cc-eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 156 ST-IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.. ......++..|+|||.+.+..++.++||||||+++|++++ |..||......+.. ......
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-~~i~~~--------------- 266 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEG--------------- 266 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-HHHHTT---------------
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcC---------------
Confidence 11 1122335678999999998899999999999999999998 99998654322211 111000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.....+..++.++.+++.+||+.||.+|||++++++.|+++.++
T Consensus 267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 00111234567799999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=328.81 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=211.1
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 4788999999999999999753 35889999987543 3445778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 039392 74 VLEYMPHGSLEKYLHSSN-----------------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSN 130 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~n 130 (285)
|||++++++|.+++.... ..++...++.++.||+.||.||| ++|++|+||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcce
Confidence 999999999999987632 45889999999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccc
Q 039392 131 VLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGE 209 (285)
Q Consensus 131 ili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~ 209 (285)
|+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 284 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence 9999999999999999987655433333345567889999999988889999999999999999999 999987643222
Q ss_pred hhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 210 MTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
.... ...... ...+..++.++.+++++||..||.+|||++++++.|+++.+.+
T Consensus 285 ~~~~-~~~~~~-------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 285 VIYY-VRDGNI-------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHH-HHTTCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHH-HhCCCc-------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1111 100000 0012345677999999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=316.90 Aligned_cols=268 Identities=23% Similarity=0.272 Sum_probs=207.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 488899999999999999975 468999999987543 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++ ++.+.+......+++..++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 156 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--R 156 (292)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--S
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--c
Confidence 976 676666665556999999999999999999999 9999999999999999999999999999998765332 2
Q ss_pred eeccccccccccCCcccCCCc-cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc-----
Q 039392 158 IQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN----- 231 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 231 (285)
......+++.|+|||.+.+.. ++.++||||||+++++|++|..||.............................
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 234456789999999987765 89999999999999999999988654443333333332222211111100000
Q ss_pred ----ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 232 ----LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 232 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...............+.++.+|+++||+.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000011111223567789999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=320.72 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=207.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
.|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 478899999999999999975 47899999998543 23455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++.... .++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 92 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 166 (294)
T 4eqm_A 92 YIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-L 166 (294)
T ss_dssp CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-c
Confidence 999999999997655 4899999999999999999999 9999999999999999999999999999997665432 1
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||................. .
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------~ 230 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV----------------P 230 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC----------------C
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC----------------C
Confidence 222345689999999999999999999999999999999999999976433222221111000 0
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC-CHHHHHHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLVKIRD 280 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~eil~~l~~l~~ 280 (285)
.........+++.+.+++.+||+.||.+|| +++++.+.|+.+..
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 000111234677899999999999999998 99999999887653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=321.18 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=206.2
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||||+++++++...+..++|||++++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 345678999999999999865 7999999999876666667788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++... .++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 127 ~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~ 199 (321)
T 2c30_A 127 GALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 199 (321)
T ss_dssp CBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBC
T ss_pred CCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccc
Confidence 9999998654 3899999999999999999999 99999999999999999999999999999987654321 223
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+++.|+|||.+.+..++.++||||||+++++|++|..||......+. ....... ... .+
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~-~~~----------------~~ 261 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRLRDS-PPP----------------KL 261 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS-SCC----------------CC
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcC-CCC----------------Cc
Confidence 45689999999999999999999999999999999999999975432211 1111110 000 01
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+++++.+++.+||..||.+|||+++++++
T Consensus 262 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123456779999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=328.39 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=208.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+++++.++||||+++++++......++|||++.
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 477889999999999999975 4689999999987655556678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCcEEEeeeccceecCcccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++|.+++......+++..++.++.||+.||.||| ++|++|+||||+||+++ ..+.++|+|||++........
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 206 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 206 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc--
Confidence 99999999876656999999999999999999999 99999999999999997 457899999999987765322
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....+|+.|+|||++.+..++.++||||||+++|+|++|..||......+. ...........
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~i~~~~~~~--------------- 269 (387)
T 1kob_A 207 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDWEF--------------- 269 (387)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCCCCC---------------
T ss_pred -eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC---------------
Confidence 2334689999999999999999999999999999999999999976432211 11111110000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+++++.++|.+||..||.+|||+++++++
T Consensus 270 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000123456779999999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=319.39 Aligned_cols=271 Identities=21% Similarity=0.289 Sum_probs=210.3
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCC--ceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE--FKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~ 77 (285)
|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..++|||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 788999999999999999754 58999999987543 233566778999999999999999999987654 78999999
Q ss_pred cCCCCHHHhhhcCCC--ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCcEEEeeeccceecC
Q 039392 78 MPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~i~df~~~~~~~ 151 (285)
+++++|.+++..... .++...++.++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++....
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999999976433 2899999999999999999999 9999999999999999 788899999999998765
Q ss_pred cccccceeccccccccccCCcccC--------CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhh---hhhhhhc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGK--------EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLK---HWVNDWL 220 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~ 220 (285)
.... .....+++.|+|||.+. +..++.++||||||+++|+|++|..||........... ......+
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 168 DDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp TTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 5321 23456899999999875 56789999999999999999999999975443332222 2222221
Q ss_pred CCCccccccccc-----cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 221 PISTKEIVDPNL-----LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 221 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
............ ....+.........+..+.+++++||+.||.+|||++|++++..+-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111110000000 0011111223467788899999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=332.21 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=208.5
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++......++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 367889999999999999973 24678999998643 23444568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---cEEEeee
Q 039392 74 VLEYMPHGSLEKYLHSSN------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHLSDF 144 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~i~df 144 (285)
|||++++++|.+++.... ..++...++.++.||+.||.||| ++|++||||||+||+++.+| .++|+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999987543 34889999999999999999999 99999999999999999555 5999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++................+++.|+|||.+.+..++.++||||||+++++|++ |..||......+.... ..... .
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-i~~~~-~-- 304 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTSGG-R-- 304 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTTC-C--
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCC-C--
Confidence 99976543332233344567889999999988899999999999999999998 9999876432221111 10000 0
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
...+..++.++.+++.+||+.||.+|||+++++++|+.+.++
T Consensus 305 ----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 305 ----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 011234567799999999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=322.85 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=196.0
Q ss_pred CCCCCceecccCceEEEEEEeCC-C---cEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCCce---
Q 039392 1 GFSENNLIGRGGFGSVFKARLGD-G---MEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFK--- 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-~---~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--- 71 (285)
+|++.+.||+|+||+||+|.... + ..||+|++... .....+.+.+|+++++.++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 48889999999999999997543 3 27999998754 344567788999999999999999999999776554
Q ss_pred ---EEEEeccCCCCHHHhhhcCC-----CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEee
Q 039392 72 ---ALVLEYMPHGSLEKYLHSSN-----YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD 143 (285)
Q Consensus 72 ---~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~d 143 (285)
+++||++.+++|.+++.... ..++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEee
Confidence 89999999999999885432 24889999999999999999999 99999999999999999999999999
Q ss_pred eccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCC
Q 039392 144 FGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPI 222 (285)
Q Consensus 144 f~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (285)
||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+..... .....
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~-- 257 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-IGGNR-- 257 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCC--
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH-hcCCC--
Confidence 999987655433333334556778999999998899999999999999999999 89998764433222111 11000
Q ss_pred CccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 223 STKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
...+..++.++.+++.+||..||.+|||++++++.|+++.+.
T Consensus 258 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 258 -----------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001234567799999999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=321.06 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=216.6
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccch-hHHHHHHHHHHHHccC-CCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 367889999999999999973 3578899999875543 3457788999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCC-----------------ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 039392 73 LVLEYMPHGSLEKYLHSSNY-----------------ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~-----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~ 135 (285)
+|||++++++|.+++..... .++...++.++.|++.||.||| ++|++|+||||+||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcC
Confidence 99999999999999876542 3889999999999999999999 999999999999999999
Q ss_pred CCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhh
Q 039392 136 NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 136 ~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 214 (285)
++.++|+|||++................+++.|+|||.+.+..++.++||||||+++++|++ |..||............
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 260 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence 99999999999987765443333445567788999999988899999999999999999999 99998765433322221
Q ss_pred hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHhc
Q 039392 215 WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~~ 284 (285)
....... ..+..++.++.+++.+||..||.+|||++++++.|+++.++...
T Consensus 261 ~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 261 IKEGFRM-------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHHTCCC-------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred hccCCCC-------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 1111100 01234567799999999999999999999999999999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=314.82 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=212.4
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||.||++...+++.||+|++..... ..+.+.+|+++++.++||||+++++++...+..+++||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 3678899999999999999988888999999875533 336788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++......++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 163 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSST 163 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTT
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccccc
Confidence 9999999877666899999999999999999999 9999999999999999999999999999998664422 11223
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...++..|+|||.+.+..++.++|+||||+++++|++ |..||......+.. ........
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~i~~~~~------------------- 223 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFR------------------- 223 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHTTCC-------------------
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH-HHHhcCCc-------------------
Confidence 3456778999999988889999999999999999999 89998754322111 11111000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
...+...+.++.+++.+||..||.+|||++++++.|+++.++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 001223466789999999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=329.03 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=211.2
Q ss_pred CCCCceecccCceEEEEEEe--------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCce
Q 039392 2 FSENNLIGRGGFGSVFKARL--------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFK 71 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~--------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 71 (285)
|.+.+.||+|+||+||+|.. .++..||+|++.... ......+.+|+++++.+ +||||+++++++...+..
T Consensus 71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence 66789999999999999974 224679999987543 34457788999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 039392 72 ALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN 136 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~ 136 (285)
++|||++++++|.+++.... ..+++..++.++.||+.||.||| +.|++|+||||+||+++.+
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcCC
Confidence 99999999999999987643 34899999999999999999999 9999999999999999999
Q ss_pred CcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhh
Q 039392 137 MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHW 215 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 215 (285)
+.+||+|||++................+++.|+|||.+.+..++.++||||||+++++|++ |..||......+. ....
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~-~~~~ 306 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLL 306 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHH
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH
Confidence 9999999999987655433333344567788999999999999999999999999999999 9999875432221 1111
Q ss_pred hhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 216 VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.... . ...+..+++++.+++.+||..||.+|||++++++.|+++...
T Consensus 307 ~~~~-~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 307 KEGH-R------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HTTC-C------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCC-C------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1100 0 001234567799999999999999999999999999999854
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=314.14 Aligned_cols=267 Identities=28% Similarity=0.444 Sum_probs=211.1
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccc----hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY----GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
..++.||+|+||.||+|.. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++...+..+++||++
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred ccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4458999999999999986 58899999986432 345577889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 79 PHGSLEKYLHSS--NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 79 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++|.+++... ...++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 999999998643 334889999999999999999999 999999999999999999999999999999876554333
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhc-CCCccccccccccCc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL-PISTKEIVDPNLLSR 235 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (285)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.................. ........+....
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 266 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN-- 266 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS--
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc--
Confidence 33345578999999998765 5899999999999999999999999765443322111111000 1111111111110
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
......+..+.+++.+||..||.+|||++++++.|+++..+
T Consensus 267 -----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 267 -----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp -----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred -----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 11345678899999999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=322.10 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=205.2
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch------hHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG------RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++......++|
T Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 778899999999999999754 689999999875432 1356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----cEEEeeeccceec
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLL 150 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~i~df~~~~~~ 150 (285)
||++++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 93 LELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999999997654 4899999999999999999999 99999999999999998877 8999999999876
Q ss_pred CcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+. ..........
T Consensus 169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~--------- 235 (326)
T 2y0a_A 169 DFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVNYE--------- 235 (326)
T ss_dssp CTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHTCCC---------
T ss_pred CCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHhcCCC---------
Confidence 5432 12345689999999999988999999999999999999999999965332211 1111110000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........++.++.+++++||..||.+|||+++++++
T Consensus 236 -------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 -------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011123557789999999999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=331.97 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=204.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||+||++.. .+|+.+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||+
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 378899999999999999974 578999999987543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCcEEEeeeccceecCccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~i~df~~~~~~~~~~ 154 (285)
+++++|.+.+..... +++..++.++.||+.||.||| ++|++||||||+||+++ .++.+||+|||++.......
T Consensus 92 ~~gg~L~~~i~~~~~-~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 92 VTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CBCCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred CCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999998876554 999999999999999999999 99999999999999998 56889999999997765432
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||......+. ...........+
T Consensus 168 --~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~~~~----------- 233 (444)
T 3soa_A 168 --QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-YQQIKAGAYDFP----------- 233 (444)
T ss_dssp --CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCCCC-----------
T ss_pred --ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhCCCCCC-----------
Confidence 122345789999999999998999999999999999999999999965432221 111111111100
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+++++.+++.+||..||.+|||++|+|++
T Consensus 234 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 -----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01123457789999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=317.25 Aligned_cols=267 Identities=22% Similarity=0.313 Sum_probs=203.5
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||+||+|...+++.+|+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||++
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 5888999999999999999888899999999865432 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++ +|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 156 (288)
T 1ob3_A 83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RK 156 (288)
T ss_dssp SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--cc
Confidence 76 999998776666999999999999999999999 9999999999999999999999999999997654321 12
Q ss_pred eccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc--------cc
Q 039392 159 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI--------VD 229 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 229 (285)
.....+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+.... ............. .+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHHCCCChhhchhhhcccccc
Confidence 2344678999999988764 589999999999999999999999976443222211 1111111100000 00
Q ss_pred ccccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+......+..+ .....++.++.+++.+||..||.+|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000000 1123467789999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=317.07 Aligned_cols=259 Identities=26% Similarity=0.409 Sum_probs=197.7
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
.|++.+.||+|+||+||+|... ..+|+|++.... ....+.+.+|+++++.++||||++++++. .....++|||++
T Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 101 (289)
T 3og7_A 25 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 101 (289)
T ss_dssp SCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred ceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence 4888999999999999999864 359999986543 44557788999999999999999999965 455688999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++++|.+++......++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp CEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999999776667999999999999999999999 99999999999999999999999999999986654332333
Q ss_pred eccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 159 QTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.....+++.|+|||.+. +..++.++||||||+++++|++|..||........................
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 249 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK--------- 249 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS---------
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh---------
Confidence 34556899999999886 556888999999999999999999999765443332222222111111100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
....++.++.+++.+||..||.+|||++++++.|+++.+
T Consensus 250 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 ------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 123456779999999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=315.27 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=198.8
Q ss_pred CCCCCceecccCceEEEEEEeC----CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|... .+..|++|.+.... ....+.+.+|+.+++.++||||+++++++. .+..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 3678899999999999999753 24579999976533 345567889999999999999999999985 45688999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999999876666999999999999999999999 99999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... .....
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~-i~~~~--------------- 234 (281)
T 1mp8_A 172 -YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGE--------------- 234 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTC---------------
T ss_pred -cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH-HHcCC---------------
Confidence 12233446778999999988889999999999999999996 9999876443322111 10000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
....+..+++++.+++.+||..||.+|||++++++.|+++.++-
T Consensus 235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00112356778999999999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=323.37 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=202.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 588999999999999999985 578999999986432 2223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+ +++|.+++..... +++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 90 ~~-~g~l~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CC-CEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred CC-CCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 99 6689888866543 899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......+++.|+|||.+.+..+ ++++||||||+++|+|++|..||.......... ....
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------~i~~------ 222 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------KVNS------ 222 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------------CCCS------
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------------HHHc------
Confidence 2234568999999999988775 789999999999999999999997532221100 0000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+...++++.+++++||..||.+|||++|++++
T Consensus 223 --~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 --CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0011133456779999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=324.27 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=209.4
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 125 (344)
T 1rjb_A 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 125 (344)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence 367789999999999999974 346789999987543 23446788999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCC----------------------ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 039392 73 LVLEYMPHGSLEKYLHSSNY----------------------ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSN 130 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~n 130 (285)
+|||++++++|.+++..... .++...++.++.||+.||.||| ++|++|+||||+|
T Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~N 202 (344)
T 1rjb_A 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN 202 (344)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGG
T ss_pred EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhh
Confidence 99999999999999976532 2788899999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccc
Q 039392 131 VLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGE 209 (285)
Q Consensus 131 ili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~ 209 (285)
|+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++++|++ |..||.......
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 9999999999999999987655433333445567888999999988889999999999999999998 999997654332
Q ss_pred hhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 210 MTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
.......... . ...+..+++++.+++.+||..||.+|||+++++++|+.+....
T Consensus 283 ~~~~~~~~~~-~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 283 NFYKLIQNGF-K------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp HHHHHHHTTC-C------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHHhcCC-C------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 2222111110 0 0012235677999999999999999999999999999987543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=312.67 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=204.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchh-------HHHHHHHHHHHHccCCCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGR-------VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++...... ..+.+.+|+++++.++||||+++++++.... +
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 477889999999999999975 57899999998643321 1156889999999999999999999997765 5
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCc-----EEEeeec
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ--VIHCDLKPSNVLLDDNMV-----AHLSDFG 145 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~di~~~nili~~~~~-----~~i~df~ 145 (285)
+|||++++++|.+.+......++...++.++.|++.||.||| ++| ++|+||||+||+++.++. ++|+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 999999999999988777667999999999999999999999 899 999999999999988776 9999999
Q ss_pred cceecCcccccceeccccccccccCCcccC--CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC
Q 039392 146 IAKLLTREDISTIQTQTLATIGYMAPEYGK--EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
++..... ......+++.|+|||.+. ...++.++||||||+++|+|++|..||...................
T Consensus 175 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-- 247 (287)
T 4f0f_A 175 LSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL-- 247 (287)
T ss_dssp TCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--
T ss_pred ccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--
Confidence 9975433 223456889999999983 4568899999999999999999999997654443322221111100
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+..+++++.+++.+||..||.+|||++++++.|+++
T Consensus 248 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 ---------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0011234567799999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=322.12 Aligned_cols=276 Identities=26% Similarity=0.357 Sum_probs=201.8
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHH--HccCCCCcccccccee-----ccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEM--MKSIHHRNIIKVISSC-----SNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~-----~~~~~~~~ 73 (285)
+|++.+.||+|+||.||+|+. +++.||+|++..... ..+..|.++ +..++|+||+++++.+ ......++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 478899999999999999976 689999999875433 233334444 4458999999999743 33446789
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCC---------CeeecCCCCCCeeeCCCCcEEEeee
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA---------QVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~---------~~~h~di~~~nili~~~~~~~i~df 144 (285)
|||++++++|.+++.... .+...++.++.||+.||.||| +. |++|+||||+||+++.++.+||+||
T Consensus 90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999999997654 588889999999999999999 88 9999999999999999999999999
Q ss_pred ccceecCcccc------cceeccccccccccCCcccCC-------CccCcchhhHHHHHHHHHHhhCCCCCccccccchh
Q 039392 145 GIAKLLTREDI------STIQTQTLATIGYMAPEYGKE-------GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT 211 (285)
Q Consensus 145 ~~~~~~~~~~~------~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (285)
|++........ ........+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987654321 112224468999999999876 45678999999999999999998776443221111
Q ss_pred hhhhhhhhcCCCc-cc----cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHhcC
Q 039392 212 LKHWVNDWLPIST-KE----IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLRN 285 (285)
Q Consensus 212 ~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~~~ 285 (285)
...+......... .. ..........+..+.....+++++.+++.+||..||.+|||++|+++.|+++...+.||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 1110000000000 00 00000111111112223456778999999999999999999999999999999988776
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=324.63 Aligned_cols=250 Identities=21% Similarity=0.335 Sum_probs=205.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||+
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 378899999999999999975 468999999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CcEEEeeeccceecCccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~---~~~~i~df~~~~~~~~~~ 154 (285)
+++++|.+.+.... .+++..++.++.||+.||.||| ++|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 110 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 110 VTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 99999999886654 4899999999999999999999 9999999999999999764 459999999998765432
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
......+++.|+|||++.+..++.++||||||+++|+|++|..||......+. ...........
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i~~~~~~~------------ 249 (362)
T 2bdw_A 186 ---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGAYDY------------ 249 (362)
T ss_dssp ---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCC------------
T ss_pred ---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCC------------
Confidence 12345689999999999998999999999999999999999999975432211 11111111100
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+++++.+++.+||..||.+|||+++++++
T Consensus 250 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011124567789999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=323.91 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=202.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 478899999999999999975 468899999986543 2344678889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++.+++|.+++..... +++..++.++.||+.||.||| +.|++||||||+||+++.+|.++|+|||++.......
T Consensus 96 ~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 169 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVH-FKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-- 169 (384)
T ss_dssp CCTTEEHHHHHHTTCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence 9999999999976544 999999999999999999999 9999999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCC---CccCcchhhHHHHHHHHHHhhCCCCCccccccchh-hhhhhhhhcCCCccccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT-LKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (285)
......+|+.|+|||++.+ ..++.++|+||||+++|+|++|..||......... ........ .
T Consensus 170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~----------- 236 (384)
T 4fr4_A 170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-V----------- 236 (384)
T ss_dssp -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-C-----------
T ss_pred -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-c-----------
Confidence 2245678999999999864 45899999999999999999999999754332211 11100000 0
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC-HHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN-AKEIVT 273 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~eil~ 273 (285)
...+..++.++.++|.+||..||.+||+ ++++++
T Consensus 237 -------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0012345677999999999999999998 777664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=322.99 Aligned_cols=257 Identities=24% Similarity=0.396 Sum_probs=202.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcE----EEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGME----VAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~----~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|+||+||+|.+ .+++. |++|.+.... ....+.+.+|+.++++++||||+++++++.... .+++
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence 478889999999999999974 34443 5777765332 344567889999999999999999999998765 7799
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
++++.+++|.+++......++...++.++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999999877667999999999999999999999 9999999999999999999999999999998776544
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||........... .....
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--~~~~~------------- 236 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--LEKGE------------- 236 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH--HHTTC-------------
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH--HHcCC-------------
Confidence 3333344556788999999999999999999999999999999 9999976443322111 11000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
....+..++.++.+++.+||+.||.+|||++++++.|+.+.++
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0011234566799999999999999999999999999998753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=321.14 Aligned_cols=269 Identities=23% Similarity=0.404 Sum_probs=208.1
Q ss_pred CCCCceecccCceEEEEEE-----eCCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccC--CceEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-----LGDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-----~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 73 (285)
|++.+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+++++.++||||+++++++... ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 6778999999999999997 3468999999987543 33456788999999999999999999999776 67899
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|||++++++|.+++......++...++.++.|++.||++|| ++|++|+||||+||+++.++.++|+|||++......
T Consensus 103 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 99999999999999766666999999999999999999999 999999999999999999999999999999877654
Q ss_pred ccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC-cccccccc
Q 039392 154 DIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS-TKEIVDPN 231 (285)
Q Consensus 154 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (285)
... .......++..|+|||.+.+..++.++||||||+++++|++|..|+......... ......... ......
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~-- 254 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK---MIGPTHGQMTVTRLVN-- 254 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HHCSCCGGGHHHHHHH--
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh---ccCCcccccCHHHHHH--
Confidence 322 2233456788899999999999999999999999999999999986432111000 000000000 000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
..........+..+++++.+++.+||..||.+|||++++++.|+++.
T Consensus 255 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 -TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp -HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000111123456778999999999999999999999999999886
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=317.57 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=204.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+++.. +|+.||+|++.... ....+.+.+|..+++.++||||+++++++......++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 4788999999999999999754 79999999987542 2334667789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++..... +++..++.++.||+.||.||| ++|++||||||+||+++.+|.++|+|||++......
T Consensus 87 ~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred CCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 9999999999976554 899999999999999999999 999999999999999999999999999999876432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+|+.|+|||++.+..++.++|+||||+++|+|++|..||........ ..........
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~--------------- 221 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAELR--------------- 221 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHCCCC---------------
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC---------------
Confidence 2345689999999999999999999999999999999999999976432211 1111111000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
.+...+.++.+++.+||..||.+|| ++++++++
T Consensus 222 -----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 -----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1223466799999999999999999 88998854
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=319.71 Aligned_cols=259 Identities=28% Similarity=0.442 Sum_probs=211.0
Q ss_pred CCCCCceecccCceEEEEEEe--------CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCc
Q 039392 1 GFSENNLIGRGGFGSVFKARL--------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEF 70 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~--------~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 70 (285)
+|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+++++.+ +||||+++++++...+.
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 115 (334)
T 2pvf_A 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115 (334)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence 367889999999999999975 346789999987543 34457788999999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHhhhcCCC---------------ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 039392 71 KALVLEYMPHGSLEKYLHSSNY---------------ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 71 ~~~v~e~~~~~~L~~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~ 135 (285)
.++|||++++++|.+++..... .++...++.++.||+.||.||| +.|++|+||||+||+++.
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcC
Confidence 9999999999999999876432 3788999999999999999999 999999999999999999
Q ss_pred CCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhh
Q 039392 136 NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 136 ~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~ 214 (285)
++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+. ...
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~ 271 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKL 271 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-HHH
Confidence 99999999999987765433333344556788999999988889999999999999999999 9999876432221 111
Q ss_pred hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 215 WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
..... . ...+..++.++.+++.+||..||.+|||++++++.|+++....
T Consensus 272 ~~~~~-~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 272 LKEGH-R------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHTC-C------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhcCC-C------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11100 0 0012345677999999999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=326.22 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=199.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|..+++.+ +||||+++++++...+.+++||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 578899999999999999975 468999999987542 23445677899999988 6999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++++|.+++.+... +++..++.++.||+.||.||| ++|++||||||+||+++.+|.+||+|||++.......
T Consensus 104 E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred eCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 99999999999876554 999999999999999999999 9999999999999999999999999999997543221
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+|+.|+|||++.+..++.++|+||||+++|+|++|..||......+. .........
T Consensus 179 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~~~--------------- 241 (353)
T 3txo_A 179 -VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEAILNDEV--------------- 241 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC---------------
T ss_pred -ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCC---------------
Confidence 222345789999999999888899999999999999999999999976433221 111111100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCH------HHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINA------KEIVT 273 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~eil~ 273 (285)
..+...+.++.+++++||..||.+||++ +++++
T Consensus 242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0022346678999999999999999998 77775
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=314.80 Aligned_cols=262 Identities=15% Similarity=0.131 Sum_probs=213.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+.+++.+ +|++++++++++......++|||++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 478899999999999999975 5799999999864432 25577899999999 7999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc-----EEEeeeccceecCcc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKLLTRE 153 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~-----~~i~df~~~~~~~~~ 153 (285)
+++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++. ++|+|||++......
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 88999999877666999999999999999999999 999999999999999987776 999999999876543
Q ss_pred ccc-----ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh--hhhhhhhhcCCCccc
Q 039392 154 DIS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT--LKHWVNDWLPISTKE 226 (285)
Q Consensus 154 ~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 226 (285)
... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......... ............
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 241 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP--- 241 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC---
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc---
Confidence 221 1224456899999999999999999999999999999999999999764332211 111111000000
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
.......+++++.+++.+||..||.+|||++++++.|+++.+++.
T Consensus 242 ------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 242 ------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp ------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 000122467789999999999999999999999999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=312.56 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=206.1
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccC--CceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|... ++.+|+|++.... ....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 4788999999999999999874 8899999987543 34456788999999999999999999999876 78899999
Q ss_pred ccCCCCHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 77 YMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++++++|.+++..... .++...++.++.|++.||.||| +++ ++|+||+|+||+++.++.+++.||++......
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 9999999999977543 4899999999999999999999 889 99999999999999999999999888754322
Q ss_pred cccceeccccccccccCCcccCCCccCc---chhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSA---NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~---~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
....+++.|+|||.+.+...+. ++||||||+++|+|++|..||..................
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------- 229 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR---------- 229 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC----------
Confidence 3345788999999988765544 799999999999999999999764333222111111000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
...+..+++++.+++.+||..||.+|||++++++.|+++++
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 ---------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01123456779999999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=312.06 Aligned_cols=263 Identities=26% Similarity=0.378 Sum_probs=201.2
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHcc--CCCCccccccceecc----CCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKS--IHHRNIIKVISSCSN----EEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~~v 74 (285)
+|++.+.||+|+||+||+|.. +++.||+|++..... ..+..|.+++.. ++||||+++++++.. ....++|
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 488999999999999999987 689999999865432 344556666655 789999999998543 4568899
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG-----YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
||++++++|.+++... .++...++.++.|++.||.|||.. .+.+++|+||||+||+++.++.+||+|||++..
T Consensus 85 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 85 THYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp ECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred hhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 9999999999999654 489999999999999999999932 157999999999999999999999999999976
Q ss_pred cCcccccc--eeccccccccccCCcccCCC------ccCcchhhHHHHHHHHHHhhC----------CCCCccccccchh
Q 039392 150 LTREDIST--IQTQTLATIGYMAPEYGKEG------RVSANGDVYSFGIMLIETFTR----------KKPTDEIFNGEMT 211 (285)
Q Consensus 150 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~l~~ll~g----------~~p~~~~~~~~~~ 211 (285)
........ ......+|+.|+|||.+.+. .++.++||||||+++|+|++| ..||.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 54432211 12334689999999998876 566899999999999999999 7777654433322
Q ss_pred hhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 212 LKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.............. ...........++.++.+++.+||..||.+|||++++++.|+++
T Consensus 243 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 243 FEDMRKVVCVDQQR---------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHTTSCCC---------CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhHHHhccCCC---------CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22221111110000 00001112345778899999999999999999999999999876
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=329.70 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=199.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++++.||+|+||+||+++.. +++.||+|++.... ....+.+.+|..+++++ +||||+++++++...+.+++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 4788899999999999999754 68899999987543 22334577889988876 7999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++++|..++.+... +++..++.++.||+.||.||| ++|++||||||+||+++.+|.+||+|||++......
T Consensus 133 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-- 206 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-- 206 (396)
T ss_dssp ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred EcCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC--
Confidence 99999999999876554 999999999999999999999 999999999999999999999999999999753322
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhh----hhhhhhhcCCCcccccccc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL----KHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 231 (285)
........+|+.|+|||++.+..++.++|+||||+++|+|++|..||.......... ..........
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------- 277 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------- 277 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC---------
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc---------
Confidence 122345678999999999999999999999999999999999999996532221110 0000000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCH------HHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINA------KEIVT 273 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~eil~ 273 (285)
....+..++.++.++|++||+.||.+||++ +++++
T Consensus 278 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 278 -------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 001123456779999999999999999996 56654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=311.96 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=210.2
Q ss_pred CCCCc-eecccCceEEEEEEe---CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 2 FSENN-LIGRGGFGSVFKARL---GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~~-~lg~G~~~~v~~~~~---~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|.+.+ .||+|+||.||+|.. .++..||+|++.... ....+.+.+|+++++.++||||+++++++ ..+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 44555 899999999999964 367889999987643 34557788999999999999999999999 4556899999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++......++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999999999776666999999999999999999999 999999999999999999999999999999877543221
Q ss_pred -ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 157 -TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 157 -~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......+++.|+|||.+.+..++.++||||||+++++|++ |..||......+.. ...... ..
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~i~~~-~~------------- 231 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQG-KR------------- 231 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HHHHTT-CC-------------
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHhcC-Cc-------------
Confidence 12223446788999999988889999999999999999998 99999764332211 111000 00
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
...+..+++++.+++.+||..||.+|||+++++++|+++..+.-
T Consensus 232 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 232 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 01123567789999999999999999999999999999987754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=310.07 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=207.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+|++
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 4788999999999999999764 78999999987543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++++|.+++.... .++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 88 SGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp TTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 9999999986544 4899999999999999999999 99999999999999999999999999999987644322223
Q ss_pred eccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....+++.|+|||.+.+..+ +.++|+||||+++++|++|..||............+......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 227 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------- 227 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT----------------
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc----------------
Confidence 345568899999999887765 789999999999999999999997654433322222211000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+..+.+++.+||..||.+|||+++++++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01123456779999999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=324.35 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=203.1
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-----hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-----RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
|++.+.||+|+||+||++.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 105 (351)
T 3c0i_A 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105 (351)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 77889999999999999975 4789999999864321 13567889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc---EEEeeecccee
Q 039392 76 EYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFGIAKL 149 (285)
Q Consensus 76 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~i~df~~~~~ 149 (285)
|++++++|.+.+... ...+++..++.++.||+.||.||| ++|++|+||||+||+++.++. ++|+|||++..
T Consensus 106 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999998877542 234899999999999999999999 999999999999999986554 99999999987
Q ss_pred cCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||..... ............
T Consensus 183 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~-------- 250 (351)
T 3c0i_A 183 LGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYK-------- 250 (351)
T ss_dssp CCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCC--------
T ss_pred ecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCC--------
Confidence 75432 122345689999999999998999999999999999999999999976321 111111111000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........++.++.+++++||..||.+|||+.+++++
T Consensus 251 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111123567789999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=320.41 Aligned_cols=260 Identities=19% Similarity=0.198 Sum_probs=211.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++..... .+.+.+|+++++.+ +||||+++++++...+..++|||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 588899999999999999985 5799999999875433 24577899999999 8999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc-----EEEeeeccceecCcc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKLLTRE 153 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~-----~~i~df~~~~~~~~~ 153 (285)
+++|.+++......++...++.++.|++.||.||| +.|++||||||+||+++.++. ++|+|||++......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 88999999876666999999999999999999999 999999999999999998887 999999999876443
Q ss_pred cccc-----eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh--hhhhhhhhcCCCccc
Q 039392 154 DIST-----IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT--LKHWVNDWLPISTKE 226 (285)
Q Consensus 154 ~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 226 (285)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||......... .............
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-- 241 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI-- 241 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH--
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH--
Confidence 2111 123567899999999999999999999999999999999999999865332221 1111110000000
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
......++ ++.+++.+||..||.+||+++++++.|+++.+..
T Consensus 242 -------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 242 -------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00011234 7999999999999999999999999999988765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=322.60 Aligned_cols=273 Identities=25% Similarity=0.349 Sum_probs=213.0
Q ss_pred CCCCCceecccCceEEEEEE-----eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceec--cCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKAR-----LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS--NEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 73 (285)
+|++.+.||+|+||.||++. ..+++.||+|++........+.+.+|++++++++||||+++++++. .....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 47789999999999999997 3468899999998776667778999999999999999999999875 5567899
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|||++++++|.+++......++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999999999876556999999999999999999999 999999999999999999999999999999877543
Q ss_pred ccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 154 DIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 154 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
... .......++..|+|||.+.+..++.++||||||+++++|++|..||.............. ...........
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~--- 255 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE--RDVPALSRLLE--- 255 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHH---
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc--cccccHHHHHH---
Confidence 322 122345577889999999888999999999999999999999999865322111000000 00000000000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
..........+..+++++.+++.+||..||.+|||+++++++|+.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 0000011112345678899999999999999999999999999988654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=323.29 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=200.3
Q ss_pred CceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCCH
Q 039392 5 NNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 83 (285)
.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999975 57899999999876656667889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee--CCCCcEEEeeeccceecCcccccceecc
Q 039392 84 EKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL--DDNMVAHLSDFGIAKLLTREDISTIQTQ 161 (285)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili--~~~~~~~i~df~~~~~~~~~~~~~~~~~ 161 (285)
.+++......+++..++.++.||+.||.||| +.|++|+||||+||++ +.++.++|+|||++........ ...
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence 9988766666999999999999999999999 9999999999999999 5778999999999987654321 233
Q ss_pred ccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhh
Q 039392 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241 (285)
Q Consensus 162 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (285)
..+++.|+|||++.+..++.++||||||+++|+|++|..||......+. ............ ..
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~----------------~~ 310 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-LNNILACRWDLE----------------DE 310 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCCSC----------------SG
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCCC----------------hh
Confidence 4689999999999988999999999999999999999999976432221 111111110000 01
Q ss_pred hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+++++.+|+.+||..||.+|||+++++++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 123457789999999999999999999999973
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=312.69 Aligned_cols=259 Identities=26% Similarity=0.453 Sum_probs=205.7
Q ss_pred CCCCceecccCceEEEEEEeCC----CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCcccccccee-ccCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLGD----GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSC-SNEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~----~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~ 75 (285)
|++.+.||+|+||+||+|...+ ...+++|.+.... ....+.+.+|+.++++++||||+++++++ ...+..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 6778999999999999997432 3358899886533 34557788999999999999999999985 5567889999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.||.+|| ++|++|+||||+||+++.++.++|+|||++........
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999876666899999999999999999999 99999999999999999999999999999987654332
Q ss_pred c--ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhC-CCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 156 S--TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 156 ~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
. .......+++.|+|||.+.+..++.++||||||+++++|++| ..||......+.... ......
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-~~~~~~------------ 250 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRR------------ 250 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-HHTTCC------------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhcCCC------------
Confidence 1 122344567889999999888999999999999999999995 455544322222111 111000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
...+..++..+.+++.+||..||.+|||++++++.|+++.+++.
T Consensus 251 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 251 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00122345679999999999999999999999999999988764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=313.41 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=194.3
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccch----hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG----RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|... ++.+|+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 4788899999999999999874 88999999865432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC---eeecCCCCCCeeeCC--------CCcEEEeeec
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ---VIHCDLKPSNVLLDD--------NMVAHLSDFG 145 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~---~~h~di~~~nili~~--------~~~~~i~df~ 145 (285)
++++++|.+++... .++...++.++.|++.||.||| ++| ++|+||+|+||+++. ++.++|+|||
T Consensus 87 ~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 87 FARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp CCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred cCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999998643 4899999999999999999999 787 899999999999985 7889999999
Q ss_pred cceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 146 IAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
++....... .....+++.|+|||.+.+..++.++||||||+++++|++|..||.................
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------ 231 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL------ 231 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC------
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC------
Confidence 998655432 1234688999999999888899999999999999999999999976433222111110000
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
....+..+++++.+++.+||..||.+|||+++++++|+++
T Consensus 232 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 -------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0011234567799999999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=315.14 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=198.1
Q ss_pred CCCCCceecccCceEEEEEEeC----CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCC-----
Q 039392 1 GFSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE----- 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 69 (285)
+|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 3678899999999999999642 35589999987542 345577889999999999999999999987654
Q ss_pred ceEEEEeccCCCCHHHhhhc-----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 70 FKALVLEYMPHGSLEKYLHS-----SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
..++|||++++++|.+++.. ....++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeec
Confidence 45899999999999998842 2345899999999999999999999 999999999999999999999999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........... ......
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~--- 267 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-LLHGHR--- 267 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCC---
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-HHcCCC---
Confidence 99987654432233334556788999999998899999999999999999999 8888876433222111 111000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...+..+++++.+++.+||..||.+|||+++++++|+++.+++
T Consensus 268 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 268 ----------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ----------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0012345677999999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=330.03 Aligned_cols=250 Identities=29% Similarity=0.441 Sum_probs=206.8
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCC-ceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE-FKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~~~~ 80 (285)
|++.+.||+|+||.||+|... ++.||||+++... ..+.+.+|+.++++++||||+++++++.... ..++|||++++
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 567889999999999999874 7899999987543 3467889999999999999999999976554 78999999999
Q ss_pred CCHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++..... .++...++.++.|++.||+||| +++++||||+|+||+++.++.+||+|||++...... .
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~ 343 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q 343 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----c
Confidence 999999976543 3689999999999999999999 999999999999999999999999999999854432 1
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... .... .
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~-------------------~ 403 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKG-------------------Y 403 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTT-------------------C
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcC-------------------C
Confidence 22356778999999999999999999999999999998 9999976543322111 1000 0
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
+...+..+++++.++|.+||..||.+|||++++++.|++++..-
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 11123457788999999999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=318.42 Aligned_cols=272 Identities=26% Similarity=0.427 Sum_probs=213.6
Q ss_pred CCCCceecccCceEEEEEE-----eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccC--CceEEE
Q 039392 2 FSENNLIGRGGFGSVFKAR-----LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE--EFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 74 (285)
|++.+.||+|+||.||++. ..+++.||+|++........+.+.+|+++++.++||||+++++++... ...++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 6788999999999999997 346899999999877667778899999999999999999999988654 378899
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
||++++++|.+++......++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999999877666999999999999999999999 9999999999999999999999999999998776543
Q ss_pred ccc-eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc--
Q 039392 155 IST-IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN-- 231 (285)
Q Consensus 155 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (285)
... ......++..|+|||.+.+..++.++||||||+++++|++|..|+........ ... ............
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMI---GNDKQGQMIVFHLI 273 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH---HHH---CTTCCTHHHHHHHH
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH---Hhh---ccccchhhhHHHHH
Confidence 221 12234567789999999888899999999999999999999998764311100 000 000000000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...........+..++.++.+++++||..||.+|||++++++.|+++++.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 000000011123456788999999999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=319.68 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=201.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcE----EEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGME----VAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~----~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|+||+||+|.+ .+++. |++|.+... .....+.+.+|+.+++.++||||+++++++.... .+++
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 478899999999999999974 34554 466666432 2345577889999999999999999999998765 7799
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
++++.+++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++.......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 9999999999999877667999999999999999999999 9999999999999999999999999999998775544
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... .....
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~--~~~~~------------- 236 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--LEKGE------------- 236 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH--HHTTC-------------
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--HHcCC-------------
Confidence 3333344556788999999999999999999999999999999 9999976443322111 10000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
....+..++.++.+++++||..||.+|||++++++.|+++.+.
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111234566799999999999999999999999999998743
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=316.29 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=195.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--------------------------hHHHHHHHHHHHHccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--------------------------RVFKSFDVECEMMKSI 53 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--------------------------~~~~~~~~e~~~l~~l 53 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+++++.+
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 478899999999999999975 4689999999865431 1235678999999999
Q ss_pred CCCccccccceecc--CCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 039392 54 HHRNIIKVISSCSN--EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNV 131 (285)
Q Consensus 54 ~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~ni 131 (285)
+||||+++++++.. ....++|||++++++|.+++.. ..+++..++.++.|++.||.||| ++|++|+||||+||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNL 168 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHE
Confidence 99999999999876 5688999999999999886543 34899999999999999999999 99999999999999
Q ss_pred eeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCc---cCcchhhHHHHHHHHHHhhCCCCCcccccc
Q 039392 132 LLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR---VSANGDVYSFGIMLIETFTRKKPTDEIFNG 208 (285)
Q Consensus 132 li~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 208 (285)
+++.++.++|+|||++....... .......+++.|+|||.+.+.. .+.++||||||+++|+|++|..||......
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999998765432 1224457899999999987664 478899999999999999999999753221
Q ss_pred chhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 209 EMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
... ......... +.....++.++.+++.+||..||.+|||++|++++
T Consensus 247 ~~~-~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 247 CLH-SKIKSQALE------------------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHH-HHHHHCCCC------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHH-HHHhcccCC------------------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111 111110000 01122456679999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=321.30 Aligned_cols=256 Identities=24% Similarity=0.378 Sum_probs=203.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcE----EEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGME----VAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~----~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|+||+||+|.+ .+++. |++|.+.... ......+.+|+.+++.++||||+++++++. ....++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 477889999999999999974 34554 7777765332 223345668999999999999999999986 4568899
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
+|++.+++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999876666899999999999999999999 9999999999999999999999999999998776544
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+...... .. .
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~-~------------- 234 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KG-E------------- 234 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TT-C-------------
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cC-C-------------
Confidence 3334445567788999999998899999999999999999999 999997644332211110 00 0
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
....+..++.++.+++.+||..||.+|||++++++.|+.+..
T Consensus 235 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 -----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000122345568899999999999999999999999998864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=312.49 Aligned_cols=264 Identities=26% Similarity=0.385 Sum_probs=201.9
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccC--CCCccccccceeccC----CceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI--HHRNIIKVISSCSNE----EFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~~v 74 (285)
+|++.+.||+|+||.||+|... ++.||+|++..... .....|.+++... +||||+++++++... ...++|
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 38 QIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 3788999999999999999874 89999999864432 3344556665554 899999999998776 678999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCC--------CeeecCCCCCCeeeCCCCcEEEeeecc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA--------QVIHCDLKPSNVLLDDNMVAHLSDFGI 146 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~--------~~~h~di~~~nili~~~~~~~i~df~~ 146 (285)
||++++++|.+++... .++...++.++.|++.||.||| +. |++|+||||+||+++.++.+||+|||+
T Consensus 114 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp ECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 9999999999999665 3899999999999999999999 77 999999999999999999999999999
Q ss_pred ceecCcccccc--eeccccccccccCCcccCCCccCcc------hhhHHHHHHHHHHhhC----------CCCCcccccc
Q 039392 147 AKLLTREDIST--IQTQTLATIGYMAPEYGKEGRVSAN------GDVYSFGIMLIETFTR----------KKPTDEIFNG 208 (285)
Q Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~------~Di~slG~~l~~ll~g----------~~p~~~~~~~ 208 (285)
+.......... ......+++.|+|||.+.+...+.. +||||||+++|+|++| ..||......
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 97765432211 1234568999999999887766555 9999999999999999 5555443332
Q ss_pred chhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 209 EMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
............... .............+++++.+++.+||..||.+|||+++++++|+++.++.
T Consensus 269 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 269 DPSYEDMREIVCIKK---------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SCCHHHHHHHHTTSC---------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCchhhhHHHHhhhc---------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 222222111111100 00011111223477889999999999999999999999999999998763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=324.42 Aligned_cols=271 Identities=18% Similarity=0.253 Sum_probs=205.3
Q ss_pred CCCCCceeccc--CceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRG--GFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G--~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+| +||+||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 47889999999 99999999864 79999999997553 344567888999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 76 EYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 76 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
|++++++|.+++... ...+++..++.++.||+.||.||| ++|++||||||+||+++.++.++|+|||.+.......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999998764 234899999999999999999999 9999999999999999999999999999986543221
Q ss_pred c-----cceeccccccccccCCcccCC--CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC----
Q 039392 155 I-----STIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS---- 223 (285)
Q Consensus 155 ~-----~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 223 (285)
. ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+...................
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 1 111223467888999999887 57999999999999999999999999775444333222111110000
Q ss_pred --ccccc-------------------cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 --TKEIV-------------------DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 --~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..... .................+++++.+||++||..||.+|||++|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 0000000001112234567889999999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=312.76 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=212.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|+||.||+|.+. ++..||+|++... ....+.+.+|+++++.++||||+++++++......++|||+++
T Consensus 14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 92 (288)
T 3kfa_A 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 92 (288)
T ss_dssp GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence 4778899999999999999754 5889999998754 3345778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 80 HGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 80 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+++|.+++... ...++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 168 (288)
T 3kfa_A 93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTA 168 (288)
T ss_dssp TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEE
T ss_pred CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-ccc
Confidence 99999998764 344899999999999999999999 9999999999999999999999999999998765433 222
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....+++.|+|||.+.+..++.++||||||+++++|++ |..||........... . ....
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~-~~~~----------------- 229 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-L-EKDY----------------- 229 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-H-HTTC-----------------
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H-hccC-----------------
Confidence 334456778999999988899999999999999999999 9999876433222111 1 0000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
....+..+++++.+++.+||..||.+|||++++++.|+++.++.
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00112345677999999999999999999999999999988754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=309.57 Aligned_cols=260 Identities=23% Similarity=0.383 Sum_probs=208.0
Q ss_pred CCCCceecccCceEEEEEEeC-C---CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCce-EEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG-D---GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFK-ALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~---~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~~v~ 75 (285)
|...+.||+|+||+||+|... + +..+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+.. ++++
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 445689999999999999742 2 3378999986543 34557788999999999999999999999766555 8999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++.+++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999876667899999999999999999999 99999999999999999999999999999986654321
Q ss_pred --cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 156 --STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 --~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
........+++.|+|||.+.+..++.++||||||+++|+|++|..|+................. .
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~------------ 246 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-R------------ 246 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-C------------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-C------------
Confidence 1222345678889999999999999999999999999999996666543322222111111110 0
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
...+..++.++.+++.+||..||.+|||++++++.|+++.+.+.
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 00123356679999999999999999999999999999998765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=318.63 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=201.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|..+++++ +||||+++++++...+.+++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 4788999999999999999854 68999999987542 34456678899999887 8999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++.+... +++..++.++.||+.||.||| ++|++||||||+||+++.+|.++|+|||++.......
T Consensus 90 e~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp CCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred eCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 99999999999876544 899999999999999999999 9999999999999999999999999999997543221
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh----hhhhhhhhcCCCcccccccc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT----LKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 231 (285)
.......+|+.|+|||++.+..++.++|+||||+++|+|++|..||......... ...........
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------- 234 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------- 234 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---------
T ss_pred -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---------
Confidence 1224457899999999999999999999999999999999999999653221110 00000000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCH------HHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINA------KEIVT 273 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~eil~ 273 (285)
....+...+.++.+++.+||..||.+||++ +++++
T Consensus 235 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 235 -------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 000123456779999999999999999996 56654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=315.11 Aligned_cols=258 Identities=22% Similarity=0.283 Sum_probs=205.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceec----cCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS----NEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++. .....++|+
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 378899999999999999985 579999999987766667788899999999999999999999986 345788999
Q ss_pred eccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 76 EYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 76 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
|++++++|.+++.. ....+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999998865 3455899999999999999999999 99999999999999999999999999999876543
Q ss_pred cccc-------ceeccccccccccCCcccCCCc---cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCC
Q 039392 153 EDIS-------TIQTQTLATIGYMAPEYGKEGR---VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI 222 (285)
Q Consensus 153 ~~~~-------~~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (285)
.... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.................
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--- 263 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ--- 263 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc---
Confidence 2111 0011234688999999987654 68999999999999999999999965322211111111100
Q ss_pred CccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 223 STKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
........++.++.+++.+||..||.+|||+++++++|+++.
T Consensus 264 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 264 ---------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ---------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 001112345677999999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=310.34 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=205.1
Q ss_pred CCCCCceecccCceEEEEEEeC----CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||+||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 4778899999999999999742 23469999987653 34557788999999999999999999998755 468999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++........
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999999876666999999999999999999999 99999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
.......+++.|+|||.+.+..++.++||||||+++++|++ |..||........... .... ..
T Consensus 169 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~~-~~------------- 232 (281)
T 3cc6_A 169 -YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEKG-DR------------- 232 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHHT-CC-------------
T ss_pred -cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-HhcC-CC-------------
Confidence 12233456778999999988889999999999999999998 9999875433222111 1100 00
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
...+..+++.+.+++.+||..||.+|||++++++.|+++.+.
T Consensus 233 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 -----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 001233567799999999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=315.83 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=204.0
Q ss_pred CCCCCceecccCceEEEEEEeC-CC-------cEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DG-------MEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~-------~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||+||+|... ++ ..||+|++........+.+.+|+++++.++||||+++++++...+..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 4778899999999999999643 33 579999998776667788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc--------EEEeee
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV--------AHLSDF 144 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--------~~i~df 144 (285)
+|||++++++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++. ++|+||
T Consensus 89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999999877666999999999999999999999 999999999999999988876 999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+............... ....
T Consensus 166 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-~~~~- 237 (289)
T 4fvq_A 166 GISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-RHQL- 237 (289)
T ss_dssp CSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCC-
T ss_pred cccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-cCCC-
Confidence 998655432 22346778999999887 67899999999999999999966554332222221111110 0000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
+...+.++.+++.+||+.||.+|||++++++.|+++..
T Consensus 238 -------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 238 -------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11224458899999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=311.69 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=199.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 478889999999999999975 57899999998742 24455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 77 YMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 77 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++++++|.+++.. ....++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999998864 3445899999999999999999999 999999999999999999999999999998766543
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
. .......+++.|+|||.+.+..++.++||||||+++++|++|..||.....................
T Consensus 190 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 257 (310)
T 2wqm_A 190 T--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP---------- 257 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC----------
T ss_pred C--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC----------
Confidence 2 1123346788999999999989999999999999999999999998754322222111111100000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.....++.++.+++.+||..||.+|||++++++.|++++..
T Consensus 258 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 258 -------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp -------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00134566799999999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=322.62 Aligned_cols=268 Identities=16% Similarity=0.239 Sum_probs=206.8
Q ss_pred CCCCCceecccCceEEEEEEeCC------CcEEEEEEeeccchhHH-----------HHHHHHHHHHccCCCCccccccc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGD------GMEVAVKVFNLQYGRVF-----------KSFDVECEMMKSIHHRNIIKVIS 63 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~------~~~~~iK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~~ 63 (285)
+|++.+.||+|+||.||+|.... ++.||+|++........ .....|+..++.++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 37889999999999999997543 47899999875542211 12334666778889999999999
Q ss_pred eeccC----CceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCC
Q 039392 64 SCSNE----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD--DNM 137 (285)
Q Consensus 64 ~~~~~----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~--~~~ 137 (285)
++... ...++|||++ +++|.+++......++...++.++.||+.||.||| ++|++||||||+||+++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCCC
Confidence 98664 4589999999 88999999877667999999999999999999999 99999999999999998 889
Q ss_pred cEEEeeeccceecCcccccce-----eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhh
Q 039392 138 VAHLSDFGIAKLLTREDISTI-----QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL 212 (285)
Q Consensus 138 ~~~i~df~~~~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~ 212 (285)
.++|+|||++........... .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999987654322111 123448999999999999999999999999999999999999998643332221
Q ss_pred hhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 213 KHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
......... ......+. ......++.++.+++..||..+|.+|||++++++.|+++.++.
T Consensus 272 ~~~~~~~~~-~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 272 RDSKIRYRE-NIASLMDK---------CFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHH-CHHHHHHH---------HSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHhhh-hHHHHHHH---------hcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 111111000 00000000 0001345778999999999999999999999999999998765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=312.13 Aligned_cols=254 Identities=29% Similarity=0.414 Sum_probs=198.9
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||+||++... ++.||+|.+... ...+.+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 3678899999999999999874 788999998643 345678899999999999999999998874 47899999999
Q ss_pred CCHHHhhhcCCC--ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc-EEEeeeccceecCcccccc
Q 039392 81 GSLEKYLHSSNY--ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV-AHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 81 ~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~-~~i~df~~~~~~~~~~~~~ 157 (285)
++|.+++..... .++...++.++.|++.||.|||..+.+|++|+||||+||+++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999999976543 3788899999999999999999322289999999999999998886 799999999765432
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....+++.|+|||.+.+..++.++||||||+++++|++|..||...................
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 222 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---------------- 222 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----------------
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----------------
Confidence 123458899999999999899999999999999999999999997543322211111110000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
......++..+.+++.+||..||.+|||++++++.|+++.+.+
T Consensus 223 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 223 --PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp --CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred --CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 0012345667999999999999999999999999999987644
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=314.88 Aligned_cols=261 Identities=24% Similarity=0.387 Sum_probs=212.6
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeeccch-hHHHHHHHHHHHHccC-CCCccccccceeccCC-ce
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNIIKVISSCSNEE-FK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~ 71 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++...+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 477889999999999999963 3568899999875433 3446788999999999 6999999999987654 58
Q ss_pred EEEEeccCCCCHHHhhhcCCCc---------------cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYI---------------LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN 136 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~---------------~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~ 136 (285)
++|||++++++|.+++...... ++...++.++.|++.||.||| +.|++|+||||+||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCC
Confidence 9999999999999999765432 789999999999999999999 9999999999999999999
Q ss_pred CcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhh
Q 039392 137 MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHW 215 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 215 (285)
+.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 264 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence 9999999999987655443334445567889999999988899999999999999999998 999987654333222221
Q ss_pred hhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 216 VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
..... ...+..+++++.+++.+||..||.+|||+++++++|+++.+...
T Consensus 265 ~~~~~-------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 265 KEGTR-------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHTCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccCcc-------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11110 00122346679999999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=333.23 Aligned_cols=253 Identities=25% Similarity=0.437 Sum_probs=208.2
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
|++.+.||+|+||+||+|...++..||||.+.... ...+.+.+|+++++.++||||+++++++. .+..++|||+++++
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g 267 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKG 267 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCC
Confidence 56778999999999999998888999999987543 34577889999999999999999999987 55788999999999
Q ss_pred CHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 82 SLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 82 ~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
+|.+++.... ..++...++.++.||+.||.||| +++++||||||+||+++.++.+||+|||++....... .....
T Consensus 268 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~ 343 (454)
T 1qcf_A 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTARE 343 (454)
T ss_dssp BHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTC
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccC
Confidence 9999997543 24888899999999999999999 9999999999999999999999999999998765422 11122
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...++..|+|||.+....++.++||||||+++|+|++ |..||.+....+.... .... .+
T Consensus 344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~-------------------~~ 403 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERG-------------------YR 403 (454)
T ss_dssp SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHHT-------------------CC
T ss_pred CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcC-------------------CC
Confidence 3445778999999988889999999999999999999 9999976433222111 1110 01
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
...+..+++++.++|.+||..||.+|||++++++.|+++..
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11134567789999999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=319.32 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=204.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 4778899999999999999854 78999999986543 2344667889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++.+... +++..++.++.||+.||.||| ++|++||||||+||+++.+|.++|+|||++.......
T Consensus 122 ~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-- 195 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp CCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred CCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence 9999999999976544 899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....+|+.|+|||++.+..++.++|+||||+++|+|++|..||......+. ..........
T Consensus 196 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~--------------- 256 (350)
T 1rdq_E 196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-YEKIVSGKVR--------------- 256 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC---------------
T ss_pred ---ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-HHHHHcCCCC---------------
Confidence 345689999999999999999999999999999999999999975432211 1111111000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
.+..++.++.++|.+||+.||.+||+ +++++++
T Consensus 257 -----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 -----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 12245677999999999999999998 8888764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=314.86 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=191.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 589999999999999999975 4689999999875432 23356778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCC-----CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 79 PHGSLEKYLHSSN-----YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 79 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
++ +|.+++.... ..++...++.++.||+.||.||| ++|++|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 DN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp CC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred CC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 75 9998876432 34889999999999999999999 999999999999999999999999999999876533
Q ss_pred cccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc----
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV---- 228 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 228 (285)
. .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+....+. ...............+.
T Consensus 162 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 162 V--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp C--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCTTTCGGGGG
T ss_pred c--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhHhhhhhh
Confidence 2 122345678999999998764 689999999999999999999999976433221 11111111110000000
Q ss_pred ----cccccCccc------chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 ----DPNLLSRED------IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ----~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+....... .........+.++.+|+.+||+.||.+|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000000 0011122456789999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=317.69 Aligned_cols=271 Identities=24% Similarity=0.399 Sum_probs=210.5
Q ss_pred CCCCceecccCceEEEEEEe-----CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceecc--CCceEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-----GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 73 (285)
|++++.||+|+||+||++.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 37889999999999988752 368899999987654 3445678899999999999999999999976 467899
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|||++++++|.+++.... ++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999997654 899999999999999999999 999999999999999999999999999999877653
Q ss_pred ccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhc-CCCcccccccc
Q 039392 154 DIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL-PISTKEIVDPN 231 (285)
Q Consensus 154 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (285)
... .......++..|+|||.+.+..++.++||||||+++++|++|..||............+..... .........
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 265 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-- 265 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH--
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh--
Confidence 322 2223455778899999999889999999999999999999999998653221111000000000 000000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
.......+..++.++.+++++||..||.+|||++++++.|+++.+++-
T Consensus 266 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 ----RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 001111234567789999999999999999999999999999988763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=328.39 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=205.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|.+++.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4788999999999999999854 79999999987543 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++.... .+++..++.++.||+.||.||| ++|++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 97 YVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp CCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 999999999997654 4999999999999999999999 9999999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||........ .........
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~--------------- 233 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-FKKICDGIF--------------- 233 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-HHHHHTTCC---------------
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-HHHHhcCCc---------------
Confidence 2234568999999999988765 7899999999999999999999976432221 111111100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..+++++.+++++||..||.+|||+++++++
T Consensus 234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0122345679999999999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=316.72 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=194.2
Q ss_pred CCCCCceecccCceEEEEEEe----CCCcEEEEEEeeccc----hhHHHHHHHHHHHHccCCCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY----GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 478889999999999999975 478999999987542 233456778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+|||++++++|.+++..... ++...++.++.||+.||.||| ++|++|+||||+||+++.+|.++|+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGI-FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEeCCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 99999999999999876543 889999999999999999999 99999999999999999999999999999875433
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++|..||........ .........
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~------------ 238 (327)
T 3a62_A 174 DG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-IDKILKCKL------------ 238 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCC------------
T ss_pred CC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCC------------
Confidence 21 122345689999999999988999999999999999999999999976432221 111111100
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
..+...+.++.+++.+||..||.+|| ++++++++
T Consensus 239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01223567799999999999999999 78888764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=321.56 Aligned_cols=246 Identities=23% Similarity=0.321 Sum_probs=201.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+..|..++..+ +||||+++++++...+.+++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 578899999999999999985 468999999987542 23345677888888876 8999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++++|.+++.+... +++..++.++.||+.||.||| ++|++||||||+||+++.+|.++|+|||++.......
T Consensus 98 E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 172 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 172 (345)
T ss_dssp ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred eCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence 99999999999976544 899999999999999999999 9999999999999999999999999999997543221
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+|+.|+|||++.+..++.++|+||||+++|+|++|..||......+. .........
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~--------------- 235 (345)
T 1xjd_A 173 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMDNP--------------- 235 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC---------------
T ss_pred -CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHhCCC---------------
Confidence 122456789999999999999999999999999999999999999976432211 111111000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHH-HHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK-EIVT 273 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-eil~ 273 (285)
..+..++.++.+++.+||..||.+||++. ++++
T Consensus 236 -----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 -----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 00123567799999999999999999997 6653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=308.56 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=204.9
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++......++|||++++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 778899999999999999754 5788999998876555667888999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCcEEEeeeccceecCcccccc
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++|.+++..... +++..++.++.|++.||.+|| ++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 91 ~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--- 163 (277)
T 3f3z_A 91 GELFERVVHKRV-FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--- 163 (277)
T ss_dssp CBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---
Confidence 999998876544 899999999999999999999 9999999999999999 788999999999998765432
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......+++.|+|||.+.+. ++.++||||||+++++|++|..||......+.... ........
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~--------------- 226 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK-IREGTFTF--------------- 226 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHCCCCC---------------
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH-HHhCCCCC---------------
Confidence 22345688999999988654 89999999999999999999999976433221111 11110000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+++++.+++.+||+.||.+|||+.+++++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 -PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp -CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122457789999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=321.49 Aligned_cols=259 Identities=26% Similarity=0.465 Sum_probs=198.5
Q ss_pred CCCCceecccCceEEEEEEe--CCC--cEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceec-cCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL--GDG--MEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCS-NEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~--~~~--~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~ 75 (285)
|++.+.||+|+||+||+|.. .++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 45678999999999999974 232 457999886433 345677889999999999999999999864 456788999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++........
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999877666899999999999999999999 99999999999999999999999999999986644321
Q ss_pred c--ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 156 S--TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 156 ~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
. .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... .....
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-~~~~~------------- 313 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGR------------- 313 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-HHTTC-------------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-HHcCC-------------
Confidence 1 11223456778999999998899999999999999999999 6677765433222111 11000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
....+..++..+.+++.+||..||.+|||++++++.|+++..++.
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 001123456779999999999999999999999999999988764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=308.79 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=209.1
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+++++.++||||+++++++.. +..++|||++++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 3678899999999999999988888999999875432 34678899999999999999999999874 458899999999
Q ss_pred CCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++.... ..++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 167 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAR 167 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECC
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccc
Confidence 99999987543 24889999999999999999999 9999999999999999999999999999998765432 1122
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||.+.+..++.++||||||+++++|++ |..||......+.. .......
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~~~~~~~------------------- 227 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGY------------------- 227 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTC-------------------
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-HHHhccc-------------------
Confidence 33456778999999988889999999999999999999 89998764332211 1111100
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
....+..++.++.+++.+||..||.+|||++++++.|+++....
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 00112345677999999999999999999999999999988653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=320.58 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=195.7
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCC--CccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHH--RNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|++.+.||+|+||.||++...+++.||+|++.... ....+.+.+|+.+++.++| +||+++++++......++|||+
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~ 90 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC
Confidence 78899999999999999988889999999987543 3445778899999999976 9999999999999999999995
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
.+++|.+++.... .++...++.++.|++.||.||| ++|++||||||+||+++ ++.++|+|||++..........
T Consensus 91 -~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 91 -GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp -CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred -CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 4779999997754 4899999999999999999999 99999999999999997 6789999999998775543333
Q ss_pred eeccccccccccCCcccCC-----------CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 158 IQTQTLATIGYMAPEYGKE-----------GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||....................
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---- 240 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI---- 240 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC----
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc----
Confidence 3345678999999998754 6789999999999999999999999976433222222111111100
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+...+.++.+++.+||..||.+|||+++++++
T Consensus 241 --------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 --------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0012234568899999999999999999999876
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=307.92 Aligned_cols=250 Identities=21% Similarity=0.337 Sum_probs=204.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..+++||+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 588899999999999999975 468999999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc---EEEeeeccceecCccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLTRED 154 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~i~df~~~~~~~~~~ 154 (285)
+++++|.+.+..... ++...++.++.|++.||.+|| +.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 87 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 87 VTGGELFEDIVAREF-YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred CCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 999999888866543 899999999999999999999 999999999999999986655 9999999998765432
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
......+++.|+|||.+.+..++.++||||||+++++|++|..||........... .........
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~----------- 227 (284)
T 3kk8_A 163 ---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ-IKAGAYDYP----------- 227 (284)
T ss_dssp ---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHTCCCCC-----------
T ss_pred ---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH-HHhccccCC-----------
Confidence 22345689999999999999999999999999999999999999965432221111 111111000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+++++.+++.+||..||.+|||+++++++
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 -----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00123456779999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=330.18 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=203.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|..+++.++||||+++++++.+...+++|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4778899999999999999754 68899999986532 1222447789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++|++|.+++... .+++..++.++.||+.||.||| ++|++||||||+||+++.+|.+||+|||++....... .
T Consensus 150 ~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~ 223 (410)
T 3v8s_A 150 YMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M 223 (410)
T ss_dssp CCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-E
T ss_pred CCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-c
Confidence 99999999998754 3899999999999999999999 9999999999999999999999999999998765432 1
Q ss_pred ceeccccccccccCCcccCCCc----cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGR----VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.......+|+.|+|||++.+.. ++.++|+||||+++|+|++|..||.+...... .........
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~------------ 290 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMNHKN------------ 290 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHH------------
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HHHHHhccc------------
Confidence 2234567999999999987665 88999999999999999999999976432221 111111100
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCC--CCCHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~~ 274 (285)
...++....++.++.+||.+||..+|.+ ||+++|++++
T Consensus 291 ----~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 ----SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0011112245677999999999999988 9999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=314.59 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=205.1
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchh------HHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGR------VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
|++.+.||+|+||.||++... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++......++|
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 788999999999999999754 6899999998754321 356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----cEEEeeeccceec
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLL 150 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~i~df~~~~~~ 150 (285)
||++++++|.+++.... .++...++.++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 94 LELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp ECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999997654 4899999999999999999999 99999999999999999887 7999999999876
Q ss_pred CcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+. ..........
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~--------- 236 (321)
T 2a2a_A 170 EDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITSVSYD--------- 236 (321)
T ss_dssp CTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCC---------
T ss_pred Cccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcccc---------
Confidence 5432 12345688999999999988999999999999999999999999975332211 1111110000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+..+.+++.+||..||.+|||+++++++
T Consensus 237 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 -------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011123456779999999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=308.00 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=185.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch---hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 478899999999999999975 5799999999865432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++......++...++.++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999999999876666999999999999999999999 999999999999999999999999999999876533211
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+++.|+|||.+.+..++.++||||||+++++|++|..||........... . ...
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~----~~~-- 227 (278)
T 3cok_A 169 --HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-------------V----VLA-- 227 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------C----CSS--
T ss_pred --ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-------------H----hhc--
Confidence 1234678899999999988899999999999999999999999875322111000 0 000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+...+.++.+++.+||..||.+|||+++++++
T Consensus 228 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 --DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 001123456779999999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=323.69 Aligned_cols=274 Identities=20% Similarity=0.274 Sum_probs=212.3
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCC--ceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE--FKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~ 77 (285)
|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..++|||+
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 788999999999999999864 58999999987543 233466778999999999999999999987654 77999999
Q ss_pred cCCCCHHHhhhcCCC--ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCcEEEeeeccceecC
Q 039392 78 MPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~i~df~~~~~~~ 151 (285)
+++++|.+++..... .+++..++.++.|++.||+||| ++|++|+||||+||++ +.++.+||+|||++....
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999999999976432 2899999999999999999999 9999999999999999 788889999999998765
Q ss_pred cccccceeccccccccccCCcccCC--------CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhh---hhhc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE--------GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWV---NDWL 220 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~ 220 (285)
... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.............. ...+
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred CCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 532 2234568999999998764 4678899999999999999999999976443332222221 1111
Q ss_pred CCCccccccccc-----cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 221 PISTKEIVDPNL-----LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 221 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
............ ....+.........+..+.+++++||..||++|||++++++.++++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111100000000 0001111223467788899999999999999999999999999988764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=318.53 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=189.8
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|++++++++||||+++++++......++|||++++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 778899999999999999864 68899999987543 235677899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCcEEEeeeccceecCcccccc
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||++.......
T Consensus 133 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--- 205 (349)
T 2w4o_A 133 GELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--- 205 (349)
T ss_dssp CBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc---
Confidence 99999987654 3899999999999999999999 999999999999999975 8999999999998665422
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....................
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~-------------- 271 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI-------------- 271 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC--------------
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC--------------
Confidence 123456899999999999989999999999999999999999999764433322222211111000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......++.++.+++++||..||.+|||+++++++
T Consensus 272 --~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 --SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00123456779999999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=319.02 Aligned_cols=247 Identities=19% Similarity=0.256 Sum_probs=202.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+..|..++..+ +||+|+++++++...+.+++||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 5788999999999999999864 58899999987542 23446677899999888 7999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||++|++|.+++.+... +++..++.++.||+.||.||| ++|++||||||+||+++.+|.++|+|||++.......
T Consensus 101 E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 99999999999976544 899999999999999999999 9999999999999999999999999999997543221
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+|+.|+|||++.+..++.++|+||||+++|+|++|..||......+. .........
T Consensus 176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~~~--------------- 238 (353)
T 2i0e_A 176 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSIMEHNV--------------- 238 (353)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC---------------
T ss_pred -cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-HHHHHhCCC---------------
Confidence 122445789999999999999999999999999999999999999976432211 111111100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
..+...+.++.+++.+||..||.+||+ +++++++
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 012245677999999999999999995 5777654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=316.29 Aligned_cols=260 Identities=23% Similarity=0.372 Sum_probs=211.0
Q ss_pred CCCCCceecccCceEEEEEEeC-CC-----cEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DG-----MEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~-----~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||.||+|... ++ ..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 4677899999999999999753 22 479999987543 33456788999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcE
Q 039392 73 LVLEYMPHGSLEKYLHSS-------------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVA 139 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~ 139 (285)
+|||++++++|.+++... ...++...++.++.|++.||.||| +.|++|+||+|+||+++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeE
Confidence 999999999999998653 234789999999999999999999 9999999999999999999999
Q ss_pred EEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhh
Q 039392 140 HLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVND 218 (285)
Q Consensus 140 ~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 218 (285)
+|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||................
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 283 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence 9999999987654433333344556788999999988889999999999999999998 889987644332222111111
Q ss_pred hcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 219 WLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
. .. ..+..++.++.+++.+||..||.+|||++++++.|+++..+.
T Consensus 284 ~-~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 284 Y-QM------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp C-CC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C-CC------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 0 00 012234567899999999999999999999999999988654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=318.46 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=196.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCc----eE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF----KA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~ 72 (285)
.|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 478899999999999999985 578999999987542 3445678899999999999999999999866543 48
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+|||++++++|.+++.... .++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++.....
T Consensus 93 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 9999999999999997654 3899999999999999999999 99999999999999999999999999999987654
Q ss_pred cccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 153 EDIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 153 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||................
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~------------- 235 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED------------- 235 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------------
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-------------
Confidence 3211 12233568999999999999999999999999999999999999997643322221111100
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHH-HHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV-TKLVKI 278 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil-~~l~~l 278 (285)
..........++.++.+++.+||+.||.+||++.+++ ..+.++
T Consensus 236 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 236 ----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0001111234677899999999999999999655544 455444
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=316.64 Aligned_cols=257 Identities=22% Similarity=0.393 Sum_probs=208.5
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 3678899999999999999643 47889999987543 3344668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC---------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 74 VLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
|||++++++|.+++.... ..++...++.++.|++.||.+|| ++|++|+||||+||+++.++.++|+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcC
Confidence 999999999999986532 23688999999999999999999 999999999999999999999999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... ......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~--- 258 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-VMEGGL--- 258 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH-HHTTCC---
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH-HHcCCc---
Confidence 99986654332233334456788999999988889999999999999999999 8889876432221111 110000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
...+..++.++.+++.+||..||.+|||++++++.|+++..
T Consensus 259 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 259 ----------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00123456779999999999999999999999999987653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=322.32 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=196.7
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCC--CCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIH--HRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.+++.+. ||||+++++++...+.+++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 78899999999999999988779999999986543 345577889999999996 5999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+.+++|.+++.... .++...++.++.||+.||.||| +.|++||||||+||+++ ++.+||+|||++..........
T Consensus 137 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 137 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 55779999997765 4888899999999999999999 99999999999999995 5899999999998765443333
Q ss_pred eeccccccccccCCcccCC-----------CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 158 IQTQTLATIGYMAPEYGKE-----------GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.....................
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~--- 288 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE--- 288 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC---
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC---
Confidence 3345678999999998765 36889999999999999999999999764332222221111111000
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+...+.++.+++.+||..||.+|||+++++++
T Consensus 289 ---------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 289 ---------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 011224568899999999999999999999865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=314.15 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=202.6
Q ss_pred CCCCceecccCceEEEEEEeCC-----CcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLGD-----GMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~-----~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence 5667899999999999996432 3469999987543 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++........
T Consensus 126 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 126 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 999999999999876666999999999999999999999 99999999999999999999999999999987654321
Q ss_pred c-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 156 S-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
. .......++..|+|||.+.+..++.++||||||+++++|++ |..||......+. ........
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~-------------- 267 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKAINDGF-------------- 267 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTTC--------------
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH-HHHHHCCC--------------
Confidence 1 11223345778999999988899999999999999999999 9999865432211 11111100
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
....+..++.++.+++.+||..||.+|||++++++.|+++.+.
T Consensus 268 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 268 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011234567799999999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=312.39 Aligned_cols=258 Identities=22% Similarity=0.279 Sum_probs=200.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 5888999999999999999854 78999999987542 3345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++.... .++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 115 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 189 (309)
T 2h34_A 115 LINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL- 189 (309)
T ss_dssp CCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-
Confidence 999999999997654 3899999999999999999999 99999999999999999999999999999876654321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ...........
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~--------------- 252 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIP--------------- 252 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCC---------------
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCC---------------
Confidence 1223456889999999999989999999999999999999999999764322 11111110000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC-CHHHHHHHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLVKIRDS 281 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~eil~~l~~l~~~ 281 (285)
........++.++.+++.+||..||.+|| |++++++.|+++..+
T Consensus 253 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 253 -RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 00011335567799999999999999999 999999999887543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=319.76 Aligned_cols=251 Identities=23% Similarity=0.249 Sum_probs=192.9
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.|++.+.||+|+||+||+++.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4788999999999999999864 789999999875432 23567789999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc--EEEeeeccceecCcccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV--AHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--~~i~df~~~~~~~~~~~~~ 157 (285)
+++|.+++..... ++...++.++.|++.||.||| ++|++||||||+||+++.++. +||+|||++...... .
T Consensus 100 ~~~L~~~l~~~~~-~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~ 172 (361)
T 3uc3_A 100 GGELYERICNAGR-FSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---S 172 (361)
T ss_dssp SCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc---C
Confidence 9999999876544 999999999999999999999 999999999999999987665 999999998743322 1
Q ss_pred eeccccccccccCCcccCCCccCcc-hhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSAN-GDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||................. ....
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~-~~~~------------ 239 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL-SVKY------------ 239 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH-TTCC------------
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh-cCCC------------
Confidence 2234568999999999888776555 8999999999999999999976544332222111110 0000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+.....+++++.+|+.+||..||.+|||+++++++
T Consensus 240 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 --SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001122346778999999999999999999999976
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=328.73 Aligned_cols=254 Identities=19% Similarity=0.248 Sum_probs=204.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch---hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|..++..++||||+++++++.+.+.+++|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4778899999999999999864 588999999875321 222347889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.+....+++..++.++.||+.||.||| +.|++||||||+||+++.+|.+||+|||++....... .
T Consensus 155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~ 230 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-T 230 (437)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-C
T ss_pred cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-C
Confidence 99999999999875556999999999999999999999 9999999999999999999999999999997765432 2
Q ss_pred ceeccccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
.......+|+.|+|||++. ...++.++|+||||+++|+|++|..||.+....+.. ...........
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~~~~-------- 301 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-GKIMNHKERFQ-------- 301 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHTHHHHCC--------
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH-Hhhhhcccccc--------
Confidence 2223457899999999886 567899999999999999999999999764332221 11111000000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCC--CCCHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~~ 274 (285)
.+.. ...+++++.+||++||+.+|++ ||+++|++++
T Consensus 302 -~p~~------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 302 -FPTQ------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -CCSS------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -CCcc------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000 1235677999999999998988 9999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=316.06 Aligned_cols=267 Identities=20% Similarity=0.255 Sum_probs=199.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhH-HHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRV-FKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||+||+|... +++.||+|++....... ...+.+|+++++.++||||+++++++...+..++|||++
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 5889999999999999999864 78999999987544322 124457999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++ +|.+++......++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~ 156 (324)
T 3mtl_A 83 DK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KT 156 (324)
T ss_dssp SE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cc
Confidence 75 899988877767999999999999999999999 9999999999999999999999999999998654332 22
Q ss_pred eccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc---c----
Q 039392 159 QTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD---P---- 230 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 230 (285)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+. ...............+.. .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHhchhhhcchhhc
Confidence 234567899999998876 5689999999999999999999999976433222 222211111111100000 0
Q ss_pred -ccc--CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 -NLL--SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 -~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
... ............+++++.+|+.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 00001112233567889999999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=331.89 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=209.6
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++......++|||++++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence 567789999999999999865 488999999875433 357788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
++|.+++... ...++...++.++.||+.||.||| +++++||||||+||+++.++.+||+|||++....... ....
T Consensus 301 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~ 376 (495)
T 1opk_A 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH 376 (495)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECC
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-eeec
Confidence 9999999764 345889999999999999999999 9999999999999999999999999999998765432 2222
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. . .... ..
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~-~~~~------------------~~ 436 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-E-LLEK------------------DY 436 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-H-HHHT------------------TC
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-H-HHHc------------------CC
Confidence 33445678999999988899999999999999999999 99998764432211 1 1110 00
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
+...+..++.++.++|.+||+.||.+|||++++++.|+.+.
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11123456778999999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=312.49 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=196.6
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCC---------
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE--------- 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 69 (285)
+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 4788999999999999999865 79999999987544 335577889999999999999999999875432
Q ss_pred ------------------------------------------------ceEEEEeccCCCCHHHhhhcCCC--ccCHHHH
Q 039392 70 ------------------------------------------------FKALVLEYMPHGSLEKYLHSSNY--ILDIYQR 99 (285)
Q Consensus 70 ------------------------------------------------~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~ 99 (285)
..+++||++++++|.+++..... ..+...+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 37899999999999999976543 2556678
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc----------ceecccccccccc
Q 039392 100 LNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS----------TIQTQTLATIGYM 169 (285)
Q Consensus 100 ~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~----------~~~~~~~~~~~~~ 169 (285)
+.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++......... .......+++.|+
T Consensus 167 ~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 999999999999999 999999999999999999999999999999877653211 1223456899999
Q ss_pred CCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHH
Q 039392 170 APEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSF 249 (285)
Q Consensus 170 ~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
|||.+.+..++.++||||||+++++|++|..|+..... ........ . ........+++
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-------~~~~~~~~---------~------~~~~~~~~~~~ 301 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-------IITDVRNL---------K------FPLLFTQKYPQ 301 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-------HHHHHHTT---------C------CCHHHHHHCHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-------HHHHhhcc---------C------CCcccccCChh
Confidence 99999999999999999999999999998776432110 00000000 0 00113455677
Q ss_pred HHHhhhcccccCcCCCCCHHHHHHH
Q 039392 250 VFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 250 l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+.+++.+||..||.+|||+++++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 8999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=319.02 Aligned_cols=264 Identities=13% Similarity=0.144 Sum_probs=206.2
Q ss_pred CCCCCceecccCceEEEEEEeC---------CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccc----------
Q 039392 1 GFSENNLIGRGGFGSVFKARLG---------DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV---------- 61 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~---------- 61 (285)
+|++.+.||+|+||.||+|... +++.||+|++... +.+.+|++++++++||||+++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 4778899999999999999764 3789999998754 456789999999999999984
Q ss_pred -----cceecc-CCceEEEEeccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 039392 62 -----ISSCSN-EEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD 134 (285)
Q Consensus 62 -----~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~ 134 (285)
++++.. ....++|||++ +++|.+++... ...+++..++.++.||+.||.||| ++|++|+||||+||+++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEc
Confidence 444443 67889999999 88999999765 345999999999999999999999 99999999999999999
Q ss_pred CCC--cEEEeeeccceecCcccccc-----eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccc
Q 039392 135 DNM--VAHLSDFGIAKLLTREDIST-----IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFN 207 (285)
Q Consensus 135 ~~~--~~~i~df~~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 207 (285)
.++ .++|+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 988 99999999998765432211 11334688999999999998999999999999999999999999987543
Q ss_pred cchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 208 GEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
................. .... .......++.++.+++.+||..||.+|||++++++.|+++.++..
T Consensus 274 ~~~~~~~~~~~~~~~~~-~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPG-PFVG---------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp CHHHHHHHHHHHHHSCC-CEEC---------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHhccCChh-hhhh---------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 33322222211111100 0000 000122446779999999999999999999999999999987753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=309.92 Aligned_cols=267 Identities=21% Similarity=0.259 Sum_probs=200.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||+
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 4888999999999999999864 68999999886543 23356678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++++|.+++.... .++...++.++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 157 (311)
T 4agu_A 84 CDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--D 157 (311)
T ss_dssp CSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--c
Confidence 99988988876554 4899999999999999999999 9999999999999999999999999999998765432 1
Q ss_pred eeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc--------cccc
Q 039392 158 IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST--------KEIV 228 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 228 (285)
......+++.|+|||.+.+ ..++.++||||||+++++|++|..||......+.... .......... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL-IRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHHHHHHTCGGG
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhccccccccccccccccc
Confidence 2234568889999998876 5689999999999999999999999976543322111 1100000000 0000
Q ss_pred cccccC---cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DPNLLS---REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...... ...........++.++.+++.+||..||.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 0000011123567789999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=315.14 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=203.9
Q ss_pred CCCCCceecccCceEEEEEEe------CCCcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++......++
T Consensus 31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (327)
T 2yfx_A 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 110 (327)
T ss_dssp GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEE
Confidence 488899999999999999973 35778999998643 23445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCcEEEeee
Q 039392 74 VLEYMPHGSLEKYLHSSN------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDF 144 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~i~df 144 (285)
|||++++++|.+++.... ..++...++.++.|++.||.||| +.|++|+||+|+||+++. +..++|+||
T Consensus 111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 999999999999997653 34888999999999999999999 999999999999999984 446999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ...... ..
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~-~~-- 263 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-EFVTSG-GR-- 263 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHHTT-CC--
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH-HHHhcC-CC--
Confidence 99875543322223334567888999999988889999999999999999998 88998654322111 111100 00
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
...+..++..+.+++.+||..||.+|||+++++++|+.+.++
T Consensus 264 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 ----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 001234567799999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=305.56 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=200.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 478899999999999999975 467899999986543 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++..... ++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~l~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 90 YAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp CCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence 9999999999876544 899999999999999999999 9999999999999999999999999999986544321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+++.|+|||.+.+..++.++||||||+++++|++|..||......... .......
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~----------------- 223 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-KRISRVE----------------- 223 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHHTC-----------------
T ss_pred --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-HHHHhCC-----------------
Confidence 23446789999999999999999999999999999999999999753322111 1111000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+...+.++.+++.+||..||.+|||+++++++
T Consensus 224 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00122356678999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=314.97 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=199.3
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-----hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-----GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 77889999999999999975 568899999986542 345577889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcC---------------------------------------CCccCHHHHHHHHHHHHHHHHHHhcC
Q 039392 76 EYMPHGSLEKYLHSS---------------------------------------NYILDIYQRLNIMIDVASTLEYLHFG 116 (285)
Q Consensus 76 e~~~~~~L~~~~~~~---------------------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~ 116 (285)
|++++++|.+++... ...+++..++.++.|++.||.|||
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-- 185 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-- 185 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--
Confidence 999999999988521 112467788999999999999999
Q ss_pred CCCCeeecCCCCCCeeeCCCC--cEEEeeeccceecCcccc--cceeccccccccccCCcccCC--CccCcchhhHHHHH
Q 039392 117 YSAQVIHCDLKPSNVLLDDNM--VAHLSDFGIAKLLTREDI--STIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGI 190 (285)
Q Consensus 117 ~~~~~~h~di~~~nili~~~~--~~~i~df~~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~ 190 (285)
+.|++|+||+|+||+++.++ .++|+|||++........ ........+++.|+|||.+.+ ..++.++||||||+
T Consensus 186 -~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp -HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred -HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 99999999999999998776 899999999986543221 112345568999999998865 57899999999999
Q ss_pred HHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHH
Q 039392 191 MLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270 (285)
Q Consensus 191 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e 270 (285)
++|+|++|..||......+...... ..... ........+++++.+++.+||+.||.+|||+.+
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~-~~~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVL-NKKLC----------------FENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHH-HCCCC----------------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHH-hcccc----------------cCCcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999999999997644332221111 11000 001112345778999999999999999999999
Q ss_pred HHHH
Q 039392 271 IVTK 274 (285)
Q Consensus 271 il~~ 274 (285)
++++
T Consensus 328 ~l~h 331 (345)
T 3hko_A 328 ALQH 331 (345)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=324.36 Aligned_cols=263 Identities=22% Similarity=0.231 Sum_probs=195.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccC------Cce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE------EFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 71 (285)
+|++++.||+|+||+||+|.. .+++.||||++... .......+.+|+.+++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 477899999999999999975 46899999998754 334456788999999999999999999998654 456
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++|||++++ ++.+.+.. .++...++.++.||+.||.||| ++|++||||||+||+++.++.+||+|||++....
T Consensus 143 ~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 999999976 56666643 2889999999999999999999 9999999999999999999999999999998765
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK------ 225 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 225 (285)
... ......+|+.|+|||++.+..++.++|||||||++++|++|..||.+....+. ..............
T Consensus 216 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp -CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTSC
T ss_pred CCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHcc
Confidence 421 22445789999999999999999999999999999999999999976432211 11111111100000
Q ss_pred --------------ccccccccCc--ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 --------------EIVDPNLLSR--EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 --------------~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+..... ...........++++.+|+.+||..||.+|||++|+|++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 000111123347789999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=304.46 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=205.6
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch------hHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG------RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 3788999999999999999865 689999999875431 135678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----cEEEeeecccee
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKL 149 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~i~df~~~~~ 149 (285)
|||++++++|.+++.... .++...++.++.|++.||.+|| +.|++|+||+|+||+++.++ .++|+|||++..
T Consensus 86 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999999997654 3899999999999999999999 99999999999999998877 899999999987
Q ss_pred cCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
..... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+. .........
T Consensus 162 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~--------- 228 (283)
T 3bhy_A 162 IEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNISAVNY--------- 228 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCC---------
T ss_pred ccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHhHhccc---------
Confidence 65432 12344688899999999988999999999999999999999999976432211 111110000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH--HHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT--KLVKIRD 280 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~--~l~~l~~ 280 (285)
..........+..+.+++.+||..||.+|||++++++ .++++++
T Consensus 229 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 229 -------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp -------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred -------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0011122355777999999999999999999999998 4555554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=313.78 Aligned_cols=249 Identities=20% Similarity=0.262 Sum_probs=181.4
Q ss_pred CceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEeccCCCC
Q 039392 5 NNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYMPHGS 82 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 82 (285)
.+.||+|+||+||++.. .+++.||+|++... ......+|+.+++.+. ||||+++++++......++|||++++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999975 46899999998644 3355678999999997 9999999999999999999999999999
Q ss_pred HHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---cEEEeeeccceecCccccccee
Q 039392 83 LEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 83 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~i~df~~~~~~~~~~~~~~~ 159 (285)
|.+++.... .+++..++.++.|++.||.||| ++|++|+||||+||+++.++ .++|+|||++....... ...
T Consensus 93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 166 (325)
T 3kn6_A 93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL 166 (325)
T ss_dssp HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence 999997754 4999999999999999999999 99999999999999997665 89999999998665432 222
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccch--hhhhhhhhhcCCCccccccccccCccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM--TLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
....+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ........... ....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~------------~~~~ 234 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK------------GDFS 234 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT------------TCCC
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc------------CCCC
Confidence 345678999999999999999999999999999999999999976432110 00111111100 0111
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........+++++.+++.+||..||.+|||+++++++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1112234567889999999999999999999998743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=307.52 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=204.9
Q ss_pred CCCCc-eecccCceEEEEEEe---CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 2 FSENN-LIGRGGFGSVFKARL---GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 2 y~~~~-~lg~G~~~~v~~~~~---~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
|++.+ .||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++ ..+..++||
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 96 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM 96 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence 55566 999999999999953 347889999987543 33457788999999999999999999999 566788999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++..... ++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 97 e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 97 EMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp ECCTTEEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EeCCCCCHHHHHHhCcC-CCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999999999977544 899999999999999999999 99999999999999999999999999999987654332
Q ss_pred cc-eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 156 ST-IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.. ......+++.|+|||.+.+..++.++||||||+++++|++ |..||......+.. ........
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~~~~~~------------ 238 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT--AMLEKGER------------ 238 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH--HHHHTTCC------------
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHHcCCC------------
Confidence 21 1223345678999999988889999999999999999999 99999764332211 11110000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...+..+++++.+++.+||..||.+|||++++++.|+++..+.
T Consensus 239 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 239 ------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 0012345677999999999999999999999999999998764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=307.55 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=199.1
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc-CCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN-EEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~ 79 (285)
+|++.+.||+|+||+||++.. +|+.||+|++.... ..+.+.+|+++++.++||||+++++++.. .+..++|||+++
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 377889999999999999987 48899999987543 44678899999999999999999998654 457899999999
Q ss_pred CCCHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 80 HGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 80 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+++|.+++..... .++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 171 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 171 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence 9999999876433 3788899999999999999999 9999999999999999999999999999987654321
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
....+++.|+|||.+.+..++.++||||||+++++|++ |..||......+.. ......
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~~~~~------------------- 230 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKG------------------- 230 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHHTTT-------------------
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcC-------------------
Confidence 23356778999999988889999999999999999998 99998764322211 111000
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
.....+..+++++.+++.+||..||.+|||++++++.|++++..-
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 001112345778999999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=312.83 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=204.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEE--EEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEV--AVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~--~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+|.. .++..+ ++|.+.... ....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 478899999999999999974 356654 899886432 33456788999999999 8999999999999999999999
Q ss_pred eccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEE
Q 039392 76 EYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH 140 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~ 140 (285)
|++++++|.+++.... ..++...++.++.||+.||.+|| ++|++|+||+|+||+++.++.++
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEE
Confidence 9999999999987643 35899999999999999999999 99999999999999999999999
Q ss_pred EeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhh
Q 039392 141 LSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDW 219 (285)
Q Consensus 141 i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 219 (285)
|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ......
T Consensus 183 L~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-~~~~~~- 257 (327)
T 1fvr_A 183 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLPQG- 257 (327)
T ss_dssp ECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHGGGT-
T ss_pred EcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH-HHhhcC-
Confidence 99999987543221 1223446778999999988889999999999999999998 99999764322211 111000
Q ss_pred cCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
.....+..+++++.+++.+||..||.+|||++++++.|+++.++.
T Consensus 258 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 258 ------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 000112345677999999999999999999999999999988653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=321.90 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=202.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+++. .+|+.||+|++.... ....+.+.+|..++..++||||+++++++...+.+|+|||
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 478889999999999999986 479999999987532 2233457889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.+.+..+++..++.++.||+.||.||| ++|++||||||+||+++.+|.+||+|||++........
T Consensus 142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~- 217 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT- 217 (412)
T ss_dssp CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-
Confidence 99999999999876556999999999999999999999 99999999999999999999999999999987654321
Q ss_pred ceeccccccccccCCcccC-------CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 157 TIQTQTLATIGYMAPEYGK-------EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~-------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
.......+|+.|+|||++. ...++.++|+||||+++|+|++|..||......+.. ...........
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~i~~~~~~~~------ 290 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY-GKIVHYKEHLS------ 290 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHTHHHHCC------
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccCcC------
Confidence 1223457899999999887 356899999999999999999999999764332211 11111000000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCC---CCHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQR---INAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~eil~~ 274 (285)
.+ .....++.++.++|++||. +|.+| |+++|++++
T Consensus 291 ---~p------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 ---LP------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---CC----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---CC------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00 0023457789999999999 99998 589998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=328.75 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=202.4
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
|++.+.||+|+||.||+|...++..||||++..... ..+.+.+|++++++++||||+++++++.. +..++|||+++++
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~g 263 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 263 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCC
Confidence 567789999999999999988788899999875432 34678899999999999999999999876 6688999999999
Q ss_pred CHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 82 SLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 82 ~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
+|.+++... ...++...++.++.|++.||+||| +++++||||+|+||+++.++.+||+|||++....... .....
T Consensus 264 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~ 339 (452)
T 1fmk_A 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQ 339 (452)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eeccc
Confidence 999999753 234889999999999999999999 9999999999999999999999999999998765432 11222
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.. ...... .+
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-~~i~~~-------------------~~ 399 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERG-------------------YR 399 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTT-------------------CC
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcC-------------------CC
Confidence 3446778999999988899999999999999999999 99998764332211 111100 00
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
...+..++..+.++|.+||..||.+|||++++++.|+++..
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11133567789999999999999999999999999988754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=329.07 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=202.2
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|++.+.||+|+||+||++... +++.||+|++.... ......+.+|++++++++||||+++++++......++|||++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 103 (486)
T 3mwu_A 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103 (486)
T ss_dssp EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcC
Confidence 788999999999999999754 78999999986432 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCcEEEeeeccceecCcccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~i~df~~~~~~~~~~~ 155 (285)
.+++|.+.+..... +++..++.++.||+.||.||| ++|++||||||+||+++ .++.++|+|||++.......
T Consensus 104 ~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 104 TGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp CSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred CCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 99999988866543 899999999999999999999 99999999999999995 45679999999997665432
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+. .........
T Consensus 179 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~--------------- 239 (486)
T 3mwu_A 179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGKY--------------- 239 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCC---------------
T ss_pred --ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC---------------
Confidence 2234568999999999876 589999999999999999999999976432221 111111110
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+++++.++|++||..||.+|||+++++++
T Consensus 240 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 -AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11112234567889999999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=329.00 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=194.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 377889999999999999975 578999999987542 2334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|+++++|.+++.... .+++..++.++.||+.||+||| + .|++||||||+||+++.++.++|+|||++.......
T Consensus 229 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 229 YANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp CCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 999999999987654 4899999999999999999999 8 899999999999999999999999999997543321
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+|+.|+|||++.+..++.++||||||+++|+|++|..||......... .........
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~i~~~~~~-------------- 367 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEEIR-------------- 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCC--------------
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-HHHHhCCCC--------------
Confidence 2234467899999999999999999999999999999999999999754322211 111110000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
.+..+++++.++|.+||..||.+|| |+++++++
T Consensus 368 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 ------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1223567799999999999999999 99999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=304.02 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=198.6
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceecc----CCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSN----EEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v 74 (285)
|++.+.||+|+||+||+|.. .++..|++|.+.... ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 56678999999999999975 468889999987543 4455778899999999999999999998754 4568999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeC-CCCcEEEeeeccceecC
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~di~~~nili~-~~~~~~i~df~~~~~~~ 151 (285)
||++++++|.+++..... ++...++.++.|++.||.||| +.+ ++|+||+|+||+++ .++.++|+|||++....
T Consensus 108 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEecCCCCHHHHHHHccC-CCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999976543 899999999999999999999 888 99999999999998 88999999999997554
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
... .....+++.|+|||.+.+ .++.++||||||+++++|++|..||..................+
T Consensus 184 ~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 248 (290)
T 1t4h_A 184 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred ccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----------
Confidence 321 233468899999998764 58999999999999999999999997644333322221111100
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......++++.+++.+||..||.+|||+++++++
T Consensus 249 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 --------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01123345679999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=314.15 Aligned_cols=245 Identities=27% Similarity=0.375 Sum_probs=200.6
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|++.+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||+
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 56788999999999999975 579999999987432 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+. ++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++......
T Consensus 136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 97 4888888665566999999999999999999999 999999999999999999999999999999765432
Q ss_pred eeccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 158 IQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
....+++.|+|||.+. ...++.++||||||+++++|++|..||.......... .......+.
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~------------ 272 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPA------------ 272 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCC------------
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCC------------
Confidence 3356899999999874 5678999999999999999999999986543222111 111100000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
......+..+.+++.+||+.||.+|||+++++++-
T Consensus 273 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 273 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 00123456789999999999999999999998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=306.89 Aligned_cols=262 Identities=19% Similarity=0.226 Sum_probs=207.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcccccccee-ccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC-SNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+++++.++|++++..+..+ ......+++||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 488999999999999999975 5789999998754432 24577899999999988877766655 6677889999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCcEEEeeeccceecCcccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~i~df~~~~~~~~~~~ 155 (285)
+++|.+++......++...++.++.|++.||.||| ++|++|+||||+||++ +.++.++|+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 88999999866666999999999999999999999 9999999999999999 7899999999999987654322
Q ss_pred c-----ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh--hhhhhhhhcCCCccccc
Q 039392 156 S-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT--LKHWVNDWLPISTKEIV 228 (285)
Q Consensus 156 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 228 (285)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......... ............
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 238 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----- 238 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-----
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-----
Confidence 1 1223456899999999999999999999999999999999999999764332111 111000000000
Q ss_pred cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
.......+++++.+++.+||+.||.+|||++++++.|+++.++..
T Consensus 239 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 239 ----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ----------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 000113456789999999999999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=315.67 Aligned_cols=239 Identities=25% Similarity=0.348 Sum_probs=199.6
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--------hHHHHHHHHHHHHccCCCCccccccceeccCCceE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--------RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 72 (285)
|++.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..+
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEE
Confidence 77889999999999999974 5789999999875431 13345678999999999999999999999999999
Q ss_pred EEEeccCCC-CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 73 LVLEYMPHG-SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 73 ~v~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+|||++.++ +|.+++..... ++...++.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++....
T Consensus 106 lv~e~~~~g~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 999998665 99999876554 999999999999999999999 9999999999999999999999999999998765
Q ss_pred cccccceeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.... .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||....... ..
T Consensus 182 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------------~~ 239 (335)
T 3dls_A 182 RGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------------EA 239 (335)
T ss_dssp TTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------------TT
T ss_pred CCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------------hh
Confidence 5322 233468999999999888776 889999999999999999999986521100 00
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ..+..++.++.+++.+||..||.+|||+++++++
T Consensus 240 ~~--------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 AI--------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cc--------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0012256679999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=320.76 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=192.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCC-CCccccccceeccC--CceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNE--EFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v 74 (285)
+|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.+++.+. ||||+++++++... ...++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 488899999999999999975 57899999998543 2344566788999999997 99999999998644 478999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
||++++ +|..++... .++...+..++.||+.||+||| +.|++||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 90 FDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EECCSE-EHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred ecccCc-CHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999974 899988764 4889999999999999999999 9999999999999999999999999999998654311
Q ss_pred -------------------ccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhh
Q 039392 155 -------------------ISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 155 -------------------~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (285)
.........+|++|+|||++.+ ..++.++|||||||++++|++|..||.+...... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ-LER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 0112234578999999998876 5789999999999999999999999976433222 121
Q ss_pred hhhhhcCCCcccccc--------------------ccccCccc-------chhhhhhHhHHHHHHhhhcccccCcCCCCC
Q 039392 215 WVNDWLPISTKEIVD--------------------PNLLSRED-------IHFVAKEQCVSFVFNVAMECTVESPEQRIN 267 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~--------------------~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 267 (285)
............... ........ ........+++++.+|+.+||..||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 211111111100000 00000000 000011245778999999999999999999
Q ss_pred HHHHHHH
Q 039392 268 AKEIVTK 274 (285)
Q Consensus 268 ~~eil~~ 274 (285)
++|++++
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=308.72 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=201.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++.+.||+|+||+||++... +|+.||+|++........+.+.+|+.+++.++||||+++++++......++|||+++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 3778899999999999999854 789999999986554445678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCcEEEeeeccceecCccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+++|.+++.... .++...++.++.|++.||.||| +.|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 90 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-- 163 (304)
T 2jam_A 90 GGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163 (304)
T ss_dssp SCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--
T ss_pred CccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--
Confidence 999999886654 3899999999999999999999 9999999999999999 788999999999987654321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+++.|+|||.+.+..++.++||||||+++++|++|..||........ ...........
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~-------------- 226 (304)
T 2jam_A 164 --MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-FEKIKEGYYEF-------------- 226 (304)
T ss_dssp --THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHCCCCC--------------
T ss_pred --cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCCCC--------------
Confidence 1234578899999999999999999999999999999999999976432211 11111111100
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......++.++.+++.+||..||.+|||+++++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 --ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001123456779999999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=313.20 Aligned_cols=266 Identities=21% Similarity=0.262 Sum_probs=196.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++..... .....+.+|+++++.++||||+++++++......++|||+
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 478899999999999999974 4789999999865432 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-----CCCCcEEEeeeccceecCc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili-----~~~~~~~i~df~~~~~~~~ 152 (285)
+++ +|.+++..... +++..++.++.||+.||.||| ++|++|+||||+||++ +..+.++|+|||++.....
T Consensus 115 ~~~-~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 115 AEN-DLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp CSE-EHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred CCC-CHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 975 99999876654 899999999999999999999 9999999999999999 4555699999999987653
Q ss_pred ccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc--
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD-- 229 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (285)
.. .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+.... ...............
T Consensus 190 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 190 PI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK-IFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCTTTSTTGG
T ss_pred cc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH-HHHHhCCCchhhhhhhh
Confidence 31 122344678999999998775 589999999999999999999999976433322211 111111111000000
Q ss_pred --------ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 --------PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
................++.++.+|+.+||..||.+|||++|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000111112222234467889999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=309.44 Aligned_cols=243 Identities=21% Similarity=0.214 Sum_probs=191.9
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHc-cCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMK-SIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|++.++||+|+||+||+|... +++.||||++.... .........|+..+. ..+|+||+++++++...+..++|||+
T Consensus 59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~ 138 (311)
T 3p1a_A 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEec
Confidence 677889999999999999865 79999999875432 222333444554444 44899999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 139 ~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--- 211 (311)
T 3p1a_A 139 C-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--- 211 (311)
T ss_dssp C-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---
Confidence 9 66999988776667999999999999999999999 9999999999999999999999999999998765432
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......+|+.|+|||.+.+ .++.++||||||+++++|++|..|+..... ....... .
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~------------------~ 268 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQG------------------Y 268 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTT------------------C
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhcc------------------C
Confidence 2234458999999998876 789999999999999999999776543211 1111000 0
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........++.++.+++.+||+.||.+|||+++++++
T Consensus 269 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0111234567889999999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=311.16 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=199.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.|++.+.||+|+||.||+|... +++.+|+|++........+.+.+|+++++.++||||+++++++...+..++|||+++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 4788899999999999999864 689999999887666667788899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++......++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 174 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKR 174 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cccc
Confidence 99999998775566999999999999999999999 999999999999999999999999999987543221 1112
Q ss_pred ccccccccccCCccc-----CCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 160 TQTLATIGYMAPEYG-----KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~-----~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
....+++.|+|||.+ ....++.++||||||+++++|++|..||........... .......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~------------- 240 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSDPP------------- 240 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHSCCC-------------
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-HhccCCc-------------
Confidence 334688899999987 466789999999999999999999999976433221111 1110000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
....+..++.++.+++.+||..||.+|||++++++
T Consensus 241 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 ----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01113345677999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=306.52 Aligned_cols=262 Identities=19% Similarity=0.227 Sum_probs=209.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcccccccee-ccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC-SNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++...... +.+.+|+.+++.++|+++++.+..+ ......++|||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 588899999999999999985 57999999998654332 4577899999999988877666655 5667789999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCcEEEeeeccceecCcccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~i~df~~~~~~~~~~~ 155 (285)
+++|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++ .++.++|+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 88999999866666999999999999999999999 99999999999999994 889999999999987654322
Q ss_pred c-----ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccch--hhhhhhhhhcCCCccccc
Q 039392 156 S-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM--TLKHWVNDWLPISTKEIV 228 (285)
Q Consensus 156 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 228 (285)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|..||........ .............
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 238 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----- 238 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-----
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-----
Confidence 1 112345689999999999999999999999999999999999999976432211 1111111000000
Q ss_pred cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
.......+++++.+++.+||+.||.+|||++++++.|+++.++..
T Consensus 239 ----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 239 ----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 000123457789999999999999999999999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=322.28 Aligned_cols=269 Identities=21% Similarity=0.255 Sum_probs=197.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccC-----CceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE-----EFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 72 (285)
+|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++++.++|+||+++++++... ...|
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 488899999999999999975 46889999998653 234456788999999999999999999998765 5789
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+|||+++ ++|.+++.... .+++..++.++.||+.||.||| +.|++||||||+||+++.++.+||+|||+++....
T Consensus 107 lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 9999996 49999987654 4999999999999999999999 99999999999999999999999999999987654
Q ss_pred cccc--------------------ceeccccccccccCCccc-CCCccCcchhhHHHHHHHHHHhhCCCCCccccccch-
Q 039392 153 EDIS--------------------TIQTQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM- 210 (285)
Q Consensus 153 ~~~~--------------------~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~- 210 (285)
.... .......+|++|+|||++ ....++.++|||||||++|+|++|..||........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 3211 122456789999999985 556799999999999999999987666543211110
Q ss_pred --------------------------hhhhhhhhhcCCCcccccc----------ccccCcccchh-hhhhHhHHHHHHh
Q 039392 211 --------------------------TLKHWVNDWLPISTKEIVD----------PNLLSREDIHF-VAKEQCVSFVFNV 253 (285)
Q Consensus 211 --------------------------~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-~~~~~~~~~l~~l 253 (285)
................+.. ..........+ .....+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 0000111011110000000 00000000000 0113467889999
Q ss_pred hhcccccCcCCCCCHHHHHHH
Q 039392 254 AMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 254 i~~~l~~~p~~Rps~~eil~~ 274 (285)
+++||..||.+|||++|+|++
T Consensus 342 l~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=330.38 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=204.3
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||+
T Consensus 28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 107 (484)
T 3nyv_A 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107 (484)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 778899999999999999754 79999999986432 33457788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCcEEEeeeccceecCccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~i~df~~~~~~~~~~ 154 (285)
+.+++|.+.+..... +++..++.++.||+.||.||| ++|++|+||||+||++ +.++.++|+|||++.......
T Consensus 108 ~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 108 YTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp CCSCBHHHHHHTCSC-CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred CCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999999998866544 899999999999999999999 9999999999999999 567899999999998765432
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||......+. .........
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~-------------- 244 (484)
T 3nyv_A 184 ---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-LKKVEKGKY-------------- 244 (484)
T ss_dssp ---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC--------------
T ss_pred ---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCC--------------
Confidence 1234568999999998866 689999999999999999999999976432221 111111110
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+++++.+++++||..||.+|||+++++++
T Consensus 245 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 --TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 01112234567889999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=307.88 Aligned_cols=249 Identities=28% Similarity=0.366 Sum_probs=201.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.|++.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..++|||+++
T Consensus 30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 4778899999999999999754 68999999987543 23667889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++......++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 182 (314)
T 3com_A 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKR 182 (314)
T ss_dssp TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCB
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--ccc
Confidence 99999999755556999999999999999999999 9999999999999999999999999999998765432 122
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+++.|+|||.+.+..++.++||||||+++++|++|..||........... ...... ..
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~----------------~~ 244 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM--IPTNPP----------------PT 244 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHSCC----------------CC
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HhcCCC----------------cc
Confidence 345688899999999998999999999999999999999999975432211111 000000 00
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+..+...+.++.+++.+||..||.+|||+++++++
T Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11133456779999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=316.47 Aligned_cols=263 Identities=17% Similarity=0.199 Sum_probs=199.5
Q ss_pred CCCCCceecccCceEEEEEEeC----CCcEEEEEEeeccchhH-----------HHHHHHHHHHHccCCCCcccccccee
Q 039392 1 GFSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQYGRV-----------FKSFDVECEMMKSIHHRNIIKVISSC 65 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~ 65 (285)
+|++.+.||+|+||.||+|... ++..+|+|++....... ...+.+|+..++.++||||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 3778899999999999999864 57889999987543211 12355788899999999999999998
Q ss_pred cc----CCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC--cE
Q 039392 66 SN----EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM--VA 139 (285)
Q Consensus 66 ~~----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~--~~ 139 (285)
.. ....++|||++ +++|.+++.... .+++..++.++.||+.||+||| +.|++|+||||+||+++.++ .+
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSE
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcE
Confidence 77 77899999999 889999997665 5999999999999999999999 99999999999999998777 99
Q ss_pred EEeeeccceecCccccc-----ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhh
Q 039392 140 HLSDFGIAKLLTREDIS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 140 ~i~df~~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (285)
+|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||............
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999876543211 1113456899999999999989999999999999999999999999653333222221
Q ss_pred hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 215 WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.......... ...........++.++.+++.+||..||.+|||++++++.|+++
T Consensus 273 ~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 273 AKTNLLDELP----------QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHTTT----------HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHhhccccc----------HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1111110000 00000001125677899999999999999999999999999765
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=328.49 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=201.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-------------hHHHHHHHHHHHHccCCCCccccccceec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-------------RVFKSFDVECEMMKSIHHRNIIKVISSCS 66 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 66 (285)
+|++++.||+|+||+||+|.. .+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 478899999999999999975 4688999999875421 23467889999999999999999999999
Q ss_pred cCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---cEEEee
Q 039392 67 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHLSD 143 (285)
Q Consensus 67 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~i~d 143 (285)
.....++|||++++++|.+.+..... +++..++.++.||+.||.||| +.|++|+||||+||+++.++ .++|+|
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999998866544 999999999999999999999 99999999999999998765 699999
Q ss_pred eccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC
Q 039392 144 FGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 144 f~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
||++....... ......+++.|+|||++. ..++.++||||+|+++|+|++|..||.+....+. .......
T Consensus 193 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~----- 262 (504)
T 3q5i_A 193 FGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-IKKVEKG----- 262 (504)
T ss_dssp CTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC-----
T ss_pred CCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcC-----
Confidence 99998775432 223456899999999886 4689999999999999999999999976432221 1111111
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...........+++++.+++++||..||.+|||+++++++
T Consensus 263 -----------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 -----------KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -----------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0111122234567889999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=305.71 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=196.0
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|++.+.||+|+||+||++.. .+++.+|+|++.... ....+.+.+|+++++.++||||+++++++......++|||+++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 77889999999999999975 468999999987553 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCcEEEeeeccceecCcc
Q 039392 80 HGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 80 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~i~df~~~~~~~~~ 153 (285)
+++|.+.+... ...++...++.++.|++.||.||| +.|++|+||+|+||++ +.++.++|+|||++......
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999888542 345999999999999999999999 9999999999999999 45688999999999765543
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
. ......+++.|+|||.+. ..++.++||||||+++++|++|..||......+........ ......
T Consensus 181 ~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~--------- 246 (285)
T 3is5_A 181 E---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-EPNYAV--------- 246 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCC---------
T ss_pred c---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-Cccccc---------
Confidence 2 223456889999999875 56899999999999999999999999764332221111100 000000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....++++.+++.+||..||.+|||++|++++
T Consensus 247 --------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 --------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011245678899999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=309.71 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=198.9
Q ss_pred CCCCCceecccCceEEEEEEe--CCCc--EEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL--GDGM--EVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~--~~~~--~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||+||+|.+ .+++ .||+|++... .....+.+.+|+++++.++||||+++++++.... .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 478899999999999999974 2333 6899988654 2345677889999999999999999999998765 789
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|+|++++++|.+++......++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999776566999999999999999999999 999999999999999999999999999999876543
Q ss_pred ccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 154 DIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 154 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
... .......++..|+|||.+.+..++.++||||||+++++|++ |..||......+.. ........
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~----------- 242 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-HKIDKEGE----------- 242 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHTSCC-----------
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH-HHHHccCC-----------
Confidence 322 12233456778999999988889999999999999999999 99999764322211 11100000
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
....+..++.++.+++.+||..||.+|||++++++.|+++.....
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 001123456779999999999999999999999999999876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=312.09 Aligned_cols=263 Identities=19% Similarity=0.295 Sum_probs=206.6
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchh-----------------HHHHHHHHHHHHccCCCCccccccc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGR-----------------VFKSFDVECEMMKSIHHRNIIKVIS 63 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~i~~~~~ 63 (285)
+|++.+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|+.+++.++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 588899999999999999988 8999999998754321 1267889999999999999999999
Q ss_pred eeccCCceEEEEeccCCCCHHHh------hhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCC
Q 039392 64 SCSNEEFKALVLEYMPHGSLEKY------LHSS-NYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDD 135 (285)
Q Consensus 64 ~~~~~~~~~~v~e~~~~~~L~~~------~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~ 135 (285)
++...+..++|||++++++|.++ +... ...++...++.++.|++.||.||| + .|++|+||+|+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcC
Confidence 99999999999999999999998 5542 445999999999999999999999 8 99999999999999999
Q ss_pred CCcEEEeeeccceecCcccccceeccccccccccCCcccCCC-ccCc-chhhHHHHHHHHHHhhCCCCCccccccchhhh
Q 039392 136 NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG-RVSA-NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLK 213 (285)
Q Consensus 136 ~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~-~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~ 213 (285)
++.++|+|||.+...... ......++..|+|||.+.+. .++. ++||||||+++++|++|..||...........
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999999999999876432 23456688999999999877 5665 99999999999999999999986554333322
Q ss_pred hhhhhhcCCCcc--ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 214 HWVNDWLPISTK--EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 214 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+.. ..... .. ..........++.++.+++.+||..||.+|||+++++++
T Consensus 264 ~i~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLYP-LT--NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHTSCCCCCCCSSSSSTTT-TC--C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhccCcCCccchhhhhcc-cc--ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222221111110 00000 00 000011124567889999999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=303.78 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=203.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..+++||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4788899999999999999754 68899999986542 2234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++..... ++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp CCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred eCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 9999999999876554 899999999999999999999 9999999999999999999999999999987654321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+++.|+|||.+.+..++.++|+||||+++++|++|..||......... ..... ..
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~----~~------------- 228 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-RRIVN----VD------------- 228 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHT----TC-------------
T ss_pred --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-HHHhc----cc-------------
Confidence 23456889999999999999999999999999999999999999754322211 11110 00
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+...+.++.+++.+||..||.+|||+++++++
T Consensus 229 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 ---LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ---cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 00122356678999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=313.45 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=201.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchh-----HHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGR-----VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+|+++++.++||||+++++++......++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 4889999999999999999854 6899999998753321 124577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
||++++ +|.+++......++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++.......
T Consensus 91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999976 899888776666888999999999999999999 9999999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc----
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD---- 229 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (285)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+....+. ...............+.+
T Consensus 167 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 167 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSS
T ss_pred --ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHcCCCChhhhhhhccC
Confidence 222345689999999988664 589999999999999999999999876433222 222222111111110000
Q ss_pred --c---cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 --P---NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 --~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ......+. ......++.++.+++++||..||.+|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPL-HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCH-HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCCh-HHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000000 01123557889999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=307.44 Aligned_cols=267 Identities=23% Similarity=0.358 Sum_probs=207.3
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHcc--CCCCccccccceeccCC----ceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKS--IHHRNIIKVISSCSNEE----FKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~~v 74 (285)
+|++.+.||+|+||.||+|.. +++.||+|++.... ...+.+|.++++. ++||||+++++++.... ..++|
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 378899999999999999987 58999999986443 3456678888877 78999999999997765 78999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG-----YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
||++++++|.+++.+. .++...++.++.|++.||.|||.. ++.+++|+||||+||+++.++.++|+|||++..
T Consensus 119 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 196 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196 (342)
T ss_dssp ECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence 9999999999999764 389999999999999999999931 146899999999999999999999999999977
Q ss_pred cCcccccc--eeccccccccccCCcccCCC------ccCcchhhHHHHHHHHHHhhC----------CCCCccccccchh
Q 039392 150 LTREDIST--IQTQTLATIGYMAPEYGKEG------RVSANGDVYSFGIMLIETFTR----------KKPTDEIFNGEMT 211 (285)
Q Consensus 150 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~l~~ll~g----------~~p~~~~~~~~~~ 211 (285)
........ ......+++.|+|||.+.+. .++.++||||||+++|+|++| ..||.........
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 276 (342)
T 1b6c_B 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276 (342)
T ss_dssp EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence 65432211 22345689999999988765 344789999999999999999 6777654433322
Q ss_pred hhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 212 LKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...+.......... ...+ .......++..+.+++.+||..||.+|||+++++++|+++.++.
T Consensus 277 ~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 277 VEEMRKVVCEQKLR--------PNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHTTSCCC--------CCCC-GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhC--------CCCc-ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 22222211111000 0000 01123466788999999999999999999999999999998763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=325.86 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=198.4
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|++++.||+|+||+||+|... ++..+|+|++.... ......+.+|+.+++.++||||+++++++......++|||++
T Consensus 39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 778999999999999999854 78999999987543 233466889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCcEEEeeeccceecCcccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~i~df~~~~~~~~~~~ 155 (285)
++++|.+.+..... +++..++.++.||+.||.||| ++|++||||||+||+++. ++.+||+|||++.......
T Consensus 119 ~~g~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 119 KGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp CSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred CCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 99999988866543 899999999999999999999 999999999999999975 4559999999998765432
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......+|+.|+|||++. ..++.++||||||+++|+|++|..||......+. ...........
T Consensus 194 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~------------- 256 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVEKGKYTF------------- 256 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCC-------------
T ss_pred --cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC-------------
Confidence 223456899999999876 4689999999999999999999999976433221 11111111110
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+++++.+++++||..||.+|||+++++++
T Consensus 257 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 ---DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ---CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 011123567789999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=327.62 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=204.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++...+.+++|||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 377889999999999999975 479999999986532 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++|++|.+++.... ..+++..++.++.||+.||.||| ++|++||||||+||+++.+|.+||+|||++.......
T Consensus 265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~- 340 (576)
T 2acx_A 265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 340 (576)
T ss_dssp CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCc-
Confidence 999999999887643 34899999999999999999999 9999999999999999999999999999998765432
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh--hhhhhhhhcCCCcccccccccc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT--LKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
......+|+.|+|||++.+..++.++|+||||+++|+|++|..||......... ........ +.
T Consensus 341 --~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~----------- 406 (576)
T 2acx_A 341 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PE----------- 406 (576)
T ss_dssp --CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CC-----------
T ss_pred --cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cc-----------
Confidence 123457899999999999999999999999999999999999999764322111 11111100 00
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
..+..+++++.++|.+||..||.+|| +++|++++
T Consensus 407 -------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 -------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00234567799999999999999999 78898864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=305.31 Aligned_cols=266 Identities=22% Similarity=0.299 Sum_probs=200.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-----hHHHHHHHHHHHHccC---CCCccccccceeccCC--
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-----RVFKSFDVECEMMKSI---HHRNIIKVISSCSNEE-- 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~-- 69 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~ 89 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence 588999999999999999985 5789999999864321 1123455677776666 4999999999987654
Q ss_pred ---ceEEEEeccCCCCHHHhhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeec
Q 039392 70 ---FKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 145 (285)
Q Consensus 70 ---~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~ 145 (285)
..+++||++.+ +|.+++..... .+++..++.++.|++.||+||| ++|++|+||||+||+++.++.++|+|||
T Consensus 90 ~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 90 REIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 57899999964 99999876543 3899999999999999999999 9999999999999999999999999999
Q ss_pred cceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 146 IAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||......... .............
T Consensus 166 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~ 241 (308)
T 3g33_A 166 LARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GKIFDLIGLPPED 241 (308)
T ss_dssp CTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH-HHHHHHHCCCCTT
T ss_pred cccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChh
Confidence 998665432 223456899999999999999999999999999999999999999764433222 2222111111111
Q ss_pred cccccc-----ccCcc--cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIVDPN-----LLSRE--DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~~~~-----~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.+.... ..... .........++.++.+++.+||+.||.+|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 110000 00000 00011123567889999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=317.25 Aligned_cols=242 Identities=26% Similarity=0.304 Sum_probs=190.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHH-HccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEM-MKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|..+ ++.++||||+++++++...+.+|+||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 4788999999999999999854 68899999987543 2233445566666 57789999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||++|++|.+++.+... +++..++.++.||+.||.||| ++|++||||||+||+++.+|.+||+|||++......
T Consensus 119 E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-- 192 (373)
T 2r5t_A 119 DYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-- 192 (373)
T ss_dssp ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--
T ss_pred eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC--
Confidence 99999999999876544 889999999999999999999 999999999999999999999999999999753222
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
........+|+.|+|||++.+..++.++|+||||+++|+|++|..||......+. .........
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~~~--------------- 256 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-YDNILNKPL--------------- 256 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-HHHHHHSCC---------------
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhccc---------------
Confidence 1123456789999999999999999999999999999999999999976432221 111111100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
..+..++.++.+++.+||..||.+||++.
T Consensus 257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 00223566799999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=314.63 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=202.2
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--------hhHHHHHHHHHHHHccC-CCCccccccceeccCCce
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--------GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFK 71 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 71 (285)
|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++++ +||||+++++++......
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 677899999999999999864 79999999987543 12345678899999998 799999999999999999
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++|||++++++|.+++.... .++...++.++.||+.||.||| +.|++|+||+|+||+++.+|.++|+|||++....
T Consensus 176 ~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999987654 3899999999999999999999 9999999999999999999999999999998765
Q ss_pred cccccceeccccccccccCCcccCC------CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE------GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........ ..........
T Consensus 252 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~---- 323 (365)
T 2y7j_A 252 PGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-LRMIMEGQYQ---- 323 (365)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC----
T ss_pred CCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCC----
Confidence 432 2234568999999998753 3588999999999999999999999965322111 1111110000
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+.++.+++.+||..||.+|||+++++++
T Consensus 324 ------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 324 ------------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ------------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111123456779999999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=310.28 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=189.6
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCcccccccee--------ccCCce
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSC--------SNEEFK 71 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--------~~~~~~ 71 (285)
|++.+.||+|+||.||++.+ .+++.||+|++........+.+.+|+.+++++. ||||+++++++ ......
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 77889999999999999985 478999999987666666678889999999996 99999999988 344568
Q ss_pred EEEEeccCCCCHHHhhhc--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCcEEEeeeccc
Q 039392 72 ALVLEYMPHGSLEKYLHS--SNYILDIYQRLNIMIDVASTLEYLHFGYSAQ--VIHCDLKPSNVLLDDNMVAHLSDFGIA 147 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~di~~~nili~~~~~~~i~df~~~ 147 (285)
++++|++. ++|.+++.. ....++...++.++.||+.||.||| +.| ++|+||||+||+++.++.++|+|||++
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 89999996 589888754 3345999999999999999999999 888 999999999999999999999999999
Q ss_pred eecCcccccc----------eeccccccccccCCccc---CCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhh
Q 039392 148 KLLTREDIST----------IQTQTLATIGYMAPEYG---KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKH 214 (285)
Q Consensus 148 ~~~~~~~~~~----------~~~~~~~~~~~~~PE~~---~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (285)
.......... ......+++.|+|||.+ .+..++.++||||||+++|+|++|..||...........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~- 264 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG- 264 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC-
Confidence 8765432111 11134578899999988 566789999999999999999999999865322111000
Q ss_pred hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 215 WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
..........+..+.+++++||+.||.+|||+++++++|+.+....
T Consensus 265 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 265 ----------------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ----------------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0001112233455889999999999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=312.30 Aligned_cols=266 Identities=20% Similarity=0.260 Sum_probs=197.3
Q ss_pred CCC-CceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEecc
Q 039392 2 FSE-NNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 2 y~~-~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
|++ .+.||+|+||+||+|.. .+++.||+|++........+.+.+|++++.++ +||||+++++++...+..++|||++
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 566 47899999999999974 47899999999776555667888999999885 7999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc---EEEeeeccceecCcccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLTREDI 155 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~i~df~~~~~~~~~~~ 155 (285)
++++|.+++.... .+++..++.++.|++.||.||| ++|++|+||||+||+++.++. ++|+|||++........
T Consensus 94 ~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 94 RGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred CCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 9999999997654 3899999999999999999999 999999999999999987776 99999999876542211
Q ss_pred -----cceeccccccccccCCcccCC-----CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC-c
Q 039392 156 -----STIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS-T 224 (285)
Q Consensus 156 -----~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 224 (285)
........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||............. ..... .
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~ 246 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG---EACPACQ 246 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc---ccchhHH
Confidence 111223458999999998865 458899999999999999999999997643322100000 00000 0
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....................++.++.+++.+||..||.+|||++|++++
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000000000000001123467789999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=313.57 Aligned_cols=249 Identities=17% Similarity=0.173 Sum_probs=202.3
Q ss_pred CCCCceecccCceEEEEEE------eCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC---CCccccccceeccCCceE
Q 039392 2 FSENNLIGRGGFGSVFKAR------LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH---HRNIIKVISSCSNEEFKA 72 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~------~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 72 (285)
|++.+.||+|+||+||+|. ..+++.||+|++..... ..+.+|.++++.++ |+||+++++.+...+..+
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 6778899999999999993 45689999999876543 34556777777776 999999999999999999
Q ss_pred EEEeccCCCCHHHhhhc----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----------CC
Q 039392 73 LVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-----------NM 137 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-----------~~ 137 (285)
+||||+++++|.+++.. ....+++..++.++.||+.||+||| ++|++||||||+||+++. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999864 3445999999999999999999999 999999999999999988 89
Q ss_pred cEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhh
Q 039392 138 VAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN 217 (285)
Q Consensus 138 ~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 217 (285)
.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---- 296 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE---- 296 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC----
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec----
Confidence 9999999999766433333444566789999999999999999999999999999999999999865432211100
Q ss_pred hhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCC-CCHHHHHHHHHHHHHH
Q 039392 218 DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQR-INAKEIVTKLVKIRDS 281 (285)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-ps~~eil~~l~~l~~~ 281 (285)
..... ...+..+.+++.+||+.+|.+| |+++++.+.|+++.++
T Consensus 297 -------------~~~~~--------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 297 -------------GLFRR--------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -------------SCCTT--------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------------hhccc--------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00000 0124557789999999999998 5888888888887754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=321.50 Aligned_cols=269 Identities=22% Similarity=0.243 Sum_probs=185.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceec-----cCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCS-----NEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 72 (285)
+|++++.||+|+||+||+|.. .+++.||||++... .....+.+.+|+++++.++||||+++++++. ....+|
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 478899999999999999975 47899999998643 2344567889999999999999999999984 336789
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+|||++ +++|.+++.... .+++..++.++.||+.||.||| +.|++||||||+||+++.++.+||+|||++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 999998 558999887654 4999999999999999999999 99999999999999999999999999999987643
Q ss_pred cccc-------------------------ceeccccccccccCCccc-CCCccCcchhhHHHHHHHHHHhh---------
Q 039392 153 EDIS-------------------------TIQTQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLIETFT--------- 197 (285)
Q Consensus 153 ~~~~-------------------------~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~~ll~--------- 197 (285)
.... .......+|++|+|||++ .+..++.++|||||||++|+|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 2110 122345679999999975 45679999999999999999999
Q ss_pred --CCCCCcccccc-------------------chhhhhhhhhhcCCCcccccc----------ccccCcccch-hhhhhH
Q 039392 198 --RKKPTDEIFNG-------------------EMTLKHWVNDWLPISTKEIVD----------PNLLSREDIH-FVAKEQ 245 (285)
Q Consensus 198 --g~~p~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~-~~~~~~ 245 (285)
|..+|.+.... ..................+.. .......... ......
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 55555432210 000000111011100000000 0000000000 011234
Q ss_pred hHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 246 CVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.++++.+|+++||..||.+|||++|+|++
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 57889999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=317.28 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=197.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||++.. .+++.||+|++..... ...+|++++.++ +||||+++++++.+....++|||++
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 378889999999999999975 4689999999875432 234577877777 7999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC----CcEEEeeeccceecCccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN----MVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~----~~~~i~df~~~~~~~~~~ 154 (285)
++++|.+.+.... .+++..++.++.||+.||.||| ++|++||||||+||++..+ +.++|+|||++.......
T Consensus 99 ~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 99 KGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999999987654 4899999999999999999999 9999999999999998532 359999999998764432
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccch--hhhhhhhhhcCCCccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEM--TLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||........ ............
T Consensus 175 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~---------- 242 (342)
T 2qr7_A 175 --GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL---------- 242 (342)
T ss_dssp --CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC----------
T ss_pred --CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc----------
Confidence 122345679999999999888899999999999999999999999975322111 111111110000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+..++.++.+++++||..||.+|||+++++++
T Consensus 243 ------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 243 ------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000123467789999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=318.11 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=192.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--------hhHHHHHHHHHHHHccCCCCccccccceeccCCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--------GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 71 (285)
+|.+.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-EE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-ce
Confidence 477889999999999999975 468999999987542 12223577899999999999999999998654 57
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---cEEEeeeccce
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHLSDFGIAK 148 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~i~df~~~~ 148 (285)
++|||++++++|.+++.... .+++..++.++.|++.||.||| ++|++|+||||+||+++.++ .+||+|||++.
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 89999999999999886654 4899999999999999999999 99999999999999997544 59999999998
Q ss_pred ecCcccccceeccccccccccCCcccCC---CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 149 LLTREDISTIQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
...... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...................
T Consensus 291 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~---- 363 (419)
T 3i6u_A 291 ILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN---- 363 (419)
T ss_dssp SCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC----
T ss_pred ecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC----
Confidence 765432 2234568999999998864 568899999999999999999999997643322222211111100
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........+++++.+++.+||..||.+|||+++++++
T Consensus 364 ------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 364 ------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0011123467789999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=304.46 Aligned_cols=247 Identities=20% Similarity=0.301 Sum_probs=204.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 3778899999999999999864 68899999986542 3445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++.... .++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 96 LCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp CCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 999999999887654 4899999999999999999999 99999999999999999999999999999987653321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+.... .....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~----------------- 231 (294)
T 2rku_A 171 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-IKKNE----------------- 231 (294)
T ss_dssp -CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHTTC-----------------
T ss_pred -ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-Hhhcc-----------------
Confidence 12345678899999999988899999999999999999999999976432221111 10000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+...+.++.+++.+||..||.+|||+++++++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00122345678999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=310.83 Aligned_cols=261 Identities=25% Similarity=0.311 Sum_probs=195.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCC------ce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE------FK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 71 (285)
.|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 478889999999999999975 57999999998543 2344567889999999999999999999987653 45
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++|||++ +++|.+++... .++...++.++.||+.||.||| ++|++|+||||+||+++.++.+||+|||++....
T Consensus 106 ~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp EEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 8999999 77999998763 3899999999999999999999 9999999999999999999999999999998765
Q ss_pred cccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.. .....+|++|+|||.+.+ ..++.++|||||||++++|++|..||.+..... ............+. .....
T Consensus 180 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~-~~~~~ 252 (367)
T 1cm8_A 180 SE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPA-EFVQR 252 (367)
T ss_dssp SS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCH-HHHHT
T ss_pred cc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH-HHHHH
Confidence 32 234567999999998877 679999999999999999999999997643221 11111111111110 00000
Q ss_pred -----------cccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 -----------NLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 -----------~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+ ......++++.+|+.+||..||.+|||+++++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000000 1123457789999999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=311.30 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=200.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||+
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4778899999999999999764 58999999986443 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+++++|.++..... .++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 106 ~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 179 (331)
T 4aaa_A 106 VDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--E 179 (331)
T ss_dssp CSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--c
Confidence 99988888765444 4999999999999999999999 9999999999999999999999999999997665432 1
Q ss_pred eeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC------------c
Q 039392 158 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS------------T 224 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~ 224 (285)
......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+..... ........ .
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI-MMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCSCCHHHHHHHHHCGGG
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-HHHhCCCChhhhhHhhhcccc
Confidence 22345688999999988775 7899999999999999999999999765432221111 10000000 0
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....+.... ..........++.++.+++.+||..||.+|||++|++++
T Consensus 259 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKE-REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSS-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccc-cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 001111123567889999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=331.80 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=203.3
Q ss_pred eecccCceEEEEEEe---CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCCC
Q 039392 7 LIGRGGFGSVFKARL---GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHGS 82 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~---~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 82 (285)
.||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++.++||||+++++++.. +..++|||++++++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 799999999999964 356779999987643 3356788999999999999999999999976 56899999999999
Q ss_pred HHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc-ceecc
Q 039392 83 LEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TIQTQ 161 (285)
Q Consensus 83 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~-~~~~~ 161 (285)
|.+++......++...++.++.||+.||.||| +++++||||||+||+++.++.+||+|||++......... .....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999776666999999999999999999999 999999999999999999999999999999876443211 11122
Q ss_pred ccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 162 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
..+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.. ...... ...
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-~~i~~~-------------------~~~ 558 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQG-------------------KRM 558 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-HHHHTT-------------------CCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcC-------------------CCC
Confidence 345678999999988899999999999999999998 99999765433221 111100 001
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
..+..+++++.++|.+||..||.+|||++++++.|+++..+.
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 113456788999999999999999999999999999988665
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=324.51 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=203.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++.....+++|||
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 265 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 367788999999999999986 469999999986543 2334667889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 77 YMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 77 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|++|++|.+++... ...+++..++.++.||+.||.||| ++|++||||||+||+++.+|.+||+|||++......
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999988654 235899999999999999999999 999999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.. ......+|+.|+|||++.+..++.++|+||||+++|+|++|..||........... .........
T Consensus 343 ~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~-~~~~i~~~~---------- 409 (543)
T 3c4z_A 343 QT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-LKQRVLEQA---------- 409 (543)
T ss_dssp CC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH-HHHHHHHCC----------
T ss_pred Cc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH-HHHHHhhcc----------
Confidence 21 12345789999999999999999999999999999999999999976432111111 110000000
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCH-----HHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVT 273 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~eil~ 273 (285)
...+..+++++.+++++||..||.+||++ +++++
T Consensus 410 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 00123456779999999999999999964 66664
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=313.81 Aligned_cols=246 Identities=20% Similarity=0.264 Sum_probs=189.6
Q ss_pred CCCC-ceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHH-ccCCCCccccccceecc----CCceEEE
Q 039392 2 FSEN-NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMM-KSIHHRNIIKVISSCSN----EEFKALV 74 (285)
Q Consensus 2 y~~~-~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~~v 74 (285)
|.+. +.||+|+||+||++.. .+++.||||++... ..+.+|++++ +..+||||+++++++.. ...+++|
T Consensus 63 y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 4444 6899999999999975 46899999998633 3455677776 45589999999998865 5678999
Q ss_pred EeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCcEEEeeeccceec
Q 039392 75 LEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLL 150 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~i~df~~~~~~ 150 (285)
|||+++++|.+++.... ..+++..++.++.||+.||.||| ++|++||||||+||+++. ++.+||+|||++...
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999999997653 35899999999999999999999 999999999999999987 789999999999866
Q ss_pred CcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchh---hhhhhhhhcCCCcccc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT---LKHWVNDWLPISTKEI 227 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 227 (285)
.... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......... ..........
T Consensus 215 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~------ 285 (400)
T 1nxk_A 215 TSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE------ 285 (400)
T ss_dssp C--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC------
T ss_pred CCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc------
Confidence 5322 223456799999999999999999999999999999999999999764322110 0111000000
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........++.++.+||++||..||.+|||+++++++
T Consensus 286 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 ----------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ----------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001123467789999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=300.51 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=195.7
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4788999999999999999864 79999999987543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++..... ++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 92 YVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp CCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred ccCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 9999999999976544 899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
......+++.|+|||.+.+..+ +.++|+||||+++++|++|..||........ .........
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~--------------- 228 (276)
T 2h6d_A 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-FKKIRGGVF--------------- 228 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC---------------
T ss_pred -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcCcc---------------
Confidence 1234467889999999887764 6899999999999999999999975322211 111110000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..++.++.+++.+||..||.+|||+++++++
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0122345678999999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=309.99 Aligned_cols=247 Identities=20% Similarity=0.294 Sum_probs=204.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|.+.+.||+|+||.||++... +++.+++|++.... ....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 3778899999999999999754 58899999987542 3455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++.... .++...++.++.||+.||.||| ++|++|+||+|+||+++.++.++|+|||++........
T Consensus 122 ~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 122 LCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp CCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred cCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 999999999887654 4899999999999999999999 99999999999999999999999999999987653321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......++..|+|||.+.+..++.++||||||+++|+|++|..||......+.... ......
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~---------------- 258 (335)
T 2owb_A 197 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-IKKNEY---------------- 258 (335)
T ss_dssp -CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHHTCC----------------
T ss_pred -cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-HhcCCC----------------
Confidence 12345688899999999988999999999999999999999999975432221111 100000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..++.++.+++.+||..||.+|||+++++++
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0122345678999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=304.03 Aligned_cols=249 Identities=24% Similarity=0.285 Sum_probs=188.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||+||++.. .+++.||+|++.... ....+.+.++...++.++||||+++++++...+..++|||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 478899999999999999985 578999999987543 22334455566668888999999999999999999999999
Q ss_pred cCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 78 MPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 78 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
+++ +|.+++.. ....+++..++.++.|++.||.||| ++ |++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 88 MDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred hcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 975 88777653 3445999999999999999999999 87 9999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCccc----CCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYG----KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
. ......+++.|+|||.+ .+..++.++||||||+++++|++|..||.....................
T Consensus 164 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 234 (290)
T 3fme_A 164 V---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL------ 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC------
T ss_pred c---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc------
Confidence 2 12334688899999985 5567899999999999999999999999764433333222222111110
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....+++++.+++.+||..||.+|||+++++++
T Consensus 235 ------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 235 ------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 012346679999999999999999999999883
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=304.79 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=204.8
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|||+++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 67889999999999999975 468999999987543 3445778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
+++|.+++... .++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 104 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 176 (303)
T 3a7i_A 104 GGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 176 (303)
T ss_dssp TEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCB
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--ccc
Confidence 99999998653 4899999999999999999999 9999999999999999999999999999998765432 122
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+++.|+|||.+.+..++.++||||||+++++|++|..||........... .......
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~----------------- 237 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL--IPKNNPP----------------- 237 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHSCCC-----------------
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH--hhcCCCC-----------------
Confidence 345688899999999999999999999999999999999999875432211111 1000000
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l 275 (285)
.....++..+.+++.+||..||.+|||+++++++.
T Consensus 238 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 238 -TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 00223456699999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=302.15 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=198.6
Q ss_pred CCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 3 SENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|||+++++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 3445999999999999975 568899999998766666678899999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCC--ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeeccceecCcccccce
Q 039392 82 SLEKYLHSSNY--ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 82 ~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+|.+++..... ..+...++.++.|++.||.+|| ++|++|+||+|+||+++. ++.++|+|||++....... ..
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~ 179 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PC 179 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Cc
Confidence 99999876532 3668889999999999999999 999999999999999987 8999999999998765422 11
Q ss_pred eccccccccccCCcccCCC--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 159 QTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....+++.|+|||.+.+. .++.++||||||+++++|++|..||...................
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 244 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--------------- 244 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC---------------
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc---------------
Confidence 2345688999999988764 37899999999999999999999997543322211111000000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+..++.++.+++.+||..||.+|||+++++++
T Consensus 245 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 245 ---PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ---CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ---ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00123456779999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=314.19 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=203.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||++
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 4788899999999999999754 78999999987653 344577889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++..... ++...++.++.|++.||.||| +. |++|+||+|+||+++.++.++|+|||++......
T Consensus 114 ~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 185 (360)
T 3eqc_A 114 DGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 185 (360)
T ss_dssp TTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred CCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----
Confidence 99999999976554 899999999999999999999 75 9999999999999999999999999998654322
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhh---hcCC-----Ccccccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVND---WLPI-----STKEIVD 229 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~ 229 (285)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||................ .... .......
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 1234568899999999999999999999999999999999999997643322211100000 0000 0000000
Q ss_pred c----ccc-----------CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 P----NLL-----------SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~----~~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ... ............++.++.+|+.+||..||.+|||+++++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 000 00000000112356789999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=305.58 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=202.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc------------
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN------------ 67 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------ 67 (285)
+|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+|+++++.++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 3778899999999999999865 79999999987553 345679999999999999999998753
Q ss_pred ----CCceEEEEeccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEe
Q 039392 68 ----EEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS 142 (285)
Q Consensus 68 ----~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~ 142 (285)
....++|||++++++|.+++... ...++...++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEEC
Confidence 45588999999999999999654 345899999999999999999999 9999999999999999999999999
Q ss_pred eeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCC
Q 039392 143 DFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI 222 (285)
Q Consensus 143 df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (285)
|||++....... ......+++.|+|||.+.+..++.++||||||+++++|++|..|+..... .... ....
T Consensus 165 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~----~~~~ 234 (284)
T 2a19_B 165 DFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTD----LRDG 234 (284)
T ss_dssp CCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---HHHH----HHTT
T ss_pred cchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---HHHH----hhcc
Confidence 999998765432 12344688999999999988899999999999999999999988643211 0000 0000
Q ss_pred CccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 223 STKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
. .+...+..+.+++.+||..||.+|||+++++++|+.++++.
T Consensus 235 ~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 235 I------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp C------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred c------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 0 01234566889999999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=308.11 Aligned_cols=263 Identities=24% Similarity=0.281 Sum_probs=201.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-----CCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-----HRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++... ......+..|+++++.+. ||||+++++++...+..++|
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv 114 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence 478899999999999999975 57899999998643 334456777999999886 99999999999999999999
Q ss_pred EeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC------------------
Q 039392 75 LEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD------------------ 135 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~------------------ 135 (285)
||++ +++|.+++.... ..++...++.++.||+.||.||| ++|++|+||||+||+++.
T Consensus 115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999 889999987654 34899999999999999999999 999999999999999975
Q ss_pred -------CCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCcccccc
Q 039392 136 -------NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNG 208 (285)
Q Consensus 136 -------~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 208 (285)
++.++|+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 889999999999865432 23456899999999999999999999999999999999999999764322
Q ss_pred chhhhhhhhhhcCCCcc-----------cccccc----ccCcccch-----------hhhhhHhHHHHHHhhhcccccCc
Q 039392 209 EMTLKHWVNDWLPISTK-----------EIVDPN----LLSREDIH-----------FVAKEQCVSFVFNVAMECTVESP 262 (285)
Q Consensus 209 ~~~~~~~~~~~~~~~~~-----------~~~~~~----~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p 262 (285)
+. .........+.+.. ...... ..+..... .......++.+.+|+.+||+.||
T Consensus 266 ~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 266 EH-LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HH-HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HH-HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 11 11111111111100 000000 00000000 00011223678899999999999
Q ss_pred CCCCCHHHHHHH
Q 039392 263 EQRINAKEIVTK 274 (285)
Q Consensus 263 ~~Rps~~eil~~ 274 (285)
.+|||++|+|++
T Consensus 345 ~~Rpta~elL~h 356 (360)
T 3llt_A 345 TLRPSPAELLKH 356 (360)
T ss_dssp GGSCCHHHHTTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=308.12 Aligned_cols=261 Identities=20% Similarity=0.281 Sum_probs=200.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceecc--CCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSN--EEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++.... .+.+.+|+++++.++ ||||+++++++.. ....++|||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 478899999999999999974 578999999987443 356778999999997 9999999999987 667899999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-cEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~i~df~~~~~~~~~~~ 155 (285)
++.+++|.+++.. ++...++.++.|++.||.||| ++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 114 ~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 114 HVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp CCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred ccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 9999999998853 888899999999999999999 99999999999999999766 89999999998765432
Q ss_pred cceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcC-------------
Q 039392 156 STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP------------- 221 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------- 221 (285)
......++..|+|||.+.+ ..++.++||||||+++++|++|..||...................
T Consensus 186 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2234568889999999877 678999999999999999999999995543322221111110000
Q ss_pred CC--ccccccccccC--cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 222 IS--TKEIVDPNLLS--REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 222 ~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ........... ...........+++++.+|+.+||..||.+|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00000000000 0001111133467889999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=309.81 Aligned_cols=260 Identities=22% Similarity=0.207 Sum_probs=192.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCC------ce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE------FK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 71 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 478899999999999999975 46899999998753 2344567889999999999999999999987654 78
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++|||++++ +|.+.+.. .++...++.++.||+.||.||| ++|++|+||||+||+++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 999999965 78887752 3889999999999999999999 9999999999999999999999999999998654
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC--------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS-------- 223 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 223 (285)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+...... ............
T Consensus 179 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHTTSC
T ss_pred ccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHhh
Confidence 321 22345688999999999998999999999999999999999999976432211 111111000000
Q ss_pred -----------------ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 -----------------TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......... .+.........+.++.+|+.+||..||.+|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVL---FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGG---SCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhccccc---CcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 001111233457889999999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=317.88 Aligned_cols=245 Identities=15% Similarity=0.166 Sum_probs=190.0
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeecc---chhHHHHHHHHHH---HHccCCCCcccccc-------ceecc
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ---YGRVFKSFDVECE---MMKSIHHRNIIKVI-------SSCSN 67 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~~~~ 67 (285)
|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++ .++.++||||++++ +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 66789999999999999985 57999999998732 3445677889994 55555799999998 44443
Q ss_pred CC-----------------ceEEEEeccCCCCHHHhhhcCCC------ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 039392 68 EE-----------------FKALVLEYMPHGSLEKYLHSSNY------ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124 (285)
Q Consensus 68 ~~-----------------~~~~v~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~ 124 (285)
.+ ..+++||++ +|+|.+++..... .++...++.++.||+.||+||| ++|++||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 32 378999999 5699999875432 2335788889999999999999 9999999
Q ss_pred CCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCC-----------ccCcchhhHHHHHHHH
Q 039392 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG-----------RVSANGDVYSFGIMLI 193 (285)
Q Consensus 125 di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----------~~~~~~Di~slG~~l~ 193 (285)
||||+||+++.++.+||+|||++..... ......+ +.|+|||.+.+. .++.++||||||+++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999999999999999999986443 1233456 889999998877 7999999999999999
Q ss_pred HHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 194 ETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 194 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
+|++|..||........... .. .....+++++.+++.+||..||.+|||++++++
T Consensus 305 elltg~~Pf~~~~~~~~~~~-------------~~------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEW-------------IF------------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHSSCCC------CCSGG-------------GG------------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHCCCCCcccccccchhh-------------hh------------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999865322111000 00 001245677999999999999999999999996
Q ss_pred --HHHHHHHH
Q 039392 274 --KLVKIRDS 281 (285)
Q Consensus 274 --~l~~l~~~ 281 (285)
.++.+++.
T Consensus 360 hp~f~~~~~~ 369 (377)
T 3byv_A 360 TPEYEQLRTE 369 (377)
T ss_dssp SHHHHHHHHH
T ss_pred ChHHHHHHHH
Confidence 45555543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=331.17 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=202.9
Q ss_pred ceecccCceEEEEEEe---CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARL---GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~---~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++.. +..++|||++++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999953 356889999987543 3345778999999999999999999999965 457899999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc-ccee
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI-STIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~-~~~~ 159 (285)
++|.+++.... .++...++.++.||+.||.||| ++|++||||||+||+++.++.+||+|||++........ ....
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999997654 4899999999999999999999 99999999999999999999999999999987654321 1222
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+.... .... .
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~-~------------------ 589 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKG-E------------------ 589 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTT-C------------------
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcC-C------------------
Confidence 33446778999999998899999999999999999998 9999976433221111 1000 0
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
....+..++.++.++|.+||..||.+|||++++++.|+++..++.
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 011133567789999999999999999999999999999988765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=309.28 Aligned_cols=269 Identities=21% Similarity=0.308 Sum_probs=201.6
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceecc--------CC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSN--------EE 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~ 69 (285)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 478899999999999999986 5789999999865432 223467789999999999999999999866 44
Q ss_pred ceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 70 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
..++|||++++ +|.+.+......++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++..
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 68999999976 788877766566999999999999999999999 99999999999999999999999999999987
Q ss_pred cCcccc--cceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc-
Q 039392 150 LTREDI--STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK- 225 (285)
Q Consensus 150 ~~~~~~--~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 225 (285)
...... ........+++.|+|||.+.+ ..++.++||||||+++++|++|..||.+...... ..............
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhh
Confidence 653221 122234567999999998876 4689999999999999999999999976433222 11111111111100
Q ss_pred --c-----cccccc-cCcc---cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 --E-----IVDPNL-LSRE---DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 --~-----~~~~~~-~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ...... .... ..........++++.+|+.+||..||.+|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 000000 0000 00111112236779999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=330.33 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=207.0
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCCC
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
|++.+.||+|+||.||+|.+.++..||||++..... ..+.+.+|++++++++|+||+++++++.. +..++|||++.++
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~g 346 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 346 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred hhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCC
Confidence 567789999999999999988788899999875432 34678899999999999999999999876 6688999999999
Q ss_pred CHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 82 SLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 82 ~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
+|.+++... ...++...++.++.||+.||.||| +++++||||+|+||+++.++.+||+|||++....... .....
T Consensus 347 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~ 422 (535)
T 2h8h_A 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQ 422 (535)
T ss_dssp EHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTC
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eeccc
Confidence 999999753 234889999999999999999999 9999999999999999999999999999998665422 11122
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.. ...... .+
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-~~i~~~-------------------~~ 482 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERG-------------------YR 482 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-HHHHTT-------------------CC
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcC-------------------CC
Confidence 3446778999999988899999999999999999999 89998764332211 111000 00
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
...+..++.++.++|.+||..||.+|||++++++.|+++..
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11133567789999999999999999999999999987753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=301.38 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=202.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---------hhHHHHHHHHHHHHccCC-CCccccccceeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---------GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEE 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 69 (285)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++++. ||||+++++++....
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4788999999999999999764 68999999987542 233466788999999995 999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 70 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
..++|||++++++|.+++.... .++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||++..
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 9999999999999999997654 4899999999999999999999 99999999999999999999999999999987
Q ss_pred cCcccccceeccccccccccCCcccC------CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGK------EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
..... ......+++.|+|||.+. ...++.++||||||+++++|++|..||........ ...........
T Consensus 174 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~- 248 (298)
T 1phk_A 174 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMIMSGNYQF- 248 (298)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCC-
T ss_pred cCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-HHHHhcCCccc-
Confidence 65432 223456888999999874 45688999999999999999999999865332211 11111110000
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
.......++.++.+++.+||..||.+|||++++++
T Consensus 249 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 249 ---------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00112356778999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=313.47 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=200.6
Q ss_pred CCCCCceecccCceEEEEEEe----CCCcEEEEEEeeccc----hhHHHHHHHHHHHHccC-CCCccccccceeccCCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY----GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 71 (285)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+++++.+ +||||+++++++......
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 477889999999999999976 478999999986432 22335566799999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++||||+++++|.+++.... .++...++.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++....
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999987654 3899999999999999999999 9999999999999999999999999999998765
Q ss_pred cccccceeccccccccccCCcccCCC--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
.... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||........... ........
T Consensus 211 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~------- 281 (355)
T 1vzo_A 211 ADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-ISRRILKS------- 281 (355)
T ss_dssp GGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HHHHHHHC-------
T ss_pred cCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH-HHHHHhcc-------
Confidence 4321 122345689999999998753 578999999999999999999999975332211111 11000000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTKL 275 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~l 275 (285)
....+..++..+.+++.+||..||.+|| |+++++++.
T Consensus 282 ---------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0001234566789999999999999999 999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=310.09 Aligned_cols=266 Identities=21% Similarity=0.253 Sum_probs=196.7
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccc-----------hhHHHHHHHHHHHHccCCCCcccccccee----
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY-----------GRVFKSFDVECEMMKSIHHRNIIKVISSC---- 65 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 65 (285)
+|++.+.||+|+||.||+|...+|+.||+|.+.... ....+.+.+|+++++.++||||+++++++
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 588999999999999999988789999999885432 22346788999999999999999999998
Q ss_pred -ccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeee
Q 039392 66 -SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF 144 (285)
Q Consensus 66 -~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df 144 (285)
......++|||++. ++|.+.+......++...++.++.||+.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred CCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCEEEEec
Confidence 33456899999997 4888888776666999999999999999999999 999999999999999999999999999
Q ss_pred ccceecCcccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC
Q 039392 145 GIAKLLTREDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
|++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......... ...........
T Consensus 179 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~ 254 (362)
T 3pg1_A 179 NLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL-NKIVEVVGTPK 254 (362)
T ss_dssp TC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCC
T ss_pred Cccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCC
Confidence 9997544322 2234567889999998877 67899999999999999999999999764322211 11111111110
Q ss_pred cc-----------ccccccccCc-ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 TK-----------EIVDPNLLSR-EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 ~~-----------~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. .......... ...........++.+.+++.+||..||.+|||+++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00 0000000000 001111223457789999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=304.99 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=200.5
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCcccccccee--ccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSC--SNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~ 75 (285)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++ ......++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4788999999999999999754 78999999987543 34556788999999999999999999987 4567899999
Q ss_pred eccCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCCeeeCCCCcEEEeeeccc
Q 039392 76 EYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGYSAQ-----VIHCDLKPSNVLLDDNMVAHLSDFGIA 147 (285)
Q Consensus 76 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-----~~h~di~~~nili~~~~~~~i~df~~~ 147 (285)
|++++++|.+++... ...++...++.++.|++.||.+|| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999998653 234899999999999999999999 777 999999999999999999999999999
Q ss_pred eecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
....... .......+++.|+|||.+.+..++.++||||||+++++|++|..||......+.. .........
T Consensus 164 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~i~~~~~~------ 234 (279)
T 2w5a_A 164 RILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFR------ 234 (279)
T ss_dssp HHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHTCCC------
T ss_pred eeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH-HHHhhcccc------
Confidence 7665432 1112345788999999999888999999999999999999999999764322111 111111000
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
..+..++.++.+++.+||..||.+|||++++++++.
T Consensus 235 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 -------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 012245677999999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=299.83 Aligned_cols=249 Identities=19% Similarity=0.289 Sum_probs=198.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc----hhHHHHHHHHHHHHccCCCCcccccccee--ccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY----GRVFKSFDVECEMMKSIHHRNIIKVISSC--SNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~ 73 (285)
+|++.+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|+++++.++||||+++++++ ......++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 589999999999999999985 468999999987543 23456788999999999999999999998 45568899
Q ss_pred EEeccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 74 VLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
|||++.++ |.+++... ...++...++.++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999775 77766543 345899999999999999999999 99999999999999999999999999999987754
Q ss_pred ccccceeccccccccccCCcccCCCc--cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGR--VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
...........+++.|+|||.+.+.. .+.++||||||+++++|++|..||......+. .........
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~i~~~~~---------- 230 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-FENIGKGSY---------- 230 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCC----------
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-HHHHhcCCC----------
Confidence 33333344566899999999887643 47899999999999999999999975322111 111111000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..++..+.+++.+||..||.+|||+++++++
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0122456678999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=313.74 Aligned_cols=257 Identities=11% Similarity=0.117 Sum_probs=184.5
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHH---HHHccCCCCccccccc-------eecc
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVEC---EMMKSIHHRNIIKVIS-------SCSN 67 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~---~~l~~l~h~~i~~~~~-------~~~~ 67 (285)
|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+.+.+|+ ..++. +||||++++. ++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence 67889999999999999985 478999999998643 23445677774 45555 7999887553 3322
Q ss_pred C-----------------CceEEEEeccCCCCHHHhhhcCCCccCHHHH------HHHHHHHHHHHHHHhcCCCCCeeec
Q 039392 68 E-----------------EFKALVLEYMPHGSLEKYLHSSNYILDIYQR------LNIMIDVASTLEYLHFGYSAQVIHC 124 (285)
Q Consensus 68 ~-----------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~------~~~~~~l~~~l~~lh~~~~~~~~h~ 124 (285)
. ...++||||++ ++|.+++...+..++...+ +.++.||+.||+||| ++|++||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccC
Confidence 1 34799999998 7999999765443455555 677799999999999 9999999
Q ss_pred CCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCC--CccCcchhhHHHHHHHHHHhhCCCCC
Q 039392 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLIETFTRKKPT 202 (285)
Q Consensus 125 di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~ 202 (285)
||||+||+++.+|.+||+|||++....... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998765321 13456689999999987 67999999999999999999999999
Q ss_pred ccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH--HHHHHHH
Q 039392 203 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT--KLVKIRD 280 (285)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~--~l~~l~~ 280 (285)
............ .. ...........+.....+++++.+++.+||..||.+|||++++++ .++++.+
T Consensus 294 ~~~~~~~~~~~~------~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 294 GLVTPGIKGSWK------RP------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp TBCCTTCTTCCC------BC------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred CCcCcccccchh------hh------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 775432211000 00 000001111112223456788999999999999999999999985 3444443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=305.35 Aligned_cols=250 Identities=20% Similarity=0.259 Sum_probs=198.5
Q ss_pred CCCC-ceecccCceEEEEEEeC-CCcEEEEEEeeccch--hHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEe
Q 039392 2 FSEN-NLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~-~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|.+. +.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.+. ||||+++++++...+..++|||
T Consensus 30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e 109 (327)
T 3lm5_A 30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE 109 (327)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEE
Confidence 3344 78999999999999754 689999999875432 33567888999999985 7999999999999999999999
Q ss_pred ccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCcEEEeeeccceecCc
Q 039392 77 YMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~i~df~~~~~~~~ 152 (285)
++++++|.+++... ...+++..++.++.|++.||.||| ++|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp CCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999988543 345899999999999999999999 999999999999999987 78999999999987654
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.. ......+++.|+|||.+.+..++.++||||||+++++|++|..||......+.... ........
T Consensus 187 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~---------- 252 (327)
T 3lm5_A 187 AC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-ISQVNVDY---------- 252 (327)
T ss_dssp ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHTCCCC----------
T ss_pred cc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-HHhccccc----------
Confidence 32 12345689999999999999999999999999999999999999976433222111 11100000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+++.+.+++.+||..||.+|||+++++++
T Consensus 253 ------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 ------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 001123456779999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=331.01 Aligned_cols=246 Identities=20% Similarity=0.268 Sum_probs=203.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++++.||+|+||+||+|.. .+++.||||++.... ....+.+..|..++..+ +||+|+++++++...+.+|+||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 477889999999999999975 468899999987532 23345677899999887 6999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++++|.+++..... +++..++.++.||+.||.||| ++|++||||||+|||++.+|.+||+|||++.......
T Consensus 422 E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 496 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 496 (674)
T ss_dssp ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred eCcCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence 99999999999977554 999999999999999999999 9999999999999999999999999999998643322
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+|+.|+|||++.+..++.++|+||||+++|+|++|..||.+....+. .........
T Consensus 497 -~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~--------------- 559 (674)
T 3pfq_A 497 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSIMEHNV--------------- 559 (674)
T ss_dssp -CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHSSCC---------------
T ss_pred -cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-HHHHHhCCC---------------
Confidence 123456789999999999999999999999999999999999999976432221 111111000
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCH-----HHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVT 273 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~eil~ 273 (285)
..+...+.++.+||++||..||.+||++ +++++
T Consensus 560 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0123456779999999999999999997 77765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=308.45 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=202.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccC-----CceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE-----EFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~ 73 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 478899999999999999975 478899999987533 34457788999999999999999999998654 46899
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|+|++.+ +|.+++.... ++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++......
T Consensus 108 v~e~~~~-~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 108 VQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEECCSE-EHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEcccCc-CHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 9999965 8999886643 899999999999999999999 999999999999999999999999999999877653
Q ss_pred cccc-eeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc--
Q 039392 154 DIST-IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD-- 229 (285)
Q Consensus 154 ~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (285)
.... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+.. .................
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH-HHHHHHHCSCCHHHHHTCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH-HHHHHHhCCCCHHHHHHhh
Confidence 2221 1234578999999997654 45899999999999999999999999765433221 11111111111100000
Q ss_pred --------ccccCcccch-hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 --------PNLLSREDIH-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 --------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......... ......+++++.+|+.+||..||.+|||+++++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 01113457789999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=304.77 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=185.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||++
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 588899999999999999974 468999999986543 334566788999999999999999999999999999999999
Q ss_pred CCCCHHHhhhc-------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 79 PHGSLEKYLHS-------SNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 79 ~~~~L~~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++++|.+++.. ....++...++.++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999998864 2344899999999999999999999 9999999999999999999999999999987654
Q ss_pred cccc---cceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 152 REDI---STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 152 ~~~~---~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
.... ........+++.|+|||.+.+ ..++.++||||||+++++|++|..||..................... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 251 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE-TGV 251 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT-C--
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc-ccc
Confidence 3211 111234568889999998865 46899999999999999999999999765443322221111110000 000
Q ss_pred ccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
. .......++.++.+++.+||..||.+|||++++++
T Consensus 252 ~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 252 Q----------DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c----------cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 00112345667999999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=304.13 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=194.8
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCC--CCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIH--HRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||.||++...+++.||+|++.... ....+.+.+|+++++.++ |+||+++++++......+++||
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 108 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence 378899999999999999998889999999986542 345577889999999997 5999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+ .+++|.+++.... .++...++.++.|++.||.||| +.|++|+||+|+||+++ ++.++|+|||++.........
T Consensus 109 ~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 109 C-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp C-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred c-CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence 4 5779999997654 4889999999999999999999 99999999999999996 489999999999876554333
Q ss_pred ceeccccccccccCCcccCC-----------CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKE-----------GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
.......+++.|+|||.+.+ ..++.++||||||+++++|++|..||....................
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 259 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--- 259 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC---
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc---
Confidence 33344568999999998865 4688899999999999999999999976433222222111110000
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+...+.++.+++.+||..||.+|||+++++++
T Consensus 260 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 260 ---------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0012235668999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.55 Aligned_cols=261 Identities=17% Similarity=0.193 Sum_probs=208.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCC-CccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHH-RNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||+|.+ .+++.||||++...... ..+.+|+++++.+.| +++..+..++......++|||++
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 488999999999999999985 57999999987654332 457789999999986 45555555667778889999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCcEEEeeeccceecCcccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~i~df~~~~~~~~~~~ 155 (285)
+++|.+++......+++..++.++.||+.||.||| ++|++|+||||+|||+ +.++.++|+|||++........
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 88999999876666999999999999999999999 9999999999999999 5889999999999987654322
Q ss_pred c-----ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhh--hhhhhhhcCCCccccc
Q 039392 156 S-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL--KHWVNDWLPISTKEIV 228 (285)
Q Consensus 156 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 228 (285)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......... ..........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------ 235 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT------ 235 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS------
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc------
Confidence 1 11225668999999999999999999999999999999999999998754322111 1110000000
Q ss_pred cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
........++.++.+++.+||..+|.+||+++++++.|+++....
T Consensus 236 ---------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 236 ---------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp ---------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 000112455778999999999999999999999999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=311.00 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=183.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccC------Cce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNE------EFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 71 (285)
+|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 478899999999999999974 57899999998653 234456788999999999999999999998654 567
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+++++++ +++|.+++... .++...++.++.||+.||.||| +.|++|+||||+||+++.++.+||+|||++....
T Consensus 110 ~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp EEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 8999999 67999888653 4899999999999999999999 9999999999999999999999999999998654
Q ss_pred cccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.. .....+++.|+|||.+.+ ..++.++|||||||++++|++|..||.+..... ............... ....
T Consensus 184 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~-~~~~ 256 (367)
T 2fst_X 184 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAE-LLKK 256 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHH-HHTT
T ss_pred cc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHH-HHHH
Confidence 32 234568899999998877 678999999999999999999999997643321 111111111111000 0000
Q ss_pred -----------cccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 -----------NLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 -----------~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+ ......++++.+|+.+||..||.+|||++++|++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000011 0112457789999999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=308.49 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=199.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc------------
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN------------ 67 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------ 67 (285)
+|++.+.||+|+||+||+|.. .+|+.||+|++...... ..+|+++++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 478899999999999999975 57999999998654322 2369999999999999999998833
Q ss_pred --------------------------CCceEEEEeccCCCCHHHhhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCC
Q 039392 68 --------------------------EEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLHFGYS 118 (285)
Q Consensus 68 --------------------------~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~ 118 (285)
...+++|||++++ +|.+.+.. ....+++..++.++.||+.||.||| +
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 159 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---S 159 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3348899999975 87776642 3445999999999999999999999 9
Q ss_pred CCeeecCCCCCCeeeC-CCCcEEEeeeccceecCcccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHh
Q 039392 119 AQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETF 196 (285)
Q Consensus 119 ~~~~h~di~~~nili~-~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll 196 (285)
+|++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++||||+|+++++|+
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 9999999999999997 68999999999998765432 22345678899999988765 5899999999999999999
Q ss_pred hCCCCCccccccchhhhhhhhhhcCCCc----------cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCC
Q 039392 197 TRKKPTDEIFNGEMTLKHWVNDWLPIST----------KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI 266 (285)
Q Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 266 (285)
+|..||.+....+. ............. .....+. ..........+...+.++.+|+.+||..||.+||
T Consensus 237 ~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 237 LGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPT-LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCC-CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred hCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCc-cCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 99999976433222 1111111111100 0000000 1111122223345678899999999999999999
Q ss_pred CHHHHHHH--HHHHHH
Q 039392 267 NAKEIVTK--LVKIRD 280 (285)
Q Consensus 267 s~~eil~~--l~~l~~ 280 (285)
|+.|++++ ++.+++
T Consensus 315 t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 315 NPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CHHHHHTSGGGHHHHH
T ss_pred CHHHHhcCHHHHHHHh
Confidence 99999953 555544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=327.77 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=204.4
Q ss_pred CCCCceecccCceEEEEEEeC----CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|++.+.||+|+||.||+|... .+..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E 470 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 470 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEE
Confidence 567889999999999999753 25678999876533 3445778899999999999999999999854 56889999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++++|.+++......++...++.++.|++.||.||| ++|++||||||+||+++.++.++|+|||++........
T Consensus 471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~- 546 (656)
T 2j0j_A 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY- 546 (656)
T ss_dssp CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc-
Confidence 99999999999876656899999999999999999999 99999999999999999999999999999987654321
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.... .....
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-i~~~~---------------- 609 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGE---------------- 609 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHHTC----------------
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCC----------------
Confidence 12233456778999999988899999999999999999997 9999876433222111 11100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
....+..+++.+.+++.+||..||.+|||++++++.|+++.++
T Consensus 610 ---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 610 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0011235677899999999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=303.23 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=195.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--------hHHHHHHHHHHHHccCCCCccccccceeccCCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--------RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 71 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+++++.++||||+++++++.... .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 378899999999999999975 4689999999864321 22345778999999999999999999987665 8
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc---EEEeeeccce
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFGIAK 148 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~i~df~~~~ 148 (285)
++|||++++++|.+++.... .++...++.++.||+.||.||| ++|++|+||+|+||+++.++. ++|+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 89999999999999886554 4899999999999999999999 999999999999999987654 9999999998
Q ss_pred ecCcccccceeccccccccccCCcccC---CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc
Q 039392 149 LLTREDISTIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225 (285)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
...... ......+++.|+|||.+. ...++.++||||||+++|+|++|..||...................
T Consensus 166 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---- 238 (322)
T 2ycf_A 166 ILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN---- 238 (322)
T ss_dssp ECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC----
T ss_pred eccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc----
Confidence 765432 122345788999999863 5578999999999999999999999997643322211111111000
Q ss_pred ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
........++.++.+++.+||..||.+|||++++++
T Consensus 239 ------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 ------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000112345778999999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=298.15 Aligned_cols=242 Identities=19% Similarity=0.267 Sum_probs=196.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+..+..+ +||||+++++++...+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 3778899999999999999864 79999999987532 33446677899999988 89999999999999999999999
Q ss_pred ccCCCCHHHhhhcCC---CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-----------------
Q 039392 77 YMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN----------------- 136 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~----------------- 136 (285)
++++++|.+++.... ..+++..++.++.||+.||.||| ++|++|+||||+||+++.+
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-------------------
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999987542 34899999999999999999999 9999999999999999844
Q ss_pred --CcEEEeeeccceecCcccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhh
Q 039392 137 --MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLK 213 (285)
Q Consensus 137 --~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~ 213 (285)
..++|+|||.+...... ....+++.|+|||.+.+. .++.++||||||+++++|++|..|+.... ...
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~ 238 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWH 238 (289)
T ss_dssp -CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----HHH
T ss_pred CceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----HHH
Confidence 47999999999876543 223588999999998766 67789999999999999999988764321 111
Q ss_pred hhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 214 HWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
....... . ..+..+++++.+++.+||..||.+|||+++++++
T Consensus 239 ~~~~~~~-------------~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 EIRQGRL-------------P------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHTTCC-------------C------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHcCCC-------------C------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111000 0 0122356779999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=312.48 Aligned_cols=264 Identities=21% Similarity=0.256 Sum_probs=181.9
Q ss_pred CceecccCceEEEEEEeC---CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcccccccee--ccCCceEEEEeccC
Q 039392 5 NNLIGRGGFGSVFKARLG---DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC--SNEEFKALVLEYMP 79 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~~~ 79 (285)
+++||+|+||+||+|... +++.||+|++..... ...+.+|+.+++.++||||+++++++ ......++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 568999999999999853 578999999865432 24577899999999999999999999 45778999999996
Q ss_pred CCCHHHhhhcC--------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCcEEEeeeccc
Q 039392 80 HGSLEKYLHSS--------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIA 147 (285)
Q Consensus 80 ~~~L~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~i~df~~~ 147 (285)
+ +|.+++... ...+++..++.++.||+.||.||| ++|++||||||+||++ +.++.++|+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5 888777532 123889999999999999999999 9999999999999999 67899999999999
Q ss_pred eecCcccc-cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccc--------hhhhhhhh
Q 039392 148 KLLTREDI-STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGE--------MTLKHWVN 217 (285)
Q Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~--------~~~~~~~~ 217 (285)
........ ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||....... ........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87654321 1223345689999999998874 58999999999999999999999997543211 11111111
Q ss_pred hhcCCCccccccccccCc----------------ccchhh--hhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 218 DWLPISTKEIVDPNLLSR----------------EDIHFV--AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~----------------~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+........ ...... .....+.++.+||.+||..||.+|||++|+|++
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111111100000000 000000 001125678899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=310.99 Aligned_cols=264 Identities=20% Similarity=0.226 Sum_probs=199.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC--------CCccccccceec----c
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH--------HRNIIKVISSCS----N 67 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~ 67 (285)
.|++.+.||+|+||+||+|.. .+++.||+|++... ....+.+.+|+++++.++ |+||+++++.+. .
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 378899999999999999975 46899999998744 344567788999998885 788999999987 5
Q ss_pred CCceEEEEeccCCCCHHHhhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCC--------
Q 039392 68 EEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSA-QVIHCDLKPSNVLLDDNM-------- 137 (285)
Q Consensus 68 ~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~di~~~nili~~~~-------- 137 (285)
....++|||++. +++.+.+.. ....++...++.++.||+.||.||| ++ |++||||||+||+++.++
T Consensus 117 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 117 GTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 678999999994 466665544 3355999999999999999999999 87 999999999999999776
Q ss_pred -----------------------------------------cEEEeeeccceecCcccccceeccccccccccCCcccCC
Q 039392 138 -----------------------------------------VAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176 (285)
Q Consensus 138 -----------------------------------------~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 176 (285)
.++|+|||++...... .....+|+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcC
Confidence 7999999999876543 234568999999999999
Q ss_pred CccCcchhhHHHHHHHHHHhhCCCCCccccccchh-----hhhhhhhhcCCCcc---------ccccc--------cccC
Q 039392 177 GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT-----LKHWVNDWLPISTK---------EIVDP--------NLLS 234 (285)
Q Consensus 177 ~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~---------~~~~~--------~~~~ 234 (285)
..++.++||||||+++|+|++|..||......... ...........+.. ..... ....
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 89999999999999999999999999764432211 11111111110000 00000 0000
Q ss_pred c-----ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 R-----EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ...........+.++.+|+.+||..||.+|||++|++++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 000111235667889999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=301.20 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=195.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceec-------------
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCS------------- 66 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------------- 66 (285)
.|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 4788999999999999999865 58999999998776677788899999999999999999998763
Q ss_pred -cCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeee
Q 039392 67 -NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDF 144 (285)
Q Consensus 67 -~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df 144 (285)
.....++|||+++ ++|.+++... .++...++.++.|++.||+||| ++|++|+||+|+||+++ .++.++|+||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 4467899999997 5999998653 4889999999999999999999 99999999999999997 6779999999
Q ss_pred ccceecCcccc-cceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCC
Q 039392 145 GIAKLLTREDI-STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPI 222 (285)
Q Consensus 145 ~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (285)
|++........ ........++..|+|||.+.+ ..++.++||||||+++++|++|..||......+. ...........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~ 244 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILESIPVV 244 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHSCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCC
Confidence 99987643211 112233456888999998765 6789999999999999999999999976433221 11111111110
Q ss_pred Cccc----------cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 223 STKE----------IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 223 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.... ...................++.++.+++.+||..||.+|||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 000000000000011123467889999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=297.71 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|+|+
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEc
Confidence 3788999999999999999864 78999999986543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CcEEEeeeccceecCccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~---~~~~i~df~~~~~~~~~~ 154 (285)
+++++|.+.+.... .++...++.++.|++.||.+|| ++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 103 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 103 YTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999998886554 3899999999999999999999 9999999999999999754 479999999987664432
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
......+++.|+|||.+.+ .++.++|+||||+++++|++|..||......+. ..........
T Consensus 179 ---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~------------- 240 (287)
T 2wei_A 179 ---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGKYA------------- 240 (287)
T ss_dssp ---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC-------------
T ss_pred ---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCC-------------
Confidence 1123457888999998865 489999999999999999999999976432211 1111111000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........++.++.+++.+||..||.+|||+++++++
T Consensus 241 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ---CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0111123557789999999999999999999999984
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=297.47 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=193.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc------------
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN------------ 67 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------ 67 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+++++.++||||+++++++..
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 478899999999999999985 47899999998643 4455778899999999999999999998743
Q ss_pred -CCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecc
Q 039392 68 -EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 146 (285)
Q Consensus 68 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~ 146 (285)
....++|||++++++|.+++......++...++.++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 45788999999999999999876666888999999999999999999 99999999999999999999999999999
Q ss_pred ceecCcccc------------cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhh
Q 039392 147 AKLLTREDI------------STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLK 213 (285)
Q Consensus 147 ~~~~~~~~~------------~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~ 213 (285)
+........ ........+++.|+|||.+.+. .++.++||||||+++|+|++ ||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 986643210 1112345578899999998765 68999999999999999998 5543221111111
Q ss_pred hhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 214 HWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........+ .......+..+.+++++||..||.+|||+++++++
T Consensus 240 ~~~~~~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 240 KLRSVSIEFP----------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHSTTCCCC----------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hccccccccC----------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111000000 00123456678999999999999999999999873
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=310.98 Aligned_cols=262 Identities=20% Similarity=0.260 Sum_probs=198.4
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC------CCCccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI------HHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~~v 74 (285)
|++.+.||+|+||+||+|.. .+++.||+|++... ......+.+|+.+++.+ +|+||+++++.+......++|
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 77889999999999999975 46899999998754 33345566777777766 578999999999999999999
Q ss_pred EeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc--EEEeeeccceecC
Q 039392 75 LEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV--AHLSDFGIAKLLT 151 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--~~i~df~~~~~~~ 151 (285)
||++. ++|.+++.... ..+++..++.++.||+.||.||| +.|++||||||+||+++.++. +||+|||++....
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99995 58998887654 34899999999999999999999 999999999999999999887 9999999997654
Q ss_pred cccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK------ 225 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 225 (285)
.. .....+++.|+|||++.+..++.++|||||||++|+|++|..||......+.. .............
T Consensus 254 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l-~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 254 QR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL-ACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp CC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHTBT
T ss_pred Cc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHHhhh
Confidence 32 23456889999999999989999999999999999999999999765332211 1111110000000
Q ss_pred ---ccccc---------------c---------------ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHH
Q 039392 226 ---EIVDP---------------N---------------LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272 (285)
Q Consensus 226 ---~~~~~---------------~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil 272 (285)
.++.. . ...........+...++++.+||++||..||.+|||++|+|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 00000 0 00000000011123367799999999999999999999998
Q ss_pred HH
Q 039392 273 TK 274 (285)
Q Consensus 273 ~~ 274 (285)
++
T Consensus 408 ~H 409 (429)
T 3kvw_A 408 RH 409 (429)
T ss_dssp TS
T ss_pred CC
Confidence 74
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=304.20 Aligned_cols=257 Identities=20% Similarity=0.323 Sum_probs=198.6
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++.+.||+|+||.||+|...+ .+++|++.... ....+.+.+|+.+++.++||||+++++++......++++|++
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 47889999999999999998743 49999986532 223355678999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc---c
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED---I 155 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~---~ 155 (285)
++++|.+++......++...++.++.|++.||.+|| ++|++|+||+|+||+++ ++.++|+|||++....... .
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 999999999877666899999999999999999999 99999999999999998 6899999999987553211 1
Q ss_pred cceeccccccccccCCcccCC---------CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 156 STIQTQTLATIGYMAPEYGKE---------GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~---------~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........... ......+. .
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~-~-- 263 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ-MGTGMKPN-L-- 263 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH-HHTTCCCC-C--
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-hccCCCCC-C--
Confidence 112233457889999998764 3578999999999999999999999976433222111 11110000 0
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
....++.++.+++.+||..||.+|||++++++.|+++.+..
T Consensus 264 ---------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 264 ---------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ---------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ---------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 01134556889999999999999999999999999987653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=306.37 Aligned_cols=260 Identities=21% Similarity=0.244 Sum_probs=195.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCce------
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFK------ 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 71 (285)
+|.+.+.||+|+||+||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 477889999999999999975 468999999987542 34456788999999999999999999999877654
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
++|||++. ++|.+.+.. .++...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 123 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp EEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 89999996 488887743 3899999999999999999999 9999999999999999999999999999998654
Q ss_pred cccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc-
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD- 229 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 229 (285)
.. .....+++.|+|||.+.+ ..++.++||||||+++++|++|..||.+....+.. ........... .....
T Consensus 196 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~-~~~~~~ 268 (371)
T 4exu_A 196 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-TQILKVTGVPG-TEFVQK 268 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCC-HHHHTT
T ss_pred cC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCc-HHHHHH
Confidence 32 234567899999998877 67899999999999999999999999764322221 11111111000 00000
Q ss_pred -----------ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 -----------PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
................+++++.+|+.+||+.||.+|||+++++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000011123457889999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=300.73 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=193.1
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceecc------CCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSN------EEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~ 72 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 477889999999999999986 4789999999875432 346678899999998 79999999999865 46789
Q ss_pred EEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 73 LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+|||++++++|.+++.... ..++...++.++.||+.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 9999999999999987643 45889999999999999999999 9999999999999999999999999999987654
Q ss_pred cccccceeccccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
... .......+++.|+|||.+. +..++.++||||||+++|+|++|..||........... .... ....
T Consensus 181 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~-~~~~--- 253 (326)
T 2x7f_A 181 RTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRN-PAPR--- 253 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHS-CCCC---
T ss_pred cCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-hhcC-cccc---
Confidence 321 1123446889999999886 45689999999999999999999999965432221111 1000 0000
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....++..+.+++.+||..||.+|||+++++++
T Consensus 254 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 254 --------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp --------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0012345679999999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=300.90 Aligned_cols=267 Identities=23% Similarity=0.239 Sum_probs=199.4
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccC-----CceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE-----EFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~ 73 (285)
+|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 5788999999999999999854 68999999986433 34456678999999999999999999987653 67899
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
+||++. ++|.+++... .++...++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++......
T Consensus 92 v~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 92 IQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 999996 4899988763 3899999999999999999999 999999999999999999999999999999876543
Q ss_pred cccc--------eeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc
Q 039392 154 DIST--------IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST 224 (285)
Q Consensus 154 ~~~~--------~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
.... ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||......... ............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 244 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL-LLIFGIIGTPHS 244 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCS
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCch
Confidence 2111 1123467899999997654 67899999999999999999999999764322211 111111111000
Q ss_pred cccccc-----------ccc-CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 KEIVDP-----------NLL-SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ~~~~~~-----------~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...... ... ............+++++.+++.+||..||++|||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000 00000001123567889999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=307.71 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=193.9
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCC------ceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE------FKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~ 75 (285)
|++.+.||+|+||+||+|....+..+|+|.+..... ...+|+++++.++||||+++++++.... .+++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 788999999999999999987666799998754322 1236999999999999999999984433 378999
Q ss_pred eccCCCCHHHhhh---cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeeeccceecC
Q 039392 76 EYMPHGSLEKYLH---SSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 76 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df~~~~~~~ 151 (285)
||+++ ++...+. .....++...++.++.||+.||.||| ++|++||||||+||+++ .++.+||+|||++....
T Consensus 118 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 118 EYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp ECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99977 4443332 23445899999999999999999999 99999999999999998 89999999999998764
Q ss_pred cccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc----
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE---- 226 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 226 (285)
.... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+....+. ...............
T Consensus 194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 194 AGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHH
T ss_pred CCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhh
Confidence 4321 2345678999999988765 589999999999999999999999976433221 111111111111000
Q ss_pred ---cccc--cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 227 ---IVDP--NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 227 ---~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.... ................++++.+|+.+||..||.+|||+.|++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 00111111122233467889999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=298.24 Aligned_cols=266 Identities=24% Similarity=0.332 Sum_probs=200.1
Q ss_pred CCCCCceecccCceEEEEEEe--CCCcEEEEEEeeccchh--HHHHHHHHHHHHccC---CCCccccccceec-----cC
Q 039392 1 GFSENNLIGRGGFGSVFKARL--GDGMEVAVKVFNLQYGR--VFKSFDVECEMMKSI---HHRNIIKVISSCS-----NE 68 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~--~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~ 68 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 478899999999999999986 46889999998654321 123455677776665 8999999999986 56
Q ss_pred CceEEEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccc
Q 039392 69 EFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 147 (285)
Q Consensus 69 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~ 147 (285)
...++|||++. ++|.+++.... ..++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 77899999997 59999887643 34899999999999999999999 999999999999999999999999999999
Q ss_pred eecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 227 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
....... ......+++.|+|||.+.+..++.++||||||+++++|++|..||......... ..............+
T Consensus 168 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 168 RIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDW 243 (326)
T ss_dssp CCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCGGGS
T ss_pred ccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHcCCCCcccC
Confidence 8765432 223456789999999999889999999999999999999999999764432221 111111111100000
Q ss_pred ccc------cccCc-ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 VDP------NLLSR-EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ~~~------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
... ..... ..........++.++.+++.+||..||.+|||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000 000011123567789999999999999999999999853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=299.03 Aligned_cols=263 Identities=19% Similarity=0.266 Sum_probs=201.2
Q ss_pred CCCCCceecccCceEEEEEEe--CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCC------ccccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL--GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHR------NIIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++... ....+.+.+|+++++.++|+ +++++++++...+..+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 478899999999999999975 36889999998643 34456678899988888655 4899999999999999
Q ss_pred EEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----------------
Q 039392 73 LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---------------- 135 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---------------- 135 (285)
+|||++ +++|.+++.... ..++...++.++.|++.||.||| ++|++|+||||+||+++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 779999887654 35889999999999999999999 999999999999999987
Q ss_pred ---CCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhh
Q 039392 136 ---NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL 212 (285)
Q Consensus 136 ---~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~ 212 (285)
++.++|+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......+. .
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~ 243 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH-L 243 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-H
T ss_pred cccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-H
Confidence 668999999999865432 2345688999999999998999999999999999999999999976433221 1
Q ss_pred hhhhhhhcCCCcc--------ccccc--ccc--------------CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCH
Q 039392 213 KHWVNDWLPISTK--------EIVDP--NLL--------------SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINA 268 (285)
Q Consensus 213 ~~~~~~~~~~~~~--------~~~~~--~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 268 (285)
..........+.. ..... ... .............++++.+++.+||..||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 1111111111000 00000 000 00000011123557889999999999999999999
Q ss_pred HHHHHH
Q 039392 269 KEIVTK 274 (285)
Q Consensus 269 ~eil~~ 274 (285)
+|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=305.56 Aligned_cols=260 Identities=24% Similarity=0.325 Sum_probs=193.5
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc------CCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN------EEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~~v 74 (285)
|++.+.||+|+||.||+|... +|+.||||.+..... ...+|+++++.++||||+++++++.. ...+++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 778899999999999999864 689999999865422 23369999999999999999998743 2346789
Q ss_pred EeccCCCCHHHhhh---cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CcEEEeeeccceec
Q 039392 75 LEYMPHGSLEKYLH---SSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL 150 (285)
Q Consensus 75 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~i~df~~~~~~ 150 (285)
|||+++ ++.+.+. .....++...++.++.||+.||.||| ++|++||||||+||+++.+ +.+||+|||++...
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999976 6666553 23445999999999999999999999 9999999999999999954 67899999999876
Q ss_pred CcccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC------
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS------ 223 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 223 (285)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+ .............
T Consensus 208 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 208 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHHH
T ss_pred ccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHh
Confidence 54321 2345679999999988765 78999999999999999999999997643222 1222211111110
Q ss_pred ----ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 ----TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+. ..............++++.+|+.+||..||.+|||+.|++++
T Consensus 284 ~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCC-CCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCc-cCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00010000 000111111123457889999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=296.80 Aligned_cols=252 Identities=25% Similarity=0.301 Sum_probs=177.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHH-HHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECE-MMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++..... .....+..|+. +++.++||||+++++++...+..++|||+
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 477889999999999999986 4789999999875432 23344445555 78888999999999999999999999999
Q ss_pred cCCCCHHHhhhc----CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 78 MPHGSLEKYLHS----SNYILDIYQRLNIMIDVASTLEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 78 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+++ +|.+++.. ....++...++.++.|++.||.+|| +. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 976 88877653 2345899999999999999999999 88 999999999999999999999999999976654
Q ss_pred ccccceeccccccccccCCccc----CCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYG----KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
.. ......+++.|+|||.+ .+..++.++||||||+++++|++|..||................ ..
T Consensus 179 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~---- 247 (327)
T 3aln_A 179 SI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG----DP---- 247 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS----CC----
T ss_pred cc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC----CC----
Confidence 32 12234688899999998 45668999999999999999999999997533211111100000 00
Q ss_pred cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..........++.++.+++.+||..||.+|||+++++++
T Consensus 248 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 -------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -------CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -------CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000000123456779999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=296.56 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=183.0
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.++..+++.++||||+++++++...+..++|||+
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 4677899999999999999864 789999999875432 2233445556678888999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
+ ++.+..+.......++...++.++.|++.||.||| +. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-- 179 (318)
T ss_dssp C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--
Confidence 9 55676666554556999999999999999999999 75 99999999999999999999999999997654422
Q ss_pred ceeccccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 157 TIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
......+++.|+|||.+. ...++.++||||||+++++|++|..||....................
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 249 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL--------- 249 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC---------
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC---------
Confidence 123446888999999884 45688999999999999999999999976433322222222111110
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
+.....++.++.+++.+||..||.+|||+++++++
T Consensus 250 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 --------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00112356679999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=297.78 Aligned_cols=250 Identities=18% Similarity=0.232 Sum_probs=172.1
Q ss_pred CCCCC-ceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc----CCceEEE
Q 039392 1 GFSEN-NLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN----EEFKALV 74 (285)
Q Consensus 1 ~y~~~-~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v 74 (285)
+|.+. +.||+|+||+||+|... +++.||+|++..... ... +....++.+.||||+++++++.. ....++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 36664 46999999999999764 799999999865322 112 23334566789999999999865 4558899
Q ss_pred EeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCcEEEeeeccceec
Q 039392 75 LEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLL 150 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~i~df~~~~~~ 150 (285)
||++++++|.+++.... ..+++..++.++.||+.||.||| ++|++|+||+|+||+++. ++.++|+|||++...
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999997654 35999999999999999999999 999999999999999976 455999999999866
Q ss_pred CcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||............. ..
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------------~~ 244 (336)
T 3fhr_A 182 TQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK-------------RR 244 (336)
T ss_dssp --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred cccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH-------------Hh
Confidence 5322 234467889999999988899999999999999999999999996543221110000 00
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...............++.++.+++.+||..||.+|||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 245 IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000001111123567789999999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=300.18 Aligned_cols=261 Identities=21% Similarity=0.246 Sum_probs=195.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCc------e
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF------K 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~ 71 (285)
+|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 477889999999999999975 469999999986532 3345678899999999999999999999977654 4
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+++||++. ++|.+++.. .++...++.++.||+.||.||| ++|++|+||+|+||+++.++.++|+|||++....
T Consensus 105 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 89999996 488887643 3899999999999999999999 9999999999999999999999999999997654
Q ss_pred cccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc-----
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK----- 225 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 225 (285)
.. .....+++.|+|||.+.+ ..++.++||||||+++++|++|..||.+....+. ..............
T Consensus 178 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 178 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTTC
T ss_pred CC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHH
Confidence 32 233467899999998876 6789999999999999999999999976432211 11111110000000
Q ss_pred ------ccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 ------EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.............-......+++++.+++.+||..||.+|||+++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000000001123567889999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=301.80 Aligned_cols=264 Identities=16% Similarity=0.224 Sum_probs=197.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-----------CCccccccceeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-----------HRNIIKVISSCSNE 68 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~ 68 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++... ....+.+.+|+.++++++ |+||+++++++...
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 478899999999999999975 57899999998743 334466778999888876 78999999998754
Q ss_pred C----ceEEEEeccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeC------CC
Q 039392 69 E----FKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSA-QVIHCDLKPSNVLLD------DN 136 (285)
Q Consensus 69 ~----~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~di~~~nili~------~~ 136 (285)
+ ..+++||++ +++|.+++... ...++...++.++.||+.||.||| ++ |++|+||||+||+++ ..
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCc
Confidence 3 788999999 78999998764 334899999999999999999999 87 999999999999994 44
Q ss_pred CcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccc-----hh
Q 039392 137 MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE-----MT 211 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-----~~ 211 (285)
+.++|+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ..
T Consensus 175 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 58999999999876542 234468999999999999899999999999999999999999997543211 11
Q ss_pred hhhhhhhhcCCCcc------------------ccccc-cccC---cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHH
Q 039392 212 LKHWVNDWLPISTK------------------EIVDP-NLLS---REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK 269 (285)
Q Consensus 212 ~~~~~~~~~~~~~~------------------~~~~~-~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (285)
...........+.. ..+.. .... ........+...+.++.+||.+||+.||.+|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 11111111110000 00000 0000 00011122356788999999999999999999999
Q ss_pred HHHHH
Q 039392 270 EIVTK 274 (285)
Q Consensus 270 eil~~ 274 (285)
|++++
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=297.62 Aligned_cols=263 Identities=21% Similarity=0.257 Sum_probs=197.2
Q ss_pred CCCCCceecccCceEEEEEEeC-CC-cEEEEEEeeccchhHHHHHHHHHHHHccCCCCc------cccccceeccCCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DG-MEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN------IIKVISSCSNEEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~-~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~ 72 (285)
+|++.+.||+|+||+||+|... ++ +.||+|++... ....+.+.+|+.+++.++|++ ++.+.+++...+..+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 4788999999999999999753 34 78999998643 344566778999998887655 888899999999999
Q ss_pred EEEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee------------------
Q 039392 73 LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLL------------------ 133 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili------------------ 133 (285)
+|||++ ++++.+.+.... ..++...++.++.||+.||.||| ++|++|+||||+||++
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999 556766665443 45899999999999999999999 9999999999999999
Q ss_pred -CCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhh
Q 039392 134 -DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL 212 (285)
Q Consensus 134 -~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~ 212 (285)
+.++.++|+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......+..
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~- 248 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL- 248 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-
T ss_pred ccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence 56789999999999865432 23456899999999999999999999999999999999999999764332211
Q ss_pred hhhhhhhcCCCcc--------ccccc--ccc--------------CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCH
Q 039392 213 KHWVNDWLPISTK--------EIVDP--NLL--------------SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINA 268 (285)
Q Consensus 213 ~~~~~~~~~~~~~--------~~~~~--~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 268 (285)
..........+.. ..... ... .............+.++.+|+++||..||.+|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 1111111111000 00000 000 00000011123446789999999999999999999
Q ss_pred HHHHHH
Q 039392 269 KEIVTK 274 (285)
Q Consensus 269 ~eil~~ 274 (285)
++++++
T Consensus 329 ~e~l~h 334 (355)
T 2eu9_A 329 AEALLH 334 (355)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=298.68 Aligned_cols=267 Identities=21% Similarity=0.237 Sum_probs=185.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCc-------eE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF-------KA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~~ 72 (285)
+|++.+.||+|+||+||+|.. .+++.||+|++.... .......++++.+..++||||+++++++..... .+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 588899999999999999986 468999999886432 223445667888888899999999999854332 78
Q ss_pred EEEeccCCCCHHHhhh---cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeeccce
Q 039392 73 LVLEYMPHGSLEKYLH---SSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAK 148 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~ 148 (285)
+|||++++ +|...+. .....++...++.++.|++.||.||| .++.|++|+||||+||+++. ++.++|+|||++.
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 99999976 5554433 23345889999999999999999999 34689999999999999996 8999999999998
Q ss_pred ecCcccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc---
Q 039392 149 LLTREDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST--- 224 (285)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 224 (285)
...... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||........ .............
T Consensus 181 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 181 KLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVLGCPSREVL 256 (360)
T ss_dssp CCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHH
T ss_pred ecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHcCCCCHHHH
Confidence 765432 22345678999999988665 489999999999999999999999976433222 1222111111100
Q ss_pred ---------cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 225 ---------KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 225 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......................+.++.+|+.+||+.||.+|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000001112357789999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=306.01 Aligned_cols=247 Identities=21% Similarity=0.358 Sum_probs=186.8
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.+.||+|+||+|+.....+++.||||++..... ..+.+|+++++.+ +||||+++++++......++|||++.+
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g 102 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA 102 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC
Confidence 677889999999997766566799999999865432 2355799999999 799999999999999999999999964
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCcEEEeeeccceecCcccc
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-----~~~~~i~df~~~~~~~~~~~ 155 (285)
+|.+++.......+...++.++.||+.||.||| ++|++||||||+||+++. ...++|+|||++........
T Consensus 103 -~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 103 -TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp -EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred -CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 999999776655555567789999999999999 999999999999999953 23578999999987654321
Q ss_pred c-ceeccccccccccCCcccCC---CccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 156 S-TIQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 156 ~-~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
. .......+|+.|+|||++.+ ..++.++|||||||++++|++ |..||.......... ... .....
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~~~---~~~~~----- 248 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLG---ACSLD----- 248 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--HTT---CCCCT-----
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--Hhc---cCCcc-----
Confidence 1 22234568999999999874 567889999999999999999 888985432221111 000 00000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
........+..+.+++.+||+.||.+|||++++++
T Consensus 249 --------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 --------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00012244666889999999999999999999995
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=303.99 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=186.2
Q ss_pred CCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEeccCCC
Q 039392 3 SENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
...+.||+|+||+||.+...+|+.||||.+.... .+.+.+|+++++++ +||||+++++++...+..++|||+++ +
T Consensus 18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 3467899999999987766789999999986543 34567899999876 89999999999999999999999996 5
Q ss_pred CHHHhhhcCCCc------cCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-------------CcEEEe
Q 039392 82 SLEKYLHSSNYI------LDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN-------------MVAHLS 142 (285)
Q Consensus 82 ~L~~~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~-------------~~~~i~ 142 (285)
+|.+++...... .+...++.++.||+.||+||| ++|++||||||+||+++.+ +.++|+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999765421 122345779999999999999 9999999999999999754 489999
Q ss_pred eeccceecCcccccc--eeccccccccccCCcccCC-------CccCcchhhHHHHHHHHHHhh-CCCCCccccccchhh
Q 039392 143 DFGIAKLLTREDIST--IQTQTLATIGYMAPEYGKE-------GRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTL 212 (285)
Q Consensus 143 df~~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~ 212 (285)
|||++.......... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||........
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-- 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-- 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--
Confidence 999998776532211 1234568999999998865 568999999999999999999 9999865433221
Q ss_pred hhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 213 KHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
.......... .........++.++.+++.+||+.||.+|||++++++
T Consensus 249 -~i~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 -NIIRGIFSLD-------------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHTCCCCC-------------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHhcCCCCcc-------------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111100 0011113456788999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=297.76 Aligned_cols=198 Identities=24% Similarity=0.337 Sum_probs=167.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CC-----ccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HR-----NIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||+||+|... +++.||||++... ......+.+|+.+++.++ |+ +++++.+.+...+..++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 4778899999999999999754 6889999998744 334456677888888774 44 48999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCcEEEeeeccceec
Q 039392 74 VLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLL 150 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~~~i~df~~~~~~ 150 (285)
|||++.+ +|.+++.... ..++...++.++.|++.||.|||. ++.|++||||||+||+++ .++.+||+|||++...
T Consensus 134 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 134 VFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 9999965 9999987654 448999999999999999999992 246899999999999995 5788999999999876
Q ss_pred CcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCcccc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIF 206 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 206 (285)
... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 212 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 212 GQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 542 234568899999999999999999999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=298.71 Aligned_cols=239 Identities=22% Similarity=0.305 Sum_probs=196.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchh------HHHHHHHHHHHHccCC--CCccccccceeccCCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGR------VFKSFDVECEMMKSIH--HRNIIKVISSCSNEEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 71 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.+++.++ |+||+++++++...+..
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 478899999999999999974 57899999998754321 2244667999999986 59999999999999999
Q ss_pred EEEEeccCC-CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeeecccee
Q 039392 72 ALVLEYMPH-GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKL 149 (285)
Q Consensus 72 ~~v~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df~~~~~ 149 (285)
++++|++.+ ++|.+++.... .++...++.++.|++.||.||| +.|++|+||+|+||+++ .++.++|+|||++..
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 999999975 79999987654 4899999999999999999999 99999999999999999 789999999999987
Q ss_pred cCcccccceeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
..... .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||..... ......
T Consensus 200 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~~~-------- 260 (320)
T 3a99_A 200 LKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQV-------- 260 (320)
T ss_dssp CCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCCC--------
T ss_pred ccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhcccc--------
Confidence 65432 233568899999998876655 7889999999999999999999865211 000000
Q ss_pred cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.....++.++.+++.+||..||.+|||+++++++
T Consensus 261 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 ------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0012356679999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=313.15 Aligned_cols=273 Identities=23% Similarity=0.286 Sum_probs=201.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceecc------CCceE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSN------EEFKA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~ 72 (285)
+|++.+.||+|+||+||+|.. .+|+.||+|++... .....+.+.+|+++++.++||||+++++++.. .+..+
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 589999999999999999975 56899999998654 34455778899999999999999999998755 67789
Q ss_pred EEEeccCCCCHHHhhhcCCC--ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCc---EEEeeeccc
Q 039392 73 LVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFGIA 147 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~i~df~~~ 147 (285)
+|||++++++|.+++..... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++. ++|+|||++
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 99999999999999976432 4888899999999999999999 999999999999999987665 899999999
Q ss_pred eecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhh-hcCCCc-c
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVND-WLPIST-K 225 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~ 225 (285)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||................ ...... .
T Consensus 172 ~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 172 KELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 8765432 2234578999999999999999999999999999999999999997542221100000000 000000 0
Q ss_pred cccccccc-CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHH-----HHHHHHHH
Q 039392 226 EIVDPNLL-SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI-----VTKLVKIR 279 (285)
Q Consensus 226 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ei-----l~~l~~l~ 279 (285)
........ ...+.........+..+.+++.+||..||.+|||++++ .+.++++.
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00000000 00011111234578889999999999999999999984 45555544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=296.09 Aligned_cols=239 Identities=25% Similarity=0.344 Sum_probs=190.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch------hHHHHHHHHHHHHccC----CCCccccccceeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG------RVFKSFDVECEMMKSI----HHRNIIKVISSCSNEE 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~ 69 (285)
+|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++++ +|+||+++++++...+
T Consensus 32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~ 111 (312)
T 2iwi_A 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE 111 (312)
T ss_dssp -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence 488999999999999999975 5789999999865432 1223455788888888 8999999999999999
Q ss_pred ceEEEEec-cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCcEEEeeeccc
Q 039392 70 FKALVLEY-MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIA 147 (285)
Q Consensus 70 ~~~~v~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~i~df~~~ 147 (285)
..++++|+ +.+++|.+++.... .++...++.++.|++.||.||| +.|++|+||+|+||+++ .++.++|+|||++
T Consensus 112 ~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 112 GFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred eEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 99999999 78899999997654 3899999999999999999999 99999999999999999 8999999999999
Q ss_pred eecCcccccceeccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccc
Q 039392 148 KLLTREDISTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 226 (285)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
....... .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||..... .....
T Consensus 188 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~------- 249 (312)
T 2iwi_A 188 ALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILEAE------- 249 (312)
T ss_dssp EECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHTC-------
T ss_pred hhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhhhc-------
Confidence 8765432 234558889999998876655 5689999999999999999999864211 00000
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+..++.++.+++.+||..||.+|||+++++++
T Consensus 250 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 -------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00123456678999999999999999999999873
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=280.13 Aligned_cols=231 Identities=14% Similarity=0.059 Sum_probs=184.3
Q ss_pred CCCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+..+..++||||+++++++...+..|+|||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 3888999999999999999864 58999999997543 3445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++|++|.+++... .....+..++.|++.||.||| ++|++|+||||+||+++.+|.++|++++
T Consensus 112 ~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 112 WIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred ecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999998543 345568889999999999999 9999999999999999999999997432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
|++ .++.++||||||+++|+|++|..||........... .........
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------~~~~~~~~~ 222 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------AERDTAGQP 222 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------CCBCTTSCB
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------HHHHhccCC
Confidence 222 268899999999999999999999976432211000 000000000
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.........+++++.+++.+||+.||.+| |++++++.|+++...
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 11111234567889999999999999999 999999999988643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=278.78 Aligned_cols=229 Identities=19% Similarity=0.278 Sum_probs=178.6
Q ss_pred CCCCC-ceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHH-ccCCCCccccccceecc----CCceEE
Q 039392 1 GFSEN-NLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMM-KSIHHRNIIKVISSCSN----EEFKAL 73 (285)
Q Consensus 1 ~y~~~-~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~~ 73 (285)
+|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. ....++
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 35555 7799999999999975 57899999998643 3455688777 66689999999999876 677899
Q ss_pred EEeccCCCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCcEEEeeecccee
Q 039392 74 VLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKL 149 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~i~df~~~~~ 149 (285)
|||++++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999987653 35899999999999999999999 999999999999999997 78999999999864
Q ss_pred cCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
.. +..++.++||||||+++|+|++|..||........... ...
T Consensus 170 ~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------------~~~ 212 (299)
T 3m2w_A 170 TT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------------MKT 212 (299)
T ss_dssp CT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------------SCC
T ss_pred cc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------------HHH
Confidence 32 23467899999999999999999999965322111000 000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
................+++++.+++.+||..||.+|||+++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000111111111224568889999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=309.51 Aligned_cols=241 Identities=20% Similarity=0.293 Sum_probs=194.8
Q ss_pred CCCCCceecccCceEEEEEEeC--CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCc-----eE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG--DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEF-----KA 72 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~ 72 (285)
+|++.+.||+|+||+||++.+. +++.||||++.... ......+.+|++++++++||||+++++++...+. .|
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 4788899999999999999864 68999999986433 3455678899999999999999999999977655 79
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+||||+++++|.+++.. .++...++.++.||+.||.||| ++|++|+||||+||+++.+ .+||+|||++.....
T Consensus 161 lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 99999999999887754 4899999999999999999999 9999999999999999875 899999999987654
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
. ....+|+.|+|||.+.+. ++.++||||||+++++|++|..||........
T Consensus 234 ~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------------- 284 (681)
T 2pzi_A 234 F------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------------- 284 (681)
T ss_dssp C------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------------
T ss_pred C------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------------------
Confidence 2 345689999999988654 48899999999999999999888654211100
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCC-CHHHHHHHHHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLVKIRDSL 282 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~eil~~l~~l~~~~ 282 (285)
. ........++.+.+++.+||..||.+|| +++++...|..+..+.
T Consensus 285 -~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 285 -P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp -C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred -c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0 0001223457799999999999999999 6777888887776543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=294.75 Aligned_cols=244 Identities=15% Similarity=0.150 Sum_probs=182.6
Q ss_pred CCCCceecccCceEEEEEE-eCCCcEEEEEEeeccch---hHHHHHHHHHHHHccCCC-Cccccccce------------
Q 039392 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHH-RNIIKVISS------------ 64 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~-~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i~~~~~~------------ 64 (285)
|...+.||+|+||+||+|. ..+|+.||||++..... ...+.+.+|+.+++.++| ++...+...
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 4567899999999999998 45799999999874332 235678899999999976 322211111
Q ss_pred ---------ecc-----CCceEEEEeccCCCCHHHhhh------cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 039392 65 ---------CSN-----EEFKALVLEYMPHGSLEKYLH------SSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124 (285)
Q Consensus 65 ---------~~~-----~~~~~~v~e~~~~~~L~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~ 124 (285)
+.. ....+++|+.+ +++|.+++. .....++...++.++.|++.||.||| ++|++||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 111 22456777776 569998884 22445778889999999999999999 9999999
Q ss_pred CCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCccc----------CCCccCcchhhHHHHHHHHH
Q 039392 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG----------KEGRVSANGDVYSFGIMLIE 194 (285)
Q Consensus 125 di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~----------~~~~~~~~~Di~slG~~l~~ 194 (285)
||||+||+++.++.+||+|||++...... .....+ +.|+|||.+ .+..++.++||||||+++|+
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999999999999999999876543 233456 899999988 55678999999999999999
Q ss_pred HhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 195 TFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 195 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
|++|..||.......... .. +.....++.++.+++.+||..||.+|||+.+++++
T Consensus 310 lltg~~Pf~~~~~~~~~~-----------------~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSE-----------------WI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHSSCCCCTTGGGSCSG-----------------GG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHCCCCCCCcchhhhHH-----------------HH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999997533211100 00 00012345779999999999999999999988765
Q ss_pred --HHHHHH
Q 039392 275 --LVKIRD 280 (285)
Q Consensus 275 --l~~l~~ 280 (285)
++.+++
T Consensus 365 ~~~~~~~~ 372 (413)
T 3dzo_A 365 PEYEQLRT 372 (413)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 444443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=280.54 Aligned_cols=240 Identities=16% Similarity=0.184 Sum_probs=182.2
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--------hhHHHHHHHHHHHHccCC-------------------
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--------GRVFKSFDVECEMMKSIH------------------- 54 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~------------------- 54 (285)
|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+++.++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~ 100 (336)
T 2vuw_A 22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV 100 (336)
T ss_dssp HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred chheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence 77899999999999999987 68999999997542 223466778888888776
Q ss_pred -------CCccccccceecc-------------CCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHh
Q 039392 55 -------HRNIIKVISSCSN-------------EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114 (285)
Q Consensus 55 -------h~~i~~~~~~~~~-------------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 114 (285)
||||+++++++.. ....++||||+++|++.+.+.+ ..+++..++.++.||+.||.|||
T Consensus 101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 6667777776664 7889999999998876665543 34899999999999999999999
Q ss_pred cCCCCCeeecCCCCCCeeeCCCC--------------------cEEEeeeccceecCcccccceeccccccccccCCccc
Q 039392 115 FGYSAQVIHCDLKPSNVLLDDNM--------------------VAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG 174 (285)
Q Consensus 115 ~~~~~~~~h~di~~~nili~~~~--------------------~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 174 (285)
. ++|++||||||+||+++.++ .+||+|||+++..... ...+|+.|+|||++
T Consensus 179 ~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 179 A--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLF 249 (336)
T ss_dssp H--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGG
T ss_pred H--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhh
Confidence 3 48999999999999999877 8999999999866432 34688999999999
Q ss_pred CCCccCcchhhHHHHHH-HHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHh
Q 039392 175 KEGRVSANGDVYSFGIM-LIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNV 253 (285)
Q Consensus 175 ~~~~~~~~~Di~slG~~-l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (285)
.+.. +.++||||+|.+ .+++++|..||................ .. . ...........+++++.+|
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~---------~-~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ---MT---------F-KTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT---CC---------C-SSCCCSHHHHHHHHHHHHH
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh---hc---------c-CcccchhhhhhcCHHHHHH
Confidence 8776 899999998776 778888999875421000000000000 00 0 0001112345688999999
Q ss_pred hhcccccCcCCCCCHHHHH
Q 039392 254 AMECTVESPEQRINAKEIV 272 (285)
Q Consensus 254 i~~~l~~~p~~Rps~~eil 272 (285)
|++||+.| |++|+|
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999977 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-33 Score=250.18 Aligned_cols=183 Identities=20% Similarity=0.140 Sum_probs=129.6
Q ss_pred cccCceEEEEEE-eCCCcEEEEEEeeccc----------hhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEEe
Q 039392 9 GRGGFGSVFKAR-LGDGMEVAVKVFNLQY----------GRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 9 g~G~~~~v~~~~-~~~~~~~~iK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+.|+.|....++ .-.|+.+++|++.... ....+.+.+|+++|+++ +|+||++++++++++..+|+|||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 445555555443 3358889999986431 23446789999999999 69999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++|++|.+++.+.+. ++.. .++.||+.||+|+| ++||+||||||+|||++.+|.+||+|||+++......
T Consensus 323 yv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-- 393 (569)
T 4azs_A 323 KLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-- 393 (569)
T ss_dssp CCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred cCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--
Confidence 9999999999977654 6654 47899999999999 9999999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCC
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKP 201 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p 201 (285)
.......+|+.|+|||++.+ .+..++|+|++|++++.+.++..+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22234679999999999876 467789999999998877666544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=218.11 Aligned_cols=183 Identities=17% Similarity=0.205 Sum_probs=143.6
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccc--------hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--------GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
.+.||+|+||.||++.. .++.+++|...... ....+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 57888888764322 1123557899999999999999966666666677799999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++++|.+++.. +..++.|++.+|.||| ++|++||||||+||+++. .+||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 9999999999865 4578999999999999 999999999999999998 9999999999987653221
Q ss_pred c-----eeccccccccccCCcccCC--CccCcchhhHHHHHHHHHHhhCCCCC
Q 039392 157 T-----IQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLIETFTRKKPT 202 (285)
Q Consensus 157 ~-----~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~ll~g~~p~ 202 (285)
. ......+|+.|+|||++.. ..|+...|+|+..+-..+-+.++-+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1 1234568999999999887 56888899999998888877776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=183.05 Aligned_cols=133 Identities=17% Similarity=0.179 Sum_probs=109.0
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccch------------------hHHHHHHHHHHHHccCCCCccccccc
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG------------------RVFKSFDVECEMMKSIHHRNIIKVIS 63 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 63 (285)
|.+++.||+|+||.||+|...+|+.||+|++..... .....+.+|+++++.++ | +++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 345599999999999999887799999999864321 13456889999999998 5 66666
Q ss_pred eeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEee
Q 039392 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD 143 (285)
Q Consensus 64 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~d 143 (285)
++.. +..++|||+++|++|.+ +.. .....++.|++.|+.+|| +.|++|+||||+||+++ ++.++|+|
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred EEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 5544 55689999999999988 422 123468999999999999 99999999999999999 99999999
Q ss_pred eccceec
Q 039392 144 FGIAKLL 150 (285)
Q Consensus 144 f~~~~~~ 150 (285)
||++...
T Consensus 236 FG~a~~~ 242 (282)
T 1zar_A 236 FPQSVEV 242 (282)
T ss_dssp CTTCEET
T ss_pred CCCCeEC
Confidence 9999743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.7e-22 Score=158.88 Aligned_cols=138 Identities=22% Similarity=0.280 Sum_probs=104.6
Q ss_pred CCCCceecccCceEEEEEEe-CCCcE--EEEEEeeccchh------------------------HHHHHHHHHHHHccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGME--VAVKVFNLQYGR------------------------VFKSFDVECEMMKSIH 54 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~--~~iK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 54 (285)
|++.+.||+|+||.||+|.. .+|+. ||||++...... ....+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999986 67888 999987543111 1235778999999998
Q ss_pred CCcc--ccccceeccCCceEEEEeccCC-C----CHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 039392 55 HRNI--IKVISSCSNEEFKALVLEYMPH-G----SLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLK 127 (285)
Q Consensus 55 h~~i--~~~~~~~~~~~~~~~v~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~ 127 (285)
|+++ +.++.. ...++||||+.+ | +|.+.... .+...+..++.|++.++.+||. +.|++|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 7764 333332 356799999942 3 66665432 2234567899999999999994 5799999999
Q ss_pred CCCeeeCCCCcEEEeeeccceecC
Q 039392 128 PSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 128 ~~nili~~~~~~~i~df~~~~~~~ 151 (285)
|+||+++. .++|+|||++....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999988 99999999997543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=152.31 Aligned_cols=138 Identities=14% Similarity=0.153 Sum_probs=97.5
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccch------------------hH----HHHHHHHHHHHccCCCCccc
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG------------------RV----FKSFDVECEMMKSIHHRNII 59 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------------------~~----~~~~~~e~~~l~~l~h~~i~ 59 (285)
|++++.||+|++|.||+|...+|+.||||++..... .. .-...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 778899999999999999988899999998753210 00 01122455555555433321
Q ss_pred cccceeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC--
Q 039392 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-- 137 (285)
Q Consensus 60 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-- 137 (285)
+...+.. ...++|||+++|.+|..+... .....++.|++.++.+|| ++|++||||||.|||++.+|
T Consensus 177 -vp~p~~~-~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 -VPEPIAQ-SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp -CCCEEEE-ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECS
T ss_pred -CCeeeec-cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCc
Confidence 1111111 123699999999888665421 123467899999999999 99999999999999998776
Q ss_pred --------cEEEeeeccceecC
Q 039392 138 --------VAHLSDFGIAKLLT 151 (285)
Q Consensus 138 --------~~~i~df~~~~~~~ 151 (285)
.+.|+||+-+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999876544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.5e-14 Score=116.51 Aligned_cols=141 Identities=16% Similarity=0.106 Sum_probs=108.6
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
||++...++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..++++++++...+..|+|||+++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 5677788888889999999754 6889999986532222345778999998885 6677889998888889999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG------------------------------------------- 116 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~------------------------------------------- 116 (285)
|.+|.+.+.. ......++.+++.++..||..
T Consensus 94 G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 94 GVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9999876421 112235778899999999941
Q ss_pred -------------CCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 117 -------------YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 117 -------------~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
....++|+|++|.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876667799998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.42 E-value=5.8e-13 Score=106.96 Aligned_cols=128 Identities=16% Similarity=0.090 Sum_probs=94.5
Q ss_pred cccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc--cccccceeccCCceEEEEeccCCCCHHHh
Q 039392 9 GRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN--IIKVISSCSNEEFKALVLEYMPHGSLEKY 86 (285)
Q Consensus 9 g~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 86 (285)
+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+..++|||+++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 356669999998777888999997643 2245667888888885434 456888888778899999999998884
Q ss_pred hhcCCCccCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------
Q 039392 87 LHSSNYILDIYQRLNIMIDVASTLEYLHFGY------------------------------------------------- 117 (285)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~------------------------------------------------- 117 (285)
... .+. ..++.+++..+..||...
T Consensus 104 ~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (264)
T 1nd4_A 104 SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 176 (264)
T ss_dssp TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence 221 111 245677778888888321
Q ss_pred ------CCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 118 ------SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 118 ------~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
..+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=3.1e-11 Score=101.60 Aligned_cols=142 Identities=13% Similarity=0.150 Sum_probs=103.2
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEee--ccch-hHHHHHHHHHHHHccCC--CCccccccceeccC---CceEEEEe
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFN--LQYG-RVFKSFDVECEMMKSIH--HRNIIKVISSCSNE---EFKALVLE 76 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~--~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~~v~e 76 (285)
.+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+++.+. +..+++++..+... +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 567899999999999865 4678899875 3221 12346778999998886 44577788887665 45889999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY--------------------------------------- 117 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--------------------------------------- 117 (285)
+++|.++.+.. ...++......++.+++.+|..||...
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99997774321 112667777888999999999999520
Q ss_pred ----------------CCCeeecCCCCCCeeeCCCCc--EEEeeeccceec
Q 039392 118 ----------------SAQVIHCDLKPSNVLLDDNMV--AHLSDFGIAKLL 150 (285)
Q Consensus 118 ----------------~~~~~h~di~~~nili~~~~~--~~i~df~~~~~~ 150 (285)
...++|+|+++.||+++.++. +.++||+.+..-
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999987653 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=4.4e-11 Score=98.32 Aligned_cols=187 Identities=18% Similarity=0.147 Sum_probs=118.0
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCc--cccccceeccCC---ceEEEEecc
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRN--IIKVISSCSNEE---FKALVLEYM 78 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~~v~e~~ 78 (285)
.+.++.|..+.||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568899999999873 56999986433 34466788999998773 322 334444433332 457899999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG------------------------------------------ 116 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~------------------------------------------ 116 (285)
+|.++.+... ..++......++.+++..+..||..
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988864322 1255666667777777777777741
Q ss_pred -------------CCCCeeecCCCCCCeeeCC--CCcEEEeeeccceecCcccccceeccccccccccCCcccCC-----
Q 039392 117 -------------YSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE----- 176 (285)
Q Consensus 117 -------------~~~~~~h~di~~~nili~~--~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~----- 176 (285)
....++|+|++|.||+++. ++.+.++||+.+..-........ ......-.+|+....
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~---~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS---LMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT---TCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH---HHhhccccCHHHHHHHHHHc
Confidence 0135799999999999987 56788999998875432110000 000000011221100
Q ss_pred C---------ccCcchhhHHHHHHHHHHhhCCCCCc
Q 039392 177 G---------RVSANGDVYSFGIMLIETFTRKKPTD 203 (285)
Q Consensus 177 ~---------~~~~~~Di~slG~~l~~ll~g~~p~~ 203 (285)
+ ....-.+.|++|.+++.+.+|..+|.
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 01222589999999999999987753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=4.5e-08 Score=78.78 Aligned_cols=133 Identities=17% Similarity=0.100 Sum_probs=93.7
Q ss_pred ecccCce-EEEEEEeC-CCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEeccCCCCHH
Q 039392 8 IGRGGFG-SVFKARLG-DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYMPHGSLE 84 (285)
Q Consensus 8 lg~G~~~-~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 84 (285)
+..|..+ .||+.... ++..+++|+.+.. ....+.+|...|+.+. +-.+.+++.++...+..++||++++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3445444 68988643 5678999986543 2345677888888775 334677888888888999999999998887
Q ss_pred HhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 039392 85 KYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY----------------------------------------------- 117 (285)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----------------------------------------------- 117 (285)
+...... .....+..++...|..||...
T Consensus 109 ~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 109 QVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 6653321 112235556666677776421
Q ss_pred --------CCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 118 --------SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 118 --------~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999988777899998875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=7.3e-08 Score=79.06 Aligned_cols=136 Identities=15% Similarity=0.130 Sum_probs=89.1
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCC---ccccccceec-cCCceEEEEeccCC
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHR---NIIKVISSCS-NEEFKALVLEYMPH 80 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~~v~e~~~~ 80 (285)
.+.++.|....||+. +..+++|+.. .......+.+|+++++.+.+. .+.+++.+.. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899988 5678999843 233446788899999988642 2455555553 45667899999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG-------------------------------------------- 116 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-------------------------------------------- 116 (285)
.++.+..-. .++......++.++...|..||..
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 887652110 022223333333333333333321
Q ss_pred -------------CCCCeeecCCCCCCeeeCC---CCc-EEEeeecccee
Q 039392 117 -------------YSAQVIHCDLKPSNVLLDD---NMV-AHLSDFGIAKL 149 (285)
Q Consensus 117 -------------~~~~~~h~di~~~nili~~---~~~-~~i~df~~~~~ 149 (285)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1346799999999999987 455 48999988764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=6.5e-08 Score=81.11 Aligned_cols=79 Identities=8% Similarity=-0.015 Sum_probs=53.3
Q ss_pred cee-cccCceEEEEEEeC-------CCcEEEEEEeeccch--h-HHHHHHHHHHHHccCC-C--CccccccceeccC---
Q 039392 6 NLI-GRGGFGSVFKARLG-------DGMEVAVKVFNLQYG--R-VFKSFDVECEMMKSIH-H--RNIIKVISSCSNE--- 68 (285)
Q Consensus 6 ~~l-g~G~~~~v~~~~~~-------~~~~~~iK~~~~~~~--~-~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~--- 68 (285)
+.| +.|..+.+|+.... +++.+++|+...... . ....+.+|+.+++.+. + -.+.+++.+....
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 566 78888999988653 267899998654321 0 1144667888887774 2 2456677776554
Q ss_pred CceEEEEeccCCCCHH
Q 039392 69 EFKALVLEYMPHGSLE 84 (285)
Q Consensus 69 ~~~~~v~e~~~~~~L~ 84 (285)
+..++|||+++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4578999999886654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.49 E-value=1.4e-06 Score=66.35 Aligned_cols=141 Identities=11% Similarity=0.044 Sum_probs=95.4
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
.+|.+++...+.+++++++|.++.|.+..|.-+-. .+.-...-+.|..|++..+|.|.+.+ ....
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 37999999888899999999999999999888721 11112344567999999999997753 1110
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
.....+.+||... ...+.+.-|||||+++|..+-...|-+.
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e------------------------------------ 138 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE------------------------------------ 138 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE------------------------------------
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc------------------------------------
Confidence 1122356787653 4557788999999999999987666322
Q ss_pred hhhhHhHHHHHHhhhccccc-------------------------CcCCCCCHHHHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVE-------------------------SPEQRINAKEIVTKLVK 277 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~-------------------------~p~~Rps~~eil~~l~~ 277 (285)
+...++.+.+||..|... .+..|+|+++|++....
T Consensus 139 --E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 139 --ERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp --EECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred --chhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 223445577777777654 34678999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.31 E-value=3.8e-06 Score=69.75 Aligned_cols=31 Identities=26% Similarity=0.338 Sum_probs=28.2
Q ss_pred CCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 118 ~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888899999998875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=3.3e-06 Score=71.75 Aligned_cols=75 Identities=17% Similarity=0.163 Sum_probs=47.2
Q ss_pred CceecccCceEEEEEEeC-CCcEEEEEEeeccch-------hHHHHHHHHHHHHccCCC--Cc-cccccceeccCCceEE
Q 039392 5 NNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQYG-------RVFKSFDVECEMMKSIHH--RN-IIKVISSCSNEEFKAL 73 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-i~~~~~~~~~~~~~~~ 73 (285)
.+.+|.|..+.||++... +++.+++|....... .....+..|.++++.+.. +. +++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999643 468899998653221 122345678888877632 33 3344443 2344579
Q ss_pred EEeccCCC
Q 039392 74 VLEYMPHG 81 (285)
Q Consensus 74 v~e~~~~~ 81 (285)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.13 E-value=3.5e-05 Score=63.04 Aligned_cols=75 Identities=15% Similarity=0.140 Sum_probs=58.2
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC---CCccccccceeccCCceEEEEeccCCC
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH---HRNIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
.+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.+. ...+++++.+....+..++|||+++|.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35788999999999976 4678999987643 2355677888888774 356778888887778899999999886
Q ss_pred CH
Q 039392 82 SL 83 (285)
Q Consensus 82 ~L 83 (285)
++
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.3e-05 Score=64.90 Aligned_cols=74 Identities=15% Similarity=0.128 Sum_probs=52.3
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCC---ccccccceeccCCceEEEEeccCCC
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHR---NIIKVISSCSNEEFKALVLEYMPHG 81 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~~v~e~~~~~ 81 (285)
.+.+|.|..+.||+....+|+.+++|+...........+..|+..|+.+... .+++++++. ..+++||++.+.
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 4578999999999999989999999987654443334567788888877422 234444432 246899998765
Q ss_pred C
Q 039392 82 S 82 (285)
Q Consensus 82 ~ 82 (285)
.
T Consensus 96 ~ 96 (288)
T 3f7w_A 96 P 96 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.98 E-value=1.8e-05 Score=64.61 Aligned_cols=71 Identities=11% Similarity=0.054 Sum_probs=44.1
Q ss_pred CceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc-ccccceeccCCceEEEEecc-CCCC
Q 039392 5 NNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI-IKVISSCSNEEFKALVLEYM-PHGS 82 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~-~~~~ 82 (285)
.+.|+.|....+|+. ..+++|+........ -...+|+.+++.+...++ .+++....+ .-+++++++ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 678888999999999 569999876543221 123457777776642223 455554332 345899999 6654
Q ss_pred H
Q 039392 83 L 83 (285)
Q Consensus 83 L 83 (285)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.0002 Score=59.14 Aligned_cols=33 Identities=27% Similarity=0.267 Sum_probs=28.4
Q ss_pred CCCeeecCCCCCCeeeCCC----CcEEEeeeccceec
Q 039392 118 SAQVIHCDLKPSNVLLDDN----MVAHLSDFGIAKLL 150 (285)
Q Consensus 118 ~~~~~h~di~~~nili~~~----~~~~i~df~~~~~~ 150 (285)
...++|+|+.+.||+++.+ +.+.++||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999874 78999999988653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.82 E-value=3.3e-05 Score=63.48 Aligned_cols=139 Identities=17% Similarity=0.182 Sum_probs=74.6
Q ss_pred ceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc--cccccce------eccCCceEEEEec
Q 039392 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN--IIKVISS------CSNEEFKALVLEY 77 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~~v~e~ 77 (285)
+.|+.|....+|+....+| .+++|+..... ..+.+..|+.+++.+...+ +.+++.. ....+..++++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4566788889999987555 68899886521 1123445666666553212 2333322 1223567899999
Q ss_pred cCCCCHHH-----------hhh-------cCCCc----cCHHHHHHH----------------HHHHHHHHHHHhc----
Q 039392 78 MPHGSLEK-----------YLH-------SSNYI----LDIYQRLNI----------------MIDVASTLEYLHF---- 115 (285)
Q Consensus 78 ~~~~~L~~-----------~~~-------~~~~~----~~~~~~~~~----------------~~~l~~~l~~lh~---- 115 (285)
++|.++.. .+. ..... .... .+.- ...+...+..+..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~-~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVD-GWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHH-HHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChH-HHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 98865311 010 00000 0100 0000 0012233444431
Q ss_pred CCCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 116 ~~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
....+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 113579999999999999887666899998875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00012 Score=62.56 Aligned_cols=33 Identities=18% Similarity=0.277 Sum_probs=28.9
Q ss_pred CCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 118 ~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
...++|+|++|.||+++.++ +.++||+.+..-.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 78899999999999998776 9999999887543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=7.2e-05 Score=62.89 Aligned_cols=140 Identities=14% Similarity=0.158 Sum_probs=81.0
Q ss_pred CceecccCceEEEEEEeC--------CCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEE
Q 039392 5 NNLIGRGGFGSVFKARLG--------DGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 75 (285)
.+.|..|-...+|+.... +++.+++|+..... .......+|..+++.+. +.-..++++.+.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888899998754 25789999864322 12344557888888775 3223566666654 2899
Q ss_pred eccCCCCHHH--------------hhhc---C----CCccC--HHHHHHHHHHHHH-------------------HHHH-
Q 039392 76 EYMPHGSLEK--------------YLHS---S----NYILD--IYQRLNIMIDVAS-------------------TLEY- 112 (285)
Q Consensus 76 e~~~~~~L~~--------------~~~~---~----~~~~~--~~~~~~~~~~l~~-------------------~l~~- 112 (285)
|+++|.+|.. .+++ . .+... ..++..|..++.. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998755421 0110 0 11121 2445555544422 1222
Q ss_pred ---Hhc-CCCCCeeecCCCCCCeeeCCC----CcEEEeeecccee
Q 039392 113 ---LHF-GYSAQVIHCDLKPSNVLLDDN----MVAHLSDFGIAKL 149 (285)
Q Consensus 113 ---lh~-~~~~~~~h~di~~~nili~~~----~~~~i~df~~~~~ 149 (285)
|.. .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 113469999999999999876 7899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.74 E-value=9.1e-05 Score=63.93 Aligned_cols=74 Identities=14% Similarity=0.170 Sum_probs=47.0
Q ss_pred CceecccCceEEEEEEeCC-CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc-ccccceeccCCceEEEEeccCCCC
Q 039392 5 NNLIGRGGFGSVFKARLGD-GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI-IKVISSCSNEEFKALVLEYMPHGS 82 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~~ 82 (285)
.+.|+.|-...+|+....+ +..+++|+......... ...+|..+++.+...++ +++++.+. + ..|++|++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3467788889999998754 57899998754332221 12468888888864444 56666663 2 25999998744
Q ss_pred H
Q 039392 83 L 83 (285)
Q Consensus 83 L 83 (285)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.70 E-value=7.4e-05 Score=64.07 Aligned_cols=71 Identities=20% Similarity=0.247 Sum_probs=46.5
Q ss_pred ceecccCceEEEEEEeCC--------CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc-ccccceeccCCceEEEEe
Q 039392 6 NLIGRGGFGSVFKARLGD--------GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI-IKVISSCSNEEFKALVLE 76 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~--------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e 76 (285)
+.|+.|....+|++...+ +..+++|+...... ...+..|..+++.+...++ +++++.+.+ .+|++
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 467788889999997542 57899999843211 1334468888887753333 556665543 28899
Q ss_pred ccCCCC
Q 039392 77 YMPHGS 82 (285)
Q Consensus 77 ~~~~~~ 82 (285)
+++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 987643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00063 Score=55.93 Aligned_cols=140 Identities=12% Similarity=0.137 Sum_probs=78.5
Q ss_pred ceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc--cccccce-----eccCCceEEEEecc
Q 039392 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN--IIKVISS-----CSNEEFKALVLEYM 78 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~~v~e~~ 78 (285)
+.++ |....||+....+|+.+++|+...... ....+..|..+++.+.... +++++.. ....+..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 778899998776777899999864321 1234556777776664212 3344432 11234567899999
Q ss_pred CCCCHH-----------Hhhh-------cC----CCccCHHH----------------------HHHHHHHHHHHHHHHh
Q 039392 79 PHGSLE-----------KYLH-------SS----NYILDIYQ----------------------RLNIMIDVASTLEYLH 114 (285)
Q Consensus 79 ~~~~L~-----------~~~~-------~~----~~~~~~~~----------------------~~~~~~~l~~~l~~lh 114 (285)
+|.++. ..+. .. ....+... ....+..++..+..+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874431 1110 00 00111110 0111122222222221
Q ss_pred c-CCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 115 F-GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 115 ~-~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 0 0256789999999999998 4 899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00014 Score=61.06 Aligned_cols=74 Identities=14% Similarity=0.199 Sum_probs=43.7
Q ss_pred CceecccCceEEEEEEeCC---------CcEEEEEEeeccchhHHHHHHHHHHHHccCCCCc-cccccceeccCCceEEE
Q 039392 5 NNLIGRGGFGSVFKARLGD---------GMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRN-IIKVISSCSNEEFKALV 74 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v 74 (285)
.+.++.|....+|+....+ +..+++|+........ .....|.++++.+...+ .+++++... -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 3467778888999997543 2689999876543322 12356777777775333 345555442 2589
Q ss_pred EeccCCCCH
Q 039392 75 LEYMPHGSL 83 (285)
Q Consensus 75 ~e~~~~~~L 83 (285)
+++++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0023 Score=52.98 Aligned_cols=32 Identities=22% Similarity=0.333 Sum_probs=28.0
Q ss_pred CCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 118 ~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0048 Score=52.57 Aligned_cols=74 Identities=12% Similarity=0.244 Sum_probs=47.3
Q ss_pred CceecccCceEEEEEEeCC--------CcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEE
Q 039392 5 NNLIGRGGFGSVFKARLGD--------GMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~--------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 75 (285)
.+.+..|-...+|+....+ +..+++|+......... ...+|..+++.+. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567778888999997643 57899999755432221 2346888887775 222345555432 26899
Q ss_pred eccCCCCH
Q 039392 76 EYMPHGSL 83 (285)
Q Consensus 76 e~~~~~~L 83 (285)
++++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99988553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0029 Score=53.69 Aligned_cols=30 Identities=27% Similarity=0.375 Sum_probs=25.3
Q ss_pred CeeecCCCCCCeee------CCCCcEEEeeecccee
Q 039392 120 QVIHCDLKPSNVLL------DDNMVAHLSDFGIAKL 149 (285)
Q Consensus 120 ~~~h~di~~~nili------~~~~~~~i~df~~~~~ 149 (285)
.++|+|+.+.||++ +.++.+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 47899999999999 4567799999988753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.67 E-value=0.51 Score=35.85 Aligned_cols=128 Identities=13% Similarity=0.226 Sum_probs=80.8
Q ss_pred HHHHHccCCCCccccccceeccCCceEEEEeccC-CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 039392 46 ECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP-HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124 (285)
Q Consensus 46 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~ 124 (285)
|+.+|.. .||++++. .+-...+.+.+.++.-+ +.++.. +. ..+....++++.+|+....+++ .=+|-
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf 103 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR-----TRYTF 103 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG-----SSEEC
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc-----CceEE
Confidence 4444543 57878766 45555566555555543 233433 22 2777888888888888775544 23566
Q ss_pred CCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCcc
Q 039392 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDE 204 (285)
Q Consensus 125 di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~ 204 (285)
-++|+|++++.++.+++.-.|+-..+ +|. ..+...=.-..=+++..+++++..|+.
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 79999999999999999877664321 222 112222234567788889999998876
Q ss_pred ccccc
Q 039392 205 IFNGE 209 (285)
Q Consensus 205 ~~~~~ 209 (285)
..++.
T Consensus 160 l~~G~ 164 (215)
T 4ann_A 160 LVEGN 164 (215)
T ss_dssp HHHSC
T ss_pred HHcCh
Confidence 54443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.55 E-value=1.8 Score=32.91 Aligned_cols=122 Identities=15% Similarity=0.162 Sum_probs=75.2
Q ss_pred HHHHHccCCCCccccccceeccCCceEEEEecc-CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHH-HHhcCCCCCeee
Q 039392 46 ECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM-PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLE-YLHFGYSAQVIH 123 (285)
Q Consensus 46 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~-~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~-~lh~~~~~~~~h 123 (285)
++.++.. .||++ -..+-...+.+.+.++.- .+.++..+ + ..+....++++.+|+.... ++ ..-++
T Consensus 41 e~~lL~~-~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~----~~~~~eKlrll~nl~~L~~~~~-----~~r~t 107 (219)
T 4ano_A 41 ELEVLKE-VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-R----KTTLLSRIRAAIHLVSKVKHHS-----ARRLI 107 (219)
T ss_dssp GGGGGGG-SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-H----TSCHHHHHHHHHHHHHHHSSCC-----SSSEE
T ss_pred HHHHHhc-cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-H----hcCHHHHHHHHHHHHHHHHHhh-----hCcee
Confidence 3444433 57777 333445666666666654 23344433 2 2677788888887777555 33 34467
Q ss_pred cCCCCCCeeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCc
Q 039392 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTD 203 (285)
Q Consensus 124 ~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 203 (285)
--++|+|++++.++.+++...|.-..+ +|.-+ +...=.-..=+++..++.++..|+
T Consensus 108 f~l~P~NL~f~~~~~p~i~hRGi~~~l-------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 108 FIVCPENLMFNRALEPFFLHVGVKESL-------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CCCCGGGEEECTTCCEEESCCEETTTB-------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCceEEEeCCCcEEEEEcCCcccC-------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 779999999999999999877764322 22211 111223356677788888888775
Q ss_pred c
Q 039392 204 E 204 (285)
Q Consensus 204 ~ 204 (285)
.
T Consensus 164 ~ 164 (219)
T 4ano_A 164 E 164 (219)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.78 E-value=0.15 Score=43.95 Aligned_cols=59 Identities=8% Similarity=0.000 Sum_probs=16.4
Q ss_pred CCceecccCceEEEEEEeCC-CcEEEE------EEeeccc--hhHHHHHHHHHHHHccCCCCcccccccee
Q 039392 4 ENNLIGRGGFGSVFKARLGD-GMEVAV------KVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSC 65 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~~~-~~~~~i------K~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 65 (285)
+.+.|| ||.||+|.+.. ..+||+ |...... .+....+.+|..+.+.++|+|+++.+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 345666 99999997643 467887 5543322 22334577788888888999999887764
|
| >3eps_A Isocitrate dehydrogenase kinase/phosphatase; ATP-binding, glyoxylate bypass, nucleotide-binding, protein phosphatase; HET: AMP ATP; 2.80A {Escherichia coli O157} PDB: 3lcb_A* 3lc6_A* | Back alignment and structure |
|---|
Probab=80.28 E-value=28 Score=30.32 Aligned_cols=136 Identities=14% Similarity=0.118 Sum_probs=90.4
Q ss_pred eecccCceEEEEEEeCCCcEEEEEEeecc----chhHHHHHHHHHHHHccCCCCcccccccee-----------------
Q 039392 7 LIGRGGFGSVFKARLGDGMEVAVKVFNLQ----YGRVFKSFDVECEMMKSIHHRNIIKVISSC----------------- 65 (285)
Q Consensus 7 ~lg~G~~~~v~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----------------- 65 (285)
.+..|--|.|..+..-.+-++|.|+++-. .+...+..++...+.+ +|..+=+..+..
T Consensus 313 i~APGikGmVM~VFTLPSf~~VFKvIKD~F~p~K~~tr~~Vk~KY~LVK--~hDRVGRMADT~Efsn~~fp~~Rfs~eLL 390 (578)
T 3eps_A 313 IEAPGIRGMVMLVFTLPGFDRVFKVIKDKFAPQKEMSAAHVRACYQLVK--EHDRVGRMADTQEFENFVLEKRHISPALM 390 (578)
T ss_dssp EECSSCCCSSEEEEECTTCSEEEEEECSSCCTTCCCCHHHHHHHHHHHH--TSCCTTTBCCCEEEEEEEEEGGGBCHHHH
T ss_pred EECCCCCceEEEEEcCCCCceEEEEEccCCCCccccCHHHHHHHHHHHH--hhhhhhhhhhhhhhhcccCchhhCCHHHH
Confidence 35567778888887667888999999732 2223344444444444 354443332221
Q ss_pred ------------ccCCceEEEEecc--C--CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 039392 66 ------------SNEEFKALVLEYM--P--HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPS 129 (285)
Q Consensus 66 ------------~~~~~~~~v~e~~--~--~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~ 129 (285)
.+++. +|..++ + -.+|.=+++. -+.+++...+...-.|++-|- ..+|.-||.=..
T Consensus 391 ~EL~~~~ps~le~~gd~--liIkHlYiERRMtPLNLYL~~----a~~~~~~~av~eYG~AIKqLA---aANIFPGDML~K 461 (578)
T 3eps_A 391 ELLLQEAAEKITDLGEQ--IVIRHLYIERRMVPLNIWLEQ----VEGQQLRDAIEEYGNAIRQLA---AANIFPGDMLFK 461 (578)
T ss_dssp HHHHHHSGGGEEEETTE--EEEEEEEEEECCEEHHHHHHH----CCTHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred HHHHHhCCccEEEcCCe--eEeeeeeeeccccchhHHHhh----CCHHHHHHHHHHHHHHHHHHH---HhcCCCcccccc
Confidence 11222 222222 1 1345555544 344567778888999999999 999999999999
Q ss_pred CeeeCCCCcEEEeeeccceecCcc
Q 039392 130 NVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 130 nili~~~~~~~i~df~~~~~~~~~ 153 (285)
|+=|+..|+|..-|++..+.+++-
T Consensus 462 NFGVTRhgRVVFYDYDEI~ylTdc 485 (578)
T 3eps_A 462 NFGVTRHGRVVFYDYDEICYMTEV 485 (578)
T ss_dssp GEEECTTCCEEECCGGGCEESTTC
T ss_pred cCCccccceEEEecccceeeeccc
Confidence 999999999999999998887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 285 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 7e-69
Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 26/282 (9%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG G FG+V+K + +VAVK+ N+ + ++F E +++ H NI+ +
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+ A+V ++ SL +LH ++ + ++I A ++YLH +IH
Sbjct: 72 YST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY---GKEGRVS 180
DLK +N+ L +++ + DFG+A + +R S Q +I +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240
DVY+FGI+L E T + P I N + + +L ++
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------------- 234
Query: 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
+ C + + EC + ++R +I+ + + SL
Sbjct: 235 --RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-60
Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 24/280 (8%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+ IG G FG V + +VA+K + F E E+M + H ++++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
C + LV E+M HG L YL + + L + +DV + YL A V
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
IH DL N L+ +N V +SDFG+ + + +D T T T + + +PE R S+
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
DV+SFG+++ E F+ K E + ++ + + P L S
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKPRLASTH----- 230
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
V+ + C E PE R ++ +L +I +S
Sbjct: 231 --------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-59
Identities = 63/281 (22%), Positives = 119/281 (42%), Gaps = 26/281 (9%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG V+ +VAVK +F E +MK + H+ ++++
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL 73
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ + E ++ EYM +GSL +L + + I L I + L++ +A + ++
Sbjct: 74 YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
IH DL+ +N+L+ D + ++DFG+A+L+ ++ T + I + APE G +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240
DV+SFGI+L E T + +++ + +V P+ E
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------RMVRPDNCPEE---- 238
Query: 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
++ + C E PE R + + L +
Sbjct: 239 ---------LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-59
Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 24/277 (8%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+ +G G FG V + +VA+K+ F E ++M ++ H ++++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
C+ + ++ EYM +G L YL + Q L + DV +EYL Q
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+H DL N L++D V +SDFG+++ + +D T + + + PE + S+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
D+++FG+++ E ++ K E F T +H + P+L S +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK----- 229
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
V+ + C E ++R K +++ ++ +
Sbjct: 230 --------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-57
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 32/297 (10%)
Query: 8 IGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN 67
IG+G FG V++ + G EVAVK+F+ + R + + E + H NI+ I++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 68 EEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH-----FGYS 118
+ LV +Y HGSL YL+ Y + + + + + AS L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDISTIQTQTLATIGYMAPEY--- 173
+ H DLK N+L+ N ++D G+A + I + T YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 174 ---GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN------DWLPIST 224
K D+Y+ G++ E R + ++ V + +
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
++ + PN+ +R + + + + EC + R+ A I L ++
Sbjct: 247 EQKLRPNIPNRWQSC-----EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 9e-57
Identities = 63/275 (22%), Positives = 117/275 (42%), Gaps = 26/275 (9%)
Query: 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G+G FG V+ VA+K ++F E ++MK + H ++++
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQL 77
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ S E +V EYM GSL +L L + Q +++ +AS + Y+
Sbjct: 78 YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MN 133
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVS 180
+H DL+ +N+L+ +N+V ++DFG+A+L+ ++ T + I + APE GR +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 181 ANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240
DV+SFGI+L E T+ + L + E +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES---------- 242
Query: 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
+ ++ +C + PE+R + + L
Sbjct: 243 ---------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-55
Identities = 58/287 (20%), Positives = 109/287 (37%), Gaps = 28/287 (9%)
Query: 4 ENNLIGRGGFGSVFKARL---GDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHHRNII 59
+ +G G FGSV + ++VA+KV + + E ++M + + I+
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
++I C E LV+E G L K+L + + ++ V+ ++YL
Sbjct: 73 RLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---K 128
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYGKEGR 178
+H DL NVLL + A +SDFG++K L +D + + APE +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 179 VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238
S+ DV+S+G+ + E + + + G + P E
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------ECPPECPPE-- 240
Query: 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLRN 285
++ + +C + E R + + ++ SL
Sbjct: 241 -----------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 2e-55
Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 32/276 (11%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
IG+G FG V G +VAVK ++F E +M + H N+++++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 66 SNEEFK-ALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
E+ +V EYM GSL YL S +L L +DV +EYL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
DL NVL+ ++ VA +SDFG+ K + S+ Q + + APE +E + S
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 184 DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243
DV+SFGI+L E ++ + + + + A
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------------DAP 222
Query: 244 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
+ C V+ V C R + ++ +L I+
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-55
Identities = 63/272 (23%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS 64
+G G FG V+KA+ + A KV + + + + VE +++ S H NI+K++ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
E +++E+ G+++ + L Q + L YLH ++IH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY-----GKEGRV 179
DLK N+L + L+DFG++ TR + T +MAPE K+
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
DV+S GI LIE + P E+ + LK ++ ++ P+ S
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-----QPSRWSSNFKD 247
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
F+ K C ++ + R ++
Sbjct: 248 FLKK-------------CLEKNVDARWTTSQL 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (451), Expect = 5e-55
Identities = 62/292 (21%), Positives = 125/292 (42%), Gaps = 34/292 (11%)
Query: 2 FSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHR 56
+IG G FG V L + VA+K Y + + F E +M H
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 87
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
N+I + + ++ E+M +GSL+ +L ++ + Q + ++ +A+ ++YL
Sbjct: 88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD- 146
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTL---ATIGYMAPEY 173
+H DL N+L++ N+V +SDFG+++ L + T L I + APE
Sbjct: 147 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233
+ + ++ DV+S+GI++ E + + + ++ +++++
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERP----------------YWDMTNQDVIN---A 245
Query: 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLRN 285
+D C S + + ++C + R +IV L D ++RN
Sbjct: 246 IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRN 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-54
Identities = 67/287 (23%), Positives = 129/287 (44%), Gaps = 29/287 (10%)
Query: 2 FSENNLIGRGGFGSVFKARLGDG-----MEVAVKVFNLQYG-RVFKSFDVECEMMKSIHH 55
+ +IG G FG V+K L + VA+K Y + F E +M H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
NII++ S + ++ EYM +G+L+K+L + + Q + ++ +A+ ++YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYG 174
+ +H DL N+L++ N+V +SDFG++++L + +T T I + APE
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234
+ ++ DV+SFGI++ E T + + +K + + + +
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD-------- 237
Query: 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281
C S ++ + M+C + +R +IV+ L K+ +
Sbjct: 238 -----------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-54
Identities = 60/299 (20%), Positives = 123/299 (41%), Gaps = 40/299 (13%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNII 59
F + + +G G G VFK G+ +A K+ +L+ ++ E +++ + I+
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ ++ ++ +E+M GSL++ L + + + I V L YL
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KH 124
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
+++H D+KPSN+L++ L DFG++ L ++ + T YM+PE +
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHY 180
Query: 180 SANGDVYSFGIMLIETFTRKKP-------------------------TDEIFNGEMTLKH 214
S D++S G+ L+E + P G +
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 215 WVNDWLPISTKEIVD--PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
++ P++ E++D N + V + FV +C +++P +R + K++
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV----NKCLIKNPAERADLKQL 295
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-54
Identities = 65/288 (22%), Positives = 121/288 (42%), Gaps = 30/288 (10%)
Query: 5 NNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHHRNII 59
N +IGRG FG V+ L G + AVK N F E +MK H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 60 KVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
++ C E +VL YM HG L ++ + + + + + VA +++L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ--TQTLATIGYMAPEYGKE 176
+ +H DL N +LD+ ++DFG+A+ + ++ ++ T + +MA E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 177 GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236
+ + DV+SFG++L E TR P N + + + ++ P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------RRLLQPEYCPDP 262
Query: 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284
++ V ++C E R + E+V+++ I + +
Sbjct: 263 -------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-54
Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 29/277 (10%)
Query: 2 FSEN----NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHH 55
F E+ +G G +G V A VAVK+ +++ ++ E + K ++H
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
N++K + L LEY G L + + + + + + YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK 175
+ H D+KP N+LLD+ +SDFG+A + + + + T+ Y+APE K
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 176 EGRVSANG-DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234
A DV+S GI+L + P D+ + W ++ +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-----PWKKID 233
Query: 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
+ + K VE+P RI +I
Sbjct: 234 SAPLALLHK-------------ILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 8e-54
Identities = 63/276 (22%), Positives = 114/276 (41%), Gaps = 33/276 (11%)
Query: 5 NNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKV 61
+ IGRG F +V+K +EVA + + F E EM+K + H NI++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 62 ISSC----SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
S ++ LV E M G+L+ YL ++ I + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 118 SAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176
+ +IH DLK N+ + + D G+A L ++ + T +MAPE E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEM-YE 186
Query: 177 GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236
+ + DVY+FG+ ++E T + P E N + + P S ++ P +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--- 243
Query: 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272
+ C ++ ++R + K+++
Sbjct: 244 ---------------EIIEGCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-53
Identities = 62/271 (22%), Positives = 112/271 (41%), Gaps = 33/271 (12%)
Query: 6 NLIGRGGFGSVFKARL-GDGMEVAVKVFN---LQYGRVFKSFDVECEMMKSIHHRNIIKV 61
+G+G FG+V+ AR +A+KV L+ V E E+ + H NI+++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ L+LEY P G++ + L + D + + ++A+ L Y H S +V
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRV 127
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
IH D+KP N+LL ++DFG + +T+ T+ Y+ PE +
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIEGRMHDE 183
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
D++S G++ E K P F + + IS E P+ ++ +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR----ISRVEFTFPDFVTEGARDLI 235
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIV 272
++ +P QR +E++
Sbjct: 236 SR-------------LLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 2e-53
Identities = 65/278 (23%), Positives = 105/278 (37%), Gaps = 36/278 (12%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNL---QYGRVFKSFDVECEMMKSIHHRN 57
FS+ IG G FG+V+ AR + + VA+K + Q ++ E ++ + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
I+ E LV+EY + + L + + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH--- 132
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY---G 174
S +IH D+K N+LL + + L DFG A ++ + T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAM 186
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234
EG+ DV+S GI IE RK P + N+ + + S
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW------S 240
Query: 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272
+FV C + P+ R ++ ++
Sbjct: 241 EYFRNFVDS-------------CLQKIPQDRPTSEVLL 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (439), Expect = 2e-53
Identities = 65/279 (23%), Positives = 113/279 (40%), Gaps = 26/279 (9%)
Query: 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
+ + +G G +G V++ + VAVK V + F E +MK I H N+++
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 77
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSA 119
++ C+ E ++ E+M +G+L YL N + L + ++S +EYL
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
IH DL N L+ +N + ++DFG+++L+T D T I + APE +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
S DV++FG++L E T + + +D
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------------EKDYR 234
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
E C V+ + C +P R + EI +
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-53
Identities = 60/299 (20%), Positives = 107/299 (35%), Gaps = 51/299 (17%)
Query: 7 LIGRGGFGSVFKARL------GDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSI-HHRNI 58
++G G FG V A G ++VAVK+ + ++ E +MM + H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN----------------------YILDI 96
+ ++ +C+ L+ EY +G L YL S +L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 97 YQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156
L VA +E+L +H DL NVL+ V + DFG+A+ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWV 216
++ + +MAPE EG + DV+S+GI+L E F+ + +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 217 NDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
+ + + + + C +R + + + L
Sbjct: 281 QNGFKMDQPFYATEEI------------------YIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-53
Identities = 61/277 (22%), Positives = 98/277 (35%), Gaps = 32/277 (11%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVI 62
IG G +G K R DG + K + + E +++ + H NI++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 63 SSCSNEEFKAL--VLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASTLEYLH--F 115
+ L V+EY G L + LD L +M + L+ H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK 175
V+H DLKP+NV LD L DFG+A++L + ++ + T YM+PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMN 187
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235
+ D++S G +L E P E+ K + I P S
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-------PYRYSD 240
Query: 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272
E + + R + +EI+
Sbjct: 241 ELNEIITR-------------MLNLKDYHRPSVEEIL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 4e-52
Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 30/278 (10%)
Query: 4 ENNLIGRGGFGSVFKARL---GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNI 58
E+ +G G FG+V K VAVK+ + + E +M+ + + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+++I C E + LV+E G L KYL + + + + ++ V+ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DISTIQTQTLATIGYMAPEYGKEG 177
+ +H DL NVLL A +SDFG++K L + + QT + + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
+ S+ DV+SFG+++ E F+ + G P RE
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------GCPAGCPRE- 238
Query: 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
++++ C E R + +L
Sbjct: 239 ------------MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 4e-52
Identities = 70/307 (22%), Positives = 120/307 (39%), Gaps = 52/307 (16%)
Query: 2 FSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIH 54
IG G FG VF+AR VAVK+ + + F E +M
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 55 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY---------------------- 92
+ NI+K++ C+ + L+ EYM +G L ++L S +
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 93 -ILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151
L ++L I VA+ + YL + +H DL N L+ +NMV ++DFG+++ +
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 152 REDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMT 211
D I +M PE R + DV+++G++L E F+ E
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 212 LKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
+ + + D N+L+ E C ++N+ C + P R + I
Sbjct: 252 IYY------------VRDGNILACP-------ENCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 272 VTKLVKI 278
L ++
Sbjct: 293 HRILQRM 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-52
Identities = 73/267 (27%), Positives = 113/267 (42%), Gaps = 26/267 (9%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISS 64
IG+G G+V+ A + G EVA++ NLQ + E +M+ + NI+ + S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 65 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHC 124
+ +V+EY+ GSL + + D Q + + LE+LH S QVIH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 125 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGD 184
D+K N+LL + L+DFG +T E + + T +MAPE D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 185 VYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKE 244
++S GIM IE + P N L + P E+ +P LS F+ +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP----ELQNPEKLSAIFRDFLNR- 252
Query: 245 QCVSFVFNVAMECTVESPEQRINAKEI 271
C E+R +AKE+
Sbjct: 253 ------------CLDMDVEKRGSAKEL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-51
Identities = 60/302 (19%), Positives = 109/302 (36%), Gaps = 46/302 (15%)
Query: 2 FSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSI- 53
S +G G FG V +A M VAVK+ ++ E +++ +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 54 HHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----------------NYILDI 96
+H NI+ ++ +C+ ++ EY +G L +L LD+
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 97 YQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156
L+ VA + +L S IH DL N+LL + + DFG+A+ + +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWV 216
++ + +MAPE + DV+S+GI L E F+ + +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 217 NDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276
+ + + E + ++ C P +R K+IV +
Sbjct: 262 KEGFRMLSPEHAPAEMY------------------DIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 277 KI 278
K
Sbjct: 304 KQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-51
Identities = 69/280 (24%), Positives = 102/280 (36%), Gaps = 30/280 (10%)
Query: 8 IGRGGFGSVFKARL----GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIK 60
+G G FG V + G + VAVK F E M S+ HRN+I+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 61 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ 120
+ K +V E P GSL L + + VA + YL S +
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 121 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDISTIQTQTLATIGYMAPEYGKEGRV 179
IH DL N+LL + + DFG+ + L + +D +Q + APE K
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 180 SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239
S D + FG+ L E FT + NG L +E
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------------------KEGER 233
Query: 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279
E C ++NV ++C PE R + L++ +
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-51
Identities = 63/274 (22%), Positives = 107/274 (39%), Gaps = 29/274 (10%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRN 57
F ++G G F +V AR L E A+K+ ++ E ++M + H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+K+ + ++E L Y +G L KY+ D ++ S LEYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH--- 125
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG 177
+IH DLKP N+LL+++M ++DFG AK+L+ E + T Y++PE E
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
+ D+++ G ++ + P F + I E P +
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQK----IIKLEYDFPEKFFPKA 237
Query: 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
V K V +R+ +E+
Sbjct: 238 RDLVEK-------------LLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 4e-50
Identities = 48/268 (17%), Positives = 95/268 (35%), Gaps = 26/268 (9%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G G FG V + G A K + ++ E + M + H ++ + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
++ ++ E+M G L + + + + + + M V L ++H +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149
Query: 126 LKPSNVLL--DDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
LKP N++ + L DFG+ L + + T T + APE + V
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYT 206
Query: 184 DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243
D++S G++ + P + E DW + + +S + F+ K
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA----FSGISEDGKDFIRK 262
Query: 244 EQCVSFVFNVAMECTVESPEQRINAKEI 271
+ P R+ +
Sbjct: 263 -------------LLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 4e-50
Identities = 53/268 (19%), Positives = 101/268 (37%), Gaps = 26/268 (9%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G G FG V + G K N Y + E +M +HH +I + +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
++ L+LE++ G L + + +Y + + +N M L+++H ++H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 126 LKPSNVLLD--DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
+KP N++ + + DFG+A L ++I + T AT + APE V
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYT 209
Query: 184 DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243
D+++ G++ + P + E DW + +S E F+
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA----FSSVSPEAKDFIKN 265
Query: 244 EQCVSFVFNVAMECTVESPEQRINAKEI 271
+ P +R+ +
Sbjct: 266 -------------LLQKEPRKRLTVHDA 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 9e-50
Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 45/299 (15%)
Query: 2 FSENNLIGRGGFGSVFKARL---GDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSI-HHR 56
++IG G FG V KAR+ G M+ A+K + + F E E++ + HH
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI---------------LDIYQRLN 101
NII ++ +C + + L +EY PHG+L +L S + L Q L+
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 102 IMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQ 161
DVA ++YL Q IH DL N+L+ +N VA ++DFG+++ +++ +T
Sbjct: 132 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTM 185
Query: 162 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLP 221
+ +MA E + N DV+S+G++L E + + +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 222 ISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
P E V+++ +C E P +R + +I+ L ++ +
Sbjct: 246 ------EKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-49
Identities = 56/283 (19%), Positives = 113/283 (39%), Gaps = 29/283 (10%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKV-----FNLQYGRVFKSFDVECEMMKSIHH 55
F + ++G G FG+V+K + +G +V + V + K E +M S+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHF 115
++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 116 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK 175
+++H DL NVL+ ++DFG+AKLL E+ I +MA E
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235
+ DV+S+G+ + E T + + + P + +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ERLPQPPICTI 240
Query: 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
+ V+ + ++C + + R +E++ + K+
Sbjct: 241 D-------------VYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (405), Expect = 2e-48
Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 31/284 (10%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGR---VFKSFDVECEMMKSIHHRNIIKVI 62
++G GG V AR L +VAVKV R + F E + +++H I+ V
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 63 SSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+ E +V+EY+ +L +H+ + + + ++ D L + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---Q 129
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLA-TIGYMAPEYGKEG 177
+IH D+KP+N+++ + DFGIA+ + S QT + T Y++PE +
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
V A DVYS G +L E T + P + +H D +P S + LS +
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR----HEGLSADL 245
Query: 238 IHFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLVKIRD 280
V K ++PE R A E+ LV++ +
Sbjct: 246 DAVVLK-------------ALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-48
Identities = 60/299 (20%), Positives = 126/299 (42%), Gaps = 38/299 (12%)
Query: 2 FSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIH 54
+ + +G+G FG V++ VA+K N R F E +MK +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 55 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI---------LDIYQRLNIMID 105
++++++ S + +++E M G L+ YL S + + + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 106 VASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLAT 165
+A + YL+ + + +H DL N ++ ++ + DFG+ + + D + L
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 166 IGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 225
+ +M+PE K+G + DV+SFG++L E T + + + E L+
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----------- 247
Query: 226 EIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284
+++ LL + D C +F + C +P+ R + EI++ + + + R
Sbjct: 248 -VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-48
Identities = 56/279 (20%), Positives = 101/279 (36%), Gaps = 29/279 (10%)
Query: 7 LIGRGGFGSVFKARL----GDGMEVAVKVFNLQYGRVFKS-FDVECEMMKSIHHRNIIKV 61
IG G FG V + + VA+K + F E M+ H +I+K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
I + E +++E G L +L Y LD+ + +++ L YL S +
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
+H D+ NVL+ N L DFG+++ + ++ I +MAPE R ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTS 188
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
DV+ FG+ + E + + N
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT----------- 237
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280
++++ +C P +R E+ +L I +
Sbjct: 238 --------LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 8e-46
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 47/298 (15%)
Query: 6 NLIGRGGFGSVFKARL--------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HH 55
+G G FG V A +VAVK+ + E EMMK I H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH---------------SSNYILDIYQRL 100
+NII ++ +C+ + +++EY G+L +YL + L +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 101 NIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160
+ VA +EYL S + IH DL NVL+ ++ V ++DFG+A+ + D T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWL 220
+ +MAPE + + DV+SFG++L E FT E K
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255
Query: 221 PISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278
P+ + E ++ + +C P QR K++V L +I
Sbjct: 256 M------DKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-44
Identities = 50/268 (18%), Positives = 101/268 (37%), Gaps = 27/268 (10%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+GRG FG V + K ++ G E ++ HRNI+ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
+ E ++ E++ + + +++S + L+ + ++ + V L++LH S + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 126 LKPSNVLLD--DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
++P N++ + + +FG A+ L Y APE + VS
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 184 DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243
D++S G ++ + P N ++ ++ +S E + FV +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----FKEISIEAMDFVDR 240
Query: 244 EQCVSFVFNVAMECTVESPEQRINAKEI 271
V+ + R+ A E
Sbjct: 241 -------------LLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-43
Identities = 59/304 (19%), Positives = 108/304 (35%), Gaps = 45/304 (14%)
Query: 2 FSENNLIGRGGFGSVFKAR------LGDGMEVAVKVFNLQYGR-VFKSFDVECEMMKSIH 54
+GRG FG V +A VAVK+ ++ E +++ I
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 55 HRNIIKVISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNY---------------ILDIY 97
H + + + L ++E+ G+L YL S L +
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 98 QRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157
+ VA +E+L S + IH DL N+LL + V + DFG+A+ + ++
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN 217
+ + +MAPE + + DV+SFG++L E F+ + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 218 DWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277
+ + + P + + ++C P QR E+V L
Sbjct: 252 EGTRMRAPDYTTPEM------------------YQTMLDCWHGEPSQRPTFSELVEHLGN 293
Query: 278 IRDS 281
+ +
Sbjct: 294 LLQA 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 8e-43
Identities = 47/268 (17%), Positives = 96/268 (35%), Gaps = 23/268 (8%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHHRNIIKVIS 63
+++G G F V A VA+K + S + E ++ I H NI+ +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
+ L+++ + G L + + ++ V ++YLH
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
LD++ +SDFG++K+ ED ++ + T GY+APE + S
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190
Query: 184 DVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAK 243
D +S G++ P + + ++ + ++ S + +S F+
Sbjct: 191 DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY----WDDISDSAKDFIRH 246
Query: 244 EQCVSFVFNVAMECTVESPEQRINAKEI 271
+ PE+R ++
Sbjct: 247 -------------LMEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 6e-42
Identities = 59/276 (21%), Positives = 106/276 (38%), Gaps = 32/276 (11%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRV---FKSFDVECE-MMKSIHHR 56
F + ++G+G FG VF A A+K + + VE + + H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
+ + + +E V+EY+ G L ++ S + D+ + ++ L++LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH-- 120
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176
S +++ DLK N+LLD + ++DFG+ K D T Y+APE
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLG 177
Query: 177 GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236
+ + + D +SFG++L E + P + E D P L +E
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFY-------PRWLEKE 229
Query: 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272
+ K V PE+R+ + +
Sbjct: 230 AKDLLVK-------------LFVREPEKRLGVRGDI 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 8e-42
Identities = 60/269 (22%), Positives = 104/269 (38%), Gaps = 34/269 (12%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKV 61
+G G FG V R +G A+KV + + + + E M+ + H II++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 62 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ + + ++++Y+ G L + +V LEYLH S +
Sbjct: 70 WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125
Query: 122 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSA 181
I+ DLKP N+LLD N ++DFG AK + + T Y+APE +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFV 241
+ D +SFGI++ E P F T+K + I E+ P + + +
Sbjct: 181 SIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEK----ILNAELRFPPFFNEDVKDLL 232
Query: 242 AKEQCVSFVFNVAMECTVESPEQRINAKE 270
++ QR+ +
Sbjct: 233 SR-------------LITRDLSQRLGNLQ 248
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (361), Expect = 8e-42
Identities = 65/288 (22%), Positives = 107/288 (37%), Gaps = 39/288 (13%)
Query: 2 FSEN----NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDV---------EC 47
F EN ++GRG V + E AVK+ ++ G F + +V E
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 48 EMMKSIH-HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV 106
++++ + H NII++ + F LV + M G L YL L + IM +
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRAL 119
Query: 107 ASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQT---L 163
+ LH ++H DLKP N+LLDD+M L+DFG + L + T L
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 164 ATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223
A D++S G+++ P + L+ ++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFG 235
Query: 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
+ E D S V++ V P++R A+E
Sbjct: 236 SPEWDD---YSDTVKDLVSR-------------FLVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-41
Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 28/284 (9%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY-----GRVFKSFDVECEMMKSIHHRNII 59
+ +G G F +V+KAR VA+K L + + ++ E ++++ + H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
++ + ++ +LV ++M + ++ +L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRV 179
++H DLKP+N+LLD+N V L+DFG+AK + T + T Y APE R+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARM 177
Query: 180 -SANGDVYSFGIMLIETFTRKKP---------TDEIFN--GEMTLKHWVNDWLPISTKEI 227
D+++ G +L E R IF G T + W +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 228 VDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
+ I A + + + + +P RI A +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLI----QGLFLFNPCARITATQA 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (355), Expect = 4e-40
Identities = 53/239 (22%), Positives = 103/239 (43%), Gaps = 16/239 (6%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNL------QYGRVFKSFDVECEMMKSIH 54
FS + +IGRGGFG V+ R G A+K + Q + + + ++ +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 55 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
I+ + + + + +L+ M G L +L + ++ LE++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH 124
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYG 174
+ V++ DLKP+N+LLD++ +SD G+A +++ ++ T GYMAPE
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVL 177
Query: 175 KEGR-VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232
++G ++ D +S G ML + P + + + + + + P L
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 9e-40
Identities = 60/288 (20%), Positives = 109/288 (37%), Gaps = 27/288 (9%)
Query: 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK 60
+++ +IG G FG V++A+L G VA+K + + E ++M+ + H NI++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 61 VISSC------SNEEFKALVLEYMPHGSLEKYLH--SSNYILDIYQRLNIMIDVASTLEY 112
+ +E + LVL+Y+P H + L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 113 LHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAP 171
+H S + H D+KP N+LLD D V L DFG AK L R + + +
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPE 192
Query: 172 EYGKEGRVSANGDVYSFGIMLIETFTRKKP------TDEIFNGEMTLKHWVNDWLPISTK 225
+++ DV+S G +L E + D++ L + +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 226 EIVDPNL--LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
+ + V + + + +P R+ E
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-39
Identities = 49/275 (17%), Positives = 94/275 (34%), Gaps = 34/275 (12%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECE-MMKSIHHRNIIKVISS 64
++G G G V + + A+K+ E E ++ +I++++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 65 C----SNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ + +V+E + G L + + + IM + ++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 120 QVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176
+ H D+KP N+L N + L+DFG AK T T T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGP 187
Query: 177 GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236
+ + D++S G+++ P ++ + + + +S E
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
+ P QR+ E
Sbjct: 248 VKMLIRN-------------LLKTEPTQRMTITEF 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (345), Expect = 2e-39
Identities = 51/278 (18%), Positives = 91/278 (32%), Gaps = 27/278 (9%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
IG G FG ++ + G EVA+K+ ++ +E ++ K + I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
E +++ + SLE + + + L + + S +EY+H S IH D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 126 LKPSNVL---LDDNMVAHLSDFGIAKLLTREDISTIQ-----TQTLATIGYMAPEYGKEG 177
+KP N L + ++ DFG+AK T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
S D+ S G +L+ P + K+ +ST V E
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248
Query: 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 275
++ C + + + +
Sbjct: 249 ATYLNF-------------CRSLRFDDKPDYSYLRQLF 273
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (344), Expect = 3e-39
Identities = 58/277 (20%), Positives = 115/277 (41%), Gaps = 17/277 (6%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNL--QYGRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG G +G V+KA+ G A+K L + + + E ++K + H NI+K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
++ LV E++ L+K L L+ + ++ + + + Y H +V+H
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-YGKEGRVSAN 182
DLKP N+L++ ++DFG+A+ + T+ Y AP+ + S
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYT--HEIVTLWYRAPDVLMGSKKYSTT 181
Query: 183 GDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHW-------VNDWLPISTKEIVDPNLLSR 235
D++S G + E + + ++ + +W ++ DPN
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 236 EDIHFVAKEQCVSFVF-NVAMECTVESPEQRINAKEI 271
E + + + + + ++ + P QRI AK+
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-38
Identities = 57/276 (20%), Positives = 95/276 (34%), Gaps = 45/276 (16%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY------GRVFKSFDVECEMMKSIH--HRN 57
L+G GGFGSV+ + D + VA+K +E ++K +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+I+++ + L+LE + L + V + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 118 SAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKE 176
+ V+H D+K N+L+D + L DFG LL T+ T T Y PE+ +
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRY 183
Query: 177 GRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235
R + V+S GI+L + P F + I ++ +S
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIP----FEHDE----------EIIRGQVFFRQRVSS 229
Query: 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
E H + C P R +EI
Sbjct: 230 ECQHLIRW-------------CLALRPSDRPTFEEI 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-38
Identities = 59/276 (21%), Positives = 104/276 (37%), Gaps = 35/276 (12%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY------GRVFKSFDVECEMMKSIHHRNII 59
+G G F V K R G++ A K + G + + E ++K I H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 60 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ N+ L+LE + G L + + L + + + + + YLH S
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH---SL 132
Query: 120 QVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGK 175
Q+ H DLKP N++L D V + DFG+A + D T ++APE
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVN 189
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235
+ D++S G++ + P F G+ + N E + S
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
F+ + V+ P++R+ ++
Sbjct: 246 LAKDFIRR-------------LLVKDPKKRMTIQDS 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-38
Identities = 65/285 (22%), Positives = 118/285 (41%), Gaps = 26/285 (9%)
Query: 6 NLIGRGGFGSVFKAR--LGDGMEVAVKVFNLQYG--RVFKSFDVECEMMK---SIHHRNI 58
IG G +G VFKAR G VA+K +Q G + S E +++ + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 59 IKVISSCSNEEFKA-----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYL 113
+++ C+ LV E++ + ++M + L++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 114 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEY 173
H S +V+H DLKP N+L+ + L+DFG+A++ + + T + T+ Y APE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEV 186
Query: 174 GKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233
+ + D++S G + E F RK + + L ++ ++ L
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRDVAL 245
Query: 234 SREDIHFVAKEQCVSFVFNVAME-------CTVESPEQRINAKEI 271
R+ H + + FV ++ C +P +RI+A
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-38
Identities = 65/282 (23%), Positives = 110/282 (39%), Gaps = 17/282 (6%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNL--QYGRVFKSFDVECEMMKSIHHRNI 58
F + IG G +G V+KAR G VA+K L + V + E ++K ++H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 59 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+K++ E LV E++ + S+ + + + + + L + H S
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 120
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-YGKEG 177
+V+H DLKP N+L++ L+DFG+A+ T + T+ Y APE
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCK 178
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
S D++S G + E TR+ + + + P ++ +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 238 IHFVAKEQCVSFVFNVAME--------CTVESPEQRINAKEI 271
Q S V E P +RI+AK
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-37
Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 23/284 (8%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVF-KSFDVECEMMKSIHHRNIIKVIS 63
+ IG G +G V A + + VA+K + + + + E +++ H NII +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 64 SCSNEEFKAL----VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSA 119
+ + ++ ++ L K L + + L + + L+Y+H SA
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SA 128
Query: 120 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDISTIQTQTLATIGYMAPEYGKEGR 178
V+H DLKPSN+LL+ + DFG+A++ D + T+ +AT Y APE +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 179 VSAN-GDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
D++S G +L E + + + P NL +R
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248
Query: 238 IHFVAKEQCVSF----------VFNVAMECTVESPEQRINAKEI 271
+ + + V + ++ + +P +RI ++
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-35
Identities = 59/291 (20%), Positives = 116/291 (39%), Gaps = 29/291 (9%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVI 62
IG+G FG VFKAR G +VA+K ++ + E ++++ + H N++ +I
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 63 SSCSNEEFKA--------LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
C + LV ++ H + + + +M + L L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQML---LNGLY 131
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS--TIQTQTLATIGYMAPE 172
+ + +++H D+K +NVL+ + V L+DFG+A+ + S T + T+ Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 173 YGKEGR-VSANGDVYSFGIMLIETFTRKKPTD-----------EIFNGEMTLKHWVNDWL 220
R D++ G ++ E +TR G +T + W N
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 221 PISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
+++ R+ + + ++ + V P QRI++ +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 127 bits (319), Expect = 2e-35
Identities = 44/287 (15%), Positives = 90/287 (31%), Gaps = 29/287 (10%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
IG G FG +F+ L + +VA+K + E K + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 66 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCD 125
E +++ + SLE L + + + ++ +H +++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 126 LKPSNVLLDDNMVAH-----LSDFGIAKLL----TREDISTIQTQTLA-TIGYMAPEYGK 175
+KP N L+ + + DFG+ K T++ I + + L+ T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 176 EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235
S D+ + G + + P + K+ ST
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246
Query: 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282
E ++ + + + + K+ + L
Sbjct: 247 EFYKYMHY-------------ARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-35
Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 31/273 (11%)
Query: 2 FSENNLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG---RVFKSFDVECEMMKSIHHRN 57
F L+G+G FG V R G A+K+ + E ++++ H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 58 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+ + + + V+EY G L +L + + ++ S LEYLH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH--- 122
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG 177
S V++ D+K N++LD + ++DFG+ K + + T Y+APE ++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDN 180
Query: 178 RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237
D + G+++ E + P F + + + I +EI P LS E
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFEL----ILMEEIRFPRTLSPEA 232
Query: 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKE 270
+A + P+QR+
Sbjct: 233 KSLLAG-------------LLKKDPKQRLGGGP 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 7e-35
Identities = 58/279 (20%), Positives = 110/279 (39%), Gaps = 19/279 (6%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVI 62
IG G +G+VFKA+ VA+K L V S E ++K + H+NI+++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 63 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVI 122
+++ LV E+ + + + + D + + + L + H V+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 123 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-YGKEGRVSA 181
H DLKP N+L++ N L++FG+A+ + + T+ Y P+ S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 182 NGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVN--------DWLPISTKEIVDPNLL 233
+ D++S G + E +P + + LK W ++ P +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 234 SREDIHFVAKEQCVSFVF-NVAMECTVESPEQRINAKEI 271
V ++ ++ +P QRI+A+E
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 1e-32
Identities = 49/241 (20%), Positives = 96/241 (39%), Gaps = 22/241 (9%)
Query: 8 IGRGGFGSVFKAR-LGDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVIS 63
+G G FG V + G A+K+ + Q + + E ++++++ ++K+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIH 123
S + +V+EY+ G + +L + T EYLH S +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIY 164
Query: 124 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANG 183
DLKP N+L+D ++DFG AK + T +APE +
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 184 DVYSFGIMLIETFTRKKP---------TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234
D ++ G+++ E P ++I +G++ + L + ++ +L
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTK 279
Query: 235 R 235
R
Sbjct: 280 R 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-32
Identities = 56/274 (20%), Positives = 104/274 (37%), Gaps = 33/274 (12%)
Query: 6 NLIGRGGFGSVFKARL----GDGMEVAVKVFN----LQYGRVFKSFDVECEMMKSI-HHR 56
++G G +G VF R G A+KV +Q + + E ++++ I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 57 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG 116
++ + + E L+L+Y+ G L +L + + I V + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIVLALEHL 145
Query: 117 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE--YG 174
+ +I+ D+K N+LLD N L+DFG++K ++ + TI YMAP+ G
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRG 204
Query: 175 KEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234
+ D +S G+++ E T P F + I E P +S
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINA 268
+ + ++ P++R+
Sbjct: 261 ALAKDLIQR-------------LLMKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (290), Expect = 5e-31
Identities = 55/289 (19%), Positives = 113/289 (39%), Gaps = 36/289 (12%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSI-HHRNIIKVIS 63
+GRG + VF+A + + +V VK+ + K E ++++++ NII +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 97
Query: 64 SCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQV 121
+ + ALV E++ + ++ + L Y M ++ L+Y H S +
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGI 150
Query: 122 IHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR-V 179
+H D+KP NV++D ++ L D+G+A+ +A+ + PE + +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 180 SANGDVYSFGIMLIETFTRKKPTD-------------EIFNGEMTLKHWVNDWLPISTKE 226
+ D++S G ML RK+P ++ E + + + +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAME----CTVESPEQRINAKEI 271
SR+ + V A++ + R+ A+E
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-31
Identities = 66/285 (23%), Positives = 110/285 (38%), Gaps = 31/285 (10%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVIS 63
+G G +G+V A G +VA+K + K E ++K + H N+I ++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 64 SCSNEEFKA------LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+ +E LV+ +M G+ L L + ++ + L Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH--- 138
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPE-YGKE 176
+A +IH DLKP N+ ++++ + DFG+A+ E T + T Y APE
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNW 193
Query: 177 GRVSANGDVYSFGIMLIETFTRKKP---------TDEIFNGEMTLKHWVNDWLPISTKEI 227
R + D++S G ++ E T K EI T L +
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 228 VDPNLLSREDIHFVAKEQCVSFVF-NVAMECTVESPEQRINAKEI 271
L E F + S + N+ + V EQR+ A E
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-29
Identities = 54/283 (19%), Positives = 104/283 (36%), Gaps = 25/283 (8%)
Query: 6 NLIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVI 62
+ +G G +GSV A G+ VAVK + + K E ++K + H N+I ++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 63 SSCSNE----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS 118
+ EF + L G+ + L ++ + L+Y+H S
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIH---S 139
Query: 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGR 178
A +IH DLKPSN+ ++++ + DFG+A+ E + T
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMH 195
Query: 179 VSANGDVYSFGIMLIETFTRKKP---------TDEIFNGEMTLKHWVNDWLPISTKEIVD 229
+ D++S G ++ E T + I T + + +
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 230 PNLLSREDIHFVAKEQCVS-FVFNVAMECTVESPEQRINAKEI 271
+L ++F + ++ + V ++RI A +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 4e-27
Identities = 49/309 (15%), Positives = 104/309 (33%), Gaps = 47/309 (15%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSC 65
+G G F +V+ A+ + + VA+K+ ++ + E ++++ ++ + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 66 SNEEFK---------------ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTL 110
+N K +V E + L + + + I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 111 EYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYM 169
+Y+H +IH D+KP NVL++ + +L IA L T ++ T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 170 APEYGKEGRVSANGDVYSFGIMLIETFTRKKP---------------------------T 202
+PE D++S ++ E T +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 203 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESP 262
+ NG+ T + + L + ++ L + + + + P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 263 EQRINAKEI 271
+R +A +
Sbjct: 317 RKRADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 5e-27
Identities = 59/295 (20%), Positives = 111/295 (37%), Gaps = 40/295 (13%)
Query: 7 LIGRGGFGSVFKAR-LGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVIS 63
IG G G V A VA+K + + K E +MK ++H+NII +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 64 SCSNEEFK------ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY 117
+ ++ LV+E M + D + ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136
Query: 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEG 177
SA +IH DLKPSN+++ + + DFG+A+ S + T + T Y APE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 178 RVSANGDVYSFGIMLIETFTRKKP---------------------TDEIFNGEMTLKHWV 216
N D++S G ++ E K + + + T++++V
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 217 NDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 271
+ + S + S ++ + V P +RI+ +
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.4 bits (195), Expect = 1e-18
Identities = 24/160 (15%), Positives = 49/160 (30%), Gaps = 20/160 (12%)
Query: 6 NLIGRGGFGSVFKARLGDGMEVAVKVFNL----------QYGRVFKSFDVECEMMKSIHH 55
L+G G +VF E VK + + F V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 56 RNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASTLEYLH 114
R + K+ + + + + L E Y + + ++ + + +
Sbjct: 66 RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 115 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154
++H DL NVL+ + + + DF + + E
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 285 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.91 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.18 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.66 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.51 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=377.80 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=207.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++++.||+|+||+||+|.+ .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+++..|+||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 488999999999999999975 4799999999875532 33466889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++|+|.+++.+.. .+++..++.++.||+.||+||| ++|++||||||+||++++++.+||+|||++...........
T Consensus 86 ~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 86 SGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 9999999997654 4999999999999999999999 99999999999999999999999999999987755433334
Q ss_pred eccccccccccCCcccCCCcc-CcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...................
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------------- 225 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------- 225 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT----------------
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Confidence 455679999999999987765 688999999999999999999997654433322222111110
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+++++.+|+.+||+.||++|||++|++++
T Consensus 226 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01123556779999999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=376.26 Aligned_cols=248 Identities=27% Similarity=0.332 Sum_probs=210.2
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++++.++||||+++++++...+.+|+||||++|
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 89999999999999999975 57999999999876655667889999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
++|.+++... .+++..++.++.||+.||+||| ++|++||||||+|||++.+|.+||+|||++....... ....
T Consensus 102 g~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~ 174 (293)
T d1yhwa1 102 GSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 174 (293)
T ss_dssp CBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBC
T ss_pred CcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cccc
Confidence 9999988654 3999999999999999999999 9999999999999999999999999999998775432 2234
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+........... .+
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------------------~~ 236 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP------------------EL 236 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC------------------CC
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC------------------CC
Confidence 567999999999999999999999999999999999999999764332221111111110 01
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..++.++.+||.+||..||.+|||++|++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1134567789999999999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-58 Score=372.34 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=208.8
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++++.||+|+||+||+|+.+ ..||||++... .....+.+.+|++++++++||||+++++++.. +.+++||||+
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 4889999999999999999864 35999998643 34556788999999999999999999998765 4578999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
++|+|.+++......+++..+..++.||+.||+||| +++++||||||+||+++.++.+||+|||++...........
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999999776666999999999999999999999 99999999999999999999999999999987665433334
Q ss_pred eccccccccccCCcccCCC---ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 159 QTQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.....+|+.|+|||++.+. .++.++||||||+++|+|+||+.||.+..+.................
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~----------- 231 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL----------- 231 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG-----------
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc-----------
Confidence 4556789999999988654 47899999999999999999999998754433322222221111111
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
...+..+++++.+++.+||..||.+|||++++++.|+.+++++
T Consensus 232 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 ----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp ----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 0113356778999999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-58 Score=375.21 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=209.7
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++++.||+|+||+||+|.+ .+++.||+|++........+.+.+|++++++++||||+++++++..++.+++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 78889999999999999975 47899999999877666678889999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
|+|.+++.+....+++..+..++.||+.||.||| ++|++||||||+||+++.+|.+||+|||++....... ....
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~ 168 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 168 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHT
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cccc
Confidence 9999998766666999999999999999999999 9999999999999999999999999999997654321 1224
Q ss_pred cccccccccCCcccC-----CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 161 QTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
...||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+.... ......
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~-i~~~~~--------------- 232 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK-IAKSEP--------------- 232 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-HHHSCC---------------
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH-HHcCCC---------------
Confidence 567899999999874 44578999999999999999999999976543332211 111100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..+..+++++.+||.+||+.||.+|||++|++++
T Consensus 233 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 --PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111234567789999999999999999999999873
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-58 Score=367.93 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=204.2
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++++.||+|+||+||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 477889999999999999998888899999987543 3346788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
|+|.+++......++...++.++.|++.||+||| +++++||||||+||++++++.+||+|||+++........ ...
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~ 160 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SST 160 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCce-eec
Confidence 9999998777667899999999999999999999 999999999999999999999999999999876543322 223
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccchh
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIHF 240 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
...+|+.|+|||++.+..++.++||||||+++|||+|+..|+....+............. .
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-------------------~ 221 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------------------L 221 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-------------------C
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-------------------C
Confidence 456889999999999999999999999999999999965554332222222222111110 1
Q ss_pred hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 241 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
..+..+++++.+++.+||+.||++|||+++++++|++++++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11234567799999999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=366.62 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=206.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++++.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 578899999999999999986 478999999986432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++|+|.+++.+... +++..++.++.||+.||+||| ++|++||||||+||+++.++.+||+|||++.......
T Consensus 87 y~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp CCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred ecCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 9999999999976554 999999999999999999999 9999999999999999999999999999997665432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+. .........
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~---------------- 221 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRISRVEF---------------- 221 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCC----------------
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-HHHHHcCCC----------------
Confidence 2345689999999999999999999999999999999999999976432221 111111100
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..+++++.+|+.+||+.||++|||++|++++
T Consensus 222 ----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0123456779999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=370.57 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=205.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 488999999999999999975 579999999987532 3344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++||+|.+++...+. +++..++.++.|++.||+||| ++|++||||||+||+++++|.+||+|||++.........
T Consensus 89 y~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred ccCCCCHHHhhhccCC-CCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999998876554 999999999999999999999 999999999999999999999999999999887654434
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... .........
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~~---------------- 227 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-FQKIIKLEY---------------- 227 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHTTCC----------------
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-HHHHHcCCC----------------
Confidence 444456799999999999999999999999999999999999999976432211 111111100
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..+++++.+||++||+.||.+|||++|++..
T Consensus 228 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0123456779999999999999999999997654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=359.79 Aligned_cols=252 Identities=23% Similarity=0.417 Sum_probs=213.6
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|+++++||+|+||+||+|+.++++.||||+++.... ..+.+.+|++++++++||||+++++++.+.+.+++||||+++
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 6899999999999999999988888999999876433 346788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccceec
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQT 160 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~~ 160 (285)
|+|.+++......+++..++.++.|+++||+||| ++|++||||||+||++++++.+||+|||+++...... .....
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~ 159 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSV 159 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceeec
Confidence 9999998776667999999999999999999999 9999999999999999999999999999998765432 22233
Q ss_pred cccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 161 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 161 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
...+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||......+.. ....... +
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-~~i~~~~-------------------~ 219 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQGL-------------------R 219 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-HHHHTTC-------------------C
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH-HHHHhCC-------------------C
Confidence 4568899999999999999999999999999999998 89999765443322 1111110 0
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVK 277 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~ 277 (285)
...+..++.++.+|+++||+.||++|||+++++++|.+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11123456779999999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=366.09 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=192.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceecc--CCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSN--EEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 75 (285)
+|++.+.||+|+||+||+|+. .+|+.||+|++.... +...+.+.+|++++++++||||+++++++.+ .+.+|+||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 588999999999999999975 578999999986543 3445678899999999999999999998854 56789999
Q ss_pred eccCCCCHHHhhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeeCCCCcEEEeeeccceec
Q 039392 76 EYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASTLEYLHFGY--SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 150 (285)
Q Consensus 76 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~~~~h~di~~~nili~~~~~~~i~df~~~~~~ 150 (285)
||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+ ..+++||||||+||+++.++.+||+|||++...
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 999999999998642 345999999999999999999999321 124999999999999999999999999999876
Q ss_pred CcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+....+. ..........
T Consensus 165 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-~~~i~~~~~~--------- 232 (269)
T d2java1 165 NHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFR--------- 232 (269)
T ss_dssp -------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCC---------
T ss_pred ccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCC---------
Confidence 5432 222346789999999999999999999999999999999999999976433221 1111111000
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..+++++.+|+++||+.||.+|||++|++++
T Consensus 233 ----------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 ----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0122456779999999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=359.63 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=199.4
Q ss_pred CCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceecc----CCceEEEE
Q 039392 3 SENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSN----EEFKALVL 75 (285)
Q Consensus 3 ~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~ 75 (285)
++.++||+|+||+||+|.+ .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5667899999999999975 468899999987543 3455678899999999999999999999854 45688999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeC-CCCcEEEeeeccceecCc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQ--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~di~~~nili~-~~~~~~i~df~~~~~~~~ 152 (285)
||+++++|.+++.+... +++..++.++.||+.||+||| +++ ++||||||+||+++ .++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcccc-ccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999976554 899999999999999999999 888 99999999999997 589999999999976443
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....+.............+
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~----------- 231 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------- 231 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-----------
Confidence 2 2234578999999998865 59999999999999999999999997644333322222111110
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
...+..+++++.+++.+||..||++|||++|++++
T Consensus 232 -------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 01123456779999999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-56 Score=366.60 Aligned_cols=257 Identities=23% Similarity=0.428 Sum_probs=200.5
Q ss_pred CCCCceecccCceEEEEEEeC-CC---cEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DG---MEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~---~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
|++.+.||+|+||+||+|... ++ ..||+|.+... .....+.+.+|+++|++++||||+++++++..++..++|||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 567789999999999999753 23 35788887654 34455778999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|+++|+|.+++......+++..++.++.||+.||+||| +++++||||||+|||++.++.+||+|||+++........
T Consensus 108 y~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp CCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred ecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999999998877667999999999999999999999 999999999999999999999999999999876543222
Q ss_pred c---eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 157 T---IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 157 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
. ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||.+....+.. ......
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~-~~i~~~-------------- 249 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI-NAIEQD-------------- 249 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHTT--------------
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH-HHHHcC--------------
Confidence 1 1122456889999999999999999999999999999998 89998764332211 111110
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.+...+..++.++.+++.+||+.||.+|||++++++.|+++.++
T Consensus 250 -----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 -----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 01111345677899999999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-56 Score=372.23 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=211.5
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++++.||+|+||+||+|.. .+|+.||||++..........+.+|++++++++||||+++++++.+++.+|+||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 388899999999999999975 5799999999987665556778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCcEEEeeeccceecCcccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
|++|.+.+......+++..++.++.||+.||+||| ++|++||||||+|||++ .++.+||+|||++.......
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--- 183 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 183 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC---
Confidence 99999988776666999999999999999999999 99999999999999997 67899999999998876542
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......+++.|+|||++.+..++.++|||||||++|+|++|..||.+....+. ...........+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~~-------------- 248 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDWEFD-------------- 248 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCCCCCC--------------
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCC--------------
Confidence 22345689999999999999999999999999999999999999976433222 111111111100
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+++++.+||.+||+.||.+|||++|+|++
T Consensus 249 --~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 --EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01123467789999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-56 Score=371.93 Aligned_cols=251 Identities=18% Similarity=0.255 Sum_probs=211.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
+|++++.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+.+++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 478899999999999999975 5799999999987666666788899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCcEEEeeeccceecCcccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
||+|.+++.+....+++..++.++.||+.||.||| ++|++||||||+||+++ .++.+||+|||++.......
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--- 180 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 180 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---
Confidence 99999998766666999999999999999999999 99999999999999996 46889999999998776532
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ ............
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~--------------- 244 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNM--------------- 244 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCS---------------
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC---------------
Confidence 2234578999999999999999999999999999999999999997643222 122111111110
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+++++.+||.+||+.||.+|||++|+|++
T Consensus 245 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 -DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011123567789999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-57 Score=372.73 Aligned_cols=266 Identities=20% Similarity=0.273 Sum_probs=205.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++++.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 488899999999999999985 578999999987553 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
++++|.+++.+.+. +++..++.++.|++.||.||| + +|++||||||+||+++.+|.+||+|||++.......
T Consensus 87 ~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 159 (322)
T d1s9ja_ 87 DGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 159 (322)
T ss_dssp TTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---
T ss_pred CCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---
Confidence 99999999976654 999999999999999999999 6 499999999999999999999999999998654321
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC--c----------c
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS--T----------K 225 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~----------~ 225 (285)
.....||+.|+|||++.+..++.++||||+||++|+|++|+.||......+.............. . .
T Consensus 160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 23457999999999999999999999999999999999999999765433222111110000000 0 0
Q ss_pred ccccccccCcccc-----------hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 EIVDPNLLSREDI-----------HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 ~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
............. ........+.++.+|+.+||..||.+|||++|+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000000000 000012346789999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-56 Score=368.11 Aligned_cols=249 Identities=19% Similarity=0.277 Sum_probs=191.2
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
|++++.||+|+||+||+|.. .+++.||||++..... .....+.+|+.+++.++||||+++++++.+++.+|+||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 78899999999999999975 4789999999875442 233567789999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCcEEEeeeccceecCccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++|.+++...+ .+++..+..++.||+.||+||| ++|++||||||+||++. .++.+||+|||++.......
T Consensus 91 gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 91 GGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp SCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 999999997654 4999999999999999999999 99999999999999995 57899999999998765432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.. .........
T Consensus 165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~i~~~~~~--------------- 227 (307)
T d1a06a_ 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-EQILKAEYE--------------- 227 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHTTCCC---------------
T ss_pred -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-HHHhccCCC---------------
Confidence 223456899999999999999999999999999999999999999764332211 111111111
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........+++++.+|+.+||..||++|||++|++++
T Consensus 228 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 -FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111133567789999999999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=357.50 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=208.2
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++.+.||+|+||+||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 366788999999999999998888999999987543 334678999999999999999999998765 457899999999
Q ss_pred CCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
|+|.+++.... ..++...++.++.||+.||.||| +++++||||||+||++++++.+||+|||+++...... ....
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~ 167 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAR 167 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECC
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cccc
Confidence 99998775433 24899999999999999999999 9999999999999999999999999999998875432 2223
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+++.|+|||++.+..++.++||||||+++|+|+||..|+................. +
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-------------------~ 228 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-------------------R 228 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------------C
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-------------------C
Confidence 445688899999999988999999999999999999997666544333222222211110 1
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
...+..+++++.+|+.+||+.||++|||++++++.|+++..
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11133567789999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=356.76 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=209.8
Q ss_pred CCCc-eecccCceEEEEEEe---CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 3 SENN-LIGRGGFGSVFKARL---GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 3 ~~~~-~lg~G~~~~v~~~~~---~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
.+.+ +||+|+||+||+|.. +++..||||+++... ....+.+.+|++++++++||||+++++++.. +.+++||||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~ 89 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 89 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEe
Confidence 3445 499999999999964 345679999987543 3455778999999999999999999999865 458899999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc-
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS- 156 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~- 156 (285)
+++|+|.+++......+++..++.++.|++.||+||| +++++||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999999998766666999999999999999999999 999999999999999999999999999999887653322
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.+....+. .......
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-~~~i~~~----------------- 228 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQG----------------- 228 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-HHHHHTT-----------------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-HHHHHcC-----------------
Confidence 22234567889999999998999999999999999999998 8999976543222 1111110
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHh
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLL 283 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~ 283 (285)
.+...+..+++++.+++.+||..||++|||+.++++.|+....++.
T Consensus 229 --~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 229 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 0111234567889999999999999999999999999998876653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-56 Score=361.75 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=210.3
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.+.||+|+||+||+|.+ .+++.||||+++.+.. ..+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccC
Confidence 56678999999999999975 4688999999875433 456788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
|+|.+++... ...+++..++.++.|++.||+||| ++|++||||||+|||++.++.+||+|||+++...... ....
T Consensus 98 g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~ 173 (287)
T d1opja_ 98 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH 173 (287)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEE
T ss_pred cchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-ceee
Confidence 9999998653 445899999999999999999999 9999999999999999999999999999998765433 2233
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+++.|+|||++.+..++.++||||||+++|+|++|..||....+............ .
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~-------------------~ 234 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------------------R 234 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-------------------C
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-------------------C
Confidence 445678899999999999999999999999999999998777654333222211111110 1
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
...+..+++++.+|+.+||+.||++|||++++++.|+.+.+
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11134567789999999999999999999999999988753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-55 Score=362.13 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=200.7
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
|+.++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 77889999999999999975 578999999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+.+++|..++... ..+++..++.++.||+.||.||| ++|++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 97 CLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 9998887666544 34999999999999999999999 999999999999999999999999999999865432
Q ss_pred eeccccccccccCCcccCC---CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 158 IQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.... ......+.
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~-i~~~~~~~------------ 233 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPA------------ 233 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHSCCCC------------
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH-HHhCCCCC------------
Confidence 34568999999998864 3589999999999999999999999976433222111 11110000
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 273 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~ 273 (285)
..+..+++++.+||.+||+.||.+|||++|+++
T Consensus 234 ------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 002235677999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=358.29 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=206.6
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc------hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY------GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
|++++.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+.+++|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 78899999999999999985 579999999986432 12356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----cEEEeeeccceec
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLL 150 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~i~df~~~~~~ 150 (285)
|||+++++|.+++.... .+++..++.++.|++.||+||| +++++||||||+||+++.++ .+|++|||++...
T Consensus 92 ~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 99999999999997655 4999999999999999999999 99999999999999998776 5999999999877
Q ss_pred CcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc
Q 039392 151 TREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 230 (285)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
.... ......+++.|+|||++.+..++.++||||+||++|+|++|..||.+....+. .........
T Consensus 168 ~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~~---------- 233 (293)
T d1jksa_ 168 DFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVNY---------- 233 (293)
T ss_dssp TTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHTTCC----------
T ss_pred CCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCC----------
Confidence 5432 22345688999999999999999999999999999999999999976432221 111111100
Q ss_pred cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.........++.++.+||++||..||++|||++|++++
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111234567789999999999999999999999873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=365.50 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=205.3
Q ss_pred CCCCceecccCceEEEEEEeC-CC-----cEEEEEEeeccch-hHHHHHHHHHHHHccC-CCCccccccceeccCCceEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DG-----MEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~-----~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 73 (285)
|++++.||+|+||+||+|+.. .+ ..||+|.+..... .....+.+|+.++.++ +||||+++++++...+.+++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 567789999999999999743 22 3689998865433 3346688899999988 89999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC----------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 039392 74 VLEYMPHGSLEKYLHSSN----------------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNV 131 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~ni 131 (285)
||||+++|+|.+++.... ..+++..++.++.|++.||+||| +++++||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhcc
Confidence 999999999999986543 23788899999999999999999 99999999999999
Q ss_pred eeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccch
Q 039392 132 LLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEM 210 (285)
Q Consensus 132 li~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~ 210 (285)
+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987665443444455668999999999999999999999999999999998 8999976544332
Q ss_pred hhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHH
Q 039392 211 TLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLV 276 (285)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~ 276 (285)
... ...... ++..+..+++++.+||.+||+.||++|||++|++++|.
T Consensus 276 ~~~-~~~~~~------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 276 FYK-LIQNGF------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHH-HHHTTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-HHhcCC------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 222 111111 11123456778999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-55 Score=353.15 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=202.8
Q ss_pred ceecccCceEEEEEEeC---CCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 6 NLIGRGGFGSVFKARLG---DGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 6 ~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
++||+|+||+||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999642 3578999998643 234456789999999999999999999998654 57899999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc-cee
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-TIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~-~~~ 159 (285)
|+|.+++.+... +++..++.++.||+.||+||| +++++||||||+||+++.++.++++|||+++........ ...
T Consensus 92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhccC-CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999876554 999999999999999999999 999999999999999999999999999999876543222 222
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCcccc
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 238 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.. ...... .
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-~~i~~~-------------------~ 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKG-------------------E 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTT-------------------C
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-HHHHcC-------------------C
Confidence 34568899999999999999999999999999999998 89999764332211 111110 0
Q ss_pred hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 239 HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
+...+..+++++.+++.+||+.||.+|||++++++.|++...+.
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 11113456788999999999999999999999999988876544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=361.71 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=207.9
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++++.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 588999999999999999985 579999999997542 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++||+|.+++.+.+. +++..++.++.||+.||+||| ++|++||||||+||+++.+|.+||+|||++.......
T Consensus 86 y~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-- 159 (337)
T d1o6la_ 86 YANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp CCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred ccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence 9999999999877654 899999999999999999999 9999999999999999999999999999998654332
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+....+.. ........
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~i~~~~~---------------- 222 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-ELILMEEI---------------- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCC----------------
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-HHHhcCCC----------------
Confidence 2234567899999999999999999999999999999999999999764332221 11111100
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
..+..+++++.+||.+||+.||.+|++ +++++++
T Consensus 223 ----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 012345777999999999999999995 8888874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=352.29 Aligned_cols=257 Identities=25% Similarity=0.438 Sum_probs=202.7
Q ss_pred CCCCceecccCceEEEEEEeCC-C----cEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLGD-G----MEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~-~----~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
|+..++||+|+||+||+|...+ + ..||||.+.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 5678899999999999997432 2 469999986543 334457889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++.++++.+++......++...++.++.|++.|++||| +++++||||||+|||++.++.+||+|||+++.......
T Consensus 89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999988777667999999999999999999999 99999999999999999999999999999987654322
Q ss_pred -cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 156 -STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 156 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
........+|+.|+|||.+.+..++.++||||||+++|||+++..|+....+...........
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---------------- 229 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---------------- 229 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT----------------
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc----------------
Confidence 222234567889999999999999999999999999999999776654433322222211111
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
.+...+..++.++.+++.+||+.||++|||++++++.|+++.+
T Consensus 230 ---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 0111233466779999999999999999999999999998875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=351.75 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=199.5
Q ss_pred CCCCCceecccCceEEEEEEeC----CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG----DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++++.||+|+||.||+|... .+..||+|.+.... ....+.+.+|++++++++||||+++++++.+ +.+++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence 3677899999999999999743 24568888876433 4445778999999999999999999999964 5688999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
|++++++|.+++......+++..++.++.||+.||.||| +++++||||||+||++++++.+||+|||++.......
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~- 162 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 162 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc-
Confidence 999999999988777667999999999999999999999 9999999999999999999999999999998765432
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccC
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 234 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... .....
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-i~~~~--------------- 226 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGE--------------- 226 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTC---------------
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCC---------------
Confidence 222334567899999999999999999999999999999998 8888876544332211 11100
Q ss_pred cccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 235 REDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
....+..+++++.+||.+||..||.+|||++|+++.|++++++
T Consensus 227 ----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0111345677899999999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-54 Score=354.70 Aligned_cols=244 Identities=25% Similarity=0.310 Sum_probs=206.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 588999999999999999985 579999999987532 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
|++|++|..++..... ++...++.++.||+.||.||| ++|++||||||+||+++.+|.+||+|||++.......
T Consensus 85 ~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 85 YIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp CCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred ecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 9999999998876654 888899999999999999999 9999999999999999999999999999998765432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.. ........
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~i~~~~~---------------- 218 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-EKILNAEL---------------- 218 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHHCCC----------------
T ss_pred ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-HHHHcCCC----------------
Confidence 3467899999999999999999999999999999999999999764322221 11111100
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
..+..+++++.+++.+||..||.+|+ |+++++++
T Consensus 219 ----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 01224567799999999999999996 89999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.5e-54 Score=347.07 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=206.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---------hhHHHHHHHHHHHHccCC-CCccccccceeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---------GRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEE 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 69 (285)
+|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 588999999999999999985 579999999987543 223456888999999997 999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 70 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
..|+||||+++++|.+++...+ .+++..++.++.||+.||+||| ++|++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 9999999999999999997655 4999999999999999999999 99999999999999999999999999999988
Q ss_pred cCcccccceeccccccccccCCcccC------CCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGK------EGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 223 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
..... ......+|+.|.|||.+. ...++.++||||+||++|+|++|+.||.+..... ............
T Consensus 160 ~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~~- 234 (277)
T d1phka_ 160 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQF- 234 (277)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC-
T ss_pred ccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCCC-
Confidence 76532 224456899999999765 3457889999999999999999999998643322 122222111110
Q ss_pred ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.......+++++.+|+.+||+.||++|||++|++++
T Consensus 235 ---------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 ---------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ---------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ---------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 011133567889999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-54 Score=350.83 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=203.9
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCC----ceEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE----FKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~ 73 (285)
|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++++.++||||+++++++...+ .+|+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 88999999999999999975 579999999987532 345567889999999999999999999986543 4789
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
||||++|++|.+++...+. +++..++.++.||+.||+||| ++|++||||||+||+++.++..+++|||.+......
T Consensus 89 vmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEECCCCCEehhhhcccCC-CCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999998876554 899999999999999999999 999999999999999999999999999998765433
Q ss_pred cc-cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 154 DI-STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 154 ~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
.. ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+............
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~----------- 233 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----------- 233 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----------
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC-----------
Confidence 21 223345578999999999999999999999999999999999999997643322222111110000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCC-CHHHHHHHHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLVKIRD 280 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~eil~~l~~l~~ 280 (285)
.......+++++.++|++||+.||.+|| |++++++.|.++++
T Consensus 234 ------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 ------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 0111234677899999999999999999 89999999998874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-54 Score=355.41 Aligned_cols=250 Identities=19% Similarity=0.282 Sum_probs=207.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 79 (285)
.|++++.||+|+||+||+|.+ .+++.||+|+++.... ....+.+|+++|+.++||||+++++++.+.+.+|+||||++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 378899999999999999975 4789999999976543 33567899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCcEEEeeeccceecCcccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~--~~~~~i~df~~~~~~~~~~~~~ 157 (285)
|++|.+++...+..+++..++.++.||+.||.||| ++|++||||||+||+++. .+.++|+|||++.......
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--- 158 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC---
Confidence 99999999877666999999999999999999999 999999999999999985 4589999999998765432
Q ss_pred eeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 158 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
......+++.|+|||...+..++.++|||||||++|+|++|..||......+. ..........
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-~~~i~~~~~~---------------- 221 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNAEYT---------------- 221 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCC----------------
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC----------------
Confidence 22345688999999999999999999999999999999999999976432221 1111111100
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........+++++.+|+.+||..||.+|||++|++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111123467789999999999999999999999974
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-54 Score=354.51 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=205.1
Q ss_pred CCCCCceecccCceEEEEEEeC-CCc----EEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGM----EVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~----~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
+|++++.||+|+||+||+|... +|+ +||+|.+.... ....+.+.+|++++++++||||+++++++.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 4888999999999999999753 444 58888875432 34557789999999999999999999999875 46688
Q ss_pred EeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccc
Q 039392 75 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 154 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~ 154 (285)
++++.+++|.+.+......+++..++.++.||+.||+||| +++++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 8999899999988877777999999999999999999999 9999999999999999999999999999998776544
Q ss_pred ccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccccc
Q 039392 155 ISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 233 (285)
Q Consensus 155 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
.........+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.+....+.. ......
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~~~--------------- 229 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKG--------------- 229 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHHHT---------------
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcC---------------
Confidence 3333344568999999999999999999999999999999998 78888764333221 111110
Q ss_pred CcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 234 SREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.+...+..+++++.+++.+||..||.+|||+++++++|+.+.+.
T Consensus 230 ----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 01112345677899999999999999999999999999988654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=344.81 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=198.4
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc-CCceEEEEeccC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN-EEFKALVLEYMP 79 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~ 79 (285)
+|++++.||+|+||.||+|.. +|+.||||+++.+ ...+.+.+|++++++++||||+++++++.+ .+.+++||||++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 367789999999999999988 4789999998644 334678899999999999999999998854 567899999999
Q ss_pred CCCHHHhhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 80 HGSLEKYLHSSN-YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 80 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
+|+|.+++.... ..++...++.++.||+.||.||| +.+++||||+|+||+++.+|.++++|||++......
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----- 156 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 156 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC-----
Confidence 999999986543 34899999999999999999999 999999999999999999999999999999865432
Q ss_pred eccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCccccccccccCccc
Q 039392 159 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 237 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
.....++..|+|||.+.+..++.++||||||+++|+|+| |+.||......+.... ... .
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~-------------------~ 216 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEK-------------------G 216 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTT-------------------T
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHc-------------------C
Confidence 233456788999999998899999999999999999998 6777765433222111 100 0
Q ss_pred chhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 238 IHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.+...+..+++++.+++.+||..||.+|||+++++++|++++..
T Consensus 217 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 01112335567899999999999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-53 Score=356.49 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch---hHHH---HHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG---RVFK---SFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~---~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++++.||+|+||+||+|+. .+|+.||||++....- .... ...+++.+++.++||||+++++++...+.+|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 588999999999999999975 4799999999864321 1112 22345778888899999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
||||++|++|.+++.+... +++..++.++.||+.||.||| ++|++||||||+|||++.+|.+||+|||++......
T Consensus 85 vmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEecCCCcHHHHHHhccc-ccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999976654 889999999999999999999 999999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccc
Q 039392 154 DISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 232 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
. .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||.......... .........
T Consensus 161 ~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~~~~~~~~~--------- 225 (364)
T d1omwa3 161 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA--------- 225 (364)
T ss_dssp C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--HHHHSSSCC---------
T ss_pred c----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhcccCC---------
Confidence 2 234578999999999864 568999999999999999999999997644332211 111000000
Q ss_pred cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 233 LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
...+..+++++.+||.+||..||.+||| +++++++
T Consensus 226 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0112345677999999999999999999 6888864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=347.32 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=202.1
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEeccCC
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
+|++++.||+|+||+||+|.+.+++.||||+++.... ..+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 4678899999999999999988888899999875433 34678999999999999999999999865 457899999999
Q ss_pred CCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccccee
Q 039392 81 GSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTIQ 159 (285)
Q Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~~ 159 (285)
|+|..++... ...+++..++.++.||+.||+||| +.|++||||||+||+++.++.+||+|||+++...... ....
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTAR 171 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ceee
Confidence 9999887643 234899999999999999999999 9999999999999999999999999999998765432 2223
Q ss_pred ccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcccch
Q 039392 160 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIH 239 (285)
Q Consensus 160 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
....+++.|+|||.+....++.++||||||+++|+|++|..|+................. +
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-------------------~ 232 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------------R 232 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------------C
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-------------------C
Confidence 345688999999999999999999999999999999997777655443332222221110 0
Q ss_pred hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 240 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
...+..++.++.+++.+||+.||++|||+++++++|++..
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1113356778999999999999999999999999887654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-53 Score=355.36 Aligned_cols=244 Identities=20% Similarity=0.238 Sum_probs=205.8
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 76 (285)
+|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 478899999999999999975 579999999986432 2344668899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~ 156 (285)
++.+++|..++.+... +++..++.++.||+.||.||| ++|++||||||+|||++.+|.+||+|||++.......
T Consensus 122 ~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp CCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred cccccchhhhHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence 9999999999876654 999999999999999999999 9999999999999999999999999999998775432
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ...........
T Consensus 196 ---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~--------------- 256 (350)
T d1rdqe_ 196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKVR--------------- 256 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC---------------
T ss_pred ---ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHhcCCCC---------------
Confidence 34568999999999999999999999999999999999999997642211 11111111100
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCC-----CHHHHHHH
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK 274 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~~ 274 (285)
.+..+++++.++|++||..||.+|+ |+++++++
T Consensus 257 -----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 -----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1234567799999999999999994 89999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=348.56 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=198.8
Q ss_pred CCCCCceecccCceEEEEEEe--CC--CcEEEEEEeecc---chhHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL--GD--GMEVAVKVFNLQ---YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~--~~--~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++.+.||+|+||.||+|+. .+ ..+||||++... .....+.+.+|++++++++||||+++++++.++ ..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhe
Confidence 478889999999999999964 22 347899988643 344567889999999999999999999999764 6789
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
||||++++++.+.+......++...++.++.|++.||.||| +++++||||||+||+++.++.+|++|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 99999999999888776666999999999999999999999 999999999999999999999999999999987554
Q ss_pred ccc-ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhhhhhhcCCCcccccccc
Q 039392 154 DIS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 231 (285)
Q Consensus 154 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+.. .......
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~-~~i~~~~------------ 231 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-HKIDKEG------------ 231 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHTSC------------
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH-HHHHhCC------------
Confidence 322 22334557788999999999999999999999999999998 89998754332221 1111110
Q ss_pred ccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHH
Q 039392 232 LLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKI 278 (285)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l 278 (285)
.++..+..+++++.+++.+||..||++|||++++++.|+++
T Consensus 232 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112345667899999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=348.11 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=198.2
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccC-CCCccccccceecc-CCce
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSI-HHRNIIKVISSCSN-EEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~ 71 (285)
+|++++.||+|+||.||+|... +++.||+|++.... ....+.+.+|...+.++ +|+||+.+++++.. ...+
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 3778899999999999999742 35689999987543 33345667777777666 68999999998755 4568
Q ss_pred EEEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 039392 72 ALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN 136 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~ 136 (285)
++||||+++|+|.+++.... ..+++..++.++.||+.||+||| +++++||||||+||+++.+
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCC
Confidence 99999999999999986432 23888999999999999999999 9999999999999999999
Q ss_pred CcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCC-CCCccccccchhhhhh
Q 039392 137 MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRK-KPTDEIFNGEMTLKHW 215 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~ 215 (285)
+.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++|. .||......+......
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~ 250 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998765544344445567899999999999999999999999999999999875 5666543333222211
Q ss_pred hhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 216 VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.... . +..+..+++++.+++.+||+.||.+|||++|++++|+++.++
T Consensus 251 ~~~~-~------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 251 KEGT-R------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHTC-C------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCC-C------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111 0 111234567799999999999999999999999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-53 Score=348.65 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=208.9
Q ss_pred CCCCCceecccCceEEEEEEeC------CCcEEEEEEeeccch-hHHHHHHHHHHHHccCCCCccccccceeccCCceEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 73 (285)
+|++++.||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++...+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 4788999999999999999742 457899999875443 345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 039392 74 VLEYMPHGSLEKYLHSSN-----------------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSN 130 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~n 130 (285)
+||++++++|.+++.... ..++...++.++.|++.||+||| +.+++||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccc
Confidence 999999999999885421 23788899999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCC-CCccccccc
Q 039392 131 VLLDDNMVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK-PTDEIFNGE 209 (285)
Q Consensus 131 ili~~~~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~-p~~~~~~~~ 209 (285)
|+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++|.. ||......+
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 9999999999999999987665544444455678889999999999999999999999999999999865 565533222
Q ss_pred hhhhhhhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHH
Q 039392 210 MTLKHWVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIR 279 (285)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~ 279 (285)
. ......... ...+..+++++.+++.+||+.||++|||+.|++++|+++.
T Consensus 251 ~-~~~v~~~~~-------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 V-IYYVRDGNI-------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp H-HHHHHTTCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred H-HHHHHcCCC-------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2 121111100 0113456678999999999999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=351.35 Aligned_cols=246 Identities=23% Similarity=0.321 Sum_probs=202.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc---hhHHHHHHHHHHHH-ccCCCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY---GRVFKSFDVECEMM-KSIHHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+..|..++ +.++||||+++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 688999999999999999975 479999999997532 23344555666655 4689999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
||+++|+|.+++..... +++..++.++.||+.||+||| ++|++||||||+|||+++++.+||+|||++.......
T Consensus 83 Ey~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred eecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 99999999999976654 899999999999999999999 9999999999999999999999999999998655432
Q ss_pred cceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCc
Q 039392 156 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 235 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+. ........+
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~--------------- 220 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMDNP--------------- 220 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC---------------
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCC---------------
Confidence 223446789999999999999999999999999999999999999976433221 111111100
Q ss_pred ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHH-HHHH
Q 039392 236 EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAK-EIVT 273 (285)
Q Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-eil~ 273 (285)
..+..+++++.+||++||..||.+|||++ ++++
T Consensus 221 -----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01234567799999999999999999995 6764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=347.99 Aligned_cols=250 Identities=20% Similarity=0.259 Sum_probs=198.3
Q ss_pred CCCCCc-eecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHc-cCCCCccccccceecc----CCceEE
Q 039392 1 GFSENN-LIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMK-SIHHRNIIKVISSCSN----EEFKAL 73 (285)
Q Consensus 1 ~y~~~~-~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~~~ 73 (285)
+|.+.. .||+|+||+||+|.+ .+++.||||+++.. ..+.+|++++. ..+||||+++++++.+ ...+|+
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 477664 699999999999975 57999999998643 34567888865 4589999999999864 467899
Q ss_pred EEeccCCCCHHHhhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCcEEEeeecccee
Q 039392 74 VLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKL 149 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~i~df~~~~~ 149 (285)
|||||+||+|.+++.+. ...+++..++.++.||+.||+||| ++|++||||||+||+++. .+.+||+|||++..
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeee
Confidence 99999999999999764 345999999999999999999999 999999999999999975 56799999999987
Q ss_pred cCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+......... . ..
T Consensus 164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-~------------~~ 227 (335)
T d2ozaa1 164 TTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-M------------KT 227 (335)
T ss_dssp CCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------------
T ss_pred ccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-H------------HH
Confidence 66532 22456789999999999999999999999999999999999999976432211100 0 00
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
................+++++.+||++||+.||++|||++|++++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000111111112234678889999999999999999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=345.61 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=198.2
Q ss_pred CCceecccCceEEEEEEe-CCCcEEEEEEeeccchh-----HHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 4 ENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGR-----VFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 4 ~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
.+++||+|+||+||+|.. .+|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 467999999999999985 57999999998654321 234578999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+.++++..+.. ....+++..+..++.||+.||+||| ++|++||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R 155 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence 98876665554 3445888999999999999999999 9999999999999999999999999999998765432 2
Q ss_pred eeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc------
Q 039392 158 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP------ 230 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 230 (285)
......+|+.|+|||++... .++.++|||||||++|+|++|..||.+....+. .................+.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhccchhccchh
Confidence 22345689999999988654 679999999999999999999999976433221 2222221111111110000
Q ss_pred ccc-Ccccch-hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 NLL-SREDIH-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ~~~-~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
... ...... .......++++.+|+.+||+.||++|||++|+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 000000 01113457789999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=344.30 Aligned_cols=268 Identities=23% Similarity=0.251 Sum_probs=202.4
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch--hHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG--RVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
+|++++.||+|+||+||+|.. .+|+.||+|+++.... ...+.+.+|++++++++||||+++++++..+...|+|||+
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 689999999999999999975 5799999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+.++.+..........+++..++.++.||+.||.||| ++|++||||||+||+++.++.+||+|||.+....... .
T Consensus 83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~ 157 (298)
T d1gz8a_ 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--R 157 (298)
T ss_dssp CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--B
T ss_pred cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--c
Confidence 9764444343444555999999999999999999999 9999999999999999999999999999998765432 2
Q ss_pred eeccccccccccCCcccCCCc-cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc----c--
Q 039392 158 IQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD----P-- 230 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-- 230 (285)
......+++.|+|||.+.... ++.++||||+|+++|+|++|+.||.+....+. ...........+...... +
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhcccccccccc
Confidence 234457899999999876654 68999999999999999999999976433221 111111111111000000 0
Q ss_pred --cc-cCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 --NL-LSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 --~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ..............+.++.+|+++||..||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 000000011123556789999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-52 Score=340.59 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=208.3
Q ss_pred CceecccCceEEEEEEeCC----CcEEEEEEeecc-chhHHHHHHHHHHHHccCCCCccccccceecc-CCceEEEEecc
Q 039392 5 NNLIGRGGFGSVFKARLGD----GMEVAVKVFNLQ-YGRVFKSFDVECEMMKSIHHRNIIKVISSCSN-EEFKALVLEYM 78 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~----~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~ 78 (285)
.++||+|+||+||+|.... ...||||.++.. .....+.+.+|++++++++||||+++++++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999997532 236899998643 45556789999999999999999999999764 56789999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCccccc--
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIS-- 156 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~-- 156 (285)
++++|.+++.......+...++.++.|++.||.|+| +.+++||||||+||++++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999998877766888889999999999999999 999999999999999999999999999999876543222
Q ss_pred ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccccccCcc
Q 039392 157 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 236 (285)
Q Consensus 157 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
.......+|..|+|||.+....++.++||||||+++|||++|..||....+.............
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~---------------- 252 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---------------- 252 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC----------------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 2223356789999999999999999999999999999999988887654333222221111110
Q ss_pred cchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHHhc
Q 039392 237 DIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSLLR 284 (285)
Q Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~~~ 284 (285)
...+..+++++.+|+.+||..||.+|||++|++++|+.+++++.+
T Consensus 253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 011234567799999999999999999999999999999987654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=343.62 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=211.9
Q ss_pred CCCCceecccCceEEEEEEe------CCCcEEEEEEeeccch-hHHHHHHHHHHHHccC-CCCccccccceeccCCceEE
Q 039392 2 FSENNLIGRGGFGSVFKARL------GDGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~------~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 73 (285)
|++++.||+|+||.||+|.. .+++.||||.++.... .....+.+|+.++..+ +||||+++++++......++
T Consensus 25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l 104 (311)
T d1t46a_ 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence 55688999999999999963 3467899999976543 3445688999999998 69999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC-----------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 039392 74 VLEYMPHGSLEKYLHSSN-----------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN 136 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~ 136 (285)
||||+++++|.+++.... ..+++..+..++.||+.|++||| +++++||||||+||+++.+
T Consensus 105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETT
T ss_pred EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccccc
Confidence 999999999999986532 24888999999999999999999 9999999999999999999
Q ss_pred CcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhh
Q 039392 137 MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWV 216 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 216 (285)
+.++++|||.+................+|+.|+|||.+.+..++.++||||||+++|+|+++..|+....+.........
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i 261 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999999887665444445567789999999999999999999999999999999995555433333322222222
Q ss_pred hhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 217 NDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
..... ...+..++.++.+||.+||+.||.+|||++++++.|++...+.
T Consensus 262 ~~~~~------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 262 KEGFR------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp HHTCC------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hcCCC------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 21111 1112345677999999999999999999999999999876654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=342.01 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=204.7
Q ss_pred CCCCceecccCceEEEEEEeC--------CCcEEEEEEeeccch-hHHHHHHHHHHHHccC-CCCccccccceeccCCce
Q 039392 2 FSENNLIGRGGFGSVFKARLG--------DGMEVAVKVFNLQYG-RVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFK 71 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~--------~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 71 (285)
|++++.||+|+||.||+|+.. ++..||||++..+.. .....+.+|...+.++ +||||+++++++..++..
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 678899999999999999632 235799999876543 3446778888888877 799999999999999999
Q ss_pred EEEEeccCCCCHHHhhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 039392 72 ALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDN 136 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~ 136 (285)
++||||+++|+|.+++.... ..++...++.++.||+.||+||| +++++||||||+||+++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCC
Confidence 99999999999999986442 34899999999999999999999 9999999999999999999
Q ss_pred CcEEEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhh-CCCCCccccccchhhhhh
Q 039392 137 MVAHLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFT-RKKPTDEIFNGEMTLKHW 215 (285)
Q Consensus 137 ~~~~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 215 (285)
+.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+ ....+
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-~~~~i 250 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFKLL 250 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHH
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-HHHHH
Confidence 9999999999988766544444455678899999999999999999999999999999998 688876533221 11111
Q ss_pred hhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 216 VNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
... . .+..+..+++++.+||.+||+.||.+|||++|+++.|+++..
T Consensus 251 ~~~-~------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 251 KEG-H------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HTT-C------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcC-C------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111 0 011123456779999999999999999999999999998854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=341.41 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=203.0
Q ss_pred CCCCCceecccCceEEEEEEeC-CCc--EEEEEEeecc-chhHHHHHHHHHHHHccC-CCCccccccceeccCCceEEEE
Q 039392 1 GFSENNLIGRGGFGSVFKARLG-DGM--EVAVKVFNLQ-YGRVFKSFDVECEMMKSI-HHRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~--~~~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 75 (285)
+|++++.||+|+||+||+|.+. +|. .||||.+... .....+.+.+|+++++++ +||||+++++++...+.+++||
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 4778899999999999999753 454 4677876543 334556789999999998 6999999999999999999999
Q ss_pred eccCCCCHHHhhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEE
Q 039392 76 EYMPHGSLEKYLHSS---------------NYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH 140 (285)
Q Consensus 76 e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~ 140 (285)
||+++|+|.+++... ...++...++.++.||+.|+.||| +++++||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceE
Confidence 999999999998643 245899999999999999999999 99999999999999999999999
Q ss_pred EeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCC-CCccccccchhhhhhhhhh
Q 039392 141 LSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKK-PTDEIFNGEMTLKHWVNDW 219 (285)
Q Consensus 141 i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~ 219 (285)
|+|||++....... ......+|..|+|||.+.+..++.++||||||+++|+|++|.. ||.+....+ ........
T Consensus 168 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-~~~~i~~~- 242 (309)
T d1fvra_ 168 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQG- 242 (309)
T ss_dssp ECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHGGGT-
T ss_pred Eccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-HHHHHHhc-
Confidence 99999998655432 1234457889999999999999999999999999999999765 565432222 11111110
Q ss_pred cCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 220 LPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.+...+..+++++.+||.+||+.||++|||++++++.|+++.++
T Consensus 243 ------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 243 ------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 01112345677899999999999999999999999999998764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-52 Score=338.56 Aligned_cols=267 Identities=21% Similarity=0.259 Sum_probs=202.0
Q ss_pred CCCCCceecccCceEEEEEEeCCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
.|+++++||+|+||+||+|++.+|+.||||++.... ....+.+.+|+.++++++||||+++++.+...+..+++++++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 488899999999999999998889999999986543 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccce
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDISTI 158 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~~ 158 (285)
.++.+..+. .....+++..++.++.||+.||+||| +.+++||||||+||+++.++.+|++|||.+....... ..
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 156 (286)
T d1ob3a_ 83 DQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RK 156 (286)
T ss_dssp SEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred hhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--cc
Confidence 775555554 44455999999999999999999999 9999999999999999999999999999998765432 12
Q ss_pred eccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc-------
Q 039392 159 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP------- 230 (285)
Q Consensus 159 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 230 (285)
.....+++.|.|||.+.+. .++.++||||||+++++|++|+.||.+....+. ...................
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhcc
Confidence 2344578899999988755 579999999999999999999999976433222 1211111111111111000
Q ss_pred -cccCcccc-hhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 -NLLSREDI-HFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 -~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
........ ........++++.+|+++||..||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 011123456789999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=335.40 Aligned_cols=273 Identities=23% Similarity=0.315 Sum_probs=199.4
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceeccCC----ceEEEEec
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE----FKALVLEY 77 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~ 77 (285)
|.+.+.||+|+||.||+|+. +|+.||||+++..... ......|+..+.+++||||+++++++...+ .+++||||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 45678999999999999986 5889999998654322 122234555556789999999999986543 57899999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFG-----YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+++|+|.+++.+.. ++...++.++.|++.|++|+|.. ++.|++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 83 HEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 99999999997653 88999999999999999999932 136999999999999999999999999999987644
Q ss_pred cccc--ceeccccccccccCCcccCCCc------cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCc
Q 039392 153 EDIS--TIQTQTLATIGYMAPEYGKEGR------VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIST 224 (285)
Q Consensus 153 ~~~~--~~~~~~~~~~~~~~PE~~~~~~------~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
.... .......+|+.|+|||.+.+.. ++.++||||||+++|+|+||..||......+.......... ...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~--~~~ 238 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSV 238 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS--CCH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc--chH
Confidence 3221 1233467899999999877543 67889999999999999999988754332222111110000 000
Q ss_pred cc----cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 225 KE----IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 225 ~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
.. .......+ ..........+...+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus 239 ~~~~~~~~~~~~~p-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQKLRP-NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCC-CCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccccCC-CCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00 00000100 0011112334567799999999999999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=337.14 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=199.9
Q ss_pred CCCCCceecccCceEEEEEEe-CC-CcEEEEEEeeccch--hHHHHHHHHHHHHccC---CCCccccccceec-----cC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GD-GMEVAVKVFNLQYG--RVFKSFDVECEMMKSI---HHRNIIKVISSCS-----NE 68 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~-~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~ 68 (285)
.|++++.||+|+||+||+|.+ .+ ++.||||++..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 488999999999999999985 34 67799999865432 2223455677776665 7999999999884 34
Q ss_pred CceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 69 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 69 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
...++++|++.++.+..........+++..++.++.|++.||+||| +++++||||||+|||++..+.+||+|||++.
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 5788999999887666555555556999999999999999999999 9999999999999999999999999999987
Q ss_pred ecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc
Q 039392 149 LLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228 (285)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....+ ................+.
T Consensus 165 ~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGGSC
T ss_pred hhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCchhccc
Confidence 655432 2345678999999999999999999999999999999999999997643322 222222111111111000
Q ss_pred cc------cccCc-ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DP------NLLSR-EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. ..... ...........++++.+|+++||..||++|||++|+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000 000111123457789999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=338.52 Aligned_cols=239 Identities=22% Similarity=0.302 Sum_probs=195.3
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccch------hHHHHHHHHHHHHccCC--CCccccccceeccCCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYG------RVFKSFDVECEMMKSIH--HRNIIKVISSCSNEEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 71 (285)
.|++++.||+|+||+||+|.. .+|+.||||++..... .....+.+|+.++++++ ||||+++++++...+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 388999999999999999975 5799999999864321 11233567999999886 89999999999999999
Q ss_pred EEEEeccCC-CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCcEEEeeecccee
Q 039392 72 ALVLEYMPH-GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKL 149 (285)
Q Consensus 72 ~~v~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~i~df~~~~~ 149 (285)
++|||++.+ +++.+++.... .+++..++.++.||+.||+||| ++|++||||||+||+++. ++.+||+|||++..
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccccee
Confidence 999999975 57777776554 4999999999999999999999 999999999999999984 57999999999987
Q ss_pred cCcccccceeccccccccccCCcccCCCc-cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc
Q 039392 150 LTREDISTIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 228 (285)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......
T Consensus 161 ~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i~~~~~-------- 221 (273)
T d1xwsa_ 161 LKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQV-------- 221 (273)
T ss_dssp CCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCCC--------
T ss_pred cccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------Hhhccc--------
Confidence 6543 223457899999999987665 46789999999999999999999965211 000000
Q ss_pred cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..+..+++++.+||++||..||++|||++|++++
T Consensus 222 ------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 ------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0122356779999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=337.27 Aligned_cols=256 Identities=22% Similarity=0.400 Sum_probs=208.0
Q ss_pred CCCCceecccCceEEEEEEeC------CCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARLG------DGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 74 (285)
|++++.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 101 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 101 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence 567889999999999999642 35789999987543 34446688999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCC---------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeec
Q 039392 75 LEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 145 (285)
Q Consensus 75 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~ 145 (285)
||++++|+|.+++.... ..++...+..++.|++.||.||| +++++||||||+||+++.++.+||+|||
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeecc
Confidence 99999999999875421 23688889999999999999999 9999999999999999999999999999
Q ss_pred cceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCC-CCCccccccchhhhhhhhhhcCCCc
Q 039392 146 IAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRK-KPTDEIFNGEMTLKHWVNDWLPIST 224 (285)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
++................+++.|+|||.+.+..++.++||||||+++|+|++|. .||.+....+ .........
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-~~~~i~~~~----- 252 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFVMEGG----- 252 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-HHHHHHTTC-----
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhCC-----
Confidence 998776544344444556889999999999999999999999999999999985 6665432222 122111100
Q ss_pred cccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHH
Q 039392 225 KEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRD 280 (285)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~ 280 (285)
....+..++.++.+++.+||+.||.+|||+++++++|++..+
T Consensus 253 --------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 --------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 011133466779999999999999999999999999987643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=326.24 Aligned_cols=268 Identities=21% Similarity=0.241 Sum_probs=209.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccCCceEEEEec
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEEFKALVLEY 77 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 77 (285)
.|++++.||+|+||+||+|++ .+++.||||+++... ......+.+|+.+++.++||||+++++++......++++++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 378999999999999999985 578999999986543 34567888999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccccc
Q 039392 78 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDIST 157 (285)
Q Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~~~ 157 (285)
+.++++..++.... .+++..++.++.|++.||+||| ++|++||||||+||+++.++.+||+|||.+....... .
T Consensus 83 ~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~ 156 (292)
T d1unla_ 83 CDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--R 156 (292)
T ss_dssp CSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--S
T ss_pred cccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC--c
Confidence 99988887775544 4899999999999999999999 9999999999999999999999999999998776532 2
Q ss_pred eeccccccccccCCcccCCCc-cCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccccc------
Q 039392 158 IQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP------ 230 (285)
Q Consensus 158 ~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 230 (285)
......++..|.|||.+.+.. ++.++||||+||++++|++|..||....+.......................
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 223445678899999887664 6999999999999999999999986544433333333222222111110000
Q ss_pred ---cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 231 ---NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 231 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
................++++.+|+++||+.||.+|||++|+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111111122234557789999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=331.98 Aligned_cols=267 Identities=21% Similarity=0.225 Sum_probs=196.9
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc-hhHHHHHHHHHHHHccCCCCccccccceeccCC----ceEEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY-GRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE----FKALVL 75 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~ 75 (285)
|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|+.++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 78899999999999999975 589999999987543 344567889999999999999999999986543 234455
Q ss_pred eccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcccc
Q 039392 76 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~~~ 155 (285)
+++.+++|.+++.... +++..++.++.||+.||+||| ++|++||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 90 THLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 5666889999997643 899999999999999999999 99999999999999999999999999999987655432
Q ss_pred cc-eeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCccccc-----
Q 039392 156 ST-IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV----- 228 (285)
Q Consensus 156 ~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 228 (285)
.. ......+++.|+|||++.. ..++.++||||+|+++++|++|..||............ .............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI-LGILGSPSQEDLNCIINL 243 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCSCCHHHHHTCCCH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH-hhhccCCChhhhhhhhhh
Confidence 22 2244668999999998754 56799999999999999999999999764332221111 1111111000000
Q ss_pred ------cccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 229 ------DPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 229 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
..................++++.+|+.+||..||.+|||++|+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000112446679999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=328.01 Aligned_cols=269 Identities=22% Similarity=0.306 Sum_probs=196.7
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceecc--------CC
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSN--------EE 69 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~ 69 (285)
.|++++.||+|+||+||+|.+ .+|+.||||++.... ......+.+|+++++.++|||++++++++.. ..
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 478899999999999999985 579999999986442 2334667899999999999999999998744 34
Q ss_pred ceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 70 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 70 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
..+++||++.++.+. ........+++..++.++.|++.||.||| ++|++||||||+||+++.++.++++|||++..
T Consensus 91 ~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 91 SIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 688999999775554 44455555999999999999999999999 99999999999999999999999999999987
Q ss_pred cCccccc--ceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcc-
Q 039392 150 LTREDIS--TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK- 225 (285)
Q Consensus 150 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 225 (285)
....... .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+..... ...............
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCCChhh
Confidence 6543322 222345689999999988765 68999999999999999999999997533222 111111111111100
Q ss_pred --cc-----cc----ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 226 --EI-----VD----PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 226 --~~-----~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
.. .. .................++++.+||.+||..||++|||++|+|++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 00 000000011111122346778899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=329.22 Aligned_cols=261 Identities=24% Similarity=0.287 Sum_probs=194.3
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeecc--chhHHHHHHHHHHHHccCCCCccccccceeccCC------ceE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQ--YGRVFKSFDVECEMMKSIHHRNIIKVISSCSNEE------FKA 72 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~ 72 (285)
|+++++||+|+||+||+|.+ .+|+.||||++... .....+.+.+|+++|++++||||+++++++...+ .++
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 77889999999999999975 57999999998743 2344567889999999999999999999987654 568
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+|||++ +.+|..++... .+++..++.++.||+.||+||| ++|++||||||+||+++.++.++++|||++.....
T Consensus 100 lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCC
Confidence 999999 56788877554 3999999999999999999999 99999999999999999999999999999987654
Q ss_pred ccccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc----
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI---- 227 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 227 (285)
. .....+++.|+|||.+.+. .++.++||||+||++|+|++|..||.+..... ............+....
T Consensus 174 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 174 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHHHHhhhc
Confidence 3 2445789999999988764 57999999999999999999999997643221 11111111111100000
Q ss_pred ------ccccccCcccch-hhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 ------VDPNLLSREDIH-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 ------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
............ ......+++++.+||.+||..||++|||++|+|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 00123456788999999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-49 Score=327.19 Aligned_cols=261 Identities=21% Similarity=0.272 Sum_probs=198.2
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceecc--CCceEEEEe
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSN--EEFKALVLE 76 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e 76 (285)
+|+++++||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++|+.++ ||||+++++++.. ...+++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 478899999999999999985 579999999987543 356778999999996 9999999999864 457899999
Q ss_pred ccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-cEEEeeeccceecCcccc
Q 039392 77 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDI 155 (285)
Q Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~i~df~~~~~~~~~~~ 155 (285)
++.+++|..+.. .+++..++.++.||+.||+||| ++|++||||||+|||++.++ .++|+|||++.......
T Consensus 113 ~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 113 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp CCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred ecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999999877642 3899999999999999999999 99999999999999998654 69999999998765432
Q ss_pred cceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhh-----------hcCCC
Q 039392 156 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVND-----------WLPIS 223 (285)
Q Consensus 156 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~ 223 (285)
......+|+.|+|||.+.+. .++.++||||+||++++|++|..||................ .....
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 23455688999999987765 57999999999999999999999997643322111111000 00000
Q ss_pred c----cccccc--cccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 T----KEIVDP--NLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 ~----~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
. ...... ...............+++++.+||++||..||.+|||++|+|++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000 00000111112234567889999999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.4e-49 Score=321.45 Aligned_cols=261 Identities=15% Similarity=0.139 Sum_probs=210.0
Q ss_pred CCCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCC-CccccccceeccCCceEEEEecc
Q 039392 1 GFSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHH-RNIIKVISSCSNEEFKALVLEYM 78 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~ 78 (285)
+|++++.||+|+||+||+|++ .+|+.||||+++.... ...+.+|++.++.++| ++++.+++++......++|||++
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 488999999999999999985 4789999999865432 2456778888888875 89999999999999999999999
Q ss_pred CCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCcEEEeeeccceecCcc
Q 039392 79 PHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~-----~~~~~i~df~~~~~~~~~ 153 (285)
+++|.+++......++...+..++.|++.||+||| +.|++||||||+||+++. ++.++|+|||+++.....
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 67999998877777999999999999999999999 999999999999999964 678999999999876542
Q ss_pred ccc-----ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhh--hhhhhhhcCCCccc
Q 039392 154 DIS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTL--KHWVNDWLPISTKE 226 (285)
Q Consensus 154 ~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~ 226 (285)
... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+........ ............
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-- 237 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-- 237 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH--
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh--
Confidence 211 12334568999999999999999999999999999999999999997644332211 111110000000
Q ss_pred cccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHHH
Q 039392 227 IVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDSL 282 (285)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~~ 282 (285)
......+|+++.+++..|+..+|++||+++.+.+.|+++.++.
T Consensus 238 -------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 238 -------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0012346778999999999999999999999999998887654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=330.39 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=203.0
Q ss_pred CCCCCceecccCceEEEEEEe----CCCcEEEEEEeeccc----hhHHHHHHHHHHHHccCCC-CccccccceeccCCce
Q 039392 1 GFSENNLIGRGGFGSVFKARL----GDGMEVAVKVFNLQY----GRVFKSFDVECEMMKSIHH-RNIIKVISSCSNEEFK 71 (285)
Q Consensus 1 ~y~~~~~lg~G~~~~v~~~~~----~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 71 (285)
+|++++.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++......
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 488899999999999999963 258899999986432 2334567789999999976 8999999999999999
Q ss_pred EEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecC
Q 039392 72 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 151 (285)
Q Consensus 72 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~ 151 (285)
+++||++.+++|.+++..... .++..++.++.||+.||.|+| +.+++||||||+||+++.+|.++|+|||++....
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999999877655 788899999999999999999 9999999999999999999999999999998775
Q ss_pred cccccceeccccccccccCCcccCCC--ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccccc
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 229 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
..... ......+++.|++||.+.+. .++.++|||||||++|+|++|..||....................
T Consensus 181 ~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~------- 252 (322)
T d1vzoa_ 181 ADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------- 252 (322)
T ss_dssp GGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------
T ss_pred ccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-------
Confidence 54322 23446788999999988755 478899999999999999999999977544333222111111110
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCC-----HHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK 274 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~eil~~ 274 (285)
...+..+++++.+|+.+||..||.+||| ++|++++
T Consensus 253 ----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0012346778999999999999999994 8898863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=328.93 Aligned_cols=263 Identities=22% Similarity=0.206 Sum_probs=190.8
Q ss_pred CCCCceecccCceEEEEEEeC-CCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceec------cCCceE
Q 039392 2 FSENNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCS------NEEFKA 72 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~ 72 (285)
|+++++||+|+||+||+|.+. +|+.||||++.... ......+.+|+.++++++||||+++++++. ....+|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 778899999999999999864 69999999997543 344567889999999999999999999985 346889
Q ss_pred EEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCc
Q 039392 73 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 152 (285)
Q Consensus 73 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~ 152 (285)
+||||+.++.+ +.+. ..+++..++.++.||+.||.||| +.|++||||||+||+++.++.++++|||++.....
T Consensus 99 iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 99 LVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcccc
Confidence 99999977544 4442 23889999999999999999999 99999999999999999999999999999876654
Q ss_pred ccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhh------------------
Q 039392 153 EDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKH------------------ 214 (285)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~------------------ 214 (285)
.. ......+|+.|+|||++.+..++.++||||+||++++|++|+.||.+..........
T Consensus 172 ~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 172 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 32 234456889999999999999999999999999999999999999754322111100
Q ss_pred ---hhhhhcCCCccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 215 ---WVNDWLPISTKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
................................++++.+|+++||..||++|||++|+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 001100000000000000011111222345568889999999999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=328.45 Aligned_cols=261 Identities=25% Similarity=0.319 Sum_probs=193.2
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCccccccceecc------CCceEEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIKVISSCSN------EEFKALV 74 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~~v 74 (285)
|+..++||+|+||+||+|+. .+|+.||||++..... ...+|++++++++|+||+++++++.. ...+++|
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 77889999999999999986 4799999999875432 23469999999999999999998843 3457899
Q ss_pred EeccCCCCHHHhhh--cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-cEEEeeeccceecC
Q 039392 75 LEYMPHGSLEKYLH--SSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLT 151 (285)
Q Consensus 75 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~i~df~~~~~~~ 151 (285)
|||++++.+..+.. .....+++..++.++.||+.||+||| ++|++||||||+|||++.++ .+||+|||++....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99997653333321 23445999999999999999999999 99999999999999999765 89999999998765
Q ss_pred cccccceeccccccccccCCcccCC-CccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCC-------
Q 039392 152 REDISTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPIS------- 223 (285)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 223 (285)
... ......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||......+. ............
T Consensus 175 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 175 RGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp TTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHH
T ss_pred CCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhhh
Confidence 432 2234578899999998765 4789999999999999999999999976433221 111111111000
Q ss_pred ---ccccccccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 224 ---TKEIVDPNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
......+.. .............++++.+|+.+||..||++|||++|+|++
T Consensus 251 ~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQI-KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCC-CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhcccccc-ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 00111111123467789999999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-49 Score=322.43 Aligned_cols=259 Identities=19% Similarity=0.205 Sum_probs=201.6
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcccc-ccceeccCCceEEEEeccC
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNIIK-VISSCSNEEFKALVLEYMP 79 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~v~e~~~ 79 (285)
|++++.||+|+||+||+|.+ .+|+.||||++...... +.+..|+++++.++|++++. +..++...+..++|||++
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 88999999999999999975 57899999998754332 45778999999998776555 455567788888999999
Q ss_pred CCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCcEEEeeeccceecCccccc
Q 039392 80 HGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDIS 156 (285)
Q Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~i~df~~~~~~~~~~~~ 156 (285)
++++.+.+......++...+..++.|++.||+||| ++|++||||||+||+++. +..++++|||++.........
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 55787777666667999999999999999999999 999999999999999864 457999999999876543211
Q ss_pred -----ceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhh--hhhhhcCCCcccccc
Q 039392 157 -----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKH--WVNDWLPISTKEIVD 229 (285)
Q Consensus 157 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 229 (285)
.......+|+.|+|||.+.+..++.++|||||||++|+|++|..||............ ........
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~------- 235 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST------- 235 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-------
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-------
Confidence 2223457899999999999999999999999999999999999999764333221111 00000000
Q ss_pred ccccCcccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHHHHHHHHH
Q 039392 230 PNLLSREDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLVKIRDS 281 (285)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~l~~l~~~ 281 (285)
........+|+++.+++.+||..+|++||+++++.+.|+++..+
T Consensus 236 --------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 --------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp --------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 00011235678899999999999999999999999999887654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=324.43 Aligned_cols=262 Identities=21% Similarity=0.256 Sum_probs=195.3
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccc--hhHHHHHHHHHHHHccCCCCccccccceeccC-----CceEE
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQY--GRVFKSFDVECEMMKSIHHRNIIKVISSCSNE-----EFKAL 73 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~ 73 (285)
|+++++||+|+||+||+|++ .+|+.||||++.... ....+.+.+|+++++.++|||++++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 78899999999999999975 579999999987543 33446688999999999999999999998532 34466
Q ss_pred EEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEeeeccceecCcc
Q 039392 74 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 153 (285)
Q Consensus 74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~df~~~~~~~~~ 153 (285)
+++++.+++|.+++... .+++..++.++.||+.||+||| ++|++||||||+||+++.+|.++++|||++......
T Consensus 100 i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp EEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred EEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCcc
Confidence 67777799999998654 3999999999999999999999 999999999999999999999999999999765443
Q ss_pred cccceeccccccccccCCcccCCC-ccCcchhhHHHHHHHHHHhhCCCCCccccccchhhhhhhhhhcCCCcccc-----
Q 039392 154 DISTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLIETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI----- 227 (285)
Q Consensus 154 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 227 (285)
.....+++.|+|||...+. .++.++|||||||++|+|++|..||.+........ ..............
T Consensus 175 -----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 175 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK-LILRLVGTPGAELLKKISS 248 (348)
T ss_dssp -----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCHHHHTTCCC
T ss_pred -----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcCCCChHHhhhccc
Confidence 2345688899999986665 56899999999999999999999997643222111 11111111100000
Q ss_pred -----ccccccCcccchh-hhhhHhHHHHHHhhhcccccCcCCCCCHHHHHHH
Q 039392 228 -----VDPNLLSREDIHF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 274 (285)
Q Consensus 228 -----~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~~ 274 (285)
............+ .....+++++.+||++||..||.+|||++|+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000000 1123567889999999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-43 Score=293.88 Aligned_cols=265 Identities=16% Similarity=0.198 Sum_probs=186.7
Q ss_pred CCCCceecccCceEEEEEEe-CCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-----------CCccccccceecc--
Q 039392 2 FSENNLIGRGGFGSVFKARL-GDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-----------HRNIIKVISSCSN-- 67 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~-- 67 (285)
|+++++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 88999999999999999985 579999999997543 33456778888888775 4788888888754
Q ss_pred CCceEEEEeccCCCC-HHH-hhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC------cE
Q 039392 68 EEFKALVLEYMPHGS-LEK-YLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNM------VA 139 (285)
Q Consensus 68 ~~~~~~v~e~~~~~~-L~~-~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~------~~ 139 (285)
....++++.++..+. ... ........+++..++.++.|++.|+.|||+ ..|++||||||+||+++.++ .+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 345556666654333 222 223344458999999999999999999992 38999999999999998655 49
Q ss_pred EEeeeccceecCcccccceeccccccccccCCcccCCCccCcchhhHHHHHHHHHHhhCCCCCccccccc-----hhhhh
Q 039392 140 HLSDFGIAKLLTREDISTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLIETFTRKKPTDEIFNGE-----MTLKH 214 (285)
Q Consensus 140 ~i~df~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~ 214 (285)
+++|||.+...... .....+++.|+|||.+.+..++.++|+||+||++++|++|+.||....... .....
T Consensus 172 kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999865432 244568999999999999999999999999999999999999997532211 01111
Q ss_pred hhhhhcCCCc---------cccc-------cccccCc------ccchhhhhhHhHHHHHHhhhcccccCcCCCCCHHHHH
Q 039392 215 WVNDWLPIST---------KEIV-------DPNLLSR------EDIHFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 272 (285)
Q Consensus 215 ~~~~~~~~~~---------~~~~-------~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil 272 (285)
........+. .... ....... ...........++++.+|+.+||..||.+|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1111000000 0000 0000000 0011122356788999999999999999999999998
Q ss_pred HH
Q 039392 273 TK 274 (285)
Q Consensus 273 ~~ 274 (285)
++
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 74
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.3e-26 Score=175.27 Aligned_cols=163 Identities=16% Similarity=0.144 Sum_probs=119.0
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccch------------------hHHHHHHHHHHHHccCCCCccccccc
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYG------------------RVFKSFDVECEMMKSIHHRNIIKVIS 63 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 63 (285)
+.++++||+|+||+||+|...+|+.||||++..... .......+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 457899999999999999988899999998753211 11233456888999999999888776
Q ss_pred eeccCCceEEEEeccCCCCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCcEEEee
Q 039392 64 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD 143 (285)
Q Consensus 64 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~i~d 143 (285)
... .+++||++++..+.. ++...+..++.|++.++.+|| ++|++|+||||+||++++++ ++++|
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liD 145 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIID 145 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEE
Confidence 532 369999998765533 333345678999999999999 99999999999999998655 88999
Q ss_pred eccceecCcccccceeccccccccccCCc-----ccCCCccCcchhhHHHHH
Q 039392 144 FGIAKLLTREDISTIQTQTLATIGYMAPE-----YGKEGRVSANGDVYSFGI 190 (285)
Q Consensus 144 f~~~~~~~~~~~~~~~~~~~~~~~~~~PE-----~~~~~~~~~~~Di~slG~ 190 (285)
||.+.....+.... |+... ......++..+|+||+.-
T Consensus 146 FG~a~~~~~~~~~~----------~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 146 FPQSVEVGEEGWRE----------ILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CTTCEETTSTTHHH----------HHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred CCCcccCCCCCcHH----------HHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 99997665332111 11110 011345788899999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.91 E-value=2.5e-09 Score=83.85 Aligned_cols=140 Identities=16% Similarity=0.131 Sum_probs=93.9
Q ss_pred CCCCceecccCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEEeccCC
Q 039392 2 FSENNLIGRGGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVLEYMPH 80 (285)
Q Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~ 80 (285)
|++.+..+.++.+.||+... ++..+++|............+.+|...++.+. +-.+.+++.+...++..++||++++|
T Consensus 16 ~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G 94 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred eEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccc
Confidence 44444444555678999865 46668889876555444445667888877664 33356778888888889999999999
Q ss_pred CCHHHhhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 039392 81 GSLEKYLHSSNYILDIYQRLNIMIDVASTLEYLHFGY------------------------------------------- 117 (285)
Q Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~------------------------------------------- 117 (285)
.++.+...... . ...++.++...+..||...
T Consensus 95 ~~~~~~~~~~~---~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T d1j7la_ 95 VLCSEEYEDEQ---S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp EEHHHHTTTCS---C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred ccccccccccc---c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence 88765442211 1 1223445555555555311
Q ss_pred -------------CCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 118 -------------SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 118 -------------~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
...++|+|+.|.||+++.++.+-++||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987777799998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.50 E-value=2.5e-07 Score=71.74 Aligned_cols=129 Identities=16% Similarity=0.070 Sum_probs=83.0
Q ss_pred ecccC-ceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCC--CccccccceeccCCceEEEEeccCCCCHH
Q 039392 8 IGRGG-FGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHH--RNIIKVISSCSNEEFKALVLEYMPHGSLE 84 (285)
Q Consensus 8 lg~G~-~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 84 (285)
+..|. .+.||+....++..+++|....... ..+..|...++.+.. -.+.+++.+...++..+++|++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34444 4688999887888899998665432 345567777766642 23566777778888899999999886553
Q ss_pred HhhhcCCCccCHHHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 039392 85 KYLHSSNYILDIYQRLNIMIDVASTLEYLHFG------------------------------------------------ 116 (285)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~------------------------------------------------ 116 (285)
+.. .... ..+.++...+..||..
T Consensus 95 ~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 95 SSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp TSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred ccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 211 1111 0112223333333310
Q ss_pred -------CCCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 117 -------YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 117 -------~~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
....++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 02247999999999999987777899998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.18 E-value=4e-06 Score=69.11 Aligned_cols=76 Identities=18% Similarity=0.165 Sum_probs=46.8
Q ss_pred CceecccCceEEEEEEeC-CCcEEEEEEeeccc-------hhHHHHHHHHHHHHccCC-C-C-ccccccceeccCCceEE
Q 039392 5 NNLIGRGGFGSVFKARLG-DGMEVAVKVFNLQY-------GRVFKSFDVECEMMKSIH-H-R-NIIKVISSCSNEEFKAL 73 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-------~~~~~~~~~e~~~l~~l~-h-~-~i~~~~~~~~~~~~~~~ 73 (285)
.+.||.|....||++... +++.+++|...+.. +....+...|++.|+.+. + | .+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999754 46789999754321 112334556888777663 2 2 34444443 3344568
Q ss_pred EEeccCCCC
Q 039392 74 VLEYMPHGS 82 (285)
Q Consensus 74 v~e~~~~~~ 82 (285)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.66 E-value=0.00021 Score=56.86 Aligned_cols=136 Identities=13% Similarity=0.122 Sum_probs=76.7
Q ss_pred cCceEEEEEEeCCCcEEEEEEeeccchhHHHHHHHHHHHHccCCCCcc--ccccc-----eeccCCceEEEEeccCCCCH
Q 039392 11 GGFGSVFKARLGDGMEVAVKVFNLQYGRVFKSFDVECEMMKSIHHRNI--IKVIS-----SCSNEEFKALVLEYMPHGSL 83 (285)
Q Consensus 11 G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~-----~~~~~~~~~~v~e~~~~~~L 83 (285)
+.-..||++...+|+.+|+|+..+... ..+.+..|...+..|...++ +.... .+...+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 334689999988899999999865422 23445667777766642222 11111 22345567788998876332
Q ss_pred H-----------Hhhhc-----------CCCccC----------------------HHHHHHHHHHHHHHHHHHh-cCCC
Q 039392 84 E-----------KYLHS-----------SNYILD----------------------IYQRLNIMIDVASTLEYLH-FGYS 118 (285)
Q Consensus 84 ~-----------~~~~~-----------~~~~~~----------------------~~~~~~~~~~l~~~l~~lh-~~~~ 118 (285)
. ..+.+ .....+ .......+.++...+...- ....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 11100 000011 1112233333444333331 1224
Q ss_pred CCeeecCCCCCCeeeCCCCcEEEeeecccee
Q 039392 119 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 149 (285)
Q Consensus 119 ~~~~h~di~~~nili~~~~~~~i~df~~~~~ 149 (285)
.+++|+|+.+.||+++. + ..++||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 57999999999999974 3 45789998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.62 E-value=9.1e-05 Score=60.80 Aligned_cols=73 Identities=19% Similarity=0.185 Sum_probs=48.6
Q ss_pred CceecccCceEEEEEEeCC--------CcEEEEEEeeccchhHHHHHHHHHHHHccCC-CCccccccceeccCCceEEEE
Q 039392 5 NNLIGRGGFGSVFKARLGD--------GMEVAVKVFNLQYGRVFKSFDVECEMMKSIH-HRNIIKVISSCSNEEFKALVL 75 (285)
Q Consensus 5 ~~~lg~G~~~~v~~~~~~~--------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 75 (285)
++.|+.|-.-.+|++...+ .+.+++++... .... ....+|..+++.+. +.-.+++++++.+ ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3567788889999987533 35688888753 2222 34557888888875 4334567777653 4889
Q ss_pred eccCCCCH
Q 039392 76 EYMPHGSL 83 (285)
Q Consensus 76 e~~~~~~L 83 (285)
++++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99877543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.51 E-value=9.1e-05 Score=58.76 Aligned_cols=31 Identities=39% Similarity=0.441 Sum_probs=28.1
Q ss_pred CCCeeecCCCCCCeeeCCCCcEEEeeeccce
Q 039392 118 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 148 (285)
Q Consensus 118 ~~~~~h~di~~~nili~~~~~~~i~df~~~~ 148 (285)
..|++|+|+.++|++++.+...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4689999999999999988888999999986
|